Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A4GALT "A14GALT, Gb3S, P(k), P1" ENSG00000128274 "Alpha 1,4-galactosyltransferase (P blood group)" Q9NPC4 22 42692112-42721298 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "NK-cell: 1.4;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 13 "dendritic cells: 3.4;NK-cells: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 21.9;ASC TERT1: 17.9;RPTEC TERT1: 14.8;TIME: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001141 Uncertain Mitochondria NA NA Mitochondria "HPA001141: AB_1078139" "unprognostic (2.59e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.24e-2)" "unprognostic (4.54e-3)" "unprognostic (7.41e-2)" "unprognostic (1.53e-1)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-1)" "unprognostic (1.28e-1)" "unprognostic (4.82e-3)" "unprognostic (4.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (8.72e-2)" "unprognostic (3.46e-2)" "unprognostic (2.74e-1)" 22.7 5.9 3.5 8.2 3.7 3.8 15.3 1.4 3.8 21.2 12.0 2.3 32.6 4.8 13.0 16.9 15.0 11.7 11.0 26.8 2.3 1.3 30.0 4.4 14.0 6.4 2.9 3.0 11.8 3.4 1.4 7.7 12.6 2.9 15.4 2.1 9.9 15.4 39.8 12.5 8.7 7.0 18.6 5.3 11.4 11.3 6.7 2.4 1.3 10.7 13.0 10.1 16.1 25.6 0.1 3.4 0.0 0.0 1.4 0.0 0.0 0.6 7.4 0.0 0.0 21.9 17.9 11.2 2.9 3.2 0.6 1.1 2.3 1.2 7.2 5.2 5.2 3.8 0.7 7.1 3.5 0.1 0.0 1.4 0.1 11.8 0.2 6.6 0.0 0.5 10.5 1.0 3.1 0.5 1.0 2.6 0.0 0.0 0.0 2.8 10.1 0.0 0.0 0.9 0.5 1.8 0.0 1.7 0.7 14.8 12.7 0.1 0.0 9.1 0.2 0.0 1.4 5.8 0.8 15.7 0.0 1.4 13.4 3.8 1.5 6.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 3.5 3.7 1.4 3.8 2.3 1.3 2.9 3.0 2.9 2.4 0.0 0.3 1.4 28.5 8.1 0.0 14.6 2.5 2.7 9.1 17.4 0.0 36.7 11.6 18.0 0.4 40.9 0.0 23.3 1.0 26.1 24.9 31.4 1.1 0.2 4.8 0.0 0.0 22.1 1.8 1.5 42.8 5.4 6.8 52.3 0.0 0.5 3.7 0.0 28.3 45.6 0.4 38.8 39.6 0.4 0.4 7.8 7.9 1.0 0.0 69.8 AARS2 "AARSL, bA444E17.1, KIAA1270" ENSG00000124608 "Alanyl-tRNA synthetase 2, mitochondrial" Q5JTZ9 6 44299654-44313326 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035636, HPA061396" Approved Enhanced Mitochondria NA NA Mitochondria "HPA035636: AB_10670837, HPA061396: AB_2684502" "unprognostic (1.56e-1)" "unprognostic (3.24e-2)" "unprognostic (2.58e-2)" "unprognostic (2.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.69e-1)" "unprognostic (8.83e-3)" "unprognostic (5.12e-2)" "unprognostic (3.64e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-1)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" 8.6 10.7 15.9 16.2 11.8 11.4 9.9 23.5 19.8 11.4 14.5 11.4 13.0 15.3 14.1 10.4 17.2 13.4 15.9 10.4 13.2 8.9 10.3 12.6 10.9 13.4 12.4 14.3 17.1 13.8 16.2 14.2 10.1 11.1 13.2 9.8 11.2 14.4 14.6 10.2 16.8 18.3 12.1 8.8 14.1 12.3 12.9 14.1 14.7 12.3 10.4 13.4 10.2 13.9 7.1 3.2 3.7 3.4 3.7 5.5 2.8 9.7 7.3 9.6 17.6 5.7 5.2 12.7 8.0 4.1 8.5 8.2 7.9 5.3 10.7 12.8 3.5 9.0 7.3 10.6 11.5 3.3 7.5 16.9 12.4 7.1 9.3 3.7 11.5 11.1 4.4 7.3 6.8 7.3 5.2 7.2 15.0 14.6 10.5 4.5 10.9 9.6 9.9 7.1 28.1 7.1 11.5 5.8 7.3 4.4 8.8 22.8 8.2 6.9 7.8 10.7 6.7 7.2 15.0 6.1 9.2 9.3 5.7 10.0 6.2 5.7 11.0 5.2 10.2 15.9 3.7 2.4 0.0 3.4 3.3 5.5 3.6 4.8 4.4 2.6 7.1 4.7 4.3 0.7 3.7 3.4 3.2 3.0 2.8 15.9 11.8 23.5 19.8 13.2 8.9 12.4 14.3 11.1 14.1 6.0 3.5 2.4 1.9 0.6 6.3 2.8 7.6 4.0 3.4 0.0 11.8 4.4 0.0 2.1 2.2 2.9 4.4 0.0 0.3 4.4 1.4 1.2 0.0 2.4 2.7 0.0 0.0 3.7 2.8 0.4 4.4 1.6 0.0 5.4 1.4 1.5 1.1 0.0 4.2 0.8 6.7 0.0 1.4 3.3 7.0 0.4 4.5 2.2 3.3 1.4 AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81117295-81166077 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;intestine: 28.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 23.6;Bipolar cells: 43.5;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.6" "Group enriched" "Detected in some" 6 "CACO-2: 30.3;SH-SY5Y: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.7 14.3 3.2 16.6 3.7 0.9 19.0 29.0 1.2 3.3 16.5 0.0 28.7 1.0 1.1 1.7 1.2 2.7 2.3 23.6 13.9 1.2 1.2 9.7 1.5 20.1 13.6 1.0 17.9 3.6 6.4 2.6 11.0 2.4 1.1 4.1 5.6 3.6 1.1 1.9 20.3 1.3 35.3 5.9 4.5 1.3 9.8 0.0 1.3 0.0 1.0 1.3 1.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 1.2 1.4 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.1 0.5 0.3 0.1 1.3 2.5 0.2 0.0 0.0 2.9 10.4 0.2 0.0 1.5 0.1 0.3 0.8 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 14.3 16.6 19.0 22.3 23.6 13.9 20.1 13.6 11.0 9.8 29.8 23.6 0.0 0.8 0.2 43.5 2.2 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 1.1 6.9 0.0 1.6 0.1 0.4 1.0 5.8 0.0 2.0 20.6 1.7 0.6 4.1 0.0 1.4 0.6 5.0 0.0 4.5 8.3 1.3 4.5 2.5 0.8 4.1 0.0 0.8 0.5 0.2 0.3 1.9 0.7 7.2 0.1 ABAT GABAT ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674565-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.3;liver: 136.5;pancreas: 54.2" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 234.8;Proximal tubular cells: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria No No 1500000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favorable (5.36e-5)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favorable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 2.1 12.6 26.1 2.7 39.3 1.7 3.2 19.9 43.3 2.2 5.2 10.9 0.1 17.5 2.1 5.0 3.0 2.8 2.7 6.2 20.4 30.9 53.3 136.5 2.8 2.8 24.5 26.1 5.3 54.2 4.0 22.1 2.3 14.3 9.9 4.2 2.6 2.6 2.5 1.4 2.1 8.4 2.1 14.1 2.5 3.9 6.3 11.8 1.0 12.7 0.4 3.3 6.4 1.1 2.2 1.9 8.8 5.8 1.6 2.5 1.8 0.2 0.0 12.1 6.9 1.9 0.7 0.5 1.4 0.8 0.7 0.2 4.5 0.3 1.4 0.5 0.8 0.4 3.1 0.8 2.8 0.9 0.8 0.6 2.0 0.0 45.3 3.1 0.4 3.1 2.5 1.3 1.2 0.5 0.3 0.2 3.9 0.3 1.0 0.2 29.1 0.7 0.2 1.0 8.5 0.1 3.5 25.6 0.6 0.4 7.2 1.9 5.8 0.7 0.4 0.0 2.5 15.9 1.2 0.2 0.2 2.0 0.9 0.0 1.1 0.1 0.3 0.3 2.1 1.4 1.1 3.1 4.1 2.5 3.6 1.1 0.8 1.7 1.7 1.9 2.2 1.1 1.8 8.8 1.6 5.8 0.3 1.6 1.8 26.1 39.3 19.9 35.1 20.4 30.9 24.5 26.1 14.3 11.8 0.0 5.8 12.2 3.3 1.3 16.6 8.9 15.3 2.7 7.9 1.8 3.9 1.2 19.9 1.2 8.3 1.4 10.3 0.0 5.5 1.2 2.1 9.6 1.1 234.8 4.3 33.4 15.0 5.5 9.1 6.0 3.4 5.4 1.7 0.0 4.9 48.7 6.3 6.5 4.2 72.0 6.0 0.0 2.5 1.5 0.9 0.5 1.1 7.2 6.8 4.2 ABCB7 "ABC7, ASAT, Atm1p, EST140535" ENSG00000131269 "ATP binding cassette subfamily B member 7" O75027 X 75051554-75156732 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034982 Approved Approved Mitochondria NA NA Mitochondria "HPA034982: AB_10601010" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.49e-2)" "unprognostic (1.83e-3)" "unprognostic (4.44e-3)" "unprognostic (1.33e-2)" "unprognostic (6.31e-2)" "unprognostic (4.39e-2)" "unprognostic (1.47e-1)" "unprognostic (2.17e-1)" "unprognostic (4.14e-2)" "unprognostic (2.55e-2)" "prognostic favorable (5.31e-6)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" 15.1 18.0 12.3 14.7 14.3 13.0 14.6 26.0 16.2 11.6 15.2 12.0 13.7 19.0 14.7 13.6 14.7 11.7 10.0 21.4 11.7 7.1 15.6 22.4 12.2 15.9 13.0 8.5 16.4 12.4 14.7 22.6 11.5 14.0 10.6 15.4 9.5 12.9 15.5 34.6 15.3 15.9 14.9 12.2 13.9 14.8 5.4 16.2 19.7 12.4 19.3 16.0 13.9 13.3 19.4 19.3 7.0 18.7 12.2 21.5 12.4 11.6 11.3 11.7 14.7 7.7 19.2 5.6 8.2 9.2 7.5 12.9 14.1 17.2 18.2 15.8 6.7 15.8 12.1 22.4 10.4 12.8 19.6 18.7 12.3 22.8 10.4 6.3 19.8 10.7 13.6 9.9 10.1 13.3 14.9 16.2 16.7 13.3 23.6 8.1 7.0 14.9 14.6 19.8 18.4 15.9 15.2 22.4 21.3 9.7 11.6 13.9 9.3 19.3 17.8 11.0 19.3 8.0 14.0 8.4 7.7 15.0 16.0 7.9 7.7 19.5 16.5 7.5 23.9 8.1 5.9 18.7 7.0 11.5 17.7 12.3 18.1 12.8 12.4 19.3 19.4 21.5 16.0 2.2 12.2 13.4 11.9 17.4 12.4 12.3 14.3 26.0 16.2 11.7 7.1 13.0 8.5 14.0 16.2 8.9 7.2 15.2 12.1 14.1 9.2 43.6 10.2 10.7 7.9 10.4 5.9 19.5 10.0 14.8 0.3 11.1 8.5 0.0 11.6 9.8 12.7 9.0 21.9 11.5 17.9 23.8 13.3 9.8 19.7 0.4 13.6 14.9 10.1 16.2 9.8 12.0 10.6 5.8 12.4 15.9 7.6 32.3 12.4 3.8 9.4 14.1 18.7 13.1 17.8 9.5 ABHD10 FLJ11342 ENSG00000144827 "Abhydrolase domain containing 10" Q9NUJ1 3 111979010-111993363 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036991, HPA036992, HPA066081" Supported Approved Mitochondria "Intracellular and membrane" No No 85000 Mitochondria "HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610" "unprognostic (1.65e-1)" "prognostic favorable (7.57e-4)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (1.14e-1)" "unprognostic (8.50e-2)" "unprognostic (1.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-2)" "prognostic favorable (4.72e-9)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (4.18e-3)" "unprognostic (2.76e-2)" 8.5 18.3 17.5 8.1 27.5 7.6 12.4 23.2 23.2 9.9 11.3 13.7 8.6 9.4 9.4 42.4 7.0 12.5 8.4 19.8 18.6 19.6 39.1 26.6 9.7 14.0 17.0 21.6 16.8 12.1 8.8 26.1 8.8 19.1 17.1 12.3 12.6 19.8 12.0 10.4 8.2 8.6 8.9 14.8 12.4 11.6 12.6 15.1 16.6 25.3 6.7 12.6 8.7 7.9 18.3 19.7 17.7 14.8 7.8 12.7 10.8 18.7 16.3 18.0 5.9 10.4 14.0 9.7 19.9 10.5 16.4 15.8 16.8 10.9 17.0 11.2 8.3 11.2 10.4 7.9 11.0 22.5 5.7 10.0 14.0 8.0 14.5 8.3 28.0 15.1 8.5 8.3 8.4 21.2 11.3 17.5 20.4 6.4 7.3 17.9 6.3 26.4 13.1 11.7 20.9 25.9 23.9 11.5 7.8 17.0 8.2 12.1 8.9 15.9 11.6 18.5 7.4 13.0 10.3 9.8 9.8 12.6 7.0 10.3 11.7 4.1 29.0 9.9 15.4 10.4 17.7 11.8 17.5 7.4 14.8 12.7 18.3 9.3 8.4 19.7 15.9 12.0 10.5 1.8 7.8 11.6 12.5 8.8 10.8 17.5 27.5 23.2 23.2 18.6 19.6 17.0 21.6 19.1 15.1 0.0 4.5 17.1 8.5 6.3 20.8 20.0 7.6 18.7 9.1 10.4 7.9 15.2 29.9 4.3 0.7 7.5 5.3 0.0 6.9 12.2 9.4 5.4 9.2 22.5 12.6 39.7 11.6 11.6 20.8 1.9 9.8 11.2 10.1 2.8 10.9 18.9 4.7 2.9 7.1 27.8 12.6 0.0 10.7 29.6 34.3 7.2 4.6 10.9 10.5 4.2 ABHD11 "PP1226, WBSCR21" ENSG00000106077 "Abhydrolase domain containing 11" Q8NFV4 7 73736094-73738867 "Disease related genes, Predicted intracellular proteins" Hydrolase "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 161.7;Urothelial cells: 241.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.7;SK-BR-3: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024042, HPA049641" Approved Supported Mitochondria NA NA 450000 Mitochondria "HPA024042: AB_1844445, HPA049641: AB_2680838" "unprognostic (4.74e-2)" "unprognostic (8.62e-3)" "unprognostic (1.42e-1)" "unprognostic (2.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-3)" "unprognostic (1.91e-2)" "unprognostic (9.32e-2)" "unprognostic (7.79e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.66e-7)" "unprognostic (3.61e-3)" "unprognostic (4.44e-2)" "unprognostic (1.02e-1)" "unprognostic (7.29e-2)" 5.6 8.9 7.7 11.5 8.7 4.2 12.2 8.8 9.2 8.1 28.5 8.3 14.8 15.7 6.0 12.7 8.3 14.0 17.0 20.1 7.1 8.1 21.6 6.6 8.4 6.9 8.6 5.6 5.0 18.9 7.3 10.8 40.2 10.0 14.7 17.5 7.8 23.9 22.2 9.8 7.9 28.1 5.6 5.9 5.2 8.3 6.1 5.6 6.9 20.1 8.4 12.6 5.8 5.4 8.3 12.9 12.2 21.0 9.7 6.7 8.0 17.5 4.1 2.8 6.4 1.4 2.0 15.6 8.1 3.4 5.0 5.9 5.0 19.8 8.3 2.4 3.4 6.8 7.8 1.2 4.6 3.4 3.1 6.0 4.1 2.7 3.1 2.6 4.4 4.5 1.8 1.9 6.4 3.0 1.8 3.5 2.9 5.5 4.8 4.7 34.7 3.3 5.6 3.2 11.1 15.1 1.9 4.5 15.4 11.5 8.3 7.2 3.0 6.6 44.2 2.7 2.1 14.3 2.9 3.4 4.3 4.0 18.2 8.4 2.9 1.5 5.6 6.8 4.2 7.9 6.1 13.1 12.2 6.0 21.0 4.8 6.3 6.7 6.2 12.9 8.3 6.3 4.4 10.5 9.7 20.7 6.3 4.4 8.0 7.7 8.7 8.8 9.2 7.1 8.1 8.6 5.6 10.0 5.6 41.7 11.2 11.1 58.4 4.8 14.7 15.3 40.8 83.0 36.4 54.1 3.9 68.1 61.3 45.0 1.0 8.4 161.7 0.0 35.7 109.7 8.7 56.7 15.0 7.8 24.5 4.8 60.0 6.2 8.9 2.1 8.3 14.8 13.5 9.0 63.5 26.4 35.6 108.7 3.2 34.8 14.2 0.0 12.0 5.4 8.0 5.5 106.8 13.1 94.5 241.0 AC008982.1 ENSG00000268083 19 38817471-38840178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "NB-4: 25.7" "Low region specificity" "Detected in all" "HPA002907, HPA051748" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA002907: AB_1847964, HPA051748: AB_2681588" "unprognostic (1.36e-2)" 1.7 1.0 0.5 0.4 1.0 4.3 0.7 0.8 3.3 0.5 3.1 0.2 0.2 2.2 1.4 3.5 1.1 0.5 0.3 4.9 0.5 0.6 1.6 6.3 5.0 5.3 0.8 0.2 1.3 1.3 0.0 0.5 0.8 0.8 1.3 0.2 0.2 0.6 0.5 5.8 1.0 1.8 0.2 0.8 2.6 1.1 3.2 0.7 2.5 1.0 2.4 0.2 0.7 1.0 1.9 5.9 2.4 2.5 2.5 3.6 2.2 1.4 0.0 0.2 0.3 0.1 0.1 1.6 0.4 0.0 0.5 0.1 0.7 0.1 0.2 1.3 0.1 0.1 0.8 0.0 0.0 0.1 1.3 0.4 0.9 0.0 0.0 0.1 0.4 0.9 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.5 0.4 0.0 1.0 1.1 25.7 1.9 0.0 0.0 1.5 0.7 0.6 0.3 0.3 0.6 3.6 0.0 0.0 4.6 0.0 0.4 5.9 0.0 0.1 2.6 1.8 2.3 1.1 0.9 2.0 0.1 0.7 0.1 1.6 2.5 2.4 2.5 2.0 3.6 1.6 2.5 2.7 2.4 1.9 2.3 2.9 0.2 2.5 1.1 5.9 3.4 2.2 0.5 1.0 0.8 3.3 0.5 0.6 0.8 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC024592.3 ENSG00000267740 19 5866171-5903787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.9;Ciliated cells: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.12e-2)" "unprognostic (2.24e-1)" "unprognostic (3.38e-1)" 8.8 15.0 8.4 8.8 8.5 11.1 10.9 8.0 17.4 10.6 9.8 5.0 8.9 10.8 9.9 7.8 12.7 6.7 9.6 24.1 7.8 9.9 8.5 14.4 8.0 11.5 9.6 10.0 8.2 16.3 3.2 7.1 6.6 7.5 7.0 3.9 7.5 12.3 8.8 22.7 12.3 10.0 9.9 8.6 7.4 7.3 5.6 5.3 7.9 8.0 16.6 7.0 12.7 8.2 7.2 10.4 6.4 8.5 5.5 7.5 12.1 5.1 6.9 2.2 5.8 4.2 0.8 1.9 3.4 4.9 6.6 4.7 2.5 4.4 4.2 3.4 2.7 3.1 3.6 1.3 4.1 1.3 1.8 2.1 1.1 3.1 5.6 2.8 1.9 2.3 1.8 7.0 5.1 2.4 2.0 2.2 6.1 1.8 5.6 1.0 4.2 6.9 1.5 3.2 2.2 3.3 6.5 2.2 5.4 3.2 1.6 3.5 4.9 2.6 3.5 3.4 1.0 2.1 6.3 4.2 1.3 3.2 8.0 6.6 5.3 5.6 2.1 4.2 6.7 2.9 6.4 8.5 4.0 6.0 7.1 5.3 7.2 6.3 5.8 8.6 6.7 7.3 5.8 4.8 5.5 6.3 10.4 7.5 12.1 8.4 8.5 8.0 17.4 7.8 9.9 9.6 10.0 7.5 5.3 3.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC093155.3 ENSG00000267561 1 86993009-87169204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 10.8" "Cell type enriched" "Detected in some" 4 "granulocytes: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.0;HEL: 13.2;HMC-1: 16.8;THP-1: 11.4" "HPA043069, HPA043603" Approved Uncertain Mitochondria NA NA Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432" "unprognostic (4.41e-1)" "unprognostic (3.13e-2)" "unprognostic (2.05e-1)" "unprognostic (1.85e-2)" "unprognostic (3.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.51e-2)" "unprognostic (5.19e-3)" "unprognostic (3.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" 10.8 3.2 0.6 0.9 0.8 0.0 3.7 0.8 0.6 2.1 1.3 0.6 0.8 0.5 1.1 0.5 2.1 4.1 0.6 0.6 0.8 4.3 2.5 0.3 0.7 3.7 0.6 0.0 0.5 2.7 0.6 1.2 0.9 0.7 1.6 0.6 1.0 2.0 0.8 0.8 0.7 2.4 0.6 0.0 2.2 0.6 0.1 0.9 4.6 0.1 0.4 0.2 0.1 0.0 0.1 0.8 2.0 2.4 9.0 0.2 0.0 0.1 0.0 0.3 0.6 0.8 0.0 0.2 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.5 13.2 0.4 0.1 0.1 0.3 16.8 1.5 0.3 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.2 0.2 0.3 1.1 0.0 0.2 0.3 0.0 0.4 0.4 0.1 0.4 0.3 0.0 0.4 0.9 0.2 11.4 0.0 0.3 0.7 0.1 1.3 0.9 3.5 0.0 0.6 0.0 0.4 2.0 0.1 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC131160.1 ENSG00000283765 3 183815568-183884889 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 12.1" HPA019545 Uncertain Approved Mitochondria NA NA Mitochondria "HPA019545: AB_1855796" 3.8 3.8 2.9 2.2 3.8 3.2 2.3 2.8 12.7 2.4 2.9 3.3 2.3 1.2 2.2 3.1 4.5 1.7 2.6 4.2 3.0 2.5 3.3 2.8 3.7 2.3 2.5 2.3 7.9 3.2 2.5 2.0 2.3 2.3 3.1 3.6 5.4 5.1 9.7 3.2 3.8 6.0 1.7 2.2 2.2 7.1 2.2 2.8 2.6 3.5 3.3 3.0 0.5 1.0 1.0 3.1 1.2 0.2 1.0 0.6 1.4 0.0 1.6 0.5 0.4 0.4 0.0 1.1 0.7 0.7 0.5 3.7 0.2 1.6 0.2 0.5 1.8 0.0 4.5 0.4 1.9 1.8 1.6 2.4 1.2 1.2 0.0 1.3 0.4 1.0 0.9 1.0 0.0 0.1 0.0 2.6 0.5 1.8 2.4 2.4 2.8 0.1 2.7 0.0 0.3 2.9 1.0 3.2 0.5 2.2 1.8 1.7 0.5 1.7 1.5 0.0 12.1 0.0 0.0 0.0 2.0 0.2 1.4 2.8 3.6 2.3 0.8 3.0 0.9 0.0 1.0 3.1 1.0 0.5 0.9 1.0 0.4 0.5 0.1 0.4 0.8 0.6 1.1 0.2 1.2 1.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC139530.2 ENSG00000262660 17 81703371-81720539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;MOLT-4: 18.5;SK-BR-3: 7.0" "HPA022853, HPA023043, HPA023048" Approved Supported Mitochondria NA NA Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950" "unprognostic (2.36e-3)" "unprognostic (1.17e-1)" "unprognostic (2.87e-1)" "unprognostic (3.83e-1)" 2.4 3.6 2.3 2.3 3.0 1.5 6.3 2.7 5.7 2.3 4.6 0.8 2.7 13.8 3.4 1.5 4.6 2.3 2.7 16.3 2.4 2.3 4.9 16.6 3.0 4.2 2.5 1.5 2.3 9.9 3.6 2.3 3.4 2.2 2.4 1.5 1.1 3.1 2.4 15.5 2.4 5.9 1.6 2.3 3.3 2.6 2.6 0.6 3.0 2.4 12.6 3.0 2.3 2.3 0.0 0.4 0.0 0.1 0.8 0.6 0.1 1.3 0.6 1.8 4.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.3 0.3 0.9 0.3 0.0 1.7 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.2 0.0 0.6 0.7 0.3 0.1 0.0 6.6 0.0 0.8 18.5 0.8 1.0 0.7 0.0 3.3 0.3 1.2 0.0 0.0 3.2 1.6 0.0 7.0 1.8 0.4 3.0 1.6 0.0 0.5 1.1 1.0 1.7 0.6 0.0 0.7 1.2 0.5 2.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 2.3 3.0 2.7 3.7 2.4 2.3 2.5 1.5 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782167-49813960 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 245.7" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 686.3;Proximal tubular cells: 536.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria NA NA 3200000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favorable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 22.7 12.9 9.4 6.9 10.7 4.4 13.0 3.6 7.0 4.1 27.2 8.0 7.8 25.9 5.1 5.1 7.1 4.1 9.2 38.9 6.8 7.0 60.3 245.7 7.9 7.5 10.7 6.1 6.4 13.6 6.3 7.1 7.5 6.7 7.9 18.4 9.5 3.3 6.2 22.9 4.2 37.0 11.3 9.7 6.9 6.0 6.5 7.5 8.4 15.7 8.8 5.0 8.1 4.9 13.0 31.8 27.5 33.0 35.5 40.9 28.6 0.8 14.1 23.6 21.6 31.3 16.6 12.0 7.2 11.8 12.2 9.5 30.0 12.3 12.6 15.5 26.6 12.6 0.9 39.3 4.6 12.1 38.6 9.2 8.9 18.5 35.6 14.8 0.1 16.9 21.9 1.5 19.7 6.2 9.9 20.0 18.3 7.7 11.9 33.9 16.3 0.5 19.5 21.4 5.3 5.7 31.0 50.5 46.2 41.3 0.6 33.9 26.9 0.5 16.6 1.1 19.5 9.4 13.1 9.5 10.4 13.1 15.7 7.9 24.2 27.9 32.2 7.4 18.2 9.5 13.1 25.9 27.5 32.1 33.0 40.9 13.0 19.2 28.6 31.8 9.7 16.4 24.3 2.5 35.5 31.1 14.9 22.6 28.6 9.4 10.7 3.6 7.0 6.8 7.0 10.7 6.1 6.7 7.5 35.7 38.9 45.7 10.9 3.2 5.9 161.7 229.3 29.4 30.7 52.4 3.9 30.0 250.4 111.1 56.2 32.3 191.9 0.0 40.7 49.6 32.6 10.2 44.9 686.3 101.9 1.6 38.5 46.6 63.1 122.0 44.5 46.6 18.6 61.3 59.2 53.2 84.8 76.3 35.0 536.1 27.2 19.4 17.6 27.7 39.6 4.3 22.5 68.2 98.9 4.5 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128916067 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria No No Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favorable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 18.1 20.6 14.0 13.1 15.4 8.0 15.4 14.7 17.9 13.6 13.4 15.9 21.1 11.3 16.9 13.1 21.6 15.6 16.4 21.6 10.7 13.2 15.8 24.0 11.6 10.4 13.6 17.8 13.1 21.1 30.6 14.2 13.8 13.6 13.0 12.4 16.0 19.0 16.0 30.8 45.0 10.1 13.8 10.2 12.1 14.6 19.5 10.8 13.9 14.8 18.2 14.9 12.6 14.0 7.2 14.0 4.1 18.1 5.0 7.5 8.9 25.1 13.2 10.6 7.9 16.4 11.6 11.3 12.5 13.8 24.1 20.7 18.5 15.3 18.7 11.7 15.7 16.3 21.1 18.5 24.5 16.0 12.3 12.6 17.0 26.7 13.1 12.0 13.3 7.9 12.6 9.6 14.0 15.8 13.9 19.4 14.9 8.0 9.1 16.0 25.4 19.6 11.1 6.4 26.0 18.9 15.2 10.0 19.0 16.9 16.1 12.3 7.9 19.5 18.3 12.1 10.0 24.2 28.8 11.5 10.1 8.8 10.2 11.9 9.1 4.4 16.3 16.1 12.4 12.7 3.1 12.0 4.1 7.5 14.7 7.2 7.2 6.8 6.4 14.0 4.9 5.7 7.3 1.0 5.0 18.1 7.9 6.5 8.9 14.0 15.4 14.7 17.9 10.7 13.2 13.6 17.8 13.6 10.8 14.9 23.7 9.7 10.0 5.6 14.5 26.4 7.6 10.7 11.4 14.0 9.8 22.7 18.3 18.4 14.9 9.8 8.1 0.0 15.5 15.2 10.1 7.5 16.1 23.3 26.7 9.5 5.2 17.8 9.5 12.6 9.5 8.4 15.1 16.2 6.3 15.8 13.0 7.6 13.8 18.0 10.9 12.9 13.3 15.6 10.0 12.4 25.6 7.5 14.1 6.0 ACADM "ACAD1, MCAD, MCADH" ENSG00000117054 "Acyl-CoA dehydrogenase medium chain" P11310 1 75724347-75787575 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7;skeletal muscle: 82.8" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 77.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006198, HPA026542" Enhanced Enhanced Mitochondria NA NA 1200000 Mitochondria "HPA006198: AB_1078087, HPA026542: AB_1844469" "unprognostic (9.04e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.30e-4)" "unprognostic (5.09e-3)" "unprognostic (1.61e-3)" "unprognostic (5.68e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (4.95e-2)" "unprognostic (9.40e-3)" "unprognostic (3.35e-1)" "prognostic favorable (3.83e-8)" "unprognostic (1.27e-1)" "unprognostic (4.09e-2)" "unprognostic (3.56e-2)" "unprognostic (1.24e-1)" 18.1 25.0 12.3 11.3 13.0 3.9 18.0 12.0 10.8 8.4 21.6 8.3 10.1 25.1 6.7 8.6 21.9 7.6 6.7 49.7 10.5 11.2 71.1 89.7 6.3 9.4 13.0 9.2 10.5 10.3 8.1 12.0 4.2 14.3 9.2 12.1 8.0 9.0 11.7 82.8 5.6 25.1 9.8 10.7 12.3 12.0 8.5 11.0 11.0 12.2 42.1 10.0 9.5 8.1 29.7 16.7 14.1 13.8 16.8 20.0 13.2 7.0 5.6 17.7 7.8 15.3 12.6 5.0 13.3 10.9 13.0 11.0 10.5 11.3 77.6 11.8 9.5 11.2 6.6 15.1 11.3 16.3 30.0 7.4 25.4 17.3 16.2 10.7 21.7 7.1 14.5 6.5 11.4 6.8 10.1 10.2 16.9 25.9 17.5 14.0 2.6 25.4 10.2 14.3 21.5 13.6 33.2 23.4 8.1 21.6 18.7 9.6 12.1 10.8 32.1 27.7 12.8 9.5 27.5 5.5 8.9 8.8 7.6 21.7 11.4 16.3 34.5 7.5 17.7 10.1 10.7 9.6 14.1 13.2 13.8 20.0 29.7 13.8 15.9 14.3 18.0 15.8 17.6 0.8 16.8 12.7 16.7 13.8 13.2 12.3 13.0 12.0 10.8 10.5 11.2 13.0 9.2 14.3 11.0 53.6 43.4 62.8 34.2 24.3 36.0 330.8 53.5 152.6 51.2 55.8 23.6 30.2 291.8 28.7 45.7 27.1 38.4 23.3 23.5 17.3 29.9 27.0 42.8 232.4 67.1 28.6 39.0 43.6 39.4 18.0 43.4 40.9 49.0 30.7 34.0 51.0 23.3 33.6 42.8 350.1 27.0 0.0 32.5 64.2 67.3 23.6 12.8 30.5 42.5 35.5 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058311 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 28.9;liver: 114.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 481.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041458, HPA063555" Enhanced Supported Mitochondria NA NA 63000 Mitochondria "HPA041458: AB_2677491, HPA063555: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favorable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favorable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 4.6 9.4 6.7 2.4 9.0 1.4 8.3 10.3 8.3 3.9 5.3 5.5 6.4 16.8 4.1 3.3 4.4 4.1 3.1 13.7 8.5 4.8 28.9 114.2 4.3 2.7 5.1 8.2 5.0 5.3 8.0 4.9 1.9 7.5 7.9 5.8 4.9 5.6 6.0 12.7 4.7 5.5 5.2 4.8 2.7 4.8 2.9 5.4 3.6 4.3 7.9 3.9 5.0 4.1 6.3 6.8 13.5 5.0 9.0 11.7 6.0 9.7 7.0 5.2 9.5 7.1 8.9 4.6 6.0 12.2 6.1 6.1 6.1 3.2 10.2 4.2 5.1 3.7 4.1 8.1 4.2 10.1 6.6 8.4 5.3 2.1 35.3 5.0 7.5 5.1 6.5 4.3 3.8 3.5 9.0 5.8 8.6 5.1 7.5 7.5 4.5 7.1 6.2 3.2 5.4 4.4 8.5 10.9 3.2 8.6 10.8 1.0 6.0 9.2 2.8 9.5 5.2 8.4 3.7 6.1 3.3 3.0 7.5 7.3 8.5 9.6 5.4 5.1 7.1 2.5 13.5 5.0 12.3 10.0 5.0 11.7 5.9 9.4 8.6 6.8 6.3 8.9 9.9 3.2 9.0 3.0 4.1 7.6 6.0 6.7 9.0 10.3 8.3 8.5 4.8 5.1 8.2 7.5 5.4 26.8 40.3 7.3 7.2 8.2 17.2 64.9 43.3 17.4 29.6 10.4 9.8 17.9 39.7 6.4 6.0 7.4 6.8 0.0 4.2 2.5 7.5 26.5 3.5 481.6 6.3 20.6 11.6 15.4 11.8 7.8 12.4 7.6 6.8 8.2 13.3 12.2 4.3 5.8 10.3 116.2 7.3 19.4 11.3 9.7 2.5 12.0 25.2 13.8 15.7 10.7 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108121516-108147776 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 267.1" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 591.9;Hepatocytes: 643.6;Proximal tubular cells: 1104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 86.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria NA NA 870000 Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 18.8 28.5 8.9 6.9 9.5 5.4 16.9 5.6 11.6 8.5 16.8 8.5 9.4 15.5 8.8 8.9 8.8 7.6 5.1 53.8 7.4 7.4 88.8 267.1 7.3 6.0 9.9 9.9 10.3 27.3 14.3 6.3 3.8 22.4 7.6 13.1 10.6 27.1 15.9 65.0 8.2 10.9 16.4 8.1 7.7 13.9 14.2 7.2 1.7 10.1 32.1 5.2 12.3 6.9 18.8 20.2 2.3 14.7 7.7 20.7 11.6 16.1 13.3 10.5 30.2 34.0 30.1 5.9 15.5 16.7 16.9 19.7 36.5 16.8 8.9 26.7 17.3 26.5 17.1 30.4 14.7 18.4 17.9 24.9 25.8 15.1 33.1 23.5 24.3 15.3 27.2 16.3 14.7 27.6 19.4 17.9 20.5 35.8 13.3 26.8 9.3 14.4 22.8 10.3 21.0 29.7 20.1 20.7 86.8 23.1 10.6 16.8 20.0 25.3 32.9 17.0 9.2 28.0 20.0 19.9 18.1 10.6 16.5 18.6 4.5 13.2 16.8 8.1 48.9 12.8 0.8 9.8 2.3 15.6 14.7 17.7 18.8 17.6 17.5 20.2 10.2 15.5 14.3 1.0 7.7 14.4 7.0 20.7 11.6 8.9 9.5 5.6 11.6 7.4 7.4 9.9 9.9 22.4 7.2 50.6 77.4 72.9 45.6 38.2 28.8 404.6 79.0 85.6 26.1 99.5 25.5 38.2 591.9 37.4 319.5 68.1 61.5 93.5 53.3 35.3 44.8 27.3 26.6 643.6 86.3 36.5 28.8 95.8 65.2 38.7 61.5 42.1 55.6 58.7 33.3 35.0 46.6 90.8 77.4 1104.9 23.8 64.7 64.3 159.1 28.1 42.3 21.1 42.4 83.1 20.7 ACO2 ACONM ENSG00000100412 "Aconitase 2" Q99798 22 41469125-41528989 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 121.0;skeletal muscle: 157.9" "Cell type enhanced" "Detected in all" 5 "Proximal tubular cells: 244.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001097 Enhanced Approved Approved Mitochondria NA NA 4000000 Mitochondria "HPA001097: AB_1078092" "unprognostic (1.95e-1)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (3.06e-2)" "unprognostic (6.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.99e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-2)" "unprognostic (7.32e-2)" "unprognostic (1.64e-2)" "unprognostic (6.07e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.46e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.12e-2)" 22.8 18.5 41.4 11.1 38.2 9.8 12.2 21.0 43.5 12.2 25.4 27.7 12.3 45.1 9.5 9.9 17.5 15.7 11.1 121.0 33.8 24.2 37.9 22.2 10.0 11.1 27.6 32.7 8.6 17.2 48.5 7.6 9.1 24.9 12.5 20.0 14.7 20.1 15.2 157.9 9.8 46.6 12.5 28.6 10.0 21.0 9.6 23.1 9.5 16.0 42.7 12.0 12.3 8.8 22.9 28.1 7.3 36.6 15.8 16.4 19.4 13.9 16.2 16.3 33.7 28.2 18.4 22.9 12.8 16.3 21.6 20.2 23.9 18.2 32.0 21.0 19.1 18.1 32.1 30.3 23.5 11.4 21.2 21.6 15.5 22.7 25.4 24.6 41.3 23.8 32.6 18.9 22.4 23.9 16.7 21.4 17.1 20.0 35.0 17.0 26.1 21.1 14.0 11.1 79.8 32.6 28.6 11.2 44.4 27.9 27.7 11.7 10.0 31.6 37.3 23.8 14.0 21.7 22.1 15.2 18.5 20.7 16.8 14.0 20.8 25.8 22.4 29.9 18.1 19.9 4.5 21.1 7.3 14.7 31.3 14.0 22.9 12.5 15.8 28.1 20.2 14.2 14.6 5.3 15.8 36.6 11.2 16.4 19.4 41.4 38.2 21.0 43.5 33.8 24.2 27.6 32.7 24.9 23.1 23.8 35.1 48.4 42.0 16.7 52.7 8.1 53.5 38.8 18.2 57.6 76.6 84.6 111.0 47.3 10.7 21.1 193.9 23.3 37.3 50.2 22.9 31.1 40.3 50.4 81.0 50.9 51.1 16.5 27.5 6.8 22.5 35.7 33.7 87.4 92.9 56.0 39.9 87.7 26.2 244.6 62.4 58.2 31.1 23.6 36.4 14.1 161.6 34.6 88.8 55.9 ACOT1 "ACH2, CTE-1, LACH2" ENSG00000184227 "Acyl-CoA thioesterase 1" Q86TX2 14 73537114-73543794 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.6" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 18.2;T-47d: 25.1" HPA043705 Approved Approved Mitochondria NA NA Mitochondria "HPA043705: AB_2678626" "unprognostic (4.74e-3)" "unprognostic (3.81e-3)" "unprognostic (7.65e-2)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (1.29e-1)" "unprognostic (4.54e-2)" "unprognostic (1.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.84e-1)" "unprognostic (4.16e-1)" "prognostic favorable (5.09e-8)" "unprognostic (1.35e-3)" "unprognostic (4.60e-2)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" 8.5 7.2 5.1 3.7 3.9 1.0 13.7 2.0 7.7 3.0 5.8 4.1 0.9 5.3 6.8 8.8 2.7 3.4 1.8 11.3 4.3 3.6 16.4 27.6 9.0 0.9 3.2 6.0 4.5 1.4 2.9 0.9 4.1 5.6 5.5 3.4 2.4 2.7 6.1 10.7 3.8 12.9 13.0 1.9 1.0 3.4 2.7 2.4 0.9 1.8 5.0 1.9 5.6 1.7 3.8 5.7 1.0 1.7 4.2 6.3 3.1 4.2 5.0 1.9 0.1 9.9 6.1 0.1 1.3 5.4 4.5 8.2 1.9 2.1 0.0 0.0 3.6 0.0 2.5 0.0 0.9 2.2 2.3 1.6 2.7 1.2 18.2 9.6 0.1 3.0 7.9 0.4 3.6 0.0 0.1 2.0 0.0 0.0 0.0 3.5 1.6 0.3 0.5 1.9 0.6 1.9 5.1 3.9 0.1 4.4 4.7 2.3 3.8 4.2 12.4 6.8 0.4 25.1 6.2 2.2 2.5 3.2 2.3 0.0 0.0 0.0 1.3 3.6 0.0 4.0 0.1 1.3 1.0 6.0 1.7 4.9 3.8 5.5 4.7 5.7 2.6 4.8 5.3 0.2 4.2 1.5 3.2 6.3 3.1 5.1 3.9 2.0 7.7 4.3 3.6 3.2 6.0 5.6 2.4 0.0 2.7 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.4 0.0 0.0 0.0 7.2 0.2 0.3 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.4 0.8 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 ACOT2 "Mte1, ZAP128" ENSG00000119673 "Acyl-CoA thioesterase 2" P49753 14 73567620-73575658 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 60.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043705, HPA060170" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043705: AB_2678626, HPA060170: AB_2732642" "unprognostic (4.44e-3)" "unprognostic (1.68e-2)" "unprognostic (3.17e-1)" "unprognostic (8.66e-2)" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (2.78e-2)" "unprognostic (6.61e-2)" "unprognostic (4.10e-2)" "unprognostic (9.21e-2)" "unprognostic (6.42e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.66e-3)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (4.35e-1)" 41.4 16.5 5.9 6.4 5.3 2.7 13.4 3.3 8.7 7.8 11.9 4.6 4.0 12.8 13.9 10.6 9.4 8.3 8.8 35.1 4.5 4.0 25.0 60.5 6.2 4.4 4.3 5.4 6.2 8.1 6.4 2.7 7.9 4.3 8.5 6.2 6.9 7.3 6.8 50.7 3.9 12.0 16.3 3.2 4.3 7.4 5.7 3.7 5.3 7.4 11.6 3.9 11.3 4.6 9.7 13.8 1.8 4.4 9.0 19.0 8.1 11.2 11.0 2.3 9.7 10.3 4.0 0.4 6.0 14.0 9.8 13.0 7.8 7.5 0.0 4.4 3.2 5.1 6.2 0.0 0.6 5.2 14.2 13.9 6.8 4.5 26.8 6.7 0.0 19.3 9.1 0.0 3.7 0.0 9.6 4.2 0.0 0.0 0.0 8.4 4.7 1.0 7.7 3.3 1.3 16.7 16.1 9.8 0.1 3.6 4.7 10.1 12.2 14.8 11.5 12.0 1.1 27.6 5.4 7.6 8.6 21.6 5.5 5.7 0.0 0.0 4.0 7.2 0.0 8.1 1.5 3.7 1.8 14.6 4.4 10.7 9.7 13.7 11.1 13.8 7.9 12.4 13.5 0.1 9.0 3.9 8.5 19.0 8.1 5.9 5.3 3.3 8.7 4.5 4.0 4.3 5.4 4.3 3.7 0.0 5.4 1.7 1.0 1.4 0.9 43.0 7.6 4.0 1.2 7.0 9.8 4.6 11.6 18.3 1.0 3.6 16.2 0.0 29.2 2.3 3.9 0.3 13.8 25.8 13.9 1.6 15.1 3.7 4.0 0.4 5.5 2.0 5.0 30.7 15.1 3.3 19.0 5.8 7.8 16.5 4.5 6.5 4.2 0.4 4.3 0.4 6.9 5.7 19.7 0.4 ACSS3 FLJ21963 ENSG00000111058 "Acyl-CoA synthetase short chain family member 3" Q9H6R3 12 80936414-81261205 "Enzymes, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 42.8;Hepatocytes: 47.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 8.3;neutrophil: 6.0" "Lineage enriched" "Detected in single" 71 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039353, HPA047956, HPA061517" Approved Supported Mitochondria NA NA Mitochondria "HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549" "unprognostic (8.59e-2)" "unprognostic (9.29e-4)" "unprognostic (1.47e-1)" "unprognostic (9.37e-3)" "unprognostic (2.46e-2)" "unprognostic (2.21e-1)" "unprognostic (9.25e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (7.18e-3)" "unprognostic (1.68e-1)" "unprognostic (7.79e-2)" "prognostic favorable (0.00e+0)" "unprognostic (6.16e-4)" "unprognostic (1.63e-1)" "unprognostic (2.00e-1)" "unprognostic (2.00e-4)" 19.6 18.3 7.4 1.9 8.3 1.0 8.1 2.7 7.7 13.2 2.6 5.5 10.8 1.2 18.2 14.4 2.0 8.3 8.1 10.9 6.4 3.9 24.4 37.1 8.8 1.7 7.4 6.5 16.7 2.6 21.3 11.0 4.1 6.5 7.1 1.6 10.3 20.4 11.4 9.8 2.1 1.9 6.6 5.5 2.8 1.9 4.0 4.1 0.0 9.2 2.9 1.6 3.5 6.3 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 2.2 0.0 9.4 10.7 0.0 1.5 7.0 1.1 1.2 0.3 0.0 0.1 0.0 3.1 3.3 0.1 0.0 0.0 0.7 0.0 1.7 0.0 0.1 26.5 3.2 0.3 0.0 7.2 0.0 0.3 0.0 9.1 0.2 0.0 0.0 0.0 5.0 0.6 0.0 0.1 3.2 0.0 0.0 0.0 12.3 1.7 0.0 0.0 2.1 0.0 0.0 11.6 0.0 4.8 5.2 0.3 0.0 1.9 1.8 0.2 0.7 0.1 0.1 0.0 2.3 0.0 2.1 8.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 7.4 8.3 2.7 7.7 6.4 3.9 7.4 6.5 6.5 4.1 20.8 42.8 0.0 7.0 0.8 31.6 19.3 15.3 6.7 5.7 12.2 3.9 1.3 5.0 4.0 33.3 1.0 0.0 0.0 2.6 0.6 4.3 4.4 0.0 47.4 0.6 27.0 0.0 3.1 2.4 6.4 22.2 0.4 0.0 0.0 0.0 19.7 0.2 0.0 22.3 26.7 4.5 6.5 5.7 4.2 0.5 0.1 0.5 0.0 0.0 2.0 ADCY1 "AC1, DFNB44" ENSG00000164742 "Adenylate cyclase 1" Q08828 7 45574140-45723116 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, cAMP biosynthesis" "Calmodulin-binding, Lyase" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018364, HPA068274" Uncertain Approved Mitochondria NA NA Mitochondria "CAB018364: AB_2223098, HPA068274: " "unprognostic (9.41e-3)" "unprognostic (7.30e-4)" "unprognostic (9.31e-2)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (3.07e-3)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (1.64e-3)" "unprognostic (2.89e-1)" "unprognostic (7.73e-3)" "unprognostic (1.54e-1)" "unprognostic (4.74e-6)" "unprognostic (2.49e-1)" "unprognostic (7.65e-3)" "unprognostic (2.87e-1)" "unprognostic (2.23e-1)" 2.8 2.8 11.5 0.7 11.7 0.4 6.8 22.7 29.0 7.8 0.9 2.0 0.0 0.7 2.7 1.1 1.2 2.4 1.2 4.0 11.6 4.0 1.8 9.6 1.0 0.8 5.8 13.4 1.2 3.6 1.0 1.5 0.9 6.2 4.1 1.0 5.0 0.8 2.1 9.2 0.6 0.7 1.6 2.2 1.0 1.8 3.9 1.2 0.0 3.0 0.2 0.8 1.0 1.5 0.5 0.4 0.6 0.1 0.0 0.2 0.0 0.5 3.9 1.5 2.2 2.9 0.0 2.7 0.1 0.0 0.5 0.2 0.4 0.0 0.0 0.2 0.1 4.0 1.2 2.5 0.2 0.0 7.0 1.8 0.0 0.0 0.3 0.0 0.1 0.0 3.4 1.9 0.3 15.3 0.0 0.1 5.8 0.2 4.7 0.2 4.6 0.0 0.0 5.7 3.3 0.0 0.0 0.0 7.6 0.0 3.8 9.2 17.6 1.4 0.0 20.3 2.2 1.3 2.3 0.0 0.4 2.9 0.3 2.3 0.0 0.0 0.0 0.0 0.0 11.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 11.5 11.7 22.7 29.0 11.6 4.0 5.8 13.4 6.2 1.2 0.0 0.0 0.0 0.4 0.2 35.8 9.0 0.0 0.0 0.0 0.0 490.9 0.1 1.7 0.0 2.3 1.0 0.0 0.0 0.8 0.1 1.9 2.6 0.0 34.7 0.3 39.7 30.0 18.4 3.2 0.4 1.7 0.0 3.3 0.0 0.2 11.9 0.9 0.0 7.1 0.2 145.7 0.0 5.0 0.7 6.8 0.1 0.0 0.0 0.5 0.3 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 AFG3L2 "SCA28, SPAX5" ENSG00000141385 "AFG3 like matrix AAA peptidase subunit 2" Q9Y4W6 18 12328944-12377314 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004479, HPA004480" Enhanced Supported Mitochondria NA NA Mitochondria "HPA004479: AB_1078109, HPA004480: AB_1078108" "unprognostic (1.11e-1)" "unprognostic (7.49e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (1.31e-1)" "unprognostic (5.06e-3)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (5.35e-2)" "unprognostic (1.54e-2)" "unprognostic (4.05e-2)" "unprognostic (3.00e-2)" "prognostic favorable (6.05e-14)" "unprognostic (5.90e-2)" "unprognostic (9.41e-2)" "unprognostic (5.74e-3)" "unprognostic (2.22e-1)" 11.5 15.8 11.8 14.3 14.0 11.7 19.9 17.2 30.3 11.2 25.7 9.5 12.7 33.1 11.4 10.1 18.3 10.4 11.2 77.4 13.2 13.1 27.2 22.9 16.3 23.7 12.0 13.2 12.0 23.1 34.3 12.6 9.9 16.9 10.8 23.5 12.2 14.9 14.8 61.0 17.5 35.0 15.1 14.0 9.9 16.0 8.9 7.1 10.7 16.9 22.4 13.2 14.0 11.6 10.1 15.8 8.5 12.3 19.9 15.2 8.4 15.0 15.4 11.0 12.4 12.7 14.0 14.7 16.9 16.8 24.2 17.8 23.8 9.3 43.4 18.6 15.3 21.5 15.2 27.8 19.4 19.8 10.1 11.9 13.0 16.9 22.3 17.4 48.9 19.5 15.4 21.3 22.9 30.3 13.4 17.6 15.6 29.2 25.7 11.8 23.9 17.5 15.0 15.3 74.6 11.4 19.7 34.8 36.2 20.8 33.5 20.6 14.4 26.5 28.8 23.7 14.8 13.2 22.1 13.3 28.9 24.8 27.4 22.0 18.1 20.8 27.8 15.8 19.3 13.2 2.6 11.5 8.5 8.7 12.3 10.7 10.1 10.4 13.7 15.8 7.7 13.3 15.2 0.8 19.9 10.8 8.1 6.4 8.4 11.8 14.0 17.2 30.3 13.2 13.1 12.0 13.2 16.9 7.1 38.7 35.6 27.6 31.2 19.7 46.8 69.2 40.8 28.1 33.0 33.2 47.1 50.2 61.3 33.0 4.2 23.3 78.3 46.7 32.4 29.6 23.8 24.6 13.9 71.5 32.6 28.6 37.6 18.4 22.3 2.7 30.5 25.6 21.9 20.8 71.9 29.1 36.4 31.7 28.3 54.2 55.2 25.8 20.6 47.7 72.0 27.4 77.6 17.5 75.2 29.8 AFMID "DKFZp686F03259, KF" ENSG00000183077 Arylformamidase Q63HM1 17 78187317-78207701 "Enzymes, Predicted intracellular proteins" "Tryptophan catabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.7" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 68.8;Hepatocytes: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.5" "Group enriched" "Detected in all" 5 "B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5" "Cell line enhanced" "Detected in all" "Hep G2: 62.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023861, HPA026536" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023861: AB_1844636, HPA026536: AB_1844637" "unprognostic (3.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.53e-1)" "unprognostic (2.65e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.78e-1)" "unprognostic (1.83e-1)" "unprognostic (1.49e-3)" "unprognostic (1.53e-2)" "unprognostic (5.78e-2)" "unprognostic (9.59e-3)" "unprognostic (9.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (7.79e-2)" 5.9 3.5 12.1 5.4 17.1 4.6 33.0 27.1 18.3 6.1 7.5 44.8 11.7 8.5 7.5 7.0 7.7 11.3 11.4 9.4 17.3 12.0 39.4 78.7 10.6 5.2 29.7 13.3 15.9 27.7 6.9 4.1 12.4 18.1 10.7 9.2 5.8 24.7 11.8 7.9 15.5 7.1 6.6 27.0 6.2 10.2 6.2 23.9 3.9 6.5 5.6 6.2 6.7 7.4 5.1 6.7 1.7 14.5 1.6 1.1 1.5 7.0 10.0 8.8 8.0 10.0 11.7 4.8 10.1 5.8 7.2 8.6 10.6 5.9 22.1 6.7 7.7 4.2 6.1 14.9 8.9 10.1 14.0 11.9 17.8 11.8 62.3 8.7 14.7 9.2 15.6 9.4 8.3 10.9 11.8 13.4 6.7 18.0 7.8 5.5 7.0 11.2 22.4 7.2 17.2 17.3 12.8 9.0 26.5 9.7 6.5 19.7 14.6 8.7 26.3 8.2 9.2 7.9 14.3 6.6 11.0 7.2 6.9 7.1 11.9 7.8 22.7 9.1 7.2 2.8 1.1 6.1 0.7 0.7 14.5 1.1 5.1 1.0 1.1 6.7 2.0 0.6 0.6 1.7 1.6 9.3 4.4 0.9 1.5 12.1 17.1 27.1 18.3 17.3 12.0 29.7 13.3 18.1 23.9 14.9 13.6 10.0 19.1 23.5 1.4 11.5 68.8 17.4 12.5 61.1 3.9 10.9 14.9 10.4 0.3 14.7 12.9 0.0 7.4 9.5 15.0 15.8 2.3 100.2 9.5 1.6 12.6 21.5 21.9 1.5 20.8 18.3 28.7 10.8 20.6 1.7 8.6 24.9 20.5 39.6 1.5 0.0 7.5 1.2 11.8 35.9 9.6 4.4 25.0 12.2 AGPAT5 "FLJ11210, LPAAT-e, LPAAT-epsilon" ENSG00000155189 "1-acylglycerol-3-phosphate O-acyltransferase 5" Q9NUQ2 8 6708357-6759666 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010644, HPA010950, HPA011646" Approved Supported Mitochondria NA NA Mitochondria "HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: " "unprognostic (1.05e-3)" "unprognostic (4.69e-1)" "prognostic favorable (8.82e-4)" "unprognostic (2.05e-2)" "unprognostic (2.99e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (4.92e-1)" "unprognostic (1.82e-1)" "unprognostic (2.98e-2)" "unprognostic (6.33e-2)" "unprognostic (2.91e-1)" "unprognostic (6.62e-2)" "unprognostic (2.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (5.09e-3)" 5.9 12.5 20.0 8.5 20.7 5.1 9.8 10.0 21.2 6.0 12.2 16.5 6.8 9.3 9.3 19.1 8.4 9.7 5.9 4.0 19.3 16.9 14.2 14.3 5.1 16.8 18.7 9.5 6.4 16.2 11.4 18.5 16.3 14.2 11.0 12.3 3.3 5.4 16.0 10.2 5.1 8.4 8.6 30.6 8.6 11.0 30.8 12.7 14.3 7.3 6.8 10.4 7.3 5.7 11.0 8.4 3.0 4.8 5.3 3.9 2.9 9.4 7.6 11.9 7.0 3.1 5.1 10.6 5.0 5.2 7.5 7.3 4.7 7.5 20.7 3.3 3.3 10.5 11.2 9.1 10.1 13.2 4.5 6.2 25.4 5.9 10.6 7.9 10.6 11.1 6.8 8.6 7.3 9.8 6.9 13.1 8.7 18.7 11.1 12.3 6.1 19.2 13.1 20.8 12.7 5.9 13.9 14.3 8.1 6.8 13.3 24.4 12.8 4.8 8.8 9.5 7.3 4.0 14.0 5.4 12.3 5.8 4.7 13.9 4.2 12.8 11.3 7.2 12.8 14.6 3.0 4.1 2.6 1.9 4.8 3.9 8.7 3.0 3.3 2.7 11.0 2.3 2.7 0.4 5.3 4.2 8.4 2.7 2.9 20.0 20.7 10.0 14.6 19.3 16.9 18.7 9.5 14.2 12.7 3.0 4.1 16.6 10.5 8.0 7.7 5.3 12.7 10.7 7.9 7.0 2.0 7.7 3.3 8.4 29.8 15.8 11.4 0.0 8.5 10.7 5.7 13.4 17.4 29.2 11.0 6.4 21.2 8.6 14.0 22.9 14.7 6.4 6.8 1.0 7.9 37.9 8.0 8.6 14.5 17.4 8.8 6.5 13.2 20.9 8.6 9.2 15.4 4.4 20.0 10.6 AIFM1 "AIF, CMTX4, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130129362-130165887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 66.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 148.9;Proximal tubular cells: 209.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 160000 Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 9.9 28.9 7.1 11.3 8.6 5.3 7.1 7.5 8.9 10.4 14.2 8.4 10.0 19.6 9.9 11.7 8.6 13.0 11.4 34.2 7.2 7.0 66.8 50.5 5.8 9.8 8.2 7.1 7.3 14.6 16.8 7.7 6.1 8.8 6.9 14.2 12.3 13.1 9.4 35.7 5.8 23.2 8.9 6.4 8.7 14.9 14.9 7.2 19.5 7.9 16.1 9.7 8.4 6.0 10.8 22.0 9.8 18.3 15.8 12.8 8.0 16.8 31.2 12.8 32.0 14.6 10.4 16.9 10.7 9.3 16.5 13.3 22.1 12.5 36.4 37.3 9.8 19.6 16.3 39.4 13.9 17.6 13.9 24.0 23.1 23.5 30.0 18.6 20.2 24.3 12.9 13.7 17.5 15.0 9.2 13.9 27.5 19.8 16.9 11.6 40.6 20.5 31.7 9.2 34.0 24.2 18.6 14.3 42.1 37.3 17.1 16.5 9.6 12.5 28.9 27.8 15.2 14.9 18.3 10.1 7.9 7.6 21.4 20.3 9.0 14.6 17.0 10.1 33.9 11.8 2.9 14.8 9.8 9.1 18.3 9.6 10.8 9.7 11.2 22.0 8.1 9.6 9.7 2.1 15.8 15.5 10.6 12.8 8.0 7.1 8.6 7.5 8.9 7.2 7.0 8.2 7.1 8.8 7.2 14.9 15.3 20.1 8.0 7.7 17.8 148.9 20.4 21.4 15.9 38.4 21.6 48.7 77.9 21.8 1.3 10.2 33.3 0.0 18.1 22.0 13.9 6.9 10.4 83.4 33.5 14.3 9.2 14.7 15.5 3.9 16.1 14.0 10.1 17.2 17.6 12.2 17.3 17.3 16.3 209.8 36.6 6.5 9.0 3.9 32.1 5.9 33.2 13.1 32.6 8.9 AIFM3 "AIFL, FLJ30473" ENSG00000183773 "Apoptosis inducing factor, mitochondria associated 3" Q96NN9 22 20965108-20981360 "Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.7;intestine: 28.0" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 42.3;Mucus-secreting cells: 33.7;Paneth cells: 29.1;Undifferentiated cells: 39.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 22 "dendritic cells: 3.8;monocytes: 5.7" "Cell line enhanced" "Detected in some" "Hep G2: 8.8;HMC-1: 13.1;T-47d: 6.4;THP-1: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001271 Supported Mitochondria NA NA Mitochondria "HPA001271: AB_1078114" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (7.49e-2)" "unprognostic (9.99e-2)" "unprognostic (6.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.73e-3)" "unprognostic (3.28e-1)" "unprognostic (1.56e-1)" "unprognostic (4.13e-3)" "unprognostic (5.13e-2)" "unprognostic (7.99e-2)" "unprognostic (6.78e-2)" "unprognostic (1.47e-1)" "unprognostic (3.37e-1)" "prognostic favorable (7.13e-5)" 1.3 1.3 20.3 4.6 19.0 5.4 0.8 14.4 18.4 1.2 28.0 9.7 0.0 4.3 0.9 0.8 0.9 1.2 1.6 0.9 14.6 9.9 0.9 0.8 1.5 1.4 14.8 12.4 1.0 0.9 0.9 1.9 1.3 21.7 1.2 13.0 5.0 2.2 1.9 0.7 0.9 3.4 1.9 9.6 2.7 1.6 1.1 7.6 0.0 1.0 0.0 0.8 1.9 0.1 0.2 3.8 0.0 5.7 0.0 0.0 0.9 1.2 2.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 2.2 0.0 8.8 0.2 0.0 13.1 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.6 0.0 0.1 0.0 0.4 0.0 0.1 0.0 1.4 0.0 1.5 1.8 1.1 1.0 0.1 0.0 0.1 6.4 9.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.7 0.0 0.2 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.9 20.3 19.0 14.4 18.4 14.6 9.9 14.8 12.4 21.7 7.6 0.0 1.0 1.7 1.6 0.6 10.9 2.4 0.0 0.0 0.0 1.8 5.9 0.9 10.0 0.7 0.0 0.7 42.3 0.0 0.6 0.6 0.4 2.9 1.1 1.8 2.9 0.0 9.9 1.3 3.7 0.0 0.0 2.2 0.0 0.0 33.7 18.1 0.6 29.1 0.0 6.0 2.9 0.0 0.8 0.0 0.7 0.6 0.7 0.0 39.2 2.2 AK2 ENSG00000004455 "Adenylate kinase 2" P54819 1 33007940-33080996 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 362.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018479, CAB079913" Approved Approved Mitochondria NA NA 5500000 Mitochondria "CAB079913: AB_2546087, HPA018479: AB_1844676" "prognostic favorable (4.37e-4)" "unprognostic (3.25e-2)" "unprognostic (2.80e-2)" "prognostic unfavorable (8.65e-4)" "unprognostic (3.16e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (7.86e-3)" "unprognostic (1.85e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (6.40e-4)" "unprognostic (4.95e-2)" "unprognostic (8.33e-3)" "unprognostic (9.56e-3)" "unprognostic (2.71e-1)" "unprognostic (1.40e-1)" "unprognostic (5.40e-3)" 24.9 27.1 16.0 27.6 20.3 18.3 24.2 19.1 17.6 21.4 31.3 24.6 22.4 36.6 20.6 22.8 31.6 17.6 25.0 33.9 15.1 14.5 51.2 46.5 17.9 18.2 23.1 9.9 24.3 23.2 27.2 16.2 18.6 19.7 22.4 31.8 20.4 31.4 21.5 73.8 20.6 37.1 18.7 25.9 24.7 24.0 29.3 25.0 40.2 37.4 34.4 28.7 26.7 23.3 31.7 51.9 50.9 41.2 27.4 24.4 43.1 45.7 20.3 19.2 22.3 13.3 16.7 19.5 25.8 20.0 38.9 40.9 39.0 41.5 85.2 30.7 19.1 27.9 33.2 44.6 43.9 41.9 37.2 32.6 56.4 39.1 29.7 31.2 100.3 32.0 16.5 33.2 33.3 67.3 21.7 26.5 36.0 59.9 32.1 23.1 23.0 37.9 55.5 26.8 44.1 31.2 44.3 32.7 56.1 38.3 27.6 28.3 16.6 29.5 32.8 82.3 23.8 26.6 71.4 19.4 23.6 28.5 36.3 48.3 33.5 43.8 79.4 32.0 95.0 27.2 11.0 41.2 50.9 22.0 37.4 23.0 31.7 20.6 20.6 51.9 27.7 21.2 19.8 11.3 27.4 31.5 39.1 24.4 43.1 16.0 20.3 19.1 17.6 15.1 14.5 23.1 9.9 19.7 25.0 47.6 66.5 38.7 80.7 111.2 21.1 86.7 71.4 46.8 83.0 106.4 78.5 137.4 217.2 94.6 81.6 64.2 135.8 0.0 107.9 138.4 58.1 76.3 39.3 127.8 84.9 7.9 48.5 31.9 41.6 29.1 43.4 51.1 82.7 58.7 70.5 20.1 99.6 51.8 41.4 362.4 38.8 51.8 59.5 97.9 21.1 107.3 181.1 37.4 94.5 113.8 AK3 "AK3L1, AK6, AKL3L1" ENSG00000147853 "Adenylate kinase 3" Q9UIJ7 9 4709559-4742043 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 86.8;HEL: 55.6" "Low region specificity" "Detected in all" HPA063324 Enhanced Supported Mitochondria NA NA 68000 Mitochondria "HPA063324: AB_2684985" "unprognostic (1.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-3)" "unprognostic (6.44e-2)" "unprognostic (2.81e-2)" "unprognostic (9.81e-3)" "unprognostic (1.90e-1)" "unprognostic (2.76e-2)" "prognostic favorable (6.07e-9)" "unprognostic (1.24e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.55e-3)" 24.6 25.1 20.9 9.8 22.4 6.8 24.0 14.6 17.5 17.7 23.7 15.3 16.0 24.4 18.9 17.5 28.3 14.0 16.1 90.0 22.4 16.4 37.7 75.1 16.4 13.1 25.2 15.2 22.4 15.7 16.9 14.1 13.0 22.9 19.0 23.0 17.4 14.5 19.1 72.0 18.1 22.0 21.2 24.1 12.1 22.5 9.3 24.9 15.2 20.8 32.8 14.9 20.1 17.1 7.0 14.4 17.0 5.6 14.7 17.1 10.2 8.8 7.5 12.8 5.2 17.9 13.2 0.9 11.3 26.5 7.1 10.6 1.3 9.9 8.3 3.8 14.3 3.9 5.8 9.3 10.8 12.0 86.8 7.0 55.6 13.3 22.5 14.1 5.8 2.9 20.8 9.7 6.0 8.4 16.5 20.8 8.5 4.2 11.3 21.1 5.3 5.6 16.9 11.4 17.4 2.8 7.6 4.6 4.1 20.6 12.5 21.1 13.3 13.2 4.3 7.5 13.0 6.0 11.7 12.8 5.9 6.0 15.5 8.8 2.9 1.8 10.2 10.9 4.4 4.2 6.8 5.6 17.0 16.2 4.4 14.7 7.0 12.5 14.8 10.5 6.9 16.6 17.1 1.9 14.7 3.4 14.4 16.7 10.2 20.9 22.4 14.6 17.5 22.4 16.4 25.2 15.2 22.9 24.9 53.6 88.6 32.0 59.7 65.9 11.9 155.8 66.2 45.5 68.2 62.8 21.6 83.2 218.8 74.1 2.6 56.6 104.3 0.0 61.0 10.9 79.1 116.1 44.0 282.7 40.3 14.3 105.2 74.3 36.8 1.9 100.7 36.7 70.9 53.3 103.3 22.3 61.2 57.5 140.7 148.4 8.8 103.5 59.8 6.6 15.3 91.2 179.0 38.5 135.0 92.5 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.7;liver: 50.7" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 223.0;Proximal tubular cells: 422.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;myeloid DC: 5.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "Hep G2: 59.4" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 18000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavorable (4.36e-4)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 12.4 1.6 11.7 3.7 11.2 2.7 13.4 12.0 9.9 4.0 9.5 4.0 4.7 2.7 3.9 4.4 12.3 4.2 8.6 26.0 9.3 7.1 89.7 50.7 1.6 1.4 6.3 9.1 5.8 1.8 8.2 2.6 4.5 7.2 8.9 7.7 4.4 9.4 7.3 2.2 14.0 3.5 13.6 8.1 1.2 7.8 6.0 5.0 0.4 1.9 5.7 3.2 12.4 7.4 0.5 5.3 1.6 6.1 0.6 0.5 1.4 20.6 1.4 1.6 7.0 15.6 14.9 3.5 3.5 4.4 7.6 21.2 31.0 2.5 11.1 9.2 5.4 9.5 13.4 5.5 26.1 30.6 9.3 6.3 10.8 7.0 59.4 0.7 8.3 1.3 8.2 14.7 7.4 21.9 12.6 0.2 3.5 13.4 0.2 11.6 8.8 0.3 0.3 7.2 0.3 12.4 0.0 12.1 2.0 11.2 0.9 6.1 4.5 6.2 0.4 4.9 8.0 8.7 3.7 1.2 12.7 10.9 0.9 5.9 11.7 5.2 0.6 20.5 3.1 0.7 1.6 6.1 0.0 0.2 1.4 0.4 0.5 0.2 0.5 5.3 0.4 0.2 0.2 1.0 0.6 0.2 0.8 0.1 1.4 11.7 11.2 12.0 9.9 9.3 7.1 6.3 9.1 7.2 5.0 0.0 0.3 4.9 19.8 44.2 14.7 91.5 61.1 5.3 6.8 29.6 2.0 1.2 48.0 16.1 1.6 17.5 13.5 0.0 11.0 13.9 10.3 33.2 0.0 223.0 3.3 15.9 5.2 5.5 5.6 4.2 3.7 2.7 23.6 7.2 6.7 27.4 22.8 3.5 8.9 422.4 6.2 6.5 27.4 2.1 5.1 65.0 4.1 1.0 22.9 16.6 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Group enriched" "Detected in many" 9 "Early spermatids: 596.3;Late spermatids: 1760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria NA NA Mitochondria "CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favorable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.2 20.4 28.3 9.3 7.3 4.8 17.0 6.8 6.6 9.0 6.4 21.8 14.6 26.1 19.4 5.2 9.5 25.9 15.8 14.9 9.0 14.3 23.0 22.2 18.0 41.3 6.9 20.8 8.6 4.2 14.9 9.9 13.9 5.1 9.1 8.0 14.8 10.1 5.2 13.9 26.3 7.9 10.4 34.4 21.9 20.2 12.0 21.3 6.0 19.3 21.7 14.3 5.4 15.8 8.8 6.4 10.9 21.5 6.7 7.9 8.8 10.2 15.3 10.0 12.5 19.7 5.0 16.3 7.0 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 32.8 37.5 15.1 21.0 20.0 35.4 133.6 33.1 6.7 45.5 5.2 45.2 18.0 1.7 15.3 596.3 10.7 60.0 0.0 14.4 10.0 9.5 23.9 3.5 54.6 8.4 35.0 44.1 10.4 8.5 1760.2 18.1 7.7 6.8 6.4 85.1 6.8 10.7 43.2 13.1 5.8 71.0 45.3 45.3 13.9 10.0 17.2 5.7 6.4 92.8 11.8 AL021546.1 ENSG00000111780 12 120438198-120460006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 9.9;HEK 293: 12.5;U-266/84: 11.1" HPA062394 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (3.79e-2)" "unprognostic (1.74e-1)" "unprognostic (2.79e-1)" "unprognostic (2.90e-1)" "unprognostic (1.71e-1)" "unprognostic (1.33e-1)" "unprognostic (9.54e-4)" "unprognostic (2.04e-1)" 4.8 6.0 12.8 3.6 11.6 4.7 4.5 8.4 14.8 4.6 16.3 4.2 3.3 3.6 5.1 3.6 6.0 7.1 3.6 6.7 8.9 6.3 11.5 12.1 5.3 4.2 10.5 7.2 9.6 10.3 3.6 4.9 5.8 11.6 6.5 3.6 3.1 5.4 4.3 4.3 4.1 11.4 3.6 5.9 9.2 7.1 4.8 7.7 3.5 6.3 3.8 4.0 6.6 5.1 6.5 12.9 5.8 10.7 2.8 7.4 4.3 2.2 3.1 0.0 0.7 0.0 0.0 0.0 2.1 0.4 0.5 0.0 9.9 0.0 0.6 3.8 0.0 1.0 1.0 0.0 0.5 0.0 1.8 12.5 0.8 0.0 0.0 0.0 4.3 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 0.0 3.6 0.4 0.4 0.0 5.0 2.0 1.4 1.1 0.0 0.0 5.3 0.4 3.3 1.0 0.0 0.0 1.0 0.5 2.8 1.7 0.5 0.0 1.5 1.1 11.1 4.0 0.7 1.5 0.0 2.0 5.8 5.8 6.5 10.7 7.4 6.5 4.0 7.4 12.9 6.0 4.5 4.0 1.7 2.8 8.1 10.0 7.2 4.3 12.8 11.6 8.4 14.8 8.9 6.3 10.5 7.2 11.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL360181.3 ENSG00000254536 10 133390834-133420495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 23.7" "HPA037826, HPA037827" Uncertain Approved Mitochondria NA NA Mitochondria "HPA037826: AB_2675692, HPA037827: AB_10670959" "unprognostic (3.71e-1)" "unprognostic (1.14e-2)" "unprognostic (3.84e-3)" "unprognostic (3.82e-1)" "unprognostic (9.99e-2)" "unprognostic (3.51e-2)" "unprognostic (6.61e-2)" "unprognostic (1.76e-1)" "unprognostic (8.11e-2)" "unprognostic (3.49e-2)" "unprognostic (2.41e-2)" "unprognostic (7.55e-2)" "unprognostic (1.34e-3)" "unprognostic (4.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.06e-2)" "unprognostic (9.86e-4)" 0.5 0.2 0.7 1.3 0.2 1.0 0.1 2.3 0.8 0.2 0.5 3.6 0.2 0.0 4.3 0.2 0.8 0.4 0.5 0.0 0.4 2.1 0.3 2.4 0.4 0.3 2.2 0.7 0.4 0.0 1.3 0.4 0.9 1.1 0.7 1.1 2.0 0.0 0.3 1.5 0.3 3.8 0.1 1.1 0.1 1.0 3.0 1.5 0.4 0.9 1.6 1.0 1.4 0.7 0.0 0.2 2.8 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.9 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.3 1.3 0.6 0.4 1.1 0.2 0.4 0.1 0.0 0.3 0.0 0.2 0.5 0.0 0.1 0.0 23.7 0.1 0.4 0.1 1.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.9 0.0 0.1 0.6 0.0 0.0 5.1 1.6 0.3 0.2 0.0 0.1 0.0 0.4 0.4 0.7 0.6 0.6 3.0 0.7 1.0 1.5 1.9 0.8 0.5 0.0 1.6 0.9 1.3 0.7 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALDH16A1 MGC10204 ENSG00000161618 "Aldehyde dehydrogenase 16 family member A1" Q8IZ83 19 49453169-49471048 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059488 Approved Approved Mitochondria NA NA 910000 Mitochondria "HPA059488: AB_2684037" "unprognostic (2.39e-1)" "unprognostic (3.95e-3)" "unprognostic (7.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-3)" "unprognostic (5.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.92e-2)" "unprognostic (4.90e-1)" "unprognostic (1.19e-3)" "unprognostic (4.28e-2)" "unprognostic (1.91e-3)" "unprognostic (2.94e-2)" "unprognostic (4.19e-1)" "unprognostic (1.27e-1)" "unprognostic (5.23e-3)" 13.3 11.0 6.9 16.9 9.6 13.3 10.5 6.0 8.2 12.3 14.2 6.6 7.4 21.0 12.5 7.7 11.4 9.9 15.3 6.2 4.8 3.0 10.5 22.0 8.7 14.2 12.1 3.1 8.9 15.1 6.5 6.0 10.8 8.5 7.8 4.0 6.2 8.0 9.6 6.5 15.2 19.9 5.6 5.2 21.8 12.4 4.5 9.6 16.8 9.4 10.6 14.6 9.6 9.9 13.2 12.0 12.0 19.8 5.8 7.4 4.5 11.5 15.7 3.8 8.9 1.7 1.2 12.4 7.4 2.4 5.8 6.0 8.0 4.4 17.5 11.9 1.0 1.3 8.0 1.5 4.3 0.7 10.9 9.1 13.5 5.6 11.5 2.5 8.2 30.4 2.1 2.5 2.8 2.2 1.1 3.7 6.0 9.4 18.1 1.4 11.7 5.9 23.5 8.1 5.0 0.0 9.9 5.4 13.0 2.8 13.7 6.7 7.7 6.7 7.5 6.1 0.9 6.8 9.5 8.4 8.6 5.7 3.9 8.2 15.2 17.5 5.0 2.1 11.7 6.0 7.6 7.1 12.0 6.8 17.7 7.4 12.5 6.8 7.4 11.3 13.2 6.3 6.4 1.3 5.8 19.8 12.0 5.4 4.5 6.9 9.6 6.0 8.2 4.8 3.0 12.1 3.1 8.5 9.6 6.0 7.8 18.6 22.3 8.9 7.2 3.5 15.3 12.0 4.5 10.4 7.9 30.8 5.0 18.8 1.2 13.5 30.2 0.0 21.3 25.9 16.0 10.3 17.3 13.7 40.0 1.6 12.6 13.5 25.6 2.3 25.9 18.9 15.1 36.1 11.3 6.7 15.0 20.1 7.8 19.0 5.2 19.4 8.6 2.1 13.6 9.3 33.8 12.2 15.6 30.4 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605929-95656706 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 68.8" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 58.2;Paneth cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 23000 Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 6.3 10.4 7.1 10.4 7.9 5.2 7.7 7.3 9.3 13.7 20.1 7.2 20.5 33.8 9.3 12.3 12.8 8.5 15.2 7.2 6.2 7.1 13.0 28.9 6.6 7.4 6.7 5.3 14.5 40.7 12.7 17.4 14.3 7.7 9.6 19.4 7.9 68.8 20.5 3.5 9.6 45.4 10.0 5.4 8.6 15.2 8.4 5.4 12.7 25.9 9.7 15.9 8.6 8.2 13.1 5.2 0.3 4.0 13.0 16.3 8.0 18.3 17.4 16.8 44.0 22.6 21.8 18.1 21.5 32.3 21.9 27.6 34.9 14.7 62.6 20.1 33.8 10.6 24.4 33.6 22.1 24.9 17.7 26.4 19.8 12.4 49.5 14.8 34.6 22.2 22.9 13.6 17.8 34.9 36.4 22.9 23.6 18.5 13.2 16.3 26.4 31.2 22.3 19.8 30.5 17.4 29.4 19.2 21.4 25.5 14.0 16.8 16.6 17.1 13.6 15.8 20.1 20.3 16.2 18.9 9.1 14.5 23.4 24.6 15.3 11.3 38.3 17.7 40.1 11.6 0.0 1.4 0.1 15.5 2.7 16.3 13.1 14.2 16.0 5.2 9.0 12.1 13.4 0.3 13.0 4.0 3.1 13.3 8.0 7.1 7.9 7.3 9.3 6.2 7.1 6.7 5.3 7.7 5.4 6.0 8.6 11.5 6.6 10.0 5.7 4.3 10.2 16.0 14.8 19.2 0.0 36.1 1.7 12.5 0.7 5.4 58.2 0.0 18.4 25.8 17.5 15.6 8.1 23.1 10.1 9.5 19.0 4.9 3.2 0.4 8.6 3.1 15.1 2.8 37.5 5.2 12.4 54.7 11.3 7.9 2.8 0.0 5.6 5.1 9.0 7.0 25.3 8.7 30.7 8.1 ALDH1L2 "FLJ38508, mtFDH" ENSG00000136010 "Aldehyde dehydrogenase 1 family member L2" Q3SY69 12 105019784-105084577 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "pancreas: 48.9;salivary gland: 31.6" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 8.3;monocytes: 6.4;Pancreatic endocrine cells: 5.6;Peritubular cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 23.0;ASC TERT1: 31.5;fHDF/TERT166: 35.7;HHSteC: 20.3;HSkMC: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039481, HPA059282" Approved Enhanced Mitochondria No No Mitochondria "HPA039481: AB_10795465, HPA059282: AB_2732633" "unprognostic (5.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.76e-1)" "unprognostic (8.86e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-1)" "unprognostic (5.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-8)" "unprognostic (3.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.53e-3)" "unprognostic (2.52e-5)" 4.2 1.2 3.2 2.7 1.9 0.7 2.7 5.3 2.7 5.5 2.2 0.9 3.3 2.4 2.9 3.2 1.5 2.6 2.7 2.9 1.6 2.0 0.7 0.4 2.7 2.0 2.0 2.1 1.0 48.9 0.7 2.8 1.1 2.5 3.6 2.3 4.8 31.6 4.5 1.0 1.5 1.3 5.4 5.3 1.2 3.7 0.8 1.3 0.0 2.2 1.4 3.0 3.9 2.2 0.2 1.3 0.0 0.1 0.0 0.1 0.1 4.4 0.4 0.2 9.6 23.0 31.5 0.5 14.2 9.2 1.8 4.9 0.5 0.0 0.0 0.6 35.7 0.0 0.0 0.0 0.3 2.3 0.0 0.1 0.2 0.0 1.1 20.3 1.8 0.0 25.5 1.1 4.8 9.1 0.0 1.0 0.0 0.7 12.9 3.7 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.3 1.6 0.0 2.9 7.2 0.1 2.1 15.2 0.1 1.4 1.4 0.0 0.7 16.0 4.2 0.0 5.8 6.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.1 3.2 1.9 5.3 2.4 1.6 2.0 2.0 2.1 2.5 1.3 0.0 1.1 0.0 0.1 0.5 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 3.7 0.1 0.0 0.0 8.3 0.3 4.3 0.3 0.0 0.0 0.4 4.8 0.0 1.8 0.3 4.5 3.4 1.1 5.0 6.4 0.0 1.2 5.6 0.0 6.3 0.0 0.5 0.0 3.1 0.4 0.0 0.5 0.2 0.0 0.0 0.1 ALDH4A1 "ALDH4, P5CDh" ENSG00000159423 "Aldehyde dehydrogenase 4 family member A1" P30038 1 18871430-18902781 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.7;liver: 92.6" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 313.9;Proximal tubular cells: 167.5" "Cancer enhanced" "Detected in all" "liver cancer: 72.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 34.6;SK-BR-3: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004645, HPA006401, HPA072759" Enhanced Supported Mitochondria NA NA 40000 Mitochondria "CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: " "unprognostic (1.17e-1)" "prognostic favorable (5.06e-4)" "unprognostic (1.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.15e-1)" "unprognostic (7.67e-2)" "unprognostic (1.28e-1)" "unprognostic (6.18e-2)" "unprognostic (1.92e-1)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-3)" "unprognostic (9.41e-3)" "unprognostic (3.83e-1)" "unprognostic (2.69e-3)" "unprognostic (9.34e-2)" 22.9 4.1 14.4 2.0 18.0 4.6 6.6 3.1 16.8 3.8 2.4 8.6 18.9 1.3 2.5 5.2 11.4 2.7 3.0 12.6 8.6 7.1 73.7 92.6 2.4 1.7 15.9 11.2 2.9 2.2 9.4 2.4 8.3 8.5 12.1 1.6 9.7 2.4 12.1 25.6 8.0 1.3 3.3 2.7 2.1 3.4 1.4 6.6 2.8 3.0 8.9 2.9 8.3 3.6 1.5 7.2 2.6 5.6 0.3 1.4 2.2 5.1 8.0 4.1 12.1 17.4 2.6 10.0 4.9 3.0 5.1 4.1 5.8 3.8 3.4 6.6 6.4 2.4 13.8 6.9 14.7 1.9 1.9 6.1 1.9 1.9 34.6 5.5 1.7 6.2 6.7 8.2 2.8 2.8 3.8 5.7 5.8 7.7 2.5 3.4 13.2 1.7 8.3 2.0 10.6 4.1 10.7 3.4 4.0 5.3 13.0 8.1 3.1 8.7 35.8 6.4 6.5 16.3 2.6 4.7 4.4 5.8 5.3 1.7 2.8 6.6 1.0 1.6 13.5 5.8 0.0 4.1 2.6 1.1 5.6 0.9 1.5 0.7 1.4 7.2 1.1 0.3 0.9 0.6 0.3 3.1 2.4 1.0 2.2 14.4 18.0 3.1 16.8 8.6 7.1 15.9 11.2 8.5 6.6 0.0 3.2 7.2 14.0 6.6 3.1 18.5 38.2 1.4 0.0 43.6 9.8 61.1 39.7 5.6 0.4 2.7 0.4 0.0 0.8 7.2 2.3 9.5 4.6 313.9 11.9 19.1 2.4 16.5 14.0 0.4 1.1 1.4 3.3 17.2 2.9 10.8 2.9 1.5 2.5 167.5 4.2 6.5 4.3 2.1 3.6 4.6 72.4 2.2 3.3 9.7 ALDH5A1 "SSADH, SSDH" ENSG00000112294 "Aldehyde dehydrogenase 5 family member A1" P51649 6 24494852-24537207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 41.1;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029715, HPA029716" Enhanced Supported Mitochondria NA NA 44000 Mitochondria "HPA029715: AB_10599994, HPA029716: AB_10601876" "unprognostic (7.43e-2)" "unprognostic (1.12e-3)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "prognostic favorable (7.61e-6)" "unprognostic (2.38e-2)" "unprognostic (2.17e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.43e-2)" "unprognostic (1.21e-1)" "prognostic favorable (3.68e-4)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.00e-2)" "unprognostic (1.08e-2)" 5.8 4.8 23.7 8.3 27.4 3.1 4.1 13.5 21.5 4.1 6.0 9.5 1.2 7.7 3.9 3.1 5.6 13.5 4.4 9.8 17.3 21.0 18.4 62.6 5.0 8.9 16.0 14.7 5.8 6.6 11.4 4.5 2.2 13.0 6.2 5.7 4.1 3.9 4.3 31.1 6.9 5.4 2.8 10.9 4.8 5.2 3.7 8.8 21.4 12.1 4.9 8.8 6.3 5.5 3.9 3.8 0.4 0.2 1.6 6.8 1.2 3.2 3.0 2.1 3.2 0.0 0.0 3.5 0.3 0.6 0.8 0.5 11.7 0.8 41.1 6.2 0.3 0.7 0.0 3.4 0.4 0.5 4.2 5.7 6.4 1.9 13.4 0.5 9.9 0.8 0.3 1.6 0.1 0.0 2.3 0.0 11.3 3.2 0.0 0.6 7.6 12.0 5.9 0.8 5.8 1.5 13.9 0.6 0.4 2.5 6.6 3.7 3.3 3.8 0.4 4.0 0.9 5.9 5.4 0.0 0.4 2.1 0.1 2.1 5.8 8.6 51.4 0.0 3.1 0.4 0.4 0.1 0.2 1.7 0.0 3.3 3.7 2.4 2.8 0.2 3.9 6.8 5.7 0.4 1.6 0.2 3.8 1.6 1.2 23.7 27.4 13.5 21.5 17.3 21.0 16.0 14.7 13.0 8.8 14.9 22.3 8.8 4.6 1.4 10.6 29.9 5.1 13.4 9.1 7.0 15.7 5.0 1.7 1.8 0.5 3.1 8.4 23.3 0.8 4.3 2.1 5.1 6.9 85.5 3.2 15.9 8.1 6.7 3.8 0.0 3.1 2.0 1.7 0.0 10.5 10.4 1.3 3.5 4.2 24.0 6.5 0.0 1.6 1.4 6.1 2.6 1.6 5.4 16.7 11.5 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 453.8;Proximal tubular cells: 730.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria No No 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favorable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favorable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.9 10.2 9.2 3.2 6.1 3.5 6.0 9.1 5.2 5.4 7.2 6.9 2.9 2.7 13.0 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.8 1.3 1.2 15.0 6.6 4.5 11.4 9.2 6.2 12.2 4.0 7.5 2.4 17.8 3.7 2.0 4.5 17.2 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 10.1 29.7 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.2 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 35.7 48.4 23.6 21.0 8.1 17.6 73.0 48.4 25.4 29.6 62.8 3.9 22.5 170.8 8.1 19.8 13.5 22.3 0.0 2.7 12.8 13.1 38.6 7.0 453.8 14.9 11.1 16.3 58.3 22.2 15.8 26.7 9.0 23.6 20.8 37.9 90.4 5.6 10.5 45.3 730.1 15.1 12.9 21.7 10.5 3.9 6.5 25.6 6.9 37.0 15.2 ALKBH7 "MGC10974, SPATA11" ENSG00000125652 "AlkB homolog 7" Q9BT30 19 6372433-6375251 "Predicted intracellular proteins" Necrosis "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 2375.8;Late spermatids: 5313.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008539, HPA039571, HPA039872" Approved Supported Mitochondria NA NA Mitochondria "HPA008539: , HPA039571: AB_2676577, HPA039872: AB_10697710" "unprognostic (5.38e-2)" "unprognostic (3.58e-2)" "unprognostic (2.20e-1)" "unprognostic (1.15e-2)" "unprognostic (7.79e-2)" "unprognostic (3.56e-3)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (3.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.72e-3)" "unprognostic (1.54e-1)" "prognostic favorable (7.83e-6)" "unprognostic (7.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" 10.8 14.7 13.7 14.1 15.2 12.7 13.6 16.3 15.8 12.3 25.0 11.1 28.4 30.9 12.4 18.8 17.2 15.4 18.7 49.3 12.6 11.9 17.1 32.7 20.2 26.3 14.2 11.9 19.0 65.0 10.2 14.0 7.9 15.8 15.5 9.8 16.0 29.7 21.5 62.9 11.9 29.6 15.8 15.9 9.9 14.2 96.5 7.3 29.9 19.4 29.5 16.2 12.6 13.6 34.3 43.8 19.7 32.8 18.4 45.9 28.4 9.8 8.6 7.6 13.2 4.3 12.1 9.4 5.9 6.4 6.5 6.9 15.1 6.4 12.7 22.3 9.1 4.6 7.6 3.4 6.0 1.3 12.9 12.0 6.8 6.3 14.0 12.6 4.1 10.3 13.8 12.1 5.6 4.4 6.3 8.0 14.4 7.7 28.6 4.9 20.0 20.1 14.1 10.5 11.7 35.9 14.2 3.9 26.8 7.2 7.8 10.1 15.0 4.0 12.9 24.8 3.8 14.6 15.5 5.3 6.5 8.4 23.8 6.8 41.2 29.8 8.4 12.2 13.4 5.6 9.9 32.8 4.9 17.1 26.5 23.5 34.3 29.8 23.3 38.8 31.6 45.9 36.0 19.7 18.4 20.4 43.8 25.3 28.4 13.7 15.2 16.3 15.8 12.6 11.9 14.2 11.9 15.8 7.3 56.6 70.3 108.8 116.9 74.4 87.5 95.6 99.3 38.8 48.9 62.8 62.8 75.6 265.2 90.7 2375.8 82.3 579.2 0.0 213.1 109.8 89.1 123.5 65.7 258.2 170.0 39.7 211.6 89.6 138.9 5313.3 95.5 116.1 126.5 202.0 317.0 99.5 112.2 399.8 83.4 312.4 107.3 90.5 100.1 945.7 49.4 88.0 91.1 82.2 334.4 200.6 ANKRD33B ENSG00000164236 "Ankyrin repeat domain 33B" A6NCL7 5 10564330-10657816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.3" "Cell type enriched" "Detected in many" 5 "Cone photoreceptor cells: 329.9" "Cancer enhanced" "Detected in many" "renal cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.1;memory B-cell: 1.4" "Group enriched" "Detected in many" 4 "B-cells: 1.4;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "HDLM-2: 27.4;HMC-1: 18.5" "Group enriched" "Detected in many" 9 "amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5" "Group enriched" "Detected in all" 6 "amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0" HPA056974 Uncertain Approved Mitochondria NA NA Mitochondria "HPA056974: AB_2683295" "unprognostic (6.19e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-2)" "unprognostic (5.65e-3)" "unprognostic (2.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (4.50e-3)" "unprognostic (4.41e-1)" "unprognostic (2.42e-3)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.16e-5)" "unprognostic (1.17e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (5.47e-2)" 3.8 1.1 6.3 8.6 9.3 13.2 3.6 1.4 25.3 5.2 3.2 0.1 0.4 0.9 7.8 1.1 3.3 5.4 1.9 7.0 8.4 2.3 10.0 1.5 3.0 5.4 2.0 7.5 1.7 2.7 0.5 1.7 3.5 1.3 3.5 2.0 12.7 2.3 4.4 9.0 11.3 3.3 6.9 1.7 11.1 3.1 5.2 1.1 7.2 1.6 12.5 7.2 4.9 16.6 1.4 0.0 2.1 0.0 0.0 0.4 0.4 2.5 3.8 0.2 0.3 9.0 4.3 11.4 0.7 1.2 1.5 1.8 4.7 2.1 14.0 12.8 2.4 1.8 2.6 1.3 1.3 1.7 27.4 0.9 5.5 3.4 0.0 4.1 4.2 18.5 2.1 1.0 0.8 5.2 0.3 1.9 1.0 1.2 6.8 0.4 0.0 0.2 5.0 3.0 0.0 1.1 1.1 2.9 0.4 5.1 1.8 0.0 0.1 0.0 0.2 0.4 10.0 0.0 5.2 5.4 0.9 5.6 4.6 1.3 8.0 8.7 1.2 0.2 6.8 0.3 0.0 0.0 2.1 0.2 0.0 0.0 1.4 0.4 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.4 6.3 9.3 1.4 25.3 8.4 2.3 2.0 7.5 1.3 1.1 11.9 1.0 1.9 1.7 0.3 14.4 4.5 0.0 0.0 1.2 3.5 329.9 1.0 1.7 1.8 4.9 2.3 0.0 0.0 0.2 0.8 5.0 3.1 0.0 0.0 0.2 6.4 0.0 2.5 0.0 0.0 1.4 0.7 1.7 26.2 0.0 5.8 0.2 0.0 0.0 18.3 67.9 0.0 0.2 0.0 1.9 1.0 0.5 0.5 0.0 1.7 ANKRD34C ENSG00000235711 "Ankyrin repeat domain 34C" P0C6C1 15 79293285-79298235 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 5.8;skin 1: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045329 Approved Mitochondria NA NA Mitochondria "HPA045329: AB_2679291" "unprognostic (3.20e-1)" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.42e-3)" "unprognostic (5.31e-2)" "unprognostic (2.48e-1)" 0.5 0.3 0.6 0.0 0.5 0.0 0.0 5.8 5.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.9 5.0 0.1 0.0 0.3 0.0 2.4 0.0 0.7 0.1 1.2 0.0 0.1 0.1 0.0 0.2 0.2 3.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD63 ENSG00000230778 "Ankyrin repeat domain 63" C9JTQ0 15 40281444-40282586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;HEK 293: 5.5;HEL: 2.7;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 4.0" "Region enhanced" "Detected in many" "basal ganglia: 50.7" "Region enhanced" "Detected in many" "basal ganglia: 40.3" HPA066743 Approved Mitochondria NA NA Mitochondria "HPA066743: " "unprognostic (9.36e-2)" "unprognostic (7.45e-2)" "unprognostic (8.32e-2)" "unprognostic (4.42e-1)" 0.2 0.2 1.8 0.4 22.4 0.2 0.2 0.3 4.7 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.2 0.7 0.3 0.5 0.3 0.4 1.3 0.2 0.2 0.3 0.3 1.1 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.5 0.2 0.0 0.7 0.3 0.7 1.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.5 2.7 1.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.1 0.0 0.0 0.2 1.9 0.2 0.0 0.4 1.4 0.0 0.4 0.0 0.1 2.0 0.2 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 22.4 0.3 2.8 0.3 0.4 0.3 1.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APBB2 "FE65L, FE65L1, MGC35575" ENSG00000163697 "Amyloid beta precursor protein binding family B member 2" Q92870 4 40810027-41216714 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 74.5;Horizontal cells: 58.8;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "naive B-cell: 9.4" "Lineage enriched" "Detected in single" 14 "B-cells: 9.4" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 41.7;TIME: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023542 Approved Approved Mitochondria No No Mitochondria "HPA023542: AB_1844909" "unprognostic (4.43e-2)" "unprognostic (4.40e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (5.91e-3)" "unprognostic (8.13e-2)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (2.51e-1)" "unprognostic (1.21e-2)" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "unprognostic (2.19e-3)" "unprognostic (9.35e-3)" "unprognostic (3.92e-2)" "unprognostic (2.29e-2)" "unprognostic (2.61e-1)" 35.1 9.1 18.4 5.1 25.5 7.2 20.9 7.6 30.1 13.9 10.8 42.9 8.3 7.9 14.2 5.9 9.0 11.6 15.8 18.8 19.4 15.1 17.0 13.9 17.5 6.7 34.3 16.8 31.5 10.1 9.8 10.2 16.3 29.8 8.4 8.2 13.7 7.6 10.3 22.4 10.6 6.0 14.4 30.7 13.2 10.1 8.8 35.1 2.3 32.9 5.3 5.4 11.8 15.4 9.4 0.3 0.6 0.4 0.2 0.1 0.4 5.3 2.7 6.2 8.6 21.3 16.4 13.7 10.4 13.6 4.2 7.4 9.5 11.4 9.9 5.9 4.6 12.7 1.6 11.0 14.4 7.7 0.3 2.2 0.1 6.7 6.3 20.7 5.5 0.3 24.4 7.8 12.5 13.0 18.0 41.7 5.7 0.3 0.2 27.0 4.7 1.8 1.0 5.1 2.8 5.2 14.8 17.9 11.5 6.2 2.5 8.3 4.8 3.3 2.0 2.1 7.6 5.0 0.6 55.2 6.0 17.4 4.1 18.0 2.5 5.1 12.0 6.6 9.1 7.1 0.6 0.4 0.2 0.1 0.1 0.1 0.7 0.1 0.1 0.3 9.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.4 18.4 25.5 7.6 24.6 19.4 15.1 34.3 16.8 29.8 35.1 74.5 12.6 0.8 3.6 9.5 6.2 13.6 15.3 4.0 7.9 8.7 5.9 12.6 6.6 3.6 13.9 32.4 4.6 0.0 5.6 2.1 18.8 2.1 1.1 12.1 2.7 58.8 2.9 45.4 5.6 15.2 33.1 3.1 6.8 0.0 3.8 11.2 5.4 4.9 35.0 4.8 7.2 58.2 24.7 3.6 9.8 10.5 5.0 0.5 6.4 2.7 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515131 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 39.2;smooth muscle: 10.9" "Cell type enhanced" "Detected in single" 29 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 43.4;hTEC/SVTERT24-B: 15.4;HUVEC TERT2: 15.6;TIME: 30.5;U-87 MG: 19.2" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria No No Mitochondria "HPA067015: AB_2685764" "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.5 0.6 0.2 0.6 0.2 0.0 5.2 0.6 0.1 3.3 1.2 0.1 0.0 0.1 2.4 0.2 0.8 0.0 2.1 5.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 3.6 0.7 3.2 39.2 1.7 0.6 0.9 0.8 10.9 0.3 0.0 0.6 0.1 0.0 0.0 0.1 1.0 0.6 6.1 5.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 9.2 0.0 0.9 0.7 0.0 2.8 0.0 0.0 43.4 0.2 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.3 0.0 15.4 0.2 3.1 15.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 6.5 0.4 0.0 8.5 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOOL "AAIR8193, CXorf33, FAM121A, Mic27, UNQ8193" ENSG00000155008 "Apolipoprotein O like" Q6UXV4 X 85003826-85093316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000612 Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA000612: AB_1078594" "prognostic unfavorable (2.68e-5)" "unprognostic (2.72e-2)" "unprognostic (6.16e-2)" "unprognostic (5.71e-3)" "unprognostic (4.27e-3)" "unprognostic (1.47e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (8.35e-2)" "unprognostic (1.10e-1)" "unprognostic (2.77e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.35e-12)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "unprognostic (7.11e-2)" "unprognostic (7.51e-2)" 9.9 13.2 6.2 5.2 11.2 4.5 8.6 4.3 11.9 7.8 8.2 7.1 6.6 8.2 8.6 8.4 14.0 7.7 6.3 16.1 8.3 6.8 16.2 20.1 6.7 4.3 8.4 7.4 8.0 14.2 17.0 12.9 7.3 14.0 7.8 9.2 7.4 9.9 6.4 20.4 9.2 10.4 8.9 8.8 4.9 9.2 4.6 8.2 7.3 12.7 11.1 5.6 11.0 9.4 7.8 5.9 7.1 6.7 3.6 5.2 2.1 11.5 9.5 6.5 7.9 16.6 11.4 7.4 7.8 7.4 6.6 7.9 8.3 7.4 8.4 8.7 8.2 15.9 8.7 19.6 7.5 11.5 9.0 8.0 8.9 11.9 7.4 9.9 16.3 8.8 12.2 9.9 11.7 19.4 6.6 9.4 11.3 16.1 13.6 10.5 8.9 6.5 4.8 5.7 9.1 14.5 7.4 14.9 8.5 7.0 9.1 0.6 9.1 14.9 11.9 7.2 7.7 7.7 6.3 11.0 8.0 12.3 17.2 8.8 6.4 27.1 8.4 9.1 12.8 7.7 7.1 4.7 3.4 4.7 6.7 3.9 7.8 4.4 3.6 5.0 4.5 5.2 4.7 1.0 3.6 5.5 5.9 3.0 2.1 6.2 11.2 4.3 11.9 8.3 6.8 8.4 7.4 14.0 8.2 14.9 15.5 9.3 11.2 4.9 25.7 45.1 15.3 10.7 9.1 19.2 13.7 13.8 11.6 15.6 0.0 11.7 9.8 0.0 12.2 9.6 7.1 20.2 20.8 41.2 10.2 20.6 35.6 14.1 12.4 0.2 12.7 10.9 0.0 3.6 15.0 15.1 14.9 16.4 14.5 24.8 15.6 19.4 8.9 2.4 7.2 3.0 16.2 4.5 14.7 14.8 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445134-74455009 "Cancer-related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 83.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3" "Group enriched" "Detected in many" 9 "granulocytes: 11.6;NK-cells: 3.3" "Cell line enhanced" "Detected in some" "CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5" "Region enriched" "Detected in single" 4 "olfactory region: 1.5" "Low region specificity" "Detected in all" "HPA008720, CAB023519" Approved Approved Mitochondria NA NA 1520000 Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 19.5 1.1 0.4 9.2 2.1 28.9 20.3 0.3 0.4 5.7 6.7 0.2 0.2 0.7 1.7 1.6 22.3 6.0 34.8 13.6 0.5 0.4 2.5 1.7 14.4 13.3 0.4 0.0 5.8 1.0 0.0 7.8 83.5 1.3 1.9 5.0 1.4 3.9 0.9 9.9 3.4 10.0 1.5 1.0 11.3 5.3 4.6 0.0 1.6 1.2 13.4 13.6 8.7 4.6 0.4 0.8 11.6 0.0 3.3 0.4 0.1 1.7 12.2 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.3 42.8 6.8 0.0 0.9 0.0 0.0 1.9 0.0 74.1 0.7 0.0 0.0 0.0 0.3 2.0 23.0 0.2 0.0 0.7 75.5 4.4 161.4 0.1 0.0 0.0 0.1 0.0 1.6 46.5 0.0 0.0 0.0 8.8 4.9 0.0 0.0 0.0 4.2 0.3 0.0 0.0 2.5 0.1 0.0 0.0 1.3 0.0 0.1 0.0 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.2 0.0 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.4 0.2 0.0 0.1 3.3 0.0 0.1 0.0 0.1 0.4 2.1 0.3 0.4 0.5 0.4 0.4 0.0 1.3 0.0 184.6 339.4 82.8 759.9 994.1 0.0 30.5 71.4 92.3 310.5 48.8 0.0 1.3 0.0 52.7 45.1 3.9 632.3 0.0 8.6 1.2 28.2 73.6 633.9 2.9 31.8 0.0 39.8 10.4 189.5 5.9 0.3 134.1 32.1 1.8 188.0 0.0 301.5 221.0 1.1 0.5 0.0 19.4 4.4 52.0 45.0 299.4 0.9 149.6 119.9 1407.8 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619798-67651720 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 53.7;thyroid gland: 75.4" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 140.3;Collecting duct cells: 157.1;Syncytiotrophoblasts: 502.9;Urothelial cells: 134.9" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria NA NA Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 1.5 3.9 2.4 1.7 6.4 0.6 2.7 8.3 5.3 9.3 5.4 0.5 2.0 2.1 3.7 2.3 7.3 0.8 4.9 2.1 3.3 5.5 41.4 2.0 1.7 0.6 3.2 1.7 8.8 2.6 32.1 22.5 4.4 4.6 53.7 1.1 3.4 26.6 3.8 17.2 0.8 10.4 2.2 3.9 0.7 1.4 1.9 2.1 0.1 75.4 13.6 2.2 5.3 4.1 2.5 1.7 2.0 1.4 0.3 2.9 3.4 3.5 0.5 6.2 4.0 0.9 0.0 8.4 2.7 7.5 9.0 15.3 15.3 1.8 6.0 0.7 1.8 4.1 0.8 24.9 11.3 11.0 0.2 6.2 2.7 1.1 17.4 2.7 0.6 16.3 0.4 14.7 4.4 21.5 0.7 15.3 16.1 7.9 0.0 0.6 1.7 0.9 0.6 11.8 1.5 0.2 0.2 0.8 6.8 7.3 5.9 13.8 5.2 1.7 1.7 2.6 15.0 6.4 0.2 3.1 2.7 6.9 0.2 2.0 0.5 0.9 2.0 5.5 3.1 4.6 0.3 1.4 2.0 1.1 0.5 0.5 0.7 0.3 0.9 1.7 2.5 0.6 0.6 1.7 0.3 1.2 0.1 2.9 3.4 2.4 6.4 8.3 5.3 3.3 5.5 3.2 1.7 4.6 2.1 0.0 4.3 3.7 140.3 7.8 5.0 5.0 2.5 2.7 27.3 157.1 9.8 82.0 31.5 9.2 12.3 3.0 14.8 23.3 2.8 5.2 3.7 84.0 6.9 1.5 12.3 9.5 35.3 1.8 0.3 1.0 0.3 3.9 10.1 1.0 4.3 40.7 4.5 3.5 0.4 75.6 16.0 6.5 4.1 7.2 2.6 4.6 502.9 5.0 3.3 134.9 ARHGAP20 KIAA1391 ENSG00000137727 "Rho GTPase activating protein 20" Q9P2F6 11 110577042-110713189 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Leydig cells: 45.1;Peritubular cells: 34.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;ASC TERT1: 7.7;HHSteC: 5.1;SiHa: 6.4;U-2197: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038458, HPA038459, HPA076303" Uncertain Approved Mitochondria NA NA Mitochondria "HPA038458: AB_10672517, HPA038459: AB_2676022, HPA076303: AB_2686792" "unprognostic (1.69e-2)" "unprognostic (3.97e-2)" "unprognostic (6.83e-2)" "unprognostic (1.34e-1)" "unprognostic (2.66e-1)" "unprognostic (8.47e-3)" "unprognostic (2.75e-1)" "unprognostic (2.90e-2)" "unprognostic (4.15e-2)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (9.52e-2)" "unprognostic (2.82e-5)" "unprognostic (1.84e-2)" "unprognostic (9.15e-2)" "unprognostic (6.21e-3)" "unprognostic (4.10e-2)" 14.4 4.6 5.9 2.6 13.0 0.6 8.4 7.7 12.0 9.1 3.7 1.9 9.2 2.0 8.3 7.0 4.4 6.2 4.4 1.3 4.8 6.2 1.2 3.4 7.6 2.3 3.4 6.3 4.3 0.8 1.6 2.0 3.4 5.8 7.7 5.5 9.7 2.7 16.8 2.0 2.2 2.9 12.1 3.0 2.7 3.9 14.1 2.2 0.0 8.9 2.1 1.9 6.3 4.9 1.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 7.7 0.0 1.0 3.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.3 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.0 0.0 0.1 0.0 1.9 0.8 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 13.0 7.7 12.0 4.8 6.2 3.4 6.3 5.8 2.2 0.0 2.9 0.0 3.5 0.7 5.8 0.8 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 8.4 1.4 0.0 0.0 0.3 0.1 3.1 0.8 1.1 2.1 0.2 3.2 0.0 9.2 1.0 2.6 45.1 1.4 3.3 0.0 0.0 0.4 0.4 0.0 34.3 0.0 1.3 0.0 1.8 2.9 10.4 0.4 0.6 0.0 0.0 0.7 ARMC1 "Arcp, FLJ10511" ENSG00000104442 "Armadillo repeat containing 1" Q9NVT9 8 65602456-65634217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026085 Approved Approved Mitochondria NA NA Mitochondria "HPA026085: AB_1845031" "prognostic unfavorable (4.81e-4)" "unprognostic (1.35e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (8.18e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (7.73e-4)" "unprognostic (4.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (9.15e-4)" "unprognostic (1.81e-1)" "unprognostic (3.30e-3)" "unprognostic (1.08e-1)" "unprognostic (1.07e-1)" "unprognostic (1.98e-1)" "unprognostic (1.66e-1)" 16.2 16.5 25.5 13.1 25.6 11.5 19.2 30.4 32.3 17.1 19.0 22.6 10.2 15.8 19.7 17.8 17.7 14.1 12.3 21.6 26.9 24.0 22.9 23.5 12.6 18.1 24.5 18.7 20.4 15.2 18.4 18.9 16.7 27.1 19.2 17.6 13.1 15.1 18.8 22.2 11.6 15.3 22.5 27.5 15.0 14.5 10.0 18.9 20.7 15.4 10.4 20.0 20.4 14.0 8.8 6.1 20.7 7.9 9.6 10.5 5.8 22.7 16.3 15.9 14.8 15.8 14.5 11.6 20.5 15.3 21.8 16.1 11.9 18.5 35.5 5.2 18.5 23.7 15.3 28.4 16.5 29.7 20.1 14.8 27.5 10.4 17.3 21.1 10.3 15.0 13.2 19.1 17.9 24.7 17.2 22.3 25.3 28.3 25.3 23.3 14.6 38.1 13.6 16.5 28.5 18.1 22.2 19.9 12.5 17.2 10.8 11.8 12.8 12.9 16.4 19.3 16.9 26.3 12.2 13.2 20.7 15.2 15.6 19.1 18.8 19.8 24.0 19.6 19.3 20.0 20.7 4.8 6.1 7.6 7.9 10.5 8.8 9.1 9.1 6.1 6.8 9.4 9.3 0.6 9.6 7.2 5.3 9.5 5.8 25.5 25.6 30.4 32.3 26.9 24.0 24.5 18.7 27.1 18.9 38.7 20.1 24.4 9.6 14.1 23.1 28.3 12.7 16.0 27.3 15.7 21.6 29.7 46.4 22.5 6.2 16.3 15.7 23.3 24.4 37.1 21.1 14.3 10.4 21.3 22.4 19.1 22.4 26.4 15.1 4.3 24.2 16.9 20.3 28.9 18.5 44.1 23.2 10.5 31.5 32.1 20.5 6.5 25.5 31.8 21.7 16.2 31.5 20.1 21.7 7.6 ARMC10 "MGC3195, SVH" ENSG00000170632 "Armadillo repeat containing 10" Q8N2F6 7 103074881-103099764 "Predicted intracellular proteins, Predicted membrane proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011036, HPA011057" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA011036: AB_1080139, HPA011057: AB_1080137" "unprognostic (7.03e-3)" "unprognostic (2.44e-1)" "unprognostic (8.18e-2)" "unprognostic (3.53e-1)" "prognostic unfavorable (8.90e-6)" "unprognostic (3.85e-3)" "prognostic unfavorable (3.58e-4)" "unprognostic (5.57e-2)" "unprognostic (3.49e-2)" "unprognostic (7.90e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (1.02e-1)" "unprognostic (5.78e-2)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (1.14e-2)" "unprognostic (5.67e-2)" 21.6 21.7 28.0 12.6 25.0 9.1 24.5 11.4 28.0 24.4 18.6 24.7 20.8 14.0 20.4 24.2 22.2 23.2 20.0 16.7 26.2 26.2 27.4 30.2 15.0 15.7 26.3 24.2 26.5 28.7 26.0 12.0 15.4 19.7 22.2 18.8 17.6 15.7 23.4 15.8 21.6 12.8 20.3 25.5 14.4 19.8 14.1 19.6 21.5 30.7 15.6 15.7 22.3 20.5 5.1 6.8 6.6 5.4 3.9 4.7 2.2 12.6 10.8 6.4 12.4 13.4 12.8 6.4 8.9 9.7 6.4 7.8 5.8 15.0 22.8 19.3 7.8 18.4 11.4 9.0 9.9 9.2 8.5 10.3 8.0 4.6 2.8 13.5 22.0 9.6 8.3 17.5 8.1 13.3 19.6 14.6 12.9 19.6 14.1 11.4 23.4 16.1 17.1 14.3 21.7 11.7 9.8 6.7 29.6 16.3 8.9 7.2 9.9 12.1 18.3 13.4 11.6 7.4 11.0 9.7 10.0 9.5 23.4 13.3 21.7 33.9 18.3 11.3 20.5 12.4 0.0 4.4 6.6 2.6 5.4 4.5 4.0 4.1 4.4 6.8 5.1 4.6 4.7 0.9 3.9 2.8 5.3 4.2 2.2 28.0 25.0 11.4 28.0 26.2 26.2 26.3 24.2 19.7 19.6 23.8 17.0 26.1 49.5 69.9 22.6 15.4 22.9 6.7 15.9 26.2 13.7 38.2 56.3 15.6 10.1 27.0 15.3 0.0 13.3 39.5 28.9 60.5 17.3 34.7 41.8 7.9 14.5 25.2 32.4 6.3 31.4 31.1 43.9 2.8 33.1 24.5 20.4 10.5 32.2 71.6 26.5 32.3 47.6 11.6 30.8 91.1 37.6 30.5 39.3 65.2 AS3MT CYT19 ENSG00000214435 "Arsenite methyltransferase" Q9HBK9 10 102869516-102901899 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 92.8;parathyroid gland: 30.0" "Cell type enhanced" "Detected in single" 20 "Club cells: 1.2" "Cancer enhanced" "Detected in single" "liver cancer: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 14.3;REH: 27.2;SH-SY5Y: 14.6;T-47d: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017856 Enhanced Approved Mitochondria NA NA Mitochondria "HPA017856: AB_1847420" "unprognostic (1.11e-1)" "unprognostic (2.02e-4)" "unprognostic (2.45e-1)" "unprognostic (2.25e-1)" "unprognostic (3.39e-1)" "unprognostic (1.66e-1)" "unprognostic (7.02e-4)" "unprognostic (3.22e-1)" "unprognostic (1.42e-1)" "unprognostic (3.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.83e-1)" "unprognostic (3.83e-10)" "unprognostic (1.04e-2)" "unprognostic (4.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" 2.0 92.8 3.7 0.7 8.6 0.5 2.6 4.5 6.4 4.0 2.0 2.2 0.4 1.3 3.8 3.2 2.1 2.1 5.2 10.0 5.7 3.1 7.4 22.4 1.7 0.9 2.8 4.4 3.9 8.7 30.0 2.4 0.5 4.6 4.2 0.8 8.9 2.2 3.4 6.0 1.8 1.3 3.9 2.7 5.6 1.7 3.5 1.6 0.3 3.2 1.0 0.7 1.8 1.8 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 3.9 14.3 8.9 0.3 0.3 2.6 4.1 3.5 6.2 7.6 10.6 0.6 0.2 1.2 5.4 0.3 0.2 12.1 0.7 6.4 0.0 3.5 0.0 1.7 10.4 4.1 0.2 0.1 1.9 1.6 0.8 0.0 11.2 0.2 13.2 0.0 0.2 5.5 0.1 2.4 0.3 6.8 0.0 0.6 27.2 0.0 0.1 1.3 0.1 0.4 14.6 0.0 0.2 1.9 4.9 22.7 0.3 0.1 1.3 0.0 2.0 0.0 0.3 0.2 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.7 8.6 4.5 6.4 5.7 3.1 2.8 4.4 4.6 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATAD3A FLJ10709 ENSG00000197785 "ATPase family, AAA domain containing 3A" Q9NVI7 1 1512151-1534687 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA058968, HPA064867, HPA065305" Approved Enhanced Mitochondria NA NA Mitochondria "HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459" "unprognostic (8.42e-2)" "unprognostic (1.67e-1)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.50e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (6.62e-2)" "unprognostic (9.53e-2)" "unprognostic (5.81e-2)" "unprognostic (4.09e-2)" "unprognostic (7.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (3.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.87e-3)" 10.8 13.9 11.2 16.3 11.3 25.0 9.3 9.3 14.8 9.2 11.0 11.1 12.5 16.4 10.4 7.6 16.8 9.3 11.9 15.9 9.2 8.2 12.9 26.7 9.7 13.9 10.5 13.3 8.5 20.4 8.1 16.6 11.3 8.3 10.7 6.2 9.6 19.5 9.5 31.1 13.3 12.2 8.9 8.5 12.4 13.0 12.7 9.1 14.0 12.4 21.1 14.3 9.3 9.4 3.3 4.7 1.3 6.2 5.1 4.0 2.1 21.1 11.9 5.3 13.5 2.7 3.2 12.6 17.5 5.2 15.5 9.4 30.5 14.6 11.7 12.1 6.9 5.7 18.1 7.4 10.3 2.6 11.2 32.0 20.4 29.3 20.4 5.1 29.3 13.1 3.7 3.4 12.5 5.2 2.0 6.7 12.9 31.8 9.0 5.5 14.9 22.0 26.8 10.8 7.1 25.6 24.0 10.0 24.2 4.2 8.9 26.7 10.5 10.8 16.5 13.7 1.9 7.2 14.5 9.1 15.8 12.3 24.1 21.3 13.5 13.2 47.1 15.4 44.0 7.0 0.2 4.0 1.3 3.3 2.9 2.5 3.3 3.8 4.0 4.7 3.0 3.4 1.5 0.1 5.1 6.2 4.4 2.8 2.1 11.2 11.3 9.3 14.8 9.2 8.2 10.5 13.3 8.3 9.1 3.0 7.0 11.9 8.0 18.1 10.3 9.5 7.6 1.4 4.5 7.0 5.9 16.8 6.6 21.0 7.6 11.1 10.0 0.0 18.2 36.3 8.9 11.6 9.2 13.1 19.8 22.3 13.2 4.3 5.0 8.2 5.2 7.7 15.1 5.4 13.0 10.2 20.6 5.8 7.4 9.7 9.0 0.0 10.3 5.4 25.6 21.2 16.5 5.3 20.7 12.2 ATAD3B "KIAA1273, TOB3" ENSG00000160072 "ATPase family, AAA domain containing 3B" Q5T9A4 1 1471769-1497848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA058968, HPA064867, HPA065305" Approved Enhanced Mitochondria NA NA Mitochondria "HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459" "unprognostic (6.05e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (1.30e-1)" "unprognostic (1.97e-2)" "unprognostic (3.68e-1)" "prognostic unfavorable (1.81e-5)" "unprognostic (1.51e-1)" "unprognostic (2.27e-2)" "unprognostic (2.17e-2)" "unprognostic (8.24e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (5.48e-9)" "unprognostic (2.38e-2)" "unprognostic (2.80e-1)" "unprognostic (3.00e-2)" "unprognostic (1.68e-1)" 13.7 7.6 7.5 18.9 9.5 24.3 10.4 11.6 10.8 7.4 9.6 8.7 8.2 12.1 10.0 7.0 11.3 8.1 8.4 6.4 7.5 6.5 9.9 14.5 9.8 17.3 9.5 8.1 10.1 16.5 3.2 13.6 10.3 7.6 11.0 3.8 8.8 16.3 16.5 9.9 15.8 12.3 8.8 6.8 14.5 15.4 9.3 8.2 7.9 9.3 6.6 13.1 5.9 10.0 0.3 0.8 1.4 3.7 0.2 2.0 0.5 6.9 0.0 2.1 11.6 0.6 0.9 15.9 11.2 2.6 11.0 8.4 25.7 20.5 9.8 3.5 4.3 6.6 12.8 14.1 7.0 2.3 8.3 13.3 6.8 16.8 15.7 2.6 11.3 8.0 2.5 0.4 18.1 1.1 0.2 3.8 3.2 20.2 2.2 4.0 3.5 13.4 13.2 22.6 4.6 25.7 10.8 3.4 7.1 3.2 4.6 8.9 7.2 8.3 10.7 9.5 1.4 1.6 4.0 4.7 3.0 6.4 17.4 11.8 6.4 8.8 23.8 9.5 18.8 3.3 0.0 0.7 1.4 1.6 3.7 2.0 0.3 1.0 1.4 0.8 0.0 0.3 0.1 0.0 0.2 1.9 0.5 0.0 0.5 7.5 9.5 11.6 10.8 7.5 6.5 9.5 8.1 7.6 8.2 6.0 26.1 12.0 6.7 23.4 14.1 4.0 10.2 1.4 7.9 8.7 19.6 10.1 1.7 7.4 3.2 6.8 8.4 0.0 6.5 33.5 8.1 6.7 11.5 7.6 10.8 12.7 6.9 4.9 2.8 1.8 4.0 6.3 10.1 3.6 9.1 7.8 9.4 8.0 2.8 1.7 15.6 6.5 8.2 5.1 9.6 20.6 14.9 8.4 10.6 10.2 ATAD3C FLJ34599 ENSG00000215915 "ATPase family, AAA domain containing 3C" Q5T2N8 1 1449689-1470158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 17.5;Collecting duct cells: 19.2;Distal tubular cells: 38.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 16.5" HPA065305 Approved Mitochondria NA NA Mitochondria "HPA065305: AB_2685459" "unprognostic (9.23e-2)" "unprognostic (3.48e-2)" "unprognostic (3.20e-2)" "unprognostic (4.35e-3)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (3.79e-2)" "prognostic favorable (5.15e-4)" "unprognostic (1.23e-1)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (2.65e-1)" "unprognostic (3.80e-2)" "unprognostic (1.83e-1)" "unprognostic (5.74e-2)" "unprognostic (2.22e-1)" "unprognostic (2.12e-3)" 0.7 0.0 2.1 1.7 2.3 0.7 2.7 0.3 1.5 1.3 1.8 0.9 1.4 2.6 0.7 2.5 1.3 0.4 2.8 1.5 3.1 4.9 2.2 0.7 2.6 1.1 5.0 0.1 1.5 0.3 4.0 0.6 5.4 4.5 0.2 1.2 0.5 1.3 4.3 0.5 0.5 0.7 4.1 0.9 2.2 0.9 2.1 0.6 2.9 0.6 1.6 4.3 0.7 0.3 0.0 0.3 0.5 0.5 0.1 0.4 0.1 0.1 0.2 0.1 1.6 3.3 0.3 0.4 0.1 0.1 0.4 1.3 0.5 0.1 0.1 1.3 0.3 0.9 2.0 0.2 0.3 0.3 0.0 0.2 0.2 1.0 0.1 0.0 0.4 0.3 3.9 0.1 0.9 0.5 1.0 0.6 0.1 0.2 0.4 0.1 16.5 1.1 0.4 2.8 1.0 0.0 0.6 0.2 3.0 3.6 0.3 0.3 0.2 0.3 0.5 0.2 1.9 2.7 0.6 0.2 0.4 0.1 2.9 0.6 1.1 1.1 0.4 4.3 2.1 1.5 1.3 0.1 1.3 1.9 1.4 2.5 1.6 0.3 0.6 2.0 0.7 6.0 17.5 0.8 3.2 3.1 4.3 3.3 0.0 1.4 3.4 19.2 15.7 0.7 38.1 4.6 0.3 3.6 0.6 0.0 8.0 0.2 1.0 3.5 3.5 5.9 1.6 6.4 4.1 3.1 2.1 1.1 1.1 1.3 3.3 0.0 1.6 2.8 4.5 0.0 4.6 10.8 8.0 0.0 1.0 0.5 0.9 5.0 0.7 2.9 1.2 2.2 ATP5F1A "ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM" ENSG00000152234 "ATP synthase F1 subunit alpha" P25705 18 46080248-46104334 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 678.0;Distal tubular cells: 994.7;Proximal tubular cells: 716.2;Syncytiotrophoblasts: 483.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013067, HPA040622, HPA044202" Enhanced Supported Mitochondria NA NA 51000000 Mitochondria "CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855" "unprognostic (3.08e-2)" "unprognostic (9.13e-2)" "unprognostic (1.84e-2)" "unprognostic (3.54e-1)" "unprognostic (6.36e-2)" "unprognostic (2.61e-1)" "unprognostic (1.89e-2)" "unprognostic (6.79e-2)" "unprognostic (8.31e-2)" "unprognostic (4.79e-2)" "unprognostic (7.30e-3)" "unprognostic (1.50e-2)" "prognostic favorable (1.22e-15)" "unprognostic (4.60e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-1)" "unprognostic (4.87e-3)" 30.1 60.0 34.7 30.3 45.8 22.4 33.9 52.6 65.0 27.0 52.1 20.5 39.3 55.6 25.2 30.5 44.4 30.0 27.9 196.2 31.4 36.1 94.0 64.8 25.2 40.2 42.3 31.8 28.6 49.0 73.2 35.9 25.7 41.5 28.3 54.9 37.6 42.6 42.8 182.2 34.0 50.4 36.6 22.6 32.1 46.7 24.0 19.9 45.6 35.1 99.7 41.1 31.5 26.4 58.7 110.9 17.9 64.5 44.2 63.6 124.8 43.2 44.1 58.7 55.1 71.5 79.5 65.1 50.1 71.1 77.2 67.7 66.0 34.2 102.6 30.7 60.6 41.4 80.7 101.1 76.9 72.1 45.6 56.8 67.8 56.9 81.7 46.9 143.4 64.4 73.2 54.0 55.6 58.0 62.1 79.6 55.7 54.7 60.7 66.0 45.0 73.7 70.6 55.0 42.4 46.6 73.0 68.3 138.6 104.7 105.9 59.8 55.8 36.7 45.9 61.5 57.6 59.1 83.8 46.3 42.5 36.8 22.3 43.6 69.7 59.6 66.1 42.4 86.3 45.2 11.8 64.5 17.9 43.5 58.2 55.8 58.7 52.4 47.5 110.9 44.0 63.6 52.8 6.7 44.2 52.2 54.0 58.9 124.8 34.7 45.8 52.6 65.0 31.4 36.1 42.3 31.8 41.5 19.9 157.8 126.7 0.0 0.0 0.0 0.0 0.0 0.0 175.3 184.2 162.3 0.0 678.0 994.7 285.1 0.0 0.0 0.0 0.0 236.7 359.7 0.0 0.0 82.5 0.0 363.9 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 313.8 0.0 0.0 195.3 0.0 0.0 716.2 0.0 0.0 0.0 0.0 0.0 0.0 483.5 0.0 0.0 0.0 ATP5F1B "ATP5B, ATPSB" ENSG00000110955 "ATP synthase F1 subunit beta" P06576 12 56638175-56646068 "Enzymes, Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001520, HPA001528, CAB017527" Enhanced Enhanced Mitochondria NA NA 100000000 Mitochondria "CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242" "prognostic unfavorable (7.17e-6)" "unprognostic (5.69e-2)" "unprognostic (1.08e-2)" "unprognostic (7.24e-2)" "unprognostic (8.39e-2)" "unprognostic (1.84e-2)" "unprognostic (2.12e-3)" "unprognostic (1.92e-2)" "unprognostic (8.19e-3)" "unprognostic (2.38e-2)" "unprognostic (1.44e-2)" "unprognostic (2.11e-2)" "prognostic favorable (1.43e-9)" "unprognostic (2.79e-1)" "unprognostic (3.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.30e-2)" 41.3 66.2 32.4 34.1 53.4 39.3 33.1 55.4 92.6 26.1 73.0 34.4 36.1 68.1 27.9 28.5 58.6 28.5 36.9 225.0 33.2 34.9 95.2 85.7 28.3 39.2 40.5 35.5 25.1 42.7 85.2 30.1 31.3 69.6 29.0 78.5 42.8 64.7 38.1 236.2 42.3 74.6 35.5 24.9 33.5 51.0 31.4 18.3 47.5 38.4 123.6 45.8 36.6 32.8 41.2 91.7 40.2 90.1 36.3 46.6 105.6 66.5 81.0 64.4 99.3 58.1 62.1 113.8 67.7 63.2 117.1 66.8 131.5 74.3 118.4 73.4 83.4 49.0 89.2 135.6 82.1 106.1 55.5 93.9 129.9 75.6 80.6 72.0 145.2 92.0 76.1 82.9 91.5 118.2 89.2 96.2 88.4 116.9 136.5 98.2 61.7 107.5 85.4 108.4 88.2 156.0 103.7 72.1 150.9 127.5 118.6 73.7 65.5 103.5 148.2 115.1 70.7 139.1 109.8 65.2 46.1 51.4 67.3 73.1 65.9 81.9 122.5 69.4 97.2 70.6 40.2 64.6 34.6 40.2 80.6 44.9 41.2 38.0 42.7 91.7 31.7 31.1 36.7 17.8 36.3 90.1 46.3 46.6 105.6 32.4 53.4 55.4 92.6 33.2 34.9 40.5 35.5 69.6 18.3 125.0 160.8 0.0 0.0 0.0 0.0 0.0 0.0 188.7 149.0 263.5 0.0 693.2 1049.5 441.8 0.0 0.0 0.0 0.0 323.3 482.8 0.0 0.0 133.7 0.0 535.7 0.0 0.0 0.0 0.0 0.0 0.0 117.6 0.0 490.5 0.0 0.0 298.7 0.0 0.0 698.1 0.0 0.0 0.0 0.0 0.0 0.0 952.2 0.0 0.0 0.0 ATP5IF1 "ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898" ENSG00000130770 "ATP synthase inhibitory factor subunit 1" Q9UII2 1 28236109-28246906 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 1141.6;Distal tubular cells: 877.0;Exocrine glandular cells: 585.4;Proximal tubular cells: 988.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027999 Supported Enhanced Mitochondria NA NA 1800000 Mitochondria "HPA027999: AB_10600984" "unprognostic (2.80e-2)" "unprognostic (3.72e-2)" "unprognostic (2.95e-1)" "prognostic favorable (6.38e-8)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (6.57e-2)" "unprognostic (2.93e-2)" "unprognostic (1.40e-2)" "prognostic favorable (8.20e-4)" "unprognostic (5.94e-2)" "unprognostic (3.52e-1)" "unprognostic (6.15e-3)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (2.79e-1)" "unprognostic (1.48e-3)" 17.1 35.1 65.9 32.1 64.0 58.5 20.9 41.8 71.7 24.6 54.5 15.7 33.8 78.2 18.6 24.1 26.4 31.9 38.4 135.2 51.8 60.7 60.2 55.4 20.1 28.7 46.8 58.7 20.5 33.8 20.7 37.6 19.4 53.0 30.4 30.5 24.8 34.5 34.4 135.2 26.3 58.7 15.4 31.0 25.9 45.0 72.4 26.2 24.3 25.0 44.6 23.5 17.9 18.6 56.5 64.2 35.7 35.2 39.1 64.8 55.2 45.6 23.7 13.9 13.2 10.5 11.5 16.6 20.5 10.2 17.6 17.3 22.8 33.5 32.3 30.9 12.4 6.6 27.9 15.9 20.4 13.9 24.1 53.6 27.6 102.7 30.7 11.4 21.0 28.0 13.3 33.9 15.6 12.6 17.2 16.8 38.6 48.8 29.5 12.5 30.3 31.2 38.9 46.3 17.2 29.3 29.9 15.4 45.6 34.2 30.4 28.2 20.3 25.4 26.5 26.1 14.2 39.3 23.3 17.3 5.7 15.7 22.2 24.1 76.4 46.0 44.6 27.0 57.7 6.6 30.3 35.2 35.7 46.5 31.7 46.2 56.5 49.6 49.1 42.3 43.7 46.7 45.0 30.9 39.1 28.3 64.2 64.8 55.2 65.9 64.0 41.8 71.7 51.8 60.7 46.8 58.7 53.0 26.2 190.6 249.0 0.0 0.0 0.0 0.0 0.0 0.0 1141.6 276.4 518.2 0.0 390.3 877.0 342.1 0.0 0.0 0.0 0.0 585.4 173.6 0.0 0.0 159.3 0.0 316.5 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 214.6 0.0 0.0 472.8 0.0 0.0 988.7 0.0 0.0 0.0 0.0 0.0 0.0 210.5 0.0 0.0 0.0 ATP5MD "bA792D24.4, DAPIT, MGC14697, USMG5" ENSG00000173915 "ATP synthase membrane subunit DAPIT" Q96IX5 10 103389041-103396466 "Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 1135.7;Ductal cells: 625.1;Exocrine glandular cells: 623.7;monocytes: 754.8;Pancreatic endocrine cells: 789.0;Proximal tubular cells: 951.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044798 Supported Mitochondria NA NA Mitochondria "HPA044798: AB_2679091" "unprognostic (4.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.59e-1)" "unprognostic (7.93e-2)" "unprognostic (1.65e-1)" "unprognostic (1.95e-2)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (5.67e-2)" "unprognostic (1.57e-2)" "unprognostic (7.41e-2)" "unprognostic (1.01e-1)" "unprognostic (3.32e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (7.46e-2)" "unprognostic (1.03e-2)" 48.0 46.2 91.7 26.2 67.0 26.6 56.1 33.5 71.7 38.4 77.9 21.2 29.2 43.8 22.1 72.3 56.3 28.8 31.0 131.5 67.8 57.4 79.3 92.5 24.6 27.7 65.2 44.4 19.7 58.1 21.1 38.2 25.9 46.0 30.0 75.8 23.4 52.7 43.3 146.9 22.4 57.3 39.1 41.4 26.1 40.9 20.2 30.7 22.9 31.3 125.5 39.8 41.2 28.9 71.3 109.1 101.2 85.2 50.7 76.6 66.4 60.6 64.4 61.0 72.7 68.2 85.7 39.9 58.4 73.7 59.7 66.8 103.7 67.7 34.9 33.9 66.0 47.2 62.2 57.1 59.5 82.4 45.8 102.5 36.2 83.0 115.9 66.3 73.8 56.2 69.1 93.4 53.6 84.8 102.3 76.9 56.6 47.4 58.3 99.7 94.1 59.9 127.2 45.3 93.2 109.2 38.9 37.2 54.3 141.9 98.9 23.1 53.5 30.8 47.3 84.0 89.1 42.0 68.6 43.5 29.6 45.3 44.8 76.4 61.5 100.4 58.2 62.5 75.8 22.3 101.2 65.9 88.7 55.9 85.2 63.3 71.3 76.6 65.7 73.3 51.5 65.9 65.6 55.8 50.7 80.6 109.1 71.7 66.4 91.7 67.0 33.5 71.7 67.8 57.4 65.2 44.4 46.0 30.7 196.5 169.5 0.0 0.0 0.0 0.0 0.0 0.0 222.1 167.2 368.2 0.0 256.1 1135.7 625.1 0.0 0.0 0.0 0.0 623.7 361.7 0.0 0.0 109.3 0.0 478.9 0.0 0.0 0.0 0.0 0.0 0.0 129.1 0.0 754.8 0.0 0.0 789.0 0.0 0.0 951.7 0.0 0.0 0.0 0.0 0.0 0.0 255.7 0.0 0.0 0.0 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria NA NA 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.9 47.3 68.2 55.5 57.4 53.4 38.0 48.7 39.0 37.0 32.9 45.4 49.5 25.9 46.9 51.5 60.1 32.0 54.9 76.8 20.3 22.9 101.4 76.2 87.7 113.3 59.7 97.0 33.6 66.2 45.1 42.4 43.0 57.8 45.2 51.7 63.0 28.4 41.9 72.0 83.6 127.1 80.1 88.1 123.8 51.0 49.8 56.4 70.7 87.2 66.2 52.0 35.4 47.7 54.0 44.7 54.5 66.9 52.4 33.3 31.6 29.3 67.9 66.4 109.5 81.9 48.9 66.9 36.4 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 142.9 207.3 0.0 0.0 0.0 0.0 0.0 0.0 337.3 224.1 840.9 0.0 343.2 1465.6 413.4 0.0 0.0 0.0 0.0 598.1 265.5 0.0 0.0 112.8 0.0 580.0 0.0 0.0 0.0 0.0 0.0 0.0 109.4 0.0 485.1 0.0 0.0 478.0 0.0 0.0 1359.9 0.0 0.0 0.0 0.0 0.0 0.0 229.9 0.0 0.0 0.0 ATP5MF-PTCD1 ATP5J2-PTCD1 ENSG00000248919 "ATP5MF-PTCD1 readthrough" 7 99419749-99466197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020106, HPA047679" Uncertain Approved Mitochondria NA NA Mitochondria "HPA020106: AB_2176551, HPA047679: AB_2680119" "unprognostic (1.15e-3)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (2.83e-1)" "unprognostic (3.29e-2)" "unprognostic (3.51e-1)" "unprognostic (1.18e-3)" "unprognostic (2.84e-2)" "unprognostic (6.44e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-1)" "unprognostic (7.45e-2)" "unprognostic (2.00e-2)" "unprognostic (7.50e-2)" 9.3 10.3 7.5 8.6 9.2 1.2 8.1 8.2 13.0 9.6 12.4 3.6 9.2 8.7 10.4 8.1 14.8 11.0 8.3 18.6 8.3 6.7 14.5 23.6 7.0 7.8 6.2 10.2 9.0 15.6 11.5 7.1 8.3 8.3 12.3 7.2 6.8 13.9 12.1 35.7 8.7 15.0 8.4 6.7 8.3 8.9 14.2 5.4 12.7 8.7 24.8 8.6 14.1 10.4 4.2 8.7 1.8 8.3 6.2 6.1 6.8 5.5 6.1 5.1 14.4 6.3 3.7 10.9 3.8 4.6 9.7 8.8 23.3 9.2 7.3 9.5 3.6 9.0 5.5 8.7 7.9 4.1 8.1 8.2 4.2 4.1 4.8 6.7 5.7 4.5 6.3 7.1 8.7 7.1 3.6 4.0 8.6 13.9 11.1 6.2 11.6 13.1 7.5 9.0 9.6 7.9 7.1 4.8 19.3 5.2 1.9 6.7 6.7 8.2 14.0 8.3 3.6 6.9 9.1 2.4 6.8 6.1 14.2 10.0 8.9 7.6 11.5 5.0 6.5 12.1 1.8 6.3 1.7 5.5 8.3 5.8 3.6 4.6 4.6 8.7 4.2 4.9 6.1 0.5 6.2 4.8 4.3 3.5 6.8 7.5 9.2 8.2 13.0 8.3 6.7 6.2 10.2 8.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP5MG "ATP5JG, ATP5L" ENSG00000167283 "ATP synthase membrane subunit g" O75964 11 118401154-118431496 "Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 1200.8;Distal tubular cells: 2463.7;Hofbauer cells: 1173.9;monocytes: 1183.1;Proximal tubular cells: 1669.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044629 Approved Supported Mitochondria NA NA 590000 Mitochondria "HPA044629: AB_2679028" "unprognostic (1.70e-1)" "unprognostic (2.40e-2)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (1.61e-1)" "unprognostic (3.27e-2)" "unprognostic (3.90e-2)" "unprognostic (8.19e-2)" "unprognostic (5.13e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-1)" "unprognostic (7.41e-2)" "prognostic favorable (4.09e-5)" "unprognostic (6.26e-2)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (3.05e-2)" 32.3 42.4 45.3 31.8 46.7 36.0 39.6 38.1 40.4 25.6 39.0 21.1 30.3 33.8 33.9 40.4 27.9 26.5 30.1 85.8 37.5 38.4 55.6 42.6 29.1 41.9 39.2 23.6 31.3 70.1 25.8 31.1 23.6 28.3 26.3 41.5 39.0 71.9 29.5 68.4 20.9 39.5 47.3 27.8 30.7 29.5 17.9 15.7 53.2 33.7 60.2 43.7 30.0 23.6 42.7 54.6 30.8 48.0 32.5 53.5 98.1 21.4 11.1 29.3 28.4 25.4 28.4 23.5 22.0 25.0 20.2 21.5 28.1 34.8 42.6 46.0 23.9 31.7 27.4 29.5 30.8 22.5 34.0 19.4 67.3 10.5 16.9 26.0 38.2 32.3 30.2 29.2 24.9 23.7 23.8 27.1 32.3 30.7 35.7 28.1 38.4 53.4 47.7 18.6 60.6 31.0 36.7 24.6 46.8 52.5 18.5 23.3 17.6 33.2 53.8 16.2 33.9 39.1 35.7 26.6 16.7 18.7 14.3 25.1 16.3 22.3 43.3 12.4 44.6 20.8 28.8 48.0 30.8 27.1 33.3 39.3 42.7 42.9 35.5 49.9 34.6 53.5 40.2 24.0 32.5 31.5 54.6 45.8 98.1 45.3 46.7 38.1 40.4 37.5 38.4 39.2 23.6 28.3 15.7 336.5 314.3 0.0 0.0 0.0 0.0 0.0 0.0 345.3 306.0 579.3 0.0 1200.8 2463.7 680.9 0.0 0.0 0.0 0.0 858.6 734.2 0.0 0.0 238.3 0.0 1173.9 0.0 0.0 0.0 0.0 0.0 0.0 317.5 0.0 1183.1 0.0 0.0 798.2 0.0 0.0 1669.9 0.0 0.0 0.0 0.0 0.0 0.0 837.4 0.0 0.0 0.0 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell type enhanced" "Detected in some" 10 "Cytotrophoblasts: 9.5;Distal tubular cells: 5.0;Extravillous trophoblasts: 7.3;Hofbauer cells: 9.6;Syncytiotrophoblasts: 8.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 2.5" HPA044629 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044629: AB_2679028" "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.7 0.3 1.0 0.2 0.6 0.3 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 1.0 0.5 0.5 0.8 0.0 0.0 1.4 0.0 0.5 0.8 1.7 1.6 0.1 0.0 0.2 0.0 0.6 0.0 2.5 0.2 0.1 0.0 0.7 0.2 0.4 0.2 0.0 0.0 1.2 0.8 0.9 0.6 0.6 1.2 0.1 0.3 0.7 1.0 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 9.5 5.0 0.4 0.0 0.0 0.0 0.0 1.0 7.3 0.0 0.0 2.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.0 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.7 6.2 7.8 20.9 15.8 11.1 3.8 16.0 18.9 21.0 15.8 16.6 7.4 20.9 4.9 4.1 6.1 26.3 21.1 6.6 9.0 19.4 18.2 4.1 14.1 2.9 18.4 9.2 10.1 7.1 44.9 6.1 9.9 4.0 24.0 11.6 40.6 8.2 14.0 5.2 9.5 3.0 13.2 18.9 13.9 3.1 15.2 9.5 13.6 8.3 14.7 16.2 16.8 12.7 12.1 49.8 20.1 20.0 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 62.5 73.9 0.0 0.0 0.0 0.0 0.0 0.0 136.5 105.8 118.7 0.0 297.5 391.3 205.2 0.0 0.0 0.0 0.0 172.3 335.0 0.0 0.0 82.5 0.0 328.7 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 172.3 0.0 0.0 151.6 0.0 0.0 348.8 0.0 0.0 0.0 0.0 0.0 0.0 290.7 0.0 0.0 0.0 ATP5PD "ATP5H, ATP5JD, ATPQ" ENSG00000167863 "ATP synthase peripheral stalk subunit d" O75947 17 75038863-75046985 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 968.2;Proximal tubular cells: 714.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042777, HPA048459" Enhanced Supported Mitochondria NA NA 1600000 Mitochondria "HPA042777: AB_2678160, HPA048459: AB_2680402" "unprognostic (1.37e-1)" "unprognostic (4.41e-2)" "unprognostic (1.70e-3)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "unprognostic (4.81e-2)" "unprognostic (7.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (2.72e-1)" "unprognostic (8.72e-2)" "unprognostic (2.56e-2)" "unprognostic (1.42e-1)" "unprognostic (3.26e-1)" "unprognostic (1.73e-1)" "unprognostic (4.29e-2)" 38.8 38.5 54.3 28.6 48.6 25.6 37.8 34.5 50.4 30.0 52.9 19.6 33.2 46.6 25.8 47.4 58.9 25.7 31.0 143.6 47.7 44.8 78.8 86.2 24.8 29.2 45.7 39.2 28.5 43.3 38.5 29.8 35.4 40.3 33.1 53.1 35.4 56.8 36.3 184.2 35.5 59.9 39.1 32.8 32.7 40.4 15.7 21.3 30.3 48.7 88.5 33.7 45.8 29.0 72.5 100.7 90.9 103.8 54.9 100.0 86.2 63.5 55.8 42.8 55.7 69.8 85.4 57.5 54.7 72.2 61.4 58.6 43.6 50.0 43.1 36.4 68.4 57.9 58.0 51.5 71.7 82.4 20.9 43.7 44.0 46.5 85.9 68.7 56.0 28.9 72.5 57.1 49.9 71.4 49.1 81.7 33.7 45.8 58.8 75.4 61.7 55.4 63.0 32.6 146.1 79.4 39.4 124.0 79.9 126.9 62.2 43.1 47.4 64.6 103.0 87.1 66.8 102.1 57.2 42.1 76.5 53.5 66.4 63.8 47.3 37.3 44.1 68.5 56.3 49.2 67.2 90.5 90.9 58.3 103.8 67.4 72.5 100.0 71.6 100.7 57.6 90.9 83.5 50.7 54.9 83.1 89.8 94.6 86.2 54.3 48.6 34.5 50.4 47.7 44.8 45.7 39.2 40.3 21.3 160.8 115.9 0.0 0.0 0.0 0.0 0.0 0.0 186.0 188.8 246.0 0.0 327.6 968.2 259.9 0.0 0.0 0.0 0.0 330.1 269.2 0.0 0.0 81.4 0.0 401.2 0.0 0.0 0.0 0.0 0.0 0.0 121.7 0.0 364.3 0.0 0.0 268.3 0.0 0.0 714.6 0.0 0.0 0.0 0.0 0.0 0.0 281.2 0.0 0.0 0.0 ATP5PF "ATP5, ATP5A, ATP5J, ATPM, CF6" ENSG00000154723 "ATP synthase peripheral stalk subunit F6" P18859 21 25716503-25735673 "Plasma proteins, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 2012.7;Proximal tubular cells: 1143.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031069 Supported Supported Mitochondria NA NA 720000 Mitochondria "HPA031069: AB_10603676" "unprognostic (3.52e-2)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (4.87e-2)" "unprognostic (1.77e-1)" "unprognostic (8.83e-2)" "prognostic favorable (2.37e-5)" "unprognostic (1.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.56e-1)" "unprognostic (2.15e-2)" 39.8 46.8 49.0 20.3 43.6 23.0 32.6 30.8 46.6 25.9 48.6 26.1 22.4 43.0 24.0 57.4 45.2 21.6 19.2 148.9 41.1 37.1 72.8 111.0 18.7 22.2 47.0 27.0 23.9 37.4 31.2 37.5 33.9 45.7 32.6 47.9 33.9 47.1 37.5 164.7 18.7 57.9 46.9 32.8 25.0 37.6 21.0 25.8 31.4 32.1 69.9 29.9 42.0 23.1 87.8 102.4 80.9 91.5 69.1 95.2 112.2 41.8 30.1 38.4 43.1 41.4 38.1 47.7 37.0 43.1 36.2 35.4 69.1 33.0 51.5 24.5 36.5 57.9 22.9 51.4 44.4 39.9 45.0 54.6 107.4 61.2 68.6 46.8 78.4 35.2 37.2 54.8 34.6 31.1 49.3 42.0 49.8 67.0 63.4 52.8 46.7 54.3 79.4 69.0 94.8 54.7 42.5 74.7 97.3 77.2 57.2 43.9 48.8 62.2 62.9 57.0 56.8 45.5 70.7 31.7 27.7 33.2 25.8 31.8 63.3 103.5 65.2 42.5 82.1 34.7 69.2 88.8 80.9 60.3 91.5 64.0 87.8 80.2 74.6 102.4 71.6 79.6 78.0 56.9 69.1 89.7 96.4 95.2 112.2 49.0 43.6 30.8 46.6 41.1 37.1 47.0 27.0 45.7 25.8 157.8 157.2 0.0 0.0 0.0 0.0 0.0 0.0 261.0 194.5 397.8 0.0 553.9 2012.7 380.3 0.0 0.0 0.0 0.0 410.7 419.1 0.0 0.0 101.1 0.0 458.5 0.0 0.0 0.0 0.0 0.0 0.0 101.3 0.0 395.0 0.0 0.0 402.6 0.0 0.0 1143.7 0.0 0.0 0.0 0.0 0.0 0.0 592.2 0.0 0.0 0.0 ATP5PO "ATP5O, ATPO, OSCP" ENSG00000241837 "ATP synthase peripheral stalk subunit OSCP" P48047 21 33903453-33915980 "Plasma proteins, Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 1520.3;Proximal tubular cells: 981.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB016209, HPA041394" Enhanced Approved Mitochondria NA NA 4000000 Mitochondria "CAB016209: AB_631361, HPA041394: AB_2677450" "unprognostic (2.08e-1)" "unprognostic (4.77e-3)" "unprognostic (3.30e-1)" "unprognostic (6.12e-3)" "unprognostic (1.51e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.34e-1)" "unprognostic (8.47e-2)" "unprognostic (1.42e-1)" "unprognostic (3.27e-1)" "unprognostic (1.81e-1)" "prognostic favorable (9.34e-4)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (3.26e-2)" "unprognostic (7.89e-3)" 32.6 26.8 49.3 27.7 43.5 34.9 37.8 35.0 44.8 28.7 45.0 21.6 24.2 48.2 25.1 34.3 44.2 28.9 30.3 139.4 40.8 36.7 61.3 57.5 20.6 31.5 45.6 38.4 38.0 40.1 29.5 19.2 25.1 46.4 32.5 52.4 27.2 38.8 28.6 130.6 28.7 57.5 34.8 29.3 27.3 43.2 25.4 20.1 42.7 37.4 98.0 36.2 39.4 26.5 71.9 94.0 48.5 71.5 46.8 73.3 112.2 41.5 19.5 54.4 53.3 37.4 48.0 60.6 23.8 41.8 40.1 39.3 57.2 40.4 55.8 20.5 36.1 39.9 23.6 58.6 81.3 47.5 41.5 58.5 83.6 31.2 56.8 43.1 63.3 29.0 48.8 49.8 38.8 63.7 45.2 55.1 46.1 67.1 72.4 51.5 42.8 48.2 62.2 62.1 105.6 57.8 49.8 53.8 105.2 109.8 37.0 44.0 25.5 40.9 61.2 54.1 49.3 61.7 70.0 31.1 26.4 31.5 47.0 26.9 47.8 52.2 58.4 48.6 108.7 38.0 33.4 69.9 48.5 44.5 71.5 53.0 71.9 58.8 52.9 94.0 59.0 73.3 61.5 17.2 46.8 62.6 55.9 70.1 112.2 49.3 43.5 35.0 44.8 40.8 36.7 45.6 38.4 46.4 20.1 226.3 164.6 0.0 0.0 0.0 0.0 0.0 0.0 187.4 223.0 211.1 0.0 511.4 1520.3 335.0 0.0 0.0 0.0 0.0 367.3 532.1 0.0 0.0 105.8 0.0 543.7 0.0 0.0 0.0 0.0 0.0 0.0 80.4 0.0 380.5 0.0 0.0 302.9 0.0 0.0 981.3 0.0 0.0 0.0 0.0 0.0 0.0 453.3 0.0 0.0 0.0 ATP6V1C2 "ATP6C2, VMA5" ENSG00000143882 "ATPase H+ transporting V1 subunit C2" Q8NEY4 2 10721649-10785110 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 40.6;SK-BR-3: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034734, HPA067305" Approved Uncertain Mitochondria NA NA Mitochondria "HPA034734: AB_2674305, HPA067305: AB_2732763" "unprognostic (2.29e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (6.55e-3)" "unprognostic (2.69e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-3)" "unprognostic (8.53e-2)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" "unprognostic (6.77e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.12e-11)" "unprognostic (6.17e-2)" "unprognostic (3.30e-1)" "unprognostic (2.37e-1)" "unprognostic (8.27e-2)" 1.4 0.9 0.4 0.4 0.5 1.1 2.4 0.5 0.8 21.2 0.8 0.6 49.3 0.1 2.1 30.5 6.9 0.8 0.8 0.7 0.8 0.3 13.2 2.0 0.8 0.5 0.4 0.4 0.9 1.1 0.1 8.9 39.0 0.5 1.8 0.7 54.4 41.8 15.1 0.4 36.7 0.7 0.4 0.6 1.3 0.6 0.8 0.4 0.9 1.4 6.0 3.5 0.5 7.2 1.1 0.8 0.6 1.7 0.9 2.2 1.1 0.3 0.4 1.3 1.5 0.0 0.0 40.6 0.6 0.0 0.0 0.0 0.8 1.0 1.0 0.8 0.0 0.6 0.6 0.6 0.0 0.0 0.5 1.5 0.5 0.6 1.4 0.0 0.9 0.6 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.4 2.0 0.0 1.2 0.3 1.5 1.0 0.6 0.4 0.8 0.7 3.3 0.0 0.9 1.1 1.3 0.3 14.5 0.4 5.5 1.4 2.1 0.2 0.5 1.0 0.6 0.5 3.5 1.0 0.6 0.6 0.8 0.4 0.3 0.8 0.6 2.2 1.7 1.3 1.1 1.0 1.7 0.5 0.9 1.0 0.5 0.0 0.9 0.8 0.8 0.9 1.1 0.4 0.5 0.5 0.8 0.8 0.3 0.4 0.4 0.5 0.4 0.0 1.6 0.0 4.2 0.3 0.0 1.0 0.0 2.7 2.3 7.0 0.0 101.4 38.1 0.0 0.6 0.1 0.0 0.0 0.2 23.0 0.5 0.6 2.3 0.0 12.0 0.0 39.9 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.4 2.0 141.4 0.0 0.6 0.3 ATPAF1 "ATP11, Atp11p, FLJ22351" ENSG00000123472 "ATP synthase mitochondrial F1 complex assembly factor 1" Q5TC12 1 46632737-46673867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 73.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 236.9;Early spermatids: 241.4;Late spermatids: 261.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028382, HPA044950" Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA028382: AB_2672574, HPA044950: AB_2679151" "unprognostic (1.34e-1)" "unprognostic (2.97e-3)" "unprognostic (1.18e-2)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (5.97e-2)" "unprognostic (3.53e-1)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (1.19e-2)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "prognostic favorable (5.33e-7)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-1)" "unprognostic (2.62e-1)" 20.6 32.0 32.9 7.5 34.5 7.9 14.0 15.9 31.0 11.1 15.2 16.1 9.3 12.0 7.8 10.8 10.6 9.8 9.0 73.4 22.3 20.8 33.3 31.9 7.5 8.6 28.2 24.9 10.6 18.8 39.5 14.6 11.0 28.5 11.6 16.9 11.9 15.9 10.8 66.9 5.7 11.7 12.7 18.6 6.9 12.8 13.4 18.2 10.8 13.0 13.1 9.4 9.8 6.1 3.1 2.4 5.8 4.2 9.2 6.6 1.8 20.8 17.0 23.0 20.5 25.2 20.4 19.3 15.6 19.6 23.5 19.0 13.6 9.1 12.4 21.0 19.7 20.9 16.2 36.2 20.3 31.8 27.1 28.6 21.9 21.2 23.6 20.3 21.6 1.3 19.9 24.4 25.1 22.0 18.8 14.7 23.3 10.0 24.6 17.9 18.9 31.8 12.0 36.2 18.1 25.7 13.8 6.2 26.9 26.8 16.6 27.3 20.4 26.5 28.2 40.7 27.8 26.0 30.5 12.7 8.1 20.0 16.2 21.2 30.6 27.7 8.5 13.3 8.4 15.1 0.0 2.5 5.8 3.5 4.2 4.6 3.1 3.7 4.0 2.4 1.7 5.2 2.4 2.1 9.2 1.7 1.8 6.6 1.8 32.9 34.5 15.9 31.0 22.3 20.8 28.2 24.9 28.5 18.2 3.0 15.2 20.4 17.4 8.4 34.1 236.9 22.9 8.1 12.5 29.6 25.5 54.8 145.9 19.3 241.4 11.3 22.6 0.0 17.5 23.1 16.9 15.2 16.1 37.5 32.6 44.5 18.5 8.0 16.4 261.4 17.5 11.1 23.6 10.8 33.8 29.9 12.2 10.5 25.1 85.7 23.3 25.8 29.3 25.6 40.1 11.8 39.2 12.5 43.6 16.1 BAD "BBC2, BCL2L8" ENSG00000002330 "BCL2 associated agonist of cell death" Q92934 11 64269830-64284704 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004205, HPA028185, HPA062105" Approved Enhanced Mitochondria NA NA Mitochondria "CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684" "unprognostic (1.47e-1)" "unprognostic (3.08e-2)" "unprognostic (1.17e-1)" "unprognostic (8.24e-3)" "unprognostic (2.60e-1)" "unprognostic (6.73e-2)" "unprognostic (1.24e-3)" "unprognostic (1.07e-1)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-1)" "unprognostic (8.26e-2)" "unprognostic (9.04e-2)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (7.95e-2)" 23.1 23.2 35.3 12.6 30.7 17.7 20.6 15.9 43.9 21.2 25.7 22.7 20.1 24.0 18.3 19.7 18.8 23.2 22.5 30.3 32.7 23.8 21.4 22.3 17.7 14.3 29.6 20.2 18.8 26.9 19.4 15.2 24.9 18.4 22.9 13.6 23.1 39.9 27.0 23.9 20.4 21.1 17.2 22.9 14.9 37.8 18.6 14.8 19.3 29.2 15.8 14.1 18.2 14.4 26.5 42.0 43.5 32.3 24.0 30.7 23.1 32.3 30.4 8.9 13.4 10.8 13.2 13.1 13.8 16.1 21.2 16.9 18.5 18.6 6.9 24.8 12.8 16.6 17.2 5.8 21.7 4.2 27.0 21.3 8.6 27.6 8.8 16.7 7.5 16.2 12.7 18.7 16.3 10.0 16.2 13.4 15.3 3.3 15.0 9.2 32.1 16.7 16.9 3.5 9.3 38.9 15.9 5.2 19.5 12.9 15.3 18.4 24.7 13.9 16.5 16.8 3.5 24.7 11.2 11.0 26.0 17.6 40.3 15.1 28.6 21.2 7.1 21.3 5.4 14.2 32.5 32.3 43.5 25.3 24.0 25.8 26.0 26.9 24.6 22.5 26.5 19.4 20.0 41.7 24.0 22.6 42.0 30.7 23.1 35.3 30.7 15.9 43.9 32.7 23.8 29.6 20.2 18.4 14.8 29.8 43.4 37.4 59.5 91.7 63.3 42.1 63.7 49.5 20.5 50.6 17.7 138.0 116.0 88.3 29.3 45.0 146.4 23.3 96.2 163.4 112.5 51.0 24.2 45.0 63.9 44.5 99.9 51.0 25.6 67.7 68.7 35.1 104.6 69.5 94.0 52.4 95.9 140.3 80.2 115.9 36.1 58.2 78.3 87.6 27.7 104.1 213.3 43.6 85.3 55.6 BCAT2 "BCAM, BCT2" ENSG00000105552 "Branched chain amino acid transaminase 2" O15382 19 48795062-48811029 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054091 Enhanced Supported Mitochondria NA NA 3400000 Mitochondria "HPA054091: AB_2682374" "unprognostic (2.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.16e-1)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.97e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-2)" "unprognostic (2.98e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.68e-5)" "unprognostic (1.87e-3)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (7.50e-3)" 11.8 34.1 6.7 10.9 7.7 3.8 15.0 15.0 10.7 11.9 16.7 11.3 15.8 10.2 12.9 9.8 24.6 11.9 15.2 25.1 6.8 6.9 22.6 8.0 19.9 16.3 9.8 7.8 22.3 42.6 9.0 12.3 27.5 22.0 16.8 12.1 6.3 24.7 17.2 23.3 9.8 10.3 17.5 7.6 10.9 22.8 15.9 10.7 12.5 19.1 23.3 16.7 29.2 12.2 15.0 18.2 1.8 9.8 8.8 15.4 7.1 17.5 21.1 5.6 11.9 23.4 7.9 10.0 7.8 4.0 9.6 9.4 21.2 10.8 20.7 8.9 6.9 3.0 8.3 8.6 13.6 4.8 12.8 21.9 7.6 9.5 1.4 22.7 10.2 7.1 11.5 8.7 7.1 10.3 9.4 13.3 16.0 9.6 12.7 3.5 21.0 13.9 10.8 4.9 27.9 10.3 21.2 9.7 22.8 9.1 72.7 30.3 8.6 11.8 19.5 5.7 4.1 12.4 5.0 7.4 9.4 9.0 11.0 9.7 12.0 15.9 9.9 5.1 16.0 6.1 0.0 8.7 1.8 9.7 9.8 13.6 15.0 11.7 12.4 16.1 12.8 10.8 9.6 0.4 8.8 3.7 18.2 15.4 7.1 6.7 7.7 15.0 10.7 6.8 6.9 9.8 7.8 22.0 10.7 26.8 34.4 9.0 26.7 5.4 8.2 22.1 20.4 6.7 13.6 12.2 19.6 54.6 61.3 34.2 5.8 13.5 15.6 0.0 18.6 15.8 11.7 16.4 23.1 8.3 23.4 1.6 19.1 12.3 4.7 6.2 16.1 8.6 23.6 33.3 25.8 5.6 19.8 14.0 28.3 28.2 11.2 19.4 16.1 7.0 17.1 6.1 38.3 7.0 30.3 40.4 BCKDK ENSG00000103507 "Branched chain ketoacid dehydrogenase kinase" O14874 16 31106107-31112791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 26.8;granulocytes: 26.6;monocytes: 33.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017995, HPA056067" Supported Supported Mitochondria NA NA Mitochondria "HPA017995: AB_1845309, HPA056067: AB_2683024" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (6.94e-2)" "unprognostic (5.20e-2)" "unprognostic (5.39e-2)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (5.47e-2)" "unprognostic (1.60e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.24e-2)" "unprognostic (2.66e-3)" "unprognostic (4.85e-2)" "unprognostic (3.93e-2)" "unprognostic (1.00e-1)" "unprognostic (4.97e-2)" 15.4 29.7 11.9 13.1 15.0 9.4 18.3 18.8 21.3 11.7 14.1 9.6 19.9 11.2 14.8 14.9 14.9 13.8 15.1 39.2 14.2 10.3 21.3 46.5 18.2 32.5 10.7 17.3 15.1 52.4 17.4 8.9 11.4 13.2 14.9 9.9 10.4 33.9 25.7 67.7 21.5 12.2 19.9 15.6 16.0 19.9 11.2 9.3 8.0 11.7 25.9 10.6 15.3 12.0 6.9 26.8 26.6 33.0 6.3 6.8 13.6 18.2 20.5 11.6 17.4 14.3 14.4 12.6 15.9 19.6 24.8 24.3 13.4 12.2 17.1 23.1 19.8 12.1 12.7 8.2 27.7 16.0 13.8 25.4 18.5 13.9 24.3 25.2 9.6 17.0 21.1 11.2 21.2 17.7 22.8 26.4 13.1 9.3 16.2 37.1 31.1 8.8 12.7 9.8 8.5 16.6 17.9 16.9 31.5 18.9 12.6 17.9 16.4 12.3 30.5 9.9 10.4 18.4 9.2 16.9 18.9 10.9 19.4 13.2 16.9 6.0 6.1 21.5 13.9 17.7 12.2 33.0 23.1 5.7 27.4 5.6 6.9 5.2 4.2 26.8 5.4 4.4 5.0 26.6 6.3 19.3 5.8 6.8 13.6 11.9 15.0 18.8 21.3 14.2 10.3 10.7 17.3 13.2 9.3 17.9 17.8 27.4 21.2 16.5 11.0 32.1 25.5 13.4 9.1 19.2 0.0 47.3 68.0 57.7 2.2 20.9 39.3 0.0 68.3 54.7 20.7 26.1 33.4 34.7 83.9 11.1 19.1 27.0 41.9 3.6 19.2 56.7 11.8 95.6 20.5 22.1 49.3 40.3 24.1 65.3 7.2 45.3 28.9 16.7 15.2 24.0 58.0 14.4 26.7 19.3 BCL2L1 "Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52" ENSG00000171552 "BCL2 like 1" Q07817 20 31664452-31723989 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Apoptosis, Endocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035734, CAB072801" Approved Approved Mitochondria NA NA Mitochondria "CAB072801: , HPA035734: AB_2674757" "unprognostic (2.29e-1)" "unprognostic (5.40e-3)" "unprognostic (1.78e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (5.04e-2)" "unprognostic (7.82e-3)" "prognostic favorable (9.57e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (1.06e-1)" "prognostic favorable (8.89e-5)" "unprognostic (9.67e-2)" "unprognostic (3.03e-2)" "unprognostic (2.02e-2)" "unprognostic (3.32e-2)" 30.8 21.4 25.1 16.4 34.3 57.0 40.7 27.7 40.7 28.2 22.6 37.0 13.0 31.3 18.7 12.2 36.9 31.5 35.9 26.9 27.0 23.7 42.6 39.3 40.6 17.8 43.4 24.3 11.5 28.5 17.5 22.8 29.0 33.4 24.8 21.4 31.5 33.8 21.5 21.9 26.1 30.4 19.2 28.8 26.6 28.0 30.2 38.4 56.4 25.8 15.4 20.7 24.5 22.4 3.9 7.8 17.0 8.9 12.5 27.2 16.5 64.0 38.2 7.1 6.8 38.0 27.5 22.6 15.3 25.1 16.1 15.4 90.1 31.1 10.5 39.2 22.1 31.2 21.7 9.4 43.4 11.4 11.0 2.4 48.0 8.2 44.8 28.5 4.8 28.5 19.7 18.1 20.3 44.2 21.8 23.0 18.4 29.7 8.0 54.3 18.3 14.1 4.6 9.7 31.8 34.1 8.9 21.3 33.3 65.8 17.9 18.3 8.6 18.8 18.6 8.8 13.5 36.9 5.5 31.8 20.3 23.5 8.1 27.5 5.3 29.7 8.7 29.9 21.1 12.8 17.0 8.1 15.4 27.2 8.2 21.0 3.9 12.4 18.1 7.8 3.7 5.7 13.0 9.8 12.5 8.9 4.7 13.8 16.5 25.1 34.3 27.7 40.7 27.0 23.7 43.4 24.3 33.4 38.4 14.9 11.6 8.2 49.1 16.4 21.1 9.0 101.9 21.4 5.7 36.6 43.2 22.9 72.9 88.0 6.3 31.5 38.7 93.5 56.7 9.6 15.0 56.5 12.7 32.5 33.2 27.0 23.7 20.9 17.2 4.2 17.5 12.2 16.9 127.2 22.5 15.8 125.9 17.5 40.3 57.4 27.1 45.3 20.2 26.5 12.6 8.5 15.8 30.5 18.5 125.1 BCL2L11 "BIM, BimEL, BimL, BimS, BOD" ENSG00000153094 "BCL2 like 11" O43521 2 111119378-111168447 "Predicted intracellular proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026332, CAB079899" Approved Supported Mitochondria NA NA Mitochondria "CAB026332: AB_566386, CAB079899: AB_10981505" "unprognostic (1.43e-1)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (1.50e-2)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-3)" "unprognostic (8.15e-3)" "unprognostic (7.86e-2)" 10.0 7.9 4.9 18.9 5.6 24.8 17.9 1.6 4.7 6.9 15.7 5.1 17.7 5.3 7.9 6.6 10.8 7.8 10.3 7.0 3.8 3.0 14.6 16.3 9.7 46.7 5.5 4.1 12.2 15.1 12.2 21.3 13.3 4.6 8.6 8.8 7.8 11.4 21.8 13.9 6.2 13.7 3.8 4.2 31.5 7.2 19.1 5.5 40.4 32.3 8.6 16.0 10.3 11.8 4.9 3.4 8.3 8.2 2.4 9.5 2.2 3.5 1.4 5.1 4.6 4.0 2.1 13.7 0.6 1.0 1.4 1.4 3.7 11.0 13.8 3.4 0.5 8.9 4.1 4.3 1.6 1.0 10.6 8.7 16.6 3.5 4.5 2.1 6.1 4.3 2.1 4.6 1.9 1.7 3.3 2.0 6.7 8.7 21.2 0.3 2.8 7.3 6.2 5.9 3.3 3.5 8.7 4.5 18.2 1.9 6.0 4.7 11.8 4.9 6.3 3.8 3.3 2.7 13.7 0.9 0.9 6.0 1.8 1.8 41.9 8.1 19.6 1.3 4.4 0.7 6.1 5.6 3.3 2.6 3.8 3.0 4.9 3.9 3.1 3.4 3.2 2.7 2.1 8.3 2.4 8.2 0.7 9.5 2.2 4.9 5.6 1.6 4.7 3.8 3.0 5.5 4.1 4.6 5.5 3.0 6.9 40.9 14.7 15.5 4.7 16.1 7.6 14.7 6.8 8.7 9.8 3.6 11.6 9.8 85.7 10.8 16.8 46.7 5.8 6.7 8.7 12.8 10.5 10.5 9.4 0.0 20.6 12.3 29.4 27.6 5.5 17.5 21.9 36.9 17.7 15.1 7.7 14.4 3.5 4.6 20.2 0.0 11.3 5.7 17.0 9.5 4.8 23.5 9.8 13.6 BCL2L13 "BCL-RAMBO, MIL1" ENSG00000099968 "BCL2 like 13" Q9BXK5 22 17628855-17730855 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 182.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002052, HPA030994, HPA050377" Uncertain Enhanced Mitochondria NA NA Mitochondria "CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107" "unprognostic (1.59e-1)" "unprognostic (8.17e-2)" "unprognostic (2.18e-3)" "unprognostic (1.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.69e-2)" "unprognostic (3.38e-1)" "unprognostic (4.97e-2)" "unprognostic (5.04e-2)" "unprognostic (9.46e-2)" "unprognostic (1.45e-2)" "unprognostic (8.21e-2)" "prognostic favorable (1.96e-8)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (4.27e-1)" "unprognostic (2.81e-1)" 15.3 17.4 13.3 7.6 14.2 10.9 17.3 13.0 17.4 9.2 11.9 14.8 8.8 8.3 10.5 10.7 14.5 11.7 10.0 18.9 12.7 12.2 18.9 20.9 10.6 9.3 14.4 13.4 10.4 22.0 25.8 12.3 14.1 12.2 11.1 14.1 15.2 12.4 9.5 61.2 15.5 12.4 11.7 13.0 8.3 11.2 22.9 11.5 12.1 13.5 14.5 12.3 14.6 10.2 6.5 11.3 4.7 17.3 10.4 8.3 9.5 13.8 6.2 9.9 9.4 16.6 15.9 13.2 9.9 17.4 14.7 16.8 7.0 9.2 12.0 7.2 14.2 14.8 19.0 11.4 15.3 15.4 11.5 8.7 11.3 5.6 3.6 20.6 15.7 9.8 12.9 17.9 12.6 34.1 18.4 12.8 10.0 28.1 11.3 16.0 9.3 8.0 5.0 7.8 22.4 7.7 8.4 15.3 4.5 15.3 9.6 14.1 8.8 13.1 13.3 23.7 25.8 9.1 15.6 12.8 8.8 4.5 12.5 9.5 9.7 8.8 10.3 13.1 12.1 15.0 3.8 17.3 4.7 4.6 15.6 5.7 6.5 6.2 5.7 11.3 5.4 5.5 4.5 4.4 10.4 11.0 5.7 8.3 9.5 13.3 14.2 13.0 17.4 12.7 12.2 14.4 13.4 12.2 11.5 20.8 11.8 21.7 29.2 21.9 182.7 38.9 12.7 14.7 29.6 17.4 11.8 42.2 44.7 26.6 26.6 14.3 28.3 23.3 27.5 28.8 15.8 31.6 8.1 30.6 23.9 46.1 22.4 12.9 27.2 9.5 13.0 22.7 15.1 58.7 26.7 45.9 28.7 14.4 14.5 33.8 30.9 0.0 15.5 21.7 21.4 23.7 80.2 19.1 22.9 31.8 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 156.0" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 20.3;U-937: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030947, HPA058709" Enhanced Approved Mitochondria NA NA Mitochondria "HPA030947: AB_10669548, HPA058709: AB_2683797" "unprognostic (2.72e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favorable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 3.5 2.8 6.6 5.2 11.2 4.7 4.6 18.1 13.8 4.0 13.9 4.6 6.3 9.6 2.1 3.6 12.9 5.5 6.1 19.6 6.3 5.8 6.0 156.0 2.0 4.2 5.9 9.1 3.0 2.8 5.8 3.6 1.4 7.7 4.5 11.1 6.2 8.6 4.4 7.3 8.0 13.7 2.4 3.5 2.3 4.7 1.8 3.6 5.4 5.2 11.3 7.4 3.6 3.6 6.1 4.6 2.9 1.6 4.7 9.9 4.0 10.4 1.4 0.6 5.4 0.9 0.0 0.0 1.2 1.0 5.4 3.1 9.4 3.5 0.0 15.6 0.3 0.4 4.9 4.7 2.5 2.1 0.1 0.0 5.5 3.6 3.2 4.0 12.3 5.8 1.6 2.9 2.1 4.6 0.5 1.3 6.3 0.0 4.2 0.1 18.6 9.5 8.3 4.1 20.3 1.9 9.0 2.0 14.3 5.8 4.8 9.9 4.3 3.8 0.5 2.0 0.2 12.5 10.3 0.1 0.3 1.8 0.0 9.8 4.8 9.1 0.1 0.3 35.0 0.6 2.9 1.6 0.6 5.9 0.2 8.2 6.1 6.5 5.3 4.2 5.5 9.9 5.9 0.0 4.7 0.3 4.6 4.2 4.0 6.6 11.2 18.1 13.8 6.3 5.8 5.9 9.1 7.7 3.6 3.0 6.5 8.0 8.1 8.2 20.4 35.0 17.8 49.5 10.3 12.2 19.6 1.6 44.7 4.7 7.8 1.5 56.7 0.0 4.9 3.6 5.1 6.8 1.1 92.8 7.2 17.5 26.2 4.9 3.3 10.3 5.2 5.5 15.1 0.0 38.7 16.2 2.2 31.6 3.9 12.1 32.8 0.0 5.4 14.1 4.7 9.5 1.6 9.6 56.2 11.9 BMP6 "VGR, VGR1" ENSG00000153162 "Bone morphogenetic protein 6" P22004 6 7726797-7881422 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.4" "Group enriched" "Detected in some" 4 "Endothelial cells: 9.0;Ito cells: 19.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 4.0;neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002773, HPA062683" Approved Approved Mitochondria "Secreted to blood" No No 4970000 21000 Mitochondria "CAB002773: , HPA062683: AB_2684832" "prognostic favorable (6.45e-4)" "unprognostic (2.99e-1)" "unprognostic (4.20e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (7.27e-2)" "unprognostic (4.66e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.29e-3)" 10.5 1.5 1.7 1.3 2.8 0.0 7.7 0.2 1.1 2.5 2.7 1.9 2.1 0.0 1.5 1.1 1.6 3.8 1.7 1.4 6.6 1.4 5.8 0.7 2.2 5.8 0.1 0.0 2.8 17.4 1.5 2.2 1.1 2.2 1.4 1.7 2.0 2.0 1.9 3.4 3.4 1.5 0.5 1.8 2.9 1.7 0.3 0.4 4.0 0.0 0.0 0.2 2.1 0.3 0.9 0.1 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.4 0.6 0.1 0.4 0.0 0.0 0.0 2.0 5.6 8.7 0.5 0.3 0.3 6.0 0.0 0.0 0.2 1.0 3.8 59.0 0.0 0.0 30.6 0.0 0.1 0.0 0.0 0.3 0.2 4.2 0.2 0.0 5.3 0.2 0.0 4.4 0.0 25.7 0.0 0.0 3.9 0.0 0.0 27.0 0.0 1.7 0.1 0.8 3.9 13.4 0.0 0.9 0.0 0.5 4.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.3 0.0 0.0 2.3 0.0 0.0 0.2 0.0 2.1 0.0 0.3 0.0 0.0 0.2 0.0 2.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.5 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 19.0 1.0 1.8 0.0 0.0 1.7 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 BPHL "Bph-rp, MCNAA, VACVase" ENSG00000137274 "Biphenyl hydrolase like" Q86WA6 6 3118374-3153578 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 61.6;liver: 47.9" "Cell type enhanced" "Detected in many" 12 "Proximal tubular cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036752, HPA036753" Enhanced Approved Mitochondria NA NA 13000 Mitochondria "HPA036752: AB_10673662, HPA036753: AB_2675291" "unprognostic (2.93e-1)" "unprognostic (1.29e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-1)" "unprognostic (3.72e-3)" "unprognostic (1.84e-1)" "unprognostic (8.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.97e-4)" "unprognostic (4.59e-2)" "unprognostic (9.46e-3)" "prognostic favorable (5.16e-7)" "unprognostic (1.60e-2)" "unprognostic (1.51e-2)" "unprognostic (6.98e-2)" "unprognostic (5.20e-2)" 12.8 9.8 8.4 5.1 12.1 4.0 8.1 6.0 10.1 6.7 19.4 6.3 4.5 19.8 6.1 17.8 8.8 7.1 8.2 6.8 7.5 9.6 61.6 47.9 3.8 4.9 7.8 5.9 5.1 9.8 4.8 8.4 3.7 10.3 5.9 6.4 6.4 8.4 4.1 12.0 6.4 29.1 7.0 6.9 2.7 6.5 7.0 3.8 4.9 4.6 8.8 5.6 6.2 5.6 15.8 13.1 7.3 11.2 11.1 11.7 6.5 13.9 11.0 18.0 16.0 11.3 10.6 8.6 7.1 12.0 15.9 14.0 13.0 15.0 16.6 14.3 11.7 14.8 13.8 16.2 16.5 37.0 19.7 10.5 8.1 8.3 16.8 3.6 10.0 4.4 8.5 7.6 15.6 23.1 9.8 23.3 13.3 7.2 8.5 24.5 20.5 12.2 6.0 13.4 14.7 24.7 12.8 20.2 16.5 12.8 15.8 17.3 13.6 10.6 5.7 27.5 23.1 17.4 4.9 8.2 19.9 16.5 11.8 13.2 7.1 21.6 13.7 4.3 5.8 22.4 7.3 8.7 0.1 7.7 11.2 9.9 15.8 8.9 7.6 13.1 11.8 8.5 11.7 1.0 11.1 6.3 7.3 4.7 6.5 8.4 12.1 6.0 10.1 7.5 9.6 7.8 5.9 10.3 3.8 6.0 9.4 4.7 8.7 7.9 11.6 3.9 35.7 45.5 14.8 15.7 19.6 23.1 59.7 24.9 0.4 7.1 17.1 0.0 11.8 27.7 12.2 7.5 2.3 62.1 19.8 15.9 15.4 3.7 1.8 0.7 13.8 10.5 30.4 21.6 10.1 11.0 17.9 10.8 13.1 218.9 7.2 6.5 9.5 6.7 21.5 8.2 11.7 5.3 16.3 6.8 BTN2A2 "BT2.2, BTF2, BTN2.2" ENSG00000124508 "Butyrophilin subfamily 2 member A2" Q8WVV5 6 26383096-26394874 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 29.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 34.7;U-266/70: 28.3" HPA051504 Uncertain Approved Mitochondria NA NA Mitochondria "HPA051504: AB_2681510" "prognostic favorable (1.01e-4)" "unprognostic (4.93e-3)" "unprognostic (1.37e-2)" "unprognostic (6.78e-2)" "unprognostic (9.26e-2)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.04e-3)" "unprognostic (1.01e-1)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (1.93e-1)" "unprognostic (1.73e-2)" "unprognostic (3.45e-1)" "unprognostic (6.54e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" 7.0 12.4 3.2 22.6 5.2 2.7 7.5 29.0 5.2 8.5 5.7 5.1 4.8 5.2 10.2 10.6 7.4 6.7 7.9 9.5 4.1 3.7 7.5 6.1 15.6 21.8 4.4 3.3 10.3 5.8 12.9 5.5 2.8 9.7 8.8 8.0 11.5 9.3 7.9 2.7 8.0 9.9 8.2 5.3 18.0 7.2 5.1 4.2 13.0 7.0 6.2 26.0 8.5 7.6 20.2 14.9 7.8 9.1 5.1 6.3 4.7 4.8 3.1 6.3 6.7 2.1 3.3 0.4 5.3 14.0 8.4 14.5 1.9 1.9 4.4 5.8 9.5 6.8 4.5 5.0 4.1 11.2 13.7 8.4 6.9 5.8 3.8 4.4 1.5 2.4 7.1 1.3 16.1 5.5 10.0 7.7 8.7 5.5 34.7 3.7 2.1 5.4 2.0 2.3 0.2 3.1 12.8 9.0 13.5 6.0 2.7 6.0 8.5 3.4 1.3 14.5 3.8 6.4 3.0 9.1 3.1 3.6 2.7 8.1 28.3 17.3 7.7 3.1 6.2 7.7 1.2 8.7 1.5 4.2 9.1 3.9 16.2 3.3 3.7 14.9 20.2 2.8 3.4 7.8 5.1 3.6 6.2 6.3 4.7 3.2 5.2 29.0 5.2 4.1 3.7 4.4 3.3 9.7 4.2 8.9 9.3 13.7 6.2 3.4 0.4 2.2 2.5 4.0 9.1 3.5 0.0 2.0 0.0 8.2 0.2 14.0 1.0 23.3 4.9 0.9 2.1 6.9 18.5 2.5 8.1 0.0 1.7 5.5 8.8 0.0 6.1 18.0 6.8 12.6 7.0 17.3 6.6 0.0 4.6 1.7 0.7 0.0 3.9 0.5 1.3 4.0 0.8 7.5 1.6 3.1 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 12.7;testis: 44.7" "Group enriched" "Detected in some" 97 "Early spermatids: 967.9;Late spermatids: 1530.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 127 "basophil: 12.7" "Lineage enriched" "Detected in single" 127 "granulocytes: 12.7" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 4.9;NTERA-2: 2.7;SuSa: 5.6;T-47d: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043022 Approved Mitochondria Yes NA Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.4 1.1 0.4 0.9 1.2 0.2 1.0 0.8 3.3 0.4 0.7 0.0 1.0 0.3 0.3 1.5 1.2 0.3 0.3 0.5 0.4 1.3 0.5 0.3 0.2 0.2 0.4 0.9 3.2 0.9 0.2 1.2 0.3 4.1 1.1 0.4 0.6 1.8 1.1 0.2 0.4 0.6 0.7 2.0 0.3 0.4 44.7 0.0 0.0 3.3 0.0 0.2 0.4 1.9 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.8 3.3 0.4 1.3 0.4 0.9 4.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 967.9 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1530.3 8.3 0.0 1.7 0.0 0.8 0.0 0.1 0.0 4.9 0.0 0.0 12.9 0.0 10.2 7.8 0.0 0.0 0.0 0.6 0.3 C18orf63 DKFZP781G0119 ENSG00000206043 "Chromosome 18 open reading frame 63" Q68DL7 18 74315813-74359187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 17.4" "Cell type enriched" "Detected in some" 14 "Spermatocytes: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.1" "Not detected" "Not detected" HPA042233 Approved Mitochondria NA NA Mitochondria "HPA042233: AB_10960843" "unprognostic (1.40e-1)" "unprognostic (1.43e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 47.2 3.4 0.0 0.0 0.0 0.0 0.0 C1orf112 FLJ10706 ENSG00000000460 "Chromosome 1 open reading frame 112" Q9NSG2 1 169662007-169854080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 24.6" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 27.7;Spermatogonia: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023778, HPA024451" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023778: AB_1848665, HPA024451: AB_1848667" "unprognostic (4.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (9.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.40e-2)" "unprognostic (2.50e-3)" "unprognostic (2.09e-1)" "unprognostic (9.11e-3)" "unprognostic (8.79e-2)" "unprognostic (3.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.65e-8)" "unprognostic (1.76e-1)" "unprognostic (2.81e-2)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" 3.4 3.1 3.3 7.4 4.9 10.1 5.0 8.4 3.6 5.2 3.2 5.0 2.2 1.5 4.8 3.5 4.0 2.2 1.8 2.3 2.7 2.4 2.6 5.2 2.6 7.4 5.0 1.5 3.3 2.6 20.1 3.7 4.2 4.5 3.2 5.3 4.9 3.3 4.9 1.9 3.1 3.3 3.6 3.6 4.2 3.0 19.7 5.9 24.6 3.2 2.9 9.5 4.0 3.3 2.9 2.7 4.3 4.9 4.9 1.6 1.6 16.5 8.9 11.7 6.0 1.9 2.6 17.3 11.0 5.7 16.2 16.5 9.9 14.6 14.8 5.0 3.6 5.7 13.6 14.6 7.7 18.6 8.7 8.6 14.0 12.0 7.2 0.6 18.2 6.2 0.8 1.1 12.0 2.9 1.9 6.8 9.1 22.5 25.3 13.1 4.0 15.8 5.1 15.4 11.8 6.4 12.0 13.1 10.0 2.2 8.4 8.6 9.0 6.9 11.6 3.6 11.6 11.0 9.5 4.9 13.1 10.4 9.5 14.9 6.9 10.3 15.7 4.9 13.6 12.6 4.3 1.8 2.2 1.3 4.5 1.0 2.9 1.6 1.4 2.7 2.8 0.6 1.4 0.3 4.9 4.9 0.7 1.6 1.6 3.3 4.9 8.4 3.6 2.7 2.4 5.0 1.5 4.5 5.9 0.0 3.5 2.2 2.6 1.5 3.8 0.4 0.0 2.7 1.2 0.0 5.9 6.0 0.0 2.3 5.9 2.1 0.9 0.0 3.0 7.4 2.3 0.8 4.6 3.0 5.0 1.6 0.0 4.3 3.1 3.1 2.0 3.0 3.3 1.0 1.0 2.6 2.5 0.0 3.5 0.4 6.5 6.5 1.2 27.7 17.7 0.9 3.2 1.9 1.6 1.4 C5orf63 "FLJ44606, YDR286C" ENSG00000164241 "Chromosome 5 open reading frame 63" A6NC05 5 127042558-127073492 "Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 46.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 32.7" HPA043240 Approved Approved Approved Mitochondria NA NA Mitochondria "HPA043240: AB_10962511" "unprognostic (2.71e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-1)" "unprognostic (2.63e-1)" "unprognostic (1.62e-1)" "unprognostic (1.93e-1)" "unprognostic (2.94e-4)" "unprognostic (1.34e-1)" "unprognostic (9.67e-2)" "unprognostic (3.40e-2)" "unprognostic (1.43e-4)" "unprognostic (1.07e-1)" "unprognostic (2.26e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-1)" "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" 4.4 4.4 3.3 10.1 4.6 2.8 5.9 6.8 21.4 2.9 10.9 5.5 3.3 5.6 7.5 4.8 7.6 4.2 3.8 7.3 4.4 4.9 8.0 7.0 4.6 6.8 4.6 4.8 4.4 7.5 9.2 27.7 2.7 6.8 5.5 11.0 11.3 13.7 3.9 6.6 3.3 9.2 3.2 6.2 5.6 6.8 13.8 3.0 8.5 9.0 5.1 9.1 4.9 5.1 11.9 9.8 3.9 1.5 12.3 10.1 2.9 0.5 2.5 0.7 1.4 1.9 3.0 0.4 2.7 0.3 3.3 2.0 6.1 7.7 0.0 11.2 2.1 4.9 1.0 4.7 2.9 4.8 1.0 3.8 6.2 9.4 7.3 4.7 3.6 0.3 3.1 7.5 4.3 2.2 2.4 2.8 2.7 0.4 1.2 3.3 5.0 0.1 3.3 0.4 5.2 1.9 2.7 1.6 4.3 3.7 3.8 6.2 5.1 3.5 1.6 0.2 1.4 6.4 5.4 2.2 7.1 6.5 8.1 1.7 3.8 9.7 0.2 32.7 0.4 3.6 3.4 0.3 3.9 6.7 1.5 5.3 11.9 6.1 7.1 3.0 10.8 9.2 6.8 1.4 12.3 0.4 9.8 10.1 2.9 3.3 4.6 6.8 3.2 4.4 4.9 4.6 4.8 6.8 3.0 6.0 13.2 11.9 9.8 0.9 10.3 29.0 5.1 16.0 3.4 15.7 13.7 9.2 16.6 13.8 20.7 3.3 8.4 0.0 8.6 7.4 2.7 7.2 9.3 8.1 4.5 0.0 10.4 3.7 0.8 12.1 2.3 1.9 8.5 1.8 10.6 10.9 10.6 15.3 2.1 5.1 9.8 6.5 1.7 46.5 13.4 1.0 2.3 4.4 13.2 11.9 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309607 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6" "Group enriched" "Detected in some" 7 "Ciliated cells: 329.2;Early spermatids: 104.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 7.4;SCLC-21H: 4.3" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria NA NA Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.3 0.3 4.4 0.3 11.4 0.3 0.3 0.1 0.8 1.5 0.3 7.5 0.1 0.3 1.0 7.2 0.3 23.9 0.3 0.3 4.3 2.7 0.3 0.3 4.7 0.3 0.3 1.0 3.4 0.3 0.3 10.4 0.3 14.5 0.3 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.3 0.8 0.3 0.3 9.6 3.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.4 0.1 0.8 4.3 2.7 0.3 1.0 14.5 3.9 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.0 329.2 22.7 0.0 0.0 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 C9orf129 bA165J3.3 ENSG00000204352 "Chromosome 9 open reading frame 129" Q5T035 9 93318199-93346414 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in many" 4 "brain: 12.7;testis: 4.3" "Group enriched" "Detected in some" 41 "Early spermatids: 17.5;Late spermatids: 49.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NTERA-2: 7.0" HPA071515 Uncertain Mitochondria NA NA Mitochondria "HPA071515: " "unprognostic (1.12e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (3.45e-1)" 0.7 0.6 5.9 1.3 7.2 0.7 0.7 4.7 12.7 1.4 0.8 0.7 0.0 1.1 0.9 2.0 1.0 1.3 0.6 0.9 4.3 5.7 0.6 0.7 0.7 0.7 3.2 9.3 0.6 1.1 0.6 0.6 0.8 4.3 1.0 0.8 0.6 0.6 1.2 1.3 0.6 0.8 1.0 2.1 1.0 1.1 4.3 1.1 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.2 4.7 12.7 4.3 5.7 3.2 9.3 4.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 C9orf131 MGC41945 ENSG00000174038 "Chromosome 9 open reading frame 131" Q5VYM1 9 35041095-35045991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 46.6" "Group enriched" "Detected in some" 32 "Early spermatids: 99.2;Late spermatids: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 4.0;RT4: 14.0" "Not detected" "Not detected" HPA022029 Approved Mitochondria NA NA Mitochondria "HPA022029: AB_10960628" "unprognostic (1.10e-2)" "unprognostic (8.99e-2)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-3)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.66e-1)" "unprognostic (9.45e-2)" "unprognostic (4.63e-2)" "unprognostic (1.75e-2)" "unprognostic (2.37e-2)" "unprognostic (9.34e-2)" "unprognostic (1.82e-1)" "unprognostic (9.90e-4)" "unprognostic (4.19e-3)" 0.2 0.1 0.2 0.2 0.3 1.3 0.3 0.6 0.3 1.0 0.2 0.2 0.2 0.0 2.2 0.8 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.3 0.7 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.8 0.5 0.2 0.2 0.2 0.2 0.2 46.6 0.2 0.2 0.3 0.2 0.2 0.3 0.2 1.0 0.1 2.7 0.5 0.9 1.4 0.0 3.4 0.1 0.3 0.8 0.7 0.0 1.0 1.0 0.0 0.0 0.0 0.9 1.8 0.7 0.3 0.0 1.2 2.2 0.0 0.0 0.4 0.3 0.5 1.2 4.0 0.9 0.0 0.4 1.2 0.0 0.5 0.0 0.0 0.0 0.5 1.4 3.4 2.4 0.0 0.5 0.7 1.8 0.6 1.0 0.0 0.0 0.3 0.0 0.3 14.0 0.3 0.0 1.2 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.9 1.3 0.3 0.5 1.5 2.7 0.5 0.0 0.5 0.0 0.0 0.5 0.4 1.4 0.0 1.0 0.5 0.8 1.3 0.9 0.0 0.1 0.1 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 99.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 26.1 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.3 0.0 0.5 0.0 0.0 0.0 CA5B ENSG00000169239 "Carbonic anhydrase 5B" Q9Y2D0 X 15688830-15788409 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.7;fHDF/TERT166: 17.9;hTERT-HME1: 23.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012618 Uncertain Supported Mitochondria NA NA Mitochondria "HPA012618: AB_1846000" "unprognostic (1.62e-2)" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.16e-2)" "unprognostic (4.59e-5)" "unprognostic (2.50e-1)" "unprognostic (6.89e-4)" "unprognostic (4.11e-1)" "unprognostic (3.89e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (6.66e-6)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (8.94e-2)" "unprognostic (3.08e-1)" 9.3 4.6 10.6 4.9 11.1 4.1 10.2 3.1 7.8 28.7 3.6 11.5 1.4 2.2 9.8 3.7 8.1 9.5 9.1 6.5 9.9 8.2 10.3 7.8 7.3 8.8 12.2 6.7 15.2 4.4 16.8 4.4 3.9 13.1 6.2 4.7 29.5 8.3 6.2 2.0 7.5 4.1 9.4 7.1 5.3 5.4 23.0 8.1 2.3 8.9 10.9 11.6 6.3 9.4 4.3 3.5 2.7 3.6 7.9 13.3 7.0 2.7 1.7 2.0 3.2 5.9 15.7 1.1 2.9 3.7 2.2 3.2 0.8 1.9 0.8 3.1 17.9 4.2 3.0 6.9 3.3 3.9 0.7 3.3 1.5 2.1 0.7 5.8 1.9 3.4 3.6 3.6 2.9 23.5 3.9 3.2 2.3 0.8 2.1 10.3 1.5 1.6 1.5 0.8 0.5 12.5 0.9 1.4 1.4 3.3 2.0 1.7 3.7 4.1 1.5 2.6 2.4 2.1 1.9 4.3 2.6 1.7 13.9 1.6 1.5 1.5 0.9 2.9 3.9 4.8 2.7 3.0 0.3 13.1 3.6 11.4 3.6 13.3 12.3 3.5 4.3 9.8 8.3 1.7 7.9 2.3 0.5 10.0 7.0 10.6 11.1 3.1 7.8 9.9 8.2 12.2 6.7 13.1 8.1 0.0 9.3 7.2 5.3 3.8 8.9 1.6 0.0 17.4 10.3 1.8 15.7 1.4 1.7 3.6 0.9 10.7 0.5 23.3 3.5 1.2 7.2 9.7 2.3 2.4 1.7 1.6 2.9 3.7 7.8 1.3 7.2 9.6 3.3 1.0 2.4 37.2 3.8 0.9 4.9 2.2 8.0 6.5 7.2 3.3 5.9 4.0 1.6 15.9 1.7 6.3 CACNA1B "CACNL1A5, CACNN, Cav2.2" ENSG00000148408 "Calcium voltage-gated channel subunit alpha1 B" Q00975 9 137877789-138124624 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 21.2" "Low region specificity" "Detected in all" "HPA022919, HPA044347" Uncertain Approved Mitochondria NA NA Mitochondria "HPA022919: , HPA044347: AB_10960837" "unprognostic (1.34e-3)" "unprognostic (2.70e-2)" "unprognostic (8.08e-2)" "unprognostic (2.51e-7)" "unprognostic (8.10e-2)" "unprognostic (1.51e-2)" "unprognostic (1.33e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.36e-2)" "unprognostic (9.73e-4)" "unprognostic (5.98e-2)" "unprognostic (6.63e-6)" "unprognostic (4.25e-2)" "unprognostic (4.72e-1)" "unprognostic (7.77e-3)" "unprognostic (8.69e-2)" 0.5 6.2 5.7 0.7 8.7 0.5 0.5 18.7 18.9 1.2 0.8 0.2 0.0 0.6 0.6 1.7 0.4 6.6 1.4 1.0 4.5 7.3 0.4 1.2 0.5 0.5 2.9 9.1 0.5 1.2 0.4 4.8 0.4 3.6 1.6 0.8 0.4 0.4 1.3 0.4 0.9 0.7 0.8 4.5 0.6 0.6 8.1 1.4 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 4.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 8.7 18.7 10.9 4.5 7.3 2.9 9.1 3.6 1.4 0.0 0.0 0.0 0.0 0.0 5.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.0 0.0 2.4 0.0 0.0 0.4 0.0 1.5 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.0 0.0 CARD16 "COP, COP1, PSEUDO-ICE" ENSG00000204397 "Caspase recruitment domain family member 16" Q5EG05 11 105041326-105101431 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.3;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 242.8;Macrophages: 269.3;monocytes: 172.3;Paneth cells: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 38.8;HHSteC: 68.1;HUVEC TERT2: 31.2;TIME: 28.5" "HPA053981, HPA062805" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA053981: AB_2682332, HPA062805: AB_2684871" "unprognostic (2.25e-3)" "unprognostic (6.56e-2)" "unprognostic (1.49e-1)" "unprognostic (8.12e-2)" "unprognostic (4.45e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-1)" "unprognostic (8.68e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-2)" "unprognostic (5.12e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.93e-7)" "unprognostic (2.81e-1)" "unprognostic (6.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.19e-1)" 11.4 4.0 3.8 21.9 6.8 20.9 8.1 2.3 4.3 5.5 13.3 1.7 4.2 16.3 4.4 4.9 9.0 5.4 11.1 6.4 4.7 2.6 8.1 7.3 30.2 14.5 6.4 3.0 7.6 7.2 0.0 3.2 28.5 6.2 8.2 11.8 4.1 5.8 4.4 4.1 5.6 20.2 5.6 9.2 52.1 7.5 2.1 6.2 6.2 5.5 7.4 11.5 10.9 12.8 23.4 57.8 126.3 110.3 19.4 47.9 68.9 0.3 0.0 0.0 38.8 1.0 5.3 0.2 0.8 2.7 0.1 0.7 0.3 0.0 4.0 5.4 2.3 5.8 2.7 0.3 5.6 0.0 16.5 0.0 0.8 0.7 0.4 68.1 5.3 0.0 9.6 2.9 3.9 2.7 0.4 31.2 0.2 0.0 0.0 0.0 0.0 1.8 4.6 0.0 0.0 0.1 4.4 0.1 5.1 0.1 2.5 0.0 0.0 6.1 0.8 19.4 1.4 0.8 12.8 28.5 2.7 0.3 1.7 0.1 0.0 0.8 0.0 3.1 17.9 0.6 44.0 85.3 61.6 26.4 110.3 25.1 23.4 24.1 25.3 57.8 17.9 14.3 21.8 126.3 19.4 97.2 6.7 47.9 68.9 3.8 6.8 2.3 4.3 4.7 2.6 6.4 3.0 6.2 6.2 26.8 49.5 67.7 15.9 23.8 0.0 8.7 28.1 18.7 42.1 14.0 0.0 7.7 1.7 5.9 0.2 66.1 70.9 0.0 19.4 3.1 27.9 3.8 59.9 2.1 81.0 0.0 15.7 50.3 242.8 0.7 19.0 269.3 13.5 172.3 70.7 0.0 7.0 336.9 17.0 0.4 0.0 6.5 9.9 0.1 0.6 13.7 10.9 108.6 47.2 28.3 CARD19 "bA370F5.1, BinCARD, C9orf89, MGC11115" ENSG00000165233 "Caspase recruitment domain family member 19" Q96LW7 9 93096218-93113283 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010921, HPA010990, HPA038297" Approved Supported Mitochondria NA NA Mitochondria "HPA010921: AB_10670295, HPA010990: AB_2668400, HPA038297: AB_2675938" "unprognostic (7.26e-2)" "unprognostic (1.15e-2)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (7.47e-5)" "unprognostic (2.22e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.21e-1)" "unprognostic (1.36e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (9.13e-2)" "unprognostic (6.82e-2)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (1.41e-1)" 15.1 17.8 9.9 8.1 10.6 6.8 19.6 19.8 15.0 13.5 18.1 13.9 6.4 13.7 13.8 14.2 12.9 12.3 13.0 14.5 9.7 7.5 18.1 12.2 12.0 7.8 14.8 10.7 9.6 9.1 6.1 8.1 7.6 13.7 10.2 7.6 9.9 12.1 10.7 15.5 14.6 12.2 12.5 12.5 12.5 15.7 19.9 10.3 5.3 10.0 13.4 7.1 15.5 12.6 5.6 17.3 23.0 21.7 9.2 11.5 12.3 12.1 11.9 1.4 3.5 1.9 3.7 5.0 10.1 5.0 7.1 3.2 2.9 4.1 2.6 7.1 3.6 5.1 21.2 1.2 8.1 0.6 50.0 4.7 4.6 2.5 6.7 8.1 4.1 4.4 9.3 2.6 5.1 2.0 7.0 8.2 2.3 2.0 4.9 4.8 24.1 4.4 11.1 1.4 7.7 27.1 2.9 8.0 10.6 8.7 4.5 3.7 6.7 5.4 2.6 11.0 0.0 6.0 4.3 8.1 3.6 7.3 6.8 3.1 3.9 3.6 0.5 14.9 4.2 12.4 14.1 21.7 12.8 6.1 16.0 6.2 5.6 6.0 6.5 17.3 3.3 5.5 5.5 23.0 9.2 9.1 6.2 11.5 12.3 9.9 10.6 19.8 15.0 9.7 7.5 14.8 10.7 13.7 10.3 20.8 18.1 6.7 38.6 0.0 10.2 0.0 25.5 4.0 10.3 15.7 15.7 18.5 53.0 70.5 28.5 24.8 23.6 0.0 51.8 27.7 20.8 42.0 27.9 12.4 72.1 4.8 15.2 34.4 46.4 9.3 42.3 64.9 0.0 71.3 25.5 15.1 83.4 7.0 41.1 43.9 21.6 58.2 0.0 75.2 29.6 0.0 18.1 22.4 21.0 66.8 CASP9 "APAF-3, ICE-LAP6, MCH6, PPP1R56" ENSG00000132906 "Caspase 9" P55211 1 15490832-15526534 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001473, CAB004348, HPA046488" Approved Approved Mitochondria NA NA Mitochondria "CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670" "prognostic favorable (5.91e-4)" "unprognostic (2.42e-1)" "unprognostic (8.94e-3)" "unprognostic (7.84e-2)" "unprognostic (1.93e-2)" "unprognostic (8.54e-3)" "unprognostic (1.90e-3)" "unprognostic (6.75e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-1)" "unprognostic (9.09e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-2)" "unprognostic (2.35e-1)" "unprognostic (3.21e-2)" "unprognostic (5.48e-2)" "prognostic favorable (1.67e-5)" 7.4 24.1 7.8 8.2 9.3 8.9 5.5 11.1 8.7 8.3 9.3 10.2 18.9 5.2 11.9 16.5 7.5 13.4 29.1 10.2 8.3 7.2 11.6 9.4 10.8 12.6 10.7 4.3 33.4 29.0 15.6 18.5 14.7 8.8 10.2 6.4 8.7 6.6 19.0 8.2 2.8 13.3 7.8 9.0 11.0 6.7 14.4 7.1 6.2 14.8 7.2 14.6 7.3 8.1 11.2 11.7 23.3 11.2 13.0 5.1 6.1 7.2 10.6 4.1 7.2 9.5 4.7 3.8 5.3 7.0 7.9 10.2 7.4 8.8 10.6 12.5 7.2 10.2 2.6 7.0 5.6 9.2 3.7 8.7 7.6 23.6 7.4 8.8 7.3 8.9 6.5 10.4 12.1 3.7 7.8 8.5 9.6 17.0 9.9 4.7 3.7 2.5 8.3 4.1 10.5 5.9 4.9 10.4 12.3 9.8 4.2 3.6 6.9 7.6 1.8 12.6 9.5 4.5 5.3 3.3 10.6 4.8 11.4 3.5 9.6 14.4 12.0 8.1 8.0 3.5 22.7 11.2 23.3 5.1 8.2 3.7 9.6 3.0 3.6 11.7 11.2 1.7 2.6 16.0 13.0 7.9 5.2 2.8 6.1 7.8 9.3 11.1 8.7 8.3 7.2 10.7 4.3 8.8 7.1 3.0 3.0 4.7 7.9 2.6 3.2 6.7 5.1 10.7 9.1 17.4 5.9 15.4 1.7 6.6 9.9 3.0 6.8 0.0 7.8 9.0 5.0 4.5 1.1 4.3 8.5 4.8 2.9 3.7 4.3 4.1 2.0 8.7 0.0 3.6 5.6 6.5 7.9 5.8 3.5 4.2 6.2 0.0 9.9 15.8 5.7 2.0 29.9 4.9 4.5 5.4 CCDC120 JM11 ENSG00000147144 "Coiled-coil domain containing 120" Q96HB5 X 49053572-49069857 "Cancer-related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 14.4;BEWO: 20.7;HaCaT: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000561 Uncertain Mitochondria NA NA Mitochondria "HPA000561: AB_2244190" "unprognostic (1.65e-1)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (7.59e-3)" "unprognostic (1.80e-3)" "unprognostic (1.08e-2)" "unprognostic (2.59e-3)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (4.85e-2)" "unprognostic (2.64e-2)" "unprognostic (3.82e-3)" "unprognostic (4.54e-3)" "unprognostic (2.34e-3)" 3.3 3.1 5.8 3.1 4.7 2.9 5.0 17.3 5.8 8.4 6.8 1.6 10.4 12.0 5.5 9.9 27.6 5.1 4.1 2.1 4.0 1.6 7.0 4.8 4.4 2.6 1.5 3.3 6.5 7.0 6.1 12.2 13.3 4.0 6.0 3.3 4.7 11.4 10.2 1.5 26.1 12.5 2.5 1.8 3.8 7.7 5.8 1.5 6.0 5.6 8.8 15.1 7.4 12.2 2.5 2.2 3.9 0.8 1.6 1.5 0.4 14.4 1.9 3.2 0.1 0.0 0.0 20.7 0.5 0.7 1.1 1.7 4.8 6.2 0.6 2.3 0.8 2.4 13.9 2.4 8.2 0.1 3.7 4.6 1.3 3.3 1.6 1.1 0.0 2.4 1.8 6.6 1.3 0.4 2.2 1.8 3.8 2.0 0.2 0.0 12.1 5.0 0.4 3.7 6.8 0.1 4.5 2.4 1.3 6.3 7.8 4.4 3.4 2.6 5.2 1.5 4.6 12.6 1.9 0.8 0.1 3.8 0.1 0.1 4.7 3.2 0.1 0.1 0.0 0.6 2.9 0.8 1.5 1.4 0.2 0.9 0.8 1.5 1.3 0.3 2.5 1.5 1.4 3.9 1.6 0.4 2.2 0.5 0.4 5.8 4.7 17.3 5.8 4.0 1.6 1.5 3.3 4.0 1.5 6.0 1.9 0.8 3.2 4.5 5.8 1.2 2.5 2.7 2.3 12.2 3.9 10.2 0.0 4.7 0.1 2.9 6.2 0.0 5.7 2.6 1.5 5.1 0.0 1.9 1.9 9.5 5.8 3.7 2.7 0.0 2.0 0.0 0.0 0.0 5.5 2.3 9.7 6.2 1.1 2.4 6.1 0.0 0.8 1.1 0.7 8.2 14.1 1.0 3.9 7.6 CCDC191 KIAA1407 ENSG00000163617 "Coiled-coil domain containing 191" Q8NCU4 3 113964137-114056613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 191.4;Spermatocytes: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047833 Approved Approved Mitochondria NA NA Mitochondria "HPA047833: AB_10961639" "unprognostic (2.59e-2)" "unprognostic (3.93e-2)" "unprognostic (1.86e-1)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (1.42e-2)" "unprognostic (6.57e-2)" "unprognostic (5.91e-2)" "unprognostic (1.08e-1)" "unprognostic (2.90e-1)" "unprognostic (6.33e-2)" "unprognostic (3.64e-2)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.62e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.45e-4)" 3.8 4.5 6.3 4.5 13.3 4.2 7.6 3.0 9.7 7.6 4.0 11.7 11.5 2.9 8.2 12.4 3.4 18.5 5.7 2.4 8.2 7.8 7.7 2.4 7.2 6.1 6.2 9.8 7.7 6.6 16.7 31.1 3.4 12.5 6.5 5.2 7.1 5.0 7.9 1.6 11.4 5.1 7.0 8.9 7.5 4.8 12.7 7.9 3.6 11.3 2.4 6.1 5.2 4.5 10.0 4.4 5.3 0.9 0.8 2.2 1.0 4.9 2.8 4.4 3.6 1.2 6.6 1.4 1.2 2.2 1.7 2.7 0.6 5.8 1.3 2.0 2.3 1.3 6.2 1.3 2.4 4.0 0.9 1.1 0.9 0.9 0.5 1.8 1.6 0.7 2.8 6.3 2.2 3.3 3.0 3.3 3.8 0.4 3.1 1.0 2.4 3.0 0.6 0.8 3.4 2.1 2.0 0.9 2.9 6.1 2.5 2.5 4.3 2.0 0.5 2.1 2.3 10.6 0.6 3.4 2.7 0.8 1.4 0.8 4.5 3.6 5.0 3.8 0.8 1.4 0.1 0.9 1.8 1.1 0.9 1.2 10.0 2.2 1.8 1.0 9.4 1.1 1.8 5.3 0.8 0.6 4.4 1.6 1.0 6.3 13.3 3.0 9.7 8.2 7.8 6.2 9.8 12.5 7.9 11.9 11.8 7.3 3.8 0.0 8.7 0.0 0.0 191.4 29.6 12.2 35.3 1.4 11.6 3.7 21.9 1.4 1.1 0.0 3.1 0.4 1.5 2.6 1.1 0.8 2.7 19.1 4.7 5.5 1.8 10.9 3.7 0.7 0.0 1.0 3.0 20.1 2.4 0.0 4.9 3.6 39.1 0.0 0.0 76.7 12.3 0.0 0.2 0.0 3.2 1.7 CCDC90B "MDS011, MDS025" ENSG00000137500 "Coiled-coil domain containing 90B" Q9GZT6 11 83259097-83286407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 347.8;Spermatocytes: 279.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011130, HPA011931" Supported Enhanced Mitochondria NA NA Mitochondria "HPA011130: AB_1846170, HPA011931: AB_2072332" "unprognostic (5.85e-2)" "unprognostic (1.33e-1)" "unprognostic (7.34e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.48e-2)" "unprognostic (2.99e-1)" "unprognostic (3.57e-3)" "unprognostic (5.76e-3)" "unprognostic (3.53e-2)" "unprognostic (6.01e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-2)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.41e-1)" 15.8 32.0 25.0 11.1 23.3 11.6 18.0 14.3 17.9 15.4 14.5 14.6 17.2 12.1 12.6 29.3 14.3 13.5 15.2 18.2 22.3 25.6 16.4 31.3 11.0 15.0 29.9 14.9 19.4 16.6 15.2 29.5 18.3 24.5 16.3 14.9 8.4 14.5 14.8 12.2 11.6 18.2 14.9 43.9 17.1 13.6 42.2 28.3 15.5 21.6 12.3 13.5 14.8 13.0 18.5 12.7 32.6 19.0 22.5 21.1 12.4 7.2 10.8 18.4 5.9 25.0 18.9 11.3 14.8 12.7 9.4 10.0 12.6 25.3 17.7 19.5 21.9 19.4 9.3 8.1 19.0 12.5 12.4 6.4 10.9 7.3 10.4 21.1 11.0 9.5 21.0 25.7 12.0 34.7 18.5 21.3 19.6 16.1 15.2 34.1 12.9 11.0 14.1 15.2 31.7 13.5 12.8 16.6 15.2 19.4 10.8 9.0 20.8 10.4 8.4 9.6 25.9 21.7 10.3 20.4 18.4 11.6 34.5 10.0 14.8 19.3 18.0 7.4 8.9 18.1 30.8 8.9 32.6 12.3 19.0 15.6 18.5 17.9 17.0 12.7 16.9 15.5 15.5 4.5 22.5 19.0 9.3 21.1 12.4 25.0 23.3 14.3 17.9 22.3 25.6 29.9 14.9 24.5 28.3 11.9 12.5 34.2 43.7 20.9 33.7 49.1 15.3 24.1 15.9 34.9 13.7 62.9 58.0 53.7 347.8 38.6 19.2 0.0 42.7 46.4 36.0 35.2 47.4 39.9 56.5 39.7 32.2 26.4 28.8 188.9 39.4 41.6 20.3 61.3 31.8 23.0 58.7 35.1 24.1 57.7 44.3 25.8 30.1 279.8 83.5 25.3 43.3 28.8 30.4 38.0 CCM2 "C7orf22, MGC4607, OSM" ENSG00000136280 "CCM2 scaffolding protein" Q9BSQ5 7 44999475-45076469 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "monocytes: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020273, HPA021669, HPA065815" Supported Enhanced Mitochondria NA NA Mitochondria "HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562" "unprognostic (4.30e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (3.17e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.37e-3)" "unprognostic (3.92e-1)" "unprognostic (2.65e-1)" "prognostic favorable (1.16e-4)" "unprognostic (3.03e-1)" "prognostic unfavorable (5.06e-7)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (2.81e-2)" "unprognostic (2.48e-1)" 16.7 18.3 31.6 20.7 52.0 11.2 8.6 21.3 36.1 9.7 12.5 13.9 8.6 10.5 7.2 7.0 10.6 8.4 9.1 13.7 29.8 23.1 7.9 31.6 12.4 30.7 29.0 14.2 8.2 17.9 16.5 11.2 11.5 17.8 7.7 8.8 6.9 13.6 12.6 27.0 13.4 10.6 13.3 14.7 20.8 11.2 10.5 11.5 37.5 7.4 8.2 23.4 15.4 12.6 14.8 7.3 32.4 13.8 17.6 50.6 11.1 13.6 15.1 9.1 18.0 17.2 15.1 6.7 16.6 13.7 11.9 16.1 10.9 14.2 19.3 12.8 21.0 37.8 17.9 5.6 21.4 7.9 21.5 10.8 8.5 12.1 7.7 15.2 3.5 23.1 17.0 14.1 20.9 9.0 11.1 21.6 28.3 9.8 15.7 23.8 20.6 16.9 46.8 10.5 11.4 16.8 9.0 5.2 15.6 12.1 13.2 17.5 13.6 13.6 10.7 7.3 12.3 12.3 16.1 16.3 16.2 13.8 16.2 15.8 28.1 22.0 38.9 15.9 12.7 19.5 27.1 10.5 31.2 17.3 12.1 11.6 13.6 20.5 18.7 7.2 14.8 19.9 14.7 32.4 17.6 13.8 7.3 50.6 11.1 31.6 52.0 21.3 36.1 29.8 23.1 29.0 14.2 17.8 11.5 17.9 20.8 51.3 20.1 41.6 18.3 12.5 17.8 6.7 21.6 14.0 3.9 22.8 21.6 27.6 5.8 25.3 21.7 0.0 33.3 31.3 26.3 15.3 34.7 50.4 43.3 77.9 15.0 27.0 34.3 8.0 19.5 45.2 32.1 208.2 13.4 21.4 35.1 11.5 19.1 17.0 11.9 19.4 27.8 16.2 36.4 20.1 8.7 56.6 13.5 16.1 CCR7 "BLR2, CD197, CDw197, CMKBR7, EBI1" ENSG00000126353 "C-C motif chemokine receptor 7" P32248 17 40553769-40565472 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "blood: 252.3;lymphoid tissue: 110.6" "Cell type enriched" "Detected in many" 6 "monocytes: 2758.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 252.3" "Lineage enriched" "Detected in many" 4 "T-cells: 252.3" "Cell line enriched" "Detected in some" 79 "HDLM-2: 175.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB003796, HPA031383, HPA074467" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693" "prognostic favorable (3.84e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.26e-3)" "unprognostic (1.32e-3)" "unprognostic (2.35e-3)" "prognostic favorable (7.61e-7)" "unprognostic (2.71e-4)" "unprognostic (2.58e-2)" "unprognostic (4.48e-2)" "unprognostic (4.68e-4)" "unprognostic (1.10e-2)" "unprognostic (3.11e-1)" "unprognostic (1.08e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.02e-1)" "unprognostic (7.95e-2)" 2.8 0.4 0.2 26.0 0.2 5.2 1.7 0.2 0.3 2.2 1.2 0.3 0.8 0.3 1.2 0.5 1.4 2.3 2.0 1.9 0.2 0.2 1.5 1.7 3.4 110.6 0.3 0.2 1.5 0.3 0.0 1.0 1.0 0.4 1.3 2.1 0.7 8.4 0.2 0.2 1.1 16.2 0.2 0.4 20.3 1.8 1.2 0.3 57.1 2.0 1.2 53.8 4.2 1.3 58.8 2.9 2.3 0.3 44.1 252.3 109.3 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 175.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.1 1.1 0.2 0.0 0.0 1.1 0.3 0.2 3.1 0.1 3.6 37.2 53.3 15.3 0.2 58.8 252.3 133.9 2.3 44.1 0.2 2.9 30.3 109.3 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.3 0.0 5.9 116.5 1.4 4.4 0.0 0.3 0.0 0.0 2.3 1.8 0.0 111.5 0.0 0.4 0.1 0.1 0.0 0.0 6.9 6.3 3.3 0.0 2.3 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 12.9 15.1 2758.4 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 3.9 0.2 0.5 3.9 432.7 16.2 0.0 3.3 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell type enhanced" "Detected in some" 9 "Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Cell line enriched" "Detected in some" 9 "HMC-1: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049527, HPA057763" Approved Uncertain Mitochondria NA NA 42000 Mitochondria "HPA049527: , HPA057763: AB_2683519" "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.2 1.9 0.1 0.0 0.0 1.1 0.1 0.8 0.0 0.0 0.1 25.3 0.3 1.3 0.0 0.1 0.2 0.2 0.5 0.1 0.6 0.1 1.5 0.0 2.9 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 0.6 0.4 0.5 0.3 0.6 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 0.0 1.4 0.5 0.1 1.1 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.1 1.1 0.4 0.7 0.0 1.7 0.0 6.2 1.3 0.3 7.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.2 0.0 0.0 1.4 0.0 4.6 0.1 0.1 CDRT4 FLJ36674 ENSG00000239704 "CMT1A duplicated region transcript 4" 17 15436015-15503608 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 36.8" "Group enriched" "Detected in some" 19 "Early spermatids: 68.3;Late spermatids: 129.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Group enriched" "Detected in many" 5 "granulocytes: 3.9;NK-cells: 1.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Hep G2: 13.2;NB-4: 10.0" "Low region specificity" "Detected in many" HPA021590 Uncertain Approved Mitochondria NA NA Mitochondria "HPA021590: AB_1848906" "unprognostic (5.46e-6)" "unprognostic (9.47e-2)" "unprognostic (7.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.51e-2)" "unprognostic (7.74e-3)" "unprognostic (9.29e-2)" "unprognostic (2.12e-2)" "unprognostic (3.93e-2)" "unprognostic (1.39e-1)" "unprognostic (2.10e-5)" "unprognostic (2.00e-3)" "unprognostic (1.74e-6)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (4.18e-1)" "unprognostic (9.27e-2)" 2.0 3.2 2.0 2.0 2.3 3.3 6.5 3.7 2.6 2.6 2.3 2.3 2.0 0.2 2.5 17.7 2.0 4.4 2.0 2.0 2.0 2.4 2.0 2.0 3.7 2.8 2.7 2.8 5.3 4.1 0.9 10.9 2.0 2.0 4.1 3.0 2.0 5.0 2.7 2.0 14.6 2.0 2.0 2.0 2.9 2.7 36.8 2.0 2.0 5.3 2.0 2.0 2.1 2.8 0.4 0.3 3.9 0.1 1.1 1.8 0.5 3.2 3.2 4.0 1.2 3.0 2.3 3.8 1.1 3.1 1.4 1.3 1.9 1.1 0.0 1.5 1.6 0.2 1.2 4.4 3.6 2.2 0.6 0.6 0.4 2.0 13.2 0.9 1.1 5.5 3.1 4.4 2.0 4.9 6.1 3.3 1.4 0.7 2.0 3.4 0.5 1.2 10.0 1.6 0.4 1.1 0.9 0.1 0.0 3.3 2.5 0.6 1.7 1.1 0.7 1.0 8.1 1.4 2.5 3.3 0.8 1.5 1.5 1.2 2.7 1.0 0.2 0.0 0.3 0.4 3.9 0.0 0.4 0.9 0.0 0.6 0.4 0.4 0.8 0.1 0.4 0.1 0.4 0.2 1.1 0.1 0.3 1.8 0.5 2.0 2.3 3.7 2.6 2.0 2.4 2.7 2.8 2.0 2.0 0.0 0.6 0.0 0.1 0.1 1.4 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.5 68.3 0.0 0.3 0.0 0.0 0.3 0.2 0.3 2.3 0.0 0.1 0.0 0.0 0.0 0.0 129.6 0.0 0.0 0.0 1.0 1.7 0.3 0.7 1.5 0.0 0.0 1.6 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.6 0.3 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 89.3;Horizontal cells: 71.5" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 7.6;Karpas-707: 17.0;SCLC-21H: 30.5;SH-SY5Y: 11.4;U-266/70: 11.9;U-87 MG: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Supported Approved Mitochondria NA NA Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 7.6 0.3 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 17.0 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.5 11.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 11.9 3.2 0.7 15.9 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 0.0 0.0 0.0 0.1 0.1 89.3 0.4 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 71.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 17.6 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 CHAC1 MGC4504 ENSG00000128965 "ChaC glutathione specific gamma-glutamylcyclotransferase 1" Q9BUX1 15 40952962-40956519 "Enzymes, Predicted intracellular proteins" "Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 29.9;Exocrine glandular cells: 24.3;Pancreatic endocrine cells: 16.5;Urothelial cells: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 1.8;monocytes: 1.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;HHSteC: 26.8;hTCEpi: 42.4;SK-MEL-30: 30.0;U-266/70: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042708, HPA043505" Approved Approved Mitochondria NA NA Mitochondria "HPA042708: AB_2678125, HPA043505: AB_2678518" "unprognostic (6.04e-3)" "unprognostic (2.81e-2)" "unprognostic (7.47e-2)" "unprognostic (2.84e-3)" "unprognostic (6.57e-3)" "unprognostic (2.00e-2)" "unprognostic (5.59e-2)" "unprognostic (2.43e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (3.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.23e-7)" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-2)" "unprognostic (3.91e-2)" 6.0 1.0 2.6 1.5 2.1 1.7 1.0 1.7 5.6 1.1 1.9 0.3 1.1 1.9 1.1 1.8 18.6 1.5 5.7 2.2 2.6 4.8 3.1 14.1 1.5 1.1 2.6 2.2 11.3 53.0 0.9 1.3 1.1 6.2 1.5 1.1 0.2 39.9 1.3 52.4 1.3 1.5 1.1 5.3 1.1 11.2 0.9 1.0 0.0 1.7 4.7 4.6 2.7 2.7 1.8 0.1 0.2 1.1 0.0 1.3 0.2 2.8 1.9 0.5 8.8 1.4 1.0 3.6 17.0 35.1 1.8 5.0 4.7 0.7 0.8 1.3 1.5 5.6 1.9 3.8 1.4 1.3 3.2 0.7 0.7 0.5 0.0 26.8 2.2 0.0 12.0 42.4 5.5 7.7 0.5 1.7 19.6 2.3 4.0 1.5 1.6 1.6 0.0 1.6 9.7 6.6 1.4 0.0 3.8 0.9 1.1 1.7 2.5 0.5 3.0 30.0 1.1 1.1 16.0 0.5 0.3 5.3 0.4 3.0 26.3 5.6 3.4 1.6 3.1 4.0 0.0 0.4 0.0 1.3 0.4 0.0 1.8 0.2 0.8 0.1 0.0 0.0 1.0 0.2 0.0 1.1 0.0 0.0 0.2 2.6 2.1 1.7 5.6 2.6 4.8 2.6 2.2 6.2 1.0 0.0 1.3 1.5 3.4 2.5 2.3 3.5 2.5 0.0 1.2 0.0 2.0 0.2 29.9 7.5 0.1 0.5 2.8 0.0 24.3 0.2 0.5 5.1 0.0 0.4 0.3 0.0 3.4 1.8 0.8 0.0 0.3 0.4 5.0 1.8 1.5 0.3 16.5 0.3 0.0 0.1 0.4 0.0 0.5 1.4 0.7 3.8 2.9 0.0 1.5 11.8 CHCHD10 "C22orf16, N27C7-4" ENSG00000250479 "Coiled-coil-helix-coiled-coil-helix domain containing 10" Q8WYQ3 22 23765834-23768443 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 127.0;skeletal muscle: 226.6" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 2117.1;Enterocytes: 1174.4;Hepatocytes: 1666.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003440 Enhanced Supported Mitochondria NA NA Mitochondria "HPA003440: AB_1078348" "unprognostic (3.88e-2)" "unprognostic (2.36e-3)" "unprognostic (8.90e-2)" "unprognostic (9.80e-2)" "unprognostic (7.68e-2)" "unprognostic (5.97e-3)" "unprognostic (1.59e-1)" "unprognostic (1.85e-1)" "unprognostic (2.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" "prognostic favorable (2.15e-7)" "unprognostic (5.19e-3)" "unprognostic (2.06e-1)" "unprognostic (5.68e-3)" "unprognostic (2.62e-3)" 23.1 14.9 25.8 16.4 33.9 5.7 20.0 11.8 31.0 17.3 39.4 9.6 18.3 30.6 6.1 15.5 20.2 7.6 11.3 127.0 23.7 23.5 40.4 86.1 8.3 16.9 25.8 18.4 4.8 24.3 36.4 12.7 11.7 14.5 11.7 31.6 24.3 33.7 22.2 226.6 7.2 30.2 12.8 12.2 13.0 17.3 4.1 9.6 3.0 27.8 73.1 15.8 13.8 9.3 9.4 7.3 7.6 7.8 0.8 5.0 1.0 5.8 16.0 4.9 20.7 10.9 6.9 8.0 2.1 5.6 5.9 6.8 29.8 8.0 18.0 5.5 10.1 3.2 18.9 27.0 8.5 5.3 5.8 29.4 4.6 12.6 28.1 18.5 13.3 21.4 13.4 22.5 8.9 2.4 1.2 7.1 3.9 8.2 11.6 5.2 29.7 4.1 8.4 3.6 47.6 40.5 15.6 0.8 41.5 27.6 13.3 8.7 4.6 2.8 35.5 27.2 9.7 12.7 10.4 3.1 0.2 0.1 3.6 0.0 4.5 2.0 12.4 4.8 11.1 2.6 0.2 3.9 7.6 2.8 7.8 1.9 9.4 3.2 4.0 1.7 7.8 5.0 3.6 0.1 0.8 6.9 7.3 3.7 1.0 25.8 33.9 11.8 31.0 23.7 23.5 25.8 18.4 14.5 9.6 11.9 8.0 277.6 303.6 42.7 134.9 422.5 295.5 4.0 11.4 397.8 108.0 25.5 2117.1 75.8 24.6 33.8 1174.4 46.7 46.5 229.6 58.5 151.0 86.1 1666.3 550.7 93.8 298.3 76.1 204.5 13.0 45.1 214.4 354.3 26.2 653.9 94.8 45.8 623.8 27.6 877.4 179.8 122.9 200.9 26.5 44.5 38.3 88.0 85.8 692.8 383.5 CHCHD2 C7orf17 ENSG00000106153 "Coiled-coil-helix-coiled-coil-helix domain containing 2" Q9Y6H1 7 56101569-56106576 "Disease related genes, Predicted intracellular proteins" Transcription Activator "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 224.0" "Low region specificity" "Detected in all" "HPA027407, HPA052510" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA027407: AB_10959659, HPA052510: AB_2681856" "unprognostic (8.68e-3)" "unprognostic (2.79e-1)" "unprognostic (8.48e-2)" "unprognostic (2.32e-1)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.90e-5)" "prognostic unfavorable (9.41e-5)" "unprognostic (4.38e-2)" "unprognostic (3.61e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (2.60e-2)" "unprognostic (4.01e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (2.40e-2)" 41.5 112.8 57.2 33.0 59.5 73.0 46.0 39.3 56.9 38.0 46.6 33.2 45.5 51.9 34.2 53.8 50.1 39.2 44.3 75.3 46.8 50.2 56.2 66.9 34.2 62.6 58.3 49.0 43.8 77.8 28.4 42.8 38.4 42.3 41.3 40.1 45.3 56.5 70.0 147.2 33.0 49.3 45.7 42.6 34.1 44.2 27.1 28.1 48.9 62.1 65.9 38.8 38.5 30.9 63.2 107.7 52.6 69.1 51.5 72.8 121.3 224.0 39.2 25.9 53.4 20.5 28.3 19.2 33.0 31.3 42.5 41.2 35.9 37.5 65.7 43.7 20.2 55.1 38.2 32.7 36.1 34.3 42.7 59.6 38.8 33.1 51.1 38.1 52.2 62.7 25.2 41.4 31.9 39.1 23.1 31.7 58.1 81.3 40.0 34.6 31.1 70.3 161.7 56.0 61.6 62.6 47.4 25.2 107.9 38.1 29.3 49.4 61.5 26.0 64.1 41.4 18.5 73.2 74.7 25.3 26.3 61.6 108.7 48.5 37.0 52.6 117.2 41.4 56.4 32.5 40.5 69.1 52.6 53.1 61.0 54.8 63.2 57.2 56.3 79.5 57.8 51.6 52.8 37.0 51.5 59.5 107.7 72.8 121.3 57.2 59.5 39.3 56.9 46.8 50.2 58.3 49.0 42.3 28.1 238.2 265.3 489.1 766.8 637.3 337.7 148.9 461.1 385.4 275.3 392.6 58.9 829.8 1576.7 867.5 105.9 435.3 847.1 303.7 1153.3 1054.3 581.8 939.9 386.6 693.4 849.1 465.6 519.8 355.4 420.9 153.5 568.7 575.0 723.7 764.7 720.0 545.6 1044.9 757.6 475.6 1300.4 258.3 420.4 656.7 417.0 565.7 628.8 1027.6 495.9 809.6 1069.0 CHCHD3 "FLJ20420, Mic19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784868-133082088 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 109.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria NA NA 110000 Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 15.2 15.8 9.9 13.4 11.6 15.4 13.7 10.1 14.2 10.5 17.3 9.8 7.9 19.9 13.2 9.7 10.5 9.7 10.4 42.6 9.5 8.9 23.2 17.9 11.7 10.6 10.4 8.0 11.6 9.8 13.9 17.0 10.7 10.9 10.5 18.3 11.5 10.6 11.1 109.1 9.0 20.5 13.9 9.7 12.2 13.9 6.4 10.8 19.7 14.6 30.1 13.2 12.9 13.6 19.0 28.2 15.4 29.9 21.2 19.9 15.3 23.4 24.1 24.5 33.8 17.7 16.3 14.5 23.0 21.9 26.3 29.2 28.3 26.1 19.5 9.2 14.6 58.5 16.5 28.3 19.8 37.2 25.5 26.8 20.1 24.9 16.4 35.2 45.1 15.0 14.7 13.7 36.0 37.7 13.2 18.3 25.8 42.8 17.9 24.3 30.9 65.6 39.6 40.2 37.9 27.9 32.7 35.9 27.9 25.6 19.5 31.3 39.1 19.1 15.1 43.5 17.5 12.6 27.1 15.1 25.2 10.8 39.4 41.2 17.3 22.1 49.2 39.7 38.7 35.3 14.9 21.8 15.4 16.1 29.9 15.3 19.0 14.7 15.5 28.2 11.7 13.0 14.5 3.1 21.2 24.1 24.6 19.9 15.3 9.9 11.6 10.1 14.2 9.5 8.9 10.4 8.0 10.9 10.8 23.8 19.2 25.3 26.1 31.0 23.1 116.2 40.8 29.4 28.4 14.0 21.6 64.7 106.1 46.3 76.6 29.3 40.2 0.0 53.2 67.5 37.3 25.3 33.5 19.2 67.5 14.3 34.4 16.0 24.0 74.9 29.1 38.1 35.4 59.5 46.7 22.9 42.8 21.0 33.2 67.4 23.8 32.3 50.9 12.7 24.7 35.3 57.2 35.5 71.7 35.4 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 71.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria NA NA Mitochondria "HPA034688: AB_10696361, HPA063727: AB_2685103" "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 11.4 13.3 15.0 8.8 16.4 3.3 12.8 11.6 17.7 9.2 15.8 12.6 9.5 15.7 8.7 11.7 12.1 10.9 9.8 27.3 13.7 13.5 22.3 20.1 7.8 8.9 17.0 10.7 11.5 18.8 21.7 9.3 9.2 13.5 12.7 17.2 9.6 10.7 13.8 32.2 8.9 12.7 15.3 11.1 9.6 11.9 9.4 14.3 7.2 13.4 12.4 13.2 14.0 16.4 14.1 19.8 7.9 18.1 16.6 14.3 8.6 8.0 16.8 8.8 8.6 7.6 8.6 25.5 8.7 8.2 10.8 9.6 9.9 6.6 17.5 8.6 6.6 11.0 6.6 18.1 18.1 13.4 10.9 18.1 20.4 12.5 13.0 12.8 13.7 8.8 7.5 19.3 17.7 28.4 7.7 12.1 14.1 21.1 15.7 11.5 17.1 17.1 8.3 13.5 25.3 22.7 12.4 8.8 37.2 12.2 8.9 7.3 8.9 9.8 31.7 12.7 7.9 15.2 14.0 4.3 9.9 7.2 12.3 15.9 8.8 23.1 17.4 9.8 21.2 7.2 5.7 12.5 7.9 6.6 18.1 11.4 11.2 11.0 9.9 19.8 14.1 14.3 9.7 5.4 16.6 17.5 8.1 12.2 8.6 15.0 16.4 11.6 17.7 13.7 13.5 17.0 10.7 13.5 14.3 14.9 7.5 18.2 10.7 8.4 7.6 21.8 12.7 5.3 6.8 8.7 0.0 20.2 71.3 16.6 1.9 8.1 15.9 0.0 11.7 16.8 9.9 11.4 10.4 16.3 18.5 4.8 4.7 3.7 6.9 4.0 10.6 8.2 8.5 7.2 12.1 7.4 10.7 13.5 9.6 37.8 5.6 6.5 7.8 16.6 36.8 10.3 10.9 7.5 17.9 10.9 CHCHD5 "C2orf9, MGC11104, MIC14, MIX14" ENSG00000125611 "Coiled-coil-helix-coiled-coil-helix domain containing 5" Q9BSY4 2 112584240-112589275 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038263 Approved Approved Mitochondria NA NA Mitochondria "HPA038263: AB_10671525" "unprognostic (3.56e-2)" "unprognostic (3.41e-2)" "unprognostic (3.36e-2)" "unprognostic (4.57e-2)" "unprognostic (1.85e-1)" "unprognostic (7.75e-2)" "unprognostic (2.72e-1)" "unprognostic (7.18e-3)" "unprognostic (8.04e-2)" "unprognostic (4.96e-2)" "unprognostic (2.07e-1)" "unprognostic (4.95e-2)" "unprognostic (1.39e-2)" "unprognostic (3.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" 12.7 17.8 15.1 11.4 15.0 15.7 15.6 9.0 13.4 10.5 12.4 11.7 19.8 17.5 11.4 17.5 16.2 20.0 16.7 20.3 12.0 12.1 20.3 36.6 12.9 17.6 16.7 11.4 10.7 36.8 10.2 20.0 11.9 10.1 13.4 6.5 11.0 12.6 37.7 33.3 12.9 16.1 11.8 12.1 11.7 15.2 50.0 12.9 20.7 20.2 23.4 8.6 13.0 12.1 27.9 40.2 32.1 35.4 28.6 37.1 28.6 13.3 22.4 10.1 0.0 4.1 8.7 9.5 5.9 7.8 12.3 8.8 24.3 16.6 10.3 23.6 8.2 10.4 9.9 3.8 13.2 1.6 11.1 18.4 13.9 7.3 19.2 18.1 11.7 9.8 11.7 11.3 16.2 10.0 5.7 6.7 0.0 14.3 15.7 7.7 33.3 10.5 18.6 11.1 10.0 11.1 0.3 8.3 20.2 16.1 12.2 12.9 14.5 7.5 11.3 13.2 2.8 14.5 10.4 9.3 12.3 17.4 7.4 8.4 28.2 26.5 11.9 17.1 3.2 14.5 11.1 35.4 32.1 26.3 31.6 22.3 24.0 25.1 24.9 31.8 27.9 26.1 26.9 19.2 28.6 28.7 40.2 37.1 28.6 15.1 15.0 9.0 13.2 12.0 12.1 16.7 11.4 10.1 12.9 8.9 15.2 54.1 60.0 38.2 19.2 30.3 101.9 40.2 23.9 78.5 9.8 114.1 185.6 95.9 138.2 39.4 145.2 46.7 153.5 94.3 60.9 61.4 24.3 180.9 108.7 6.4 88.1 50.3 119.7 199.0 28.4 59.4 50.6 95.6 80.7 31.0 111.8 144.0 26.5 166.5 20.8 12.9 43.8 100.6 34.5 50.7 77.6 55.4 82.6 66.3 CHCHD6 "CHCM1, MGC13016, Mic25, PPP1R23" ENSG00000159685 "Coiled-coil-helix-coiled-coil-helix domain containing 6" Q9BRQ6 3 126704220-126960406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 136.0;Melanocytes: 163.6" "Cancer enhanced" "Detected in all" "melanoma: 34.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047673, HPA051975" Approved Supported Mitochondria NA NA Mitochondria "HPA047673: AB_10961761, HPA051975: AB_2681679" "unprognostic (3.94e-2)" "prognostic favorable (7.46e-4)" "unprognostic (6.20e-2)" "unprognostic (1.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (6.83e-3)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (6.76e-4)" "unprognostic (6.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.11e-3)" 5.5 13.8 23.2 5.8 20.8 3.8 8.7 8.9 27.0 7.4 5.3 8.7 4.9 4.1 6.7 5.6 7.2 14.6 5.6 11.6 31.1 17.0 7.5 6.1 8.3 3.7 15.3 18.8 14.5 15.1 6.7 7.7 4.4 11.4 7.0 3.4 7.6 14.2 8.9 4.0 8.1 4.6 5.8 9.9 4.8 7.4 34.0 7.6 3.3 12.3 5.9 4.3 5.0 7.4 10.5 6.3 1.8 3.5 6.3 11.1 4.3 18.9 11.1 9.8 23.8 3.5 5.4 5.6 7.3 5.0 8.6 8.4 15.2 8.3 8.3 17.1 4.3 9.4 11.1 7.3 20.1 4.2 2.3 20.0 6.8 8.1 14.8 10.4 14.9 4.6 5.4 12.3 4.1 8.8 7.0 5.6 15.0 6.2 5.0 7.5 14.2 21.7 14.9 11.8 10.8 12.6 11.7 15.0 20.0 7.5 8.3 18.1 11.2 7.5 12.9 23.4 5.0 7.5 5.6 5.0 9.7 12.1 13.0 7.5 6.4 3.0 10.3 10.9 4.9 9.0 0.0 2.3 1.8 6.9 3.5 8.7 7.8 9.8 8.1 6.3 10.5 9.5 11.1 0.0 6.3 3.3 4.4 8.9 4.3 23.2 20.8 8.9 25.6 31.1 17.0 15.3 18.8 11.4 7.6 17.9 8.4 6.5 16.7 26.3 12.6 12.6 5.1 37.5 21.6 14.0 17.7 27.5 49.7 22.8 69.0 6.8 2.6 0.0 21.3 9.3 13.9 13.7 13.9 5.9 136.0 19.1 7.5 6.2 6.6 82.1 14.7 9.4 163.6 3.6 9.1 14.0 15.3 7.0 20.8 22.3 13.5 0.0 18.8 64.1 46.7 26.3 12.9 5.3 12.0 17.3 CIAPIN1 Anamorsin ENSG00000005194 "Cytokine induced apoptosis inhibitor 1" Q6FI81 16 57428169-57447528 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 158.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041350, HPA042182" Enhanced Supported Mitochondria No No 6400 Mitochondria "HPA041350: AB_10796665, HPA042182: AB_10794646" "unprognostic (1.78e-2)" "unprognostic (9.62e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.41e-3)" "unprognostic (8.15e-3)" "unprognostic (1.99e-1)" "unprognostic (2.48e-2)" "unprognostic (4.70e-3)" "unprognostic (1.62e-1)" "prognostic favorable (4.42e-4)" "unprognostic (5.61e-2)" "unprognostic (3.86e-2)" "unprognostic (8.90e-3)" "unprognostic (1.16e-1)" 13.5 21.0 12.8 12.6 19.1 11.5 12.2 18.3 29.3 10.6 19.3 14.8 8.7 14.5 11.9 10.7 18.9 10.8 15.9 23.9 12.8 16.5 20.7 19.7 13.1 14.1 15.6 17.6 10.5 17.2 18.9 11.9 21.8 21.0 11.7 17.3 14.2 15.0 11.3 35.3 17.5 15.0 14.2 10.6 14.4 13.7 44.0 10.7 19.2 15.8 18.0 20.9 13.1 12.1 22.7 32.4 17.3 27.5 27.5 48.8 45.5 16.0 24.0 25.8 19.9 14.8 10.2 22.3 18.9 16.0 32.8 15.4 26.9 13.1 17.3 27.3 14.2 10.5 31.0 34.5 25.2 28.4 10.0 21.1 22.2 21.0 28.2 24.3 26.9 23.1 16.1 27.8 23.6 30.2 12.9 31.9 21.8 31.0 10.6 18.8 15.9 26.6 21.6 35.0 18.6 35.3 49.7 31.1 36.1 21.9 18.3 22.7 28.5 40.4 28.9 18.2 21.9 21.1 23.6 20.4 14.5 18.8 14.5 21.0 28.5 36.1 57.8 17.5 25.8 22.7 13.9 27.5 17.3 26.9 25.7 24.8 22.7 22.7 28.3 32.4 22.3 48.8 43.0 6.7 27.5 20.8 27.7 24.3 45.5 12.8 19.1 18.3 29.3 12.8 16.5 15.6 17.6 21.0 10.7 14.9 22.4 13.4 13.2 12.7 27.8 33.0 22.9 12.0 17.0 21.0 9.8 78.3 33.2 50.4 14.5 20.3 15.4 0.0 45.2 38.8 14.3 13.0 10.4 15.7 34.7 22.3 17.9 19.6 10.5 25.4 13.0 17.7 23.6 57.7 17.2 26.1 42.5 24.6 19.4 28.0 14.6 38.8 12.2 158.4 51.5 13.9 88.8 14.6 23.8 13.2 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 606.8;Proximal tubular cells: 437.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Supported Mitochondria NA NA Mitochondria "HPA074383: AB_2686684" "prognostic unfavorable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 12.1 6.2 4.9 9.0 6.7 7.5 2.9 10.3 11.9 10.3 14.2 14.5 11.5 21.7 8.7 10.6 6.0 8.0 13.4 9.2 9.3 9.7 18.2 5.7 10.3 11.7 7.6 10.0 4.5 9.3 7.6 9.8 15.1 8.8 12.0 11.0 12.5 10.2 7.1 4.1 8.5 10.8 5.3 9.3 19.5 6.6 18.3 11.4 13.9 4.3 15.7 5.6 7.9 21.2 7.3 4.5 14.1 5.4 11.8 4.4 8.0 12.8 12.2 10.4 16.9 16.3 11.9 10.0 4.3 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 56.6 40.8 43.2 69.2 114.4 85.6 290.3 127.4 66.9 55.7 127.4 41.2 139.3 606.8 85.2 163.9 59.9 102.8 23.3 70.7 53.7 53.8 54.1 34.5 218.9 59.2 39.7 216.5 78.0 41.4 266.7 39.1 30.5 173.7 19.8 105.2 33.6 75.5 104.0 37.8 437.6 44.2 32.3 59.0 46.8 59.2 99.9 60.8 26.6 102.8 57.1 CLPP ENSG00000125656 "Caseinolytic mitochondrial matrix peptidase proteolytic subunit" Q16740 19 6361452-6368910 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010649 Supported Supported Mitochondria NA NA Mitochondria "HPA010649: AB_1078538" "unprognostic (2.28e-1)" "unprognostic (7.14e-2)" "unprognostic (2.82e-1)" "unprognostic (4.34e-2)" "unprognostic (2.17e-2)" "unprognostic (1.15e-2)" "unprognostic (6.17e-3)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (1.31e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (6.97e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (5.86e-3)" 22.1 27.3 18.4 22.5 18.8 20.1 19.9 16.6 20.9 16.1 23.2 17.9 22.2 25.4 16.9 15.1 26.6 15.3 19.2 28.9 17.4 16.7 28.5 64.7 15.5 35.5 19.0 15.2 23.7 32.7 11.6 18.5 18.4 13.6 19.1 14.1 18.6 26.3 23.4 73.1 17.8 26.0 14.8 16.7 21.2 21.3 21.1 11.4 54.8 27.0 25.1 25.3 20.7 23.2 29.7 37.5 14.9 20.0 27.6 46.3 32.9 31.6 21.1 15.4 28.1 9.7 13.5 16.0 18.8 13.8 26.8 24.1 16.9 11.6 31.9 29.3 15.0 15.3 19.8 15.3 23.7 10.2 33.1 47.9 23.5 18.6 25.0 26.3 21.2 31.1 17.1 17.4 18.6 20.8 18.4 26.0 42.3 23.3 43.3 17.5 37.0 36.3 22.2 22.2 24.5 49.5 25.6 18.6 48.4 19.9 17.7 25.5 24.5 11.9 29.2 27.6 10.0 15.0 30.4 18.2 17.8 16.5 41.6 35.4 55.6 46.4 30.7 24.3 30.0 28.2 5.5 20.0 10.5 28.0 17.7 33.2 28.3 39.9 34.5 24.1 29.7 35.2 34.1 14.9 27.6 12.1 37.5 46.3 32.9 18.4 18.8 16.6 20.9 17.4 16.7 19.0 15.2 13.6 11.4 20.8 35.7 37.2 49.7 40.0 30.7 40.3 58.6 36.1 17.0 41.8 11.8 60.5 122.7 78.4 82.6 46.3 64.7 23.3 84.4 102.0 37.0 67.2 25.4 81.5 71.6 20.6 33.9 49.1 31.4 188.9 39.4 35.5 52.3 93.8 43.9 34.4 88.0 56.1 40.7 126.3 20.5 12.9 36.0 68.8 45.8 32.4 48.3 53.2 60.6 56.1 CMC2 "C16orf61, DC13, MGC45036" ENSG00000103121 "C-X9-C motif containing 2" Q9NRP2 16 80966448-81020270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Spermatocytes: 265.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006871, CAB026396" Approved Supported Mitochondria NA NA Mitochondria "CAB026396: , HPA006871: AB_1845581" "unprognostic (2.43e-1)" "unprognostic (3.63e-2)" "unprognostic (1.70e-1)" "unprognostic (3.52e-2)" "unprognostic (1.50e-1)" "unprognostic (3.01e-3)" "unprognostic (2.48e-2)" "unprognostic (6.36e-2)" "unprognostic (9.20e-2)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (4.57e-3)" "prognostic favorable (2.64e-5)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (2.68e-1)" 8.2 17.0 31.5 8.9 30.9 25.5 15.0 18.7 28.7 7.2 11.8 22.2 8.7 12.8 6.4 11.9 12.5 5.5 11.5 42.3 28.3 27.9 24.7 29.1 9.5 13.3 30.7 16.0 5.7 19.7 19.2 11.1 11.0 23.9 15.2 11.8 7.0 10.3 9.3 32.0 6.2 13.5 10.6 27.8 9.5 13.5 28.1 20.3 9.8 10.3 13.0 11.0 11.8 7.0 21.9 25.3 20.1 17.9 24.7 34.6 10.3 22.1 31.7 23.8 14.2 7.9 8.0 14.0 22.6 10.3 20.1 10.4 21.6 15.3 10.3 16.9 10.8 19.8 16.0 16.1 13.1 26.8 15.1 19.4 15.7 22.6 23.1 13.1 12.8 26.8 7.0 7.4 24.3 13.7 9.2 17.8 25.4 37.0 13.8 19.5 42.4 20.0 41.6 14.0 18.0 19.1 25.2 12.9 13.1 15.6 11.2 20.0 11.6 34.3 12.2 25.8 12.9 24.3 11.9 10.2 18.3 25.7 17.6 22.6 14.2 30.9 57.1 14.0 16.6 21.3 14.9 16.6 20.1 17.4 16.0 16.3 21.9 22.1 17.9 17.8 18.9 15.7 17.8 7.1 24.7 17.9 25.3 34.6 10.3 31.5 30.9 18.7 28.7 28.3 27.9 30.7 16.0 23.9 20.3 32.8 44.6 52.4 56.6 86.7 30.0 177.4 35.7 33.5 28.4 45.4 51.1 35.1 134.3 31.7 74.7 35.1 25.7 46.7 32.9 52.1 47.6 68.0 91.4 80.0 46.5 28.6 36.8 28.3 51.5 128.4 22.7 64.0 62.4 25.2 36.6 25.0 35.2 31.6 27.6 119.0 15.4 58.2 55.6 265.1 102.6 89.3 31.8 58.9 37.9 64.1 CMC4 "MTCP1, MTCP1NB, p8, P8MTCP1" ENSG00000182712 "C-X9-C motif containing 4" P56277 X 155061622-155071362 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 8.1;Club cells: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 36.5" "Low region specificity" "Detected in all" HPA045866 Approved Supported Mitochondria NA NA Mitochondria "HPA045866: AB_10964642" "unprognostic (4.54e-3)" "unprognostic (7.31e-2)" 11.5 9.2 13.4 9.2 12.6 6.2 26.7 7.1 8.9 11.0 11.3 6.7 13.2 9.7 9.9 13.6 12.5 8.9 8.3 49.6 10.9 10.0 12.0 21.8 15.0 26.2 13.7 5.7 11.9 34.6 7.1 11.4 6.8 11.6 10.5 6.0 7.6 14.5 12.6 21.2 8.2 11.4 15.2 15.8 8.3 8.5 7.3 7.4 5.4 14.5 10.0 7.7 12.4 8.7 11.3 10.8 11.8 7.5 12.0 9.0 4.6 19.9 5.1 3.0 6.7 8.5 8.2 4.7 4.0 5.7 5.7 9.7 3.8 3.8 13.7 10.5 4.4 16.0 6.6 4.0 5.2 4.0 14.5 10.3 2.3 3.5 4.5 8.7 4.2 3.1 7.8 8.6 5.9 7.6 5.3 4.7 8.3 2.3 5.0 5.9 7.5 5.7 8.0 1.8 7.9 14.5 4.4 7.1 8.9 6.4 1.2 6.2 5.1 5.3 5.9 6.8 3.9 4.4 2.5 5.6 8.7 5.4 5.6 5.3 20.6 20.6 36.5 8.2 9.9 5.7 1.1 7.5 11.8 9.0 4.2 8.7 11.0 7.1 8.3 10.8 11.3 2.2 5.9 0.8 12.0 1.5 2.1 8.2 4.6 13.4 12.6 7.1 8.9 10.9 10.0 13.7 5.7 11.6 7.4 0.0 2.6 0.0 0.9 0.7 1.0 0.0 2.5 8.1 10.3 0.0 0.0 0.9 3.3 0.8 0.0 0.0 1.1 0.0 0.4 0.8 1.5 0.4 4.7 3.6 0.9 0.0 1.7 2.5 1.0 1.3 3.4 1.2 1.7 1.0 0.9 1.8 0.9 0.3 1.8 2.8 0.3 0.0 0.3 1.5 0.4 2.0 1.0 2.5 1.7 0.6 COA1 "C7orf44, FLJ10803, MITRAC15" ENSG00000106603 "Cytochrome c oxidase assembly factor 1 homolog" Q9GZY4 7 43608456-43729717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA011944 Approved Supported Mitochondria NA NA Mitochondria "HPA011944: AB_1848671" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (2.22e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.21e-1)" "unprognostic (4.42e-2)" "unprognostic (2.22e-2)" "unprognostic (5.22e-2)" "unprognostic (6.74e-2)" "unprognostic (1.52e-1)" "unprognostic (3.52e-1)" "unprognostic (1.02e-2)" "unprognostic (2.56e-2)" "unprognostic (5.39e-2)" 13.8 16.2 22.4 14.4 21.7 17.6 14.5 13.8 24.0 11.8 10.9 14.4 17.4 11.4 14.8 14.3 15.1 9.6 10.9 47.8 19.7 18.5 23.4 14.4 11.9 24.2 23.0 13.2 11.1 23.9 9.4 22.1 11.3 17.4 10.9 14.7 17.9 17.5 17.7 55.5 7.0 12.6 9.7 19.9 16.2 14.5 11.8 14.3 16.2 15.8 22.4 28.3 14.8 8.8 21.0 17.9 24.2 17.2 18.6 21.0 14.4 10.5 28.5 23.6 23.2 6.9 7.8 15.8 14.8 25.4 20.2 21.0 21.7 24.2 20.1 25.1 9.0 42.6 15.4 27.2 22.8 25.6 18.0 25.0 25.0 16.8 19.9 11.4 19.4 11.1 6.4 14.6 14.6 21.8 21.7 18.3 24.4 42.3 17.5 16.4 14.4 28.5 48.8 14.8 22.1 20.6 17.3 21.6 37.1 24.6 11.9 14.5 26.0 14.9 27.7 9.6 35.6 20.7 13.1 13.6 10.0 21.9 9.8 20.9 42.2 34.1 36.1 28.5 25.0 26.6 1.3 15.3 16.0 12.9 17.2 9.5 19.7 12.0 13.2 17.9 21.0 16.9 21.0 24.2 18.6 14.6 16.0 11.5 14.4 22.4 21.7 13.8 24.0 19.7 18.5 23.0 13.2 17.4 14.3 26.8 35.0 59.1 58.9 11.6 42.6 55.7 17.8 29.4 23.9 33.2 43.2 28.3 99.5 49.1 4.8 25.8 16.9 46.7 37.1 43.0 26.0 44.0 25.4 19.2 50.1 31.8 26.6 18.4 33.8 6.6 27.3 34.8 35.4 48.7 20.9 22.3 38.8 10.5 18.4 100.4 53.4 12.9 22.7 54.2 85.2 14.6 15.0 52.2 24.9 37.6 COA3 "CCDC56, COX25, HSPC009, MITRAC12" ENSG00000183978 "Cytochrome c oxidase assembly factor 3" Q9Y2R0 17 42795147-42798704 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 601.8;Proximal tubular cells: 547.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031966, HPA071122" Approved Enhanced Mitochondria NA NA Mitochondria "HPA031966: AB_10602115, HPA071122: " "unprognostic (1.20e-1)" "prognostic favorable (3.40e-4)" "unprognostic (5.65e-2)" "prognostic favorable (8.93e-4)" "unprognostic (7.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.78e-2)" "unprognostic (1.16e-2)" "unprognostic (1.48e-1)" "unprognostic (2.25e-2)" "unprognostic (8.44e-3)" "unprognostic (1.52e-1)" "prognostic favorable (6.62e-4)" "unprognostic (1.64e-1)" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" "unprognostic (3.01e-2)" 13.4 17.8 34.5 11.1 26.7 4.6 20.6 19.5 31.8 18.7 33.7 18.0 18.2 35.9 14.0 62.6 30.2 26.2 20.0 26.3 29.3 26.0 57.2 44.1 13.7 14.1 31.2 22.2 17.0 97.0 16.2 15.0 17.8 26.1 22.0 31.6 14.9 30.3 25.1 28.7 12.6 33.5 14.5 21.6 12.2 27.1 9.5 17.1 13.1 22.8 28.6 19.8 14.1 18.1 56.1 49.2 46.0 59.1 46.2 50.5 59.7 16.2 55.2 25.4 13.9 23.5 20.0 15.6 12.8 19.6 30.7 27.8 21.7 20.6 0.9 36.4 15.5 28.9 15.9 19.5 31.3 29.1 15.9 51.3 11.0 26.0 68.6 16.6 14.8 13.3 20.3 23.6 28.9 16.6 15.7 24.3 7.9 17.5 14.1 27.1 26.7 4.8 32.4 11.6 33.5 19.9 19.4 37.1 27.9 31.1 22.5 19.0 15.9 13.1 13.9 22.2 22.9 43.2 19.4 14.8 33.5 17.5 14.1 16.9 16.7 18.0 8.7 25.1 14.8 22.6 46.0 59.1 36.8 39.8 54.9 41.6 56.1 41.4 40.2 49.2 51.2 38.4 38.2 6.3 46.2 45.5 32.9 50.5 59.7 34.5 26.7 19.5 31.8 29.3 26.0 31.2 22.2 26.1 17.1 26.8 53.5 65.9 51.4 32.6 33.1 216.0 178.3 105.7 47.8 253.0 19.6 126.9 601.8 110.3 8.4 56.1 184.6 0.0 208.4 149.1 56.0 56.9 34.6 366.5 106.3 42.9 76.7 73.6 73.2 15.0 51.8 46.4 84.4 81.2 165.8 62.7 139.6 178.9 42.5 547.1 26.6 38.8 61.8 48.1 47.3 48.6 85.5 37.4 224.0 60.3 COA5 "C2orf64, FLJ27524, MGC52110, Pet191" ENSG00000183513 "Cytochrome c oxidase assembly factor 5" Q86WW8 2 98599310-98608515 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 152.5;Proximal tubular cells: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057768 Uncertain Supported Mitochondria No No Mitochondria "HPA057768: AB_2683521" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (1.67e-3)" "unprognostic (2.61e-2)" "unprognostic (7.11e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.32e-3)" "unprognostic (3.71e-3)" "unprognostic (8.00e-3)" "unprognostic (3.08e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-1)" "unprognostic (4.93e-2)" "unprognostic (2.50e-1)" "prognostic favorable (1.00e-5)" 13.7 21.4 30.9 12.2 29.3 9.1 20.6 31.3 28.2 18.6 15.0 20.3 18.5 15.4 20.2 33.5 11.1 20.5 13.4 19.3 28.3 26.5 28.1 23.4 13.9 15.8 30.7 29.0 23.6 16.8 21.0 19.1 14.2 23.4 19.8 15.9 13.7 16.2 20.3 30.7 18.0 13.5 14.7 32.7 15.6 16.0 15.6 21.5 15.3 24.5 10.1 16.1 13.9 15.0 24.7 30.3 28.1 25.5 18.1 30.0 22.0 12.6 5.4 16.8 12.2 19.7 16.4 14.0 7.3 5.8 7.9 8.4 10.9 10.9 6.4 13.4 5.8 14.9 9.0 14.6 7.8 9.7 16.7 13.6 8.9 11.0 17.8 14.4 8.5 8.3 15.8 16.8 5.6 7.3 14.0 8.6 18.1 12.6 7.5 8.7 10.6 11.3 15.1 11.6 13.0 11.9 6.9 12.5 14.1 17.4 6.9 12.8 16.2 6.2 7.8 18.4 20.1 9.6 17.9 7.5 12.2 11.0 7.2 6.0 12.4 17.3 8.1 14.7 18.9 9.9 18.2 25.5 28.0 25.2 22.7 21.9 23.5 23.0 24.1 24.1 24.7 28.1 27.9 28.1 18.1 23.7 30.3 30.0 22.0 30.9 29.3 31.3 25.9 28.3 26.5 30.7 29.0 23.4 21.5 14.9 23.7 29.0 25.9 9.3 26.2 56.8 43.3 42.8 15.9 45.4 5.9 31.9 152.5 31.4 11.8 26.0 22.5 0.0 21.6 31.2 23.0 26.9 26.5 53.8 45.3 20.6 25.9 27.0 33.2 9.0 30.2 29.1 27.0 31.5 39.0 31.3 29.2 21.0 32.9 133.1 22.2 12.9 25.2 75.6 33.2 10.2 27.3 20.8 36.0 29.5 COQ4 CGI-92 ENSG00000167113 "Coenzyme Q4" Q9Y3A0 9 128322536-128334072 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021406, HPA042945" Supported Supported Mitochondria NA NA Mitochondria "HPA021406: AB_2670691, HPA042945: AB_10961047" "unprognostic (9.15e-2)" "prognostic favorable (2.97e-5)" "unprognostic (2.29e-1)" "prognostic favorable (4.93e-6)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (7.51e-2)" "unprognostic (2.11e-1)" "unprognostic (1.31e-3)" "unprognostic (2.89e-2)" "prognostic favorable (5.76e-6)" "unprognostic (6.21e-3)" "unprognostic (1.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.14e-3)" 15.5 29.4 22.6 21.4 29.9 12.2 25.4 20.7 33.8 19.8 23.0 15.7 34.8 53.8 14.8 30.5 32.8 37.7 24.0 23.9 22.6 21.7 31.8 33.4 28.9 28.6 18.9 31.4 18.1 43.8 24.7 30.7 13.1 27.7 22.2 18.0 15.2 32.9 50.7 29.6 31.6 37.3 20.1 25.7 15.9 23.1 17.5 14.3 13.6 34.5 25.0 16.7 18.5 17.9 18.3 28.2 8.0 15.5 14.1 21.1 13.2 11.1 16.8 10.2 11.1 7.5 10.6 18.4 9.8 6.4 12.9 9.2 14.3 14.0 15.0 8.8 7.5 9.4 31.9 8.7 11.7 4.8 7.2 17.3 5.5 36.3 16.0 12.3 15.6 8.4 12.3 13.7 10.7 11.7 7.5 10.1 12.8 36.4 10.2 8.1 30.9 19.0 12.0 11.3 22.6 19.8 18.6 14.1 28.5 15.8 11.0 19.0 13.6 19.2 22.9 11.9 4.8 29.5 5.3 13.9 12.3 11.5 17.8 13.1 17.5 14.4 12.3 15.6 7.6 8.5 7.8 14.2 8.0 21.1 15.5 19.1 18.3 19.2 20.9 17.7 16.0 15.5 18.9 1.8 14.1 15.2 28.2 15.2 13.2 22.6 29.9 20.7 33.8 22.6 21.7 18.9 31.4 27.7 14.3 20.8 25.3 41.0 43.1 25.5 29.2 33.9 33.1 141.8 30.7 54.1 25.5 75.4 121.0 46.8 11.0 23.3 99.8 23.3 55.3 39.9 29.9 34.1 36.8 66.0 44.1 28.6 30.5 26.4 24.0 19.1 27.9 22.1 38.8 27.1 55.4 23.8 40.3 56.2 29.0 133.2 46.9 25.8 26.7 41.4 31.6 43.7 39.5 30.2 71.7 40.9 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226897536-226987545 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 216.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 18.7;Collecting duct cells: 31.4;Exocrine glandular cells: 28.2;monocytes: 19.8;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8;RPMI-8226: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria NA NA Mitochondria "HPA061662: AB_2684578" "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 13.3 25.4 2.8 2.7 4.5 5.3 8.5 14.5 3.9 3.2 7.3 4.1 4.2 6.9 3.6 5.5 7.3 5.0 6.1 41.0 2.7 1.8 3.8 17.7 2.7 4.1 5.0 2.4 7.2 20.3 1.6 1.6 2.0 3.8 6.5 2.0 1.9 7.2 5.0 216.5 4.4 4.4 7.8 2.9 3.5 8.8 3.0 4.7 2.7 4.6 50.2 5.8 10.2 3.5 15.2 9.3 32.3 11.5 9.9 11.8 11.6 3.1 5.8 1.5 4.4 4.7 3.0 23.4 1.5 1.3 2.1 2.8 9.1 5.1 9.4 7.2 1.0 1.2 3.7 2.9 3.3 0.5 9.9 32.8 6.6 4.8 15.0 1.0 9.9 4.0 5.9 5.0 1.7 2.3 2.1 1.0 9.7 11.3 7.8 0.3 4.3 5.7 14.6 6.4 24.3 11.9 5.7 7.0 29.9 0.7 2.4 24.1 9.9 2.9 11.7 8.5 1.7 6.2 13.5 1.2 2.5 2.3 3.4 5.4 17.5 15.3 4.9 2.3 11.3 2.4 19.7 11.5 32.3 8.7 8.6 8.3 12.1 8.5 7.7 9.3 15.2 11.8 9.0 21.9 9.9 6.5 4.1 10.6 11.6 2.8 4.5 14.5 3.9 2.7 1.8 5.0 2.4 3.8 4.7 3.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.9 31.4 0.0 10.4 13.3 14.2 0.0 0.0 0.0 0.0 28.2 7.8 0.0 0.0 12.8 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 19.8 0.0 0.0 14.5 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 COQ8B "ADCK4, COQ8, FLJ12229" ENSG00000123815 "Coenzyme Q8B" Q96D53 19 40691529-40718207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 11.9;Ciliated cells: 16.0;Collecting duct cells: 12.2;Ductal cells: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027229, HPA027277, HPA027279, HPA028303" Supported Enhanced Mitochondria NA NA Mitochondria "HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551" "unprognostic (7.57e-2)" "unprognostic (9.48e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-2)" "unprognostic (2.33e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (2.27e-1)" "unprognostic (2.82e-2)" "unprognostic (1.48e-1)" "unprognostic (2.93e-2)" "unprognostic (6.18e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (2.65e-2)" 13.6 17.8 21.1 13.1 16.4 11.5 10.0 24.1 19.2 13.6 13.6 18.6 14.8 17.9 15.0 13.2 16.6 26.5 16.7 14.7 15.7 10.7 11.8 15.6 12.1 12.2 15.5 12.1 16.3 19.4 12.6 32.7 7.9 13.2 15.1 5.7 12.3 16.8 17.6 10.3 12.9 18.6 16.2 15.6 12.1 17.5 12.5 16.7 16.8 15.5 6.9 13.2 14.8 11.8 12.9 15.0 17.7 15.6 9.7 13.1 10.5 8.3 34.3 7.0 13.5 6.3 6.1 6.5 7.8 8.5 5.9 6.3 10.7 15.2 11.2 15.1 4.5 7.0 7.3 4.9 8.7 2.1 13.4 10.2 10.7 20.9 5.9 10.8 3.7 16.8 8.0 9.3 4.3 5.2 6.7 6.6 13.9 5.7 6.2 4.1 5.1 4.8 4.5 5.4 9.2 3.6 8.0 9.9 8.5 10.2 14.2 12.6 10.3 10.5 16.1 16.9 4.5 14.4 14.0 6.2 5.1 17.3 3.6 4.6 6.8 5.5 5.7 19.3 4.2 7.0 15.8 15.6 14.6 11.6 15.4 13.1 12.9 9.0 12.4 15.0 11.7 8.9 9.1 17.7 9.7 13.7 8.7 8.8 10.5 21.1 16.4 24.1 19.2 15.7 10.7 15.5 12.1 13.2 16.7 11.9 4.6 0.0 0.0 0.0 0.0 0.0 0.0 16.0 4.5 12.2 0.0 9.4 10.0 12.4 0.0 0.0 0.0 0.0 9.5 7.9 0.0 0.0 1.1 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 10.4 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 COX14 "C12orf62, MGC14288" ENSG00000178449 "COX14, cytochrome c oxidase assembly factor" Q96I36 12 50111979-50120457 "Disease related genes, Predicted membrane proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Proximal tubular cells: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044618, HPA062014" Approved Supported Mitochondria NA NA Mitochondria "HPA044618: AB_10960419, HPA062014: AB_2684657" "unprognostic (5.71e-2)" "unprognostic (1.86e-2)" "unprognostic (1.43e-1)" "unprognostic (4.04e-1)" "unprognostic (1.87e-2)" "unprognostic (3.66e-2)" "unprognostic (2.20e-2)" "unprognostic (4.20e-3)" "prognostic unfavorable (7.90e-4)" "unprognostic (7.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.09e-3)" "unprognostic (3.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.84e-2)" "unprognostic (3.07e-3)" 33.1 30.2 25.9 16.7 33.7 17.5 27.8 46.4 28.9 18.5 24.0 16.7 29.7 28.1 13.9 34.0 17.6 17.1 22.1 60.1 23.4 24.9 39.5 40.4 18.2 18.6 29.6 28.7 16.6 19.6 19.5 26.1 15.0 27.8 18.5 22.0 25.1 26.4 30.5 75.4 13.1 27.1 20.5 24.8 19.0 20.9 8.4 26.6 8.7 25.4 38.5 16.7 19.3 21.8 56.8 65.7 56.4 52.2 38.7 58.6 52.5 16.7 32.2 7.1 16.2 31.7 19.4 14.3 12.9 16.7 19.1 16.5 30.7 21.8 15.8 37.3 15.7 17.1 16.3 12.1 18.3 16.5 17.3 45.4 31.0 28.6 24.7 13.2 24.2 27.6 24.5 25.3 14.3 16.6 19.8 17.4 16.8 15.0 30.8 19.4 36.7 19.5 34.4 11.7 23.7 43.4 16.1 12.5 36.2 27.6 27.9 19.0 11.4 19.8 35.8 37.6 15.2 23.8 20.5 15.2 11.9 12.9 19.3 11.3 22.6 32.2 19.2 17.3 21.0 6.4 56.4 52.2 46.0 43.2 48.9 45.4 56.8 54.5 47.6 49.5 47.1 52.0 50.9 18.8 38.7 44.3 65.7 58.6 52.5 25.9 33.7 46.4 28.9 23.4 24.9 29.6 28.7 27.8 26.6 56.6 95.2 111.2 77.0 110.9 65.4 464.4 165.6 93.7 63.7 211.1 21.6 164.5 479.1 104.3 5.5 95.2 364.2 46.7 148.2 95.7 85.9 119.9 65.6 322.2 191.9 44.5 149.9 73.6 123.3 17.9 119.7 114.8 141.7 202.0 184.1 64.2 118.9 228.0 102.9 571.4 49.0 103.5 154.3 38.4 50.3 139.3 106.6 109.0 191.6 86.0 COX15 CEMCOX2 ENSG00000014919 "COX15, cytochrome c oxidase assembly homolog" Q7KZN9 10 99711844-99732100 "Disease related genes, Predicted membrane proteins" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037727, HPA037728, HPA066096" Uncertain Supported Mitochondria NA NA Mitochondria "HPA037727: AB_10672391, HPA037728: AB_10672463, HPA066096: AB_2685616" "unprognostic (9.74e-2)" "unprognostic (1.20e-1)" "unprognostic (1.99e-1)" "unprognostic (6.55e-3)" "unprognostic (1.50e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.96e-1)" "unprognostic (6.84e-2)" "unprognostic (1.76e-1)" "unprognostic (3.40e-2)" "unprognostic (8.34e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.08e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-2)" "unprognostic (3.40e-2)" 14.0 31.6 15.5 13.5 23.8 7.8 15.3 15.2 25.6 13.8 17.9 23.0 14.2 15.5 18.2 15.5 17.3 16.4 16.8 19.3 14.4 15.5 25.3 27.1 11.0 15.4 15.2 16.2 20.7 15.3 17.0 26.7 17.1 22.7 15.9 20.1 21.9 13.5 14.0 28.8 14.4 14.1 16.0 14.6 17.0 15.1 14.2 14.0 21.0 18.9 12.0 23.0 19.4 13.6 17.4 18.0 21.7 23.1 11.7 13.0 12.9 14.6 31.6 13.4 29.3 19.4 15.1 11.0 11.2 14.4 17.0 16.1 23.6 21.0 27.3 18.5 9.8 11.1 21.6 28.7 15.8 18.4 12.6 14.1 15.7 16.1 24.4 20.4 21.1 15.0 16.5 14.7 17.9 29.0 25.9 17.7 24.6 17.7 21.2 15.5 15.4 15.1 15.5 14.9 14.7 15.0 18.8 19.6 17.6 15.7 10.6 11.0 18.2 20.2 11.1 19.0 11.4 42.3 8.8 13.9 8.9 12.6 13.2 16.7 17.3 22.4 18.4 15.6 34.2 7.5 21.7 17.4 16.4 10.7 20.1 12.4 17.4 12.2 12.3 18.0 16.5 12.6 12.9 13.3 11.7 23.1 8.3 13.0 12.9 15.5 23.8 15.2 25.6 14.4 15.5 15.2 16.2 22.7 14.0 20.8 6.7 13.3 8.0 5.5 13.2 21.4 15.3 34.8 14.8 14.0 9.8 20.0 24.9 14.4 1.6 10.6 13.4 0.0 13.8 18.5 7.1 8.1 2.3 22.2 15.6 12.7 16.8 4.9 25.1 1.4 9.8 10.9 11.8 13.6 10.9 12.4 13.3 10.5 9.6 20.3 14.9 0.0 8.2 8.4 9.8 8.2 19.0 8.7 16.6 6.8 COX16 "C14orf112, HSPC203" ENSG00000133983 "COX16, cytochrome c oxidase assembly homolog" Q9P0S2 14 70325081-70359731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria NA NA Mitochondria "HPA062659: AB_2684823" "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favorable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.3 25.2 23.6 15.4 20.4 10.9 23.5 14.8 23.3 16.2 19.6 16.8 16.8 21.8 12.4 29.6 19.9 18.3 18.5 24.0 19.4 20.1 30.6 40.6 15.3 16.0 20.9 16.2 16.9 32.3 12.3 18.3 19.1 20.3 19.7 21.2 13.4 28.9 16.7 39.7 17.0 24.6 11.3 20.6 23.5 24.4 11.7 15.3 19.9 25.9 29.2 18.4 14.2 14.2 22.3 22.9 11.1 17.2 20.4 19.4 18.0 30.8 14.6 18.5 17.7 11.7 18.0 14.3 16.0 14.1 14.9 15.6 10.5 28.9 10.3 11.9 14.8 9.5 12.7 13.5 16.8 19.5 9.1 14.5 11.6 11.7 10.5 6.8 13.4 14.4 16.0 12.5 9.3 9.2 12.7 16.1 19.6 8.2 16.3 18.3 24.7 20.1 13.9 18.5 32.1 22.0 14.7 18.4 16.9 19.8 14.4 20.3 17.8 15.2 30.1 10.8 13.9 22.6 19.8 15.2 13.8 25.2 14.4 15.2 14.5 12.3 9.4 24.4 5.0 16.3 11.1 16.7 3.9 13.3 17.1 15.5 22.3 17.2 15.2 17.6 17.9 17.3 17.6 1.3 20.4 17.2 22.9 19.4 18.0 23.6 20.4 14.8 23.3 19.4 20.1 20.9 16.2 20.3 15.3 47.6 45.1 20.6 6.7 75.0 8.5 6.1 50.9 77.6 44.3 22.7 2.0 13.2 44.7 40.3 1.6 19.1 23.8 0.0 56.0 16.1 13.5 10.6 31.3 50.0 16.2 1.6 30.0 28.8 37.5 2.5 17.0 50.6 91.1 28.9 36.9 14.6 53.1 24.6 14.9 32.9 8.0 6.5 33.3 15.8 21.3 88.1 9.2 27.4 37.4 11.9 COX17 ENSG00000138495 "COX17, cytochrome c oxidase copper chaperone" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria NA NA 1000000 Mitochondria "HPA042226: AB_2677911, HPA048158: AB_2680292" "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 16.6 42.9 20.0 18.2 19.4 21.2 30.4 21.1 20.4 10.2 16.8 9.2 43.5 22.0 11.9 22.9 11.7 11.0 13.6 53.5 17.2 23.0 27.6 37.0 17.8 20.3 23.2 15.2 7.9 39.9 21.1 45.7 18.2 33.7 17.2 16.2 19.4 25.6 33.3 80.4 8.7 21.0 15.4 20.8 15.3 22.3 13.4 16.7 11.1 16.6 37.1 17.2 13.7 20.1 35.6 53.5 52.8 46.9 19.8 33.9 22.0 27.7 28.9 15.8 3.9 6.1 5.7 5.7 15.5 9.3 14.3 14.9 25.5 20.1 20.1 18.8 7.4 22.1 10.5 15.7 15.8 8.6 25.2 18.8 17.4 22.9 20.1 7.0 25.3 32.5 6.5 15.2 8.9 12.3 9.8 9.2 25.2 14.1 48.2 16.6 45.1 25.4 36.5 17.8 25.2 48.4 11.2 10.7 33.1 22.2 16.3 26.4 11.6 19.1 18.4 23.2 10.4 23.1 40.3 7.3 12.3 19.3 7.7 21.3 34.4 34.3 42.5 17.5 19.4 21.2 50.1 22.4 52.8 21.8 33.2 23.0 35.6 27.2 24.7 22.9 27.2 21.7 22.6 17.7 19.8 46.9 53.5 33.9 22.0 20.0 19.4 21.1 20.4 17.2 23.0 23.2 15.2 33.7 16.7 145.9 163.6 145.9 99.6 83.6 101.3 592.3 244.5 194.1 118.3 472.8 41.2 125.7 606.8 206.9 59.6 165.4 386.9 210.2 359.2 147.4 95.8 189.0 295.2 628.7 191.0 71.5 205.8 109.2 171.8 19.7 84.3 254.2 263.2 453.6 223.0 88.7 397.0 333.1 128.7 464.7 118.6 181.1 142.8 266.2 132.2 109.7 176.4 137.1 121.4 191.1 COX20 "FAM36A, FLJ43269" ENSG00000203667 "COX20, cytochrome c oxidase assembly factor" Q5RI15 1 244835322-244845057 "Disease related genes, Predicted membrane proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043617, HPA045490" Approved Enhanced Mitochondria NA NA Mitochondria "HPA043617: AB_10965694, HPA045490: AB_10962869" "unprognostic (5.84e-3)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (2.86e-1)" "unprognostic (3.62e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.99e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (2.54e-2)" "unprognostic (3.70e-2)" "unprognostic (3.10e-1)" "unprognostic (7.02e-3)" 13.1 37.9 30.2 17.5 28.9 12.5 14.9 22.0 25.8 11.8 20.5 11.8 9.3 18.2 17.5 16.9 20.6 11.4 16.2 35.4 22.8 27.7 36.7 23.6 11.1 13.4 32.1 18.3 26.7 15.1 14.3 15.1 15.0 19.2 20.2 11.8 27.9 11.3 15.5 33.3 8.1 19.4 42.5 22.0 10.1 17.9 21.1 17.0 10.4 17.5 20.2 10.7 23.0 16.5 18.2 16.3 11.6 18.4 12.2 22.5 10.5 36.7 9.2 9.3 29.0 6.4 4.8 21.9 15.5 10.3 8.9 8.0 26.2 25.7 5.6 19.7 10.4 17.3 9.6 4.9 12.4 12.0 15.6 3.4 10.8 13.5 24.1 8.6 26.4 16.6 4.3 6.0 13.1 9.2 12.8 10.1 6.3 22.2 23.3 18.3 9.1 14.2 11.8 24.6 26.6 19.2 10.5 11.5 34.0 16.5 8.7 5.4 14.9 19.4 10.2 20.1 9.8 18.9 7.6 19.6 19.8 26.0 17.2 33.2 37.0 50.7 11.9 25.2 29.5 18.9 5.7 8.8 11.6 15.4 18.4 15.1 18.2 18.3 16.8 15.0 16.0 11.0 16.9 1.7 12.2 17.8 16.3 22.5 10.5 30.2 28.9 22.0 25.8 22.8 27.7 32.1 18.3 19.2 17.0 17.9 46.2 77.5 98.6 75.7 105.2 57.3 178.3 52.2 58.0 181.5 43.2 203.1 351.5 126.1 26.1 56.2 109.3 93.5 164.5 133.4 54.1 70.8 70.6 249.2 109.9 84.2 59.4 39.3 60.1 57.2 64.5 84.0 69.2 129.8 72.2 94.2 142.7 87.5 75.3 253.1 99.4 64.7 95.9 66.9 97.5 66.0 221.2 70.2 105.2 80.4 COX4I1 "COX4, COX4-1" ENSG00000131143 "Cytochrome c oxidase subunit 4I1" P13073 16 85798633-85807044 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002485, CAB004080" Supported Supported Mitochondria NA NA 970000 Mitochondria "CAB004080: AB_2085427, HPA002485: AB_1078559" "unprognostic (4.73e-2)" "unprognostic (9.14e-3)" "unprognostic (2.65e-1)" "unprognostic (6.18e-3)" "unprognostic (2.47e-1)" "unprognostic (4.52e-2)" "unprognostic (2.65e-1)" "unprognostic (1.46e-1)" "unprognostic (5.97e-2)" "unprognostic (7.82e-3)" "unprognostic (3.32e-2)" "unprognostic (2.29e-1)" "prognostic favorable (2.56e-8)" "unprognostic (4.23e-2)" "unprognostic (4.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.38e-2)" 41.6 38.6 101.1 54.0 100.2 66.5 60.6 51.6 86.9 38.1 87.1 38.9 43.9 77.6 33.9 69.3 54.7 50.4 59.8 218.6 82.3 73.0 59.7 69.5 29.6 49.1 100.1 65.9 45.4 71.2 55.7 36.3 36.8 57.0 37.6 98.4 40.6 65.9 53.1 172.3 48.0 76.5 51.2 58.4 40.1 56.5 21.8 38.7 46.6 49.1 112.6 70.2 47.1 52.4 123.0 144.1 74.8 130.8 74.7 121.9 222.6 44.7 73.0 49.7 66.3 92.0 86.3 85.7 40.9 83.7 77.5 38.8 123.5 67.9 73.5 50.3 65.1 42.4 90.2 70.6 82.2 69.1 24.9 73.0 41.0 61.8 119.9 83.0 37.2 30.6 100.0 127.6 63.4 86.6 81.2 80.9 60.5 68.9 30.2 65.7 161.5 74.4 115.3 66.6 99.8 86.1 84.6 31.2 64.3 114.9 88.9 59.1 48.0 86.6 55.1 66.2 55.7 80.8 103.9 56.8 38.9 45.1 35.7 43.7 60.9 57.8 168.9 59.4 73.8 43.6 50.9 130.8 74.8 72.5 112.8 88.4 123.0 96.3 85.0 144.1 116.1 121.9 100.0 50.7 74.7 98.6 107.7 102.7 222.6 101.1 100.2 51.6 86.9 82.3 73.0 100.1 65.9 57.0 38.7 256.1 363.9 981.6 971.7 1003.2 230.7 3140.6 1197.4 362.7 382.2 600.2 123.7 1081.3 2332.7 965.7 464.1 701.9 2320.1 280.4 1145.7 924.4 671.8 956.9 507.1 1060.0 1395.9 200.2 970.5 596.0 1378.7 820.3 462.0 1118.7 1086.5 1424.7 1513.6 283.9 1228.5 1740.3 336.3 1959.5 260.3 349.3 760.4 345.7 304.0 1190.3 1239.3 852.8 1984.7 1551.2 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria NA NA 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.9 23.3 14.4 23.9 17.0 15.5 62.3 25.7 14.4 17.1 19.1 64.4 20.9 33.7 55.3 16.4 27.0 30.5 16.6 25.8 7.8 26.2 70.6 45.4 25.8 76.9 32.7 43.0 33.3 28.7 22.9 16.4 12.8 17.5 14.6 27.0 33.3 14.9 13.2 49.4 27.1 62.4 28.4 34.1 122.6 26.7 24.8 50.4 23.0 30.7 28.6 30.6 25.0 30.2 48.2 20.0 16.1 45.1 26.5 15.6 26.6 25.0 16.5 38.9 36.8 25.7 28.3 37.0 16.1 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 205.4 224.6 375.1 495.2 343.3 204.5 3263.7 647.1 369.4 268.4 759.0 214.0 640.2 3068.8 479.5 156.4 370.1 2132.4 140.2 527.3 778.4 340.5 424.2 320.2 1125.6 767.8 133.5 711.5 338.8 489.5 270.1 325.7 488.5 865.4 798.1 1204.0 259.4 460.5 1508.0 286.4 1849.4 303.9 439.8 473.4 213.2 290.0 419.6 512.8 265.9 1320.1 744.1 COX6A1 COX6A ENSG00000111775 "Cytochrome c oxidase subunit 6A1" P12074 12 120438090-120440742 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062394 Approved Supported Mitochondria NA NA Mitochondria "HPA062394: AB_2684749" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (5.10e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-1)" "unprognostic (8.78e-2)" "unprognostic (3.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (3.22e-2)" "unprognostic (2.82e-1)" "prognostic favorable (6.50e-7)" "unprognostic (2.53e-1)" "unprognostic (1.31e-1)" "unprognostic (5.48e-2)" "unprognostic (2.63e-2)" 49.2 48.0 171.0 32.1 103.0 52.6 43.8 44.4 107.5 37.3 96.8 38.5 32.4 102.8 28.0 47.0 59.3 41.8 37.6 41.5 121.5 92.0 85.8 102.6 32.4 39.6 140.0 57.9 27.7 62.7 43.8 38.3 44.4 86.9 43.1 74.3 31.3 63.8 44.2 10.6 37.7 85.7 38.1 67.2 32.1 60.8 28.1 61.2 33.7 48.2 36.0 40.1 42.1 35.0 74.5 102.2 60.5 69.8 47.8 87.4 83.0 47.2 101.2 57.6 60.1 44.4 37.9 70.6 30.1 40.3 53.5 45.7 122.3 48.3 99.6 90.1 42.5 41.4 79.1 56.1 66.1 34.7 59.7 121.0 53.4 57.9 89.5 41.1 58.5 38.4 45.5 81.6 48.8 57.9 44.2 45.0 72.6 52.3 31.2 44.4 132.3 84.4 148.2 52.5 92.1 148.4 57.7 38.6 93.3 84.4 114.0 76.0 66.1 55.2 54.2 70.7 33.5 97.2 66.9 33.9 33.4 41.3 34.4 41.8 48.5 66.6 77.1 52.4 57.4 44.4 38.5 65.5 58.3 54.4 69.5 58.5 74.5 64.3 59.5 95.1 59.2 59.1 59.3 60.5 47.8 69.8 102.2 87.4 83.0 171.0 103.0 44.4 107.5 121.5 92.0 140.0 57.9 86.9 61.2 369.2 267.5 329.6 423.0 340.5 204.2 104.8 682.8 548.7 311.7 734.5 543.9 662.2 1255.0 574.2 113.2 290.2 1336.6 93.5 578.7 601.6 281.6 433.2 262.5 840.8 680.4 138.2 495.4 264.6 384.0 100.3 279.6 388.0 497.7 739.4 694.0 232.4 574.7 1129.3 249.6 1194.5 252.8 336.3 428.1 355.7 331.5 339.1 775.3 316.6 860.7 644.8 COX6B1 "COX6B, COXG" ENSG00000126267 "Cytochrome c oxidase subunit 6B1" P14854 19 35648223-35658861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 2503.3;Distal tubular cells: 2530.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004192 Supported Supported Mitochondria NA NA 1200000 Mitochondria "HPA004192: AB_1847180" "unprognostic (5.12e-2)" "unprognostic (1.86e-2)" "unprognostic (3.81e-2)" "unprognostic (1.22e-1)" "unprognostic (1.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.18e-1)" "unprognostic (6.16e-2)" "unprognostic (3.52e-1)" "unprognostic (4.80e-2)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" "prognostic favorable (5.42e-4)" "unprognostic (2.10e-2)" "unprognostic (6.98e-2)" "unprognostic (5.74e-2)" "unprognostic (5.48e-3)" 37.2 32.2 62.1 32.1 58.7 46.2 42.8 31.1 57.6 34.1 65.0 25.2 41.2 52.7 27.1 70.2 52.4 36.3 39.8 132.5 51.5 52.2 61.1 68.9 24.7 40.4 57.4 60.2 29.2 41.1 41.4 28.8 30.2 39.2 30.2 77.1 31.8 54.9 44.2 168.4 35.1 63.2 37.6 38.7 30.7 42.0 21.0 29.0 42.7 37.6 110.6 52.7 33.8 31.6 110.6 115.5 111.1 116.1 61.2 107.9 167.5 36.4 87.1 37.8 50.4 49.7 50.9 35.1 29.7 45.1 49.1 49.7 71.1 36.7 41.1 52.6 46.7 32.9 26.8 60.7 50.4 48.3 47.8 41.5 70.4 46.6 69.6 39.3 63.2 36.7 59.8 63.3 45.8 26.6 47.1 47.6 44.7 43.9 61.6 49.3 70.5 44.4 46.6 28.1 184.2 58.8 38.5 41.6 68.0 111.9 72.9 33.2 38.0 47.8 82.4 29.3 46.1 32.7 68.7 28.4 28.4 32.5 30.1 46.2 37.0 44.4 55.8 37.5 49.0 36.5 87.7 108.6 94.7 65.5 116.1 62.4 110.6 90.5 76.1 111.8 92.7 89.6 79.4 111.1 61.2 107.8 115.5 107.9 167.5 62.1 58.7 31.1 57.6 51.5 52.2 57.4 60.2 39.2 29.0 226.3 220.0 458.4 406.9 379.4 129.5 2503.3 772.0 354.7 217.2 663.0 60.9 533.3 2530.0 637.7 277.5 330.3 1579.1 210.2 701.4 649.3 430.6 454.9 274.7 1065.5 910.2 84.2 601.2 320.4 754.1 587.8 303.5 609.7 710.3 822.4 1028.9 175.1 735.8 1153.8 256.7 1262.3 137.8 258.7 388.3 116.9 177.2 494.3 560.9 394.4 1027.2 623.0 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 17.0 6.9 8.0 32.8 18.3 13.3 13.4 5.6 5.3 3.8 4.3 6.9 36.5 41.4 42.4 8.7 6.1 22.7 4.5 46.4 6.4 7.5 11.6 85.9 8.2 20.1 11.9 39.6 26.6 12.3 61.8 3.2 7.1 17.0 5.7 13.0 6.0 74.4 6.4 16.3 41.1 36.5 15.4 25.7 15.9 47.8 2.6 40.5 58.2 90.8 24.9 15.2 3.9 85.1 41.6 8.6 60.0 25.4 4.9 29.1 37.9 30.7 7.9 18.5 14.9 24.6 40.9 16.1 25.7 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 375.2 414.8 374.3 402.8 435.9 194.1 2063.7 626.8 575.5 377.6 574.0 96.2 831.0 1886.7 571.0 645.5 416.6 1532.5 303.7 739.7 730.3 697.7 423.0 347.2 1528.6 904.1 147.8 776.1 376.3 443.5 180.9 615.6 499.6 695.0 943.2 982.6 392.7 687.3 1094.2 552.3 1121.0 205.6 485.0 628.5 756.0 487.0 560.0 1492.7 393.7 1121.0 582.7 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 140.2;Extravillous trophoblasts: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria No No 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: AB_2682490" "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.6 8.1 7.2 12.7 13.5 10.0 20.7 10.8 7.8 11.1 12.7 13.4 5.2 1.7 12.1 5.7 12.3 12.1 8.9 11.6 19.0 5.3 7.8 58.1 4.6 17.3 6.9 12.2 13.8 7.8 9.8 10.5 4.4 13.1 10.6 7.2 11.1 7.5 10.4 5.1 12.3 10.5 8.5 9.3 14.8 8.8 16.4 7.7 9.4 6.9 4.8 4.7 11.4 3.9 32.3 8.4 6.1 7.9 8.8 16.6 16.3 9.5 7.8 11.6 9.1 9.4 16.5 13.5 12.1 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 3.0 8.3 6.9 4.0 6.5 3.4 7.1 2.5 1.4 0.0 3.5 7.9 21.7 1.7 3.0 0.0 5.8 6.4 140.2 1.6 67.8 9.9 4.4 1.1 30.1 11.2 0.0 8.1 11.6 10.8 0.0 6.9 8.9 11.8 10.8 8.6 6.0 2.8 0.0 7.4 5.1 5.3 12.9 9.0 0.0 3.2 8.9 8.9 10.7 9.7 3.7 CPT1A "CPT1, CPT1-L, L-CPT1" ENSG00000110090 "Carnitine palmitoyltransferase 1A" P50416 11 68754620-68844410 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008835 Supported Supported Mitochondria NA NA 790000 Mitochondria "HPA008835: AB_1078563" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-3)" "unprognostic (3.04e-3)" "unprognostic (2.46e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (2.17e-1)" "unprognostic (4.99e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-1)" "prognostic favorable (2.67e-7)" "unprognostic (9.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (2.46e-3)" 18.0 18.3 9.9 9.9 12.1 15.8 24.4 7.0 10.3 12.8 31.9 8.2 14.1 33.7 17.0 7.2 11.2 12.8 14.7 14.6 12.0 6.6 30.6 62.0 13.1 10.1 10.5 8.6 17.0 24.4 16.9 13.8 8.7 10.8 15.6 22.0 19.7 12.9 11.4 6.9 10.3 33.4 16.9 8.7 18.9 16.8 10.4 9.0 17.9 13.2 7.5 7.6 11.3 30.2 2.5 11.9 10.6 8.6 5.7 8.8 2.5 8.1 14.5 2.1 14.2 9.3 8.4 0.6 6.5 5.4 5.2 1.0 0.5 27.6 0.0 24.2 17.2 18.2 26.9 18.4 3.9 1.5 13.0 1.8 20.1 15.8 6.7 13.9 11.6 24.3 8.7 1.9 10.4 6.3 7.1 18.3 8.1 2.1 16.5 4.7 23.4 9.4 20.6 0.2 42.2 15.4 26.5 0.3 35.6 12.2 20.4 0.2 9.3 18.0 34.9 5.7 1.4 31.1 11.3 18.4 11.3 0.2 22.6 9.4 12.9 16.4 8.3 11.9 8.6 12.3 9.2 7.8 10.6 8.8 8.6 5.1 2.3 5.5 5.3 5.0 2.5 3.4 7.0 3.8 5.7 7.2 11.9 2.9 2.5 9.9 12.1 7.0 10.3 12.0 6.6 10.5 8.6 10.8 9.0 35.7 36.9 11.5 7.7 8.4 4.9 22.1 28.1 32.1 22.7 22.7 60.9 12.9 16.6 11.2 9.2 25.4 82.1 0.0 8.1 4.1 13.9 7.4 27.8 79.0 14.6 1.6 15.5 37.4 42.3 15.7 8.9 13.5 0.0 11.8 44.9 12.9 9.7 40.3 30.1 9.4 41.0 38.8 16.0 12.1 8.8 6.8 6.5 16.6 59.0 6.4 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 207.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria NA NA 4400000 Mitochondria "CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.8 38.8 31.7 41.1 42.1 39.2 20.6 29.9 29.4 52.7 36.8 54.7 35.2 70.1 29.4 37.7 22.6 38.9 87.5 45.0 50.4 24.3 44.5 48.1 28.2 39.4 23.6 58.8 34.6 43.1 43.0 41.3 50.1 43.4 59.1 36.6 49.8 42.1 45.9 28.8 48.7 18.1 25.2 27.2 56.1 47.5 37.2 52.9 32.6 36.4 41.6 27.3 38.7 46.1 30.3 30.8 64.1 34.3 39.2 26.6 37.3 37.5 31.5 27.8 42.3 45.6 24.5 43.4 24.9 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 14.9 33.2 16.0 18.6 34.7 21.7 207.5 22.9 10.7 19.4 12.2 58.9 15.6 29.9 31.3 5.1 27.0 51.5 0.0 38.6 26.0 18.2 26.3 27.6 26.2 31.0 9.5 16.3 17.2 29.2 3.6 18.7 33.5 10.1 27.1 43.6 15.1 37.2 23.0 18.7 17.3 36.0 12.9 25.9 18.4 24.7 45.7 14.1 18.1 64.8 26.5 CTU2 "C16orf84, NCS2" ENSG00000174177 "Cytosolic thiouridylase subunit 2" Q2VPK5 16 88706463-88715386 "Predicted intracellular proteins" "tRNA processing" "Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041135, HPA041894" Uncertain Supported Mitochondria NA NA Mitochondria "HPA041135: AB_10794543, HPA041894: AB_10796463" "unprognostic (4.19e-1)" "unprognostic (3.62e-2)" "unprognostic (5.19e-2)" "unprognostic (5.77e-2)" "unprognostic (3.00e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (4.83e-2)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (1.19e-3)" "unprognostic (2.90e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" 10.9 10.5 13.0 10.9 12.8 12.0 7.8 11.6 17.4 9.0 8.8 11.7 4.6 9.5 11.4 6.7 8.1 8.8 8.5 11.0 12.8 10.2 6.5 11.4 7.7 12.2 12.9 15.3 12.5 15.7 7.0 10.9 7.5 9.9 8.3 4.4 5.8 15.6 9.6 25.4 11.5 7.8 14.7 8.7 9.1 9.5 22.8 11.2 9.3 9.7 11.1 7.9 8.3 7.2 7.5 7.7 1.4 8.0 8.1 9.3 4.6 6.9 11.0 4.3 9.3 3.7 3.8 10.7 7.4 5.6 8.2 4.0 12.9 6.6 10.4 9.9 4.7 3.8 7.0 7.2 7.2 2.2 3.1 21.6 7.2 4.6 12.9 6.3 7.0 5.4 4.2 5.3 6.5 6.9 3.0 6.9 6.4 26.4 3.0 3.1 18.8 19.1 15.9 6.5 6.1 17.9 15.5 3.4 10.9 2.9 2.7 14.4 7.0 12.0 2.2 4.6 2.7 6.5 7.7 7.7 8.6 11.0 9.8 8.0 9.7 4.8 29.3 7.2 15.2 9.3 1.4 6.4 0.0 9.3 8.0 7.8 6.9 8.4 9.0 7.7 7.5 8.9 7.1 0.5 8.1 6.5 7.6 4.7 4.6 13.0 12.8 11.6 17.4 12.8 10.2 12.9 15.3 9.9 11.2 0.0 4.1 8.9 7.8 12.2 12.7 2.2 10.2 4.0 5.7 1.8 5.9 9.5 10.0 5.8 9.8 4.5 5.8 0.0 11.6 13.2 8.0 6.1 0.0 5.9 8.8 12.7 5.2 3.1 2.2 5.5 7.5 4.6 5.0 4.6 5.0 5.7 7.9 6.0 9.2 5.8 8.2 0.0 9.9 17.9 23.5 9.4 6.8 5.7 8.9 7.1 CYCS "CYC, HCS" ENSG00000172115 "Cytochrome c, somatic" P99999 7 25120091-25125361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Respiratory chain, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 109.6;skeletal muscle: 103.7" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 1409.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004222, CAB005126, CAB018597" Enhanced Supported Mitochondria NA NA 190000000 Mitochondria "CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383" "unprognostic (3.06e-2)" "unprognostic (3.39e-1)" "unprognostic (3.32e-2)" "unprognostic (4.11e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.81e-4)" "unprognostic (4.44e-2)" "unprognostic (7.04e-3)" "unprognostic (5.67e-2)" "unprognostic (6.22e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "prognostic favorable (1.30e-5)" "unprognostic (1.18e-1)" "unprognostic (4.94e-2)" "unprognostic (8.75e-3)" "unprognostic (7.04e-2)" 20.3 29.3 29.8 20.0 44.8 17.1 14.7 25.1 41.1 12.1 62.1 13.3 9.6 35.4 11.4 10.7 26.6 11.0 13.1 109.6 30.2 26.4 39.8 37.0 13.4 13.8 30.7 34.7 12.2 9.3 24.8 18.6 10.3 29.9 13.7 58.5 13.5 14.9 15.7 103.7 11.3 30.2 21.8 28.0 15.6 24.3 23.5 18.1 17.3 18.3 41.2 20.0 15.9 14.3 35.5 38.0 17.1 38.3 25.2 31.0 25.2 41.7 23.4 25.3 35.2 14.6 11.2 26.1 40.3 16.6 30.2 35.1 38.7 28.6 48.1 19.8 17.6 89.2 49.7 51.4 37.9 53.3 14.2 23.0 40.0 27.8 27.4 22.9 91.5 35.7 14.9 34.0 30.1 65.4 13.1 27.0 29.5 73.3 51.0 32.0 19.3 49.9 35.6 47.4 94.1 44.3 35.2 30.4 46.0 47.0 41.0 51.4 24.4 21.0 89.6 32.4 46.5 46.4 54.8 19.4 27.8 50.5 42.8 74.3 52.8 61.1 107.5 37.0 66.7 76.8 17.1 20.0 14.0 25.3 38.3 31.0 35.5 23.4 26.8 38.0 26.0 22.4 26.8 3.0 25.2 33.6 27.8 29.5 25.2 29.8 44.8 25.1 41.1 30.2 26.4 30.7 34.7 29.9 18.1 77.4 123.3 298.1 610.6 612.7 158.0 675.3 165.6 120.5 170.6 174.5 72.6 180.3 1409.2 260.2 374.4 142.6 539.3 116.8 187.6 286.9 225.4 312.0 210.9 174.2 320.2 125.5 369.3 82.3 121.9 99.1 83.4 292.4 560.1 339.0 300.1 181.9 228.9 349.1 88.1 469.8 154.2 135.8 467.2 297.7 184.8 625.2 292.1 228.4 388.1 691.0 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell type enriched" "Detected in some" 36 "Syncytiotrophoblasts: 1678.9" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 45.7 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.3 0.1 3.7 0.3 0.0 0.0 15.3 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 8.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.0 0.0 13.4 0.0 0.0 0.0 1.6 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.3 7.7 0.2 0.0 1678.9 0.0 0.0 0.0 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell type enhanced" "Detected in many" 11 "Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.2 0.4 0.0 24.6 26.4 0.0 0.1 0.8 0.2 2.3 0.0 5.5 0.0 3.6 3.2 0.5 10.8 0.0 0.7 0.4 1.0 0.7 0.0 4.0 0.0 6.8 0.0 0.0 105.7 10.3 5.7 0.2 24.4 0.0 0.0 0.1 0.0 0.1 5.2 0.0 4.0 1.4 1.8 2.5 0.0 0.0 0.0 2.5 0.1 0.1 0.4 49.2 7.2 0.0 1.4 9.1 1.9 0.0 0.2 0.0 20.2 0.0 0.0 0.0 0.0 26.8 0.0 2.2 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 17.9 50.6 0.5 98.2 15.8 0.9 2.7 0.0 12.0 35.2 43.6 0.0 0.4 13.3 5.0 11.7 36.8 0.0 0.0 0.5 0.7 41.1 345.6 3.5 9.7 12.6 0.0 1.7 5.5 116.2 8.6 147.9 28.1 16.9 39.7 0.3 0.5 0.4 0.0 160.5 0.8 0.3 19.4 20.8 1.0 1.8 12.4 0.2 0.0 0.8 295.9 D2HGDH "D2HGD, FLJ42195, MGC25181" ENSG00000180902 "D-2-hydroxyglutarate dehydrogenase" Q8N465 2 241734579-241768816 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056216, HPA060548" Uncertain Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA056216: AB_2683070, HPA060548: AB_2732650" "unprognostic (2.85e-1)" "unprognostic (3.35e-2)" "unprognostic (6.98e-3)" "unprognostic (7.88e-2)" "unprognostic (2.42e-1)" "prognostic favorable (9.11e-4)" "unprognostic (2.49e-3)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (7.82e-3)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (9.60e-2)" "unprognostic (3.05e-2)" 7.3 17.0 10.9 13.3 10.7 11.5 7.7 9.8 9.5 12.2 15.9 11.7 32.4 7.8 14.6 30.6 12.0 11.7 22.6 8.7 11.3 7.9 13.8 18.7 8.7 7.7 12.2 8.5 10.6 17.1 18.7 26.4 7.4 13.0 12.3 10.1 13.1 13.8 22.2 24.3 27.1 10.5 11.8 7.0 10.0 9.9 4.3 11.3 6.1 15.2 14.0 12.5 11.3 9.5 5.0 1.1 0.0 0.6 0.0 2.8 0.3 6.6 7.1 4.2 6.7 10.1 5.4 14.6 6.1 8.1 6.5 5.2 7.7 14.6 5.5 3.0 6.3 7.4 15.3 3.9 5.1 2.9 6.0 3.9 10.2 6.4 13.2 5.6 12.0 8.1 9.7 9.2 5.1 5.1 12.5 6.3 8.6 13.0 3.5 5.7 11.2 10.1 12.4 2.0 8.9 13.7 12.6 4.7 10.3 11.8 24.0 13.7 4.5 6.2 16.0 4.2 2.9 9.8 4.3 2.5 10.1 3.8 5.2 3.7 6.5 1.2 8.4 7.0 13.4 6.6 0.0 0.5 0.0 0.8 0.6 1.2 5.0 0.3 2.8 1.1 0.6 1.6 0.6 0.0 0.0 0.6 0.3 1.9 0.3 10.9 10.7 9.8 9.5 11.3 7.9 12.2 8.5 13.0 11.3 8.9 14.7 13.7 22.9 17.5 12.5 7.8 30.6 9.4 11.4 17.4 13.7 36.9 19.9 8.4 2.3 8.4 24.4 0.0 7.5 13.6 12.0 16.9 5.7 34.6 15.1 11.1 30.5 13.5 9.2 1.6 15.5 7.8 3.3 1.8 55.3 46.4 7.6 21.0 17.0 25.8 11.2 6.5 10.3 1.7 6.1 12.9 18.9 10.7 47.9 17.3 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974762 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;heart muscle: 13.7" "Cell type enriched" "Detected in single" 29 "Cardiomyocytes: 13.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.2 2.0 0.9 0.9 2.5 3.0 0.4 1.4 1.4 0.2 3.6 2.1 0.0 0.4 0.4 0.4 0.3 0.1 0.7 13.7 0.4 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.4 0.4 0.4 0.2 0.0 3.8 0.2 0.5 3.6 2.6 0.0 0.2 0.7 2.5 0.4 1.6 0.1 0.7 0.8 0.3 0.0 0.5 0.0 0.0 0.3 0.2 1.6 1.4 5.3 0.6 1.4 1.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.7 0.3 0.0 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.1 0.8 0.4 1.3 0.0 0.5 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.2 0.1 1.1 21.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.1 2.7 0.6 1.3 0.7 0.4 0.6 0.9 0.4 0.4 0.2 1.6 0.7 1.2 5.3 1.4 0.3 1.4 0.2 0.3 0.9 2.5 1.4 0.8 0.4 0.3 0.5 0.0 3.8 0.3 0.0 0.0 0.0 0.2 0.1 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 DBT ENSG00000137992 "Dihydrolipoamide branched chain transacylase E2" P11182 1 100186919-100249834 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026481, HPA026485, HPA026533" Enhanced Supported Mitochondria NA NA Mitochondria "HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506" "unprognostic (1.23e-1)" "unprognostic (1.23e-1)" "unprognostic (3.67e-2)" "unprognostic (5.29e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "unprognostic (3.88e-2)" "unprognostic (1.65e-2)" "unprognostic (6.01e-2)" "unprognostic (1.21e-1)" "unprognostic (2.37e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.79e-12)" "unprognostic (1.63e-1)" "unprognostic (3.77e-1)" "unprognostic (9.67e-2)" "unprognostic (9.92e-2)" 8.6 14.1 8.3 5.0 13.6 3.9 8.7 8.0 11.8 8.5 7.8 7.9 13.6 6.6 9.8 6.6 13.6 8.6 5.2 18.1 8.6 7.3 22.2 29.1 8.0 5.3 10.2 8.2 9.1 13.7 10.2 12.3 7.3 9.4 12.0 7.6 5.2 11.3 8.3 15.7 8.1 5.8 11.2 8.6 6.0 12.6 5.7 8.2 9.6 13.0 8.7 6.3 12.8 7.7 4.4 2.6 3.3 3.1 4.0 5.0 2.1 11.7 5.8 5.3 10.8 11.7 10.3 12.4 8.0 6.5 7.2 8.7 12.0 4.5 10.7 11.7 4.8 4.6 10.5 11.8 8.5 9.0 11.2 6.8 7.7 11.1 5.9 10.1 10.1 3.7 10.0 9.4 5.9 9.3 6.5 6.7 10.0 12.4 11.7 5.7 2.7 8.4 3.3 11.2 7.8 11.5 8.2 19.4 8.0 7.9 10.6 9.4 5.8 17.8 15.9 13.4 9.8 12.5 6.3 7.7 7.1 4.7 9.1 7.2 8.2 8.3 5.5 8.4 6.2 3.1 3.3 2.2 1.8 4.9 3.1 5.0 4.4 4.4 4.2 2.2 4.1 4.5 4.2 2.1 4.0 2.7 2.6 3.4 2.1 8.3 13.6 8.0 11.8 8.6 7.3 10.2 8.2 9.4 8.2 20.8 28.4 16.7 5.9 6.1 21.3 62.5 20.4 16.0 9.1 12.2 37.3 16.0 43.1 8.1 0.6 6.7 8.1 0.0 7.2 10.3 7.5 7.4 2.3 43.1 7.4 14.3 8.7 10.4 7.5 0.9 14.1 7.8 3.3 6.4 12.5 15.6 6.7 3.5 19.8 26.5 20.8 6.5 8.1 2.4 5.5 6.4 6.9 10.0 12.7 4.6 DCAF5 "BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22" ENSG00000139990 "DDB1 and CUL4 associated factor 5" Q96JK2 14 69050881-69153150 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 118.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041575, HPA048098" Uncertain Approved Mitochondria NA NA Mitochondria "HPA041575: AB_2677558, HPA048098: AB_2680263" "unprognostic (8.12e-2)" "unprognostic (3.28e-2)" "unprognostic (4.26e-3)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.27e-2)" "unprognostic (3.13e-2)" "unprognostic (1.25e-1)" "unprognostic (2.43e-1)" "unprognostic (5.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.63e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.06e-1)" 23.5 18.1 18.5 18.1 21.7 19.0 21.7 23.5 24.0 23.1 24.4 21.4 20.2 15.6 26.9 17.2 24.5 22.0 19.9 22.2 17.9 11.7 19.3 23.8 23.8 18.4 13.6 13.5 24.5 17.8 32.6 30.1 20.6 15.5 23.7 16.0 23.4 20.6 24.9 47.7 23.4 20.5 24.5 20.1 22.3 20.6 41.8 17.5 38.7 25.0 14.0 27.9 24.2 24.6 5.3 3.5 9.6 2.5 17.5 19.4 7.2 26.0 8.3 19.6 18.2 21.9 19.2 12.9 12.3 18.0 14.2 17.9 10.7 16.7 14.4 11.3 19.1 10.7 12.8 13.8 18.4 13.3 19.5 7.6 15.5 8.4 7.6 16.6 5.9 18.9 21.6 19.3 12.6 17.8 24.6 21.1 17.3 11.9 12.2 14.0 15.5 18.5 10.3 8.8 12.3 13.3 12.4 18.6 5.7 18.8 20.4 14.0 15.8 16.5 17.3 11.0 17.7 21.1 12.0 19.0 24.2 22.9 11.1 7.2 16.1 5.2 13.3 16.1 7.1 7.3 9.6 2.5 9.0 19.4 2.4 16.4 5.0 10.5 14.2 3.3 5.3 10.1 12.5 3.2 17.5 1.6 3.5 4.7 7.2 18.5 21.7 23.5 24.0 17.9 11.7 13.6 13.5 15.5 17.5 41.7 52.6 15.9 17.8 23.4 17.5 53.4 35.7 48.2 46.6 14.0 25.5 16.4 1.7 19.9 118.8 28.9 18.0 0.0 21.6 14.7 21.8 18.2 34.8 28.0 16.9 17.5 22.4 26.4 20.9 68.0 28.7 19.0 10.1 17.2 21.1 20.8 25.0 17.5 32.2 10.8 23.8 45.3 28.3 45.2 16.4 17.3 12.8 27.7 18.3 18.7 DDAH2 G6A ENSG00000213722 "Dimethylarginine dimethylaminohydrolase 2" O95865 6 31727038-31730617 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 10.7;ASC TERT1: 13.4;EFO-21: 17.1;fHDF/TERT166: 10.6;SK-MEL-30: 10.7;U-2 OS: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012389, HPA012509" Uncertain Supported Mitochondria NA NA 1800000 Mitochondria "HPA012389: , HPA012509: AB_1847533" "unprognostic (2.29e-2)" "unprognostic (1.38e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-1)" "unprognostic (7.67e-2)" "unprognostic (1.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.62e-1)" "unprognostic (8.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (9.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.24e-2)" "unprognostic (2.72e-2)" 24.3 7.8 12.5 11.1 10.3 5.5 22.7 3.1 7.8 32.1 17.0 7.9 12.9 2.6 34.6 22.0 18.4 18.1 26.7 20.7 11.8 10.8 16.9 12.9 37.4 16.5 10.6 6.6 22.5 4.3 3.0 6.2 13.7 13.1 19.8 5.4 13.0 18.1 13.2 6.8 15.1 22.3 27.1 18.9 21.4 11.4 7.3 9.9 14.1 35.4 17.1 8.9 16.3 23.4 2.9 5.5 8.0 2.7 2.3 0.5 0.3 0.4 6.6 0.2 1.4 10.7 13.4 0.7 0.6 0.3 0.4 0.1 4.4 0.7 0.2 17.1 10.6 0.0 0.8 0.0 6.2 0.0 0.1 9.0 0.5 0.5 0.1 0.3 0.9 0.0 8.6 0.1 0.8 0.1 0.7 0.1 9.7 0.2 2.3 0.0 3.6 0.5 2.5 0.1 1.4 0.2 0.3 0.5 0.0 7.6 0.7 0.4 1.0 0.3 0.0 10.7 0.7 0.7 0.9 1.2 0.8 12.7 0.2 0.1 2.7 9.3 2.5 7.4 1.5 0.2 8.0 0.8 7.7 0.5 2.6 0.3 2.9 0.2 0.3 1.5 2.5 0.1 0.1 1.3 2.3 2.7 5.5 0.4 0.3 12.5 10.3 3.1 7.8 11.8 10.8 10.6 6.6 13.1 9.9 26.8 17.1 39.8 83.5 59.4 4.0 32.5 38.2 33.5 17.0 78.5 27.5 13.7 150.9 113.3 87.7 94.4 114.4 0.0 28.5 24.3 96.9 77.4 109.8 27.2 186.9 0.0 143.9 57.7 101.8 14.7 167.1 97.2 97.8 79.4 47.6 79.4 71.2 98.2 143.9 116.9 22.9 103.5 127.7 2.6 12.4 51.8 15.1 33.1 63.1 53.8 DDT DDCT ENSG00000099977 "D-dopachrome tautomerase" P30046 22 23971365-23980469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Melanin biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.8;liver: 58.4" "Cell type enriched" "Detected in all" 5 "Hepatocytes: 4710.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 68.5" "HPA049871, HPA074115" Enhanced Approved Mitochondria NA NA Mitochondria "HPA049871: AB_2680926, HPA074115: " "unprognostic (1.77e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (8.09e-2)" "unprognostic (4.00e-3)" "unprognostic (2.02e-3)" "unprognostic (6.58e-2)" "unprognostic (4.66e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (7.34e-2)" "unprognostic (3.30e-1)" "unprognostic (3.81e-1)" "unprognostic (2.61e-3)" 9.7 6.6 5.4 3.4 4.8 8.8 4.5 2.1 4.4 3.0 9.8 11.8 2.7 4.3 5.8 2.8 1.4 7.7 4.2 4.0 11.3 58.4 3.2 2.9 5.4 4.1 14.4 1.3 1.8 2.5 5.8 6.4 7.1 4.4 10.4 3.7 11.6 2.0 4.6 3.2 8.2 1.2 3.7 2.7 4.3 3.2 30.4 52.8 27.8 38.0 23.8 29.0 28.6 27.1 11.6 4.0 9.4 7.7 6.8 24.5 7.9 5.3 6.9 7.2 10.2 7.9 26.0 7.4 4.1 10.2 22.5 10.0 9.8 4.5 11.0 68.5 15.6 15.8 22.2 7.8 34.2 15.7 6.8 7.5 6.9 6.1 8.0 7.4 4.1 14.1 10.5 6.9 13.3 7.5 31.0 12.1 24.0 35.0 16.5 7.5 37.1 12.3 10.0 13.7 13.2 16.3 30.9 23.2 5.7 7.8 10.8 8.5 7.2 16.0 7.3 8.2 32.4 10.7 16.3 14.1 12.7 13.8 20.7 38.0 27.8 19.9 32.4 20.3 30.4 24.1 21.1 35.7 28.4 21.9 21.3 24.2 23.8 29.6 52.8 29.0 28.6 77.4 62.3 170.5 177.4 123.4 46.7 20.4 580.9 78.9 76.2 230.3 84.4 209.3 608.5 198.5 156.1 122.0 650.8 116.8 322.3 247.0 92.9 222.4 128.0 4710.9 242.3 41.3 249.4 161.4 217.6 261.8 108.4 147.1 150.1 220.0 322.2 63.3 238.6 309.5 104.0 969.7 70.4 77.6 140.0 72.1 40.3 164.4 250.7 154.1 488.9 247.4 DDX49 "Dbp8, FLJ10432" ENSG00000105671 "DEAD-box helicase 49" Q9Y6V7 19 18919675-18928633 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041870, HPA048093" Enhanced Approved Mitochondria NA NA Mitochondria "HPA041870: AB_2677717, HPA048093: AB_2680262" "unprognostic (3.51e-1)" "prognostic favorable (2.01e-6)" "unprognostic (2.28e-2)" "unprognostic (1.28e-1)" "unprognostic (8.56e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (4.12e-2)" "unprognostic (2.41e-3)" "unprognostic (8.67e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "prognostic unfavorable (7.44e-5)" "unprognostic (3.93e-2)" "unprognostic (2.99e-2)" "unprognostic (4.97e-2)" "unprognostic (3.24e-1)" 14.8 16.8 17.6 17.3 16.9 28.3 18.0 17.0 30.7 15.3 15.8 19.0 14.8 19.5 15.6 13.2 23.4 16.5 12.2 18.2 19.2 12.9 15.5 25.6 13.0 19.3 15.7 14.8 15.7 26.8 13.0 11.1 23.3 16.2 15.5 10.3 13.5 24.3 15.8 27.2 23.6 18.7 12.7 16.8 16.7 15.7 19.7 16.3 23.4 18.8 16.6 18.7 16.4 15.6 8.2 25.0 13.5 19.5 14.1 14.0 9.7 15.8 16.5 6.7 21.0 9.8 7.9 25.2 10.1 6.8 17.9 14.5 18.8 16.1 20.8 30.9 10.0 5.7 13.6 14.9 13.8 5.1 6.3 39.6 10.2 17.9 16.3 23.3 26.1 14.2 15.7 13.3 14.2 15.0 5.0 8.1 16.6 19.2 14.9 6.3 35.5 18.9 12.2 21.8 17.2 40.3 21.0 11.2 22.5 9.6 10.0 23.6 24.3 13.3 13.2 16.1 3.7 13.5 12.6 10.4 8.7 9.8 31.5 16.5 19.6 23.4 19.0 11.0 30.2 13.6 10.5 17.7 13.5 12.8 19.5 10.6 8.1 9.7 9.6 25.0 8.2 9.7 10.2 7.9 14.1 12.6 11.2 14.0 9.7 17.6 16.9 17.0 30.7 19.2 12.9 15.7 14.8 16.2 16.3 3.0 7.7 21.6 16.0 20.0 17.5 12.5 15.3 8.1 12.5 17.4 3.9 39.6 31.5 25.8 28.0 10.8 42.3 0.0 45.8 41.7 17.9 16.3 18.4 13.9 29.8 9.5 24.8 8.0 19.8 81.0 19.8 18.3 25.3 26.2 20.9 16.0 25.6 30.6 18.7 21.4 20.9 19.4 20.2 29.7 36.4 24.7 35.2 15.8 30.7 17.3 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria NA NA Mitochondria "HPA076422: AB_2686799" "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.9 10.6 14.0 10.4 61.0 39.4 10.9 42.0 47.3 29.5 35.5 9.8 11.5 11.9 54.6 38.0 17.9 15.9 16.3 14.3 32.8 17.4 29.1 8.6 11.7 5.9 37.1 17.2 18.7 39.2 32.0 27.1 15.3 30.9 29.1 6.6 12.6 13.2 37.8 5.5 8.7 9.3 17.4 8.2 15.7 8.0 19.8 7.7 37.5 4.1 9.1 14.7 22.3 35.2 22.2 26.8 11.9 25.1 26.5 28.4 9.0 32.6 40.9 9.4 11.1 11.0 30.6 8.6 31.8 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 77.4 27.7 37.9 37.6 218.5 30.5 15.7 12.7 22.7 20.5 10.4 13.7 229.8 11.6 30.3 15.3 49.6 4.2 23.3 38.8 36.5 83.9 44.4 103.9 18.1 85.9 17.5 14.3 60.2 49.3 8.5 58.4 80.4 65.8 75.7 5.0 21.7 25.8 5.8 74.6 25.8 15.9 103.5 85.6 67.0 42.8 280.0 166.4 61.0 5.6 12.9 DHFR ENSG00000228716 "Dihydrofolate reductase" P00374 5 80626228-80654983 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Methotrexate resistance, One-carbon metabolism" "Oxidoreductase, RNA-binding" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 163.5;Spermatocytes: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB037129, HPA051465" Uncertain Approved Mitochondria NA Yes Mitochondria "CAB037129: AB_439683, HPA051465: AB_2681494" "unprognostic (1.44e-2)" "unprognostic (1.03e-2)" "unprognostic (2.24e-3)" "unprognostic (2.91e-3)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (2.83e-2)" "unprognostic (2.35e-2)" "unprognostic (2.02e-2)" "unprognostic (4.19e-3)" "unprognostic (1.83e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (1.82e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.09e-1)" 17.7 6.1 16.0 11.6 13.9 28.3 10.9 10.2 14.0 7.5 12.6 18.1 11.7 14.5 5.9 9.0 9.8 4.7 6.9 9.7 17.3 14.4 13.1 35.5 8.6 23.2 18.9 9.4 7.5 4.9 9.6 7.2 8.5 13.0 5.9 15.5 8.6 8.0 8.4 10.4 5.9 14.5 7.3 25.3 9.1 7.4 10.5 11.5 13.4 9.2 2.3 22.8 7.9 6.1 2.4 3.3 3.5 2.6 2.1 4.0 2.1 19.8 13.8 35.1 25.9 6.6 7.0 12.9 15.9 12.2 27.8 32.1 13.1 24.0 40.4 7.0 9.2 22.7 14.0 45.1 20.5 45.0 17.9 27.8 19.3 23.0 12.1 1.4 22.5 8.6 4.8 2.1 24.9 2.8 4.7 13.4 29.7 21.7 31.1 28.1 19.9 55.4 9.1 17.7 9.9 8.1 36.0 68.9 40.0 16.0 12.7 28.7 20.0 22.5 10.5 11.4 18.6 20.8 22.3 8.0 8.8 13.4 24.6 30.4 14.6 29.2 43.7 19.7 45.8 22.6 0.8 1.2 1.1 2.3 2.6 1.1 2.1 2.7 3.2 1.9 2.4 2.1 2.7 3.5 2.1 1.7 3.3 4.0 2.1 16.0 13.9 10.2 14.0 17.3 14.4 18.9 9.4 13.0 11.5 6.0 9.4 21.6 5.3 6.2 3.7 13.2 7.6 8.1 6.8 14.0 2.0 13.0 8.3 6.6 4.3 3.6 20.0 163.5 3.3 35.4 9.5 2.1 2.3 41.2 36.1 3.2 4.7 9.2 13.2 4.6 13.0 8.3 0.0 2.8 11.1 10.0 4.3 5.8 15.2 33.5 3.4 12.9 9.0 92.4 48.0 4.8 11.1 10.1 21.0 3.7 DHFR2 "DHFRL1, DHFRP4, FLJ16119" ENSG00000178700 "Dihydrofolate reductase 2" Q86XF0 3 94047836-94063389 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 11.9;Ciliated cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 13 "hTERT-RPE1: 61.0" HPA051465 Uncertain Approved Mitochondria NA NA Mitochondria "HPA051465: AB_2681494" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-2)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (1.38e-1)" "unprognostic (5.92e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (4.62e-2)" "unprognostic (2.95e-1)" "unprognostic (1.52e-1)" "prognostic favorable (2.30e-6)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-2)" 6.6 8.0 9.7 5.2 10.9 2.2 7.7 5.2 13.2 9.8 6.3 15.2 2.8 5.8 11.7 9.9 5.3 9.4 7.6 5.1 9.8 8.1 10.6 9.3 7.1 7.3 10.2 6.9 15.3 10.8 15.4 13.1 4.5 12.2 9.5 6.7 6.2 6.6 8.9 2.8 5.8 10.1 9.0 12.6 9.4 6.6 8.2 8.6 16.9 10.3 4.8 6.4 7.3 6.2 5.0 4.1 3.8 3.3 2.8 7.3 2.5 1.3 2.1 1.6 1.6 2.3 2.9 0.6 2.1 2.3 1.1 1.2 0.4 2.2 0.9 1.4 1.1 1.4 1.9 1.2 1.5 1.7 3.0 0.7 1.1 1.0 1.2 2.3 0.7 1.3 2.9 2.0 1.2 1.6 61.0 1.1 4.6 0.5 2.1 1.4 1.7 3.9 0.4 1.3 3.9 2.6 1.0 2.1 1.5 1.5 0.7 2.0 2.1 3.1 0.8 3.5 1.3 2.1 1.1 1.7 1.7 2.9 0.7 0.8 1.6 1.5 1.3 1.7 2.0 2.3 3.6 2.2 3.8 3.8 3.2 7.3 3.8 5.1 6.1 1.4 5.0 6.9 6.2 3.5 2.8 3.3 4.1 6.1 2.5 9.7 10.9 5.2 13.2 9.8 8.1 10.2 6.9 12.2 8.6 11.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 16.0 3.4 3.5 0.0 2.0 3.3 4.8 0.0 0.0 0.0 0.0 4.8 1.5 0.0 0.0 2.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.6 0.0 0.0 4.6 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068972-12123225 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.5" "Group enriched" "Detected in many" 4 "Hepatocytes: 213.4;Proximal tubular cells: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Enhanced Supported Mitochondria NA NA Mitochondria "HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617" "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 5.7 6.3 6.5 4.7 6.6 2.2 5.0 5.7 7.2 5.5 5.7 9.8 5.0 4.5 4.7 5.0 5.1 4.2 4.5 7.7 5.3 4.8 23.8 69.5 4.2 6.9 7.5 5.2 7.1 16.6 5.4 4.1 4.7 6.2 7.6 6.3 7.2 9.7 7.1 10.5 3.6 4.3 3.5 6.1 5.1 6.1 4.4 6.6 10.1 6.8 6.7 8.0 5.2 4.1 9.5 12.5 16.8 11.0 10.2 4.1 3.3 11.4 8.8 13.2 10.5 8.2 4.9 16.0 5.8 3.7 10.4 9.2 5.6 6.9 8.3 1.9 3.6 4.8 16.3 13.8 4.5 11.9 4.6 6.2 4.5 3.5 4.3 8.1 1.8 1.7 6.0 3.5 6.0 2.4 4.1 5.6 10.1 7.0 6.7 2.8 22.2 6.0 3.2 7.3 10.6 2.1 10.3 4.3 7.0 6.7 2.7 3.4 15.5 11.4 20.4 6.8 14.8 45.0 6.5 2.5 3.4 2.5 7.0 4.2 6.0 4.2 5.3 4.3 3.2 5.6 16.8 4.8 10.7 3.2 6.8 3.4 9.5 2.5 2.1 8.6 7.8 2.5 3.3 14.0 10.2 11.0 12.5 4.1 3.3 6.5 6.6 5.7 7.2 5.3 4.8 7.5 5.2 6.2 6.6 11.9 32.1 21.6 5.5 4.6 11.5 26.6 25.5 5.3 6.8 15.7 9.8 22.3 16.6 9.3 2.6 7.4 10.3 0.0 9.7 18.5 6.6 11.2 8.1 213.4 8.4 25.4 10.9 11.6 11.9 3.1 11.5 11.3 5.0 13.6 19.6 10.8 9.7 10.5 11.3 55.4 18.7 12.9 5.0 5.6 3.6 5.3 11.3 7.1 15.0 6.2 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000184047 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207663-122226568 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 9.3;Extravillous trophoblasts: 9.1;Hofbauer cells: 5.7;Syncytiotrophoblasts: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001825, CAB003857, CAB016688" Supported Enhanced Mitochondria NA Yes 21000 Mitochondria "CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247" "unprognostic (3.67e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-1)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (2.38e-3)" "unprognostic (1.40e-3)" "unprognostic (5.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (6.68e-2)" "unprognostic (2.36e-1)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" 17.2 29.7 21.9 15.5 24.0 26.7 24.8 21.9 30.1 20.4 25.9 29.0 14.3 20.6 22.2 36.6 23.5 21.8 19.2 20.3 21.2 26.8 31.7 37.2 15.8 20.9 28.3 23.6 22.4 32.6 22.9 30.6 28.5 27.0 21.1 24.2 22.4 22.2 20.2 25.8 18.2 21.3 21.8 29.2 18.5 19.8 62.7 21.8 23.2 26.9 23.0 22.8 20.5 17.9 32.8 35.0 27.5 29.1 29.9 32.1 26.8 19.2 38.3 27.1 18.4 19.5 19.1 20.8 20.1 19.8 23.7 21.3 33.1 10.1 23.6 18.9 18.1 17.6 19.2 29.5 24.0 28.1 20.4 23.0 25.9 15.8 30.3 27.7 27.8 10.8 26.3 17.1 27.9 41.9 26.9 27.3 23.6 29.6 10.0 23.0 28.8 22.7 40.9 21.8 27.7 36.0 20.7 27.0 25.9 26.7 30.1 25.7 26.2 26.8 10.8 21.8 31.9 36.3 19.6 18.6 18.3 22.5 20.7 18.1 21.9 36.6 33.8 23.3 21.5 24.0 23.6 28.9 27.5 30.4 29.1 29.1 32.8 28.4 28.4 35.0 26.0 27.9 28.2 12.7 29.9 26.5 26.8 32.1 26.8 21.9 24.0 21.9 30.1 21.2 26.8 28.3 23.6 27.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000284934 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207662-122227534 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 17.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 21.4" HPA001825 Uncertain Approved Mitochondria NA NA 21000 Mitochondria "HPA001825: AB_1857247" 0.1 8.7 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.2 5.3 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.9 2.4 0.0 1.2 0.6 1.1 0.6 0.6 2.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.7 0.0 0.4 1.9 21.4 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.5 0.3 1.4 0.6 1.0 0.3 1.0 2.3 0.6 1.2 0.3 1.3 1.1 0.6 0.2 0.4 2.2 0.5 0.0 1.1 2.9 4.0 4.4 7.1 0.0 10.2 0.0 1.2 0.0 3.9 0.0 0.0 0.2 4.3 1.9 8.8 0.0 0.0 0.0 2.4 3.1 4.6 2.8 0.0 3.2 7.0 4.3 1.9 3.9 5.2 0.8 3.3 0.0 7.8 7.2 0.2 9.7 3.2 0.0 9.1 6.5 4.1 17.0 15.2 4.3 0.0 5.0 9.3 3.3 DLAT "DLTA, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112024814-112064390 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 55.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 95.8;Distal tubular cells: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Supported Mitochondria NA NA Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favorable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favorable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 14.1 10.7 10.6 8.8 11.9 4.8 10.9 10.5 14.2 6.7 13.3 6.3 7.8 12.4 6.3 8.1 12.2 7.2 6.4 55.4 10.4 13.5 19.1 12.0 6.6 8.7 11.2 9.7 7.9 6.0 15.8 7.8 8.3 13.0 8.3 13.5 7.6 10.4 9.9 41.0 7.2 13.0 6.6 7.3 6.9 8.1 7.3 4.2 12.7 10.7 22.1 8.8 7.5 6.7 9.2 9.1 7.9 8.9 7.2 10.3 8.0 6.1 6.2 8.3 11.0 11.6 8.7 9.9 8.5 4.9 9.4 10.7 19.7 18.2 25.3 16.7 7.7 12.8 13.3 17.2 9.1 10.7 9.1 10.8 16.1 6.6 12.1 8.3 20.3 9.2 10.5 10.0 9.4 9.5 7.2 8.5 12.5 26.2 12.1 11.0 4.8 9.2 24.3 9.7 15.8 12.1 14.3 11.2 28.5 17.2 6.5 15.9 9.7 10.2 28.9 6.4 9.9 21.4 12.6 5.7 9.4 10.2 9.4 10.9 4.0 6.3 38.4 2.6 22.2 7.3 7.9 6.6 4.7 8.3 8.9 9.5 9.2 8.2 8.9 9.1 7.5 10.3 8.3 0.5 7.2 8.9 7.4 8.8 8.0 10.6 11.9 10.5 14.2 10.4 13.5 11.2 9.7 13.0 4.2 11.9 12.6 16.4 7.1 10.0 7.6 95.8 12.7 32.1 7.9 10.4 0.0 17.8 63.0 16.0 3.0 8.3 19.1 0.0 10.1 34.1 8.5 6.3 3.5 14.3 16.4 7.9 16.6 5.5 12.3 2.3 5.8 7.9 16.9 18.0 18.5 8.6 12.5 3.5 10.3 29.2 10.5 0.0 11.3 21.6 15.8 8.5 14.5 8.6 24.8 9.1 DMAC2 "ATP5SL, FLJ10241" ENSG00000105341 "Distal membrane arm assembly complex 2" Q9NW81 19 41431318-41440717 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 41.9;Ductal cells: 37.6;Extravillous trophoblasts: 58.6;monocytes: 55.1;Syncytiotrophoblasts: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041427 Approved Approved Mitochondria NA NA Mitochondria "HPA041427: AB_2677473" "unprognostic (1.42e-3)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.20e-1)" "unprognostic (6.88e-3)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.77e-4)" "unprognostic (4.37e-1)" "unprognostic (3.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "prognostic favorable (4.07e-5)" "unprognostic (5.20e-2)" "unprognostic (2.48e-1)" "unprognostic (6.60e-2)" "unprognostic (7.29e-3)" 12.9 16.2 12.3 9.9 13.5 10.3 18.3 10.9 21.9 12.1 21.4 14.1 11.1 28.9 15.8 7.2 15.8 13.1 13.5 48.1 12.5 11.1 18.6 20.0 15.2 15.7 12.9 13.7 12.3 18.3 14.2 11.3 12.2 15.4 14.9 11.9 13.6 16.3 14.4 38.7 14.0 31.4 16.2 11.6 12.9 17.3 10.6 10.9 17.9 22.3 22.0 14.1 16.8 12.1 14.3 29.4 17.0 20.3 15.0 17.8 15.1 15.6 55.6 20.3 13.5 14.5 13.3 12.1 13.2 15.3 23.3 21.1 39.5 18.0 16.4 20.2 19.2 12.2 11.8 15.4 24.0 12.0 14.9 19.6 15.3 16.0 28.6 21.5 25.7 15.5 22.4 22.3 19.0 13.4 16.0 27.7 22.6 20.7 16.4 15.8 19.4 23.5 10.7 25.2 22.3 17.0 19.5 15.6 14.4 22.5 21.9 14.5 24.1 21.1 17.5 14.2 16.8 16.4 29.3 20.6 20.3 22.2 12.2 22.5 17.3 16.3 14.7 18.1 18.7 14.5 9.7 20.3 17.0 17.2 18.8 17.8 13.1 13.1 17.1 29.4 14.3 14.2 13.4 6.7 15.0 15.4 19.1 15.3 15.1 12.3 13.5 10.9 21.9 12.5 11.1 12.9 13.7 15.4 10.9 26.8 16.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 10.3 12.2 0.0 41.9 33.2 37.6 0.0 0.0 0.0 0.0 35.0 58.6 0.0 0.0 7.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 55.1 0.0 0.0 28.2 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997606-79236038 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 50.2;liver: 81.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.2;Hepatocytes: 84.9;Late spermatids: 27.1;Proximal tubular cells: 59.0" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.7;Hep G2: 11.5;hTEC/SVTERT24-B: 3.6;Karpas-707: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria NA NA 440000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859" "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favorable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favorable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 2.8 2.2 0.8 0.8 1.3 0.0 1.5 0.4 0.6 0.5 0.5 0.7 1.9 0.1 0.9 5.9 0.4 0.4 0.6 1.3 0.8 0.8 50.2 81.8 0.1 0.1 0.8 0.3 1.0 0.5 0.3 2.1 0.0 1.1 0.9 0.1 2.7 0.4 1.1 0.6 0.2 0.3 2.0 1.7 0.0 0.4 1.2 0.2 0.0 1.5 0.8 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 1.4 0.4 0.3 5.7 1.3 2.3 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 11.5 3.2 0.0 0.0 2.7 3.3 3.6 2.6 2.5 0.0 1.3 0.0 3.6 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.3 0.4 0.6 0.8 0.8 0.8 0.3 1.1 0.2 0.0 0.6 1.4 0.4 0.1 1.5 0.8 2.5 2.7 0.0 8.7 2.0 0.2 16.6 0.4 25.2 0.6 0.5 0.0 0.6 0.1 0.8 0.9 0.0 84.9 0.1 0.0 1.2 1.3 2.4 27.1 2.3 0.4 0.0 0.0 1.1 3.5 0.7 0.6 2.5 59.0 4.1 0.0 0.1 3.4 5.2 0.3 0.2 0.5 0.6 0.7 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 49.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.5" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria No No Mitochondria "HPA037487: AB_10672493, HPA057526: AB_2683456" "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.6 1.2 2.0 13.7 2.4 7.0 3.0 6.2 3.8 1.6 4.5 1.1 0.8 3.5 3.0 1.8 3.2 1.0 2.4 2.0 2.5 2.2 3.4 6.2 3.3 8.4 2.9 5.0 1.9 2.4 1.1 2.3 4.0 1.7 3.0 5.0 0.9 2.3 0.8 2.3 2.9 5.2 1.9 3.0 5.2 2.6 7.0 1.4 49.1 1.5 5.1 10.8 2.3 2.0 0.4 0.1 0.9 0.1 5.5 0.6 0.1 13.9 7.2 16.5 11.6 1.9 1.3 11.6 6.9 5.8 9.9 12.2 17.2 9.1 14.3 2.6 2.1 3.8 8.6 9.4 3.6 12.0 8.8 7.1 8.7 4.5 6.6 0.5 14.9 9.4 1.0 1.5 7.0 2.1 2.5 4.4 9.5 12.7 13.0 5.7 4.9 23.0 10.8 11.6 5.9 13.6 18.0 11.4 4.6 4.2 6.5 7.5 9.0 9.5 12.1 2.3 12.2 9.3 6.3 1.8 3.8 11.9 4.8 13.1 6.6 7.4 21.4 3.2 14.3 5.0 0.0 0.0 0.9 0.2 0.0 0.2 0.4 0.2 0.6 0.1 0.4 0.3 0.3 0.1 5.5 0.1 0.0 0.4 0.1 2.0 2.4 6.2 3.8 2.5 2.2 2.9 5.0 1.7 1.4 6.0 0.6 0.0 0.7 2.1 2.2 7.3 2.5 0.0 1.2 1.8 5.9 2.0 0.0 0.5 1.6 0.7 1.3 70.0 0.8 3.8 1.9 3.2 0.0 4.4 1.8 0.0 1.2 1.3 2.2 3.1 0.6 0.0 0.0 0.0 1.3 0.2 0.7 0.0 0.7 0.4 3.6 0.0 1.0 5.0 14.2 1.5 1.0 1.5 2.3 0.9 DNAJC11 FLJ10737 ENSG00000007923 "DnaJ heat shock protein family (Hsp40) member C11" Q9NVH1 1 6634168-6701924 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023707, HPA028705" Uncertain Supported Mitochondria No No Mitochondria "HPA023707: , HPA028705: AB_10603662" "unprognostic (3.74e-2)" "unprognostic (3.19e-2)" "unprognostic (4.06e-2)" "unprognostic (6.05e-3)" "unprognostic (9.55e-2)" "unprognostic (6.65e-2)" "unprognostic (4.38e-3)" "unprognostic (6.10e-2)" "unprognostic (6.34e-2)" "unprognostic (2.89e-1)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.30e-2)" "unprognostic (1.76e-1)" "unprognostic (9.77e-2)" "unprognostic (1.04e-1)" 13.8 24.0 20.5 16.1 25.2 10.2 12.7 19.1 31.3 13.0 23.4 17.3 10.5 22.4 14.6 11.2 19.5 12.7 11.9 26.9 15.7 13.0 33.5 25.8 11.2 14.4 13.9 19.6 16.5 15.3 21.4 13.4 15.5 25.0 12.6 27.4 15.4 13.8 12.4 44.2 16.6 19.5 15.1 14.6 19.6 16.2 12.4 14.2 12.6 12.3 17.2 18.4 14.0 12.6 8.1 12.2 7.2 13.4 10.0 10.1 8.6 16.6 16.3 19.3 17.5 16.9 11.9 17.8 16.7 14.4 33.3 23.6 19.6 24.2 26.8 16.3 19.2 14.2 22.6 33.0 27.0 29.5 15.1 22.7 27.3 31.0 19.7 16.4 32.8 15.0 17.2 7.5 30.0 19.8 11.9 15.6 20.5 34.4 12.0 16.7 13.5 20.3 16.9 19.6 23.4 28.1 22.7 16.7 19.4 21.3 14.6 25.8 18.3 19.1 39.2 20.9 17.0 15.4 17.0 15.3 19.8 10.6 16.3 19.5 13.9 15.1 35.6 19.2 35.7 9.8 7.2 9.6 3.4 9.4 12.5 9.4 8.1 6.9 10.1 12.2 8.1 7.4 5.9 0.3 10.0 13.4 5.3 7.2 8.6 20.5 25.2 19.1 31.3 15.7 13.0 13.9 19.6 25.0 14.2 8.9 10.2 8.3 3.9 17.4 16.6 8.1 2.5 14.7 7.9 12.2 27.5 18.0 29.9 12.1 11.3 7.5 24.2 0.0 11.9 18.8 12.3 3.0 4.7 10.6 14.8 19.1 14.0 5.5 7.6 7.4 7.5 11.1 27.0 8.2 26.0 12.1 9.7 21.0 4.2 25.9 17.5 6.5 14.4 13.3 12.2 15.9 19.9 4.8 33.7 4.8 DNASE1L2 DNAS1L2 ENSG00000167968 "Deoxyribonuclease 1 like 2" Q92874 16 2235816-2238711 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 11.7;skin 1: 20.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 1.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044714 Uncertain Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA044714: AB_10962870" "unprognostic (9.88e-2)" "unprognostic (1.11e-3)" "unprognostic (6.80e-4)" "unprognostic (4.29e-2)" "unprognostic (2.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (2.50e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-3)" "unprognostic (2.17e-2)" "unprognostic (4.67e-4)" "unprognostic (1.40e-4)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.94e-4)" 0.6 1.3 1.3 0.6 2.1 0.8 2.1 8.8 2.8 0.6 0.6 0.6 0.6 0.8 1.2 3.5 0.6 0.4 0.6 0.6 1.6 2.1 0.9 1.6 0.6 0.6 1.5 0.6 0.7 1.9 0.2 2.1 1.3 1.3 0.8 0.2 0.6 11.7 0.6 0.7 20.6 0.8 0.6 1.3 1.0 0.9 1.9 0.6 2.4 2.7 7.1 3.4 0.6 0.6 0.0 0.0 1.6 0.0 0.0 0.2 0.0 1.9 4.0 1.7 1.8 1.4 0.8 6.9 0.6 0.5 1.6 0.8 4.4 4.1 2.6 2.1 0.2 0.5 0.6 0.6 0.2 0.2 5.1 3.8 1.1 6.2 1.0 0.2 1.2 4.2 0.9 1.4 1.2 0.3 1.6 0.3 3.0 3.5 3.9 0.6 4.5 3.6 7.5 1.7 0.5 2.7 6.7 2.0 3.5 0.9 0.9 3.5 1.8 0.9 1.5 2.8 0.4 6.1 2.7 0.2 3.4 4.4 1.9 1.4 9.5 4.5 2.4 1.1 2.5 1.7 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 2.1 8.8 2.8 1.6 2.1 1.5 0.6 1.3 0.6 0.0 1.1 0.0 0.0 0.1 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 DTNB ENSG00000138101 "Dystrobrevin beta" O60941 2 25377198-25673647 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 49.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061357 Uncertain Approved Mitochondria NA NA Mitochondria "HPA061357: AB_2684489" "unprognostic (1.14e-1)" "unprognostic (1.39e-2)" "unprognostic (3.17e-2)" "unprognostic (7.40e-2)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.78e-2)" "unprognostic (3.67e-3)" "unprognostic (3.98e-2)" "unprognostic (9.45e-2)" "unprognostic (4.67e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-2)" "unprognostic (6.49e-2)" 3.6 3.5 19.1 5.2 21.3 4.7 13.9 14.5 24.6 7.7 2.7 9.5 13.6 2.2 4.7 14.0 4.6 7.3 5.9 3.4 20.6 12.6 6.3 5.1 6.6 4.6 12.4 11.7 7.2 10.3 12.2 9.6 5.4 13.2 10.5 2.4 4.2 49.4 13.9 2.7 4.6 2.3 3.1 13.1 4.4 7.7 9.0 7.3 6.3 15.7 1.0 5.4 5.2 4.3 7.4 1.1 7.2 2.2 5.1 7.4 2.8 8.9 7.6 6.2 6.9 3.6 4.6 0.2 2.7 3.7 3.4 4.9 2.9 2.3 4.7 1.1 2.2 4.4 3.2 4.3 11.7 1.9 7.2 10.0 3.7 2.3 8.9 2.6 4.7 3.7 3.7 10.1 3.6 6.3 4.3 4.7 9.7 0.3 7.2 2.6 9.0 7.7 3.9 7.1 2.4 5.2 6.2 10.1 8.9 6.4 8.4 8.2 11.9 8.9 15.8 10.9 3.4 8.3 2.8 1.9 1.4 6.4 2.0 4.8 12.7 5.6 8.5 4.0 8.6 5.1 0.5 2.2 7.2 5.8 1.1 6.6 5.7 7.4 5.2 0.7 7.4 7.3 5.0 4.3 5.1 0.6 1.1 6.4 2.8 19.1 21.3 14.5 24.6 20.6 12.6 12.4 11.7 13.2 7.3 8.9 10.9 3.7 21.9 7.1 8.6 2.2 12.7 0.0 5.7 14.0 5.9 3.1 10.0 3.9 2.3 3.8 0.0 0.0 10.2 1.2 2.1 14.7 1.1 5.0 26.1 20.6 2.9 2.5 4.7 4.5 1.4 3.1 11.8 2.8 2.3 15.1 6.9 0.3 2.5 7.1 7.8 6.5 1.4 9.4 12.4 1.8 1.7 8.6 1.0 16.0 DTYMK "CDC8, TMPK, TYMK" ENSG00000168393 "Deoxythymidylate kinase" P23919 2 241675742-241686991 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 118.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042593, HPA042719" Approved Approved Mitochondria NA NA Mitochondria "HPA042593: AB_10959590, HPA042719: AB_10960633" "unprognostic (1.90e-1)" "unprognostic (6.95e-2)" "unprognostic (4.14e-1)" "unprognostic (8.61e-2)" "unprognostic (1.89e-1)" "unprognostic (9.45e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (2.64e-2)" "unprognostic (5.50e-2)" "unprognostic (2.60e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (7.13e-2)" "unprognostic (6.81e-2)" "unprognostic (5.07e-2)" "unprognostic (9.19e-2)" 12.4 17.6 11.6 17.3 15.0 29.1 14.4 14.5 12.4 10.0 13.8 16.5 9.3 12.0 12.4 9.7 20.0 9.7 10.2 9.4 9.0 6.5 15.5 19.5 10.5 21.0 14.0 9.5 9.5 13.6 5.0 8.8 10.4 11.8 11.5 11.7 10.8 9.6 10.0 6.7 17.9 13.0 13.0 9.5 18.8 13.5 11.1 15.1 20.7 9.4 16.1 17.9 11.7 11.9 19.8 21.1 12.0 24.7 15.7 21.8 15.7 25.1 27.8 24.2 30.7 8.0 8.7 25.6 20.6 15.5 27.5 32.4 12.7 30.5 12.2 6.4 16.6 32.8 21.2 22.2 25.1 14.8 28.7 26.4 26.1 23.3 24.1 6.6 16.5 21.7 6.1 6.8 26.5 10.8 8.4 26.4 17.7 29.4 10.3 29.1 26.2 30.5 28.7 23.8 28.2 23.4 26.1 35.6 17.0 15.9 14.6 29.2 18.3 13.4 20.6 16.5 7.7 18.7 29.6 17.1 40.1 28.8 25.5 38.0 11.6 12.2 34.2 32.1 26.5 46.6 12.0 14.9 9.5 17.4 24.7 16.8 19.2 16.1 18.2 10.5 19.8 16.0 14.7 2.5 15.7 18.8 21.1 21.8 15.7 11.6 15.0 14.5 12.4 9.0 6.5 14.0 9.5 11.8 15.1 8.9 4.3 11.9 17.5 13.5 18.2 9.2 25.5 8.1 11.4 24.4 2.0 48.5 18.3 37.3 1.8 17.5 9.3 46.7 29.4 118.6 22.0 17.5 15.0 16.6 74.0 4.8 13.8 20.9 13.1 2.0 15.3 23.4 21.9 57.7 19.9 16.3 27.3 14.0 18.0 27.5 14.2 25.8 16.1 27.6 57.7 10.5 23.0 15.8 34.8 12.0 ECH1 HPXEL ENSG00000104823 "Enoyl-CoA hydratase 1" Q13011 19 38815422-38832005 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002907, HPA005835" Supported Supported Supported Mitochondria No No 5700000 Mitochondria "HPA002907: AB_1847964, HPA005835: AB_1847965" "unprognostic (1.91e-1)" "unprognostic (3.03e-2)" "unprognostic (3.64e-2)" "unprognostic (6.43e-2)" "unprognostic (5.73e-3)" "unprognostic (6.90e-2)" "unprognostic (1.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.43e-1)" "unprognostic (5.86e-2)" "unprognostic (2.24e-1)" "unprognostic (3.37e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.54e-1)" "unprognostic (3.52e-1)" "unprognostic (1.74e-2)" 33.0 52.0 17.6 21.7 20.9 14.7 29.6 11.4 19.8 14.8 34.1 19.5 19.8 25.8 16.8 15.4 30.2 18.9 30.6 130.6 18.6 15.5 40.0 105.8 16.9 19.6 22.2 17.2 16.0 36.5 11.5 11.3 32.8 17.5 20.9 27.1 20.8 27.4 15.2 130.9 18.7 24.4 27.0 13.3 28.1 24.8 26.2 20.6 15.9 24.5 43.5 21.5 21.3 19.3 68.7 60.7 49.9 61.1 61.4 72.6 83.3 12.6 55.6 8.6 14.3 33.7 17.5 12.7 6.2 10.9 5.5 5.6 35.7 25.1 19.8 24.5 14.7 5.0 6.0 14.4 14.9 4.3 68.5 8.0 24.0 16.9 28.8 34.3 25.4 24.3 23.2 38.6 7.2 12.5 10.9 13.0 26.2 11.3 33.1 12.1 23.7 17.7 14.6 5.7 55.9 13.4 20.1 26.0 39.4 34.8 28.8 10.8 13.9 32.7 16.2 17.2 5.8 21.8 57.1 10.9 9.7 8.3 9.6 5.8 25.1 29.1 18.9 14.8 32.8 18.6 49.1 61.1 49.9 51.9 46.8 48.9 68.7 50.9 51.2 60.7 62.2 45.7 51.4 8.1 61.4 38.3 41.4 72.6 83.3 17.6 20.9 11.4 19.8 18.6 15.5 22.2 17.2 17.5 20.6 80.4 82.4 123.2 165.8 73.0 19.3 280.9 234.4 97.7 73.9 137.9 15.7 632.1 432.7 146.8 45.4 83.1 264.9 46.7 80.0 307.0 84.6 125.8 115.7 460.6 245.2 35.0 181.6 92.7 111.3 42.2 121.1 102.2 138.3 289.5 227.3 54.7 110.4 235.9 134.4 659.8 17.5 77.6 99.9 79.1 47.7 79.4 485.8 139.5 278.3 180.2 ECHDC2 FLJ10948 ENSG00000121310 "Enoyl-CoA hydratase domain containing 2" Q86YB7 1 52895910-52927212 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.9" "Cell type enhanced" "Detected in all" 8 "Hepatocytes: 663.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 15.4;HHSteC: 11.1;THP-1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026731, HPA026768" Enhanced Approved Mitochondria NA NA 410000 Mitochondria "HPA026731: AB_1847969, HPA026768: AB_1847970" "unprognostic (2.73e-3)" "unprognostic (1.52e-2)" "unprognostic (4.08e-2)" "unprognostic (3.76e-1)" "unprognostic (7.67e-2)" "prognostic favorable (6.65e-4)" "unprognostic (1.51e-3)" "unprognostic (1.40e-3)" "unprognostic (6.11e-2)" "unprognostic (7.16e-2)" "unprognostic (2.98e-3)" "unprognostic (4.40e-2)" "unprognostic (5.47e-2)" "unprognostic (5.12e-2)" "unprognostic (2.93e-1)" "unprognostic (3.62e-1)" "prognostic favorable (2.70e-4)" 10.2 13.3 4.8 9.3 7.4 3.1 10.3 12.3 2.9 10.0 11.2 2.6 20.3 14.5 10.4 20.5 10.2 9.1 20.7 11.1 4.8 2.6 21.3 74.9 9.2 2.5 2.9 3.6 11.8 9.9 8.4 18.1 4.4 5.3 10.9 3.8 15.9 11.2 25.6 22.2 6.0 13.3 16.2 4.6 3.8 10.2 3.8 4.2 1.8 16.4 11.1 8.1 8.0 10.7 5.2 8.2 1.7 1.8 4.8 11.0 3.8 0.0 1.5 0.0 0.0 1.1 0.5 15.4 1.2 7.1 1.5 2.4 0.0 1.1 0.0 7.1 1.2 0.0 0.8 0.0 1.2 0.3 0.0 7.2 0.0 2.6 3.2 11.1 0.0 2.1 1.6 3.2 1.0 1.1 2.1 4.4 0.0 1.1 0.2 0.0 3.8 0.0 0.8 0.1 6.2 1.6 0.0 0.1 0.6 4.9 6.0 0.7 0.3 2.1 5.6 0.1 0.8 1.1 9.3 1.7 0.0 0.0 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.3 0.0 1.8 1.7 11.0 1.4 8.2 5.2 9.0 10.3 8.2 2.6 10.2 6.2 0.4 4.8 0.7 2.0 10.8 3.8 4.8 7.4 12.3 2.9 4.8 2.6 2.9 3.6 5.3 4.2 50.6 72.4 17.1 77.5 27.2 30.8 55.4 119.8 60.2 70.5 82.0 308.3 162.8 150.9 46.2 111.4 19.6 107.0 46.7 52.0 12.3 46.8 90.9 28.9 663.7 26.8 39.7 50.1 25.8 25.9 134.0 142.6 17.0 38.8 10.0 59.3 58.0 41.0 123.8 105.7 257.8 155.8 19.4 46.6 14.2 12.8 25.7 103.7 39.2 56.8 67.7 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362480-133373689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.2" "Cell type enhanced" "Detected in all" 11 "Hepatocytes: 1338.6;Proximal tubular cells: 2021.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria NA NA 1500000 Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favorable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 36.5 18.7 16.6 9.1 16.6 5.0 15.2 8.2 18.3 8.8 21.8 13.0 34.7 22.8 9.5 14.1 16.5 12.2 17.4 29.8 14.6 11.5 62.1 148.2 6.3 7.8 14.8 10.3 11.6 16.3 9.2 11.0 12.8 11.1 13.9 14.0 11.0 40.2 38.4 35.7 8.8 32.1 9.9 11.9 7.3 11.0 10.2 10.2 3.9 16.2 17.5 13.0 11.2 7.8 39.4 53.7 18.3 45.7 33.5 32.1 44.5 28.9 36.3 19.8 49.3 28.7 18.6 18.1 21.3 28.2 29.8 25.2 79.7 28.1 21.8 18.5 23.9 15.6 27.2 25.7 21.6 21.6 16.7 45.0 21.8 22.0 56.6 24.2 28.1 15.5 20.7 18.7 19.7 25.2 26.5 26.3 15.9 19.6 19.2 28.9 68.6 14.0 55.0 13.8 45.9 43.6 24.2 24.0 11.6 36.8 37.1 12.8 20.3 22.0 36.6 27.7 11.9 28.5 27.2 21.1 13.4 19.5 27.9 28.0 14.4 8.8 24.8 31.9 15.4 11.1 17.0 41.7 18.3 24.9 45.7 32.1 39.4 28.1 27.1 53.7 32.2 28.9 27.9 4.4 33.5 34.3 23.2 26.0 44.5 16.6 16.6 8.2 18.3 14.6 11.5 14.8 10.3 11.1 10.2 41.7 72.4 78.2 79.8 60.7 58.8 224.4 180.9 62.9 56.9 165.7 5.9 406.8 479.1 144.4 24.0 65.0 374.4 46.7 88.5 126.6 74.8 83.9 89.0 1338.6 193.8 42.9 126.4 78.5 88.6 29.7 71.9 72.7 128.2 149.7 152.5 112.9 99.9 252.6 86.3 2021.6 42.1 84.1 76.9 50.6 40.1 66.7 250.1 49.0 276.7 103.8 ECI1 DCI ENSG00000167969 "Enoyl-CoA delta isomerase 1" P42126 16 2239395-2252300 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.3" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 255.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041746, HPA043227" Enhanced Enhanced Mitochondria NA NA 11000000 Mitochondria "HPA041746: AB_10960693, HPA043227: AB_10960273" "unprognostic (4.99e-2)" "prognostic favorable (3.04e-5)" "unprognostic (3.75e-1)" "unprognostic (2.92e-3)" "unprognostic (8.90e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.07e-4)" "unprognostic (1.98e-1)" "unprognostic (2.17e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-2)" "unprognostic (2.66e-2)" "prognostic favorable (8.99e-8)" "unprognostic (2.61e-2)" "unprognostic (3.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.08e-3)" 15.7 12.5 12.5 9.8 10.8 9.1 16.8 12.8 11.3 10.9 27.6 9.7 20.3 30.9 10.6 16.7 15.5 13.4 17.3 56.4 10.1 10.3 36.5 57.4 10.3 10.7 12.4 8.8 10.8 30.4 11.1 11.9 10.6 13.0 13.4 8.4 16.3 40.9 19.1 90.3 10.4 31.2 14.1 10.1 8.0 17.2 8.4 9.6 10.4 38.7 25.4 10.5 14.4 11.5 7.6 6.5 3.9 7.1 5.8 6.7 1.7 7.3 17.7 6.8 27.8 2.6 3.7 25.5 7.4 5.2 6.2 9.1 31.1 22.7 10.7 18.7 4.6 4.4 18.3 7.9 7.1 0.8 18.5 40.7 3.3 16.5 38.4 23.8 9.6 1.5 6.8 16.8 5.1 11.1 4.4 6.1 0.2 17.7 22.7 2.1 30.4 0.9 14.4 15.7 11.9 17.9 33.6 7.3 51.4 11.7 8.4 23.4 14.8 18.1 34.1 22.5 3.5 22.0 17.1 5.0 4.8 18.1 5.2 8.3 25.2 14.8 17.4 6.3 8.9 6.8 3.2 6.8 2.7 3.8 7.1 6.0 7.6 5.5 2.9 5.5 7.4 6.7 5.6 3.9 5.8 4.2 6.5 6.7 1.7 12.5 10.8 12.8 11.3 10.1 10.3 12.4 8.8 13.0 9.6 3.0 23.3 31.8 94.0 18.9 51.2 90.1 94.3 9.4 14.8 73.3 41.2 151.4 255.4 28.6 6.2 23.5 150.2 0.0 31.7 67.6 25.6 72.7 5.7 199.4 41.4 20.6 43.7 26.4 26.7 4.2 22.7 23.7 37.1 14.4 73.5 52.4 28.1 70.2 22.6 187.7 57.7 0.0 30.2 2.5 15.8 19.4 91.9 17.5 89.4 98.4 EEF1G EF1G ENSG00000254772 "Eukaryotic translation elongation factor 1 gamma" P26641 11 62559601-62574086 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 334.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 310.9;Ciliated cells: 275.7;Club cells: 547.1;granulocytes: 349.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040688, HPA055316" Enhanced Approved Mitochondria NA NA 4600000 Mitochondria "HPA040688: AB_10961632, HPA055316: AB_2732593" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (2.44e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-1)" "unprognostic (9.22e-4)" "unprognostic (1.14e-1)" "unprognostic (5.14e-2)" "unprognostic (5.07e-3)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (8.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (6.04e-2)" 46.5 38.1 33.0 41.3 40.0 60.6 84.9 30.4 56.5 53.8 45.4 30.6 29.7 40.9 48.6 43.0 71.1 61.0 35.1 62.2 34.6 24.7 49.4 64.5 41.7 98.8 29.1 31.8 105.3 103.9 29.9 31.7 41.4 51.4 50.4 49.2 29.0 58.9 35.5 207.2 88.5 45.0 38.2 39.6 48.4 45.8 236.9 28.8 43.9 41.1 118.6 70.9 47.7 66.1 203.5 136.9 27.4 83.9 114.5 251.4 334.5 88.9 94.8 99.1 140.2 149.4 193.7 99.4 77.9 141.5 97.8 75.0 105.3 113.3 264.8 124.4 123.9 56.2 105.5 117.1 114.8 89.6 85.1 108.9 69.0 106.6 107.7 162.6 139.0 81.5 221.3 208.1 96.7 237.9 162.2 134.5 93.4 138.1 127.9 115.1 183.7 151.0 248.8 119.4 79.5 83.0 126.5 127.4 251.8 130.4 117.8 85.9 107.0 46.9 159.4 211.8 66.0 182.6 155.2 90.6 56.9 79.8 109.8 67.3 89.6 86.7 132.4 64.6 103.1 79.6 27.4 83.9 21.0 87.3 78.5 173.5 203.5 167.7 112.9 136.9 187.5 251.4 169.1 12.3 114.5 64.0 108.5 119.2 334.5 33.0 40.0 30.4 56.5 34.6 24.7 29.1 31.8 51.4 28.8 140.0 310.9 21.7 1.8 7.0 0.2 0.0 15.3 275.7 547.1 1.8 2.0 15.0 3.3 107.6 3.5 4.3 75.4 0.0 165.8 22.5 5.1 2.5 349.5 4.3 11.2 0.0 142.8 8.6 9.7 16.1 2.8 8.0 1.7 204.6 135.2 0.7 121.7 69.1 2.1 8.2 0.3 0.0 5.1 1.4 0.5 5.4 17.6 20.3 189.4 2.0 EFEMP1 "DHRD, FBLN3, FBNL, MTLV, S1-5" ENSG00000115380 "EGF containing fibulin extracellular matrix protein 1" Q12805 2 55865967-55924139 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016368, HPA049806, HPA070841, HPA071588" Supported Supported Mitochondria "Secreted to extracellular matrix" NA NA 1800000000 Mitochondria "CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: " "unprognostic (8.21e-2)" "unprognostic (7.68e-2)" "unprognostic (9.01e-3)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.43e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-1)" "unprognostic (9.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.89e-8)" "unprognostic (3.15e-3)" "unprognostic (4.94e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (6.68e-5)" 63.1 14.1 13.6 14.1 35.1 0.1 45.5 8.0 12.8 14.8 20.4 22.0 16.6 6.2 20.1 31.9 22.0 38.6 37.1 55.4 8.2 9.7 16.3 3.5 38.5 24.5 12.5 15.5 52.9 10.9 3.3 6.6 84.5 25.8 47.5 22.9 116.9 26.8 40.5 15.6 13.8 12.0 29.9 8.6 10.1 12.6 9.3 13.5 0.9 57.4 18.1 7.3 45.5 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.2 0.4 0.0 20.0 13.0 0.0 12.5 13.4 1.5 1.1 0.0 1.2 0.0 8.1 15.1 1.3 20.9 0.0 15.0 0.5 0.0 0.0 0.0 5.3 0.0 55.0 0.0 0.0 64.6 6.9 1.5 17.2 129.3 263.2 0.0 0.0 0.0 5.6 1.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 17.3 6.5 0.0 0.4 20.2 0.0 233.1 0.1 7.0 25.8 8.0 0.7 0.0 0.0 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 35.1 8.0 8.8 8.2 9.7 12.5 15.5 25.8 13.5 232.3 83.7 0.0 78.5 70.5 1.6 12.3 10.2 99.0 89.9 26.2 0.0 1167.9 8.3 27.4 0.3 12.2 0.0 0.0 23.4 127.3 186.9 9.1 2.3 0.4 83.0 0.0 0.0 68.7 0.6 0.8 39.4 4.3 16.9 1.0 0.0 149.0 2.2 0.0 0.0 6.9 3.9 0.0 22.5 0.0 0.2 27.7 744.0 0.0 0.0 3.9 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein alpha subunit" P13804 15 76215355-76311472 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria NA NA 6300000 Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favorable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 18.8 39.9 12.8 16.4 13.6 10.7 26.1 7.6 13.4 8.6 26.4 7.3 9.6 27.5 10.1 11.1 18.9 7.7 12.6 84.4 13.3 8.5 36.4 78.3 9.8 15.7 11.9 12.9 7.8 28.1 7.6 11.0 24.0 11.8 11.2 26.0 9.4 15.8 10.8 84.0 12.3 29.2 17.3 11.8 11.7 18.5 9.7 10.8 10.8 11.9 37.9 12.8 14.8 11.5 24.6 50.7 25.2 38.8 36.0 29.3 39.4 21.7 35.9 23.8 24.9 26.9 28.7 37.5 26.4 30.5 34.2 30.7 31.8 40.7 36.6 26.5 26.2 25.9 55.9 92.3 36.6 39.9 43.8 18.0 39.8 26.1 36.7 21.9 37.9 29.7 21.4 34.7 17.3 28.9 18.8 34.5 11.8 37.6 38.0 35.0 34.3 7.8 31.7 18.5 40.5 10.8 34.4 29.6 48.9 37.7 70.2 24.9 12.6 39.9 91.2 36.1 57.7 46.9 40.2 20.2 33.4 22.7 29.2 31.8 18.6 38.1 45.1 24.1 50.5 23.6 11.2 38.8 25.2 22.1 34.5 20.8 24.6 20.8 22.7 50.7 20.2 17.0 21.1 9.9 36.0 28.4 20.3 29.3 39.4 12.8 13.6 7.6 13.4 13.3 8.5 11.9 12.9 11.8 10.8 53.6 38.2 49.8 84.3 47.5 12.6 330.7 79.0 33.5 34.2 34.9 21.6 240.1 177.4 96.7 9.4 51.7 207.6 70.0 73.2 147.6 65.4 64.8 37.0 330.0 115.9 50.9 62.8 52.2 76.6 5.4 55.0 77.4 54.0 158.7 117.7 20.6 89.9 152.0 54.8 301.8 18.1 45.3 63.7 39.6 31.3 49.9 251.0 56.8 156.2 138.0 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1022.8;Proximal tubular cells: 1001.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 183.6;OE19: 84.6" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria NA NA 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favorable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favorable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.0 33.8 4.7 12.9 15.0 17.6 7.5 8.9 6.9 7.2 7.2 28.4 21.5 13.1 9.1 14.3 3.8 11.6 9.3 19.0 2.2 19.5 36.2 10.3 20.7 183.6 16.5 9.8 7.7 27.3 5.7 9.8 10.1 9.1 6.1 12.9 15.4 14.7 9.3 26.5 10.2 9.3 3.0 84.6 41.9 11.4 12.6 24.5 9.9 15.0 10.5 5.1 19.7 5.6 10.1 3.5 14.7 9.5 8.6 7.6 7.9 8.1 8.1 22.6 13.7 11.6 38.5 14.6 19.4 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 74.5 84.5 90.8 84.9 57.8 71.3 216.3 254.8 84.3 67.1 115.1 29.5 201.1 484.1 142.6 109.5 67.1 494.9 140.2 122.3 163.1 89.1 73.5 87.6 1022.8 188.0 41.3 161.8 136.9 151.1 228.9 99.5 69.4 271.7 69.5 259.6 93.2 146.4 263.1 107.5 1001.5 53.3 97.0 80.2 54.2 48.9 55.7 133.9 91.6 302.4 92.8 ETHE1 "HSCO, YF13H12" ENSG00000105755 "ETHE1, persulfide dioxygenase" O95571 19 43506719-43527244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.7" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 485.2;Paneth cells: 571.2;Undifferentiated cells: 334.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 49.1;OE19: 77.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028360, HPA029028, HPA029029" Enhanced Enhanced Mitochondria No No 13000 Mitochondria "HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998" "unprognostic (8.04e-2)" "unprognostic (3.33e-1)" "unprognostic (1.50e-2)" "unprognostic (2.45e-1)" "unprognostic (8.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.58e-4)" "unprognostic (7.75e-2)" "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" "unprognostic (2.73e-2)" 7.7 10.5 5.2 28.3 6.3 13.1 8.8 4.5 6.7 10.9 80.7 4.6 9.6 27.4 7.1 12.2 28.2 7.1 18.4 8.9 4.4 4.1 19.0 21.3 11.4 15.5 5.6 4.9 7.4 12.7 3.0 7.2 16.7 5.1 12.0 72.1 5.6 18.5 6.7 9.4 9.1 40.3 11.8 4.5 11.0 13.2 3.3 4.7 12.0 26.2 23.3 24.4 10.9 13.3 7.9 35.8 7.4 24.3 9.9 20.2 15.1 11.5 15.3 3.1 10.9 17.1 11.6 1.2 18.0 49.1 15.5 15.9 4.5 11.8 0.0 13.5 17.2 4.9 9.4 4.5 27.1 4.1 5.8 1.4 2.9 6.6 12.7 7.7 4.3 4.1 11.9 21.3 6.0 16.8 20.5 11.5 11.2 1.9 19.5 7.6 7.8 5.0 4.0 0.8 77.6 7.4 5.7 1.3 2.5 33.7 24.1 0.0 3.9 4.6 16.5 10.8 5.3 5.0 7.2 9.6 2.5 10.7 3.0 3.3 5.5 4.3 0.3 10.9 17.9 12.9 7.4 24.3 0.6 17.2 12.7 20.0 7.9 20.2 16.3 35.8 3.4 15.6 14.8 0.7 9.9 8.5 7.1 19.4 15.1 5.2 6.3 4.5 6.7 4.4 4.1 5.6 4.9 5.1 4.7 20.8 18.9 42.5 70.4 30.7 9.5 8.3 53.5 14.7 17.0 52.4 0.0 162.0 46.4 62.5 0.4 49.6 485.2 0.0 56.4 70.8 54.7 70.7 36.9 78.8 100.9 4.8 61.2 36.8 100.2 1.6 16.4 79.3 75.9 58.7 224.1 9.4 73.6 571.2 15.2 90.3 4.6 19.4 61.2 1.8 5.5 20.3 77.3 53.3 334.8 123.3 EVC2 LBN ENSG00000173040 "EvC ciliary complex subunit 2" Q86UK5 4 5542772-5709548 "Disease related genes, Predicted membrane proteins" "Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 5.5;Fibroblasts: 5.3;Leydig cells: 10.6;Peritubular cells: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.0;BJ hTERT+: 8.9;HHSteC: 12.4;hTERT-HME1: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040910, HPA048122" Uncertain Approved Mitochondria NA NA Mitochondria "HPA040910: AB_2677195, HPA048122: AB_2680272" "unprognostic (6.56e-2)" "unprognostic (6.74e-2)" "unprognostic (5.10e-2)" "unprognostic (2.25e-1)" "unprognostic (8.23e-3)" "unprognostic (2.80e-1)" "unprognostic (2.05e-2)" "unprognostic (1.22e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "unprognostic (8.57e-2)" "unprognostic (9.37e-2)" "prognostic favorable (1.58e-4)" "unprognostic (2.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.61e-2)" "unprognostic (6.29e-5)" 6.9 1.2 1.2 7.6 1.6 0.3 15.7 1.6 1.0 13.2 5.2 1.1 3.4 1.3 14.1 8.5 5.1 6.3 8.2 4.7 1.9 0.7 8.0 1.4 4.1 3.7 1.6 0.5 14.4 5.0 8.1 2.5 2.6 1.3 8.6 1.3 7.7 5.0 4.2 2.8 5.6 2.9 14.2 1.7 3.6 3.5 4.5 0.6 1.1 12.4 3.7 7.9 7.2 24.6 0.8 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.5 0.0 6.1 8.0 9.0 0.0 3.7 8.9 3.3 5.6 0.0 0.0 4.6 0.0 2.9 1.9 2.6 0.0 1.5 3.2 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 5.6 4.2 4.3 9.9 0.0 3.5 0.0 0.0 0.2 4.8 0.0 0.0 0.0 3.6 0.0 0.0 7.6 7.6 0.0 0.3 0.0 0.4 0.6 0.0 0.0 0.0 1.5 0.0 0.5 6.0 0.0 0.0 2.2 0.0 3.8 4.1 1.1 2.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.6 1.6 1.0 1.9 0.7 1.6 0.5 1.3 0.6 0.0 0.3 0.0 3.9 1.9 0.0 0.9 2.5 0.0 1.2 0.0 0.0 5.5 0.0 1.3 1.4 1.0 0.0 0.0 0.4 0.2 5.3 2.2 2.3 0.0 0.5 0.0 0.0 1.8 0.0 0.4 10.6 0.0 0.0 0.0 0.0 1.7 0.8 0.0 7.4 0.6 0.0 0.0 1.9 1.6 2.0 0.6 1.1 0.0 0.0 1.2 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 52.2;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 7.4 9.9 14.1 12.8 14.2 8.1 6.6 18.5 14.1 8.2 8.0 10.5 6.6 5.4 9.7 8.9 5.2 7.4 9.0 22.8 11.7 9.1 7.2 5.8 7.2 12.9 11.1 11.0 8.0 7.4 7.6 16.8 7.3 8.7 9.4 8.2 6.8 5.9 9.3 9.5 4.8 8.1 11.2 8.0 10.8 6.6 9.7 11.2 11.5 8.7 4.0 11.0 9.0 6.4 24.5 6.8 2.1 5.2 12.0 13.6 2.6 3.7 6.7 7.7 6.7 5.2 7.7 3.1 12.0 7.7 10.5 11.8 6.1 3.7 13.0 3.2 4.9 2.9 3.8 9.7 4.2 8.9 14.5 8.7 9.8 10.1 6.3 6.3 10.6 8.2 5.9 4.6 9.3 4.9 4.9 14.1 7.3 4.5 8.6 16.6 2.5 7.4 3.5 7.4 3.2 8.5 4.8 4.3 5.8 5.5 5.1 3.5 1.8 7.4 1.8 3.2 3.6 2.6 5.0 11.7 8.7 6.2 9.3 9.7 4.8 8.2 11.9 6.6 9.1 6.3 0.4 5.0 2.1 13.6 4.4 11.9 24.5 13.0 13.0 3.4 22.4 13.1 13.0 0.2 12.0 5.2 6.8 5.8 2.6 14.1 14.2 18.5 14.1 11.7 9.1 11.1 11.0 8.7 11.2 6.0 5.0 24.1 5.1 2.6 52.2 29.9 12.7 8.1 1.2 10.4 53.0 9.3 0.0 7.6 3.0 9.0 3.9 0.0 4.6 1.1 10.8 4.4 1.1 5.4 5.9 38.1 16.3 8.6 7.0 2.9 25.0 5.6 11.8 8.2 6.9 18.4 5.5 10.1 16.6 2.8 77.1 12.9 11.2 37.0 22.8 0.9 1.6 25.4 9.0 5.0 F7 ENSG00000057593 "Coagulation factor VII" P08709 13 113105788-113120681 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "liver: 68.0" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 131.2" "Cancer enriched" "Detected in some" 17 "liver cancer: 41.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 9 "CACO-2: 16.6;Hep G2: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA004826 Approved Mitochondria "Secreted to blood" NA NA 351000000 1500000000 Mitochondria "HPA004826: AB_10602805" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-3)" "unprognostic (3.81e-1)" "unprognostic (4.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.35e-3)" "unprognostic (3.36e-3)" "unprognostic (1.09e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 68.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.2 0.0 0.5 0.0 0.0 131.2 0.1 0.0 0.0 3.7 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.5 0.0 0.0 FAM136A FLJ14668 ENSG00000035141 "Family with sequence similarity 136 member A" Q96C01 2 70295975-70302090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030103, HPA030104" Enhanced Approved Mitochondria NA NA Mitochondria "HPA030103: AB_10600194, HPA030104: AB_10600534" "unprognostic (2.81e-1)" "unprognostic (5.76e-2)" "unprognostic (9.16e-2)" "unprognostic (3.69e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" "unprognostic (5.91e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (4.95e-3)" "unprognostic (3.03e-1)" "unprognostic (4.03e-1)" "unprognostic (2.00e-3)" 8.9 12.2 16.4 12.9 17.7 13.2 13.0 18.0 16.5 12.4 19.4 6.4 18.4 19.9 13.4 11.8 18.1 11.2 13.7 18.0 13.3 17.5 18.7 26.3 9.1 12.0 15.3 10.3 9.0 53.1 14.0 11.4 15.9 17.6 13.4 21.4 8.8 38.3 17.7 16.6 11.0 23.0 14.9 9.0 17.1 16.7 9.6 7.6 13.6 16.1 14.0 15.7 13.3 11.9 21.8 22.2 17.1 22.9 29.1 19.8 16.0 25.0 22.7 14.2 19.9 7.5 11.2 22.0 13.6 13.0 18.9 13.1 59.7 14.5 17.5 12.4 11.7 16.4 11.8 29.2 10.8 19.4 17.8 33.5 26.6 17.0 37.0 10.8 43.8 17.6 7.6 7.6 17.7 15.1 10.1 20.2 25.4 42.4 14.1 14.0 37.0 28.2 38.3 35.9 34.1 24.7 19.1 26.7 28.6 29.0 17.7 33.5 14.6 10.2 25.0 20.0 13.7 10.3 12.8 12.1 8.1 23.9 12.4 25.8 11.8 18.1 20.2 20.2 25.0 13.7 17.1 16.7 12.1 13.7 22.9 19.8 21.8 15.1 16.1 22.2 18.4 17.6 17.9 1.5 29.1 15.3 14.7 11.8 16.0 16.4 17.7 18.0 16.5 13.3 17.5 15.3 10.3 17.6 7.6 38.7 24.0 49.8 25.7 24.8 22.9 48.4 10.2 34.8 27.3 31.4 23.6 78.4 59.7 64.0 1.0 16.7 50.0 0.0 86.0 86.9 33.9 45.3 27.6 50.4 62.1 7.9 31.6 12.9 19.3 2.3 12.4 29.2 27.0 45.9 49.3 16.1 76.3 56.1 17.3 54.2 18.5 12.9 21.7 9.1 52.8 36.6 24.7 34.1 58.8 40.2 FAM160A2 "C11orf56, DKFZP566M1046, FHIP, FLJ22665, KIAA1759" ENSG00000051009 "Family with sequence similarity 160 member A2" Q8N612 11 6211335-6234711 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055994, HPA063987" Approved Approved Mitochondria NA NA Mitochondria "HPA055994: AB_2682999, HPA063987: AB_2685166" "unprognostic (1.40e-1)" "unprognostic (1.58e-1)" "unprognostic (3.44e-2)" "unprognostic (9.59e-3)" "unprognostic (2.20e-2)" "unprognostic (1.51e-1)" "unprognostic (4.16e-2)" "unprognostic (2.64e-1)" "unprognostic (2.19e-1)" "unprognostic (5.02e-2)" "unprognostic (2.16e-1)" "unprognostic (8.04e-2)" "unprognostic (6.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.64e-1)" "unprognostic (9.58e-2)" "unprognostic (1.85e-1)" 13.6 12.9 11.5 10.5 21.6 29.8 15.6 23.0 23.8 16.6 20.7 15.7 20.5 26.6 19.8 11.7 11.7 18.4 18.6 10.7 9.9 6.0 12.6 17.4 14.1 12.5 12.5 12.3 20.2 21.0 19.6 15.8 10.7 12.0 14.0 22.4 16.1 15.9 15.0 11.3 18.2 25.9 12.9 9.7 12.2 15.9 26.5 9.8 10.5 20.3 9.0 12.8 14.2 14.5 2.8 3.7 6.1 6.0 1.9 6.0 3.1 10.7 10.7 7.5 11.1 10.2 11.1 16.3 6.2 7.5 9.3 8.9 9.1 20.1 8.5 6.9 7.2 15.3 14.3 7.6 11.2 5.7 9.2 10.9 2.8 17.6 4.8 8.4 7.0 9.8 10.0 14.2 8.4 14.9 12.2 9.4 13.3 9.0 10.6 5.8 8.5 6.7 13.6 11.2 14.0 10.1 7.5 3.9 6.8 8.7 7.8 10.1 6.6 8.9 10.6 5.5 8.1 7.2 10.0 8.0 11.5 8.9 17.0 6.5 14.2 12.1 6.4 12.7 5.7 10.1 1.7 6.0 5.9 6.0 2.5 3.7 2.5 2.4 4.4 3.7 2.8 1.9 3.3 6.1 1.9 1.9 1.1 0.4 3.1 11.5 21.6 23.0 23.8 9.9 6.0 12.5 12.3 12.0 9.8 17.9 14.4 13.7 10.9 11.1 13.3 4.1 7.6 12.0 7.9 12.2 15.7 10.6 6.6 9.5 12.0 12.7 61.0 0.0 9.9 8.5 8.9 10.5 6.9 20.2 8.7 6.4 24.0 11.1 16.5 4.5 9.2 9.4 13.5 5.4 31.6 6.8 12.6 40.3 7.1 6.9 22.2 12.9 8.9 27.8 20.7 13.0 9.6 15.0 30.3 7.4 FAM167A C8orf13 ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421463-11474715 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.0;thyroid gland: 51.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 14.9;Distal tubular cells: 11.6;Early spermatids: 17.1;Intestinal endocrine cells: 18.3;Late spermatids: 27.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 24.6;RPMI-8226: 26.0;SH-SY5Y: 19.7;U-698: 19.7;U-87 MG: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria NA NA Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.8 1.6 13.8 1.8 11.2 1.3 2.0 7.1 20.0 1.1 1.4 12.6 0.0 1.1 0.9 1.3 1.4 2.0 1.8 0.9 13.8 7.6 6.6 0.8 10.5 2.8 8.6 11.8 0.8 2.8 0.8 12.3 2.5 12.2 2.1 1.4 0.5 3.3 5.7 0.8 11.8 1.3 0.8 7.0 1.9 2.7 3.2 7.6 0.8 51.1 0.3 3.5 1.3 1.0 4.0 1.3 0.1 1.8 0.9 0.1 0.1 2.0 1.3 2.7 0.2 0.2 1.1 0.0 7.4 7.0 4.5 1.9 0.0 0.6 24.6 0.4 7.9 2.1 0.7 0.0 1.7 5.3 10.6 0.3 0.0 0.0 0.0 9.3 0.0 0.0 1.3 1.1 2.3 14.5 14.5 0.0 0.0 0.1 1.0 2.6 0.7 0.0 0.0 0.7 0.0 0.0 0.1 0.0 26.0 2.3 0.2 11.7 19.7 0.3 2.1 0.9 0.3 0.8 0.0 12.5 0.4 0.7 11.4 0.1 7.9 5.7 19.7 16.3 0.0 0.7 0.1 0.2 0.0 0.0 1.8 0.1 4.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.9 1.7 1.3 0.0 0.1 13.8 11.2 7.1 12.5 13.8 7.6 8.6 11.8 12.2 7.6 14.9 2.6 0.0 0.4 5.3 0.0 0.6 2.5 1.4 0.0 5.2 9.8 0.0 11.6 1.8 17.1 0.0 0.0 0.0 1.7 0.0 0.5 1.1 0.0 0.0 0.1 0.0 18.3 0.0 0.3 27.3 0.3 0.0 0.0 0.0 1.3 1.8 0.9 2.9 0.4 0.0 1.7 0.0 0.0 1.2 2.5 3.0 0.0 0.0 0.0 0.1 FAM92A "FAM92A1, FLJ38979" ENSG00000188343 "Family with sequence similarity 92 member A" A1XBS5 8 93698561-93731527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.0" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 46.8;Distal tubular cells: 34.9;Proximal tubular cells: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034760, HPA058942" Enhanced Approved Mitochondria NA NA Mitochondria "HPA034760: AB_10599947, HPA058942: AB_2732628" "unprognostic (2.65e-3)" "unprognostic (6.81e-2)" "unprognostic (2.48e-3)" "unprognostic (2.44e-1)" "unprognostic (1.62e-2)" "unprognostic (2.93e-1)" "unprognostic (3.56e-1)" "unprognostic (3.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (2.28e-3)" "unprognostic (1.97e-1)" "unprognostic (1.71e-1)" "unprognostic (6.85e-3)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (3.07e-2)" 11.2 13.3 15.9 4.2 14.7 2.8 8.4 13.6 19.1 9.4 7.0 2.9 5.5 2.8 12.0 19.9 5.5 10.1 10.5 16.3 12.9 11.2 15.3 11.4 7.1 4.2 8.4 15.9 13.8 15.1 15.2 21.6 7.5 9.7 9.8 4.8 5.2 3.3 9.2 6.9 5.1 4.1 11.1 6.2 3.7 5.4 71.0 6.4 1.8 9.4 3.1 2.7 11.6 10.6 0.9 6.2 0.3 3.8 2.8 1.6 1.0 13.6 7.3 19.7 20.3 21.3 30.6 5.3 12.5 18.3 17.0 16.4 1.3 3.1 1.1 16.3 18.4 19.5 9.8 19.9 11.9 15.4 0.4 11.0 8.0 7.3 6.7 24.5 0.3 2.0 19.3 5.3 16.6 13.6 24.5 18.1 6.7 4.7 0.6 13.3 5.1 8.4 1.4 8.3 0.3 0.4 0.8 14.8 0.2 13.3 3.1 5.7 7.3 9.0 0.1 15.1 9.3 3.0 4.2 10.0 16.7 6.7 17.3 10.1 0.9 0.9 0.4 14.6 1.1 5.8 0.3 3.8 0.0 0.4 2.2 0.5 0.9 1.1 0.4 6.2 0.2 0.2 0.7 0.1 2.8 0.3 0.8 1.6 1.0 15.9 14.7 13.6 19.1 12.9 11.2 8.4 15.9 9.7 6.4 8.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 46.8 15.9 7.0 0.0 10.8 34.9 16.9 0.0 0.0 0.0 0.0 14.8 11.6 0.0 0.0 3.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 0.0 0.0 14.6 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 FASTKD2 KIAA0971 ENSG00000118246 "FAST kinase domains 2" Q9NYY8 2 206765357-206792509 "Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067191 Supported Mitochondria NA NA Mitochondria "HPA067191: AB_2685801" "unprognostic (1.19e-1)" "unprognostic (2.45e-1)" "unprognostic (3.50e-3)" "unprognostic (1.36e-3)" "unprognostic (7.40e-2)" "unprognostic (2.69e-3)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.69e-2)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.32e-2)" "unprognostic (4.87e-2)" "unprognostic (7.18e-2)" "unprognostic (1.03e-3)" "unprognostic (3.57e-2)" 17.2 20.0 12.8 11.2 24.2 9.4 17.1 18.7 23.9 15.5 15.0 9.0 13.1 14.1 19.7 12.7 20.9 15.5 11.2 23.9 12.1 8.4 19.0 27.4 12.8 12.4 10.4 18.1 16.9 15.1 16.6 29.4 12.3 21.2 13.5 17.0 10.3 15.5 11.5 42.0 17.1 14.5 15.6 11.0 14.0 16.3 10.8 11.8 14.2 17.7 19.4 16.0 16.7 14.2 13.4 19.6 5.1 13.9 19.2 19.5 12.8 14.7 13.5 12.6 14.3 14.4 17.3 23.6 17.2 14.6 29.6 16.9 23.9 16.2 18.6 19.4 18.0 34.2 20.2 15.7 24.3 26.3 5.7 10.2 14.5 13.9 23.0 17.5 31.3 13.6 18.5 24.9 22.5 24.7 15.0 19.9 13.7 27.3 9.4 21.7 12.6 13.2 13.3 22.5 13.9 25.9 11.6 19.6 19.0 20.5 24.7 18.4 11.8 13.3 22.6 20.5 19.7 10.6 16.4 15.4 18.1 16.2 12.4 17.9 9.5 15.7 24.0 21.0 14.6 14.9 5.1 13.9 3.2 13.1 13.5 14.4 13.4 14.6 13.7 19.6 10.8 19.5 17.5 0.8 19.2 9.8 9.4 11.3 12.8 12.8 24.2 18.7 23.9 12.1 8.4 10.4 18.1 21.2 11.8 26.8 10.7 17.1 24.7 21.1 17.4 21.4 7.6 14.7 13.6 12.2 21.6 24.0 8.3 16.4 17.3 14.1 7.3 0.0 13.1 18.5 14.3 10.5 4.7 16.6 13.2 6.4 7.0 11.1 4.7 5.1 8.9 8.9 5.0 11.8 9.0 10.9 11.2 10.4 13.1 10.2 21.6 12.9 15.6 18.9 11.9 18.7 21.5 15.0 11.0 21.3 FBP1 FBP ENSG00000165140 "Fructose-bisphosphatase 1" P09467 9 94603133-94640249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 248.1;lung: 87.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 322.6;Proximal tubular cells: 631.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 73.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005857, HPA012513, CAB033869" Enhanced Approved Mitochondria NA NA 23000000 Mitochondria "CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (1.40e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.13e-2)" "unprognostic (1.37e-1)" "prognostic favorable (1.79e-4)" "unprognostic (6.94e-3)" "unprognostic (4.52e-2)" "unprognostic (7.79e-2)" "unprognostic (7.59e-2)" "unprognostic (1.12e-1)" "prognostic favorable (6.86e-7)" "unprognostic (6.91e-2)" "unprognostic (3.22e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.64e-5)" 19.3 5.8 0.6 2.3 0.9 1.1 7.0 0.4 0.8 2.2 48.8 0.7 17.6 40.7 0.6 2.5 0.7 0.9 9.7 1.3 0.8 0.5 34.6 248.1 87.8 8.9 0.9 0.7 1.0 8.1 17.1 1.9 1.0 1.0 6.4 3.0 1.5 9.1 17.7 0.5 1.7 60.4 3.1 1.2 2.8 10.4 1.0 0.8 0.5 4.3 1.0 1.1 22.4 9.6 0.6 17.1 73.5 30.7 2.8 3.3 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.3 5.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 64.2 0.0 1.1 0.2 10.4 2.3 0.0 0.2 0.4 0.0 42.1 0.2 1.2 0.1 12.3 0.0 0.2 7.3 1.8 0.0 0.0 0.2 0.2 0.0 0.0 0.2 30.5 0.0 0.3 0.0 10.6 13.0 73.5 1.5 30.7 2.3 0.6 0.9 0.9 17.1 0.6 3.3 1.6 2.3 2.8 16.3 6.1 0.4 5.2 0.6 0.9 0.4 0.8 0.8 0.5 0.9 0.7 1.0 0.8 71.5 142.5 10.2 6.5 0.7 0.0 0.6 107.0 13.4 68.2 59.3 0.0 9.7 94.5 14.4 0.0 1.8 32.6 23.3 56.4 1.6 1.7 17.4 45.2 322.6 187.5 0.0 30.7 11.1 49.8 0.8 1.4 103.2 11.8 0.0 49.9 2.1 23.8 68.4 3.9 631.0 0.0 6.5 1.2 0.6 0.1 0.9 8.5 13.1 59.5 51.2 FBXL12 "Fbl12, FLJ20188" ENSG00000127452 "F-box and leucine rich repeat protein 12" Q9NXK8 19 9810267-9827816 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002843 Approved Mitochondria NA NA Mitochondria "HPA002843: AB_2666679" "unprognostic (7.65e-2)" "unprognostic (5.88e-2)" "unprognostic (7.72e-2)" "unprognostic (3.82e-2)" "unprognostic (8.21e-2)" "prognostic favorable (3.21e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.38e-3)" "unprognostic (1.49e-2)" "unprognostic (4.07e-3)" "unprognostic (9.28e-3)" "unprognostic (1.41e-1)" "unprognostic (1.36e-1)" "unprognostic (2.61e-1)" "unprognostic (4.77e-3)" 14.3 10.4 6.6 12.4 9.8 25.1 16.3 12.2 12.6 14.7 16.8 10.5 8.6 16.2 18.6 18.7 13.2 17.0 15.6 12.1 6.9 7.1 12.0 15.3 14.8 14.1 8.8 8.7 19.3 12.4 8.2 13.4 16.3 10.5 16.5 11.7 10.0 9.9 17.8 17.3 11.3 18.6 14.5 6.7 13.9 12.9 11.8 7.6 87.9 13.5 9.2 12.7 17.8 13.4 19.0 17.1 27.3 14.7 22.5 18.4 11.6 9.5 4.8 11.3 10.7 12.8 11.4 12.7 10.3 10.7 11.3 13.5 14.7 6.4 9.0 16.7 10.4 8.8 9.1 8.4 9.1 9.0 8.9 16.2 17.2 9.6 14.6 16.6 12.4 10.7 16.3 6.2 10.9 9.7 8.3 8.1 23.4 13.0 18.7 5.9 7.6 18.4 38.6 12.8 5.8 9.1 10.8 8.3 16.2 8.0 13.0 6.9 9.5 7.6 5.7 11.8 10.8 7.8 14.8 9.2 15.6 7.5 20.8 10.1 25.3 9.8 13.9 6.6 11.3 7.3 20.8 14.7 27.3 15.9 12.1 18.2 13.6 15.6 18.3 16.6 19.0 18.4 14.5 10.9 22.5 11.3 17.1 16.5 11.6 6.6 9.8 12.2 12.6 6.9 7.1 8.8 8.7 10.5 7.6 6.0 8.6 10.9 13.9 6.5 7.3 20.7 7.6 6.7 7.9 12.2 3.9 36.4 5.0 9.9 1.1 18.8 27.5 0.0 8.5 25.3 20.3 11.5 3.5 6.6 14.9 7.9 12.1 14.7 8.9 2.1 24.5 10.8 10.1 22.6 15.0 8.6 8.0 18.1 20.5 7.9 10.5 12.9 20.4 20.4 18.1 9.7 53.0 17.5 16.9 18.7 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141988-117190531 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 78.4" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 208.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 8.1 29.4 17.8 8.8 21.6 5.2 11.4 27.0 28.0 12.6 10.5 18.8 25.5 10.6 16.1 70.1 10.2 78.4 14.2 18.9 17.9 18.4 33.3 17.0 11.2 8.2 13.5 21.4 38.8 19.0 17.3 18.8 12.3 17.5 17.4 9.8 14.0 10.7 19.8 16.3 11.8 9.5 12.8 17.0 11.6 11.8 27.8 14.2 9.9 19.1 6.9 9.3 12.7 10.2 12.8 8.5 3.7 10.5 9.2 13.0 7.1 9.5 22.8 14.4 7.9 11.9 12.4 16.5 12.8 14.0 12.1 9.9 14.7 6.8 12.6 12.7 13.1 9.0 13.1 16.9 12.8 14.6 7.1 15.1 0.6 12.6 11.8 10.8 4.1 4.5 12.2 12.4 9.6 15.5 19.8 16.8 11.2 5.0 4.2 10.3 15.6 11.6 2.9 21.5 14.7 14.9 13.8 20.9 13.2 12.1 22.9 28.6 17.3 32.1 8.5 6.9 12.1 19.9 1.6 12.9 8.1 10.4 9.4 8.3 7.4 7.6 16.5 11.7 6.4 11.2 1.1 5.8 3.7 10.7 10.5 11.2 9.8 11.3 11.1 8.5 12.8 13.0 11.7 0.5 9.2 10.1 5.8 11.4 7.1 17.8 21.6 27.0 28.0 17.9 18.4 13.5 21.4 17.5 14.2 29.8 27.8 27.2 40.8 33.1 41.6 47.8 30.6 36.1 45.5 48.8 39.3 49.4 38.1 52.1 35.4 34.8 15.1 0.0 44.6 30.7 30.8 42.7 3.5 35.9 13.3 69.9 37.5 41.1 21.5 46.7 92.3 14.7 21.9 16.2 24.9 57.0 28.8 17.5 208.9 69.6 32.7 103.5 45.3 20.0 40.5 39.5 54.8 27.7 25.9 40.4 FBXW5 "DKFZP434B205, Fbw5, MGC20962" ENSG00000159069 "F-box and WD repeat domain containing 5" Q969U6 9 136940435-136944696 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 460.8;Late spermatids: 1531.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046615 Approved Approved Mitochondria No No Mitochondria "HPA046615: AB_10965648" "unprognostic (1.11e-1)" "unprognostic (1.10e-2)" "unprognostic (1.56e-2)" "prognostic favorable (1.02e-4)" "unprognostic (4.26e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-2)" "unprognostic (7.16e-3)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (3.51e-3)" "unprognostic (3.23e-2)" "prognostic favorable (4.74e-4)" "unprognostic (1.73e-2)" "unprognostic (3.64e-1)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" 17.6 13.9 13.3 12.4 14.4 14.7 11.8 11.2 24.3 9.8 17.0 9.6 12.7 23.7 11.1 11.8 19.5 8.5 15.9 30.7 15.3 9.6 13.4 31.0 9.0 10.8 11.8 10.9 8.4 25.9 8.8 10.5 12.8 12.0 13.7 7.5 9.3 25.7 16.1 68.2 11.5 23.4 18.2 6.5 12.7 16.4 67.8 9.6 16.2 12.8 17.3 16.0 14.4 11.6 16.3 38.7 33.0 28.4 20.1 41.2 26.0 15.1 26.3 6.0 14.7 14.7 9.6 35.8 15.9 10.9 11.1 6.1 17.5 19.8 10.4 18.4 16.2 8.7 20.0 5.4 13.8 1.8 13.9 18.3 9.0 35.9 18.0 16.3 13.1 23.3 11.0 12.4 10.1 8.4 8.9 11.3 8.1 17.5 17.2 8.3 40.1 10.2 15.7 11.1 18.4 28.8 11.5 9.2 18.9 9.6 15.5 12.7 12.8 19.6 21.2 21.1 2.4 24.4 20.7 21.9 16.6 15.0 30.9 13.7 14.4 17.1 6.9 22.6 11.7 12.5 19.6 24.8 33.0 41.2 28.4 31.3 16.3 31.3 34.5 23.3 12.9 14.0 23.2 13.1 20.1 21.9 38.7 36.3 26.0 13.3 14.4 11.2 24.3 15.3 9.6 11.8 10.9 12.0 9.6 17.9 47.9 36.0 34.0 25.4 26.7 73.4 48.4 13.4 19.4 22.7 15.7 58.4 63.0 97.4 460.8 47.6 329.2 0.0 129.2 114.9 40.1 69.0 28.8 95.6 79.2 57.2 64.6 41.1 51.5 1531.1 47.8 44.4 65.8 159.7 119.4 39.5 113.5 143.8 66.8 98.2 31.7 58.2 56.1 189.9 37.9 31.5 84.8 55.4 85.6 54.2 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429883-110464881 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.9;seminal vesicle: 55.6" "Cell type enhanced" "Detected in all" 11 "Syncytiotrophoblasts: 953.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favorable (3.58e-7)" "prognostic favorable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 5.5 113.9 3.9 4.7 4.5 3.9 5.6 2.7 4.0 3.2 7.5 5.2 33.7 7.9 3.2 3.9 5.1 3.0 5.6 9.6 3.6 4.3 10.7 22.8 7.8 4.7 4.5 2.5 3.5 8.6 3.5 3.7 48.4 3.1 4.8 4.2 4.2 4.1 55.6 7.3 3.3 12.3 3.6 3.4 3.9 5.0 5.3 2.6 5.2 8.7 5.0 3.5 5.6 5.4 10.7 6.9 3.4 5.8 4.4 8.7 2.9 5.4 3.8 5.8 6.4 5.7 10.2 13.1 5.0 6.1 4.4 7.5 12.9 9.1 12.7 14.8 6.4 7.9 6.4 6.8 7.5 6.1 12.1 8.6 6.4 6.7 7.9 10.1 6.7 10.5 17.7 6.3 4.0 9.6 7.7 9.0 8.8 6.4 18.9 9.4 6.0 9.5 14.9 5.2 10.3 7.2 14.0 5.6 11.7 9.6 9.8 8.0 4.1 9.5 10.9 6.3 7.1 6.4 4.6 5.3 4.5 5.5 5.4 5.3 4.3 3.3 38.1 3.4 13.7 5.7 1.8 5.7 3.4 5.3 4.2 5.8 10.7 7.3 7.4 6.9 7.5 8.6 6.1 0.7 4.4 5.8 5.3 8.7 2.9 3.9 4.5 2.7 4.0 3.6 4.3 4.5 2.5 3.1 2.6 17.9 39.7 88.0 75.8 60.8 27.9 46.0 104.4 6.7 9.1 76.8 7.9 144.7 207.2 62.6 22.7 33.8 131.1 46.7 128.1 138.7 46.5 71.9 46.0 160.8 108.7 39.7 46.0 33.7 54.7 7.0 43.4 60.1 65.8 51.3 45.4 26.2 79.9 67.0 42.8 255.2 15.0 25.8 42.6 41.2 70.7 85.2 953.0 57.5 77.9 120.2 FDXR ADXR ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 93.9" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 47.2;Syncytiotrophoblasts: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 30.1;Hep G2: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favorable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 1.7 93.9 2.6 2.1 3.1 1.3 1.8 8.4 2.7 2.1 4.6 3.2 6.4 2.6 2.6 23.8 8.7 6.6 6.1 1.9 3.4 1.7 2.7 4.1 4.4 1.7 2.9 3.5 7.1 3.9 2.3 1.5 2.6 3.6 3.3 2.1 0.9 5.3 4.2 7.9 5.6 2.5 2.0 4.4 9.7 2.2 32.1 3.0 3.9 2.0 7.7 3.7 3.0 3.0 5.4 7.4 4.8 6.4 10.0 15.2 5.6 4.0 21.6 3.2 3.6 2.3 3.1 30.1 4.8 5.3 2.9 5.8 6.0 3.5 9.6 0.8 2.0 1.6 8.3 2.3 6.0 0.8 9.1 5.0 7.3 3.5 55.1 6.5 1.6 25.5 10.1 6.8 3.0 1.0 2.3 14.7 3.6 11.5 1.6 4.4 17.1 6.2 3.3 1.8 3.8 4.7 3.4 5.4 5.1 2.4 6.8 1.7 4.0 3.3 7.2 3.5 3.8 15.7 1.5 6.8 2.0 17.9 3.1 2.4 4.4 0.7 2.1 5.4 2.5 6.7 1.8 6.4 4.8 6.2 4.3 5.3 5.4 5.6 7.3 7.4 2.8 4.9 6.1 2.1 10.0 3.2 1.4 15.2 5.6 2.6 3.1 8.4 2.7 3.4 1.7 2.9 3.5 3.6 3.0 3.0 4.6 3.7 12.8 8.7 4.9 3.4 5.1 21.4 5.7 8.7 3.9 47.2 5.0 9.7 5.2 2.8 14.8 0.0 6.8 14.1 6.1 4.3 5.7 12.5 18.6 3.2 6.8 12.3 4.6 12.2 5.5 3.6 5.0 3.6 10.8 10.9 8.3 21.0 4.2 16.3 4.9 0.0 6.4 7.1 7.6 15.8 38.6 8.5 17.6 13.1 FGFR1OP2 DKFZp564O1863 ENSG00000111790 "FGFR1 oncogene partner 2" Q9NVK5 12 26938383-26966650 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038308, HPA038696" Supported Approved Mitochondria NA NA Mitochondria "HPA038308: AB_10672524, HPA038696: AB_10675948" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (1.95e-1)" "unprognostic (2.34e-1)" "unprognostic (4.01e-2)" "unprognostic (1.19e-1)" "unprognostic (4.37e-3)" "unprognostic (1.72e-1)" "unprognostic (8.17e-2)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (1.55e-2)" "unprognostic (6.82e-2)" "unprognostic (1.40e-1)" "unprognostic (5.33e-2)" "unprognostic (1.36e-2)" 22.4 32.2 25.5 21.4 30.5 38.5 19.9 20.8 40.1 20.4 18.1 18.2 13.8 16.9 24.0 23.0 17.5 17.9 21.9 23.5 26.9 21.0 23.4 20.5 20.1 28.5 24.7 28.5 46.6 11.6 16.4 30.7 19.8 25.6 17.0 15.4 12.1 14.5 14.9 18.7 17.4 16.9 20.4 32.5 23.3 14.8 16.7 25.7 30.4 18.3 16.3 22.1 20.3 21.6 12.5 13.4 34.0 17.3 13.3 31.8 12.7 11.5 14.1 12.2 16.4 21.1 15.4 17.6 20.3 23.6 15.6 17.1 22.1 13.5 17.0 10.0 17.7 15.0 12.3 8.4 15.1 22.3 12.7 12.1 28.8 15.8 14.7 25.0 16.4 22.1 11.1 9.9 19.0 24.8 21.5 22.3 15.5 17.0 13.1 18.2 13.7 21.8 40.7 20.1 15.0 23.6 13.2 33.7 14.2 13.8 14.2 3.7 7.4 23.0 8.6 19.7 29.4 15.3 25.5 24.2 21.0 21.0 38.2 18.7 9.2 9.3 36.1 17.5 19.4 16.9 34.0 17.3 20.9 18.2 16.2 16.4 12.5 19.2 17.5 13.4 10.4 17.9 19.3 17.5 13.3 15.3 11.2 31.8 12.7 25.5 30.5 20.8 40.1 26.9 21.0 24.7 28.5 25.6 25.7 35.7 30.4 58.0 54.3 124.7 52.2 41.1 12.7 21.4 51.2 26.2 72.6 36.4 61.3 26.5 13.6 75.5 17.5 116.8 20.3 31.3 77.3 39.0 57.8 25.1 53.4 55.6 25.8 59.5 52.7 12.7 97.5 56.4 84.4 35.1 20.1 59.9 24.4 25.9 160.5 49.5 44.4 45.3 78.4 32.9 69.0 104.6 49.8 105.0 18.4 59.2 FH fumarase ENSG00000091483 "Fumarate hydratase" P07954 1 241497603-241519761 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Tricarboxylic acid cycle" Lyase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 161.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017785, HPA025770, HPA025948, HPA027341" Enhanced Supported Enhanced Mitochondria NA NA 2800000 Mitochondria "CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222" "unprognostic (1.03e-2)" "unprognostic (3.82e-2)" "unprognostic (9.46e-3)" "unprognostic (2.18e-1)" "unprognostic (2.10e-1)" "unprognostic (2.07e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-1)" "unprognostic (5.14e-2)" "unprognostic (1.85e-2)" "unprognostic (1.27e-2)" "unprognostic (1.09e-1)" "prognostic favorable (2.76e-7)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (4.41e-2)" "unprognostic (1.24e-2)" 14.3 28.1 15.7 10.4 20.2 9.3 13.3 15.7 24.4 10.5 22.7 9.9 16.7 23.2 13.7 10.7 17.7 10.3 9.5 59.0 22.9 13.9 35.0 93.4 9.9 13.3 15.2 19.4 9.4 13.9 25.2 11.4 14.3 18.4 12.3 24.4 10.2 18.4 20.6 65.1 13.4 21.4 14.7 14.4 11.1 17.5 14.0 11.7 13.8 12.3 45.2 13.4 13.4 11.2 16.0 26.4 4.5 18.8 10.4 13.9 8.9 29.3 24.6 23.3 21.0 22.9 27.1 37.0 36.4 28.5 41.1 25.8 35.1 18.3 18.6 24.1 27.8 18.0 41.8 35.6 27.0 35.8 21.3 11.5 17.5 26.0 30.0 20.6 40.8 15.9 19.6 16.9 23.0 26.0 14.4 25.2 41.2 53.1 24.1 29.9 14.6 35.1 27.3 24.8 42.8 52.8 29.1 25.5 83.6 39.6 24.9 30.0 26.0 30.6 36.3 23.2 16.8 27.7 27.7 24.8 18.5 23.8 32.6 60.5 21.6 23.1 22.6 20.6 46.9 26.5 4.5 12.8 2.7 9.7 18.8 12.6 16.0 11.4 9.0 26.4 14.1 13.9 12.7 0.7 10.4 15.7 13.2 13.2 8.9 15.7 20.2 15.7 24.4 22.9 13.9 15.2 19.4 18.4 11.7 35.7 27.5 27.0 18.6 17.7 23.0 151.3 33.1 30.8 22.7 22.7 13.7 91.1 66.3 49.6 161.2 17.9 46.4 23.3 39.2 43.6 21.6 16.1 18.5 73.1 45.3 33.4 17.2 11.6 12.6 20.1 22.2 26.8 23.6 29.7 35.6 28.0 29.4 35.1 25.1 58.8 32.6 38.8 21.7 82.8 44.5 16.3 138.9 12.9 60.7 16.3 FIS1 "CGI-135, Fis1, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017430 Approved Supported Mitochondria NA NA 590000 Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favorable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 35.1 46.8 53.4 22.3 49.9 32.7 35.8 26.0 60.0 30.3 34.4 57.9 38.0 30.0 31.1 42.7 35.6 47.0 39.4 78.6 52.6 44.8 39.6 58.3 27.8 23.6 65.3 37.8 41.2 56.6 39.5 37.1 34.0 45.1 29.3 26.3 28.8 45.2 43.8 120.5 29.7 29.2 32.4 87.9 28.1 31.1 30.4 44.1 21.3 47.1 48.8 22.6 30.5 29.3 73.0 73.4 63.6 67.4 55.6 72.8 87.9 25.0 29.5 22.1 31.7 25.6 34.2 15.1 27.2 33.1 24.9 21.5 20.3 41.2 24.5 36.3 37.3 22.8 14.8 15.4 43.9 13.9 19.0 22.4 11.1 42.9 26.9 30.5 20.7 17.3 32.6 41.4 17.3 26.7 28.0 44.9 13.6 23.3 33.7 37.4 115.0 32.2 37.4 24.5 50.6 28.7 15.8 12.4 53.8 37.6 29.0 28.7 33.6 13.0 62.5 18.4 20.3 20.8 23.5 36.8 29.2 18.8 30.2 28.9 28.6 21.8 14.1 27.1 23.6 38.1 58.9 67.4 63.6 63.2 65.5 65.1 72.2 61.0 59.7 73.4 73.0 60.7 63.5 51.4 55.6 59.0 61.4 72.8 87.9 53.4 49.9 26.0 60.0 52.6 44.8 65.3 37.8 45.1 44.1 95.3 100.9 113.2 110.6 93.2 42.7 311.2 216.6 109.7 67.1 218.1 15.7 209.3 475.9 225.3 158.1 164.5 399.5 537.3 254.1 253.9 149.0 192.6 133.9 365.3 254.4 33.4 210.7 152.2 158.6 575.1 179.5 136.4 207.5 212.0 223.3 159.0 210.6 475.1 168.3 613.6 43.3 97.0 162.7 157.3 182.7 118.6 271.1 129.8 226.8 173.1 FKBP10 "FKBP6, FLJ20683, FLJ22041, FLJ23833, hFKBP65" ENSG00000141756 "FK506 binding protein 10" Q96AY3 17 41812680-41823217 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isomerase, Rotamase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 83.0;Leydig cells: 43.4;Peritubular cells: 42.1;Sertoli cells: 58.2;Smooth muscle cells: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051171, HPA057021" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA 5500 Mitochondria "HPA051171: AB_2681371, HPA057021: AB_2683312" "unprognostic (8.30e-2)" "prognostic unfavorable (4.16e-4)" "unprognostic (9.05e-2)" "unprognostic (1.71e-2)" "unprognostic (4.77e-2)" "unprognostic (2.95e-2)" "unprognostic (1.14e-2)" "unprognostic (9.98e-2)" "unprognostic (2.21e-2)" "unprognostic (7.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.34e-2)" "unprognostic (5.77e-2)" "prognostic unfavorable (3.43e-5)" "prognostic unfavorable (4.99e-4)" 16.9 16.5 6.6 13.2 7.2 0.2 14.9 3.4 8.4 43.0 11.5 6.0 15.8 3.8 42.7 39.0 14.0 21.4 28.6 19.2 5.6 3.6 10.3 3.2 16.2 17.1 5.3 6.7 35.5 13.5 24.7 22.7 33.8 5.2 21.3 5.7 17.1 6.5 17.0 9.6 8.8 7.6 27.9 5.5 7.9 8.5 15.1 5.7 1.2 16.9 9.5 8.1 24.4 19.2 0.3 0.0 0.0 0.0 2.0 0.9 0.1 0.0 16.2 15.0 49.1 52.8 61.7 13.2 66.9 67.0 25.2 21.8 8.4 0.6 0.0 0.9 72.6 6.4 0.1 8.9 17.8 10.7 4.4 13.5 6.4 18.3 24.0 57.7 0.0 0.0 66.2 0.0 20.6 15.8 48.4 21.4 0.0 0.2 2.3 21.0 21.1 0.0 0.0 11.7 34.3 5.5 1.3 17.7 2.1 4.3 0.0 3.7 13.1 0.1 48.1 22.4 19.8 7.5 0.4 24.2 30.4 15.8 20.2 10.2 0.1 0.0 0.0 41.7 0.0 29.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.9 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.1 6.6 7.2 3.4 5.8 5.6 3.6 5.3 6.7 5.2 5.7 0.0 7.4 0.0 10.9 7.6 0.8 1.6 2.5 0.0 2.3 0.0 0.0 6.3 0.0 8.8 0.5 23.9 0.0 0.0 4.2 23.1 83.0 4.1 0.0 0.0 4.2 14.3 0.0 34.4 0.0 1.9 43.4 2.2 15.1 0.0 1.4 29.2 3.0 0.0 42.1 0.0 1.0 58.2 43.4 0.5 8.3 4.4 10.0 0.0 0.6 1.7 FMC1 "C7orf55, HSPC268" ENSG00000164898 "Formation of mitochondrial complex V assembly factor 1 homolog" Q96HJ9 7 139339457-139346319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 68.3;Collecting duct cells: 80.3;Distal tubular cells: 169.1;Proximal tubular cells: 98.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045663, HPA050553" Approved Approved Mitochondria NA NA Mitochondria "HPA045663: AB_2679410, HPA050553: AB_2681173" "unprognostic (3.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.69e-1)" "unprognostic (3.80e-2)" "unprognostic (8.90e-2)" "unprognostic (9.00e-2)" "unprognostic (4.39e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.19e-1)" "prognostic favorable (5.63e-6)" "unprognostic (1.04e-3)" "unprognostic (2.39e-2)" "prognostic favorable (2.05e-5)" "unprognostic (1.50e-1)" "unprognostic (3.40e-2)" "unprognostic (4.67e-1)" "unprognostic (3.02e-2)" 9.2 9.7 11.2 6.0 16.9 7.0 10.2 6.2 18.6 8.4 8.8 7.2 15.1 8.4 7.1 13.6 6.5 11.5 9.7 26.7 10.3 10.0 12.2 17.5 7.2 7.9 12.8 10.2 10.6 22.1 5.5 10.7 4.4 12.2 12.9 6.2 7.1 14.2 13.2 28.3 5.2 6.0 8.1 9.2 6.0 8.7 6.4 11.9 5.3 15.4 18.7 4.0 7.9 10.9 15.9 15.0 7.4 7.7 10.4 12.1 5.3 2.4 9.1 5.4 5.6 2.9 2.5 2.2 0.8 2.3 6.3 4.6 3.0 3.3 5.9 5.5 2.7 5.8 2.0 5.1 2.2 1.4 2.9 30.8 3.0 9.3 12.7 6.1 2.4 4.0 6.3 4.4 2.0 1.7 2.4 4.8 3.9 5.6 8.6 3.5 17.6 5.8 14.6 5.1 4.2 13.1 3.5 2.7 7.6 4.9 2.3 10.2 6.8 2.8 2.3 3.8 0.9 1.1 1.8 2.3 2.2 2.1 2.7 2.3 3.0 2.9 6.5 5.4 5.3 3.6 7.4 7.7 7.4 8.3 4.6 7.4 15.9 10.3 8.3 8.4 14.6 12.1 8.7 3.5 10.4 5.0 15.0 11.3 5.3 11.2 16.9 6.2 18.6 10.3 10.0 12.8 10.2 12.2 11.9 41.7 34.6 0.0 0.0 0.0 0.0 0.0 0.0 68.3 36.4 80.3 0.0 54.8 169.1 29.3 0.0 0.0 0.0 0.0 30.9 18.2 0.0 0.0 11.6 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 22.6 0.0 0.0 24.3 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 FN3K ENSG00000167363 "Fructosamine 3 kinase" Q9H479 17 82735575-82751197 "Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 45.2;Distal tubular cells: 76.3;Rod photoreceptor cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 17.8;Hep G2: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059151, HPA061358" Supported Approved Mitochondria NA NA 1400000 Mitochondria "HPA059151: AB_2683931, HPA061358: AB_2684490" "unprognostic (4.74e-2)" "unprognostic (9.19e-2)" "unprognostic (4.22e-2)" "prognostic favorable (1.10e-4)" "unprognostic (6.10e-2)" "unprognostic (1.39e-1)" "unprognostic (6.45e-2)" "unprognostic (9.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.61e-1)" "prognostic favorable (2.40e-4)" "unprognostic (6.66e-2)" "prognostic favorable (1.39e-6)" "unprognostic (2.68e-2)" "unprognostic (8.02e-2)" "unprognostic (4.77e-1)" "unprognostic (1.22e-2)" 12.0 29.4 25.7 3.1 32.7 8.9 5.0 24.8 48.1 10.0 11.0 44.8 6.4 19.4 7.8 7.0 4.7 11.9 6.6 38.1 24.7 22.8 41.7 34.7 7.4 2.6 28.9 25.3 14.0 14.9 17.9 11.9 5.2 34.2 10.4 8.8 11.4 24.6 11.9 14.8 5.0 12.4 6.6 30.8 4.4 10.7 4.6 25.3 0.0 8.2 3.5 2.7 5.6 4.5 0.2 0.0 0.0 0.0 0.9 0.4 0.2 0.6 8.2 2.3 12.1 3.7 3.1 1.5 1.5 1.1 2.8 1.4 10.7 1.7 0.1 2.1 1.3 2.4 0.3 17.8 1.3 1.0 0.5 1.2 6.3 6.8 33.0 10.1 0.1 5.3 2.6 4.7 1.1 0.0 3.0 5.5 0.5 11.1 0.3 0.5 0.9 0.1 0.1 1.5 3.8 6.8 1.0 0.2 0.0 6.0 2.3 3.7 11.9 2.7 0.6 7.7 2.1 8.0 2.3 1.2 0.2 0.8 2.9 2.2 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.2 25.7 32.7 24.8 48.1 24.7 22.8 28.9 25.3 34.2 25.3 3.0 1.3 1.4 2.7 1.3 35.7 5.1 2.5 1.4 2.3 29.6 45.2 9.7 76.3 3.2 0.0 2.1 9.2 0.0 1.0 1.9 4.3 3.2 1.1 4.7 6.5 30.2 5.2 4.9 1.2 0.0 4.9 2.0 11.8 1.0 10.1 26.8 2.2 7.0 2.8 38.4 70.5 0.0 5.1 0.3 3.6 1.6 7.0 1.3 8.6 3.0 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055015: AB_2682673" "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favorable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.3 11.3 12.3 9.2 11.6 13.3 6.5 9.7 15.5 6.9 8.0 7.5 5.6 6.7 5.2 13.9 5.8 5.7 10.7 19.3 12.1 29.8 7.9 5.2 13.9 9.2 6.0 8.7 6.8 12.2 13.3 6.9 11.4 9.7 26.4 5.7 0.1 9.9 11.5 6.3 6.5 16.4 9.7 8.7 11.4 0.0 5.6 4.5 10.8 7.0 8.2 4.1 6.4 11.0 2.6 17.3 6.9 5.1 16.1 0.0 4.5 7.6 8.8 2.4 13.7 7.6 0.0 12.3 4.1 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 8.9 14.3 3.9 2.7 2.6 5.7 10.0 7.6 13.4 7.9 15.7 3.9 4.1 1.7 7.4 11.0 4.4 4.1 0.0 7.4 5.7 6.2 6.5 4.7 3.4 4.6 11.1 16.8 12.3 5.4 3.7 4.6 4.3 8.5 1.0 10.9 7.3 8.1 0.0 3.5 2.8 3.8 6.5 5.7 14.9 7.8 3.1 2.7 3.5 8.9 2.6 FOXRED1 H17 ENSG00000110074 "FAD dependent oxidoreductase domain containing 1" Q96CU9 11 126269055-126278131 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Oxidoreductase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039620, HPA046192" Uncertain Supported Mitochondria NA NA Mitochondria "HPA039620: AB_2676602, HPA046192: AB_2679580" "prognostic unfavorable (7.36e-4)" "unprognostic (4.62e-2)" "unprognostic (2.71e-1)" "unprognostic (3.47e-3)" "unprognostic (1.76e-1)" "unprognostic (1.84e-1)" "unprognostic (9.59e-2)" "unprognostic (1.43e-1)" "unprognostic (8.14e-2)" "unprognostic (1.20e-1)" "unprognostic (1.20e-2)" "unprognostic (1.59e-1)" "prognostic favorable (2.01e-6)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (2.00e-1)" "unprognostic (1.94e-1)" 7.2 12.3 14.6 8.5 14.9 10.4 7.8 12.6 19.2 6.1 11.7 9.2 6.4 10.3 6.8 6.9 7.7 7.7 7.5 20.1 11.1 11.7 14.6 36.2 5.1 9.2 12.9 18.2 4.3 7.5 9.2 7.7 7.1 13.6 5.8 13.0 8.0 7.5 11.9 15.0 6.1 8.2 8.0 8.7 9.5 8.8 6.8 11.7 8.3 6.2 9.8 10.0 8.0 4.9 7.5 16.5 5.3 12.4 8.5 8.9 7.7 9.5 10.9 8.0 10.0 6.1 2.8 11.1 4.9 6.2 9.3 9.3 16.2 9.8 15.5 13.8 4.0 12.2 15.9 21.4 12.9 5.8 8.3 5.8 32.3 7.1 19.1 8.0 7.9 6.9 2.6 5.0 6.1 11.2 2.5 10.2 16.7 18.5 8.5 7.8 13.1 9.0 13.9 6.6 25.0 18.9 14.8 14.3 18.3 8.5 4.9 10.5 9.0 9.9 14.9 5.3 5.3 36.0 13.4 3.7 5.6 4.6 10.0 7.9 5.2 7.4 12.7 6.8 27.1 7.6 1.6 9.7 5.3 6.9 12.4 7.1 7.5 5.5 8.9 11.8 6.2 7.9 6.9 1.9 8.5 8.9 16.5 7.6 7.7 14.6 14.9 12.6 19.2 11.1 11.7 12.9 18.2 13.6 11.7 8.9 8.6 13.7 6.7 3.2 24.4 19.1 5.1 2.7 6.8 3.5 25.5 25.0 6.6 9.7 2.5 6.2 9.7 0.0 12.1 19.1 8.9 3.9 9.2 25.2 17.5 12.7 12.6 13.5 5.4 6.0 5.2 8.3 8.5 6.4 8.7 17.9 8.9 3.5 10.6 15.8 29.3 6.5 9.2 13.6 23.0 5.0 17.6 7.9 13.3 2.7 FRMD6 "C14orf31, EX1, MGC17921, willin" ENSG00000139926 "FERM domain containing 6" Q96NE9 14 51489100-51730727 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 119.7;Early spermatids: 184.0;Late spermatids: 333.9;Suprabasal keratinocytes: 120.2;Urothelial cells: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.3;naive CD4 T-cell: 2.5" "Group enriched" "Detected in many" 5 "granulocytes: 3.3;T-cells: 2.5" "Cell line enhanced" "Detected in many" "BJ: 58.1;fHDF/TERT166: 121.7;U-138 MG: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001297 Uncertain Supported Approved Mitochondria NA NA Mitochondria "HPA001297: AB_1078913" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-1)" "unprognostic (2.64e-2)" "unprognostic (8.05e-2)" "unprognostic (8.19e-2)" "unprognostic (3.55e-3)" "unprognostic (1.28e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.28e-4)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-2)" 7.8 6.4 2.7 7.6 5.3 0.2 12.9 14.3 4.6 44.6 9.8 4.8 14.1 2.2 52.3 11.6 32.8 8.8 16.0 9.0 4.3 2.1 2.7 4.7 5.4 4.1 3.8 2.8 12.0 2.8 1.0 2.7 10.7 4.4 21.5 5.0 13.2 10.7 23.0 3.8 20.4 4.8 27.5 3.6 8.3 5.4 14.0 2.1 5.2 4.8 20.9 23.3 20.3 18.5 0.1 0.0 3.3 0.6 0.3 2.5 0.7 12.2 2.1 3.5 6.7 7.3 11.2 1.4 58.1 30.2 32.4 29.2 7.6 2.8 0.2 1.8 121.7 10.1 12.7 1.0 18.6 39.0 0.1 1.3 0.1 1.1 0.3 9.3 0.0 0.6 9.6 7.5 26.9 33.4 14.2 9.8 0.6 0.1 3.9 33.7 1.8 1.0 0.0 0.8 0.0 4.2 0.1 13.6 0.1 6.0 18.4 0.6 7.8 4.1 0.8 5.7 7.3 0.5 0.1 36.4 49.8 19.0 12.5 12.4 3.0 2.4 0.0 3.2 0.0 19.7 3.3 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 1.9 0.2 0.3 0.6 0.0 0.0 0.7 2.7 5.3 14.3 4.6 4.3 2.1 3.8 2.8 4.4 2.1 3.0 1.0 0.0 119.7 99.0 0.4 2.2 10.2 0.0 5.7 0.0 0.0 32.7 0.0 13.0 184.0 10.3 0.0 0.0 2.5 3.7 47.2 36.8 1.1 3.4 3.3 0.0 0.0 9.8 0.3 333.9 16.4 3.3 30.4 1.0 0.0 10.1 37.9 0.0 20.8 0.3 0.2 6.5 24.7 4.4 6.4 120.2 32.6 0.0 0.0 134.9 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 258.1;pancreas: 68.9;salivary gland: 91.7" "Group enriched" "Detected in many" 5 "Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 14.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 25 "MOLT-4: 141.0;RPTEC TERT1: 323.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA064218, HPA068838" Supported Approved Mitochondria NA NA 26000 Mitochondria "HPA064218: AB_2685214, HPA068838: AB_2686047" "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favorable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 0.3 0.2 0.2 0.2 0.1 0.0 0.7 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.3 2.8 0.3 0.3 54.7 0.2 0.1 0.2 258.1 2.2 0.2 0.6 0.1 0.0 0.4 68.9 0.0 0.3 0.6 0.1 0.3 0.0 0.1 91.7 0.1 0.1 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.0 9.5 0.2 0.3 0.4 0.2 0.6 0.4 3.2 0.0 1.1 8.4 14.1 2.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.2 0.0 0.0 0.0 0.0 141.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 323.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 1.1 0.2 1.8 14.1 0.2 0.4 5.1 4.1 0.0 8.4 0.0 3.2 1.6 2.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.1 0.8 1434.4 0.0 0.0 413.5 0.0 0.1 2501.8 465.3 14.4 1.3 0.0 0.0 8.3 0.1 1.1 0.1 0.0 2.4 2.9 0.0 14.6 5.5 4.3 15.4 8.6 2.6 0.0 14.4 0.0 0.5 33.3 0.0 7.1 3101.2 3.5 6.5 3.9 0.4 0.2 0.6 0.2 0.0 0.0 0.0 GATB "PET112, PET112L" ENSG00000059691 "Glutamyl-tRNA amidotransferase subunit B" O75879 4 151670504-151761023 "Predicted intracellular proteins" "Protein biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 317.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042610 Uncertain Supported Mitochondria NA NA Mitochondria "HPA042610: AB_10797502" "unprognostic (2.52e-1)" "unprognostic (3.33e-1)" "unprognostic (1.01e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-1)" "unprognostic (6.91e-2)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (2.06e-1)" "unprognostic (6.76e-2)" "unprognostic (1.37e-1)" "unprognostic (8.17e-2)" "prognostic favorable (1.20e-10)" "unprognostic (1.91e-1)" "unprognostic (8.39e-2)" "unprognostic (3.09e-2)" "unprognostic (2.46e-1)" 11.2 17.0 12.3 10.5 13.6 8.2 9.2 10.7 19.8 7.3 9.7 11.2 6.4 5.8 5.9 8.9 10.1 9.1 7.0 31.3 10.7 10.8 21.4 21.8 5.3 6.8 15.8 11.1 12.1 6.8 14.6 8.4 9.9 10.6 5.9 9.9 7.8 7.7 7.1 22.7 8.5 6.3 8.1 22.6 6.9 7.4 7.8 10.4 10.5 7.7 18.9 9.3 8.0 5.8 9.1 17.0 1.5 13.2 6.8 6.8 8.3 8.8 6.9 9.9 9.5 14.5 14.0 8.6 11.7 15.3 20.8 16.3 11.6 14.5 12.0 3.1 12.1 12.7 8.3 21.2 22.4 22.3 6.7 13.0 5.5 9.6 23.9 14.2 11.3 5.5 14.4 14.4 20.0 7.0 12.0 15.4 17.1 21.4 10.5 15.9 9.7 14.1 12.2 10.1 7.4 13.0 12.0 9.5 9.5 18.8 7.4 10.3 11.4 9.4 13.0 13.7 10.0 11.0 8.2 8.4 10.5 5.7 7.2 8.0 12.6 16.3 10.0 14.7 10.0 7.6 0.7 9.4 1.5 4.0 13.2 6.3 9.1 5.3 5.6 17.0 8.2 6.8 6.4 0.9 6.8 9.4 6.7 5.4 8.3 12.3 13.6 10.7 19.8 10.7 10.8 15.8 11.1 10.6 10.4 8.9 3.7 2.2 5.5 0.0 8.7 58.8 0.0 2.7 6.8 10.4 7.9 19.7 23.2 8.8 5.7 2.9 2.6 0.0 6.4 13.2 7.4 2.9 1.1 13.6 15.4 9.5 2.4 2.5 6.5 6.0 4.9 5.8 0.0 13.6 5.9 317.1 6.9 6.5 4.2 14.9 13.6 6.5 3.6 12.2 12.0 0.0 11.2 1.5 8.8 2.6 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in many" 8 "Hepatocytes: 1105.8;Proximal tubular cells: 2889.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Group enriched" "Detected in some" 4 "RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria Yes NA 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.8 9.0 0.3 0.0 1.5 0.6 4.5 0.1 0.1 0.4 0.0 0.7 0.1 0.0 0.2 5.2 0.7 0.2 0.2 0.0 0.1 0.0 0.1 2.1 0.1 0.2 0.0 0.1 0.6 0.1 3.2 7.9 0.0 0.1 57.1 0.4 0.9 15.0 6.6 1.1 1.8 0.1 0.3 0.6 0.8 5.9 0.0 0.0 0.1 0.0 1.7 35.3 44.6 0.2 0.5 0.1 0.4 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 3.0 0.6 33.0 12.7 48.2 8.6 29.5 191.1 2.7 5.7 68.0 0.0 1.0 250.4 36.2 7.4 7.8 4.2 23.3 255.7 0.9 9.9 3.9 3.5 1105.8 69.7 7.9 0.0 20.9 55.8 11.0 4.0 39.6 21.9 5.4 0.2 18.7 151.7 0.3 3.2 2889.0 4.0 6.5 11.3 22.9 7.4 116.9 1.5 6.9 0.4 15.5 GCDH ACAD5 ENSG00000105607 "Glutaryl-CoA dehydrogenase" Q92947 19 12891026-12914207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 102.5;Proximal tubular cells: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043252, HPA048492" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043252: AB_2678390, HPA048492: AB_2680418" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" "unprognostic (6.79e-3)" "unprognostic (8.07e-3)" "unprognostic (8.20e-3)" "unprognostic (3.14e-2)" "prognostic favorable (7.28e-5)" "prognostic favorable (3.35e-4)" "unprognostic (1.62e-1)" "unprognostic (3.03e-2)" "unprognostic (7.50e-3)" "unprognostic (7.46e-2)" "prognostic favorable (6.79e-8)" "unprognostic (7.09e-3)" "unprognostic (3.42e-1)" "unprognostic (5.32e-2)" "unprognostic (1.59e-1)" 12.5 12.1 11.4 8.6 13.3 8.2 9.5 11.5 14.0 9.5 10.5 15.5 8.6 9.1 11.7 7.3 9.1 10.5 7.5 19.8 9.3 8.0 20.2 62.6 6.3 12.1 15.5 14.1 13.7 12.3 7.9 8.7 4.9 9.7 10.4 6.9 9.6 14.7 9.7 17.5 6.6 8.1 8.2 8.7 8.6 11.3 4.9 11.8 13.0 10.9 13.7 9.0 12.0 6.6 10.9 14.5 7.2 8.1 21.7 20.6 12.3 11.2 6.3 6.8 12.5 9.9 5.0 6.3 8.4 5.0 9.8 7.5 11.5 4.8 16.3 15.9 4.6 4.9 7.1 9.3 7.2 4.9 14.0 9.9 10.5 10.9 14.1 11.4 19.7 8.4 6.3 9.0 6.9 7.5 4.0 8.4 19.3 25.4 5.1 4.9 12.3 23.1 17.3 7.7 9.8 16.2 22.1 6.9 31.7 5.7 5.2 15.0 9.0 11.8 10.4 7.2 4.5 8.0 13.1 6.0 8.0 6.0 14.9 8.1 27.5 13.9 17.2 5.6 22.6 6.9 7.2 8.1 4.6 11.7 7.1 11.6 10.7 15.0 13.7 14.5 10.9 20.6 15.5 2.0 21.7 5.3 8.6 12.5 12.3 11.4 13.3 11.5 14.0 9.3 8.0 15.5 14.1 9.7 11.8 3.0 4.0 29.5 12.5 7.0 13.8 9.2 20.4 6.7 1.2 10.4 23.6 13.5 44.7 12.0 2.2 4.9 11.4 23.3 9.8 18.6 8.7 10.2 6.9 102.5 18.9 7.9 15.0 13.5 13.0 1.2 12.0 6.9 16.9 27.1 10.8 16.7 9.8 8.6 12.0 94.5 12.2 0.0 7.8 7.2 6.4 4.5 13.6 15.0 19.3 11.8 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139440-84153245 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 1967.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria NA NA Mitochondria "HPA016464: AB_1849656, HPA061664: AB_2684579" "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favorable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 28.7 50.7 46.0 21.9 53.3 25.3 26.0 30.9 62.7 21.4 45.5 20.2 23.9 43.3 21.2 24.5 30.0 19.9 21.8 94.9 40.8 42.8 80.5 71.6 19.2 23.2 45.2 42.4 20.7 25.1 29.9 24.0 20.9 62.8 22.6 46.0 24.3 26.0 24.5 87.6 19.9 35.6 28.9 24.6 20.1 30.1 41.7 17.5 21.5 29.3 47.6 26.6 26.1 19.1 46.8 63.7 60.6 67.5 44.4 51.6 106.0 42.0 43.7 18.7 42.8 32.2 28.7 33.3 29.0 51.3 37.7 35.4 53.1 35.0 33.3 32.7 38.3 33.2 38.0 39.7 38.0 36.5 33.2 30.1 23.6 45.7 52.3 61.0 73.5 38.8 32.3 74.7 38.9 113.5 39.3 32.5 28.6 54.7 62.3 34.6 36.7 26.0 58.8 18.9 34.4 39.0 23.7 17.2 50.0 52.3 33.9 15.3 17.9 29.3 25.7 58.6 22.6 52.5 47.3 27.5 18.4 24.7 26.7 46.7 44.1 48.0 37.4 48.3 68.2 12.7 52.6 64.3 60.6 42.2 67.5 47.1 46.8 44.2 44.9 63.7 37.2 41.5 44.4 51.3 44.4 59.6 33.0 51.6 106.0 46.0 53.3 30.9 62.7 40.8 42.8 45.2 42.4 62.8 17.5 89.3 83.5 136.2 153.4 151.3 140.5 659.4 145.2 87.0 79.6 150.1 66.8 215.6 490.7 245.2 963.4 127.2 319.8 303.7 203.3 204.3 113.7 156.4 99.3 296.0 241.3 95.3 120.5 81.0 150.4 1967.2 102.1 154.3 155.3 237.2 171.1 217.8 200.8 261.9 128.7 653.0 105.3 142.3 188.3 222.7 145.0 148.9 322.8 152.2 238.2 177.5 GJB2 "CX26, DFNA3, DFNB1, NSRD1" ENSG00000165474 "Gap junction protein beta 2" P29033 13 20187463-20193010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 447.5" "Region enhanced" "Detected in some" "pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013093, HPA014362" Uncertain Approved Mitochondria NA NA Mitochondria "CAB013093: AB_2533903, HPA014362: " "unprognostic (2.21e-1)" "unprognostic (1.25e-3)" "unprognostic (2.43e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (4.45e-4)" "unprognostic (9.77e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.33e-1)" "unprognostic (3.69e-3)" "prognostic unfavorable (2.90e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (2.53e-6)" "unprognostic (5.78e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (8.93e-3)" 0.2 0.0 0.2 1.5 0.3 0.5 0.7 1.0 0.5 52.8 3.9 0.4 0.4 2.4 4.2 0.6 128.1 0.1 2.7 0.1 0.5 0.1 3.5 9.1 0.1 0.0 1.3 0.7 0.1 0.1 0.0 0.5 0.2 4.5 0.3 3.4 0.3 19.7 0.2 0.2 10.3 1.9 0.4 3.7 0.0 1.5 0.2 0.2 3.2 0.2 129.0 71.1 2.3 64.9 0.0 0.0 0.4 0.6 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.4 43.7 0.0 0.2 0.0 0.3 8.7 1.6 4.3 0.0 3.6 0.5 0.0 0.0 0.1 0.0 0.0 1.5 0.7 32.6 0.5 6.0 0.0 0.0 0.6 0.0 3.2 0.0 0.4 0.3 0.0 0.1 22.7 4.3 0.0 0.0 2.4 0.0 50.8 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.0 0.0 0.0 0.7 6.5 2.6 2.7 0.0 5.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.5 0.5 0.1 1.3 0.7 4.5 0.2 3.0 0.0 0.8 8.0 62.0 0.0 0.4 5.1 0.0 3.4 1.8 0.0 0.0 0.0 3.5 0.7 0.2 19.0 0.0 8.8 0.2 1.6 7.8 0.0 24.2 0.7 0.0 4.1 0.0 0.8 0.9 0.0 1.2 1.7 8.2 3.9 0.0 8.1 15.0 0.0 14.7 0.0 0.0 2.0 0.2 0.4 25.1 0.1 0.0 19.7 15.6 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 58.4" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" NA NA 78000 Mitochondria "HPA040481: AB_2677004, HPA048216: AB_2680317" "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 8.3 12.2 6.5 4.9 14.2 0.6 8.8 58.4 12.1 8.4 12.1 12.4 7.8 13.5 6.3 6.9 10.2 5.9 7.2 5.5 5.8 8.5 13.3 16.0 8.4 5.3 9.4 8.1 12.9 5.9 9.0 12.0 12.6 14.4 5.7 14.0 10.8 11.7 8.9 4.1 9.8 11.2 6.8 10.2 4.0 8.8 6.1 7.6 5.4 4.1 8.4 5.8 6.3 5.6 0.6 4.0 0.1 4.4 0.5 4.0 1.9 3.9 3.5 2.4 4.2 8.2 7.8 0.8 7.4 9.9 5.8 11.0 2.9 10.0 2.4 3.7 6.0 7.3 6.0 5.2 4.8 11.8 0.9 5.7 4.0 6.7 3.0 7.9 1.7 8.2 5.3 3.3 7.1 8.1 4.2 50.9 1.8 1.6 2.6 10.8 2.4 1.0 3.0 1.2 4.0 2.5 2.4 9.8 3.0 5.3 4.2 7.7 1.6 7.6 4.7 15.7 1.7 3.4 2.4 17.7 5.6 6.9 6.1 6.5 1.1 1.5 0.5 5.6 2.9 8.0 0.0 4.4 0.1 0.7 3.4 1.2 0.6 1.8 0.8 3.6 0.5 1.2 1.5 0.1 0.5 4.4 4.0 4.0 1.9 6.5 14.2 58.4 12.1 5.8 8.5 9.4 8.1 14.4 7.6 0.0 12.5 5.7 9.1 4.2 10.3 6.2 7.6 25.4 5.7 10.4 9.8 20.3 5.0 10.4 3.2 13.9 15.7 0.0 12.1 9.9 5.9 4.9 2.3 24.6 13.5 7.9 19.5 16.5 14.6 3.3 5.8 7.7 8.5 11.8 26.4 12.9 12.9 23.4 16.6 14.0 15.4 12.9 3.9 13.0 13.4 5.6 27.6 4.4 26.5 12.1 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761750-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.2;kidney: 10.2;liver: 7.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 11.6;Enterocytes: 17.1;Paneth cells: 10.5;Proximal tubular cells: 31.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;Hep G2: 2.2;K-562: 1.9;MCF7: 6.5;SCLC-21H: 1.3;T-47d: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010667 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.2 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.4 14.7 0.2 0.2 10.3 0.4 5.6 0.3 1.6 3.5 0.2 0.2 0.0 10.2 7.8 1.5 0.2 0.2 0.2 0.4 1.1 0.0 0.6 0.2 0.2 0.4 5.7 1.5 0.6 0.2 0.2 0.1 25.2 0.2 0.2 0.2 1.3 0.7 0.2 0.4 1.9 0.2 0.5 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.3 0.4 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 1.6 0.0 0.4 0.0 0.2 0.0 2.5 4.0 0.0 7.0 0.0 0.0 11.6 0.4 0.1 0.0 17.1 0.0 0.8 0.1 0.0 0.5 0.0 6.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.3 1.2 10.5 0.0 31.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.5 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 439.3;Erythroid cells: 490.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria NA NA Mitochondria "HPA042465: AB_10794048, HPA063716: AB_2685102" "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favorable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 13.7 24.1 19.3 11.2 16.9 54.8 9.7 10.5 17.3 7.4 16.6 7.7 8.1 17.6 9.1 10.8 10.7 8.4 12.6 45.3 16.1 14.5 22.5 43.3 7.7 8.4 15.5 9.5 15.8 19.1 8.3 9.4 27.3 10.4 9.9 9.9 13.3 11.6 11.0 68.8 7.9 15.7 12.6 8.3 9.1 12.8 24.2 7.1 19.9 14.8 25.6 9.7 10.0 10.8 6.0 9.9 5.5 4.5 4.8 8.7 3.0 14.0 18.9 8.7 11.5 8.5 6.3 39.3 10.4 6.8 9.0 8.6 24.7 15.4 20.3 15.4 5.2 5.5 14.2 12.9 10.4 7.5 13.3 19.5 17.4 12.1 36.8 9.7 27.7 18.6 7.7 8.6 6.4 9.0 4.1 9.0 15.0 20.6 16.0 6.3 39.5 21.8 28.2 14.8 11.1 21.1 39.8 30.9 12.1 9.9 17.0 23.1 14.4 9.9 12.6 14.2 7.7 19.4 11.9 10.7 5.7 12.7 13.9 14.6 8.7 10.3 15.4 12.5 16.8 13.2 1.0 3.5 5.5 5.2 4.5 6.1 6.0 6.4 7.7 5.4 5.8 5.9 5.8 2.2 4.8 2.7 9.9 8.7 3.0 19.3 16.9 10.5 17.3 16.1 14.5 15.5 9.5 10.4 7.1 26.8 28.8 35.7 48.6 96.4 37.5 144.4 68.8 8.1 12.5 90.7 31.4 78.3 439.3 9.8 246.8 42.7 50.7 490.6 13.4 138.0 62.7 73.1 14.9 132.8 51.0 47.7 51.9 30.7 26.9 69.9 50.3 48.4 82.7 7.2 63.3 72.3 13.6 31.6 69.3 215.3 32.2 58.2 72.1 35.6 88.2 109.2 45.0 39.2 74.7 69.4 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880827-190965552 "Enzymes, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 127.9" "Cell type enhanced" "Detected in all" 6 "Collecting duct cells: 371.6;Proximal tubular cells: 372.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 141.8;RPTEC TERT1: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" No No 25000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 16.5 37.3 37.8 20.4 24.7 10.7 34.3 43.8 47.3 11.9 13.1 5.8 8.9 36.9 14.6 11.9 7.6 11.0 17.7 15.7 23.3 22.8 127.9 5.3 22.6 25.4 20.6 36.8 14.1 17.0 26.4 10.1 14.8 35.1 9.4 13.1 10.8 9.0 13.9 7.4 13.0 40.9 15.5 11.7 19.3 8.7 6.9 12.1 15.0 17.7 8.0 22.9 14.1 16.1 5.2 5.0 6.0 2.1 3.9 9.4 1.5 6.4 7.1 5.0 6.6 15.7 11.0 13.0 19.2 14.6 14.0 16.1 8.7 6.4 13.2 141.8 40.5 7.1 8.4 8.8 7.5 20.6 32.5 5.7 21.9 10.5 10.7 14.4 12.7 10.3 9.9 7.9 11.0 7.5 14.0 18.1 5.5 10.1 26.9 31.1 3.4 8.6 12.3 13.4 3.8 11.7 11.0 12.9 11.4 65.2 11.8 6.9 7.2 26.2 5.8 24.4 18.7 2.3 7.9 12.9 20.3 14.9 10.1 23.2 8.7 19.8 18.1 7.3 10.5 16.1 6.0 1.5 2.5 5.5 2.1 9.4 4.8 6.5 7.0 2.2 5.2 6.8 8.1 3.0 3.9 1.4 5.0 5.6 1.5 37.8 24.7 43.8 47.3 23.3 22.8 20.6 36.8 35.1 12.1 175.7 95.7 52.1 47.3 155.0 91.0 32.2 30.6 16.0 40.9 371.6 198.3 3.3 43.1 22.6 4.4 51.8 120.5 23.3 20.9 10.2 63.7 42.0 35.8 4.9 25.8 25.4 56.7 57.7 27.2 3.6 26.4 55.5 84.4 88.4 25.7 10.0 29.5 31.6 40.7 372.1 117.6 19.4 70.9 10.7 11.0 142.3 3.3 62.3 28.1 52.1 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694488-52706032 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria NA NA Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 18.6 23.7 16.1 14.5 20.9 4.7 21.0 15.3 19.9 29.3 17.3 18.3 22.1 14.6 23.5 26.8 14.1 31.9 19.9 19.3 16.6 17.0 23.2 39.4 16.8 16.0 17.9 14.4 32.4 23.6 24.3 40.8 34.7 18.1 21.1 18.9 19.7 22.0 25.2 11.5 13.0 15.2 18.7 17.4 14.8 16.0 43.3 21.6 17.5 37.8 11.6 14.7 21.8 16.8 8.6 15.7 20.5 8.4 20.1 16.3 6.6 8.1 9.7 19.7 15.5 43.7 55.6 11.0 20.6 31.9 18.2 20.9 4.5 15.5 6.9 5.9 35.7 22.0 9.3 12.4 21.1 24.1 12.4 9.0 6.5 17.8 20.6 21.0 9.7 20.5 31.9 18.8 15.6 20.2 42.3 27.0 12.0 8.3 16.0 23.8 8.3 6.5 14.9 10.0 14.4 18.2 5.0 11.2 23.3 21.2 8.9 8.1 13.9 17.1 8.4 13.9 19.2 14.1 12.8 19.7 13.2 10.3 19.1 11.4 18.1 20.5 7.7 23.1 15.5 16.6 20.5 8.4 14.1 13.3 5.7 13.2 8.6 16.0 14.3 8.1 6.4 16.3 11.5 4.8 20.1 6.0 15.7 10.6 6.6 16.1 20.9 15.3 19.9 16.6 17.0 17.9 14.4 18.1 21.6 0.0 8.1 11.5 17.3 10.8 37.5 11.3 7.6 33.5 15.9 17.4 11.8 47.2 19.9 28.5 40.0 19.6 13.1 0.0 23.8 55.2 49.3 12.9 5.7 29.3 23.5 20.6 17.9 35.0 14.5 13.6 49.8 10.6 23.6 34.3 18.6 33.9 21.1 19.2 45.6 19.8 17.9 25.8 15.9 90.1 50.7 6.9 21.9 21.5 17.5 6.7 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050486-87094866 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 182.4" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 357.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 108.1" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" NA NA 26000000 Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favorable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 15.5 21.5 57.8 9.9 54.5 5.9 23.2 13.4 37.9 12.1 14.5 19.9 5.5 18.4 10.9 7.5 17.0 11.5 12.6 16.7 44.1 35.3 56.2 182.4 13.1 11.5 40.6 30.8 17.5 15.2 8.7 6.6 13.5 31.1 26.5 14.6 8.1 10.0 13.3 9.2 15.3 19.8 14.0 22.7 10.2 12.2 6.4 33.2 12.6 16.1 8.7 13.1 14.0 9.5 9.2 15.8 9.2 14.6 13.7 11.9 5.9 24.5 19.8 15.6 26.4 29.7 36.6 17.1 19.4 33.6 18.8 20.7 45.8 24.1 27.6 15.9 28.3 10.8 38.7 20.3 19.5 20.2 19.9 16.0 13.4 11.9 108.1 66.3 31.3 19.4 25.2 36.9 20.9 62.6 28.7 22.4 21.8 13.5 25.0 20.3 17.8 28.2 28.1 17.8 26.7 16.0 21.4 19.9 18.0 54.1 20.1 8.0 15.0 17.4 13.8 24.7 15.7 19.0 22.1 22.2 9.8 8.7 19.8 19.7 15.0 15.4 33.0 23.6 35.9 5.8 5.5 13.8 9.2 8.7 11.1 10.9 9.2 11.8 10.6 15.8 8.8 10.6 8.5 1.3 13.7 14.6 5.9 11.9 5.9 57.8 54.5 13.4 37.9 44.1 35.3 40.6 30.8 31.1 33.2 20.8 19.2 40.4 53.0 94.2 20.7 49.8 53.5 17.4 45.5 57.6 35.3 77.3 132.6 27.7 11.2 45.6 54.7 46.7 29.4 52.4 55.2 96.0 43.7 357.2 63.1 14.3 37.8 50.3 67.1 18.7 81.4 68.2 99.5 30.7 44.6 133.3 37.2 42.1 85.2 119.8 60.1 64.7 76.2 9.6 6.4 107.0 39.8 55.4 40.7 75.9 GLUD2 GLUDP1 ENSG00000182890 "Glutamate dehydrogenase 2" P49448 X 121047588-121050080 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.3;testis: 31.9" "Cell type enhanced" "Detected in some" 6 "Cytotrophoblasts: 2.7;Hepatocytes: 3.2;Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 8.0;K-562: 8.8;SK-MEL-30: 11.3;THP-1: 5.6;WM-115: 12.7" "HPA042492, HPA044839, HPA061369" Uncertain Approved Mitochondria NA NA Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.44e-1)" "unprognostic (5.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.42e-1)" "unprognostic (2.61e-1)" "unprognostic (2.35e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (4.77e-3)" "unprognostic (5.96e-2)" 3.1 2.5 4.8 0.8 7.3 0.5 1.6 2.2 3.5 1.1 0.7 2.0 0.6 0.6 1.0 5.2 0.7 1.0 1.6 1.5 5.7 1.8 4.7 11.3 0.9 0.9 2.7 6.2 0.7 1.5 0.7 0.7 2.7 4.3 0.8 0.6 0.2 0.9 3.1 0.7 0.8 1.0 1.0 1.5 0.5 0.9 31.9 4.1 0.0 1.4 0.0 0.8 0.8 0.6 0.8 1.2 0.7 1.1 1.2 0.7 0.4 0.0 2.1 0.5 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.3 0.0 1.1 0.0 0.8 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 1.7 0.0 0.0 1.6 4.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 11.3 0.3 2.7 5.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.6 0.8 0.7 0.4 1.1 0.7 0.8 0.7 0.7 1.2 0.4 0.7 0.5 0.0 1.2 1.1 0.2 0.7 0.4 4.8 7.3 2.2 3.5 5.7 1.8 2.7 6.2 4.3 4.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.0 2.7 1.7 0.1 1.8 0.0 0.0 0.0 0.3 0.3 0.6 0.3 0.0 3.2 0.5 0.0 0.0 0.0 1.9 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.9 1.1 0.1 2.1 0.0 0.0 0.1 GLYATL2 "BXMAS2-10, MGC24009" ENSG00000156689 "Glycine-N-acyltransferase like 2" Q8WU03 11 58834065-58904215 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 2.2;Glandular cells: 1.9;Melanocytes: 1.7;Sertoli cells: 6.5;Suprabasal keratinocytes: 1.8;Urothelial cells: 1.8" "Cancer enhanced" "Detected in many" "breast cancer: 16.7;endometrial cancer: 15.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.2;HAP1: 6.6;SK-BR-3: 15.8;U-2197: 7.6" "Not detected" "Not detected" "HPA060292, HPA065454" Uncertain Approved Mitochondria NA NA Mitochondria "HPA060292: AB_2684245, HPA065454: " "unprognostic (1.02e-2)" "unprognostic (3.79e-3)" "unprognostic (8.11e-4)" "prognostic favorable (9.05e-7)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "unprognostic (2.66e-2)" "unprognostic (9.98e-3)" "unprognostic (1.27e-1)" "unprognostic (9.18e-3)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (7.42e-5)" "unprognostic (7.79e-3)" "unprognostic (8.28e-2)" "unprognostic (9.11e-3)" "unprognostic (2.31e-2)" 0.4 0.0 0.4 0.1 0.2 0.0 11.2 0.1 0.3 18.8 0.1 0.1 0.1 0.1 1.2 0.1 0.8 0.1 6.6 0.2 0.3 0.4 0.1 0.1 0.6 0.2 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.0 0.1 25.8 0.1 0.1 1.2 0.1 0.1 1.5 1.1 0.1 0.1 0.1 0.1 0.1 4.4 9.9 0.1 0.3 0.4 0.1 2.1 0.4 0.2 0.2 0.9 0.0 0.0 0.5 0.0 0.9 3.1 0.0 1.9 5.9 2.6 4.2 0.0 0.0 0.2 0.0 1.6 1.2 0.5 6.6 0.0 2.2 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.0 0.6 0.2 2.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 15.8 0.0 0.0 0.0 0.0 0.0 2.2 0.1 7.6 2.3 0.0 0.0 0.1 0.0 0.0 0.8 0.8 0.2 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.1 2.1 0.2 0.0 0.1 0.0 0.9 0.4 0.2 0.1 0.3 0.3 0.4 0.6 0.1 0.1 0.1 0.0 0.0 0.0 2.2 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 6.5 1.0 0.0 0.0 1.8 0.0 0.0 0.0 1.8 GNG12 ENSG00000172380 "G protein subunit gamma 12" Q9UBI6 1 67701466-67833467 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057790, HPA062208" Enhanced Supported Approved Mitochondria NA NA Mitochondria "HPA057790: AB_2683527, HPA062208: AB_2684711" "unprognostic (5.18e-2)" "unprognostic (1.76e-3)" "unprognostic (4.46e-3)" "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (4.71e-2)" "unprognostic (5.29e-2)" "unprognostic (5.84e-3)" "unprognostic (5.50e-2)" "unprognostic (3.41e-2)" "unprognostic (4.46e-3)" "unprognostic (8.13e-2)" "unprognostic (4.12e-3)" "unprognostic (2.33e-2)" "unprognostic (9.33e-2)" "unprognostic (7.78e-2)" "unprognostic (2.14e-3)" 28.7 23.8 10.3 13.8 9.4 0.0 49.4 5.1 7.7 28.3 34.5 10.9 16.6 40.1 41.5 20.7 34.0 21.2 27.2 14.2 11.8 9.3 36.1 15.4 16.4 12.4 9.1 6.3 24.9 16.0 23.9 17.1 40.1 14.3 21.4 22.2 14.6 16.4 19.3 9.0 33.0 86.2 51.8 22.9 17.5 19.5 11.6 9.6 3.6 23.1 20.5 16.5 31.5 26.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.0 9.4 10.0 5.4 42.8 37.2 10.3 31.1 40.6 27.5 24.8 4.4 9.9 0.0 13.3 43.5 17.2 7.5 6.2 25.5 48.5 0.0 4.8 0.1 8.4 0.0 17.1 0.0 0.5 22.3 15.3 29.3 38.9 38.7 43.1 0.0 0.5 0.0 30.1 1.7 0.0 0.0 7.6 11.0 11.7 0.0 20.7 0.1 26.4 9.0 2.3 4.6 21.5 9.0 41.7 8.9 4.6 0.1 55.4 32.0 20.9 57.5 19.1 0.5 0.0 0.0 20.2 1.2 43.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 10.3 9.4 5.1 7.7 11.8 9.3 9.1 6.3 14.3 9.6 50.6 25.1 2.4 66.8 178.8 1.5 25.9 48.4 69.6 34.2 55.8 5.9 52.0 63.0 84.4 7.6 66.7 171.8 0.0 120.2 89.1 65.8 79.6 3.5 38.9 22.5 3.2 33.4 86.0 16.9 10.4 66.2 12.4 74.2 6.4 58.8 1.3 115.9 90.3 71.1 129.0 17.2 51.8 74.6 1.7 24.7 189.6 147.1 4.3 51.3 91.1 GPAM "GPAT1, KIAA1560, MGC26846" ENSG00000119927 "Glycerol-3-phosphate acyltransferase, mitochondrial" Q9HCL2 10 112149864-112215377 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 107.3;liver: 56.6" "Group enriched" "Detected in many" 5 "Hepatocytes: 165.5;Horizontal cells: 42.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 20.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 76.6;Hep G2: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046339, HPA060090" Approved Approved Mitochondria NA NA Mitochondria "HPA046339: AB_2679627, HPA060090: AB_2684202" "unprognostic (1.82e-1)" "unprognostic (6.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (6.80e-2)" "unprognostic (8.75e-2)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" "unprognostic (4.59e-1)" "unprognostic (4.80e-1)" "unprognostic (2.37e-2)" "unprognostic (5.44e-2)" "prognostic favorable (4.54e-6)" "unprognostic (2.84e-1)" "unprognostic (4.41e-2)" "unprognostic (2.52e-2)" "unprognostic (1.37e-1)" 107.3 17.2 11.4 2.6 12.1 1.8 30.8 6.6 11.0 2.0 3.2 6.5 5.1 2.2 4.1 32.1 2.4 1.9 3.0 5.8 12.2 2.9 2.4 56.6 2.2 2.3 7.2 7.3 3.5 2.8 3.2 2.3 1.8 5.6 2.3 2.6 12.0 6.8 2.9 3.6 1.8 3.3 3.4 3.8 1.7 2.4 2.8 7.2 2.8 6.1 2.4 2.3 3.2 1.6 3.2 2.0 0.5 1.2 1.1 3.4 1.0 2.8 2.1 2.9 3.8 76.6 2.8 3.8 2.7 3.1 1.9 1.5 5.0 1.7 2.0 1.5 1.9 1.8 3.6 4.6 2.3 3.7 1.4 2.4 1.8 2.3 20.6 2.3 3.2 1.0 13.4 3.9 3.5 7.1 15.0 1.7 2.8 2.3 1.8 2.2 1.6 2.7 2.5 2.4 1.6 3.0 2.7 7.6 1.4 1.3 1.9 1.2 3.6 3.7 1.8 4.2 2.8 1.8 1.1 1.3 2.3 1.4 2.8 4.2 1.8 2.0 4.2 2.6 2.8 1.7 0.0 1.0 0.5 2.5 1.2 3.2 1.9 1.9 1.9 1.2 3.2 2.0 3.4 0.0 1.1 1.0 2.0 1.9 1.0 11.4 12.1 6.6 11.0 12.2 2.9 7.2 7.3 5.6 7.2 8.9 19.0 7.8 0.6 0.3 5.8 15.7 17.8 5.3 5.7 5.2 9.8 4.6 1.7 2.5 0.4 4.5 1.7 0.0 2.8 2.1 2.5 1.2 2.3 165.5 2.5 42.9 1.2 5.5 8.9 0.4 4.9 2.1 1.7 0.0 3.8 6.0 2.6 2.9 11.3 2.7 8.9 6.5 1.9 2.9 3.2 0.1 1.6 3.2 4.5 0.5 GPAT2 CT123 ENSG00000186281 "Glycerol-3-phosphate acyltransferase 2, mitochondrial" Q6NUI2 2 96021946-96039451 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 23 "Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0" "Low region specificity" "Detected in single" HPA036841 Uncertain Approved Mitochondria NA NA Mitochondria "HPA036841: AB_10601479" "unprognostic (1.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.69e-2)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.38e-3)" "unprognostic (4.99e-2)" "unprognostic (3.28e-2)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (5.96e-2)" "unprognostic (4.67e-2)" "unprognostic (7.43e-6)" "unprognostic (2.11e-1)" "unprognostic (7.68e-2)" "unprognostic (3.49e-1)" "unprognostic (3.65e-1)" 4.3 1.1 1.5 1.9 3.1 1.5 3.6 0.2 1.6 0.8 1.0 0.0 1.1 5.1 0.9 1.0 2.2 3.9 1.1 0.7 0.5 0.5 1.3 3.2 1.2 0.9 1.1 0.0 0.2 2.0 0.6 1.5 1.8 4.9 1.4 0.5 1.3 2.4 2.3 4.4 3.0 7.3 1.2 2.6 2.6 0.8 4.3 1.1 0.5 2.5 0.2 3.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.0 17.5 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 2.6 1.9 2.8 4.3 1.3 2.0 1.1 4.1 0.8 3.0 0.0 0.2 2.5 0.0 1.3 1.5 0.0 0.6 2.4 0.6 0.9 0.7 1.6 2.5 0.0 0.0 1.8 0.0 0.1 1.7 1.7 1.5 2.9 0.4 0.0 1.6 0.2 2.2 0.5 1.1 0.0 2.2 7.9 0.0 6.7 1.0 4.3 0.6 1.0 1.7 1.0 0.7 0.9 0.8 0.6 0.0 0.0 0.2 97.0 18.3 27.9 16.8 0.1 0.1 0.7 1.3 1.6 GPD2 ENSG00000115159 "Glycerol-3-phosphate dehydrogenase 2" P43304 2 156435290-156613735 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 81.5;Late spermatids: 75.7;Urothelial cells: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008012, HPA045506" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 7600000 Mitochondria "HPA008012: AB_1079013, HPA045506: AB_2679355" "unprognostic (1.30e-1)" "unprognostic (2.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.79e-3)" "unprognostic (3.25e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (2.60e-3)" "unprognostic (6.67e-2)" "unprognostic (6.02e-3)" "unprognostic (1.73e-1)" "unprognostic (1.89e-1)" "unprognostic (2.41e-1)" "unprognostic (1.01e-2)" 12.7 5.5 19.6 12.4 21.4 11.4 15.2 23.1 16.3 10.9 17.6 8.8 8.1 13.7 9.1 5.0 23.1 18.4 8.6 6.2 18.7 12.7 7.7 3.4 11.4 9.0 11.3 11.8 9.0 7.4 26.6 11.0 7.9 10.3 10.8 17.8 6.8 21.5 7.5 21.2 12.0 24.9 5.9 9.4 10.6 17.1 9.5 8.3 6.7 11.8 17.6 14.0 10.1 10.5 0.5 5.1 3.1 6.5 0.7 0.9 2.7 17.5 11.3 7.1 10.7 14.9 19.0 0.0 22.5 13.8 14.4 17.3 22.2 16.1 3.1 14.6 11.7 5.9 20.2 13.0 20.1 18.4 10.8 4.6 2.6 20.6 0.0 5.2 4.8 5.9 9.0 6.4 24.8 12.4 9.1 10.9 1.6 5.5 0.8 18.0 10.3 0.1 0.4 12.7 6.6 15.0 5.5 4.5 4.1 16.9 22.0 12.6 4.5 20.0 15.1 13.1 11.9 5.1 12.6 10.6 2.8 12.0 12.2 15.8 0.6 0.1 0.1 15.5 1.3 21.5 0.6 6.5 3.1 0.5 3.3 0.9 0.3 0.3 0.9 5.1 0.5 0.7 0.5 2.3 0.7 4.3 0.5 0.9 2.7 19.6 21.4 23.1 16.3 18.7 12.7 11.3 11.8 10.3 8.3 17.9 10.5 5.1 17.9 17.7 4.3 11.3 10.2 10.7 10.3 21.0 5.9 7.0 1.7 8.3 81.5 8.4 22.3 0.0 11.6 12.6 7.8 44.4 12.7 1.8 19.2 4.8 16.7 11.6 14.5 75.7 11.2 13.3 23.6 6.4 14.3 4.3 13.0 20.4 6.7 3.4 9.5 0.0 5.7 1.6 2.0 18.7 9.3 6.9 16.6 62.5 GPT2 ALT2 ENSG00000166123 "Glutamic--pyruvic transaminase 2" Q8TD30 16 46884378-46931297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 103.0;skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051514 Approved Approved Mitochondria No No Mitochondria "HPA051514: AB_2681516" "unprognostic (1.65e-2)" "unprognostic (3.32e-2)" "unprognostic (2.87e-1)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.95e-3)" "unprognostic (3.44e-2)" "unprognostic (6.12e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.90e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.44e-2)" "unprognostic (4.86e-1)" "unprognostic (3.54e-3)" "unprognostic (3.18e-1)" 19.9 4.1 20.2 2.1 17.8 1.9 6.4 3.9 15.1 2.5 3.4 11.8 10.0 1.3 2.1 13.4 30.8 3.7 4.4 3.0 13.4 8.0 9.8 40.4 1.4 2.1 12.9 7.8 1.5 103.0 4.3 4.3 1.8 11.3 10.2 2.6 1.5 27.6 8.5 60.9 14.9 1.7 1.9 11.3 1.4 15.4 6.0 12.3 0.7 3.6 19.0 14.6 1.9 2.1 4.2 1.4 1.3 0.7 0.0 0.4 0.4 13.0 6.0 7.6 29.0 10.8 2.3 13.9 9.1 3.4 9.9 6.2 20.4 5.5 9.2 8.0 6.5 5.0 10.5 13.7 13.5 6.6 4.3 6.7 3.2 3.4 49.2 7.4 23.1 3.0 5.0 11.9 9.6 15.0 6.6 4.8 17.7 2.6 7.4 3.2 23.4 4.5 19.3 8.1 16.2 17.2 0.1 8.4 21.4 4.0 6.5 23.8 12.2 4.7 24.4 12.4 3.2 6.2 21.1 3.5 6.9 13.5 4.5 7.3 35.6 10.8 26.1 10.6 15.0 3.7 1.3 0.7 0.0 0.3 0.0 0.0 4.2 0.0 0.3 1.4 2.5 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.4 20.2 17.8 3.9 15.1 13.4 8.0 12.9 7.8 11.3 12.3 6.0 4.3 3.0 4.2 14.2 13.4 14.7 12.7 0.0 6.8 17.4 21.6 7.1 10.0 7.8 9.4 1.6 5.5 0.0 26.2 22.2 7.7 12.4 3.5 105.1 3.3 6.4 12.6 4.3 3.5 17.1 4.4 2.4 8.5 1.0 7.4 57.6 23.6 4.9 14.5 29.4 5.9 0.0 1.4 2.2 19.2 14.3 69.7 1.5 3.2 3.8 GREB1L "C18orf6, FLJ13687, KIAA1772" ENSG00000141449 "Growth regulation by estrogen in breast cancer 1 like" Q9C091 18 21242242-21525417 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 49.1;Leydig cells: 42.6;Peritubular cells: 33.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 22.1;BEWO: 44.8;CACO-2: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041647, HPA044218" Uncertain Approved Mitochondria NA NA Mitochondria "HPA041647: AB_2677597, HPA044218: AB_2678859" "unprognostic (1.88e-3)" "unprognostic (9.01e-4)" "unprognostic (2.92e-1)" "unprognostic (2.45e-1)" "unprognostic (5.03e-2)" "unprognostic (3.67e-3)" "unprognostic (3.65e-1)" "unprognostic (1.11e-2)" "unprognostic (1.07e-1)" "unprognostic (1.97e-1)" "unprognostic (4.32e-3)" "unprognostic (2.87e-2)" "unprognostic (3.30e-8)" "unprognostic (4.72e-3)" "unprognostic (1.89e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-1)" 5.0 3.2 12.5 0.8 5.9 0.8 5.5 2.3 4.5 2.5 1.1 4.0 25.0 0.8 4.9 12.4 0.9 6.7 0.8 9.2 5.5 3.9 1.3 3.9 0.7 0.7 5.6 2.6 7.2 0.5 0.9 3.1 5.4 5.8 3.8 0.7 1.0 1.3 14.2 15.9 2.5 1.5 2.1 2.8 0.6 1.7 12.0 3.0 0.0 7.4 0.0 0.5 0.5 1.7 0.2 0.2 2.8 0.1 0.0 0.6 0.0 0.0 0.3 22.1 0.0 5.1 0.0 44.8 1.1 1.0 1.8 1.7 20.1 1.6 0.0 2.3 3.3 0.0 4.2 8.5 1.0 3.2 0.3 4.2 0.0 5.4 0.1 0.1 0.0 0.0 0.0 0.3 0.0 4.1 0.2 0.0 0.6 0.0 0.1 4.4 1.4 0.1 0.1 2.1 0.2 2.7 0.0 0.0 0.8 2.1 3.7 1.4 0.0 0.0 0.7 0.1 6.0 1.1 0.0 9.2 0.2 1.3 2.1 0.0 0.0 0.2 0.0 0.9 0.0 0.1 2.8 0.1 0.1 0.6 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 12.5 5.9 2.3 4.5 5.5 3.9 5.6 2.6 5.8 3.0 0.0 0.3 0.0 0.1 0.1 49.1 10.6 0.0 4.0 1.2 3.5 2.0 1.3 0.0 0.1 6.6 0.1 0.0 0.0 0.4 11.2 1.8 0.4 0.0 3.0 0.5 0.0 0.0 0.0 0.0 11.7 42.6 0.0 1.7 0.0 0.0 0.7 1.7 0.0 33.6 0.0 1.5 6.5 0.2 0.7 4.7 0.6 1.3 0.0 0.0 0.1 GRK6 GPRK6 ENSG00000198055 "G protein-coupled receptor kinase 6" P43250 5 177403204-177442901 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.1" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015327, HPA018903" Approved Approved Mitochondria NA NA 7500 Mitochondria "HPA015327: AB_1850334, HPA018903: AB_1850335" "unprognostic (1.06e-1)" "unprognostic (3.39e-2)" "unprognostic (4.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.66e-6)" "unprognostic (2.63e-1)" "unprognostic (6.45e-2)" "unprognostic (8.96e-2)" "prognostic favorable (1.22e-4)" "unprognostic (1.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.83e-3)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.47e-1)" 6.8 5.5 7.8 26.8 7.3 68.1 10.2 7.7 10.9 5.9 9.2 6.6 5.0 10.9 8.0 6.0 11.0 6.6 9.3 6.2 8.0 7.3 5.7 6.6 11.1 37.6 7.1 10.7 6.1 12.1 3.5 5.6 4.9 6.7 8.1 5.5 5.0 10.8 5.2 7.4 7.7 14.5 7.8 5.4 34.3 9.1 10.5 5.1 32.3 5.3 6.4 26.5 11.4 6.5 9.2 5.7 32.1 22.6 17.4 11.7 9.1 12.1 13.3 4.8 21.1 1.4 2.4 20.7 8.9 4.7 11.3 11.2 30.8 10.4 14.5 13.7 4.7 16.7 8.9 7.5 20.5 4.4 39.6 23.4 12.8 10.8 10.4 7.9 17.2 16.3 3.8 5.1 11.2 6.6 2.8 6.3 26.7 13.3 52.3 3.4 34.8 17.7 18.1 8.3 6.1 14.7 17.0 7.8 20.9 3.3 9.9 11.2 15.2 7.4 13.1 17.3 2.3 10.4 19.0 8.0 9.2 13.8 9.8 22.4 15.1 18.3 11.8 6.2 28.2 8.9 4.5 9.5 32.1 11.7 16.5 8.4 9.2 9.8 10.7 5.5 9.2 10.4 9.0 23.2 17.4 22.6 5.7 11.7 9.1 7.8 7.3 7.7 10.9 8.0 7.3 7.1 10.7 6.7 5.1 0.0 2.1 37.2 46.6 21.1 9.5 2.0 7.6 0.0 3.4 3.5 5.9 10.9 13.3 3.9 31.4 4.5 11.3 23.3 7.1 10.5 8.0 37.0 14.9 5.3 18.5 15.9 10.9 8.6 27.3 57.4 5.8 20.0 13.5 1.8 13.4 6.1 8.1 13.3 4.9 6.9 7.3 12.9 10.3 2.2 3.6 17.8 10.6 41.1 16.3 52.8 GRK7 GPRK7 ENSG00000114124 "G protein-coupled receptor kinase 7" Q8WTQ7 3 141778148-141818490 "Enzymes, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.4" "Cell type enriched" "Detected in some" 168 "Cone photoreceptor cells: 310.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HeLa: 1.5;U-937: 1.8" "Not detected" "Not detected" "HPA075093, HPA078232" Enhanced Approved Mitochondria NA NA Mitochondria "HPA075093: , HPA078232: " "unprognostic (1.11e-1)" "unprognostic (1.70e-2)" "unprognostic (3.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-2)" "unprognostic (5.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.53e-8)" "unprognostic (3.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.91e-1)" 0.2 0.5 0.3 0.5 0.4 1.5 0.2 0.9 0.3 0.2 0.1 0.4 0.3 0.0 0.3 0.3 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.6 0.3 0.7 0.2 0.2 0.3 0.0 0.4 0.2 1.6 1.5 0.4 0.0 0.2 0.4 0.1 1.0 0.1 0.3 0.1 0.3 0.7 0.2 2.4 0.4 0.5 0.6 0.1 0.0 0.1 0.1 0.6 0.4 0.0 4.1 0.1 0.0 0.0 0.1 0.2 0.6 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.5 0.2 1.5 0.2 0.0 0.4 0.3 0.1 1.1 0.0 0.1 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.2 0.7 0.4 0.2 0.2 0.2 0.1 0.2 0.0 0.5 0.3 0.4 0.2 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 1.8 0.2 0.2 0.4 0.3 0.4 0.2 0.6 0.6 0.5 0.3 0.1 0.7 0.5 0.5 2.4 0.5 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.3 1.0 0.2 0.0 0.0 0.0 0.0 310.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 GRPEL1 "FLJ25609, GrpE, hMGE" ENSG00000109519 "GrpE like 1, mitochondrial" Q9HAV7 4 7058906-7068197 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036647 Supported Supported Mitochondria NA NA 1900000 Mitochondria "HPA036647: AB_10672359" "unprognostic (6.13e-3)" "unprognostic (3.66e-2)" "unprognostic (1.92e-2)" "unprognostic (6.31e-2)" "unprognostic (9.77e-2)" "unprognostic (2.12e-3)" "unprognostic (2.17e-1)" "unprognostic (2.21e-3)" "unprognostic (1.51e-1)" "unprognostic (5.53e-2)" "unprognostic (4.99e-2)" "unprognostic (3.86e-2)" "prognostic favorable (2.00e-6)" "unprognostic (9.61e-2)" "unprognostic (7.18e-2)" "unprognostic (2.81e-1)" "unprognostic (7.30e-2)" 14.7 35.8 11.5 7.3 10.8 20.7 11.4 10.6 15.2 7.9 9.9 9.3 8.5 8.9 7.8 8.8 11.4 8.7 7.6 22.8 10.9 11.6 22.6 46.8 8.1 9.0 12.5 10.9 10.9 12.9 9.6 7.7 11.0 14.8 8.3 9.9 7.2 9.1 8.5 38.0 10.2 10.4 8.4 11.4 17.2 10.7 14.2 11.7 8.1 9.4 15.8 10.7 11.2 8.3 17.6 22.9 24.8 16.8 15.8 21.5 15.8 9.9 9.4 5.4 10.6 10.5 8.9 6.7 13.2 10.5 14.9 11.0 16.5 13.1 21.6 8.9 10.0 23.2 10.2 21.4 15.1 17.6 5.1 13.4 23.0 8.5 17.8 12.3 23.2 11.7 8.8 20.0 13.2 16.0 7.6 13.0 14.6 13.5 9.1 17.5 10.1 18.3 28.8 8.1 18.1 31.4 12.3 20.3 9.0 14.9 10.5 15.3 7.4 10.3 10.3 11.1 5.7 9.2 13.6 11.2 10.0 6.2 14.2 22.8 9.8 14.0 14.5 13.6 15.1 7.9 6.3 16.0 24.8 15.3 16.8 21.5 17.6 16.7 17.3 22.9 12.8 21.4 16.4 5.5 15.8 13.4 13.9 16.3 15.8 11.5 10.8 10.6 15.2 10.9 11.6 12.5 10.9 14.8 11.7 23.8 27.2 41.9 79.6 118.5 28.6 86.2 40.8 37.5 30.7 36.6 9.8 62.7 112.7 73.0 41.6 39.6 43.9 0.0 41.4 65.1 35.6 36.7 55.6 100.8 54.6 27.0 17.7 21.5 28.9 58.0 25.9 42.5 60.8 70.3 20.9 23.6 69.6 25.2 27.3 143.8 22.5 0.0 77.8 36.3 49.8 109.4 72.0 46.5 36.2 76.0 GRPEL2 "DKFZp451C205, FLJ23713, Mt-GrpE#2" ENSG00000164284 "GrpE like 2, mitochondrial" Q8TAA5 5 149345430-149354583 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018173, HPA023211" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA018173: AB_1850358, HPA023211: AB_1850360" "unprognostic (3.13e-2)" "unprognostic (1.69e-1)" "prognostic favorable (3.87e-5)" "prognostic unfavorable (2.21e-4)" "unprognostic (3.22e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.16e-8)" "unprognostic (1.34e-1)" "unprognostic (8.16e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.20e-1)" "unprognostic (2.26e-1)" 7.4 5.1 5.4 6.5 6.4 5.3 9.8 10.9 8.9 13.3 4.8 3.7 3.9 6.0 5.4 5.8 43.1 5.1 4.3 6.3 5.5 5.6 7.5 5.7 10.2 8.1 5.1 5.2 7.5 6.8 7.2 6.5 8.5 8.4 5.1 4.8 3.7 7.2 6.7 7.8 5.4 5.8 4.3 4.4 5.9 6.1 4.9 5.1 7.4 7.9 14.4 12.8 6.1 11.5 3.5 3.8 8.2 2.5 3.7 13.5 4.6 9.1 4.9 7.2 25.6 4.6 4.7 14.3 8.1 6.9 7.9 11.1 12.0 6.1 9.4 8.6 4.2 10.7 7.0 11.4 11.7 10.1 5.0 9.5 11.9 9.4 6.8 13.7 11.1 6.1 6.9 14.4 9.7 15.3 3.3 4.7 12.4 10.3 23.4 5.8 6.4 7.3 9.6 9.4 5.6 18.0 9.1 9.9 12.5 5.1 8.5 14.8 12.2 8.1 15.1 24.1 4.9 13.2 13.4 5.3 8.6 9.5 6.1 11.9 8.6 11.5 9.2 8.6 16.3 7.7 8.2 2.5 3.3 5.1 2.4 6.2 3.5 7.7 5.7 3.8 1.9 10.3 7.7 1.9 3.7 2.5 1.0 13.5 4.6 5.4 6.4 10.9 8.9 5.5 5.6 5.1 5.2 8.4 5.1 8.9 5.4 1.4 4.4 15.9 6.6 7.7 2.5 1.4 4.5 8.7 7.9 7.8 1.7 5.1 5.7 14.0 4.5 0.0 5.1 14.0 6.0 4.4 2.3 7.5 5.1 3.2 5.8 18.4 10.1 4.0 3.7 3.6 6.8 3.6 4.4 4.3 6.3 3.5 4.9 4.8 6.6 0.0 5.1 10.3 10.8 17.1 4.7 6.9 7.0 6.7 GRSF1 ENSG00000132463 "G-rich RNA sequence binding factor 1" Q12849 4 70815782-70839945 "Predicted intracellular proteins" "mRNA processing, tRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.8" "Cell type enhanced" "Detected in many" 9 "monocytes: 449.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036984, HPA036985" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA036984: AB_2675415, HPA036985: AB_10672785" "unprognostic (1.45e-3)" "unprognostic (1.82e-2)" "prognostic favorable (1.47e-5)" "unprognostic (8.63e-2)" "unprognostic (6.73e-2)" "unprognostic (4.15e-3)" "prognostic unfavorable (8.29e-5)" "unprognostic (1.94e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (7.68e-2)" "unprognostic (8.05e-2)" "prognostic favorable (2.72e-9)" "unprognostic (6.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-1)" "unprognostic (9.65e-3)" 17.9 33.4 21.3 22.3 19.9 8.8 29.0 19.1 42.5 16.8 22.7 19.7 15.0 18.1 17.2 18.2 21.7 18.9 22.9 33.3 22.9 22.6 23.9 23.6 23.7 24.6 24.8 20.2 17.3 26.9 19.6 13.7 18.3 23.6 17.7 27.1 12.0 32.1 20.9 101.8 18.7 17.2 18.1 24.1 17.3 22.5 13.6 19.1 37.0 19.7 31.1 21.7 21.1 15.4 5.7 20.0 7.6 11.6 14.3 11.7 5.6 32.3 22.1 26.0 27.0 27.6 32.3 37.4 39.3 24.9 29.7 24.4 22.5 33.3 46.8 30.1 40.4 15.4 12.4 46.0 30.7 39.8 25.4 15.1 24.6 22.7 31.1 34.1 35.9 14.2 27.1 29.6 29.9 20.9 35.9 30.5 26.1 28.1 27.2 41.2 34.6 59.1 25.3 27.7 35.4 23.4 24.4 40.5 19.9 36.6 40.5 27.2 24.5 18.5 52.8 64.8 31.8 22.9 17.7 27.8 27.8 29.3 22.9 24.7 22.7 18.0 30.1 23.0 23.4 27.0 7.6 11.6 5.2 7.6 8.8 9.5 5.7 11.2 11.7 20.0 4.9 11.2 9.5 1.6 14.3 10.5 19.3 9.3 5.6 21.3 19.9 19.1 42.5 22.9 22.6 24.8 20.2 23.6 19.1 29.8 29.3 32.1 42.4 44.4 17.5 125.4 40.8 21.4 26.1 26.2 23.6 87.9 63.0 61.2 5.7 32.2 41.3 0.0 53.0 115.0 34.8 51.4 17.3 45.7 56.0 27.0 66.2 28.8 58.2 5.3 32.2 42.5 59.1 449.1 69.7 23.1 55.3 42.1 36.7 56.1 17.4 19.4 40.1 21.9 55.1 44.2 64.5 37.9 79.0 54.6 GSDMC MLZE ENSG00000147697 "Gasdermin C" Q9BYG8 8 129748196-129786888 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 41.3;Suprabasal keratinocytes: 46.4" "Group enriched" "Detected in many" 6 "cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 8.3;HaCaT: 5.9;hTCEpi: 3.1;HUVEC TERT2: 3.3;TIME: 8.7" "HPA023670, HPA024767, HPA026317" Supported Approved Mitochondria NA NA Mitochondria "HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008" "unprognostic (6.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.61e-3)" "unprognostic (4.23e-2)" "unprognostic (2.11e-2)" "unprognostic (4.22e-3)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (8.28e-2)" "unprognostic (7.51e-2)" "unprognostic (4.92e-3)" "unprognostic (5.71e-2)" "unprognostic (2.93e-3)" "unprognostic (1.87e-2)" "unprognostic (1.88e-1)" "unprognostic (8.66e-2)" "unprognostic (1.90e-1)" 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.2 25.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.4 0.0 0.0 14.1 0.0 0.0 0.2 25.0 0.0 0.0 0.0 0.1 0.1 19.2 17.5 1.4 5.9 0.3 0.3 1.2 0.1 0.4 0.3 0.0 8.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 5.9 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.7 41.3 0.0 2.4 0.0 0.0 3.4 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 46.4 0.0 0.0 0.0 2.3 GTPBP3 "FLJ14700, GTPBG3, MSS1, MTGP1, THDF1" ENSG00000130299 "GTP binding protein 3, mitochondrial" Q969Y2 19 17334920-17342735 "Disease related genes, Predicted intracellular proteins" "tRNA processing" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042158 Approved Supported Mitochondria NA NA Mitochondria "HPA042158: AB_10964400" "unprognostic (1.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (3.08e-3)" "unprognostic (1.34e-1)" "unprognostic (2.18e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (6.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.70e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (2.81e-4)" "prognostic unfavorable (1.64e-4)" "unprognostic (4.94e-3)" "unprognostic (1.21e-1)" "unprognostic (2.56e-1)" "unprognostic (1.79e-1)" 8.0 13.8 8.1 12.0 14.7 10.0 9.3 11.7 12.6 9.6 8.2 7.4 9.8 12.5 10.2 6.9 13.0 9.8 12.4 7.9 11.3 10.7 9.2 13.7 7.5 13.4 7.8 11.6 11.3 12.3 14.8 11.0 8.0 11.4 10.6 7.2 10.3 13.2 15.6 14.3 22.9 10.6 8.6 6.7 13.2 11.0 3.5 6.3 16.7 9.2 10.9 16.2 8.5 10.0 6.6 9.3 1.3 4.4 6.3 7.3 3.7 9.2 5.6 5.2 6.7 1.8 1.6 25.4 4.4 1.8 4.0 4.0 7.7 7.5 14.1 11.3 1.6 2.9 8.3 6.6 3.7 3.3 11.7 30.6 8.5 8.1 10.0 2.3 9.0 5.5 1.7 5.5 3.7 4.8 2.8 3.2 10.1 16.1 6.4 2.0 7.3 10.8 8.0 11.0 5.7 25.2 12.9 4.1 13.3 3.7 4.2 12.2 10.9 4.7 7.3 6.0 3.6 6.4 3.7 3.5 6.3 5.6 13.8 7.7 10.9 16.9 17.0 4.9 11.9 4.7 0.5 3.1 0.6 7.1 4.4 5.8 4.5 6.5 6.1 4.8 6.6 7.3 6.8 1.3 6.3 2.4 9.3 4.4 3.7 8.1 14.7 11.7 12.6 11.3 10.7 7.8 11.6 11.4 6.3 3.0 4.0 2.2 7.8 15.1 16.9 6.5 5.1 2.7 1.2 5.2 29.5 16.2 6.6 10.3 0.3 8.2 7.1 0.0 9.3 20.5 8.6 5.5 2.3 8.9 8.8 11.1 2.9 9.2 3.3 0.0 10.9 5.8 10.1 8.2 8.8 8.4 8.6 8.0 12.7 6.2 19.1 6.5 7.2 2.1 5.3 15.3 7.0 10.2 12.4 4.6 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990918-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria No No Mitochondria "HPA034831: AB_10671506, HPA058631: AB_2683783" "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favorable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 7.5 9.3 7.4 7.3 7.8 9.5 7.3 8.5 10.1 7.1 11.9 9.2 8.3 8.0 8.3 5.2 12.2 6.4 7.4 20.0 7.6 7.6 12.2 8.2 6.2 13.2 7.6 8.3 10.4 12.1 13.0 12.1 9.3 9.5 8.2 9.3 6.6 9.6 5.2 25.3 6.5 11.8 7.4 11.7 9.3 9.1 22.7 8.9 25.4 13.4 14.3 10.2 9.6 8.0 6.7 12.2 6.7 7.0 11.9 15.8 7.8 19.6 9.0 11.9 13.4 7.3 12.6 9.5 13.6 11.8 14.0 17.5 15.8 8.5 12.9 8.0 7.5 11.3 13.5 15.8 13.1 16.1 5.7 11.1 35.3 9.0 8.2 6.9 22.5 8.7 10.0 9.4 7.7 5.5 14.5 12.8 15.2 12.4 15.3 13.4 7.7 14.3 11.0 24.5 9.9 17.1 12.2 11.0 8.2 9.8 12.4 13.8 14.0 11.0 8.7 18.1 10.7 9.8 15.3 7.7 10.2 15.1 3.7 12.7 10.0 13.1 18.0 10.2 18.7 11.2 6.7 7.0 4.5 10.4 4.6 9.1 6.7 11.9 10.0 12.2 5.9 15.8 10.3 1.0 11.9 3.9 5.8 8.2 7.8 7.4 7.8 8.5 10.1 7.6 7.6 7.6 8.3 9.5 8.9 14.9 9.6 16.3 11.9 11.9 9.3 24.2 7.6 13.4 7.9 5.2 5.9 23.6 19.9 14.6 58.0 10.3 10.5 23.3 15.9 20.5 12.6 10.8 19.6 7.2 20.3 9.5 9.8 10.4 14.5 21.7 10.9 14.2 10.1 12.6 9.7 8.9 13.4 10.2 5.3 23.1 12.2 0.0 17.5 35.6 28.1 10.7 12.7 16.7 11.9 16.1 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Supported Supported Mitochondria No No 8700000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 36.6 19.5 8.5 15.6 9.2 6.1 41.7 5.4 9.7 15.2 29.7 10.6 9.4 23.3 18.3 13.3 20.5 15.7 12.4 98.3 7.8 8.1 37.2 60.3 10.6 8.8 10.0 7.0 17.1 17.8 9.8 6.8 5.1 9.2 15.6 25.0 11.6 20.4 12.5 64.6 9.0 37.1 19.6 10.2 8.0 19.1 12.6 7.2 40.9 16.1 38.0 13.1 14.2 10.6 18.6 22.6 5.6 10.7 20.2 13.0 8.9 8.7 8.2 17.7 12.9 42.7 13.8 8.6 12.9 19.2 14.0 13.8 5.9 16.5 49.8 6.9 10.5 9.1 11.8 23.6 17.8 15.5 15.2 12.3 11.6 15.6 13.0 6.8 24.4 5.4 14.3 9.5 9.9 9.1 11.5 9.4 35.0 14.3 26.5 15.8 15.9 41.4 9.7 8.4 38.7 10.9 31.6 24.9 24.9 15.1 35.6 21.5 12.3 12.4 44.5 12.7 10.8 21.2 19.3 5.2 9.9 5.6 13.9 7.0 15.0 17.3 21.6 13.5 16.6 7.6 0.0 6.1 5.6 10.1 7.8 12.5 18.6 11.4 12.1 19.7 15.5 13.0 13.0 0.7 20.2 10.7 22.6 10.0 8.9 8.5 9.2 5.4 9.7 7.8 8.1 10.0 7.0 9.2 7.2 26.8 26.0 29.0 45.8 13.9 7.3 194.2 61.1 81.7 36.4 33.2 3.9 27.5 135.9 37.9 159.1 14.3 244.0 46.7 28.1 33.2 15.5 29.6 10.4 229.1 96.2 6.4 31.2 19.0 32.4 78.4 42.8 17.2 20.3 6.4 71.1 24.6 30.7 84.2 33.2 241.4 5.7 38.8 30.8 25.1 20.1 15.8 14.2 16.2 172.2 38.7 HADHA "GBP, LCEH, LCHAD, MTPA" ENSG00000084754 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" P40939 2 26190635-26244726 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015536, HPA056070" Approved Enhanced Mitochondria NA NA 2700000 Mitochondria "HPA015536: AB_1850473, HPA056070: AB_2683026" "unprognostic (2.02e-1)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (3.43e-1)" "unprognostic (2.67e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.16e-2)" "unprognostic (3.45e-1)" "unprognostic (3.81e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.68e-5)" "unprognostic (7.97e-2)" "unprognostic (1.71e-1)" "unprognostic (2.87e-3)" "unprognostic (2.64e-2)" 41.6 35.3 18.1 13.1 19.5 17.0 23.9 17.4 16.9 20.2 44.9 26.5 15.7 48.1 21.1 15.3 30.8 20.5 15.1 80.0 15.6 15.5 41.3 71.7 17.7 19.3 21.6 13.1 27.3 37.5 29.8 23.5 21.3 24.8 21.9 32.2 23.6 21.1 16.6 117.5 23.3 66.4 25.1 27.8 24.0 24.1 18.7 19.0 25.2 25.1 41.3 24.6 26.9 18.8 15.3 28.9 12.4 32.2 13.5 17.6 26.0 23.6 21.1 13.9 22.7 55.2 34.5 11.8 18.5 20.0 19.1 16.6 26.6 23.0 15.6 12.2 32.6 19.7 15.1 24.3 35.9 17.3 35.0 29.8 23.4 22.4 44.3 19.0 29.4 17.2 35.3 23.6 27.1 27.3 20.0 32.0 16.8 31.8 31.7 24.6 29.0 12.8 33.0 11.9 17.8 40.7 11.9 30.0 33.5 21.9 28.5 9.8 19.5 21.8 22.7 25.1 11.3 12.1 28.6 29.3 11.1 16.5 16.7 13.6 10.4 20.6 27.8 17.4 34.9 13.4 8.1 27.7 12.4 12.3 32.2 14.8 15.3 14.2 15.0 28.9 11.2 16.7 15.3 7.4 13.5 28.0 11.0 17.6 26.0 18.1 19.5 17.4 16.9 15.6 15.5 21.6 13.1 24.8 19.0 83.4 81.9 90.4 122.8 79.0 34.1 285.8 71.4 101.7 126.3 73.3 49.1 149.8 111.0 102.7 26.5 92.1 406.5 23.3 94.5 78.0 88.0 61.7 134.2 168.3 142.3 19.1 87.7 68.7 130.6 58.2 85.7 124.9 77.6 129.0 139.2 61.8 86.9 196.4 79.2 150.1 61.9 51.8 104.9 121.4 35.2 90.3 108.0 105.4 168.5 92.1 HADHB MTPB ENSG00000138029 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta" P55084 2 26243170-26290468 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.0;skeletal muscle: 155.6" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 922.0;Distal tubular cells: 441.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037539, HPA037540, HPA066099" Enhanced Supported Mitochondria No No 1100000 Mitochondria "HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618" "unprognostic (5.15e-2)" "unprognostic (8.72e-2)" "unprognostic (8.21e-2)" "unprognostic (8.67e-2)" "unprognostic (7.70e-2)" "unprognostic (2.59e-2)" "unprognostic (7.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (2.03e-1)" "unprognostic (8.94e-2)" "prognostic favorable (1.37e-9)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (2.88e-1)" "unprognostic (9.68e-2)" 23.3 45.5 24.8 11.0 24.7 9.9 16.6 16.6 17.4 13.8 21.4 31.1 19.3 43.6 17.1 16.2 20.6 13.9 12.6 126.0 18.0 20.0 45.8 62.4 12.8 16.1 34.8 18.3 16.2 23.7 19.9 13.1 12.6 27.8 15.8 22.8 19.9 27.2 15.9 155.6 13.2 35.0 20.3 29.5 15.3 19.5 15.8 23.8 10.6 22.4 44.9 14.5 18.5 12.8 20.2 45.2 21.5 49.1 23.8 26.8 33.9 23.1 18.3 12.8 22.9 79.0 43.7 13.0 19.5 29.9 20.1 19.7 21.8 22.6 11.6 13.7 31.9 22.6 18.3 21.2 27.6 24.7 26.1 18.5 26.6 10.9 42.7 33.9 21.5 20.4 42.3 45.5 20.9 34.0 34.3 37.2 18.0 22.3 18.8 41.9 17.0 12.0 41.5 8.9 34.8 19.9 13.3 42.2 22.0 41.3 32.9 6.1 21.1 33.4 38.1 51.2 16.0 23.6 38.4 25.7 19.0 19.9 17.8 14.0 14.1 21.2 20.4 21.8 34.3 18.8 21.0 49.1 18.9 14.2 43.4 18.1 20.2 19.3 17.6 45.2 14.8 18.0 16.3 21.5 23.8 33.2 15.3 26.8 33.9 24.8 24.7 16.6 17.4 18.0 20.0 34.8 18.3 27.8 23.8 44.7 32.2 48.9 103.6 55.2 29.0 922.0 127.4 46.8 42.1 92.5 53.0 177.3 441.0 96.4 60.4 68.1 196.9 116.8 50.2 61.8 59.6 61.5 62.2 218.5 127.1 12.7 71.9 67.5 100.7 74.5 52.3 80.0 84.4 77.5 85.7 52.4 56.5 91.7 59.1 244.7 72.5 71.1 92.4 75.6 46.1 47.8 156.1 48.0 100.9 85.2 HAX1 "HCLSBP1, HS1BP1" ENSG00000143575 "HCLS1 associated protein X-1" O00165 1 154272511-154275875 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055141, HPA075289" Approved Supported Mitochondria NA NA Mitochondria "HPA055141: AB_2682714, HPA075289: AB_2686742" "unprognostic (1.32e-1)" "unprognostic (2.68e-1)" "unprognostic (9.50e-2)" "unprognostic (6.93e-2)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (2.20e-1)" "unprognostic (9.09e-3)" "unprognostic (3.09e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (3.96e-1)" 24.0 25.4 28.6 16.0 33.9 12.2 29.2 15.1 36.6 24.9 24.8 21.9 22.9 18.6 20.2 42.7 27.7 24.5 20.2 59.5 24.7 26.3 32.1 61.7 17.3 20.3 25.8 20.3 29.3 47.8 21.0 35.2 18.4 23.5 26.1 25.0 26.6 52.0 26.3 90.4 17.8 27.8 25.1 22.6 23.2 23.9 31.3 17.0 23.8 32.4 45.8 27.7 27.0 18.6 39.1 34.9 59.1 39.6 30.9 51.8 42.8 20.5 17.6 14.9 32.7 18.5 20.7 24.2 19.6 32.2 41.6 38.7 23.3 23.2 30.0 28.5 33.2 19.5 17.8 34.2 27.1 32.2 30.7 25.6 14.6 14.5 20.1 41.3 30.3 31.7 19.2 50.2 31.2 37.5 14.6 23.1 44.0 28.4 44.8 26.7 49.6 30.4 25.1 16.5 49.0 38.6 21.6 11.0 57.6 21.9 11.5 23.0 22.9 17.5 42.5 59.3 25.7 35.1 83.9 11.5 17.3 23.3 18.1 27.0 52.3 54.5 56.2 26.4 28.0 28.5 58.3 28.4 59.1 34.2 33.5 39.1 39.1 43.1 38.7 34.0 38.2 51.8 41.2 17.2 30.9 39.6 34.9 50.8 42.8 28.6 33.9 15.1 36.6 24.7 26.3 25.8 20.3 23.5 17.0 26.8 32.8 105.0 105.1 66.2 57.5 96.8 56.0 32.1 31.8 43.6 45.2 70.2 154.2 76.6 107.7 63.1 62.2 46.7 92.7 108.3 57.2 80.6 98.1 74.9 86.5 38.1 55.3 44.8 55.3 88.4 56.7 70.8 82.7 180.3 58.5 75.4 79.5 58.8 58.4 123.1 86.4 58.2 76.2 186.3 97.5 66.9 74.3 99.1 65.0 89.4 HCCS "CCHL, MLS" ENSG00000004961 "Holocytochrome c synthase" P53701 X 11111301-11123078 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002946 Approved Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA002946: AB_1079041" "prognostic unfavorable (8.69e-5)" "unprognostic (6.89e-3)" "unprognostic (8.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.34e-1)" "unprognostic (5.44e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (9.18e-2)" "unprognostic (2.73e-1)" "unprognostic (2.52e-2)" "unprognostic (2.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.17e-8)" "unprognostic (2.66e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.93e-2)" 10.6 14.2 8.8 9.0 12.7 11.8 9.6 11.0 17.7 6.7 15.5 7.4 8.0 17.2 8.5 5.5 15.8 6.9 9.8 36.9 8.4 8.3 15.9 19.0 9.5 10.1 8.2 11.1 10.0 11.4 11.5 10.0 12.8 10.6 7.8 15.2 9.3 12.8 8.0 41.6 13.8 14.4 10.4 6.3 12.3 12.2 10.5 6.0 10.3 10.8 16.4 11.8 11.4 17.3 18.1 28.4 13.3 29.7 8.4 11.1 8.7 23.2 26.7 12.5 12.0 11.8 11.4 13.3 23.4 17.9 29.6 25.4 31.0 17.0 14.4 12.1 18.8 33.0 21.6 25.9 22.4 29.0 13.5 20.3 14.5 34.3 15.4 20.9 15.7 17.7 11.1 17.5 28.2 19.3 16.0 21.0 11.1 26.8 16.8 19.9 31.5 11.4 12.8 22.7 14.1 29.0 11.2 25.1 28.4 19.9 18.3 9.0 10.7 23.4 25.5 15.0 27.6 19.7 11.4 20.6 19.2 10.4 49.2 19.9 12.3 12.6 19.2 15.5 12.7 18.4 10.1 22.5 13.3 9.9 29.7 9.5 18.1 9.7 8.9 28.4 15.5 8.5 11.1 6.2 8.4 24.8 25.9 10.4 8.7 8.8 12.7 11.0 17.7 8.4 8.3 8.2 11.1 10.6 6.0 6.0 4.5 22.9 41.8 48.7 5.1 47.6 20.4 16.0 15.9 15.7 0.0 29.4 43.1 32.7 3.8 15.8 37.0 23.3 25.6 30.7 17.7 30.5 12.7 15.3 36.7 7.9 10.4 12.3 22.9 1.3 12.4 23.8 23.6 31.5 20.2 8.7 46.3 31.6 9.9 30.7 7.1 6.5 25.0 13.4 25.4 40.3 34.2 13.8 28.1 88.7 HDHD5 CECR5 ENSG00000069998 "Haloacid dehalogenase like hydrolase domain containing 5" Q9BXW7 22 17137511-17165287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 36.5;Ductal cells: 28.6;Exocrine glandular cells: 24.8;Extravillous trophoblasts: 35.3;Hofbauer cells: 38.3;Proximal tubular cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005548 Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA005548: AB_1078497" "unprognostic (4.04e-2)" "unprognostic (5.04e-2)" "unprognostic (4.54e-3)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.04e-3)" "unprognostic (7.35e-2)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (5.76e-2)" "unprognostic (2.35e-1)" "unprognostic (1.10e-1)" "unprognostic (7.07e-3)" "unprognostic (1.71e-1)" "unprognostic (1.20e-2)" "unprognostic (7.21e-3)" 12.2 22.2 10.3 11.3 13.3 12.8 14.7 13.2 13.2 10.6 23.7 11.3 8.8 23.7 12.6 10.1 15.3 11.9 16.0 29.5 9.9 8.4 14.7 29.8 12.5 12.4 16.4 10.4 13.6 25.3 8.9 9.6 7.4 13.2 12.7 13.1 7.7 17.3 10.0 37.2 15.7 16.5 12.0 9.9 14.6 13.6 12.4 13.7 15.1 9.4 25.9 11.6 11.9 10.7 10.1 29.3 2.9 34.6 11.1 15.0 17.5 22.7 15.1 11.3 15.3 6.7 4.1 14.5 6.5 7.2 17.6 19.0 22.1 8.5 37.4 11.0 7.8 8.6 16.1 14.3 15.3 8.2 11.3 20.9 0.0 10.9 0.0 11.2 16.8 8.8 10.0 19.1 7.8 8.7 9.9 12.3 24.8 10.9 9.7 9.2 22.2 29.5 34.6 17.3 35.2 13.5 16.9 17.1 9.4 12.0 12.6 23.0 17.4 12.7 18.5 19.5 9.4 18.5 21.1 10.6 15.0 11.1 10.5 11.2 15.5 16.8 27.5 12.0 0.0 12.5 2.9 34.6 1.6 11.8 21.4 14.7 10.1 11.2 10.7 29.3 9.6 15.0 12.5 1.7 11.1 11.6 12.1 11.3 17.5 10.3 13.3 13.2 13.2 9.9 8.4 16.4 10.4 13.2 13.7 6.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 9.1 5.2 0.0 21.4 36.5 28.6 0.0 0.0 0.0 0.0 24.8 35.3 0.0 0.0 4.7 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 9.0 0.0 0.0 21.7 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 HEATR6 "ABC1, FLJ22087" ENSG00000068097 "HEAT repeat containing 6" Q6AI08 17 60043194-60078931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 49.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030789, HPA062157" Uncertain Approved Mitochondria NA NA Mitochondria "HPA030789: AB_10601660, HPA062157: AB_2684700" "unprognostic (1.98e-1)" "unprognostic (7.95e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.22e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.02e-6)" "unprognostic (2.24e-1)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (6.81e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" 8.3 14.5 14.6 9.2 15.4 12.0 10.3 28.5 15.1 12.2 13.0 18.0 11.1 6.8 14.4 12.6 9.4 13.0 9.1 12.3 11.2 9.9 9.0 7.1 11.8 11.0 15.3 12.6 17.8 10.3 16.7 18.4 10.7 13.7 13.2 10.6 10.0 11.3 13.0 12.6 13.3 11.2 15.0 12.8 14.1 9.5 10.5 15.8 10.0 9.5 7.2 9.7 12.3 18.9 10.8 12.8 6.8 10.4 4.1 6.8 4.6 4.7 9.3 8.2 5.6 5.5 8.1 5.9 4.7 7.9 8.9 8.6 4.0 3.5 1.7 7.7 8.3 7.3 5.7 6.5 6.4 11.6 3.3 8.3 9.1 7.3 6.0 7.1 5.7 8.2 8.1 10.4 6.5 9.2 9.8 5.1 5.2 5.2 5.7 5.9 49.1 7.6 2.1 4.2 4.3 8.7 2.9 14.2 5.0 4.8 5.8 5.4 12.4 4.4 1.6 4.7 8.1 7.1 3.9 4.7 8.3 12.6 6.2 7.7 4.8 5.2 0.0 7.3 4.4 6.3 5.1 6.1 6.8 6.8 10.4 5.5 10.8 5.5 5.7 12.8 8.4 5.9 5.1 1.2 4.1 9.9 4.4 5.6 4.6 14.6 15.4 28.5 15.1 11.2 9.9 15.3 12.6 13.7 15.8 11.9 4.6 4.7 3.2 0.8 10.6 8.2 2.5 14.7 10.3 7.0 9.8 4.9 3.3 4.0 0.7 2.2 0.9 0.0 2.9 2.8 3.1 1.8 10.5 2.6 4.1 6.4 6.4 3.7 4.1 0.7 3.1 6.5 1.7 19.8 1.5 8.2 2.4 0.0 10.6 2.8 6.3 6.5 3.3 3.4 7.5 1.9 1.7 2.5 2.5 1.1 HIBCH ENSG00000198130 "3-hydroxyisobutyryl-CoA hydrolase" Q6NVY1 2 190189735-190344193 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 262.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036540, HPA036541, HPA067080" Enhanced Enhanced Mitochondria NA NA 90000 Mitochondria "HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: " "unprognostic (3.60e-3)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.36e-3)" "unprognostic (3.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.96e-1)" "unprognostic (1.89e-1)" "unprognostic (2.88e-1)" "prognostic favorable (1.22e-4)" "unprognostic (7.32e-2)" "unprognostic (1.37e-2)" "prognostic favorable (1.04e-10)" "unprognostic (1.34e-1)" "unprognostic (3.73e-1)" "unprognostic (1.36e-1)" "unprognostic (4.18e-3)" 13.7 38.6 18.1 10.1 19.5 5.0 15.8 16.4 18.7 16.3 15.8 14.5 13.0 24.7 17.0 13.0 20.2 10.2 10.0 13.7 18.5 12.7 65.7 56.8 7.6 8.2 20.1 10.8 9.5 29.5 35.8 24.7 7.8 21.0 11.7 18.7 15.0 10.6 12.2 17.5 23.7 16.5 11.3 18.2 9.0 10.4 10.6 22.2 10.5 17.4 15.4 9.3 12.5 49.2 24.2 15.1 14.6 7.6 17.3 20.0 7.3 9.8 7.6 16.3 10.3 15.4 13.6 9.0 10.7 5.7 10.1 11.0 23.5 8.7 15.0 15.3 9.2 7.2 18.9 17.2 14.7 15.3 21.5 13.4 20.0 15.9 20.5 5.2 14.2 7.4 11.0 7.9 11.8 2.1 14.8 16.3 14.3 24.2 13.1 11.0 9.1 14.5 16.4 5.1 13.4 15.5 18.0 11.7 38.0 22.8 29.9 12.4 11.7 9.2 13.2 30.2 24.8 14.9 11.1 11.5 10.7 10.0 7.2 7.5 8.4 17.8 12.5 9.7 12.4 8.4 12.9 6.7 14.6 11.9 7.6 12.8 24.2 13.3 12.5 11.1 18.7 14.2 18.2 3.5 17.3 5.7 15.1 20.0 7.3 18.1 19.5 16.4 18.7 18.5 12.7 20.1 10.8 21.0 22.2 20.8 19.6 31.1 98.9 49.7 35.7 23.4 40.8 28.1 28.4 34.9 96.2 40.5 97.8 21.8 145.2 29.2 35.8 0.0 25.6 16.9 26.6 30.4 10.3 97.2 29.6 23.8 36.2 76.7 17.4 44.8 32.2 15.7 43.9 14.4 25.9 37.9 16.2 17.3 42.8 262.7 51.0 38.8 26.4 17.5 27.2 35.5 16.7 21.3 53.3 81.2 HINT2 ENSG00000137133 "Histidine triad nucleotide binding protein 2" Q9BX68 9 35812960-35815354 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 537.2;Hepatocytes: 366.2;Proximal tubular cells: 463.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020961, HPA059109" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA 1100000 Mitochondria "HPA020961: AB_1850715, HPA059109: AB_2683906" "unprognostic (9.64e-3)" "unprognostic (1.53e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (3.97e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.71e-3)" "unprognostic (2.87e-2)" "prognostic favorable (2.97e-9)" "unprognostic (4.29e-2)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (1.72e-1)" 18.4 27.2 16.0 14.5 15.5 10.3 15.6 9.5 16.5 10.0 16.4 11.0 26.1 15.3 8.9 24.1 12.6 14.4 21.7 33.7 13.3 13.3 34.8 68.7 15.2 14.2 15.3 13.6 6.8 30.8 21.0 14.1 12.8 12.5 10.8 16.4 12.2 20.2 31.0 30.9 10.3 15.8 17.0 12.3 11.3 16.7 10.3 8.2 16.8 14.9 29.8 11.8 10.4 7.5 24.6 62.0 7.8 20.3 15.1 25.5 18.5 9.7 26.8 16.7 16.1 10.7 9.0 10.9 9.2 13.8 15.1 16.7 17.5 10.8 12.7 10.6 8.8 21.6 9.8 7.6 14.3 16.0 27.6 13.8 13.8 23.3 15.7 24.8 7.7 14.0 10.0 13.2 14.3 23.4 6.0 11.7 31.3 8.1 41.4 12.0 20.8 19.5 9.8 7.4 24.0 46.1 19.6 11.1 17.5 21.5 7.6 13.3 15.9 12.0 14.9 16.0 10.4 16.1 15.1 5.3 8.1 12.8 10.5 11.6 36.0 40.0 18.3 17.9 10.8 12.7 7.8 20.3 1.1 18.5 14.3 16.7 24.6 19.9 18.5 28.6 23.8 15.4 15.9 1.9 15.1 13.0 62.0 25.5 18.5 16.0 15.5 9.5 16.5 13.3 13.3 15.3 13.6 12.5 8.2 20.8 10.8 63.0 60.5 40.3 34.2 96.4 124.9 53.5 13.6 76.8 19.6 143.0 537.2 101.9 54.3 49.6 142.5 46.7 149.8 55.2 58.2 44.3 18.4 366.2 96.3 19.1 92.3 63.3 58.2 111.5 37.4 47.7 114.7 71.3 106.7 69.3 83.1 158.4 42.1 463.5 36.6 45.3 71.8 32.1 82.2 40.1 47.5 67.1 120.6 54.5 HK1 ENSG00000156515 "Hexokinase 1" P19367 10 69269984-69401884 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycolysis, Immunity, Inflammatory response, Innate immunity" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 307.9;Horizontal cells: 287.6;Late spermatids: 870.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007043, HPA007044, CAB010052" Supported Supported Mitochondria NA NA 16000000 Mitochondria "CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049" "unprognostic (8.80e-2)" "unprognostic (1.78e-1)" "unprognostic (2.03e-1)" "unprognostic (2.00e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-3)" "unprognostic (1.12e-1)" "unprognostic (1.37e-3)" "unprognostic (7.25e-2)" "unprognostic (1.40e-2)" "unprognostic (2.00e-3)" "unprognostic (3.86e-2)" 17.5 10.5 21.1 19.9 30.4 23.5 15.8 40.0 48.6 16.6 16.9 10.1 7.6 6.3 13.5 9.4 44.8 15.2 12.6 61.6 19.8 23.3 10.8 4.4 17.2 14.3 19.8 31.3 9.0 4.6 12.5 14.7 22.6 31.3 25.5 15.4 21.2 21.5 26.8 62.1 30.7 8.6 25.6 9.7 13.3 20.3 28.9 10.6 18.9 33.6 32.6 23.0 25.8 23.1 11.4 25.5 17.8 39.3 8.9 23.0 29.6 17.7 10.1 13.6 12.9 15.2 11.4 8.6 17.7 46.6 23.7 25.7 2.9 2.0 1.3 14.0 29.7 17.2 15.6 12.7 39.6 22.7 11.8 9.9 44.2 10.8 0.2 17.3 0.8 33.5 17.2 23.1 33.9 75.8 29.8 24.6 6.6 73.7 9.3 32.4 29.5 5.1 2.2 20.8 9.1 45.1 7.8 8.3 0.1 16.4 21.0 13.9 16.4 20.2 39.4 11.7 20.1 21.5 2.9 25.2 35.5 16.2 19.5 24.7 11.3 7.4 3.1 46.0 23.3 10.2 17.8 27.3 13.4 14.0 39.3 23.0 11.4 16.2 15.8 25.5 6.8 14.5 11.5 6.6 8.9 39.3 2.9 17.8 29.6 21.1 30.4 40.0 48.6 19.8 23.3 19.8 31.3 31.3 10.6 23.8 29.6 15.8 44.3 42.8 67.3 110.0 7.6 32.1 31.8 26.2 51.1 51.0 11.6 26.4 307.9 34.4 10.3 23.3 26.9 78.8 26.0 25.9 22.0 0.8 45.7 287.6 18.0 25.8 31.3 870.1 14.1 40.6 35.4 24.4 21.8 29.7 36.4 11.5 17.3 0.7 85.2 19.4 42.8 4.3 4.4 45.2 99.4 25.4 12.6 42.9 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220303-69267559 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 77.4" "Cell type enhanced" "Detected in many" 25 "Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.3;T-reg: 6.6" "Lineage enriched" "Detected in single" 29 "T-cells: 8.3" "Cell line enhanced" "Detected in some" "A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2" "Region enhanced" "Detected in some" "cerebral cortex: 12.2" "Low region specificity" "Detected in all" "HPA064198, HPA064230" Enhanced Enhanced Mitochondria No No Mitochondria "HPA064198: AB_2685210, HPA064230: AB_2685219" "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.2 0.0 0.9 1.2 1.6 0.0 0.2 0.8 1.4 0.5 29.8 0.5 0.2 29.9 0.5 1.0 0.3 2.5 11.2 0.2 0.5 0.6 15.6 4.6 1.3 0.3 0.3 0.2 1.0 4.7 0.0 0.5 0.2 0.4 0.2 2.3 12.0 0.2 0.2 0.2 0.0 77.4 0.2 0.2 0.2 0.4 0.6 0.2 0.2 5.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 8.3 1.6 0.4 14.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.1 41.7 0.0 12.9 0.1 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.2 1.0 0.0 0.0 0.0 0.1 0.1 1.2 0.2 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.5 0.0 0.4 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.7 0.0 4.4 1.4 0.0 0.0 8.3 3.2 0.0 0.2 0.0 0.0 6.6 1.6 0.9 1.6 0.8 0.4 0.5 0.6 0.3 0.2 0.4 0.2 3.0 3.7 0.8 0.0 0.0 1.0 0.8 30.6 0.0 0.0 15.7 0.0 0.0 1.7 30.8 0.4 0.0 44.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 172.8 19.9 7.0 0.0 9.5 4.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.2 0.1 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119747996-119768905 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 257.0" "Cell type enhanced" "Detected in many" 24 "Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3" "Cancer enhanced" "Detected in many" "liver cancer: 441.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "OE19: 35.4;RT4: 63.6" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Supported Mitochondria NA NA 820000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favorable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favorable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 0.3 0.1 0.3 8.7 0.3 0.0 20.6 0.3 0.3 0.3 30.8 0.4 0.3 13.8 0.3 0.3 0.7 0.1 4.4 42.0 0.4 0.0 7.4 257.0 0.8 0.3 0.3 0.3 0.3 1.4 0.0 0.3 0.8 0.7 3.8 19.8 18.9 5.1 0.3 1.4 1.8 12.2 1.9 0.3 0.3 8.1 6.1 0.3 0.4 0.3 0.6 2.1 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.2 0.2 0.0 63.6 0.0 0.2 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.3 0.7 0.3 3.0 6.7 7.5 3.6 0.1 0.0 4.5 68.8 0.0 0.0 29.6 0.0 0.2 0.0 0.0 1.5 0.0 76.1 0.0 0.0 0.1 0.0 10.3 4.6 901.4 0.2 0.0 70.2 16.0 17.8 2.7 1.4 0.0 5.0 0.0 249.3 0.0 0.1 126.7 0.0 0.3 0.0 6.5 0.0 0.5 0.4 0.3 7.9 0.0 248.3 15.4 HRASLS2 FLJ20556 ENSG00000133328 "HRAS like suppressor 2" Q9NWW9 11 63552770-63563383 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 16.1;intestine: 42.5" "Group enriched" "Detected in many" 6 "Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 16.1;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 12 "B-cells: 16.1" "Cell line enriched" "Detected in some" 8 "U-266/70: 54.4" HPA058997 Approved Approved Mitochondria NA NA Mitochondria "HPA058997: AB_2683874" "unprognostic (4.76e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.4 0.0 0.4 1.5 0.4 0.0 4.7 0.4 0.4 0.6 20.6 0.5 0.4 33.4 0.6 1.1 0.5 2.1 0.4 1.0 0.4 0.2 5.5 1.9 3.3 1.1 0.4 0.4 0.4 0.4 0.0 0.4 1.4 0.4 0.4 6.5 0.4 0.7 0.4 0.4 0.2 42.5 0.4 0.4 0.7 8.8 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 16.1 0.8 0.1 0.1 1.2 0.9 3.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.4 0.0 0.4 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 3.5 0.8 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 54.4 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.9 16.1 0.2 0.9 0.0 5.3 0.2 0.6 0.1 1.2 0.0 0.8 0.0 3.6 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 0.4 0.4 3.0 0.6 3.0 19.5 0.1 0.0 0.3 5.1 45.5 5.7 0.0 0.0 0.1 8.3 0.4 0.3 0.0 59.0 0.0 0.4 0.3 0.0 6.2 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.7 7.0 0.0 75.2 0.0 0.0 0.0 0.7 0.1 0.0 0.7 1.0 0.9 43.6 HRNR "FLG3, S100A16, S100a18" ENSG00000197915 Hornerin Q86YZ3 1 152212082-152224193 "Plasma proteins, Predicted intracellular proteins" Keratinization "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.0" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 1.6;Rod photoreceptor cells: 3.3" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "A549: 1.6;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.2;TIME: 1.2;U-2 OS: 1.6;U-2197: 1.5" HPA031469 Uncertain Approved Mitochondria No No 210000000 Mitochondria "HPA031469: AB_10603771" "unprognostic (1.34e-1)" "unprognostic (4.51e-2)" "unprognostic (3.01e-2)" "unprognostic (8.72e-4)" "unprognostic (1.61e-2)" "unprognostic (1.45e-1)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (6.09e-2)" "unprognostic (3.38e-2)" "unprognostic (1.87e-2)" "unprognostic (1.59e-2)" "unprognostic (1.65e-2)" "unprognostic (2.49e-2)" "unprognostic (1.71e-1)" "unprognostic (2.07e-1)" "unprognostic (3.64e-2)" 0.3 0.4 0.0 0.1 0.2 0.1 0.3 0.0 1.3 0.7 0.1 0.1 0.5 0.0 1.8 0.8 0.6 0.5 0.1 0.1 1.0 0.0 0.1 0.4 0.0 1.6 1.5 0.0 0.4 0.1 0.6 0.0 0.2 0.0 0.1 4.0 0.2 0.0 0.1 0.1 0.1 1.3 1.6 0.0 0.4 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.6 1.2 0.1 1.6 1.5 0.3 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 HS2ST1 KIAA0448 ENSG00000153936 "Heparan sulfate 2-O-sulfotransferase 1" Q7LGA3 1 86914648-87109998 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043069, HPA043603, HPA075001" Supported Approved Mitochondria "Intracellular and membrane" No No Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726" "unprognostic (1.04e-1)" "unprognostic (1.50e-1)" "unprognostic (1.28e-3)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.20e-2)" "unprognostic (5.34e-2)" "unprognostic (7.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.45e-1)" "unprognostic (5.80e-2)" "unprognostic (1.63e-2)" "unprognostic (5.07e-2)" "unprognostic (3.24e-1)" "unprognostic (7.58e-2)" 8.8 28.7 15.5 9.6 25.2 2.8 7.3 8.9 15.1 10.3 9.5 6.2 5.4 8.6 9.0 9.4 6.4 6.5 9.6 6.8 14.7 10.2 12.8 15.5 8.0 9.7 9.2 13.8 12.3 9.0 15.9 12.1 7.5 10.1 8.9 8.3 8.2 8.3 9.7 5.3 7.2 8.0 7.1 7.6 18.6 7.2 8.0 7.7 16.5 11.8 4.3 10.0 9.2 7.1 5.6 1.3 9.0 4.3 1.8 3.0 1.8 9.9 8.5 25.0 16.3 13.9 40.6 8.7 9.7 12.8 8.2 9.1 32.4 12.8 21.9 9.5 6.7 14.2 6.1 11.4 8.1 13.3 17.1 9.5 26.3 9.4 25.8 5.8 13.5 13.2 16.7 7.2 13.2 11.0 13.0 12.1 12.4 17.9 11.6 11.8 3.5 13.5 8.2 8.7 10.9 5.6 16.8 23.7 4.7 10.0 20.9 5.4 8.1 12.9 11.1 11.2 6.8 7.3 6.2 10.6 10.3 12.8 18.0 12.2 10.7 7.9 20.6 6.3 9.8 10.5 9.0 2.0 1.7 2.6 1.2 3.0 2.0 2.8 2.8 1.3 5.6 2.8 1.8 2.1 1.8 4.3 1.3 1.5 1.8 15.5 25.2 8.9 15.1 14.7 10.2 9.2 13.8 10.1 7.7 14.9 11.3 8.0 7.0 14.7 8.7 11.5 15.3 9.4 19.4 19.2 3.9 8.0 11.6 13.0 3.6 12.6 10.5 0.0 10.0 7.5 16.7 8.7 18.5 24.1 29.9 7.9 22.4 17.2 12.6 3.0 6.4 11.8 11.8 5.4 13.5 26.9 11.0 3.5 19.1 14.7 16.3 0.0 14.2 7.4 13.9 13.8 3.7 7.5 13.0 6.8 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112379937-112472410 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favorable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favorable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 31.0 26.3 18.3 5.8 17.7 4.1 13.8 5.7 12.1 10.1 14.1 11.9 6.2 15.2 11.0 5.0 14.4 8.8 7.6 52.1 16.1 13.7 29.3 70.5 11.4 7.8 17.9 10.8 21.3 11.4 7.9 7.7 9.9 12.4 12.2 11.0 10.2 7.3 6.9 54.1 12.5 18.3 13.3 12.9 10.1 9.9 5.9 14.5 5.7 13.2 27.7 6.9 14.2 10.7 3.6 4.6 23.3 5.0 2.6 4.1 2.4 15.0 13.5 10.2 5.1 17.7 17.5 11.7 10.3 6.4 7.4 6.2 25.9 17.0 9.7 5.7 15.1 9.5 17.3 10.9 14.5 9.1 40.5 7.2 10.0 21.8 25.3 11.0 5.6 6.5 18.6 10.5 11.0 8.0 10.8 8.5 11.9 13.9 6.5 20.1 9.9 13.9 5.3 6.0 36.1 17.5 9.1 30.7 14.2 15.6 13.7 7.3 5.2 25.9 17.2 8.7 8.7 24.3 6.9 9.7 10.7 10.0 29.7 10.0 7.7 18.9 4.6 13.2 8.4 6.2 21.9 4.0 15.2 2.3 3.9 3.5 3.3 2.5 2.6 4.5 3.6 3.0 3.1 23.3 2.6 5.0 4.6 4.1 2.4 18.3 17.7 5.7 12.1 16.1 13.7 17.9 10.8 12.4 14.5 92.3 61.8 13.9 14.4 11.7 9.4 160.9 12.7 48.2 43.3 14.0 5.9 21.7 54.7 13.9 135.8 13.9 29.7 0.0 16.4 25.3 13.4 15.9 30.0 98.6 31.2 6.4 14.3 19.6 18.9 127.6 25.3 23.6 8.5 56.9 28.3 22.3 14.4 24.6 44.2 86.7 14.6 45.3 30.3 11.8 16.2 14.2 26.5 7.5 34.3 26.2 HSPA9 "GRP75, HSPA9B, mot-2, mthsp75, PBP74" ENSG00000113013 "Heat shock protein family A (Hsp70) member 9" P38646 5 138554882-138575444 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000898, CAB005219" Supported Supported Mitochondria NA NA 3100000 Mitochondria "CAB005219: AB_647720, HPA000898: AB_1079032" "prognostic unfavorable (2.93e-4)" "unprognostic (1.86e-1)" "prognostic favorable (4.53e-4)" "unprognostic (3.73e-2)" "unprognostic (2.33e-1)" "unprognostic (9.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (9.85e-2)" "unprognostic (2.53e-1)" "unprognostic (2.74e-1)" "unprognostic (1.31e-1)" "unprognostic (8.78e-3)" "unprognostic (1.02e-1)" "unprognostic (2.15e-1)" "unprognostic (3.27e-2)" "unprognostic (2.29e-1)" 26.4 76.4 30.9 22.1 33.2 39.8 27.7 24.3 39.5 20.0 28.7 30.4 24.0 27.8 23.1 29.7 28.5 19.1 19.3 55.0 28.2 32.5 59.9 117.7 20.5 22.8 35.5 31.3 28.9 31.9 56.7 25.5 24.6 43.7 25.3 32.7 20.6 26.0 26.4 84.2 24.0 25.7 24.0 29.3 24.6 27.7 18.6 32.0 21.1 41.0 32.8 29.1 23.7 33.1 19.3 24.1 6.6 20.9 20.5 28.3 23.3 32.8 41.5 23.7 45.5 24.9 16.3 48.8 34.8 30.9 39.1 42.6 79.1 35.0 62.9 47.8 25.9 81.7 27.9 63.1 46.7 54.3 31.5 30.9 34.7 37.4 52.7 67.3 34.8 38.5 27.7 70.9 43.2 97.5 18.6 18.5 34.9 43.2 54.2 30.8 40.3 36.5 30.0 34.8 41.2 34.5 41.0 34.3 48.6 43.9 47.3 28.5 21.8 40.3 64.2 131.8 54.2 36.9 40.9 17.7 38.4 24.3 32.0 55.1 66.8 47.8 63.2 47.3 61.5 38.3 6.6 16.9 6.5 24.0 20.9 28.3 19.3 20.6 23.0 24.1 14.1 23.0 22.8 3.9 20.5 20.6 14.1 18.2 23.3 30.9 33.2 24.3 39.5 28.2 32.5 35.5 31.3 43.7 32.0 92.3 107.5 91.5 189.1 78.1 88.6 317.9 48.4 133.8 137.6 94.2 78.5 173.0 189.0 95.9 8.0 72.1 76.6 0.0 92.2 101.6 79.5 116.1 162.9 146.7 117.6 93.8 70.0 42.4 46.7 9.5 62.5 101.4 79.2 92.0 66.7 103.5 85.4 66.6 68.2 159.6 83.0 45.3 128.1 52.3 83.5 64.5 146.8 88.6 107.5 141.4 HSPBAP1 "FLJ22623, PASS1" ENSG00000169087 "HSPB1 associated protein 1" Q96EW2 3 122740003-122793824 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 56.9;Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044930 Approved Approved Mitochondria NA NA Mitochondria "HPA044930: AB_10961122" "unprognostic (3.40e-3)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (6.70e-3)" "unprognostic (3.40e-3)" "unprognostic (3.40e-2)" "unprognostic (8.61e-4)" "unprognostic (2.68e-2)" "unprognostic (6.95e-2)" "unprognostic (3.35e-2)" "unprognostic (2.36e-1)" "unprognostic (8.91e-2)" "unprognostic (1.24e-3)" "unprognostic (4.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.34e-1)" "unprognostic (4.12e-3)" 7.2 9.3 6.7 9.2 6.9 4.5 13.1 3.1 6.7 6.8 6.0 7.0 9.1 4.1 7.9 5.3 5.2 5.3 6.0 6.1 6.0 5.3 7.1 5.8 10.4 9.1 7.8 4.5 5.8 6.3 5.3 9.0 17.0 8.7 5.8 5.9 10.2 6.0 6.4 25.4 7.0 5.9 8.1 10.8 11.4 5.4 16.5 8.3 9.1 10.6 8.9 8.8 7.9 5.6 8.3 9.2 22.0 15.5 4.5 7.2 5.8 4.5 3.5 5.1 4.5 6.1 4.6 9.9 2.3 5.8 5.4 7.6 4.7 3.6 5.8 3.7 1.6 13.6 5.5 7.8 4.3 6.3 3.6 2.1 3.8 4.1 2.7 13.8 3.5 5.4 6.8 15.8 4.4 14.4 5.1 5.0 5.9 2.5 5.0 4.8 2.9 5.0 4.4 5.8 3.5 7.1 5.2 6.8 5.6 5.5 1.7 5.6 5.7 5.3 2.1 19.1 5.0 2.5 7.4 5.0 6.3 3.7 2.0 3.1 5.0 5.0 6.9 3.9 5.2 6.1 13.3 12.1 8.3 4.7 8.6 5.8 8.3 6.1 4.6 9.2 5.6 6.8 6.5 22.0 4.5 15.5 3.1 7.2 5.8 6.7 6.9 3.1 6.7 6.0 5.3 7.8 4.5 8.7 8.3 6.0 7.7 8.7 3.7 9.5 5.3 4.1 2.5 5.3 2.3 5.2 56.9 13.9 3.3 4.6 17.2 4.7 3.9 0.0 5.2 9.6 4.2 2.6 5.8 2.5 11.6 7.9 0.0 12.9 18.1 3.6 8.9 21.8 5.0 17.2 2.6 3.4 3.9 2.6 4.6 3.6 10.8 6.5 3.8 22.6 7.1 6.6 40.6 10.2 3.3 1.7 HSPD1 "GroEL, HSP60, SPG13" ENSG00000144381 "Heat shock protein family D (Hsp60) member 1" P10809 2 197486581-197516737 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, Isomerase" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 162.6" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001523, CAB002775, HPA050025, CAB072816" Supported Enhanced Mitochondria NA NA 53000000 Mitochondria "CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995" "unprognostic (2.79e-2)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.59e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (2.25e-4)" "unprognostic (3.51e-2)" "unprognostic (9.91e-2)" "unprognostic (8.63e-3)" "unprognostic (3.47e-2)" "unprognostic (7.83e-3)" "unprognostic (5.64e-3)" "unprognostic (1.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (4.10e-2)" 28.5 125.2 28.7 23.4 31.8 21.0 55.9 18.2 24.3 17.4 30.3 17.8 23.3 28.9 17.5 18.5 27.2 25.3 16.3 24.0 24.2 27.8 67.1 147.5 22.4 25.3 35.5 16.1 30.2 50.6 32.5 25.9 27.1 33.6 25.9 37.2 11.9 17.6 21.0 36.4 13.7 32.0 23.6 32.4 22.7 25.2 10.9 35.8 22.7 38.7 29.4 30.3 33.3 162.6 25.6 30.3 6.2 29.3 23.1 33.5 22.2 41.2 50.8 42.6 38.2 29.2 30.6 62.0 43.0 22.7 51.8 38.0 170.3 24.9 125.5 56.1 22.4 64.2 42.2 166.7 47.4 73.5 30.8 66.9 89.1 82.2 197.1 27.5 98.7 28.0 34.5 55.0 45.9 80.9 36.5 40.6 69.3 109.7 49.2 38.0 52.8 61.2 99.9 84.2 54.3 106.3 73.7 52.6 90.6 54.4 43.2 55.8 31.7 43.1 46.7 55.2 91.1 32.3 58.6 18.1 32.2 44.7 41.4 67.9 27.6 60.7 104.2 37.8 59.7 34.5 4.5 19.7 5.3 15.5 29.3 28.8 25.6 25.0 21.8 30.3 21.0 33.5 29.0 6.2 23.1 25.8 20.2 19.7 22.2 28.7 31.8 18.2 24.3 24.2 27.8 35.5 16.1 33.6 35.8 154.9 133.3 218.4 1171.9 219.0 70.0 213.1 150.3 448.3 361.7 75.0 241.5 780.7 318.3 195.2 4.9 145.2 151.1 70.0 125.9 299.2 219.4 456.8 297.3 264.5 289.1 90.6 262.9 61.4 70.1 9.9 120.8 249.2 155.3 160.5 166.4 117.0 164.4 153.9 106.8 589.7 103.4 84.1 310.2 68.2 82.2 181.0 837.2 136.4 347.8 853.1 HTRA2 "OMI, PARK13, PRSS25" ENSG00000115317 "HtrA serine peptidase 2" O43464 2 74529377-74533348 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Apoptosis "Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004004, HPA006602, HPA027366" Uncertain Supported Mitochondria NA NA Mitochondria "CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301" "unprognostic (3.09e-1)" "unprognostic (4.06e-2)" "unprognostic (2.82e-1)" "unprognostic (2.58e-2)" "unprognostic (1.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.77e-8)" "unprognostic (2.12e-3)" "unprognostic (4.18e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-2)" "unprognostic (8.15e-2)" "unprognostic (7.23e-3)" "unprognostic (4.03e-1)" "unprognostic (1.73e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-2)" 16.4 12.7 10.6 14.9 11.3 18.9 12.9 10.7 17.7 12.3 12.8 12.6 9.7 12.6 12.9 6.9 10.7 10.6 9.0 12.9 11.6 8.7 13.1 11.4 11.3 13.2 10.8 11.9 18.7 12.9 10.5 9.0 10.4 13.5 11.6 5.5 10.2 13.1 9.2 17.6 9.0 12.6 11.8 9.1 17.3 11.8 13.9 12.6 12.2 16.8 12.6 9.3 10.4 15.2 12.9 9.4 5.9 8.1 5.5 7.8 7.0 8.0 5.0 5.7 5.0 7.9 3.2 15.4 7.0 3.7 4.2 2.5 9.2 3.6 7.3 5.5 4.0 11.8 9.1 6.8 8.0 1.1 16.4 13.6 14.6 4.8 8.1 7.4 6.8 10.7 3.8 5.4 8.0 6.8 6.8 5.3 12.3 19.1 10.8 3.2 5.3 12.6 14.4 4.8 9.6 14.3 8.6 16.3 8.0 3.5 3.3 6.7 8.0 3.8 8.6 13.3 3.4 3.9 6.6 3.7 7.4 9.1 14.9 15.6 13.3 4.4 4.7 6.4 10.8 5.9 5.9 8.1 4.8 7.3 6.2 7.8 12.9 7.3 6.2 9.4 11.6 6.3 6.4 3.2 5.5 4.7 6.6 7.4 7.0 10.6 11.3 10.7 17.7 11.6 8.7 10.8 11.9 13.5 12.6 0.0 3.7 23.9 16.6 18.3 12.1 0.8 17.8 9.4 9.1 10.4 0.0 20.6 29.9 26.3 24.4 29.4 13.6 116.8 15.4 31.8 26.6 15.0 26.5 10.6 27.5 9.5 8.6 16.5 9.5 32.5 23.0 17.8 28.7 36.1 10.3 19.0 22.8 14.2 19.4 29.1 11.9 25.8 26.4 55.8 34.3 19.3 16.9 25.4 19.8 12.9 IARS2 FLJ10326 ENSG00000067704 "Isoleucyl-tRNA synthetase 2, mitochondrial" Q9NSE4 1 220094102-220148041 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Cataract, Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024212, HPA024594, HPA024596" Enhanced Enhanced Mitochondria NA NA 26000 Mitochondria "HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370" "unprognostic (2.15e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.42e-3)" "unprognostic (3.22e-2)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (1.78e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.24e-5)" "unprognostic (9.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.01e-1)" "unprognostic (2.16e-1)" "unprognostic (8.87e-2)" "unprognostic (6.27e-3)" 25.9 39.3 18.0 17.9 16.9 6.7 31.9 15.1 20.8 16.9 26.2 14.8 24.3 18.9 21.5 16.8 23.8 18.8 16.5 40.0 17.5 12.6 29.5 37.3 16.8 25.9 15.6 16.0 20.5 20.5 42.5 15.3 26.2 17.4 18.5 24.9 15.0 22.4 22.3 57.8 22.2 23.4 17.7 15.7 16.1 18.5 15.7 13.7 19.5 17.8 25.9 20.1 24.9 18.7 16.8 20.0 17.2 19.0 18.5 22.6 16.8 38.3 36.0 20.7 20.3 31.3 31.6 49.9 23.4 25.2 25.9 21.0 34.6 40.1 35.5 31.7 28.9 20.1 37.3 28.7 29.2 30.0 24.5 34.6 17.6 29.4 38.8 19.5 27.9 19.1 22.8 29.8 28.0 29.0 25.1 25.2 23.1 43.4 20.6 33.9 21.3 22.0 20.2 26.9 30.0 23.9 19.5 41.3 56.8 37.3 25.8 11.2 31.5 35.4 55.0 36.4 24.8 63.6 31.7 25.7 25.6 21.4 34.3 39.1 17.7 27.1 25.8 27.1 22.0 28.3 17.2 16.7 15.1 16.8 19.0 22.6 16.8 18.4 22.0 20.0 13.6 20.8 19.0 3.3 18.5 14.5 7.3 19.7 16.8 18.0 16.9 15.1 20.8 17.5 12.6 15.6 16.0 17.4 13.7 32.8 33.1 24.4 24.3 17.9 26.7 126.1 15.3 58.9 45.5 27.9 23.6 68.4 10.0 37.8 12.3 43.0 33.8 0.0 56.4 44.9 24.9 20.4 18.5 88.4 40.3 19.1 34.8 38.6 46.6 2.0 34.5 26.7 18.6 25.2 50.3 28.6 54.2 28.8 40.0 28.3 31.0 45.3 22.6 32.5 40.2 23.2 60.0 22.7 61.0 20.5 IBA57 "C1orf69, FLJ12734" ENSG00000181873 "IBA57, iron-sulfur cluster assembly" Q5T440 1 228165815-228182257 "Disease related genes, Predicted intracellular proteins" "Heme biosynthesis" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030555, HPA030556, HPA030557" Approved Supported Mitochondria NA NA Mitochondria "HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433" "unprognostic (3.00e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-1)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "unprognostic (8.16e-3)" "unprognostic (1.03e-1)" "unprognostic (6.11e-2)" "unprognostic (7.01e-2)" "unprognostic (8.00e-3)" "unprognostic (2.87e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.71e-9)" "unprognostic (4.94e-2)" "unprognostic (5.02e-1)" "unprognostic (5.04e-3)" "unprognostic (7.14e-2)" 5.2 7.5 4.7 5.3 5.5 8.2 6.1 7.8 5.1 4.7 4.5 4.1 3.8 4.5 5.3 4.2 4.7 3.8 6.8 7.9 4.9 3.2 5.8 9.5 6.3 12.7 3.5 4.5 5.9 18.3 7.4 2.9 6.4 5.2 4.5 3.9 4.9 5.3 3.1 22.9 8.0 5.7 4.9 3.5 4.9 5.3 3.1 3.2 5.0 5.2 6.4 4.7 3.6 3.7 2.8 3.4 4.7 1.7 2.8 3.5 0.9 3.3 3.5 3.8 1.7 2.0 2.3 4.6 2.0 1.0 1.6 0.9 7.3 2.9 7.2 4.5 2.2 0.9 6.2 2.9 4.4 1.4 1.5 6.3 4.3 4.3 3.5 1.7 4.8 4.8 3.1 2.7 1.8 2.2 1.5 2.2 4.6 7.1 3.4 1.5 2.6 4.8 2.9 2.8 4.6 4.0 6.0 4.3 1.2 2.3 6.9 5.8 4.0 3.4 10.5 2.6 0.7 8.3 6.6 5.1 4.3 4.0 2.9 5.1 2.5 1.2 3.7 1.9 2.0 3.2 4.7 1.7 0.8 2.3 1.4 3.5 1.5 1.9 1.8 1.2 2.8 2.8 2.6 2.7 2.8 1.5 3.4 1.7 0.9 4.7 5.5 7.8 4.6 4.9 3.2 3.5 4.5 5.2 3.2 8.9 14.1 9.1 7.6 7.2 5.4 13.5 5.1 4.0 13.6 0.0 11.8 9.6 6.6 4.4 17.2 6.7 9.9 23.3 5.8 7.0 4.2 5.1 15.0 7.3 4.8 3.2 6.9 5.5 4.3 24.4 3.4 4.4 6.8 2.8 5.6 5.4 7.1 5.3 6.7 5.4 19.9 6.5 4.1 11.9 11.2 5.3 13.6 5.4 9.5 7.4 ICA1L "ALS2CR14, ALS2CR15" ENSG00000163596 "Islet cell autoantigen 1 like" Q8NDH6 2 202773150-202871985 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 62.5;Cone photoreceptor cells: 56.9;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042507 Approved Approved Mitochondria NA NA Mitochondria "HPA042507: AB_10797016" "unprognostic (4.14e-3)" "unprognostic (3.60e-3)" "unprognostic (5.15e-2)" "unprognostic (5.63e-3)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (8.05e-4)" "unprognostic (1.66e-1)" "unprognostic (9.60e-2)" "unprognostic (4.50e-4)" "unprognostic (4.15e-1)" "unprognostic (8.15e-3)" "unprognostic (2.97e-2)" "unprognostic (1.74e-1)" "unprognostic (9.79e-2)" "unprognostic (1.58e-3)" 3.3 7.3 11.6 2.2 15.6 5.4 3.8 24.8 19.8 5.8 5.2 8.5 4.1 2.3 10.1 8.9 4.2 12.6 5.5 6.5 11.1 12.1 3.3 1.2 3.2 2.2 7.3 14.0 9.4 3.2 15.2 22.6 7.6 9.1 8.8 2.7 5.8 1.9 9.5 8.1 3.0 2.0 7.6 7.2 2.2 3.6 11.9 7.8 1.0 7.8 1.8 2.1 4.5 3.2 5.3 4.6 4.2 5.3 6.7 4.2 1.6 1.6 1.2 2.8 8.4 2.8 5.1 20.8 2.7 3.7 1.9 2.5 1.6 0.6 1.6 0.8 3.3 4.7 0.8 4.0 1.4 2.5 2.0 3.2 3.3 1.6 1.8 1.6 4.1 2.2 2.0 2.4 1.9 1.5 4.9 2.3 5.8 2.8 1.5 2.3 0.7 3.5 5.5 7.9 0.5 2.9 4.2 4.1 0.7 1.6 3.7 8.0 8.1 4.1 0.2 1.7 2.5 1.0 3.1 1.6 7.4 1.8 1.5 4.0 5.7 8.1 4.8 4.0 1.3 1.4 2.2 2.6 1.5 2.6 2.7 2.2 4.0 1.9 2.1 4.6 5.3 3.1 4.2 4.2 6.7 5.3 2.8 1.8 1.6 11.6 15.6 24.8 16.9 11.1 12.1 7.3 14.0 9.1 7.8 8.9 11.4 2.9 3.3 1.8 62.5 11.8 2.5 40.2 13.6 17.4 56.9 13.7 0.0 4.2 21.4 4.7 1.1 0.0 4.3 31.3 12.4 4.0 5.8 1.1 3.3 15.9 18.5 4.9 4.1 24.6 29.4 6.8 6.8 1.0 1.5 26.8 3.3 0.0 43.5 2.2 78.4 0.0 5.7 29.9 7.6 1.9 6.3 5.7 1.6 2.2 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial" P48735 15 90083045-90102504 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.2;skeletal muscle: 190.7" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 682.3;Distal tubular cells: 989.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria NA NA 53000000 Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favorable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 5.4 2.0 14.9 10.1 16.6 22.6 8.8 4.9 19.1 6.4 16.2 13.8 12.4 16.1 5.9 15.3 23.7 6.0 9.4 126.2 10.2 9.3 25.0 93.2 6.9 15.8 14.4 12.0 3.0 25.1 8.4 3.3 15.1 11.9 13.3 14.5 6.0 28.0 21.9 190.7 11.0 13.9 15.8 11.0 7.5 27.9 1.2 7.6 28.2 3.4 69.0 13.6 11.0 8.6 16.8 32.8 17.2 56.3 22.2 29.5 31.2 10.3 5.9 30.6 30.3 4.3 5.2 26.0 13.0 19.8 12.3 13.2 2.8 9.0 12.3 3.7 10.7 11.7 3.6 4.4 3.9 5.8 24.2 2.9 21.0 2.2 20.6 5.2 14.4 21.3 11.0 2.2 2.9 2.3 14.9 25.1 43.6 3.1 10.6 9.4 30.2 69.1 22.4 9.1 14.2 2.4 58.6 21.9 36.7 18.9 12.5 44.1 22.4 16.1 64.4 5.2 17.8 51.9 44.5 6.0 21.9 3.2 2.8 6.0 17.5 3.2 1.4 7.0 30.3 12.6 9.0 26.4 17.2 26.1 48.0 12.4 16.8 18.7 29.5 32.8 9.8 10.2 18.2 5.1 22.2 56.3 17.8 15.9 31.2 14.9 16.6 4.9 19.1 10.2 9.3 14.4 12.0 11.9 7.6 6.0 21.8 67.0 66.5 35.4 5.3 402.1 104.4 56.2 21.6 71.5 9.8 682.3 989.8 188.2 4.7 25.3 53.5 23.3 255.6 386.0 36.6 189.5 30.1 240.4 229.9 9.5 59.3 41.1 60.4 2.5 13.0 70.5 55.6 96.4 122.1 17.5 127.7 132.1 33.2 128.5 5.1 12.9 38.3 0.5 4.5 58.6 479.2 123.2 268.2 90.1 IDH3A ENSG00000166411 "Isocitrate dehydrogenase 3 (NAD(+)) alpha" P50213 15 78131498-78171949 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 47.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041465, HPA062971" Supported Enhanced Mitochondria No No 2000000 Mitochondria "HPA041465: AB_10794377, HPA062971: AB_2684913" "unprognostic (2.33e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-3)" "unprognostic (2.26e-1)" "unprognostic (1.02e-1)" "unprognostic (4.01e-1)" "unprognostic (2.29e-1)" "unprognostic (6.47e-2)" "unprognostic (1.69e-2)" "unprognostic (2.30e-1)" "unprognostic (3.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (6.49e-8)" "unprognostic (1.40e-1)" "unprognostic (3.08e-2)" "unprognostic (4.49e-2)" "unprognostic (3.39e-2)" 14.6 18.1 18.0 13.0 25.3 6.5 7.7 16.1 29.5 9.9 17.6 11.9 6.1 24.5 11.2 5.9 12.0 8.4 6.5 41.5 16.6 16.8 15.2 10.4 8.8 11.0 20.6 18.1 8.0 9.2 18.5 12.4 8.4 29.0 10.1 18.8 10.4 11.2 11.9 47.7 11.1 23.8 11.9 18.1 10.1 8.9 11.5 13.8 16.2 8.1 26.5 16.4 11.1 10.3 10.1 47.2 6.1 17.0 5.5 6.0 7.4 16.0 22.0 4.0 14.0 10.0 10.3 8.7 19.1 9.3 15.7 11.9 15.7 9.8 34.2 14.2 11.2 23.2 24.3 37.2 14.8 14.5 15.0 12.3 13.2 23.9 7.1 8.6 25.6 18.9 7.8 9.1 15.2 16.0 7.5 9.8 12.2 16.9 14.1 9.9 15.3 18.7 6.8 4.9 9.3 8.3 10.9 17.2 10.6 13.0 21.9 16.0 6.2 21.9 31.4 17.8 7.7 12.5 13.9 10.0 18.5 17.1 24.3 30.8 16.1 35.8 18.2 13.0 24.5 14.4 4.2 9.4 2.7 5.3 17.0 5.7 9.2 5.2 4.8 14.2 10.1 5.6 6.0 6.1 5.5 16.6 47.2 5.6 7.4 18.0 25.3 16.1 29.5 16.6 16.8 20.6 18.1 29.0 13.8 8.9 13.9 26.8 49.8 49.7 32.4 15.3 10.2 40.2 11.4 24.4 35.3 35.1 69.6 20.4 40.5 16.4 42.3 0.0 15.5 32.0 20.6 24.1 26.5 21.2 23.7 25.4 18.5 11.1 22.8 17.5 19.2 26.5 25.3 6.4 36.6 24.2 18.9 28.8 22.3 37.6 27.3 12.9 34.3 41.4 22.6 36.0 57.2 20.3 49.2 35.8 IDH3B RP46 ENSG00000101365 "Isocitrate dehydrogenase 3 (NAD(+)) beta" O43837 20 2658395-2664219 "Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049387, HPA054180" Supported Enhanced Mitochondria NA NA Mitochondria "HPA049387: AB_2680740, HPA054180: AB_2682407" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.12e-1)" "unprognostic (2.43e-2)" "unprognostic (3.24e-2)" "unprognostic (6.83e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.76e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "unprognostic (1.39e-2)" "prognostic favorable (6.78e-8)" "unprognostic (8.89e-2)" "unprognostic (4.02e-2)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" 19.5 20.0 19.4 15.5 31.7 20.6 18.5 32.1 30.5 16.4 23.9 16.9 14.5 30.5 19.2 16.7 20.7 17.9 19.2 57.3 19.8 20.0 29.7 25.2 15.1 17.6 24.0 29.4 20.2 15.2 27.6 12.2 17.0 31.2 15.4 25.6 16.2 19.3 19.5 75.5 20.9 24.9 21.5 17.1 19.2 19.9 19.6 16.0 19.7 19.1 37.7 22.5 16.7 17.4 34.7 49.4 25.8 44.7 29.5 38.6 33.9 26.5 36.0 16.5 14.4 18.2 14.4 19.0 14.3 18.3 33.8 27.0 46.4 28.0 30.0 13.1 19.6 31.2 37.5 30.4 46.4 31.1 8.3 23.8 36.4 14.0 48.0 17.9 39.6 8.0 19.0 17.9 31.5 16.6 14.9 19.9 26.0 46.0 16.8 20.5 14.6 34.4 45.4 32.0 27.4 34.2 28.2 30.1 33.7 19.4 24.9 29.8 21.5 17.6 58.5 30.1 13.3 29.3 17.6 17.7 26.4 16.6 8.9 32.8 22.9 52.4 31.7 12.4 41.0 25.0 22.2 41.7 25.8 33.9 44.7 25.6 34.7 29.4 30.7 49.4 30.6 34.4 29.8 11.9 29.5 38.3 22.9 38.6 33.9 19.4 31.7 32.1 30.5 19.8 20.0 24.0 29.4 31.2 16.0 35.7 26.2 48.5 51.6 50.5 32.7 162.9 58.6 28.1 22.7 22.7 31.4 112.2 132.6 64.7 47.2 52.0 101.0 23.3 88.6 72.5 49.7 37.2 48.4 51.2 85.2 12.7 48.7 37.4 56.7 72.9 41.7 53.5 65.8 90.2 63.3 41.3 56.4 67.7 44.6 135.3 32.3 77.6 67.4 39.5 53.0 52.4 90.7 57.9 90.9 44.0 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria NA NA Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.4 7.3 4.0 9.0 4.7 21.7 134.5 157.3 0.7 5.7 0.5 54.1 2.1 35.6 0.5 0.5 1.0 4.4 11.1 1.8 3.4 1.1 0.4 1.9 1.1 4.5 4.3 0.1 8.1 0.1 2.1 1.2 3.1 0.2 9.5 1.5 0.4 4.1 14.5 0.4 2.7 4.5 2.8 1.2 1.3 1.1 0.0 3.2 2.9 5.8 1.3 95.5 0.7 0.6 4.4 2.1 1.2 1.9 0.9 0.8 11.3 6.4 0.3 2.4 10.1 3.5 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 131.0 105.4 20.9 17.6 20.8 10.1 13.4 73.9 88.3 37.5 61.1 9.8 3308.6 16.6 186.8 2.9 139.0 7.0 0.0 304.1 1015.8 142.9 71.5 60.2 43.3 628.8 3.2 56.0 68.2 47.6 8.5 102.4 129.6 67.4 56.9 22.2 79.9 144.2 8.7 192.3 28.3 5.5 109.9 38.2 1.7 0.9 19.6 3573.6 51.2 8.0 13.6 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704305-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "salivary gland: 22.7" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 22.7;Distal tubular cells: 18.3" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 3.9" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RH-30: 2.9" "CAB026459, HPA037851" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026459: , HPA037851: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.3 0.1 0.7 0.2 3.9 0.0 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.6 0.3 0.2 0.2 0.1 0.7 0.3 0.4 1.5 0.2 0.2 0.2 0.3 0.3 0.2 1.2 0.5 0.0 0.5 0.2 0.2 0.2 0.0 0.2 22.7 0.2 0.5 4.6 0.4 0.2 0.2 0.2 0.0 2.2 0.2 0.2 0.2 1.3 0.3 0.5 0.2 0.2 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.7 3.9 0.2 1.1 0.4 1.5 0.3 0.2 0.2 0.2 0.0 0.3 1.5 3.6 2.2 1.3 1.5 0.0 2.7 1.2 22.7 0.0 0.0 18.3 2.6 1.0 0.0 0.7 0.0 3.8 0.0 0.6 3.7 2.3 0.0 1.3 1.6 3.5 0.6 0.3 3.2 1.4 0.8 0.0 1.0 4.9 0.5 7.4 3.5 0.7 1.4 0.9 0.0 0.5 0.0 0.4 1.5 0.0 1.7 2.9 7.5 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.9 0.3 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.5 0.0 1.9 0.0 13.8 0.8 2.5 0.6 0.1 29.8 5.2 20.0 6.8 1.1 2.2 3.6 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.7 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.4 2.4 0.4 0.0 0.0 0.0 0.1 32.0 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 0.0 13.3 0.0 1.0 0.7 0.0 1.5 0.0 5.3 3.4 1.8 0.0 0.0 1.7 0.8 0.0 7.1 0.0 0.0 0.5 0.7 2.2 0.8 104.4 6.2 0.1 0.0 0.0 13.5 3.1 0.0 0.3 19.4 3.3 0.0 0.0 0.3 0.7 0.0 0.0 0.8 0.0 6.5 0.9 0.2 0.4 0.9 0.0 22.4 0.0 0.7 IMMP1L "FLJ25059, IMMP1" ENSG00000148950 "Inner mitochondrial membrane peptidase subunit 1" Q96LU5 11 31432401-31509645 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038372, HPA058308" Approved Enhanced Mitochondria NA NA Mitochondria "HPA038372: AB_10669643, HPA058308: AB_2732620" "unprognostic (2.39e-1)" "unprognostic (1.20e-2)" "unprognostic (1.12e-1)" "unprognostic (6.17e-2)" "unprognostic (9.67e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (7.59e-2)" "unprognostic (4.66e-3)" "unprognostic (5.15e-3)" "prognostic favorable (6.72e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-2)" "unprognostic (4.66e-1)" "unprognostic (4.52e-2)" "unprognostic (1.37e-2)" "unprognostic (1.04e-3)" 9.1 16.6 25.4 11.6 27.8 8.8 15.4 28.4 18.5 10.0 11.3 11.7 12.8 12.1 9.6 25.6 8.4 7.7 5.1 20.4 21.7 17.4 16.2 11.9 10.7 11.2 16.1 12.1 14.0 23.8 7.2 18.2 8.7 11.4 11.2 8.3 17.4 13.6 12.0 39.8 10.1 10.3 9.3 13.2 7.6 10.8 13.8 12.6 17.6 10.0 13.3 10.8 6.8 7.5 16.4 20.0 14.8 1.7 16.9 21.7 7.8 10.2 15.0 39.6 11.7 5.3 3.6 7.4 13.6 3.0 5.7 4.4 11.4 7.9 10.7 9.5 5.8 16.5 11.9 13.6 10.3 8.6 14.4 28.8 12.6 22.4 14.5 5.7 16.5 12.2 3.0 9.2 3.3 7.4 15.9 6.1 21.7 20.2 12.9 5.4 12.7 20.7 23.7 8.0 42.7 13.2 16.3 34.2 10.4 19.4 12.7 10.9 12.5 15.8 7.9 13.5 26.8 18.0 16.9 2.9 13.4 13.3 10.4 21.7 11.8 24.4 18.6 17.6 11.3 13.1 9.0 1.7 14.8 15.6 1.6 14.5 16.4 14.0 15.5 4.0 15.0 17.7 21.7 0.3 16.9 1.6 20.0 16.6 7.8 25.4 27.8 28.4 18.5 21.7 17.4 16.1 12.1 11.4 12.6 32.8 10.5 28.2 25.1 16.3 29.6 46.2 20.4 24.1 9.1 57.6 31.4 31.7 101.2 15.6 27.8 14.6 14.3 23.3 21.0 26.9 15.5 23.7 20.9 35.9 18.2 41.3 54.3 17.8 9.5 7.0 12.4 11.6 8.5 10.8 27.6 51.1 14.4 21.0 19.4 81.2 35.9 32.3 15.3 62.7 19.8 23.8 19.8 28.7 31.9 22.3 IMMP2L "IMMP2L-IT1, IMP2" ENSG00000184903 "Inner mitochondrial membrane peptidase subunit 2" Q96T52 7 110663051-111562517 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026711 Approved Approved Mitochondria NA NA Mitochondria "HPA026711: AB_1851760" "unprognostic (2.55e-2)" "unprognostic (1.40e-2)" "unprognostic (4.29e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (5.64e-3)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (5.68e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.89e-3)" "unprognostic (1.32e-1)" "unprognostic (6.65e-2)" "unprognostic (1.79e-1)" "unprognostic (2.71e-1)" 12.4 12.4 7.9 7.3 10.8 2.9 11.8 5.4 9.1 12.4 11.1 5.7 10.6 5.2 23.8 10.4 8.0 11.5 5.8 8.6 7.1 6.0 23.8 17.7 7.4 4.4 5.7 6.1 14.4 10.0 13.4 15.7 8.0 6.3 13.8 5.8 31.6 11.6 15.8 18.6 7.5 10.9 14.4 5.6 5.3 9.8 9.0 5.6 8.2 16.7 8.3 9.5 11.0 9.2 18.1 11.7 5.8 8.4 24.3 15.1 5.1 7.9 4.7 2.8 11.8 7.6 7.8 5.0 5.5 5.5 3.7 3.9 2.3 9.2 13.0 15.0 4.7 6.8 4.5 3.0 10.9 6.1 8.1 3.1 4.4 18.9 6.4 11.7 8.2 0.5 13.5 14.6 1.5 10.2 16.7 4.8 12.2 14.2 10.1 2.7 5.5 10.8 9.2 2.8 15.1 7.4 2.3 23.7 6.8 13.3 3.4 3.4 10.5 2.4 11.2 30.2 8.5 4.5 4.8 3.0 5.6 5.9 5.6 6.5 5.8 1.5 7.9 6.2 3.9 29.5 5.8 5.1 1.6 6.4 6.4 11.4 16.3 10.8 7.2 9.4 18.1 15.1 10.5 0.2 24.3 8.4 11.7 6.4 5.1 7.9 10.8 5.4 9.1 7.1 6.0 5.7 6.1 6.3 5.6 17.9 10.4 9.1 30.1 29.2 10.8 17.3 10.2 12.0 18.2 45.4 7.9 18.7 135.9 25.4 7.3 16.5 7.1 0.0 7.2 20.5 12.8 27.2 3.5 21.5 10.0 7.9 18.6 7.4 5.9 4.0 45.8 4.9 20.3 14.4 6.8 10.4 12.7 5.9 32.9 52.2 15.8 12.9 24.0 17.5 9.1 23.2 13.6 4.3 10.0 16.1 IMMT "HMP, Mic60, MINOS2, P87, P89" ENSG00000132305 "Inner membrane mitochondrial protein" Q16891 2 86143932-86195770 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 201.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022439, HPA036164, HPA036165" Supported Enhanced Mitochondria NA NA 240000 Mitochondria "CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980" "unprognostic (3.83e-3)" "unprognostic (1.56e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.40e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (5.66e-2)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (7.35e-2)" "unprognostic (2.21e-1)" "prognostic favorable (3.51e-6)" "unprognostic (2.06e-3)" "unprognostic (6.35e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" 20.0 36.9 15.6 17.0 23.5 15.3 15.4 17.5 27.1 13.6 24.8 16.0 15.4 25.1 16.5 13.6 19.1 13.9 12.3 67.3 15.1 18.0 37.5 35.1 14.3 17.7 18.4 18.8 13.3 23.1 31.4 17.6 21.6 32.2 12.8 26.3 17.3 16.7 21.2 78.6 15.4 25.6 17.9 12.1 20.0 22.0 28.3 15.0 29.1 16.2 38.3 19.9 18.0 14.1 10.9 21.5 7.6 21.6 13.2 16.1 14.4 33.9 33.5 30.4 13.9 29.6 27.3 31.1 24.4 25.6 33.0 30.1 48.1 27.0 52.0 24.5 25.8 27.2 25.3 38.9 35.2 40.5 21.0 31.7 41.1 21.2 56.9 30.1 39.6 28.2 31.2 25.7 31.1 37.2 20.8 37.2 30.1 40.0 29.6 31.9 29.2 39.4 41.4 36.2 52.1 26.7 26.3 65.1 46.8 37.7 38.5 37.0 27.5 25.0 38.1 37.2 25.1 21.6 28.1 27.9 23.7 26.2 34.3 30.2 23.6 29.8 35.7 27.0 47.3 28.7 7.5 18.6 7.6 16.1 21.6 14.6 10.9 14.4 13.3 21.5 8.8 13.1 15.5 2.5 13.2 19.9 11.1 14.9 14.4 15.6 23.5 17.5 27.1 15.1 18.0 18.4 18.8 32.2 15.0 50.6 42.2 33.5 27.5 20.7 39.1 201.3 17.8 52.2 63.7 38.4 31.4 84.0 112.7 49.3 128.3 35.3 53.1 23.3 46.0 62.7 35.8 15.4 45.2 57.1 62.8 22.3 53.9 35.6 49.3 95.4 25.6 41.4 16.9 81.2 42.6 25.5 37.2 31.7 34.6 68.6 39.4 6.5 37.2 87.7 51.5 21.8 82.4 36.6 63.4 30.8 ITPK1 ENSG00000100605 "Inositol-tetrakisphosphate 1-kinase" Q13572 14 92936914-93116320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Isomerase, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 79.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.2" "Group enriched" "Detected in all" 5 "granulocytes: 24.2;monocytes: 13.0" "Cell line enhanced" "Detected in all" "WM-115: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055230 Approved Approved Mitochondria NA NA Mitochondria "HPA055230: AB_2682748" "unprognostic (1.93e-3)" "unprognostic (2.50e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.56e-4)" "unprognostic (4.27e-1)" "unprognostic (2.04e-2)" "unprognostic (6.97e-2)" "unprognostic (1.32e-1)" "unprognostic (1.24e-2)" "unprognostic (2.86e-2)" "unprognostic (8.14e-2)" "unprognostic (2.27e-1)" "unprognostic (1.37e-3)" "unprognostic (2.39e-1)" "unprognostic (2.02e-1)" "unprognostic (4.20e-1)" "unprognostic (7.25e-3)" 32.0 10.2 44.3 11.9 49.5 12.2 14.4 19.3 50.5 23.8 20.0 29.7 9.6 34.9 20.2 10.2 18.7 15.9 16.1 18.4 49.0 30.6 11.4 13.4 13.0 7.6 42.1 27.1 11.4 15.0 13.2 5.3 11.2 18.5 15.1 13.6 14.5 8.3 19.1 9.4 5.5 36.6 19.4 44.8 14.1 11.9 9.4 26.1 3.4 10.0 3.2 5.5 16.7 16.2 1.9 3.9 24.2 13.0 1.3 1.9 2.4 10.3 21.5 4.0 10.2 9.0 5.0 10.8 4.4 6.7 8.9 5.4 12.3 18.7 6.6 22.2 7.0 3.4 12.3 11.5 19.1 2.8 24.4 5.0 14.5 5.7 10.6 6.7 6.6 16.2 3.2 11.5 4.5 10.4 3.9 8.7 6.9 7.9 7.6 4.3 27.9 5.6 9.4 8.4 13.6 9.7 10.8 5.9 9.8 6.0 17.5 10.9 13.8 11.2 22.8 19.0 3.2 30.6 8.1 6.8 6.2 6.8 10.4 7.0 7.5 6.8 4.2 5.7 5.2 42.6 2.5 5.2 9.5 1.9 8.6 1.1 1.9 1.2 1.2 3.9 0.7 0.7 1.3 24.2 1.3 13.0 1.9 1.7 2.4 44.3 49.5 19.3 50.5 49.0 30.6 42.1 27.1 18.5 26.1 11.9 12.0 6.7 6.5 6.5 9.7 21.5 15.3 4.0 5.7 27.9 17.7 6.9 11.6 20.4 8.3 10.1 79.1 0.0 23.9 8.8 7.8 13.3 16.1 25.9 18.3 6.4 27.6 12.3 38.1 17.6 13.8 26.0 25.3 15.4 25.6 15.5 29.8 38.6 45.3 17.0 9.3 19.4 15.3 2.8 12.8 3.9 5.7 9.6 25.9 7.9 JADE1 "JADE-1, PHF17" ENSG00000077684 "Jade family PHD finger 1" Q6IE81 4 128809623-128875224 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020016 Approved Approved Mitochondria NA NA Mitochondria "HPA020016: AB_1855292" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (1.63e-2)" "unprognostic (3.19e-1)" "unprognostic (2.09e-2)" "unprognostic (7.59e-2)" "unprognostic (6.96e-3)" "unprognostic (6.93e-2)" "unprognostic (8.16e-2)" "unprognostic (9.39e-2)" "unprognostic (8.38e-3)" "prognostic favorable (8.22e-6)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (9.92e-2)" "unprognostic (1.68e-1)" 20.5 14.6 5.7 12.7 7.9 25.9 27.9 16.3 9.7 10.8 9.8 4.6 18.9 5.6 8.4 9.0 8.1 11.8 14.3 14.2 5.7 7.1 22.1 7.4 12.6 13.2 6.9 4.9 18.6 55.7 17.4 10.8 7.2 7.3 12.0 4.3 8.5 25.6 16.8 10.5 8.6 10.6 16.3 5.4 10.2 12.5 6.1 8.5 13.3 28.7 7.2 7.9 12.1 31.1 12.6 6.9 23.0 14.3 20.1 18.4 10.4 6.1 12.3 12.2 9.0 16.8 11.9 16.1 10.0 6.0 10.9 10.0 10.7 11.0 19.1 11.9 5.7 4.8 2.2 14.3 3.5 12.3 14.8 6.3 10.6 16.9 9.7 29.0 17.3 8.6 13.2 5.7 13.3 9.9 9.1 11.8 12.5 16.9 26.4 8.5 7.5 21.8 13.0 32.8 6.3 6.2 15.6 8.4 10.3 17.4 3.0 15.9 11.6 9.6 7.8 7.7 17.9 6.3 9.8 8.1 10.8 17.8 8.2 11.7 17.5 13.9 21.7 11.8 17.4 8.8 17.2 7.2 23.0 12.3 11.6 15.3 9.5 13.4 13.5 6.9 12.6 18.4 14.5 9.1 20.1 14.3 3.3 9.4 10.4 5.7 7.9 16.3 9.7 5.7 7.1 6.9 4.9 7.3 8.5 35.7 20.1 17.2 15.1 13.3 37.9 30.3 33.1 32.1 19.4 47.1 47.1 22.1 16.6 28.2 2.8 23.2 6.3 0.0 42.1 12.0 18.5 12.6 17.3 35.0 9.1 27.0 9.8 16.5 28.2 3.2 33.4 11.9 20.3 4.6 7.2 27.1 37.2 7.6 45.3 28.6 26.8 84.1 34.0 4.8 22.2 11.7 3.3 31.9 7.3 5.2 KCNAB3 "AKR6A9, KCNA3B" ENSG00000170049 "Potassium voltage-gated channel subfamily A regulatory beta subunit 3" O43448 17 7921859-7929803 "Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 36.1;endometrium 1: 17.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 123.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "cerebellum: 36.1;cerebral cortex: 31.6" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 14.9;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077993 Approved Mitochondria NA NA Mitochondria "HPA077993: AB_2686872" "unprognostic (3.02e-2)" "unprognostic (5.59e-2)" "unprognostic (6.95e-2)" "unprognostic (2.62e-2)" "unprognostic (6.13e-2)" "unprognostic (5.84e-4)" "unprognostic (2.19e-1)" "unprognostic (5.72e-2)" "unprognostic (8.50e-2)" "unprognostic (8.55e-2)" "unprognostic (3.27e-4)" "unprognostic (7.47e-3)" "unprognostic (3.03e-6)" "unprognostic (2.12e-1)" "unprognostic (5.00e-2)" "unprognostic (4.97e-2)" "unprognostic (9.54e-3)" 1.4 0.7 4.2 2.7 5.2 5.5 1.2 36.1 31.6 1.8 1.4 0.8 0.0 1.3 17.2 2.2 0.8 3.5 2.1 0.7 4.7 2.9 1.7 1.1 1.5 3.8 2.4 6.3 2.1 1.0 0.8 4.9 1.6 5.9 2.3 2.0 3.8 1.3 1.4 1.0 3.3 1.9 11.4 5.2 2.6 2.2 1.7 1.9 0.8 1.6 0.0 3.3 1.0 1.0 0.1 1.7 0.5 0.2 0.0 0.7 0.1 1.3 1.1 5.5 1.4 0.6 1.4 2.0 4.9 3.1 4.2 4.8 0.7 0.3 2.2 0.3 0.8 0.2 0.4 1.5 0.7 6.0 1.8 2.3 0.7 0.9 0.0 5.1 0.2 3.0 2.2 1.6 4.6 0.2 0.2 0.3 6.1 0.5 0.3 0.7 1.0 0.8 2.6 0.8 0.0 0.7 14.9 1.5 0.6 0.5 1.7 0.3 8.1 0.4 0.0 0.9 0.2 1.4 0.1 0.3 0.7 2.8 1.1 0.4 1.1 1.2 1.2 2.1 3.0 1.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.1 0.2 0.2 0.5 0.0 0.0 1.7 0.0 0.1 4.2 5.2 36.1 31.6 4.7 2.9 2.4 6.3 5.9 1.9 3.0 2.4 0.0 0.6 0.5 22.9 0.8 0.0 0.0 1.2 0.0 3.9 0.2 0.0 0.5 0.3 0.1 0.4 0.0 0.5 0.2 1.1 0.6 1.1 0.2 0.7 123.9 0.0 0.6 0.0 0.0 1.7 0.8 0.0 1.8 0.3 12.0 0.5 0.0 0.7 0.0 6.3 0.0 0.3 3.1 1.5 0.4 0.1 0.0 0.2 0.1 KCTD12 "C13orf2, KIAA1778, PFET1" ENSG00000178695 "Potassium channel tetramerization domain containing 12" Q96CX2 13 76880166-76886390 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 180.7;Intestinal endocrine cells: 371.5;Kupffer cells: 375.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 17 "dendritic cells: 5.9;granulocytes: 1.6;monocytes: 6.4" "Cell line enhanced" "Detected in many" "ASC diff: 31.0;HUVEC TERT2: 61.5;TIME: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056987, HPA077376" Supported Approved Mitochondria NA NA 19000000 Mitochondria "HPA056987: , HPA077376: " "unprognostic (6.42e-2)" "unprognostic (2.67e-1)" "unprognostic (5.13e-1)" "unprognostic (1.04e-3)" "unprognostic (5.82e-2)" "unprognostic (3.98e-2)" "unprognostic (2.02e-1)" "unprognostic (1.32e-3)" "unprognostic (1.35e-2)" "unprognostic (1.90e-1)" "unprognostic (9.83e-3)" "unprognostic (1.23e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" 29.6 7.5 12.1 14.3 17.9 2.1 24.7 11.7 9.4 13.1 10.3 10.3 5.1 5.5 14.2 9.2 10.7 21.6 15.1 10.3 10.5 8.2 8.5 6.4 17.2 21.5 17.0 5.9 13.6 6.8 8.2 6.6 22.9 13.8 9.9 11.7 13.8 8.4 4.9 11.2 7.7 8.4 17.9 14.0 21.3 8.3 10.0 13.5 3.1 8.4 5.8 8.4 11.0 15.0 0.0 5.9 1.6 6.4 0.0 0.2 1.4 0.4 0.4 4.1 0.0 31.0 14.7 1.1 1.8 0.4 1.1 1.5 0.1 0.0 0.0 1.0 4.9 1.3 14.4 1.7 17.6 0.9 0.3 9.4 0.0 10.6 0.0 1.3 4.8 0.0 5.9 5.8 0.7 13.4 2.3 61.5 3.5 0.0 0.0 14.5 0.3 2.1 0.0 2.1 4.3 2.0 0.1 2.0 5.1 4.7 0.0 1.1 2.1 4.6 0.1 0.6 5.2 0.2 3.1 49.3 0.7 1.3 0.1 3.6 0.7 0.1 0.0 11.6 1.0 4.3 0.0 6.4 1.1 0.0 4.1 0.0 0.0 0.1 0.0 5.9 0.0 0.1 0.2 1.6 0.0 2.3 3.0 0.0 1.4 12.1 17.9 11.7 7.5 10.5 8.2 17.0 5.9 13.8 13.5 23.8 9.6 6.7 2.5 35.5 1.8 19.3 2.5 116.4 23.9 92.5 13.7 2.6 14.9 3.0 3.1 150.3 2.9 0.0 0.5 82.6 78.3 3.2 6.9 2.1 180.7 0.0 371.5 47.3 375.3 5.6 145.6 119.3 49.0 2.8 70.7 4.3 0.6 0.0 42.1 5.4 1.0 25.8 26.9 1.4 6.0 30.1 3.5 2.2 48.5 1.4 KCTD18 "6530404F10Rik, FLJ31322, FLJ37818" ENSG00000155729 "Potassium channel tetramerization domain containing 18" Q6PI47 2 200488952-200519784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045498, HPA058028" Approved Approved Mitochondria NA NA Mitochondria "HPA045498: AB_10959387, HPA058028: AB_2683583" "unprognostic (2.90e-1)" "unprognostic (1.81e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-1)" "unprognostic (4.01e-1)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.76e-2)" "unprognostic (2.40e-2)" "unprognostic (1.18e-2)" "unprognostic (5.21e-1)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" 14.3 14.6 13.7 13.1 15.4 11.5 14.3 9.2 14.8 12.3 13.8 17.4 15.5 11.6 13.5 19.4 16.1 12.5 16.5 14.8 13.6 11.2 13.8 13.3 11.4 14.9 16.3 11.4 15.0 16.5 17.1 13.2 10.0 14.9 15.9 11.7 13.7 14.1 14.0 14.7 12.3 11.3 24.0 17.6 13.0 12.9 9.3 14.6 18.0 19.4 19.9 14.6 17.4 11.7 7.2 7.2 11.4 7.9 7.1 9.6 5.6 7.3 6.8 3.4 12.6 16.4 20.4 8.7 9.0 11.5 5.8 7.7 5.4 8.4 5.2 6.9 9.1 9.5 7.1 3.3 10.9 7.5 12.4 3.6 7.4 4.9 3.8 11.1 6.0 8.8 13.6 20.7 6.7 12.9 13.6 5.0 7.8 5.0 7.1 10.3 7.5 12.9 5.9 1.9 6.3 6.2 9.0 7.7 6.0 7.6 7.3 3.9 5.4 7.1 6.2 10.7 7.7 8.2 9.7 8.3 11.9 2.7 6.0 4.3 13.6 9.8 5.9 13.7 6.4 8.4 11.4 5.5 10.4 5.9 7.9 9.0 7.2 7.7 8.5 5.9 7.1 9.6 9.6 4.4 7.1 5.2 7.2 8.5 5.6 13.7 15.4 9.2 14.8 13.6 11.2 16.3 11.4 14.9 14.6 6.0 6.5 7.5 5.0 3.9 7.0 5.3 10.2 8.1 6.8 3.5 0.0 6.5 1.7 5.8 17.3 5.1 5.9 0.0 7.5 5.9 5.4 4.4 2.3 7.8 6.5 9.5 1.2 9.2 8.3 4.5 10.9 7.6 6.8 16.2 7.9 10.0 5.1 7.0 11.7 9.4 9.3 19.4 4.7 17.6 14.5 3.4 4.2 6.7 8.0 3.1 KIF16B "C20orf23, dJ971B4.1, FLJ20135, SNX23" ENSG00000089177 "Kinesin family member 16B" Q96L93 20 16272104-16573434 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051198 Approved Uncertain Mitochondria NA NA Mitochondria "HPA051198: AB_2681385" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-1)" "unprognostic (3.92e-2)" "unprognostic (2.44e-1)" "unprognostic (6.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.38e-1)" "unprognostic (5.34e-2)" "unprognostic (3.95e-2)" "unprognostic (5.52e-1)" "prognostic favorable (7.61e-6)" "unprognostic (4.04e-2)" "unprognostic (2.78e-1)" "unprognostic (4.74e-2)" "unprognostic (1.61e-2)" 11.3 26.2 10.5 14.8 11.2 4.8 15.1 6.3 11.2 9.4 21.6 10.3 15.7 15.1 10.6 12.8 10.3 6.1 9.4 10.7 10.3 8.4 16.6 10.9 12.9 5.6 12.1 7.0 13.0 8.4 25.7 13.9 5.7 8.4 8.4 17.8 6.6 8.5 28.2 22.8 11.3 23.7 11.7 15.3 9.9 11.6 5.7 11.1 6.5 10.5 8.6 8.2 10.6 15.0 5.2 5.8 0.9 3.7 8.2 5.0 2.6 4.9 12.6 6.0 5.5 4.7 3.4 5.9 4.8 3.0 3.0 3.3 6.1 12.2 6.9 3.2 5.1 8.5 4.5 7.1 7.2 4.5 3.6 4.1 3.1 3.2 11.2 2.9 0.0 7.0 5.4 14.3 3.6 7.2 4.7 1.1 5.3 5.5 0.0 4.9 7.8 0.1 1.2 1.7 16.0 5.7 5.1 4.8 12.1 4.8 7.9 2.7 5.3 5.2 25.3 15.4 7.5 7.5 4.0 2.4 4.7 4.0 7.6 2.2 0.0 3.0 2.0 4.5 2.0 9.4 0.1 3.7 0.9 3.7 3.0 5.0 4.2 4.1 2.8 5.8 5.2 4.5 3.2 0.4 8.2 2.9 2.8 2.7 2.6 10.5 11.2 6.3 11.2 10.3 8.4 12.1 7.0 8.4 11.1 17.9 34.3 9.9 14.0 16.9 8.4 24.2 2.5 14.7 18.2 5.2 17.7 11.8 3.3 5.5 9.6 11.9 40.0 0.0 10.9 4.8 7.6 7.9 9.2 12.8 15.8 35.0 22.4 9.8 9.5 6.6 10.6 15.8 10.1 1.0 36.6 8.0 10.1 28.1 13.8 16.1 10.7 6.5 8.6 8.4 15.9 19.6 31.4 4.1 18.2 19.6 L2HGDH "C14orf160, FLJ12618" ENSG00000087299 "L-2-hydroxyglutarate dehydrogenase" Q9H9P8 14 50237563-50312548 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 38.7;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065409, HPA069708" Approved Enhanced Mitochondria NA NA Mitochondria "HPA065409: AB_2685485, HPA069708: AB_2686179" "unprognostic (1.74e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-2)" "unprognostic (1.23e-3)" "unprognostic (1.04e-2)" "unprognostic (4.33e-2)" "unprognostic (8.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (9.91e-2)" "unprognostic (2.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (9.75e-10)" "unprognostic (1.24e-2)" "unprognostic (5.88e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" 5.4 5.1 6.9 3.6 8.4 3.5 5.1 12.7 10.9 3.5 5.6 4.9 4.8 6.2 3.4 4.3 9.0 4.4 3.2 7.7 6.1 4.7 25.5 16.0 2.5 3.3 7.7 4.7 4.2 5.4 7.1 5.8 2.6 5.7 4.6 6.8 7.7 5.0 5.6 17.7 7.0 5.0 4.7 5.3 2.3 5.6 6.0 6.0 3.7 6.5 6.2 5.2 4.6 4.4 1.4 1.5 10.5 0.6 2.4 3.3 0.8 14.0 9.9 4.1 3.9 2.0 1.3 11.5 4.7 2.6 7.4 8.8 15.8 6.5 11.0 5.5 1.9 5.9 10.3 12.3 4.9 8.3 8.8 7.0 23.9 6.8 2.2 1.9 8.4 8.3 1.2 3.1 4.9 4.3 1.8 3.2 11.5 8.3 7.0 1.9 16.9 9.5 3.8 5.9 12.0 10.5 9.0 13.3 8.6 6.9 16.5 8.4 6.0 13.8 10.5 6.0 5.7 13.8 2.3 2.9 4.7 13.2 5.4 6.2 6.4 14.5 15.6 2.6 4.3 5.2 10.5 0.6 1.4 1.5 0.3 3.3 1.4 1.7 1.6 0.9 1.2 2.1 2.6 0.9 2.4 0.3 1.5 2.4 0.8 6.9 8.4 12.7 10.9 6.1 4.7 7.7 4.7 5.7 6.0 38.7 16.3 4.4 2.3 3.3 15.6 12.6 0.0 32.1 35.2 12.2 53.0 4.7 13.3 3.5 21.5 2.1 4.7 0.0 3.8 5.8 2.1 2.4 17.4 13.9 1.9 11.1 7.5 3.1 1.5 5.6 2.3 1.4 1.7 2.8 5.3 6.1 2.4 2.9 4.2 18.5 40.7 0.0 2.1 11.6 10.6 5.5 4.1 3.3 6.8 1.8 LACTB "FLJ14902, MRPL56" ENSG00000103642 "Lactamase beta" P83111 15 63121800-63142061 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protease" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 175.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036361, HPA036362" Supported Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA036361: AB_10672244, HPA036362: AB_10670798" "unprognostic (6.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.22e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.10e-2)" "unprognostic (8.08e-2)" "unprognostic (6.25e-2)" "unprognostic (8.98e-2)" "unprognostic (3.08e-1)" "unprognostic (6.22e-3)" "unprognostic (5.16e-3)" "unprognostic (6.28e-2)" "unprognostic (3.24e-1)" "unprognostic (8.64e-2)" "unprognostic (7.90e-2)" "unprognostic (3.88e-3)" 26.5 22.7 9.2 13.1 12.2 31.5 9.3 7.3 9.1 6.8 11.4 6.3 4.0 12.5 7.0 6.9 9.8 5.7 9.2 24.9 7.9 6.1 20.5 38.3 18.8 12.9 8.5 6.1 7.2 9.3 6.7 10.4 7.4 9.5 7.6 10.4 5.8 9.3 4.7 37.3 10.1 19.6 8.1 8.0 21.6 8.3 13.2 9.8 8.3 8.4 11.1 9.0 11.5 12.8 3.3 10.4 5.8 8.9 2.3 3.1 2.0 21.5 13.6 3.9 2.7 19.6 10.6 3.3 9.5 14.6 16.3 30.4 3.4 13.9 2.9 11.7 13.7 17.7 6.1 13.1 6.1 20.5 19.8 3.2 5.6 4.6 8.5 18.3 5.0 9.7 14.3 13.1 16.7 13.8 24.4 16.7 17.0 5.3 8.2 27.5 8.2 3.8 6.0 5.8 13.2 4.2 2.8 10.0 6.6 8.8 33.9 3.5 1.6 6.8 7.7 20.4 14.2 5.8 8.3 29.9 22.0 17.2 9.8 11.9 8.6 7.6 0.7 16.8 14.2 10.0 3.6 8.8 4.6 1.3 8.9 2.0 3.3 1.1 1.0 10.4 2.9 1.0 1.6 5.8 2.3 7.6 0.9 3.1 2.0 9.2 12.2 7.3 9.1 7.9 6.1 8.5 6.1 9.5 9.8 23.8 19.9 13.7 23.6 51.7 5.9 40.8 17.8 9.4 7.9 12.2 11.8 13.0 21.6 45.5 42.5 22.5 20.6 0.0 37.1 32.4 22.4 24.9 64.7 50.3 87.0 7.9 7.0 9.2 54.2 26.0 13.3 86.6 25.3 175.9 24.0 5.8 61.1 20.1 15.2 52.5 10.6 6.5 32.5 93.3 10.6 52.4 15.1 15.8 15.3 33.8 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.1;lung: 6.8" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 7.8;Suprabasal keratinocytes: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 17.2;HMC-1: 5.6;K-562: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria NA NA Mitochondria "HPA005470: AB_2134886, HPA076575: AB_2732315" "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 1.2 0.8 0.7 0.3 2.3 0.9 0.4 2.5 2.4 1.2 3.8 0.7 0.2 0.6 0.5 0.3 4.6 0.2 0.9 0.7 1.1 2.8 0.4 0.2 6.8 0.4 1.3 1.3 1.3 0.2 0.1 1.7 0.2 2.2 0.6 2.8 2.5 1.1 0.9 1.0 2.6 1.1 1.9 1.8 0.2 2.2 1.8 0.9 0.2 1.2 1.7 1.2 1.8 2.9 0.3 0.2 7.1 0.2 1.1 1.8 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.1 2.5 0.3 0.0 0.0 0.3 17.2 1.8 0.0 0.0 0.0 5.6 0.0 0.5 0.0 0.1 0.0 0.3 0.0 3.9 0.0 1.2 0.0 0.2 0.3 0.4 0.2 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 1.2 0.0 0.0 1.6 0.7 0.0 0.0 2.9 0.0 0.4 7.1 0.2 0.9 1.0 0.2 0.8 0.2 0.4 1.8 0.1 0.3 0.1 1.0 1.1 1.1 0.2 0.2 0.6 0.7 0.7 2.3 2.5 2.4 1.1 2.8 1.3 1.3 2.2 0.9 3.0 2.6 0.0 1.1 7.8 0.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.2 0.1 0.4 0.5 1.1 0.0 0.1 3.2 1.7 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.5 1.3 0.9 1.4 0.0 1.4 0.0 1.7 0.2 1.7 3.9 0.1 1.0 0.6 2.2 LETM1 SLC55A1 ENSG00000168924 "Leucine zipper and EF-hand containing transmembrane protein 1" O95202 4 1811479-1856247 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011029, HPA011100" Supported Supported Mitochondria NA NA Mitochondria "HPA011029: AB_1852804, HPA011100: AB_1852802" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (3.85e-2)" "unprognostic (5.04e-2)" "unprognostic (5.48e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.37e-3)" "unprognostic (1.87e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.77e-4)" "prognostic favorable (8.90e-4)" "unprognostic (8.06e-3)" "unprognostic (3.24e-1)" "unprognostic (1.57e-2)" "unprognostic (2.42e-1)" 16.9 15.3 11.9 11.2 13.1 9.9 16.8 17.3 19.9 6.7 23.7 10.0 7.5 20.3 8.5 6.9 22.0 8.1 15.0 18.9 10.2 10.2 16.2 20.4 9.4 10.7 10.6 10.5 9.5 19.7 13.0 8.7 7.6 10.7 8.2 16.3 9.2 9.7 7.2 17.2 18.5 19.4 8.0 7.7 10.6 15.6 12.6 9.0 50.7 10.9 19.9 16.6 8.0 9.7 5.0 14.7 3.8 5.6 6.7 7.1 2.1 12.0 20.6 6.4 19.8 9.9 6.9 11.5 12.0 5.9 12.1 9.5 19.0 13.5 20.0 8.6 12.5 18.9 12.3 16.3 16.9 7.4 13.2 17.0 20.4 16.7 13.6 12.8 20.7 16.8 11.3 12.2 13.8 12.2 5.6 10.4 12.3 26.8 12.6 8.3 13.3 29.9 23.7 16.8 13.2 23.7 17.2 9.0 11.7 9.4 16.9 16.4 14.4 13.7 17.3 7.1 5.8 16.3 10.8 15.6 13.9 8.3 11.7 19.9 11.0 16.8 15.9 12.3 18.1 11.1 3.8 4.5 2.1 7.1 5.6 7.0 5.0 6.0 6.1 4.7 4.6 4.0 5.9 0.7 6.7 5.3 14.7 4.6 2.1 11.9 13.1 17.3 19.9 10.2 10.2 10.6 10.5 10.7 9.0 14.9 7.8 27.6 25.3 35.5 17.1 18.2 7.6 1.4 9.1 26.2 31.4 14.6 26.6 22.9 25.3 14.3 78.7 23.3 27.0 18.4 16.4 20.8 10.3 24.1 19.6 14.3 15.0 16.5 15.3 31.9 18.7 15.0 18.6 10.0 27.0 11.6 31.9 43.2 15.6 38.2 26.2 12.9 19.8 34.8 40.1 44.7 12.7 20.2 29.9 41.9 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;brain: 15.7;lymphoid tissue: 7.1" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 32.9" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Cell type enhanced" "Detected in some" "eosinophil: 6.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 6.9" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 7 "basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5" "HPA043781, HPA059558" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043781: AB_2678668, HPA059558: AB_2684062" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.1 0.2 2.2 3.1 15.7 2.8 0.0 4.6 2.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.2 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 1.2 0.0 0.4 7.1 1.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 6.9 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.1 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.6 0.2 0.0 0.1 1.9 0.0 4.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.9 0.1 6.9 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.0 0.1 0.0 2.9 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 32.9 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.2 3.2 0.0 0.0 2.1 0.0 0.0 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 LRPPRC "GP130, LRP130, LSFC" ENSG00000138095 "Leucine rich pentatricopeptide repeat containing" P42704 2 43886508-43996005 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Transcription, Transcription regulation, Transport" "DNA-binding, RNA-binding" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033786, HPA036408, HPA036409" Enhanced Enhanced Mitochondria No No 16000 Mitochondria "CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108" "unprognostic (1.49e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-3)" "prognostic unfavorable (1.72e-5)" "unprognostic (1.68e-1)" "unprognostic (8.34e-3)" "prognostic unfavorable (2.31e-7)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.44e-3)" "unprognostic (7.68e-2)" "prognostic favorable (6.65e-6)" "unprognostic (9.07e-2)" "unprognostic (1.92e-1)" "unprognostic (1.12e-1)" "unprognostic (5.00e-2)" 20.6 25.5 20.2 27.7 24.8 26.7 37.2 34.3 51.8 16.4 31.7 15.1 15.9 21.8 21.5 19.2 22.5 18.6 15.2 36.6 24.3 21.9 41.7 31.6 26.3 38.0 21.9 22.9 23.6 28.0 33.3 19.7 17.6 29.2 18.9 32.5 13.6 17.8 22.8 63.2 22.4 19.1 32.6 17.9 18.0 20.7 20.7 16.0 25.4 20.5 30.5 19.9 20.4 17.8 15.8 15.5 5.5 11.7 13.2 18.1 12.4 30.3 25.0 15.7 20.0 15.5 20.7 27.0 20.3 14.7 22.2 17.1 39.9 16.1 43.7 19.6 12.5 14.8 25.8 29.4 21.7 29.6 26.3 18.5 39.5 19.7 52.9 22.9 56.8 18.0 20.5 19.0 20.4 33.2 12.9 17.8 13.2 58.2 17.7 19.4 16.8 29.8 65.8 26.2 31.0 17.7 33.4 35.2 35.5 24.3 28.0 27.9 27.0 22.9 30.8 36.9 21.5 22.6 34.5 15.3 16.0 21.9 16.8 21.6 18.1 20.3 38.1 15.3 35.3 13.8 5.5 10.7 1.8 9.5 10.8 18.0 15.2 12.8 12.6 15.5 15.8 18.1 15.4 0.8 13.2 11.7 6.2 10.5 12.4 20.2 24.8 34.3 51.8 24.3 21.9 21.9 22.9 29.2 16.0 20.8 25.6 25.1 22.2 41.1 62.9 81.9 33.1 20.1 33.0 43.6 29.5 31.3 18.3 23.0 4.4 27.5 30.2 0.0 15.2 17.8 26.0 19.8 28.8 45.9 22.1 62.0 26.4 20.9 34.3 4.2 23.3 24.7 20.3 26.2 41.4 27.0 20.3 28.1 22.3 48.9 54.5 12.9 37.3 27.9 28.6 38.8 27.8 19.2 70.4 27.0 LRRIQ4 LRRC64 ENSG00000188306 "Leucine rich repeats and IQ motif containing 4" A6NIV6 3 169821922-169837775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 7.1" "Group enriched" "Detected in some" 51 "Early spermatids: 39.4;Late spermatids: 18.7" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 13 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "HEL: 2.6;JURKAT: 2.3;RT4: 4.8;T-47d: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036271, HPA036706" Uncertain Approved Mitochondria NA NA Mitochondria "HPA036271: , HPA036706: AB_2675264" "unprognostic (5.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-4)" "unprognostic (5.26e-3)" "unprognostic (2.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (9.72e-2)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "unprognostic (7.47e-2)" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (4.56e-3)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 1.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.6 7.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.3 0.0 0.3 0.2 0.0 0.4 0.0 0.0 1.7 0.3 0.2 1.6 0.0 0.7 0.0 0.4 2.0 0.1 2.6 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.2 0.0 0.1 0.5 0.4 1.1 0.7 1.0 0.0 0.0 0.1 4.8 1.9 0.6 0.1 0.4 0.0 0.0 4.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 MACC1 "7A5, SH3BP4L" ENSG00000183742 "MACC1, MET transcriptional regulator" Q6ZN28 7 20134655-20217404 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.5;kidney: 23.9" "Cell type enhanced" "Detected in many" 11 "Club cells: 103.5;Pancreatic endocrine cells: 96.6;Urothelial cells: 233.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 41.3;CAPAN-2: 9.7;HaCaT: 29.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020081, HPA020103, HPA029476, CAB068194" Supported Approved Mitochondria NA NA Mitochondria "CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136" "unprognostic (1.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.26e-1)" "unprognostic (1.42e-2)" "unprognostic (7.01e-2)" "unprognostic (2.52e-2)" "unprognostic (2.05e-1)" "unprognostic (2.43e-2)" "unprognostic (2.43e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.71e-9)" "unprognostic (4.49e-2)" "unprognostic (2.91e-1)" "unprognostic (1.78e-1)" "unprognostic (6.93e-3)" 4.8 2.6 0.5 5.6 0.4 0.7 4.5 0.4 0.5 8.3 13.7 0.0 4.4 10.1 0.7 6.1 14.1 0.9 9.6 0.5 0.5 0.5 23.9 1.0 13.3 1.1 0.4 0.0 1.3 11.3 0.1 4.0 1.6 0.1 3.9 3.3 0.1 11.4 6.0 0.5 4.5 29.5 0.1 0.8 6.0 5.0 0.8 0.0 1.7 1.5 16.0 13.6 4.0 5.1 2.3 1.0 1.4 1.0 0.8 0.6 0.5 41.3 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 9.2 9.7 5.8 0.4 0.0 0.0 29.1 0.1 0.4 0.0 0.0 0.1 5.5 0.1 0.0 0.0 2.3 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 5.9 2.8 0.0 3.4 0.0 0.5 0.4 8.1 0.0 0.0 0.3 4.4 7.3 2.8 0.1 0.2 0.0 3.3 0.0 0.2 1.7 0.1 0.1 0.1 0.0 0.0 0.1 8.9 0.4 2.2 0.0 0.3 0.0 1.0 0.6 0.3 0.3 0.7 0.6 2.3 0.2 0.5 0.3 2.0 0.3 0.3 1.4 0.8 1.0 1.0 0.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.4 0.0 0.1 0.0 65.5 63.4 1.4 71.9 2.5 2.1 0.6 22.9 58.9 103.5 38.4 2.0 0.5 6.6 49.2 2.2 0.7 25.7 0.0 55.2 0.1 2.3 64.3 11.6 1.0 4.6 1.6 37.1 3.7 2.4 0.8 2.0 4.4 1.7 13.6 15.0 0.5 96.6 14.0 2.5 12.9 1.0 0.0 0.4 0.2 0.4 3.4 0.2 3.9 13.3 233.0 MAIP1 "C2orf47, DKFZp666A212, FLJ22555" ENSG00000162972 "Matrix AAA peptidase interacting protein 1" Q8WWC4 2 199955317-200008540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 31.5;Ductal cells: 26.6;Extravillous trophoblasts: 27.2;Proximal tubular cells: 51.4;Syncytiotrophoblasts: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064013, HPA072231" Approved Approved Mitochondria NA NA Mitochondria "HPA064013: AB_2685175, HPA072231: AB_2732196" "unprognostic (4.89e-2)" "unprognostic (7.36e-2)" "unprognostic (7.40e-3)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.81e-4)" "unprognostic (4.86e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.02e-3)" "unprognostic (7.03e-2)" "unprognostic (2.00e-2)" "unprognostic (5.21e-3)" "unprognostic (1.45e-1)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (2.70e-2)" 11.3 16.7 10.5 8.6 10.7 14.4 18.5 13.6 14.4 7.1 12.6 5.9 9.2 18.3 8.2 7.5 11.6 8.3 11.0 16.2 8.3 8.1 26.8 39.4 11.3 14.6 10.3 8.4 7.6 14.7 7.6 7.2 10.5 9.0 8.5 11.9 6.1 9.3 8.8 18.1 9.2 16.3 8.8 7.8 8.7 11.4 5.2 10.4 13.6 9.1 12.7 8.9 8.6 7.8 13.2 16.9 9.0 13.1 8.9 14.0 8.3 12.9 12.1 11.0 8.6 9.8 9.9 25.4 11.8 11.4 17.6 16.9 32.8 11.8 8.6 17.0 8.1 14.6 14.4 16.1 12.6 16.6 13.4 18.5 14.5 11.2 29.9 13.2 19.8 10.3 10.5 10.4 11.6 12.6 10.1 11.1 16.8 18.9 11.2 11.4 17.1 14.9 18.5 14.0 13.8 29.2 14.4 13.0 17.2 20.7 16.9 12.5 8.7 12.1 13.8 21.4 14.5 12.2 12.2 9.8 10.3 14.8 8.8 13.0 10.7 12.4 18.6 15.5 11.6 10.5 7.2 13.1 9.0 11.4 12.5 14.0 13.2 11.6 8.2 16.9 12.0 11.1 9.4 2.2 8.9 11.9 13.7 13.6 8.3 10.5 10.7 13.6 14.4 8.3 8.1 10.3 8.4 9.0 10.4 8.9 12.2 0.0 0.0 0.0 0.0 0.0 0.0 10.7 9.1 3.5 0.0 24.6 31.5 26.6 0.0 0.0 0.0 0.0 24.5 27.2 0.0 0.0 3.5 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 11.8 0.0 0.0 20.2 0.0 0.0 51.4 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 MALSU1 "C7orf30, mtRsfA" ENSG00000156928 "Mitochondrial assembly of ribosomal large subunit 1" Q96EH3 7 23298739-23311729 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AN3-CA: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020487, HPA052210" Approved Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA020487: AB_1845757, HPA052210: AB_2681762" "unprognostic (3.62e-1)" "unprognostic (3.68e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-3)" "unprognostic (5.24e-3)" "prognostic unfavorable (9.71e-4)" "unprognostic (1.08e-1)" "unprognostic (1.51e-2)" "unprognostic (9.79e-2)" "unprognostic (1.83e-3)" "unprognostic (3.15e-2)" "unprognostic (7.15e-2)" "unprognostic (2.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.43e-2)" "unprognostic (4.51e-2)" "unprognostic (1.68e-1)" 7.9 11.3 9.5 6.9 9.4 7.6 11.0 8.6 11.1 7.9 8.4 8.3 5.8 5.1 9.2 10.2 12.3 10.1 7.6 29.8 8.8 9.1 12.5 21.2 8.2 10.2 8.9 7.2 10.3 10.1 8.0 7.8 12.6 12.7 7.9 7.8 17.2 10.6 10.3 20.1 6.7 7.0 8.9 8.1 6.9 7.5 13.7 5.6 8.5 14.8 14.9 8.0 9.2 7.5 6.1 4.8 3.5 5.4 4.2 7.3 5.1 4.8 6.1 4.5 26.3 4.4 3.1 4.5 3.7 2.7 3.5 3.2 10.2 4.1 4.9 4.1 2.4 14.3 5.0 4.4 2.3 4.3 2.4 7.9 2.9 8.3 15.7 2.9 6.4 1.8 2.6 3.6 2.9 3.2 20.9 3.1 4.5 8.7 1.3 4.4 3.4 4.4 20.0 8.2 9.1 16.4 3.8 3.7 6.5 3.4 4.4 4.1 4.9 3.1 5.0 7.7 9.1 2.5 3.8 5.5 2.8 2.5 5.3 6.6 2.0 4.8 8.5 10.6 7.9 8.7 3.4 5.4 3.5 4.4 4.0 5.0 6.1 6.1 4.9 4.7 5.7 7.3 4.9 3.4 4.2 3.3 4.8 5.7 5.1 9.5 9.4 8.6 11.1 8.8 9.1 8.9 7.2 12.7 5.6 35.7 32.4 26.7 44.7 38.8 30.2 85.9 30.6 44.2 29.6 41.8 15.7 68.8 97.8 85.3 113.0 32.3 23.8 23.3 83.4 55.2 42.4 35.4 13.9 91.2 47.7 17.5 18.5 37.4 30.7 19.1 45.8 21.4 33.7 38.7 30.2 34.9 64.5 28.1 46.3 93.2 28.6 32.3 41.9 55.6 72.8 38.6 41.6 20.8 44.3 42.7 MAPK11 "p38-2, p38Beta, PRKM11, SAPK2" ENSG00000185386 "Mitogen-activated protein kinase 11" Q15759 22 50263713-50270767 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 13.2;Ito cells: 14.7;Rod photoreceptor cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012961, HPA045069" Approved Approved Mitochondria NA NA Mitochondria "CAB012961: AB_2533144, HPA045069: AB_2679207" "unprognostic (1.11e-1)" "unprognostic (1.28e-1)" "unprognostic (1.49e-2)" "unprognostic (1.92e-1)" "unprognostic (1.18e-2)" "unprognostic (1.64e-3)" "unprognostic (1.02e-1)" "unprognostic (5.84e-2)" "unprognostic (5.89e-2)" "unprognostic (2.46e-1)" "unprognostic (4.96e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (6.02e-6)" "unprognostic (9.84e-2)" "unprognostic (4.25e-2)" "unprognostic (9.16e-2)" "unprognostic (2.10e-2)" 20.4 5.7 14.2 7.5 17.3 0.8 8.2 22.0 23.7 6.6 2.7 2.8 1.0 1.9 8.2 6.2 5.3 7.0 8.8 8.8 11.7 9.1 5.0 1.5 8.5 8.5 7.2 19.9 5.3 3.1 6.4 10.9 8.4 6.6 7.2 2.7 4.1 5.7 8.0 5.0 6.4 2.6 9.8 5.5 7.3 4.6 3.1 4.1 0.9 4.5 5.3 6.1 6.0 4.4 1.1 0.0 0.0 0.3 0.0 0.9 0.0 1.7 4.2 4.7 17.6 6.2 9.4 0.1 6.6 4.7 4.4 1.7 1.7 3.2 0.0 5.9 6.1 7.3 4.3 3.1 2.6 0.3 9.1 2.1 6.2 5.6 0.4 7.1 1.5 9.7 13.0 7.8 1.2 0.5 4.9 9.6 6.7 5.0 17.0 4.3 7.5 0.3 5.7 0.4 5.2 4.9 17.0 0.1 6.0 6.6 0.0 4.4 11.8 5.6 2.3 4.6 0.6 7.7 4.9 15.0 13.2 11.0 0.9 2.4 0.7 2.0 7.2 6.7 1.8 11.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.4 0.2 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 14.2 17.3 22.0 23.7 11.7 9.1 7.2 19.9 6.6 4.1 0.0 1.4 1.3 1.1 1.6 2.6 2.8 0.0 0.0 0.0 0.0 5.9 0.0 1.7 0.8 3.7 13.2 0.0 0.0 0.2 0.3 1.7 3.3 0.0 1.0 0.2 0.0 0.0 14.7 2.6 5.7 2.8 0.0 5.0 0.0 0.0 5.6 0.7 0.0 2.1 1.4 10.9 0.0 1.0 1.2 2.1 1.1 0.0 1.0 0.0 0.9 MARC1 "FLJ22390, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786759-220819657 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.3;breast: 81.3" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 94.8;Extravillous trophoblasts: 36.6;Syncytiotrophoblasts: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5" "Group enriched" "Detected in many" 32 "granulocytes: 28.5;monocytes: 20.6" "Cell line enhanced" "Detected in many" "BEWO: 51.6;HeLa: 22.0;Hep G2: 25.3;NTERA-2: 21.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028702 Approved Supported Mitochondria NA NA Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 71.3 3.0 4.6 7.5 6.1 7.3 81.3 3.1 4.0 3.4 7.8 2.1 18.7 3.3 1.4 5.5 3.4 2.8 6.4 6.7 3.7 4.6 3.4 33.6 4.3 4.3 4.0 3.3 2.5 4.0 4.0 3.3 9.7 4.3 14.9 6.8 4.4 27.8 10.5 4.2 1.4 3.8 2.6 2.6 4.3 3.2 0.6 1.4 0.1 22.0 2.7 1.4 3.9 7.5 0.2 0.7 28.5 20.6 0.0 0.1 4.9 5.7 3.1 2.0 0.0 0.4 0.1 51.6 0.5 0.4 0.3 0.5 17.0 0.3 0.0 2.1 0.5 0.0 0.0 10.7 1.0 0.7 0.0 10.9 0.0 22.0 25.3 1.3 0.1 0.1 2.0 0.6 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.3 5.6 0.0 10.9 21.8 16.8 9.5 0.0 0.0 0.1 2.4 6.4 6.1 14.2 3.1 3.8 0.0 6.0 14.4 13.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.0 20.6 8.1 0.1 1.5 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 28.5 0.0 0.4 0.2 0.0 4.9 4.6 6.1 3.1 4.0 3.7 4.6 4.0 3.3 4.3 1.4 0.0 12.8 0.9 0.0 0.8 5.7 5.1 0.0 2.7 0.0 8.7 0.0 94.8 1.7 0.0 4.4 2.9 6.3 0.0 0.0 36.6 1.0 0.0 2.3 22.1 10.4 0.0 4.1 3.1 22.0 2.6 0.6 0.2 0.0 0.0 22.2 12.4 0.0 9.5 5.6 2.5 1.4 0.0 3.1 0.0 0.7 0.5 62.8 0.0 9.5 0.0 MARCH5 "FLJ20445, MARCH-V, MITOL, RNF153" ENSG00000198060 "Membrane associated ring-CH-type finger 5" Q9NX47 10 92291163-92353964 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056596 Supported Mitochondria NA NA Mitochondria "HPA056596: AB_2683181" "unprognostic (4.00e-2)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (4.10e-2)" "unprognostic (5.47e-3)" "unprognostic (2.33e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.24e-2)" "unprognostic (9.77e-2)" "unprognostic (5.50e-3)" "unprognostic (4.02e-3)" "unprognostic (6.14e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (4.53e-1)" "unprognostic (2.85e-2)" 18.2 21.7 17.5 17.7 18.3 20.7 27.1 16.8 25.7 15.5 15.4 12.7 20.7 15.8 19.3 18.8 28.0 14.8 15.4 18.4 15.8 15.1 21.7 27.6 16.5 16.6 16.3 17.9 20.9 16.7 16.3 12.3 16.3 14.8 22.2 14.8 14.5 19.4 19.3 42.6 13.7 16.0 18.1 14.0 12.1 14.4 20.1 13.5 25.0 24.5 21.5 17.3 14.7 21.0 7.3 9.4 16.8 10.2 6.5 8.7 6.6 16.2 8.8 17.5 20.0 11.9 12.4 9.0 14.6 16.1 18.2 18.7 5.9 11.7 9.5 10.1 14.2 8.0 13.4 12.1 12.2 26.2 7.1 14.3 7.6 8.3 13.8 14.5 12.1 7.6 12.7 16.5 12.0 25.2 24.3 16.0 10.2 8.3 11.9 14.5 10.3 10.7 14.0 4.1 10.6 13.3 11.6 17.9 5.6 18.6 10.5 8.1 15.0 12.6 9.4 15.4 8.7 16.4 9.5 15.5 8.6 9.4 9.3 19.9 12.1 9.2 8.4 7.8 16.9 5.7 5.2 8.3 9.0 7.6 10.2 7.6 7.3 8.4 8.0 9.4 6.7 8.7 8.3 16.8 6.5 8.5 6.2 7.8 6.6 17.5 18.3 16.8 25.7 15.8 15.1 16.3 17.9 14.8 13.5 20.8 22.1 26.1 0.0 78.5 12.2 22.9 20.4 9.4 9.1 19.2 7.9 35.2 72.9 0.0 116.8 22.5 30.7 0.0 0.0 36.8 29.4 0.0 28.8 32.6 30.8 9.5 28.6 20.3 24.8 37.2 27.3 19.9 37.1 0.0 22.9 18.6 0.0 23.0 17.3 56.2 10.9 19.4 24.5 37.4 28.3 68.3 54.6 25.5 24.7 0.0 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria NA NA 230000 Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favorable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favorable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 15.9 13.9 13.0 15.5 17.7 10.8 25.5 17.7 15.7 12.3 18.5 17.2 15.1 17.2 14.9 10.6 17.3 13.8 12.2 15.4 12.3 8.0 13.3 13.9 18.1 17.4 19.9 9.0 18.9 22.5 23.4 13.7 12.0 13.8 13.1 18.6 13.6 15.3 22.4 39.4 22.1 17.0 17.1 13.7 12.7 15.8 5.9 17.1 15.1 14.6 14.0 14.3 18.2 21.6 5.1 5.6 6.4 6.9 5.9 4.8 4.6 16.6 19.4 7.9 9.8 21.8 14.9 6.2 10.1 13.0 10.8 7.9 15.1 10.8 7.2 6.2 14.1 30.8 21.0 9.4 15.1 11.1 4.4 4.6 13.9 7.2 24.0 12.1 8.7 5.9 15.0 12.9 18.3 10.9 10.8 10.9 9.5 15.6 5.6 10.5 15.0 13.1 7.4 5.0 8.3 10.7 9.9 11.0 7.2 11.4 16.7 5.9 6.2 11.5 22.5 9.7 11.7 12.0 8.1 16.4 14.8 5.5 17.4 11.7 11.4 13.7 5.1 5.8 10.7 7.5 4.4 6.9 6.1 4.8 5.1 3.6 3.8 3.8 3.7 4.4 5.1 4.4 4.4 6.4 5.9 5.5 5.6 3.0 4.6 13.0 17.7 17.7 15.7 12.3 8.0 19.9 9.0 13.8 17.1 53.6 40.3 27.3 12.5 1.9 31.8 52.6 66.2 25.4 35.2 27.9 15.7 28.8 11.6 21.9 0.9 25.1 79.6 23.3 26.2 23.2 18.1 15.7 8.1 39.0 21.3 42.9 33.4 41.1 29.1 1.5 28.4 13.1 1.7 17.2 28.4 23.6 28.0 21.0 26.5 18.3 34.3 32.3 8.1 4.2 3.8 1.8 15.1 19.2 45.8 14.3 MBD3L2 ENSG00000230522 "Methyl-CpG binding domain protein 3 like 2" Q8NHZ7 19 7049321-7051735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.9" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L2B ENSG00000196589 "Methyl-CpG binding domain protein 3 like 2B" A0A1B0GVZ6 19 7018969-7021450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 18 "testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2 OS: 2.7" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L3 ENSG00000182315 "Methyl-CpG binding domain protein 3 like 3" A6NE82 19 7056209-7058640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.3" HPA060924 Approved Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L4 ENSG00000205718 "Methyl-CpG binding domain protein 3 like 4" A6NDZ8 19 7037748-7040179 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.6" HPA060924 Approved Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L5 ENSG00000237247 "Methyl-CpG binding domain protein 3 like 5" A6NJ08 19 7030578-7033011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "smooth muscle: 1.0;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060924 Approved Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCAT "fabD, FASN2C, MCT, MCT1, MT, NET62" ENSG00000100294 "Malonyl-CoA-acyl carrier protein transacylase" Q8IVS2 22 43132206-43143394 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003122, HPA035471" Approved Supported Mitochondria NA NA Mitochondria "HPA003122: AB_2666795, HPA035471: AB_10670590" "unprognostic (1.05e-1)" "unprognostic (1.57e-2)" "unprognostic (1.39e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-3)" "unprognostic (4.71e-2)" "unprognostic (5.13e-2)" "unprognostic (2.94e-1)" "unprognostic (1.32e-1)" "unprognostic (9.86e-2)" "prognostic favorable (2.18e-4)" "prognostic favorable (3.89e-4)" "unprognostic (3.67e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-1)" 10.4 18.2 13.3 8.2 17.2 11.0 12.8 10.4 24.6 10.6 11.9 9.4 10.7 9.5 11.0 17.2 12.3 20.7 21.4 12.9 14.4 14.2 25.6 24.3 8.6 7.1 12.0 12.0 14.4 16.2 20.3 14.3 9.2 15.1 12.8 10.6 9.9 14.5 10.2 17.7 11.7 9.7 8.6 6.0 7.6 12.1 19.6 5.2 18.4 20.1 14.0 9.9 8.5 8.1 10.2 13.9 2.5 9.5 11.6 10.3 5.6 7.2 9.5 6.8 11.8 5.7 6.1 6.9 8.1 7.2 11.0 10.2 9.5 7.4 12.2 8.4 6.0 6.2 12.2 12.8 10.7 8.2 4.2 37.8 4.5 11.0 10.5 9.1 21.6 5.5 4.5 10.5 10.7 8.5 6.4 7.8 7.4 10.7 5.0 5.3 13.3 10.0 23.5 6.5 10.2 16.9 13.3 6.6 19.3 13.7 6.3 8.9 4.7 8.7 17.1 12.3 3.2 8.8 14.0 4.6 4.8 9.4 10.3 11.4 8.9 9.2 8.8 10.3 8.3 5.7 0.0 9.5 0.7 7.7 9.1 10.3 8.3 8.6 10.1 13.9 10.2 10.1 7.1 2.5 11.6 5.5 13.7 5.5 5.6 13.3 17.2 10.4 24.6 14.4 14.2 12.0 12.0 15.1 5.2 6.0 5.0 6.7 9.1 15.9 10.0 8.7 30.6 10.7 4.5 19.2 0.0 16.7 43.1 25.8 13.8 7.1 10.0 0.0 19.0 8.4 9.3 14.1 3.5 20.8 13.6 6.4 13.9 16.5 8.2 9.0 6.9 4.8 6.8 8.2 12.4 9.5 19.8 17.5 15.6 67.4 8.7 19.4 9.8 29.0 10.4 18.3 7.7 4.9 22.7 9.5 MCCC1 MCCA ENSG00000078070 "Methylcrotonoyl-CoA carboxylase 1" Q96RQ3 3 183015218-183116075 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008310 Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA008310: AB_1853620" "unprognostic (4.01e-2)" "unprognostic (1.83e-3)" "unprognostic (2.05e-2)" "unprognostic (2.59e-3)" "unprognostic (3.46e-2)" "unprognostic (4.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-3)" "unprognostic (2.57e-3)" "unprognostic (9.82e-2)" "unprognostic (9.74e-2)" "unprognostic (7.65e-2)" "prognostic favorable (3.68e-4)" "unprognostic (4.73e-1)" "unprognostic (2.21e-1)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" 25.1 26.0 14.1 10.4 16.4 9.0 24.6 23.1 20.6 9.0 12.6 15.1 10.1 12.6 11.0 11.4 15.8 9.5 11.6 24.4 12.2 10.1 42.4 41.1 13.8 8.0 17.0 14.4 12.8 32.3 10.2 15.8 5.5 13.4 11.4 13.7 9.9 14.2 15.6 19.4 11.5 10.1 11.3 10.5 8.3 17.7 8.9 16.4 8.9 14.0 8.5 13.2 23.2 9.5 13.1 19.4 17.1 11.3 18.9 11.6 7.6 14.2 5.4 3.4 3.6 15.1 6.9 7.0 6.6 9.2 7.2 8.2 7.5 5.7 15.8 10.7 5.8 12.6 7.4 5.2 4.3 9.3 5.3 5.8 13.4 6.2 7.9 10.0 8.9 7.7 7.8 5.0 3.4 7.8 4.9 9.7 13.9 7.4 8.3 8.1 11.7 8.7 4.5 3.9 22.4 6.0 7.2 7.8 20.2 10.6 22.7 7.7 5.6 25.2 34.7 7.1 3.7 53.1 12.7 4.7 5.6 4.5 4.4 9.7 8.5 15.5 16.0 6.1 12.9 5.2 8.5 9.7 17.1 8.3 11.3 9.4 13.1 10.8 9.0 19.4 11.1 11.6 10.4 1.6 18.9 11.2 12.7 6.8 7.6 14.1 16.4 23.1 20.6 12.2 10.1 17.0 14.4 13.4 16.4 8.9 42.2 11.0 15.2 6.3 10.8 27.0 33.1 25.4 13.6 26.2 9.8 24.8 28.2 16.0 4.4 5.2 9.2 0.0 14.9 3.5 6.7 11.8 7.0 30.1 14.2 7.9 5.8 5.5 9.7 4.1 8.1 11.7 6.8 10.0 11.7 12.1 18.1 19.5 9.9 36.0 11.4 6.5 8.1 6.4 3.2 5.1 23.7 10.1 22.9 19.4 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 74.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favorable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 12.4 29.4 9.2 11.8 13.6 2.7 30.5 7.9 10.0 11.2 15.3 12.2 15.1 13.0 9.7 20.0 14.5 9.1 12.3 74.3 7.6 8.1 35.6 61.9 8.4 11.6 7.8 8.0 9.6 18.9 14.1 10.3 15.1 13.4 24.6 18.1 12.8 20.6 29.4 17.6 10.8 14.1 7.8 17.0 11.0 13.6 6.9 6.9 9.4 22.2 13.3 14.3 15.7 8.5 8.8 16.7 1.7 11.5 12.9 10.2 6.7 11.9 16.5 7.1 27.1 7.6 7.8 12.1 5.7 9.6 11.8 8.5 28.9 15.2 27.7 21.0 8.3 9.2 9.9 12.3 19.0 14.8 14.7 15.7 15.0 8.5 31.7 13.3 7.4 14.3 10.0 10.0 10.8 8.6 5.3 10.3 8.0 18.9 10.4 8.1 32.6 0.1 13.6 9.3 10.5 9.3 14.5 20.4 40.7 30.6 21.6 11.2 12.4 24.9 36.9 12.1 3.5 30.6 18.9 7.5 4.8 7.5 8.7 15.3 7.5 13.8 17.2 7.9 20.7 11.9 1.7 7.4 1.6 6.1 11.5 7.9 8.8 7.9 6.9 16.7 8.6 8.0 8.7 1.2 12.9 6.8 7.4 10.2 6.7 9.2 13.6 7.9 10.0 7.6 8.1 7.8 8.0 13.4 6.9 14.9 23.4 22.9 14.2 11.7 12.8 60.9 17.8 16.0 18.2 15.7 5.9 40.3 18.3 18.3 3.1 14.2 19.6 0.0 16.1 19.0 8.9 25.3 12.7 79.8 15.6 3.2 28.4 8.0 10.8 7.4 12.7 12.2 11.8 19.0 22.7 19.0 14.2 17.5 19.1 48.4 11.4 6.5 9.1 3.9 13.3 12.0 53.2 12.9 28.8 18.5 MCL1 "BCL2L3, Mcl-1" ENSG00000143384 "MCL1, BCL2 family apoptosis regulator" Q07820 1 150574551-150579738 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.1" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 12 "U-698: 335.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002781, HPA008455, HPA031125, CAB068195" Approved Enhanced Mitochondria Yes No Mitochondria "CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026" "unprognostic (3.82e-2)" "unprognostic (8.79e-2)" "unprognostic (9.15e-2)" "unprognostic (2.05e-2)" "unprognostic (1.34e-1)" "unprognostic (3.91e-2)" "unprognostic (3.16e-2)" "unprognostic (2.43e-2)" "unprognostic (1.29e-1)" "unprognostic (8.60e-2)" "unprognostic (1.57e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (7.16e-4)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "unprognostic (4.87e-2)" "unprognostic (4.46e-2)" 67.7 37.1 19.0 59.3 21.6 134.5 46.3 15.3 18.9 35.9 38.5 19.0 23.9 21.2 36.1 27.6 56.5 57.2 73.3 32.5 20.4 14.9 30.5 76.7 61.8 52.4 28.2 11.4 32.1 41.9 20.3 27.7 59.4 26.7 34.0 30.7 31.0 36.0 24.5 39.8 45.7 50.2 38.9 26.4 51.1 44.3 19.8 23.0 32.3 45.4 53.3 57.4 40.6 59.4 5.0 6.2 42.1 8.0 3.8 11.1 3.9 10.0 5.2 9.7 5.8 19.6 20.6 13.2 12.3 12.7 13.0 10.5 6.4 8.3 12.8 7.3 8.8 7.0 13.5 7.3 14.8 13.1 10.5 5.0 5.2 8.3 7.4 15.4 8.8 11.9 11.3 17.0 12.7 24.8 12.1 14.3 3.9 11.7 18.6 17.0 11.1 4.3 6.7 17.8 8.6 9.1 6.6 7.8 6.7 14.3 7.3 7.5 10.1 8.8 12.0 15.9 15.3 7.6 13.6 17.5 8.3 8.7 5.2 15.5 23.8 27.9 335.8 14.2 7.0 10.8 7.6 8.0 18.8 6.1 6.5 7.2 5.0 8.0 6.7 6.2 4.6 9.6 7.2 42.1 3.8 5.8 3.7 11.1 3.9 19.0 21.6 15.3 18.9 20.4 14.9 28.2 11.4 26.7 23.0 184.6 337.7 161.5 413.1 434.6 37.7 75.0 170.7 65.6 141.0 31.4 56.9 80.9 34.9 139.8 191.3 189.6 281.5 23.3 149.6 178.6 195.3 286.6 340.1 210.0 235.2 11.1 249.0 192.8 356.1 271.6 67.3 381.9 259.8 113.6 185.2 58.8 165.7 122.2 57.3 57.2 70.9 77.6 218.3 33.9 33.0 500.0 226.1 179.7 132.6 219.4 MCU "C10orf42, CCDC109A, FLJ46135" ENSG00000156026 "Mitochondrial calcium uniporter" Q8NE86 10 72692131-72887694 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 41.0" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016480 Approved Supported Mitochondria No No 1400000 Mitochondria "HPA016480: AB_2071893" "unprognostic (2.42e-2)" "unprognostic (1.58e-2)" "unprognostic (3.01e-2)" "unprognostic (5.37e-2)" "unprognostic (7.84e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (6.06e-5)" "unprognostic (1.23e-1)" "unprognostic (2.28e-1)" "unprognostic (2.33e-1)" "unprognostic (5.12e-3)" "unprognostic (1.73e-1)" "prognostic favorable (5.07e-4)" "unprognostic (4.51e-2)" "unprognostic (3.79e-1)" "unprognostic (2.74e-2)" "unprognostic (2.48e-2)" 8.2 6.5 6.3 9.4 6.1 12.3 9.8 41.0 6.8 7.0 19.8 4.1 8.5 19.1 10.9 7.4 13.4 7.8 11.5 6.9 4.8 4.3 11.1 7.2 10.1 7.4 3.4 4.1 5.8 12.1 8.2 5.5 8.8 5.5 4.6 21.9 5.1 9.5 5.8 41.4 9.0 23.0 11.0 3.8 4.9 29.4 4.7 3.5 4.9 5.4 14.9 7.3 10.1 15.0 3.4 5.4 16.6 7.6 1.9 4.6 3.6 19.7 32.0 8.3 6.0 12.7 14.3 8.5 12.2 17.4 12.2 13.1 19.0 18.9 8.4 9.8 14.9 6.6 18.1 10.9 14.5 16.4 9.2 10.2 10.5 12.0 10.5 9.9 26.3 8.9 14.5 12.4 10.9 23.4 19.2 14.6 9.0 6.5 6.3 11.3 11.5 7.1 5.7 9.2 21.6 6.7 7.4 17.8 2.2 16.5 10.8 8.9 3.9 15.0 16.8 3.6 10.5 3.3 6.9 11.8 5.9 10.2 12.7 8.1 4.7 5.9 5.9 7.9 13.2 4.5 1.7 6.1 16.6 2.9 6.7 3.1 3.4 3.0 3.5 5.4 1.7 2.3 2.6 8.2 1.9 7.6 1.9 4.6 3.6 6.3 6.1 41.0 6.8 4.8 4.3 3.4 4.1 5.5 3.5 32.8 13.4 2.7 10.4 10.4 3.0 5.9 10.2 18.7 26.1 17.4 2.0 6.4 1.7 7.2 10.7 7.4 22.6 0.0 22.1 8.3 6.7 8.1 8.1 5.0 6.3 0.0 8.1 8.6 6.3 4.7 4.9 3.7 8.5 2.8 24.0 4.8 27.5 8.6 3.9 6.1 3.3 12.9 8.9 3.9 4.9 10.8 7.8 2.5 20.4 20.7 MDH2 ENSG00000146701 "Malate dehydrogenase 2" P40926 7 76048051-76067508 "Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019714, HPA019716, HPA019848, HPA026720" Enhanced Enhanced Mitochondria No No 47000000 Mitochondria "HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685" "unprognostic (3.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-3)" "unprognostic (8.94e-2)" "unprognostic (6.45e-2)" "unprognostic (3.77e-2)" "unprognostic (3.60e-1)" "unprognostic (2.02e-2)" "unprognostic (1.40e-1)" "unprognostic (9.70e-2)" "prognostic favorable (1.49e-5)" "unprognostic (8.57e-2)" "unprognostic (9.64e-2)" "unprognostic (5.68e-2)" "unprognostic (2.66e-1)" 18.1 39.1 17.4 15.4 20.6 18.3 22.2 15.3 34.4 14.9 27.0 13.5 16.9 32.5 16.6 13.5 31.8 19.4 17.6 103.1 17.1 18.8 29.1 101.9 13.8 26.6 17.4 21.9 17.3 35.5 16.8 16.9 17.5 20.5 17.9 24.3 15.0 26.8 21.5 175.8 24.6 26.7 21.9 12.8 21.1 22.3 17.6 9.5 22.4 20.1 76.2 23.8 19.9 17.8 37.1 52.8 22.1 45.3 30.1 45.6 44.7 29.0 47.7 17.3 43.2 19.7 21.7 29.7 19.5 25.2 28.0 25.4 41.9 35.0 44.0 8.8 25.7 30.3 29.7 44.3 29.2 20.0 31.3 64.1 24.4 25.6 38.6 24.3 38.0 25.3 27.4 26.1 27.2 40.6 22.0 26.0 27.4 76.9 25.7 25.9 65.8 32.9 67.0 38.5 51.5 60.2 26.9 21.3 63.2 26.2 38.4 43.3 39.4 19.6 98.1 40.3 23.0 55.7 42.9 20.1 28.1 26.6 30.5 38.8 28.9 23.8 48.7 24.4 48.7 42.7 22.1 38.9 18.2 32.7 43.5 34.2 37.1 36.9 35.3 52.8 32.1 36.0 33.1 10.2 30.1 45.3 47.1 45.6 44.7 17.4 20.6 15.3 34.4 17.1 18.8 17.4 21.9 20.5 9.5 47.6 54.0 113.9 144.7 120.7 61.8 448.3 122.3 80.3 48.9 109.9 17.7 283.1 379.7 210.0 208.8 86.2 316.5 0.0 291.5 257.6 93.5 138.9 53.1 240.8 220.1 68.3 162.9 73.1 117.9 127.9 92.0 117.1 172.1 171.3 226.5 63.6 223.7 228.0 93.3 301.0 48.8 84.1 129.5 71.9 69.5 145.2 246.6 109.1 306.4 194.4 ME2 ENSG00000082212 "Malic enzyme 2" P23368 18 50878734-50954257 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008247, HPA008880" Enhanced Supported Mitochondria NA NA 3400000 Mitochondria "HPA008247: AB_1853704, HPA008880: AB_1853702" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (9.57e-3)" "unprognostic (2.22e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.29e-8)" "unprognostic (1.97e-1)" "unprognostic (3.66e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-2)" "unprognostic (4.75e-2)" "unprognostic (1.43e-2)" "unprognostic (4.27e-3)" "unprognostic (2.30e-1)" "unprognostic (2.47e-1)" "unprognostic (4.09e-1)" 12.6 18.1 17.1 18.4 16.2 11.6 10.7 13.2 16.0 9.4 26.4 14.3 16.8 30.2 10.5 7.7 10.6 9.3 10.5 34.6 15.8 17.8 12.1 12.1 10.3 24.1 18.7 14.0 11.1 16.7 20.6 20.2 10.5 47.7 11.8 26.6 9.4 8.8 23.1 29.5 7.1 44.8 16.9 18.9 36.6 20.3 15.3 8.7 24.3 9.0 7.8 17.3 14.2 15.7 4.9 9.6 14.3 17.4 6.7 6.0 4.5 13.0 13.1 17.5 20.4 8.0 8.9 8.1 10.9 8.2 14.3 12.1 6.0 7.2 46.7 4.3 9.7 13.1 10.9 26.1 11.1 16.5 19.3 4.0 11.9 8.3 7.0 23.6 39.6 14.3 5.5 13.6 18.0 29.3 9.4 18.3 27.8 12.6 11.4 9.7 2.7 28.6 3.9 11.7 9.4 5.4 18.8 8.7 13.5 15.6 2.8 21.7 11.5 10.2 6.3 10.9 11.0 4.8 19.3 11.3 10.2 11.4 5.3 14.5 21.3 8.6 22.9 10.3 28.3 10.8 5.0 11.6 14.3 5.0 13.1 4.1 4.9 3.3 6.0 9.6 4.9 2.9 3.5 13.3 6.7 17.4 3.2 3.1 4.5 17.1 16.2 13.2 16.0 15.8 17.8 18.7 14.0 47.7 8.7 8.9 11.0 34.0 15.3 13.5 17.4 93.2 7.6 5.3 26.1 14.0 13.7 14.6 33.2 28.0 13.4 14.8 44.5 0.0 34.2 14.5 10.8 15.2 15.1 7.4 87.2 7.9 11.5 30.7 83.1 4.7 10.6 39.2 11.8 27.9 24.3 13.0 27.5 20.1 15.6 14.0 55.9 6.5 15.4 50.9 20.4 9.4 7.2 26.1 35.2 14.8 MECR "CGI-63, ETR1, FASN2B, NRBF1" ENSG00000116353 "Mitochondrial trans-2-enoyl-CoA reductase" Q9BV79 1 29192873-29230942 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022018, HPA022030, HPA028740" Enhanced Supported Mitochondria NA NA Mitochondria "HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133" "unprognostic (2.53e-1)" "unprognostic (1.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.06e-2)" "unprognostic (8.66e-2)" "prognostic favorable (5.81e-6)" "unprognostic (7.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.29e-4)" 16.4 11.9 16.0 6.6 17.0 6.0 12.3 7.8 17.7 13.0 9.7 8.6 7.1 7.8 10.5 8.4 9.4 10.9 8.5 24.8 15.7 11.5 11.0 13.7 8.3 10.0 14.7 16.3 11.7 14.3 8.1 10.0 10.8 12.8 7.5 8.9 10.8 12.6 10.0 45.5 11.3 5.9 10.2 10.7 5.4 8.1 8.2 10.5 4.4 8.3 12.8 7.6 8.0 7.2 8.3 14.7 0.3 11.5 11.6 13.1 6.5 10.2 9.8 4.8 22.2 4.9 8.7 17.6 7.8 8.8 10.2 9.9 7.4 21.0 13.5 15.6 7.6 3.2 12.8 6.0 15.8 6.3 9.2 12.4 11.7 6.3 9.4 15.2 12.9 6.0 8.6 14.1 5.4 19.9 8.5 11.2 17.3 10.0 14.0 12.7 11.5 10.9 7.1 12.9 19.5 12.5 6.7 8.1 23.7 10.8 5.9 7.3 11.3 11.5 16.4 14.4 9.8 6.0 12.5 11.3 7.4 8.0 11.5 11.4 13.4 5.5 10.0 20.0 17.2 14.0 0.1 7.0 0.0 8.3 11.5 13.1 8.3 7.8 6.7 14.7 7.4 8.4 8.5 0.3 11.6 7.0 8.6 6.3 6.5 16.0 17.0 7.8 17.7 15.7 11.5 14.7 16.3 12.8 10.5 11.9 3.8 8.2 13.8 4.9 12.0 17.1 15.3 2.7 11.4 19.2 9.8 41.0 34.9 18.9 31.2 8.0 7.8 0.0 17.2 32.6 12.7 8.1 5.7 18.3 18.3 7.9 7.5 4.9 4.9 60.9 12.7 6.0 15.1 12.6 9.8 10.9 14.2 7.0 10.3 32.7 62.2 12.9 8.9 6.7 15.0 6.5 23.3 4.9 19.9 15.6 METTL4 "FLJ23017, HsT661" ENSG00000101574 "Methyltransferase like 4" Q8N3J2 18 2537525-2571509 "Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040061, HPA046734" Approved Approved Mitochondria NA NA Mitochondria "HPA040061: AB_10697713, HPA046734: AB_2732532" "unprognostic (1.85e-2)" "unprognostic (1.27e-1)" "unprognostic (7.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (5.06e-3)" "unprognostic (1.12e-5)" "unprognostic (1.74e-1)" "unprognostic (5.12e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.72e-2)" "unprognostic (3.26e-1)" "unprognostic (4.00e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-3)" 13.2 8.9 10.1 13.5 15.7 6.1 15.8 18.4 15.6 13.5 10.6 8.6 15.7 9.7 14.0 12.3 11.9 11.1 10.9 9.9 10.1 11.8 10.5 9.2 11.2 19.9 15.9 8.5 13.9 8.6 16.3 23.6 10.4 14.2 12.9 12.7 10.1 17.7 15.6 6.4 11.0 14.6 12.6 17.3 19.9 10.0 12.4 15.8 15.3 16.2 7.2 19.5 13.8 16.8 7.5 3.5 14.4 2.5 5.6 9.4 4.8 7.8 3.4 10.8 6.4 4.9 7.6 12.4 12.3 11.2 12.9 12.8 6.9 5.9 16.5 7.8 5.8 10.5 7.0 17.4 6.6 16.6 11.9 6.0 6.3 6.8 5.9 7.5 14.6 8.4 4.9 14.8 13.2 8.5 7.4 13.3 10.2 8.8 20.7 11.0 3.8 10.9 4.8 6.2 6.9 5.6 7.5 8.6 11.3 7.6 4.9 19.4 8.9 9.8 6.8 12.9 9.5 7.6 10.1 8.6 14.8 18.5 14.3 17.6 10.3 26.4 9.6 9.9 10.3 17.1 14.4 2.5 6.5 6.6 2.3 8.0 6.8 7.6 8.6 1.9 7.5 9.4 8.6 10.1 5.6 2.0 3.5 8.4 4.8 10.1 15.7 18.4 15.6 10.1 11.8 15.9 8.5 14.2 15.8 11.9 8.0 10.0 10.0 4.2 10.1 3.1 5.1 13.4 12.5 3.5 13.7 6.4 0.0 4.9 2.5 9.0 7.8 0.0 6.3 7.9 5.7 9.4 6.9 3.8 5.1 7.9 2.4 12.9 7.6 2.6 11.8 5.7 3.3 1.8 5.1 8.0 6.6 4.2 10.3 4.0 5.8 12.9 6.6 27.0 20.9 4.3 8.7 10.9 4.9 15.4 MFF "C2orf33, GL004" ENSG00000168958 "Mitochondrial fission factor" Q9GZY8 2 227325151-227357836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 827.2;Late spermatids: 1262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010968, HPA074625" Enhanced Supported Mitochondria No No Mitochondria "HPA010968: AB_1845714, HPA074625: AB_2686704" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.07e-2)" "unprognostic (1.32e-1)" "unprognostic (6.07e-2)" "unprognostic (3.00e-2)" "unprognostic (6.24e-3)" "unprognostic (5.50e-2)" "unprognostic (1.00e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" "unprognostic (3.22e-1)" 20.2 23.9 31.6 18.0 27.6 22.3 21.3 25.7 38.4 19.6 22.5 26.5 14.7 22.1 21.9 20.9 21.5 18.0 17.1 40.5 27.8 28.4 33.7 24.4 16.6 27.1 30.2 20.2 25.7 27.6 25.0 19.3 17.7 28.0 20.6 22.5 25.6 20.6 27.6 37.4 16.7 18.6 22.9 33.4 16.9 18.8 97.0 20.6 25.9 19.8 22.2 23.3 20.7 17.8 40.2 34.9 59.9 33.8 29.3 44.1 33.1 23.2 20.0 24.6 33.8 31.9 30.7 32.7 23.2 31.4 28.3 30.3 21.7 16.6 13.3 27.8 25.3 29.8 19.3 40.4 29.5 38.5 28.1 32.5 28.1 51.6 54.4 42.1 27.1 25.2 27.5 38.9 26.8 28.7 37.1 24.4 30.7 24.4 40.0 25.0 23.4 28.6 41.8 33.3 25.0 21.2 26.0 31.1 25.7 41.3 22.0 26.1 24.5 50.9 23.7 33.8 21.2 15.2 26.9 16.4 27.6 23.3 40.8 25.7 32.6 22.1 26.7 36.5 24.2 37.5 42.4 32.9 59.9 32.8 33.8 35.3 40.2 34.5 32.0 34.5 38.2 36.6 31.0 31.0 29.3 30.6 34.9 44.1 33.1 31.6 27.6 25.7 38.4 27.8 28.4 30.2 20.2 28.0 20.6 29.8 37.7 68.1 54.7 42.8 34.0 71.6 35.7 26.8 52.4 57.6 29.5 82.2 107.8 83.0 827.2 38.3 47.7 93.5 82.7 82.5 63.5 55.3 20.9 54.0 67.9 38.1 31.0 41.1 54.0 1262.3 81.4 51.9 77.6 56.9 59.6 185.4 78.7 66.6 80.6 97.9 56.3 58.2 52.6 274.7 48.3 41.4 76.9 53.7 69.3 60.3 MFN1 FLJ20693 ENSG00000171109 "Mitofusin 1" 3 179347692-179394931 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033437, HPA059230" Approved Supported Mitochondria NA NA Mitochondria "CAB033437: AB_2250540, HPA059230: AB_2683952" "unprognostic (2.94e-2)" "unprognostic (5.56e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (6.70e-4)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (6.37e-2)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "unprognostic (3.76e-3)" "unprognostic (7.91e-2)" "unprognostic (7.90e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (9.79e-2)" 13.7 16.5 12.2 12.1 17.2 9.9 15.4 24.3 22.4 18.4 16.5 15.9 19.4 12.0 19.6 21.3 19.6 18.5 13.4 31.1 12.0 11.4 17.9 14.9 12.3 16.0 16.9 14.5 16.6 29.9 18.2 22.3 12.4 21.5 17.7 14.6 12.8 17.4 17.4 21.7 19.6 16.6 15.7 16.0 18.2 17.8 11.8 17.0 16.9 14.5 20.1 19.6 17.6 15.1 10.5 4.1 8.9 4.5 4.1 7.3 2.1 16.7 5.0 9.7 15.8 14.0 13.0 12.9 10.5 10.8 11.1 13.2 12.5 7.0 5.7 11.0 15.4 22.4 9.9 13.6 10.3 19.5 9.0 10.5 9.3 11.6 6.8 11.5 4.9 9.0 9.0 9.1 11.9 8.5 9.2 14.0 9.6 6.8 7.6 15.4 8.9 7.2 3.7 11.5 16.9 9.3 5.1 15.3 21.1 10.6 17.8 9.2 13.1 9.8 26.3 14.2 10.4 36.0 3.6 11.7 9.7 10.8 15.0 15.3 10.2 11.0 9.5 10.8 8.3 10.5 5.5 3.8 8.5 4.3 4.5 7.3 7.8 4.9 4.4 3.4 10.5 4.6 5.1 8.9 4.1 3.6 4.1 4.4 2.1 12.2 17.2 24.3 22.4 12.0 11.4 16.9 14.5 21.5 17.0 23.8 33.7 14.5 9.5 14.8 16.0 28.0 10.2 33.5 27.3 17.4 37.3 9.7 8.3 11.0 2.3 9.4 11.7 23.3 15.0 8.4 13.8 17.9 8.1 16.6 7.2 11.1 9.8 17.2 10.7 2.5 12.4 11.3 11.8 6.4 16.0 11.5 14.1 8.6 16.6 10.3 16.6 6.5 13.9 25.4 11.5 23.6 11.0 7.4 13.3 20.1 MFN2 "CMT2A2, CPRP1, KIAA0214, MARF" ENSG00000116688 "Mitofusin 2" O95140 1 11980181-12013514 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.9;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 308.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030554, CAB079902" Uncertain Supported Mitochondria NA NA Mitochondria "CAB079902: AB_2724683, HPA030554: AB_10603018" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.38e-2)" "unprognostic (8.36e-2)" "unprognostic (9.71e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (3.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.43e-1)" "unprognostic (3.55e-1)" "prognostic favorable (2.36e-8)" "unprognostic (4.69e-2)" "unprognostic (2.76e-1)" "unprognostic (8.84e-3)" "unprognostic (2.12e-1)" 12.8 10.1 16.4 8.9 20.3 17.2 10.1 15.9 32.1 8.7 17.0 17.0 11.2 16.5 12.1 8.7 20.1 9.0 9.0 100.9 17.9 16.0 14.8 20.4 10.6 8.0 18.8 19.3 10.2 9.0 22.0 9.3 12.9 20.8 14.1 13.2 16.5 10.7 23.7 111.1 18.8 25.7 22.9 15.7 10.2 14.0 11.3 10.9 7.3 18.7 28.5 12.1 16.3 10.6 7.3 8.9 18.5 16.9 5.8 10.2 13.4 26.0 15.9 18.1 23.8 18.3 13.8 21.0 20.6 19.1 28.3 22.1 26.3 17.4 19.1 22.4 24.9 18.6 27.9 29.9 47.8 25.4 69.2 22.7 27.3 25.6 20.4 19.0 27.7 17.2 17.4 36.9 39.8 36.9 12.2 19.9 10.3 28.2 16.8 20.9 13.1 16.8 12.7 12.5 17.5 23.5 19.7 26.4 17.8 17.0 17.4 21.1 13.8 24.2 25.8 23.9 14.2 13.9 16.7 19.9 19.0 19.0 28.8 21.5 20.1 21.1 31.3 22.5 31.2 20.5 8.5 10.3 7.1 9.6 13.5 10.2 7.3 7.2 8.6 8.9 6.6 6.3 8.0 18.5 5.8 16.9 4.6 8.0 13.4 16.4 20.3 15.9 32.1 17.9 16.0 18.8 19.3 20.8 10.9 20.8 18.6 11.5 8.2 20.3 24.8 308.6 12.7 12.0 14.8 14.0 11.8 12.2 18.3 12.7 3.6 12.0 31.1 23.3 17.3 13.2 9.3 12.5 10.4 39.2 14.2 28.6 17.3 13.5 18.1 4.4 6.6 11.8 16.9 10.0 20.9 11.6 13.9 14.0 14.2 13.3 18.6 12.9 14.4 27.7 16.8 26.3 21.1 9.6 22.1 12.9 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4" "Low region specificity" "Detected in some" "HPA015994, HPA070835" Enhanced Supported Mitochondria NA NA Mitochondria "HPA015994: AB_2630370, HPA070835: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.7 0.0 1.6 0.0 0.0 0.1 0.0 0.1 15.9 4.6 0.2 2.3 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.9 0.1 0.1 3.9 0.3 1.7 0.1 3.8 32.4 0.1 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 4.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 0.0 0.0 0.0 0.7 1.4 140.5 2.5 0.0 0.0 0.0 0.0 7.9 0.2 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 2.4 0.3 0.0 0.0 0.5 197.0 0.0 0.6 0.0 0.0 15.8 0.0 0.0 0.0 0.0 424.1 0.1 0.0 23.3 7.6 28.7 0.0 0.4 0.7 0.3 0.6 0.2 0.0 0.0 0.3 MGME1 "bA504H3.4, C20orf72, DDK1" ENSG00000125871 "Mitochondrial genome maintenance exonuclease 1" Q9BQP7 20 17968913-17991122 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040913 Approved Supported Mitochondria NA Yes Mitochondria "HPA040913: AB_10962835" "unprognostic (5.81e-3)" "unprognostic (5.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-3)" "unprognostic (5.42e-2)" "unprognostic (1.44e-2)" "prognostic unfavorable (6.98e-8)" "unprognostic (5.31e-2)" "unprognostic (7.05e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (8.70e-2)" "unprognostic (6.89e-2)" 8.7 14.2 6.4 12.0 7.6 10.9 14.9 7.0 6.7 8.4 10.5 11.7 8.2 10.2 7.3 8.6 14.3 5.4 6.5 10.5 7.3 4.8 10.5 11.3 6.5 13.9 11.5 7.2 5.8 9.6 7.1 14.1 19.9 8.4 8.5 10.7 10.4 11.0 7.8 17.8 26.9 10.9 5.2 9.8 19.5 7.6 12.9 8.3 31.8 15.5 7.6 16.9 10.6 9.6 13.2 10.9 24.1 8.5 8.8 9.2 4.5 17.1 20.0 16.4 15.4 6.7 12.0 22.0 14.5 10.7 14.0 19.2 24.6 17.5 20.4 8.2 6.4 15.9 25.8 16.9 21.6 21.3 7.5 13.9 13.3 11.1 37.1 5.0 8.6 22.8 7.2 15.1 20.8 11.0 6.6 11.1 10.4 18.0 13.4 28.1 12.8 15.4 11.8 14.4 10.3 17.7 11.7 36.8 19.4 12.1 12.6 12.7 10.6 10.2 25.1 21.9 13.9 23.9 6.1 8.9 24.3 19.7 12.0 15.6 10.1 22.3 17.5 6.2 6.7 17.7 24.0 8.5 24.1 4.9 8.1 6.4 11.4 6.3 6.4 6.8 13.2 4.5 4.3 8.2 8.8 7.5 10.9 9.2 4.5 6.4 7.6 7.0 6.7 7.3 4.8 11.5 7.2 8.4 8.3 0.0 11.4 23.1 13.1 41.2 6.4 10.5 20.4 5.3 12.5 7.0 7.9 18.8 33.2 9.6 4.5 11.3 18.3 0.0 8.9 21.7 7.5 9.0 45.2 8.9 26.4 7.9 6.9 17.8 29.3 4.2 7.8 16.2 20.3 6.4 12.9 10.8 8.6 7.0 5.3 20.9 9.6 12.9 5.7 31.1 51.2 40.9 15.1 15.3 19.0 10.2 MICU1 "CALC, CBARA1, EFHA3, FLJ12684" ENSG00000107745 "Mitochondrial calcium uptake 1" Q9BPX6 10 72367327-72626191 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037479, HPA037480" Approved Supported Mitochondria NA NA Mitochondria "HPA037479: AB_2675495, HPA037480: AB_10696934" "unprognostic (8.18e-2)" "unprognostic (6.98e-3)" "unprognostic (6.71e-2)" "unprognostic (8.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.91e-2)" "unprognostic (3.60e-2)" "unprognostic (2.96e-3)" "unprognostic (3.38e-2)" "unprognostic (7.43e-2)" "unprognostic (2.23e-2)" "prognostic favorable (4.66e-7)" "unprognostic (1.70e-1)" "unprognostic (1.55e-1)" "unprognostic (5.35e-2)" "unprognostic (6.70e-2)" 16.8 36.4 22.9 14.4 25.3 17.0 15.4 56.3 30.7 18.2 16.9 18.9 11.6 20.9 29.7 14.3 13.3 20.5 18.6 24.0 23.3 21.7 58.9 64.7 16.7 11.2 20.9 22.7 25.0 11.6 21.1 23.4 16.3 25.2 14.9 19.2 15.1 15.5 13.8 36.9 16.3 21.5 22.2 17.5 18.1 24.1 11.8 15.0 15.1 13.8 14.6 11.9 20.0 15.2 6.5 9.5 39.0 21.7 5.6 6.5 11.5 15.8 28.1 17.9 21.0 29.0 27.3 8.1 17.5 39.9 26.3 36.3 16.5 30.2 21.5 14.9 24.6 21.5 19.1 22.5 15.8 31.1 19.2 18.4 14.5 15.7 23.8 23.0 19.9 16.1 27.2 14.4 28.8 26.9 36.2 22.6 20.8 22.4 25.5 30.5 14.5 17.5 18.9 7.5 17.2 6.9 19.2 24.1 14.2 32.2 11.9 13.8 19.9 20.8 26.0 16.1 18.8 15.5 19.4 13.9 13.1 20.3 25.8 14.5 13.5 22.5 15.1 26.1 26.7 8.8 7.3 21.7 39.0 6.5 18.3 5.7 5.8 5.8 6.0 9.5 6.5 5.7 4.8 18.3 5.6 18.4 6.1 5.5 11.5 22.9 25.3 56.3 30.7 23.3 21.7 20.9 22.7 25.2 15.0 50.6 25.2 26.6 13.0 8.9 30.3 31.7 30.6 44.2 53.4 33.2 19.6 16.4 68.0 29.8 7.7 21.6 24.5 0.0 23.4 16.0 19.5 12.8 17.4 51.2 30.8 15.9 13.8 19.0 33.9 7.9 24.7 24.0 11.8 20.8 23.9 57.0 39.7 23.0 24.4 60.0 30.6 6.5 15.5 61.4 40.5 12.4 18.0 14.9 22.1 12.3 MIGA1 "FAM73A, FLJ35093" ENSG00000180488 "Mitoguardin 1" Q8NAN2 1 77779624-77879539 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 27.0;Collecting duct cells: 22.7;Proximal tubular cells: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017589 Approved Supported Mitochondria NA NA Mitochondria "HPA017589: AB_1848409" "unprognostic (3.27e-1)" "unprognostic (1.19e-2)" "unprognostic (7.31e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (3.48e-2)" "unprognostic (2.70e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.89e-1)" "unprognostic (1.68e-1)" "unprognostic (4.71e-2)" "unprognostic (4.75e-2)" 11.7 11.0 12.2 6.9 23.7 8.1 19.2 18.1 25.4 10.5 8.2 20.3 7.2 9.7 12.0 7.5 8.7 9.1 10.3 8.6 15.7 16.1 20.2 11.2 8.3 6.6 19.2 19.7 12.7 8.9 28.0 13.9 10.1 26.4 13.3 8.0 7.6 12.1 9.6 15.7 7.6 10.6 10.1 29.9 7.5 9.8 7.6 18.8 5.9 21.8 5.1 5.9 10.5 8.1 6.2 3.7 7.3 6.8 5.8 6.7 3.2 8.6 5.6 3.5 4.5 8.7 11.4 9.3 12.5 5.9 7.4 7.6 6.2 6.0 3.8 13.9 8.6 8.9 6.0 4.7 7.4 14.1 5.5 4.8 4.4 6.9 2.9 8.9 4.1 3.4 8.1 8.1 15.1 11.0 10.6 7.4 3.4 2.4 5.2 11.2 1.4 3.9 2.3 3.0 4.3 7.0 2.1 8.6 1.9 9.0 9.4 7.1 5.8 5.8 8.8 16.0 6.1 3.3 2.7 11.8 10.6 4.9 16.0 13.1 3.1 4.3 2.4 9.4 3.6 4.6 7.3 5.5 6.6 5.9 6.8 6.2 4.6 4.7 4.7 3.7 6.2 6.7 5.9 3.5 5.8 4.3 3.0 4.3 3.2 12.2 23.7 18.1 25.4 15.7 16.1 19.2 19.7 26.4 18.8 32.8 27.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 19.4 22.7 0.0 13.4 5.0 13.8 0.0 0.0 0.0 0.0 12.6 10.5 0.0 0.0 11.6 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 4.6 0.0 0.0 15.3 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 MINOS1 "C1orf151, FLJ36999, Mic10, MIO10, RP5-1056L3.2" ENSG00000173436 "Mitochondrial inner membrane organizing system 1" Q5TGZ0 1 19596977-19629821 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059930 Enhanced Supported Mitochondria NA NA Mitochondria "HPA059930: AB_2684167" "unprognostic (3.84e-2)" "unprognostic (8.74e-3)" "unprognostic (2.66e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.88e-1)" "unprognostic (8.74e-2)" "unprognostic (3.96e-1)" "unprognostic (1.37e-1)" "unprognostic (2.43e-2)" "unprognostic (1.24e-3)" "unprognostic (7.13e-2)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "prognostic favorable (8.11e-4)" 10.1 9.7 22.0 8.1 21.3 5.4 12.6 20.4 22.2 17.7 16.3 7.2 7.5 10.6 14.5 13.7 15.1 15.2 13.7 25.4 18.3 21.4 19.8 12.5 9.7 8.3 20.6 15.5 14.0 13.3 14.5 16.6 8.3 17.0 17.2 18.3 9.3 13.8 17.8 25.2 10.1 17.4 18.2 12.1 8.9 11.4 5.0 11.8 7.7 13.7 20.3 11.8 13.9 10.9 7.0 8.4 9.0 10.5 3.7 11.3 8.9 7.6 10.6 6.0 6.6 11.6 11.1 3.7 6.7 7.6 7.9 8.0 7.4 7.1 6.5 5.6 8.8 6.4 5.6 10.5 8.8 12.8 9.8 7.3 5.7 17.0 10.2 5.1 8.8 4.3 9.0 14.5 7.9 9.7 6.0 11.5 4.9 12.1 4.9 11.8 13.6 4.5 11.5 5.1 10.0 13.5 4.5 7.3 8.6 19.3 4.7 12.5 5.6 7.4 6.0 5.8 5.0 5.9 4.9 7.6 6.2 4.8 7.8 6.6 3.1 5.2 6.7 4.8 16.9 5.8 5.6 8.1 9.0 6.4 10.5 5.8 7.0 8.7 7.0 8.2 6.7 11.3 8.1 5.5 3.7 10.5 8.4 7.8 8.9 22.0 21.3 20.4 22.2 18.3 21.4 20.6 15.5 17.0 11.8 157.8 125.9 175.7 110.6 149.9 78.1 411.9 318.5 207.5 112.6 347.2 43.2 260.0 704.6 351.8 112.1 128.1 424.9 46.7 394.4 215.9 199.3 157.4 195.4 297.4 460.5 85.8 231.3 133.8 238.8 184.5 222.6 223.0 214.2 236.3 403.3 76.4 343.8 474.2 207.9 655.8 74.3 64.7 206.0 163.1 143.3 192.6 153.4 121.5 528.4 124.4 MIPEP MIP ENSG00000027001 "Mitochondrial intermediate peptidase" Q99797 13 23730189-23889419 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 80.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030676, HPA031669, HPA031670" Approved Enhanced Mitochondria NA NA Mitochondria "HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198" "unprognostic (2.05e-1)" "unprognostic (3.17e-2)" "unprognostic (3.75e-3)" "unprognostic (3.72e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-2)" "unprognostic (1.12e-1)" "unprognostic (7.54e-2)" "unprognostic (4.76e-1)" "prognostic favorable (7.66e-12)" "unprognostic (1.62e-2)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (6.90e-3)" 7.3 14.9 6.2 7.1 12.2 4.4 11.0 4.7 10.3 8.1 12.2 12.9 12.1 8.4 9.6 20.4 14.4 17.1 11.7 16.9 8.8 5.3 24.7 12.0 8.2 8.4 5.1 8.0 8.5 14.7 8.1 15.4 5.3 9.1 10.9 13.1 9.1 12.9 10.1 16.2 22.0 8.9 11.5 4.4 6.5 9.8 13.9 4.9 8.9 10.9 15.7 11.1 11.2 8.6 9.2 6.5 1.2 10.6 9.7 10.0 3.9 7.8 8.9 4.4 10.3 10.1 13.7 9.4 5.7 8.9 8.6 7.3 11.8 15.7 9.3 5.8 4.6 7.6 19.9 10.1 12.0 10.7 5.4 6.4 4.0 4.2 10.1 8.3 9.4 2.2 6.7 15.0 8.9 7.9 7.3 10.7 7.1 7.7 1.5 13.4 5.8 6.7 5.3 6.1 35.4 9.0 7.5 11.9 8.0 19.2 5.2 10.3 3.4 6.1 10.0 12.0 5.8 10.3 5.3 5.9 5.2 4.4 8.6 6.1 1.5 2.1 5.0 9.1 4.8 6.5 0.0 3.0 1.2 7.9 3.7 10.0 9.2 7.7 7.1 6.5 7.7 7.4 7.3 0.0 9.7 10.6 5.6 5.1 3.9 6.2 12.2 4.7 10.3 8.8 5.3 5.1 8.0 9.1 4.9 14.9 7.5 0.8 5.9 35.4 3.2 80.7 15.3 36.1 10.3 8.7 5.9 8.4 24.9 20.8 6.6 3.7 5.5 0.0 9.4 7.7 4.5 5.6 2.3 5.6 8.7 14.3 5.8 2.5 2.7 5.9 6.4 4.1 5.0 3.6 6.4 5.2 8.0 8.6 8.1 18.1 10.7 0.0 5.2 9.5 19.0 36.9 4.2 2.9 12.4 3.8 MMAB "cblB, CFAP23" ENSG00000139428 "Methylmalonic aciduria (cobalamin deficiency) cblB type" Q96EY8 12 109553737-109573874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 187.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039017 Approved Approved Mitochondria NA NA Mitochondria "HPA039017: AB_10673603" "unprognostic (1.16e-1)" "unprognostic (1.25e-2)" "unprognostic (1.90e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-1)" "unprognostic (4.22e-1)" "unprognostic (2.04e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-3)" "unprognostic (2.58e-1)" "prognostic favorable (1.55e-4)" "unprognostic (4.90e-2)" "unprognostic (1.51e-1)" "unprognostic (2.23e-1)" "unprognostic (9.65e-2)" 7.3 26.1 12.7 7.2 12.2 5.2 13.0 7.2 17.2 7.0 12.2 12.6 9.4 12.7 7.7 21.9 14.8 9.8 11.8 18.1 11.6 11.5 13.6 47.9 11.8 13.0 12.4 8.2 14.2 20.2 9.1 11.7 5.3 14.0 15.7 8.3 11.2 15.1 10.6 16.5 8.9 8.5 8.7 15.7 6.7 10.7 7.8 14.8 4.3 16.6 15.7 7.5 6.0 7.5 14.1 9.4 3.8 8.1 8.5 13.9 9.2 13.4 9.1 9.5 7.5 3.9 8.0 4.9 3.0 6.9 4.4 4.7 10.6 12.6 8.6 8.7 3.4 8.4 14.1 6.2 23.3 2.0 3.4 25.6 3.5 6.8 17.4 13.9 7.5 3.1 10.6 14.6 9.6 4.2 5.4 4.1 6.9 11.2 6.6 3.1 31.1 6.8 12.1 11.7 1.4 13.1 5.7 3.6 22.4 19.5 12.7 14.8 6.4 6.7 12.6 5.2 2.7 26.2 21.2 2.3 3.8 1.6 2.7 4.3 5.2 3.8 9.7 8.3 9.2 10.3 3.8 5.9 0.8 13.5 8.1 10.8 11.1 9.9 10.7 9.4 14.1 13.9 13.1 1.7 8.5 8.0 7.7 4.7 9.2 12.7 12.2 7.2 17.2 11.6 11.5 12.4 8.2 14.0 14.8 32.8 66.2 26.6 23.6 9.2 31.3 44.8 66.2 65.6 43.3 40.1 27.5 51.9 127.6 40.5 30.4 16.2 42.1 0.0 62.2 27.8 17.9 25.9 16.1 187.6 29.6 98.5 31.8 24.5 19.7 56.0 37.4 16.3 25.3 35.1 43.5 29.1 27.3 31.6 28.7 102.6 27.3 12.9 16.0 30.5 15.1 17.2 51.7 21.7 53.3 20.1 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 875.4;Distal tubular cells: 1458.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA045119: AB_10960421, HPA055790: AB_2682923" "unprognostic (3.30e-2)" "prognostic favorable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favorable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favorable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 27.9 23.6 13.6 12.0 7.5 12.2 11.8 11.5 9.9 4.6 13.7 13.6 11.6 9.5 6.2 12.1 9.5 8.3 9.3 20.8 6.8 10.1 32.9 9.8 26.2 8.9 10.9 13.4 9.6 6.9 3.6 9.5 21.3 23.6 21.9 7.3 10.4 18.2 48.6 4.1 37.3 9.2 10.0 13.5 34.2 22.0 5.2 25.5 22.6 8.7 38.0 8.6 7.0 9.0 39.4 6.6 6.9 7.1 24.2 7.7 15.0 10.3 11.4 6.3 32.4 10.9 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 110.2 37.1 53.6 36.9 40.5 51.2 875.4 183.4 44.2 47.8 101.2 9.8 19.1 1458.9 78.7 46.1 45.8 147.2 23.3 122.5 67.4 59.4 34.7 70.3 365.8 104.2 46.1 35.7 38.6 74.2 5.6 61.5 76.9 123.2 111.8 87.8 137.3 56.8 120.7 84.5 301.3 55.1 90.5 90.6 126.5 39.4 48.8 20.4 54.3 110.8 45.7 MRM1 FLJ22578 ENSG00000278619 "Mitochondrial rRNA methyltransferase 1" Q6IN84 17 36601572-36608971 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021598 Supported Supported Mitochondria NA NA Mitochondria "HPA021598: AB_1854097" "unprognostic (9.07e-3)" "unprognostic (1.50e-1)" "unprognostic (1.86e-1)" "unprognostic (1.19e-1)" "unprognostic (4.86e-2)" "unprognostic (1.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (4.90e-2)" "unprognostic (2.47e-2)" "unprognostic (8.56e-2)" "unprognostic (2.75e-1)" "unprognostic (5.67e-2)" "unprognostic (2.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.74e-2)" 2.2 6.8 2.9 3.9 6.4 2.9 3.5 1.9 4.9 1.2 4.2 5.2 3.2 5.9 3.2 3.4 3.6 4.0 3.4 3.8 3.7 2.4 4.0 2.2 4.6 6.5 3.0 4.2 4.1 0.9 0.9 1.0 2.8 2.1 5.6 2.4 2.9 4.7 5.9 2.2 4.5 1.2 3.4 5.2 2.5 1.5 3.5 0.9 3.2 1.8 3.8 3.4 0.0 6.7 3.3 0.0 4.4 7.3 7.6 3.7 0.9 6.1 0.0 3.6 3.2 3.8 11.8 0.2 0.0 0.0 0.0 0.4 0.1 0.4 7.1 0.0 3.0 15.1 0.1 0.2 0.0 4.7 2.1 10.5 3.5 6.4 1.9 5.2 5.5 3.0 0.3 7.5 0.0 1.1 3.7 4.7 6.2 4.0 4.3 0.1 10.5 3.2 0.1 14.7 0.1 8.4 0.0 13.5 3.1 7.1 2.8 1.8 0.0 4.4 4.6 4.5 4.6 1.8 1.8 3.6 6.0 4.1 0.0 9.3 10.8 4.5 0.0 5.9 2.6 0.0 2.9 0.0 4.3 4.4 7.6 6.7 3.6 4.1 2.9 6.1 5.5 5.8 0.0 7.3 1.8 3.3 2.8 3.7 0.0 1.0 2.9 2.8 1.0 0.7 7.3 0.0 0.0 1.2 3.5 3.9 6.2 8.3 3.1 0.0 2.9 4.3 0.0 1.6 4.9 2.3 2.6 0.0 1.6 5.5 6.4 1.7 1.3 1.5 0.0 3.1 1.3 1.7 2.8 4.6 1.5 2.7 7.0 1.4 4.1 1.2 0.0 1.4 0.9 2.7 0.4 1.5 0.8 9.7 1.7 MRM3 "FLJ10581, HC90, RMTL1, RNMTL1" ENSG00000171861 "Mitochondrial rRNA methyltransferase 3" Q9HC36 17 782273-792509 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 22.9;Distal tubular cells: 16.6;Ductal cells: 16.4;Exocrine glandular cells: 16.0;Extravillous trophoblasts: 19.4;monocytes: 18.0;Proximal tubular cells: 15.9;Syncytiotrophoblasts: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022534, HPA023031, HPA023292" Enhanced Supported Mitochondria NA NA Mitochondria "HPA022534: AB_1856386, HPA023031: AB_1856387, HPA023292: AB_1856388" "unprognostic (1.66e-1)" "unprognostic (5.83e-3)" "unprognostic (6.72e-2)" "prognostic favorable (2.81e-4)" "unprognostic (2.67e-1)" "unprognostic (1.83e-1)" "unprognostic (2.48e-1)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (8.20e-2)" "unprognostic (3.72e-3)" "unprognostic (8.47e-2)" "prognostic favorable (3.00e-4)" "unprognostic (3.82e-2)" "unprognostic (9.98e-2)" "unprognostic (1.05e-2)" "unprognostic (1.42e-2)" 10.0 13.8 7.2 12.4 11.9 16.4 10.5 12.8 11.8 7.1 9.1 7.8 8.0 8.6 8.6 8.2 12.0 9.4 10.1 14.7 7.1 7.2 11.1 20.5 6.5 11.9 9.7 7.7 10.3 21.2 8.3 9.2 7.6 10.1 8.2 8.9 7.0 11.4 8.6 31.0 14.6 8.2 8.7 4.8 10.8 12.4 21.4 8.9 12.2 10.1 13.8 10.1 8.7 10.8 22.1 14.8 8.0 14.2 17.6 20.2 14.8 13.5 28.3 6.1 10.6 9.1 7.8 12.1 7.3 6.9 14.7 12.6 16.5 6.3 24.5 7.6 5.8 7.1 11.5 18.1 6.5 14.2 8.2 29.5 9.4 16.4 14.3 9.2 8.1 8.6 9.1 9.1 15.6 13.7 7.7 11.2 15.0 15.8 11.0 7.8 14.6 13.8 10.6 9.0 10.2 14.9 17.0 4.4 13.0 9.8 7.4 8.1 9.4 10.4 8.8 13.6 5.3 10.9 7.3 8.7 7.9 6.1 11.4 20.0 4.3 6.1 9.9 9.9 11.4 10.6 4.9 14.2 8.0 15.2 11.3 16.4 22.1 16.6 18.5 14.8 20.9 20.2 17.6 1.1 17.6 10.9 11.8 17.2 14.8 7.2 11.9 12.8 11.8 7.1 7.2 9.7 7.7 10.1 8.9 6.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 5.2 0.0 22.9 16.6 16.4 0.0 0.0 0.0 0.0 16.0 19.4 0.0 0.0 3.5 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 18.0 0.0 0.0 11.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 MRPL1 BM022 ENSG00000169288 "Mitochondrial ribosomal protein L1" Q9BYD6 4 77862520-77952790 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043656 Supported Approved Mitochondria NA NA Mitochondria "HPA043656: AB_2678601" "unprognostic (9.03e-3)" "unprognostic (3.25e-1)" "unprognostic (1.11e-3)" "unprognostic (2.88e-1)" "unprognostic (4.52e-2)" "unprognostic (5.29e-3)" "unprognostic (4.69e-3)" "unprognostic (5.44e-2)" "unprognostic (1.66e-2)" "unprognostic (5.14e-3)" "unprognostic (8.79e-2)" "unprognostic (2.22e-2)" "prognostic favorable (3.35e-5)" "unprognostic (7.63e-2)" "unprognostic (1.87e-1)" "unprognostic (7.13e-2)" "unprognostic (9.17e-3)" 13.6 16.5 14.8 10.9 16.0 13.5 14.0 12.3 20.3 13.6 16.2 4.4 9.6 11.8 12.5 13.6 17.2 10.5 6.9 23.5 18.5 14.7 22.4 22.4 7.6 12.4 13.5 14.0 12.0 12.0 10.5 18.9 16.1 16.6 17.3 17.9 4.3 11.1 11.5 46.6 8.2 12.0 20.3 12.1 15.4 12.3 5.4 9.5 11.9 11.7 24.7 13.4 17.2 14.3 14.9 12.0 4.7 10.1 12.6 18.3 8.9 12.2 7.7 15.2 12.7 11.7 15.4 13.2 14.1 8.8 18.2 12.5 15.6 22.2 21.7 17.6 11.3 11.7 10.4 21.9 25.3 23.8 14.5 11.5 18.4 8.3 16.4 15.5 38.0 9.0 11.9 23.9 16.1 16.4 12.0 21.8 15.5 26.6 7.3 22.8 13.1 23.9 24.7 16.9 28.6 10.2 27.3 19.0 12.4 35.4 11.8 16.5 8.4 10.9 28.3 26.0 12.8 13.7 19.2 12.8 12.1 18.2 12.1 19.9 6.5 8.2 22.6 10.2 21.6 15.4 4.7 6.5 3.9 12.7 10.1 12.5 14.9 14.0 13.9 12.0 14.3 16.8 18.3 1.1 12.6 8.5 9.8 16.6 8.9 14.8 16.0 12.3 20.3 18.5 14.7 13.5 14.0 16.6 9.5 23.8 33.1 40.2 16.9 11.3 24.1 104.6 61.1 17.4 22.7 31.4 17.7 59.7 114.4 39.4 8.2 35.1 21.4 23.3 31.6 43.1 28.8 13.4 40.5 105.0 42.2 23.8 46.0 44.8 26.3 4.9 28.7 23.1 15.1 31.5 58.4 19.3 32.8 17.5 31.5 99.5 36.0 38.8 23.7 17.6 52.2 11.2 29.2 50.3 64.2 8.9 MRPL10 "L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8" ENSG00000159111 "Mitochondrial ribosomal protein L10" Q7Z7H8 17 47823272-47831534 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021234, HPA029885" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA021234: AB_1854098, HPA029885: AB_2673233" "unprognostic (6.84e-3)" "unprognostic (1.03e-1)" "unprognostic (8.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.97e-1)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.21e-2)" "unprognostic (1.03e-1)" "unprognostic (8.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.16e-2)" "unprognostic (1.29e-1)" "unprognostic (2.82e-1)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.87e-2)" 20.8 23.2 18.3 23.8 25.2 17.7 34.3 22.2 25.9 19.2 24.7 11.5 24.4 21.2 22.8 26.5 20.3 25.6 28.7 44.0 18.9 18.1 21.6 26.0 29.6 39.6 18.0 19.4 42.9 34.7 17.8 12.3 19.3 16.9 17.6 19.6 16.5 18.2 27.5 43.2 15.5 17.6 37.9 21.4 19.6 23.8 18.6 13.2 19.2 20.4 26.6 21.2 26.0 19.6 17.7 20.4 11.2 18.3 11.6 31.6 17.7 12.8 28.5 12.0 12.2 28.8 26.5 22.4 11.3 19.1 19.5 16.8 54.8 17.7 20.9 26.5 14.6 12.9 12.3 17.1 22.1 17.4 20.1 27.1 16.8 15.3 38.3 24.9 15.0 9.4 29.8 19.2 23.2 32.9 23.1 18.7 20.1 22.4 21.0 15.0 25.3 15.3 18.9 19.8 22.1 27.4 12.3 23.5 23.2 21.3 12.7 14.5 23.3 8.6 9.9 24.2 23.7 29.6 15.9 11.5 17.6 14.6 11.8 15.9 36.9 28.5 16.8 15.5 11.4 11.8 11.2 17.6 8.2 31.6 18.3 29.8 15.9 21.8 27.9 20.4 17.7 18.6 21.9 7.1 11.6 14.7 12.4 24.3 17.7 18.3 25.2 22.2 25.9 18.9 18.1 18.0 19.4 16.9 13.2 6.0 9.9 19.7 19.4 11.1 14.0 30.8 12.7 4.0 12.5 14.0 5.9 74.6 39.7 34.5 17.5 17.7 16.1 23.3 47.8 49.4 18.8 14.3 8.1 12.3 36.0 30.2 8.2 18.4 26.5 24.9 22.7 16.2 15.1 35.1 19.1 17.0 35.4 10.5 22.6 32.9 10.6 6.5 35.8 15.6 29.8 10.9 64.6 59.9 28.1 15.7 MRPL11 ENSG00000174547 "Mitochondrial ribosomal protein L11" Q9Y3B7 11 66435075-66466738 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057685 Approved Supported Mitochondria NA NA Mitochondria "HPA057685: AB_2683502" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.21e-2)" "unprognostic (1.79e-2)" "unprognostic (9.30e-2)" "unprognostic (1.12e-2)" "unprognostic (1.81e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-1)" "unprognostic (8.32e-3)" "unprognostic (2.85e-2)" "unprognostic (3.21e-1)" "unprognostic (1.31e-2)" "unprognostic (9.34e-2)" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" 13.9 12.9 10.1 18.9 10.6 18.2 25.6 10.6 12.5 13.7 20.7 7.0 13.5 15.7 16.5 16.2 22.3 16.3 17.5 32.0 8.5 8.7 19.4 33.1 15.7 27.5 9.0 7.5 20.2 36.6 15.1 9.5 14.8 7.7 15.2 23.2 10.8 21.5 17.7 41.4 13.5 21.8 18.5 7.5 18.5 18.5 14.0 6.7 23.3 19.8 29.7 19.0 16.4 17.7 23.4 25.5 3.4 20.2 16.3 20.9 19.2 18.9 15.1 14.4 13.8 7.2 8.1 20.6 11.1 12.7 21.2 16.3 42.3 23.6 23.9 19.3 10.5 23.6 16.6 21.0 21.7 15.0 11.0 14.0 15.0 13.0 22.3 8.7 24.8 10.1 9.6 13.0 13.0 16.2 10.2 15.7 23.1 21.8 10.5 9.1 32.3 28.5 39.6 26.3 51.3 22.2 18.2 28.7 29.9 9.2 13.1 15.1 13.1 12.2 18.5 38.1 12.8 21.0 13.1 8.8 12.8 17.2 12.0 13.0 7.7 12.1 27.0 13.2 16.0 8.6 0.8 16.3 3.4 17.7 20.2 18.9 23.4 19.7 17.4 25.5 19.3 20.9 19.1 1.1 16.3 17.7 15.4 19.8 19.2 10.1 10.6 10.6 12.5 8.5 8.7 9.0 7.5 7.7 6.7 11.9 27.0 69.2 72.1 44.3 19.7 56.0 53.5 49.5 43.3 31.4 7.9 118.1 104.5 54.8 29.3 52.4 58.7 23.3 74.3 168.1 46.4 55.6 30.1 63.8 111.5 19.1 49.0 46.6 43.8 7.0 46.9 58.8 64.1 89.2 93.5 22.6 57.8 56.1 43.2 94.3 17.9 25.8 49.5 69.9 31.1 42.9 64.8 67.3 153.6 64.7 MRPL12 "MRPL7, MRPL7/L12, RPML12" ENSG00000262814 "Mitochondrial ribosomal protein L12" P52815 17 81703357-81707526 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022853, HPA023043" Supported Supported Mitochondria NA NA Mitochondria "HPA022853: AB_1854099, HPA023043: AB_1854100" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (6.59e-2)" "unprognostic (1.66e-2)" "unprognostic (9.52e-2)" "unprognostic (5.97e-2)" "unprognostic (5.97e-3)" "prognostic unfavorable (2.35e-4)" "unprognostic (1.78e-1)" "unprognostic (6.47e-3)" "unprognostic (8.17e-2)" "unprognostic (3.07e-1)" "unprognostic (8.77e-3)" "unprognostic (3.41e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (9.26e-2)" 15.7 18.6 15.3 14.5 16.9 14.4 27.7 13.6 18.6 9.8 27.2 8.3 14.9 25.2 10.7 8.6 24.4 12.6 14.8 63.7 14.8 13.7 22.8 64.9 15.4 20.4 17.8 10.5 8.9 40.7 13.3 10.7 12.8 13.1 11.6 20.5 9.3 19.6 13.9 79.1 12.6 18.2 11.4 9.4 17.2 15.2 14.4 7.5 16.1 12.2 50.4 16.0 10.9 11.2 24.7 34.6 5.0 30.0 14.7 20.5 17.7 28.1 48.3 12.9 15.1 9.9 10.9 24.0 22.1 13.6 33.4 25.0 40.3 13.6 43.9 13.4 14.5 22.6 24.0 16.6 28.4 17.1 10.2 83.3 33.5 25.8 45.1 14.6 36.7 17.6 12.5 20.8 23.0 25.7 10.7 27.7 21.9 32.5 14.6 16.5 35.6 31.1 54.4 20.3 30.8 63.0 29.8 21.1 32.4 24.7 23.6 33.2 42.7 16.2 70.2 36.2 14.0 35.7 33.5 14.4 25.5 30.2 19.9 44.8 28.3 9.7 24.9 17.4 26.6 19.1 5.0 24.1 3.2 15.0 30.0 20.5 24.7 15.1 16.6 34.6 23.1 16.0 14.3 2.6 14.7 17.3 28.4 12.9 17.7 15.3 16.9 13.6 18.6 14.8 13.7 17.8 10.5 13.1 7.5 17.9 10.9 51.4 58.7 47.4 14.4 76.5 94.3 20.1 20.5 43.6 3.9 154.3 185.6 101.2 30.5 40.0 177.2 46.7 102.2 149.2 34.5 46.3 31.0 198.0 146.6 22.3 99.8 41.1 56.4 97.4 36.5 37.4 55.6 57.7 173.6 25.5 108.9 97.9 30.8 211.9 12.4 32.3 36.8 47.3 51.0 52.9 94.1 34.1 243.5 97.4 MRPL14 "MRP-L32, RPML32" ENSG00000180992 "Mitochondrial ribosomal protein L14" Q6P1L8 6 44113454-44127457 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 116.6" "Low region specificity" "Detected in all" "HPA038769, HPA076790" Uncertain Supported Mitochondria NA NA Mitochondria "HPA038769: AB_10673288, HPA076790: AB_2686815" "unprognostic (4.58e-1)" "unprognostic (8.39e-2)" "unprognostic (1.84e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.21e-2)" "unprognostic (7.20e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.74e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (7.46e-5)" "unprognostic (7.13e-2)" "unprognostic (1.65e-1)" "prognostic favorable (1.08e-4)" "unprognostic (3.27e-2)" 10.1 16.1 12.5 9.6 12.8 7.9 11.7 10.5 12.7 10.5 16.4 9.6 8.4 16.2 12.1 12.3 15.7 10.4 14.8 18.5 10.0 8.4 12.4 35.5 25.9 10.4 10.9 11.5 7.1 17.5 4.9 9.6 11.8 10.6 9.7 16.3 13.7 14.0 9.4 61.4 16.0 14.0 12.7 7.9 10.2 12.7 19.0 10.4 13.1 26.3 27.8 12.4 12.3 10.0 33.2 36.4 9.0 36.1 46.7 32.5 30.3 39.8 17.1 12.1 16.7 10.5 10.3 15.5 14.9 14.9 19.9 20.0 35.6 14.1 17.4 16.9 12.7 19.2 16.3 13.6 24.3 15.9 20.6 37.1 17.9 15.1 43.5 13.0 17.0 12.6 9.5 13.2 18.8 11.2 15.4 16.4 15.0 37.6 11.2 17.6 40.3 20.3 26.8 10.6 116.6 16.4 14.6 13.6 23.6 32.8 19.8 27.1 10.5 9.6 18.8 18.5 11.0 17.2 17.5 13.1 17.8 26.6 12.7 25.8 14.0 12.3 40.8 20.1 16.9 12.9 9.0 36.1 7.5 25.4 32.7 29.9 33.2 32.5 28.6 32.4 30.2 25.8 26.5 2.0 46.7 21.9 36.4 21.9 30.3 12.5 12.8 10.5 12.7 10.0 8.4 10.9 11.5 10.6 10.4 348.4 202.5 87.1 148.9 205.3 26.8 126.7 117.2 72.3 125.1 54.1 29.5 154.6 172.5 198.2 197.3 76.8 185.2 23.3 191.9 163.1 85.4 198.8 43.8 284.0 228.8 31.8 89.7 48.5 40.9 90.3 69.0 86.6 65.8 216.4 126.1 48.1 252.2 194.7 50.2 212.2 55.1 45.3 85.8 91.7 125.6 245.9 133.9 72.7 153.8 317.1 MRPL15 "HSPC145, L15mt, MRP-L15, MRP-L7, RPML7" ENSG00000137547 "Mitochondrial ribosomal protein L15" Q9P015 8 54135210-54147901 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.5" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044425 Enhanced Supported Mitochondria NA NA Mitochondria "HPA044425: AB_10969629" "unprognostic (5.67e-3)" "unprognostic (8.89e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (9.30e-2)" "unprognostic (1.90e-2)" "unprognostic (2.57e-2)" "unprognostic (3.10e-3)" "unprognostic (1.39e-1)" "unprognostic (3.39e-2)" "unprognostic (1.94e-3)" "unprognostic (1.57e-2)" "unprognostic (2.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (1.06e-1)" "unprognostic (1.06e-2)" 13.7 15.2 16.2 10.2 17.7 6.7 16.1 10.7 28.0 11.6 21.8 8.7 7.4 18.4 11.3 10.2 16.9 11.8 10.9 54.2 14.4 16.3 31.2 32.3 9.1 14.5 17.5 15.4 10.1 14.9 16.8 9.0 20.9 18.7 9.9 22.1 12.3 15.2 10.8 77.5 16.2 16.5 13.9 10.2 12.7 14.2 5.4 8.1 11.3 12.4 25.0 16.7 15.8 10.9 28.2 38.5 8.2 32.2 13.6 21.2 21.9 30.3 25.4 19.2 22.2 15.2 22.6 24.6 25.7 18.1 32.6 28.8 27.2 35.0 46.3 32.9 20.1 30.7 30.5 37.5 30.5 38.7 21.7 28.1 32.6 13.6 35.0 22.3 17.1 32.4 21.4 33.6 30.1 32.0 15.7 66.2 18.7 37.6 14.9 47.5 32.8 44.5 38.8 38.9 59.0 16.1 31.2 12.3 24.1 42.7 28.7 11.1 17.2 13.0 36.7 29.9 20.5 36.0 17.3 24.7 17.5 22.5 27.3 27.3 18.9 23.5 38.0 17.3 26.5 27.3 8.2 25.9 7.4 15.4 32.2 18.6 28.2 19.4 20.1 38.5 21.6 18.4 17.2 1.0 13.6 28.9 24.1 21.2 21.9 16.2 17.7 10.7 28.0 14.4 16.3 17.5 15.4 18.7 8.1 23.8 11.8 46.2 33.1 20.9 28.0 114.6 56.0 24.1 19.4 34.9 27.5 128.1 210.5 90.3 14.2 23.7 36.5 23.3 61.2 122.6 25.7 20.9 25.3 57.8 93.7 23.8 17.3 29.4 48.6 3.2 23.0 37.9 32.1 61.3 48.9 22.6 78.0 35.1 21.2 95.0 46.9 12.9 17.9 7.9 32.5 30.1 166.4 20.2 75.9 40.0 MRPL19 "KIAA0104, MRP-L15, RLX1, RPML15" ENSG00000115364 "Mitochondrial ribosomal protein L19" P49406 2 75646783-75690851 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046805, HPA056622" Approved Supported Mitochondria NA NA Mitochondria "HPA046805: AB_2679816, HPA056622: AB_2683195" "unprognostic (9.24e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.39e-4)" "unprognostic (8.40e-2)" "unprognostic (1.59e-2)" "unprognostic (7.52e-3)" "unprognostic (5.75e-2)" "unprognostic (9.86e-2)" "unprognostic (6.21e-3)" "unprognostic (9.71e-3)" "prognostic unfavorable (1.97e-5)" "unprognostic (2.42e-1)" "unprognostic (3.67e-2)" "unprognostic (1.55e-1)" "unprognostic (3.30e-1)" "unprognostic (1.12e-1)" "unprognostic (1.20e-1)" 21.3 33.9 22.5 13.0 25.2 8.8 21.1 15.9 26.7 23.0 19.5 24.1 12.1 16.8 19.1 19.6 25.7 13.9 15.6 24.4 21.3 20.4 40.8 44.9 13.0 13.5 26.0 21.2 17.3 17.8 30.9 20.6 18.4 26.6 16.4 23.0 13.2 17.7 19.6 47.3 17.2 16.3 21.1 27.7 18.1 16.3 12.0 24.4 19.2 27.3 22.0 17.3 15.1 15.9 18.5 23.7 9.6 17.1 15.5 18.0 11.1 36.3 21.2 20.1 18.1 22.1 26.6 28.6 23.5 21.2 29.8 23.8 32.7 15.1 20.6 23.7 25.6 27.9 25.8 31.3 35.5 45.0 22.8 26.9 28.0 16.6 41.3 23.6 29.8 16.9 17.6 27.4 30.2 27.7 19.0 31.3 22.6 30.8 12.1 29.4 22.2 27.0 23.5 26.3 37.5 23.7 34.2 44.0 27.1 50.5 22.8 22.3 19.3 23.0 26.7 26.1 21.2 22.8 12.0 21.0 26.1 28.9 23.1 34.6 12.6 18.9 17.0 20.6 29.6 22.7 9.6 14.1 9.2 16.0 17.1 18.0 18.5 16.5 16.9 19.9 16.1 14.7 18.0 0.9 15.5 15.4 23.7 17.4 11.1 22.5 25.2 15.9 26.7 21.3 20.4 26.0 21.2 26.6 24.4 17.9 23.5 28.2 24.4 25.8 35.5 37.0 20.4 25.4 29.6 47.1 49.1 79.0 106.1 76.8 15.8 17.3 26.5 23.3 53.4 71.7 27.2 28.3 18.5 62.2 42.7 46.1 26.6 25.2 15.1 7.8 32.8 25.7 32.1 33.3 32.5 38.9 50.8 31.6 34.3 130.8 48.5 19.4 25.3 60.1 14.7 24.7 48.3 20.8 41.3 30.5 MRPL20 FLJ10024 ENSG00000242485 "Mitochondrial ribosomal protein L20" Q9BYC9 1 1401908-1407313 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047074 Supported Supported Mitochondria NA NA Mitochondria "HPA047074: AB_10964064" "unprognostic (4.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-2)" "unprognostic (5.79e-2)" "unprognostic (3.71e-1)" "unprognostic (2.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (2.80e-2)" "unprognostic (2.33e-1)" "unprognostic (4.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (1.64e-1)" 36.7 36.2 44.4 31.0 40.7 22.6 41.2 30.3 46.8 24.8 33.4 24.2 38.8 30.7 28.1 52.3 33.8 32.7 39.9 75.3 37.3 38.6 40.1 48.8 31.5 59.7 39.9 31.4 26.5 72.8 28.4 36.3 27.2 35.6 35.1 33.1 29.1 50.5 47.7 121.8 27.3 28.9 44.5 39.1 30.5 33.6 27.7 29.7 22.8 34.3 54.8 35.9 27.1 26.9 50.6 77.5 37.5 52.1 40.5 59.9 51.7 39.6 38.5 28.9 29.2 22.3 24.3 21.3 35.6 27.3 46.4 33.3 45.7 48.6 42.5 50.0 30.5 21.7 25.4 47.1 38.4 36.1 36.7 66.6 45.9 67.7 44.9 31.0 67.4 29.7 28.3 14.9 35.6 38.4 27.0 34.3 40.7 46.3 25.4 38.9 39.8 51.8 51.5 30.0 46.4 77.9 34.5 26.7 54.1 36.2 26.7 51.4 42.4 33.9 71.0 52.2 25.3 30.4 50.0 29.3 28.4 33.0 42.4 43.9 39.0 55.4 82.8 43.8 54.9 19.7 27.8 52.1 37.5 46.8 49.1 52.4 50.6 52.3 46.4 53.2 47.5 59.9 57.3 24.1 40.5 37.7 77.5 45.0 51.7 44.4 40.7 30.3 46.8 37.3 38.6 39.9 31.4 35.6 29.7 62.5 114.8 142.1 105.7 115.6 77.1 229.7 152.8 116.4 110.3 153.5 33.4 194.5 449.3 166.0 28.9 116.1 135.5 210.2 283.0 213.3 100.7 167.9 100.8 326.9 195.7 47.7 132.8 120.3 122.8 28.2 99.8 123.4 131.6 174.1 154.0 179.7 210.2 161.2 104.3 475.5 87.1 64.7 124.6 122.1 210.0 137.9 189.1 99.7 179.2 143.3 MRPL22 "HSPC158, MRP-L25, RPML25" ENSG00000082515 "Mitochondrial ribosomal protein L22" Q9NWU5 5 154941070-154969411 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047063 Uncertain Approved Mitochondria NA NA Mitochondria "HPA047063: AB_2679919" "unprognostic (9.17e-2)" "unprognostic (1.18e-2)" "unprognostic (2.16e-2)" "unprognostic (2.56e-2)" "unprognostic (5.42e-2)" "unprognostic (6.65e-2)" "unprognostic (1.80e-2)" "unprognostic (4.86e-2)" "unprognostic (2.03e-1)" "unprognostic (3.01e-3)" "unprognostic (3.40e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (3.54e-1)" "unprognostic (2.69e-1)" "unprognostic (4.09e-2)" "unprognostic (4.29e-2)" 16.3 29.7 16.7 14.5 21.8 25.9 20.2 18.8 19.6 15.2 21.0 18.8 8.3 19.3 16.5 20.6 23.0 14.6 11.9 29.7 16.8 16.2 27.8 38.9 14.7 19.2 21.1 19.5 14.6 25.2 15.9 22.6 19.2 21.6 14.5 21.6 15.6 24.4 18.8 28.2 16.5 18.4 18.3 17.7 20.0 19.3 29.0 16.0 20.1 19.7 20.7 19.3 17.3 15.8 35.7 34.0 21.6 29.5 30.6 36.7 30.7 20.5 20.3 18.0 24.9 14.1 17.9 21.4 14.7 17.4 29.8 37.8 58.5 25.7 28.5 26.4 12.3 31.7 18.9 25.9 27.8 31.9 9.7 29.4 10.9 21.1 33.1 18.5 24.3 14.9 11.7 18.8 20.0 24.5 13.3 50.3 26.2 16.4 25.7 18.3 30.3 22.0 23.5 13.6 22.5 15.8 20.3 15.6 29.4 28.9 15.6 20.7 7.7 19.3 27.9 31.0 13.6 40.8 21.7 14.6 18.4 18.4 16.0 27.1 13.7 16.9 31.2 18.5 30.3 17.2 15.3 26.1 21.6 26.1 29.5 26.1 35.7 28.8 27.7 34.0 29.4 26.9 30.6 10.1 30.6 28.8 26.4 36.7 30.7 16.7 21.8 18.8 19.6 16.8 16.2 21.1 19.5 21.6 16.0 23.8 22.6 43.2 46.3 56.7 28.3 207.4 50.9 54.9 33.0 57.6 25.5 126.5 189.0 94.4 21.3 64.6 46.2 23.3 110.2 113.6 72.3 40.4 43.9 83.1 86.1 30.2 47.6 52.2 29.7 19.6 61.2 50.3 49.0 79.4 45.4 23.0 97.4 77.2 70.7 152.4 21.6 32.3 60.8 102.1 69.2 57.5 65.7 42.4 71.2 45.7 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 367384-370527 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria NA NA Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 18.3 21.7 32.2 18.6 36.6 25.1 19.5 17.9 38.4 15.3 26.0 19.1 14.6 21.7 16.8 21.3 21.1 21.2 20.0 49.6 30.9 22.5 26.9 35.5 15.1 24.5 24.9 20.9 15.7 21.4 23.6 15.5 15.8 17.7 16.2 12.0 16.8 21.7 18.4 42.1 16.0 19.2 19.6 16.8 18.1 15.8 25.7 10.4 24.9 20.3 36.3 20.4 16.9 14.7 38.0 47.1 48.2 42.0 28.0 47.7 33.7 17.8 41.8 17.9 21.5 10.1 13.1 24.5 21.0 27.4 37.9 37.5 51.3 24.9 26.4 23.9 21.2 19.5 23.5 27.4 44.2 20.2 23.7 66.4 19.3 32.3 42.1 32.7 23.9 26.1 19.6 22.0 35.3 28.4 18.3 27.8 26.0 35.4 19.8 23.6 72.3 37.8 27.4 28.8 17.8 26.7 47.1 21.9 37.8 31.0 11.0 30.9 28.2 25.9 26.5 21.5 17.9 34.1 25.0 21.8 23.4 32.6 18.5 23.3 31.3 24.1 34.9 15.7 17.5 36.5 30.4 42.0 45.8 30.1 40.8 24.6 34.3 26.2 28.4 37.7 38.0 18.6 23.8 48.2 28.0 40.7 47.1 47.7 33.7 32.2 36.6 17.9 38.4 30.9 22.5 24.9 20.9 17.7 10.4 35.7 28.5 54.4 43.0 30.8 29.9 47.6 43.3 36.1 30.7 66.3 7.9 72.2 164.2 92.3 75.5 43.2 76.2 46.7 97.0 87.9 37.6 40.1 25.5 57.1 86.3 27.0 61.5 39.9 64.5 166.1 35.4 45.0 67.4 176.7 45.6 55.2 87.0 56.0 36.0 146.8 31.1 38.8 39.2 91.0 46.2 28.2 38.3 40.5 57.0 41.7 MRPL37 "MRP-L2, RPML2" ENSG00000116221 "Mitochondrial ribosomal protein L37" Q9BZE1 1 54184041-54225464 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025767, HPA025826, HPA025951" Supported Supported Mitochondria NA NA Mitochondria "HPA025767: AB_1854105, HPA025826: AB_1854106, HPA025951: AB_1854107" "unprognostic (2.00e-1)" "unprognostic (6.81e-2)" "prognostic favorable (6.99e-4)" "unprognostic (1.71e-3)" "unprognostic (8.24e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (2.49e-2)" "unprognostic (1.56e-1)" "unprognostic (1.64e-1)" "unprognostic (1.92e-2)" "unprognostic (1.84e-1)" "unprognostic (3.07e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.43e-1)" "unprognostic (2.62e-1)" "unprognostic (7.67e-3)" 21.3 35.0 16.2 15.8 24.0 26.0 18.0 16.9 34.8 15.8 22.9 18.0 13.9 23.5 17.6 13.7 29.0 18.2 18.6 32.0 15.4 14.0 25.1 65.2 13.8 20.6 16.0 14.6 21.2 30.8 15.4 10.9 19.4 23.0 16.2 25.2 20.1 33.5 15.3 68.0 24.0 25.0 19.3 11.9 17.9 20.9 20.0 9.0 31.4 18.1 39.9 28.1 16.2 17.5 39.0 40.8 14.8 35.3 29.1 37.4 38.5 39.4 22.8 20.8 28.0 21.1 28.3 37.2 26.9 25.3 48.1 41.9 45.6 18.3 53.8 24.4 30.1 45.9 31.9 40.9 39.8 37.7 26.2 51.6 46.2 48.3 46.0 36.2 54.6 21.6 31.1 34.2 49.8 39.1 27.0 42.9 42.3 51.0 16.2 34.2 29.1 37.6 53.3 42.6 32.0 50.9 41.4 42.4 45.3 27.4 29.6 41.2 19.2 37.2 64.1 49.4 28.7 27.7 62.0 21.3 30.9 28.1 38.8 53.9 20.6 28.9 41.9 40.2 55.8 29.2 14.8 35.3 14.6 24.1 29.9 28.2 39.0 29.8 27.2 40.8 32.8 30.3 27.0 1.9 29.1 27.9 34.1 37.4 38.5 16.2 24.0 16.9 34.8 15.4 14.0 16.0 14.6 23.0 9.0 20.8 18.9 20.8 36.7 30.8 8.2 68.7 48.4 18.7 17.0 17.4 2.0 102.8 68.0 71.3 25.7 28.2 48.4 46.7 83.7 118.7 37.0 38.0 13.9 148.6 76.9 6.4 31.9 38.1 35.8 43.5 24.2 28.1 21.9 58.7 48.4 9.1 62.0 31.6 26.9 83.4 6.9 12.9 26.2 21.7 38.3 32.6 61.8 25.9 80.6 43.8 MRPL38 "HSPC262, MGC4810, MRP-L3, RPML3" ENSG00000204316 "Mitochondrial ribosomal protein L38" Q96DV4 17 75898643-75905413 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023054, HPA023135" Approved Supported Mitochondria NA NA Mitochondria "HPA023054: AB_1854109, HPA023135: AB_1854110" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.83e-1)" "unprognostic (3.68e-3)" "unprognostic (2.47e-2)" "unprognostic (1.50e-2)" "unprognostic (4.44e-2)" "unprognostic (1.61e-1)" "unprognostic (7.59e-2)" "unprognostic (5.24e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (5.58e-4)" "unprognostic (3.06e-2)" "unprognostic (2.40e-1)" "unprognostic (3.72e-1)" "prognostic favorable (9.21e-5)" 10.8 14.1 12.4 6.7 14.8 6.0 8.2 8.4 20.8 9.6 11.7 23.3 6.5 10.6 9.5 7.8 11.2 15.4 10.2 21.2 11.7 9.2 11.7 17.6 8.4 8.1 15.7 18.1 12.0 17.5 8.7 7.7 7.3 14.8 8.7 8.2 8.8 17.1 13.6 41.8 9.5 8.9 17.9 11.3 8.8 10.3 15.1 14.7 8.3 8.8 14.1 9.5 10.9 7.5 28.5 29.4 9.9 21.8 24.0 24.6 21.3 17.7 24.9 5.0 6.1 7.4 6.1 20.5 6.0 10.5 23.4 17.0 30.4 10.7 17.2 7.1 10.3 12.2 12.6 17.9 16.3 6.1 5.1 33.7 11.4 7.0 27.2 18.5 15.2 10.3 8.8 18.6 15.1 12.2 5.9 22.7 20.5 14.3 7.8 8.3 37.1 18.3 15.1 6.4 23.2 24.7 13.8 17.3 18.5 17.4 8.9 9.8 11.0 11.2 26.3 24.3 5.0 24.6 15.2 6.9 8.9 15.4 7.0 15.8 10.2 6.4 4.9 10.8 11.8 8.2 4.5 20.0 9.9 23.7 21.8 23.8 28.3 24.5 22.2 29.4 28.5 24.6 23.7 1.6 24.0 17.5 20.9 24.5 21.3 12.4 14.8 8.4 20.8 11.7 9.2 15.7 18.1 14.8 14.7 17.9 5.3 2.7 0.6 1.3 0.9 1.7 0.0 16.0 7.9 3.5 0.0 4.3 3.3 19.9 0.9 1.0 9.8 0.0 18.4 3.7 2.3 1.2 3.5 2.0 2.9 1.6 9.9 3.1 0.3 0.9 2.8 2.7 6.8 22.6 12.2 0.9 17.8 18.7 2.8 5.1 2.7 0.0 3.1 2.3 1.7 1.3 2.9 2.9 18.8 0.5 MRPL39 "C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5" ENSG00000154719 "Mitochondrial ribosomal protein L39" Q9NYK5 21 25585656-25607517 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018331 Approved Supported Mitochondria NA NA Mitochondria "HPA018331: AB_1854111" "unprognostic (3.81e-3)" "unprognostic (5.34e-2)" "unprognostic (8.55e-3)" "unprognostic (4.61e-1)" "unprognostic (2.61e-1)" "unprognostic (4.32e-2)" "unprognostic (6.75e-2)" "unprognostic (2.35e-1)" "unprognostic (4.74e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (5.84e-4)" "unprognostic (7.48e-2)" "unprognostic (7.32e-3)" "unprognostic (9.81e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (6.89e-2)" 15.3 29.4 18.7 14.4 22.7 12.0 17.1 24.0 25.6 11.7 17.8 12.8 13.6 15.8 14.1 27.3 20.9 13.1 9.9 38.2 22.1 13.8 24.9 33.5 12.9 19.4 23.4 23.9 13.7 18.8 28.9 13.6 16.0 19.6 13.1 20.6 8.3 14.8 13.3 35.0 15.5 14.3 16.7 16.6 13.9 17.2 35.9 21.6 13.2 12.7 26.7 21.9 13.7 14.3 28.8 19.7 14.4 13.3 15.4 24.9 8.8 28.7 14.2 20.2 12.8 10.2 14.9 31.3 18.7 16.6 26.1 22.0 27.9 16.3 31.8 10.5 11.6 23.7 8.5 42.7 25.3 29.2 16.0 22.3 32.5 15.4 29.4 11.9 32.8 10.8 12.0 22.6 25.8 21.2 14.5 19.3 33.3 35.7 26.3 25.7 18.1 21.4 17.9 32.1 29.0 22.1 25.1 32.8 33.4 26.9 11.7 12.8 12.3 17.1 31.6 24.3 14.9 22.9 18.7 12.1 14.0 20.7 14.8 22.6 18.6 23.6 39.6 20.8 35.5 20.9 14.4 8.1 9.0 18.1 13.3 22.5 28.8 22.1 20.3 14.0 22.6 22.1 19.5 1.3 15.4 9.3 19.7 24.9 8.8 18.7 22.7 24.0 25.6 22.1 13.8 23.4 23.9 19.6 21.6 23.8 8.0 16.6 17.4 17.7 21.4 70.6 5.1 33.5 17.0 24.4 9.8 41.0 26.6 27.7 164.4 23.3 8.5 0.0 29.4 36.2 20.2 11.4 15.0 17.9 26.8 9.5 7.5 13.5 8.8 22.4 13.8 14.2 18.6 18.0 9.1 19.0 23.6 5.8 21.9 40.7 14.3 45.3 21.7 74.3 25.8 14.8 30.9 13.8 18.9 10.9 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551199-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 55.8;skeletal muscle: 60.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 826.6;Distal tubular cells: 824.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 49.0;PC-3: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria NA NA Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 15.3 8.0 12.8 3.5 14.4 3.1 2.8 4.1 10.7 2.4 8.3 7.1 2.3 1.0 1.7 2.1 1.5 16.4 10.3 7.7 6.8 10.7 2.6 3.3 8.5 4.2 6.3 1.8 2.9 1.6 9.5 2.2 10.8 3.8 60.6 5.3 6.2 1.5 4.0 6.2 10.5 2.1 2.0 1.5 2.7 2.1 38.3 55.8 43.7 42.5 21.8 42.2 42.8 10.0 17.0 2.9 6.8 4.3 3.6 13.2 12.9 3.3 5.9 4.8 11.8 5.7 7.4 16.9 3.1 8.9 21.4 3.8 6.1 0.6 10.8 21.1 6.8 9.3 18.4 9.9 11.0 31.4 7.1 8.4 5.3 1.9 2.6 5.4 6.5 14.8 3.2 3.1 49.0 3.7 35.8 10.9 12.8 48.0 4.6 4.9 10.3 5.0 6.7 9.4 10.2 8.5 15.8 20.9 1.7 15.0 10.0 10.6 10.3 14.3 18.5 16.7 9.6 13.3 13.1 11.9 10.9 7.8 43.7 42.5 31.5 31.2 34.1 29.5 38.3 33.8 35.9 34.6 28.5 32.2 30.2 5.1 21.8 31.1 55.8 42.2 42.8 26.8 28.1 87.8 111.7 124.4 47.8 826.6 188.5 41.5 37.5 249.5 9.8 105.5 824.0 135.5 238.0 93.7 424.6 0.0 166.2 127.5 105.3 182.0 54.1 733.3 213.4 27.0 257.8 98.2 123.7 565.6 112.8 114.0 212.6 190.2 235.6 66.7 187.8 270.0 98.3 497.0 34.2 109.9 97.6 90.9 72.6 145.2 68.8 110.7 282.5 152.7 MRPL45 MGC11321 ENSG00000278845 "Mitochondrial ribosomal protein L45" 17 38297023-38323218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 12.6;Daudi: 30.3;K-562: 18.4;REH: 14.8;RT4: 11.3;U-266/84: 17.5;U-698: 22.4" "Low region specificity" "Detected in all" "HPA023373, HPA023385" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA023373: AB_1854114, HPA023385: AB_1854115" "unprognostic (8.56e-3)" "unprognostic (4.09e-2)" "unprognostic (1.11e-2)" "unprognostic (3.08e-1)" "unprognostic (9.50e-2)" "unprognostic (2.22e-3)" "unprognostic (1.11e-2)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.35e-1)" "unprognostic (6.01e-3)" "unprognostic (3.07e-1)" "unprognostic (1.00e-1)" "unprognostic (2.40e-1)" "unprognostic (8.13e-2)" 3.1 0.6 1.4 2.6 2.4 1.8 4.9 1.8 6.3 9.6 3.6 1.4 0.7 0.3 10.3 1.1 2.1 0.4 5.8 3.7 1.2 5.9 7.0 2.6 9.6 1.7 1.7 3.9 9.1 0.3 2.4 2.5 2.7 7.7 6.9 1.8 3.8 1.1 11.1 2.4 13.2 1.4 1.8 1.2 1.4 1.7 1.3 1.2 2.6 2.8 10.5 0.9 1.5 6.1 9.3 1.6 5.9 6.9 8.7 4.3 0.0 0.1 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.7 30.3 0.0 0.0 8.1 0.1 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 14.8 0.0 11.2 0.0 11.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 6.2 0.0 0.0 0.0 8.8 17.5 22.4 0.0 0.0 0.1 0.4 5.7 1.6 4.7 5.9 5.5 6.1 7.0 3.7 9.3 5.2 8.7 5.3 0.1 6.9 1.2 3.3 5.2 4.3 11.9 8.9 24.2 33.1 26.9 10.5 39.2 33.1 21.4 12.5 24.4 7.9 57.8 51.4 33.7 13.9 22.5 11.9 0.0 32.6 54.7 20.5 25.4 23.1 26.1 37.2 15.9 15.6 16.5 31.0 11.5 19.2 19.8 18.6 45.9 24.4 10.9 32.1 10.5 15.6 50.2 9.8 6.5 28.8 16.4 16.6 28.2 59.5 18.3 41.0 29.2 MRPL47 "CGI-204, NCM1" ENSG00000136522 "Mitochondrial ribosomal protein L47" Q9HD33 3 179588285-179604654 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 290.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037553, HPA047779" Approved Supported Mitochondria NA NA Mitochondria "HPA037553: AB_10671375, HPA047779: AB_2680154" "unprognostic (6.37e-2)" "prognostic favorable (6.44e-4)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (1.53e-1)" "unprognostic (8.55e-3)" "unprognostic (1.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.58e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-2)" "unprognostic (1.29e-2)" "unprognostic (5.64e-2)" "unprognostic (3.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.71e-1)" "unprognostic (8.84e-2)" 17.4 23.5 22.3 16.4 21.7 29.6 20.2 23.9 25.0 14.2 22.5 12.8 13.0 16.7 16.8 17.3 21.3 13.3 13.4 35.5 21.1 21.8 34.0 31.8 14.8 19.3 25.6 19.4 15.2 12.1 18.1 23.8 17.8 28.5 15.9 23.6 11.2 14.5 14.7 31.7 13.5 20.3 17.8 20.1 20.2 17.4 32.8 22.0 25.3 20.1 27.8 20.7 16.3 13.9 21.0 28.2 24.6 29.0 22.7 28.1 18.9 32.1 12.5 21.9 20.1 13.9 14.6 25.0 18.9 16.9 29.8 24.9 50.8 13.5 26.4 37.5 16.1 36.4 24.4 26.8 19.8 32.1 30.3 23.5 25.3 12.6 28.4 27.1 45.4 14.4 13.4 17.3 22.0 22.6 14.2 20.0 24.8 14.8 21.3 23.0 25.0 24.3 42.5 37.9 29.3 30.0 26.0 21.4 44.3 31.3 20.4 19.0 22.1 20.8 33.7 37.2 17.2 52.0 34.9 15.9 16.2 23.2 20.3 51.5 27.0 44.1 57.8 18.9 37.4 19.6 15.9 19.3 24.6 20.0 24.8 19.9 21.0 22.2 21.5 28.2 17.4 19.9 20.2 5.1 22.7 29.0 24.4 28.1 18.9 22.3 21.7 23.9 25.0 21.1 21.8 25.6 19.4 28.5 22.0 20.8 17.1 55.1 67.4 66.5 17.4 73.3 66.2 62.9 26.1 54.1 9.8 90.1 218.8 97.2 290.3 43.8 39.9 46.7 100.3 89.9 50.5 55.2 55.4 55.9 88.0 9.5 52.6 46.1 44.3 51.4 39.7 53.0 45.5 92.0 41.1 32.9 97.8 52.6 46.3 153.7 21.7 58.2 63.4 159.6 42.8 61.6 87.1 52.9 59.0 80.8 MRPL48 CGI-118 ENSG00000175581 "Mitochondrial ribosomal protein L48" Q96GC5 11 73787316-73865133 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040241, HPA040864" Approved Supported Mitochondria NA NA Mitochondria "HPA040241: AB_2676899, HPA040864: AB_2677175" "unprognostic (2.41e-1)" "unprognostic (1.80e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-3)" "unprognostic (1.99e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (8.89e-2)" "unprognostic (4.41e-2)" "unprognostic (3.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.85e-2)" "unprognostic (4.61e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (3.30e-1)" 9.3 15.5 20.8 13.3 31.0 12.4 25.2 21.5 22.6 18.3 19.9 17.9 14.0 15.8 10.8 17.9 13.2 16.3 7.1 14.6 23.1 19.5 21.2 17.0 10.8 13.8 25.5 17.0 15.7 23.0 18.9 9.4 11.9 32.4 12.7 18.9 8.6 15.7 13.9 29.0 9.5 13.3 9.7 31.7 11.9 13.6 5.2 24.0 14.8 14.5 16.7 15.9 10.8 13.3 18.9 22.3 18.9 19.0 16.9 22.5 19.0 10.0 11.7 13.1 7.3 7.7 6.0 5.6 6.3 7.0 9.5 8.1 22.2 9.3 24.4 12.9 8.6 6.7 12.4 12.8 13.1 8.6 9.7 14.7 12.5 13.1 15.6 8.8 20.7 9.0 5.0 14.2 8.5 11.8 8.8 13.6 14.2 15.7 13.5 9.6 16.0 24.9 20.2 9.9 33.0 12.6 11.0 15.9 27.9 10.7 12.3 10.3 10.2 5.0 17.4 50.9 6.4 11.1 13.2 4.8 7.9 10.2 5.5 8.3 6.5 12.9 35.2 3.4 13.5 6.3 18.9 14.7 7.7 17.8 19.0 18.6 18.9 20.8 21.5 21.7 17.3 22.5 21.9 2.9 16.9 16.9 22.3 21.8 19.0 20.8 31.0 21.5 22.6 23.1 19.5 25.5 17.0 32.4 24.0 8.9 15.6 36.3 30.6 17.1 8.9 30.8 35.7 34.8 14.8 24.4 3.9 80.3 74.6 33.4 4.8 17.5 30.2 23.3 34.6 61.0 20.6 25.6 20.7 20.3 37.7 14.3 23.2 20.9 28.1 13.7 17.0 20.0 42.2 23.4 34.8 17.4 30.1 42.1 17.0 57.3 7.1 0.0 20.2 9.8 24.9 17.2 50.0 32.8 45.5 29.4 MRPL51 "bMRP64, CDA09, HSPC241, MRP64" ENSG00000111639 "Mitochondrial ribosomal protein L51" Q4U2R6 12 6491886-6493841 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 738.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039923 Approved Supported Mitochondria NA NA Mitochondria "HPA039923: AB_10795373" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (3.81e-3)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (1.43e-1)" "unprognostic (3.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.36e-1)" "unprognostic (2.62e-1)" "unprognostic (1.17e-1)" "unprognostic (8.33e-2)" 21.4 32.4 36.3 30.4 31.8 24.4 29.1 14.7 29.5 21.0 29.2 18.8 27.2 20.7 22.0 35.2 35.8 20.8 26.8 48.9 29.3 29.6 38.5 50.1 18.1 29.8 36.9 21.3 20.9 52.7 18.8 26.2 26.6 28.4 23.2 30.0 15.8 36.2 28.7 74.0 19.5 24.3 21.5 28.9 27.3 24.0 46.6 25.8 37.5 32.8 52.1 36.7 21.7 26.7 58.4 85.4 59.7 56.2 50.2 61.2 69.5 35.2 43.1 51.1 34.6 33.5 30.5 54.8 24.7 30.5 37.2 36.0 59.5 47.2 43.7 17.3 37.2 47.8 31.5 35.5 40.2 56.6 53.8 44.9 30.2 62.7 50.5 31.1 41.1 30.0 29.4 32.0 34.4 44.8 52.3 34.1 40.7 21.5 16.4 47.9 55.1 48.1 66.1 103.8 66.0 43.8 33.4 49.7 37.5 34.1 48.2 18.4 32.7 37.9 52.2 42.8 101.3 15.8 47.1 26.1 33.6 47.2 27.0 55.2 16.2 23.3 112.5 42.8 31.3 44.7 49.1 56.2 59.7 52.2 51.2 58.7 58.4 56.4 57.5 63.4 54.4 57.6 59.4 21.2 50.2 49.6 85.4 61.2 69.5 36.3 31.8 14.7 29.5 29.3 29.6 36.9 21.3 28.4 25.8 98.3 68.5 97.5 142.6 120.9 43.2 273.6 168.2 99.0 78.5 162.3 11.8 231.8 397.9 217.7 738.9 110.2 117.5 23.3 240.5 337.1 125.9 189.7 91.1 309.5 231.7 41.3 144.0 136.9 142.5 334.3 141.8 111.9 183.9 403.0 155.0 81.7 214.9 150.8 139.0 412.8 36.2 109.9 124.6 380.4 168.5 137.1 180.2 102.2 183.9 151.7 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471958-74473322 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 71.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria NA NA Mitochondria "HPA034612: , HPA056185: AB_2683060" "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 16.8 26.4 15.8 16.9 15.2 14.0 23.2 14.8 17.7 14.1 16.9 15.2 8.5 18.6 15.1 14.6 19.4 17.5 16.8 40.2 14.0 13.2 25.5 44.8 16.0 28.2 16.6 12.3 23.8 31.2 14.8 18.4 19.9 13.3 18.6 8.9 20.1 36.9 19.8 44.1 12.5 16.3 16.1 15.5 20.3 17.8 13.2 12.2 27.7 28.9 20.3 18.9 14.3 14.6 45.9 42.9 26.1 35.6 19.0 42.5 38.9 8.0 29.8 9.9 6.4 11.1 10.1 14.5 8.6 8.1 10.3 8.2 33.6 11.3 6.7 5.3 7.8 13.6 9.7 4.4 14.3 3.7 16.9 26.1 9.1 11.1 22.1 8.1 5.7 9.2 12.5 8.7 13.3 6.7 11.3 9.8 16.5 9.5 18.8 8.8 41.0 13.8 17.1 6.3 23.4 16.4 10.6 17.9 16.4 10.5 7.3 10.7 10.1 5.9 18.7 10.6 7.0 8.4 7.2 6.1 13.7 12.2 11.1 10.7 19.7 18.3 12.7 10.2 7.4 11.9 24.7 35.6 14.3 21.6 31.9 26.3 44.8 30.2 23.8 29.3 45.9 42.5 31.2 26.1 19.0 29.9 42.9 34.9 38.9 15.8 15.2 14.8 17.7 14.0 13.2 16.6 12.3 13.3 12.2 8.9 18.0 20.8 5.8 15.2 1.7 1.2 5.1 71.0 12.5 10.4 0.0 12.7 18.3 27.3 7.1 11.7 28.4 0.0 49.2 14.7 14.3 5.6 32.4 21.7 15.5 1.6 38.2 13.5 30.7 2.1 8.1 19.3 25.3 46.9 25.4 2.2 34.1 43.2 4.2 18.9 2.8 6.5 14.1 8.8 7.0 22.0 13.2 20.6 22.1 5.8 MRPL54 ENSG00000183617 "Mitochondrial ribosomal protein L54" Q6P161 19 3762664-3768575 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042117, HPA046767" Uncertain Approved Mitochondria No No Mitochondria "HPA042117: AB_2677856, HPA046767: AB_2679795" "unprognostic (2.09e-1)" "unprognostic (1.00e-3)" "unprognostic (3.81e-2)" "unprognostic (1.85e-3)" "unprognostic (1.00e-1)" "unprognostic (4.43e-2)" "unprognostic (1.23e-2)" "unprognostic (1.32e-3)" "unprognostic (7.19e-2)" "unprognostic (1.70e-2)" "unprognostic (2.22e-2)" "unprognostic (2.88e-2)" "unprognostic (1.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.26e-1)" "unprognostic (2.64e-2)" "unprognostic (6.54e-3)" 23.8 34.2 26.2 20.7 27.0 42.4 24.4 19.4 28.8 16.5 27.8 12.7 32.9 25.0 20.5 29.2 26.2 27.5 32.3 34.1 22.2 20.7 28.9 56.7 26.2 35.5 23.2 30.0 20.6 54.0 16.0 26.4 28.6 19.5 22.3 20.7 16.5 44.4 29.7 32.9 19.8 22.1 25.8 21.8 21.8 26.0 38.2 16.0 20.6 26.7 26.9 22.4 18.7 19.5 46.1 45.6 26.0 43.0 41.5 54.4 45.4 33.7 19.3 18.0 17.6 10.7 17.2 15.3 16.2 20.8 39.0 33.6 16.5 12.0 24.4 16.9 19.9 14.7 21.6 23.6 21.3 16.6 15.6 35.9 12.4 11.1 21.0 28.0 26.2 29.4 20.1 37.0 16.3 28.7 15.2 31.9 17.1 23.2 48.2 20.3 22.9 23.5 27.8 23.8 23.7 14.2 20.5 10.2 36.1 29.4 17.2 25.2 20.9 13.2 31.7 24.0 9.0 21.3 37.7 22.7 24.8 14.3 42.0 34.6 29.6 39.2 23.7 24.5 41.9 18.4 24.9 41.7 26.0 37.0 43.0 34.1 46.1 40.8 43.3 45.6 42.5 39.4 36.2 12.0 41.5 40.9 41.4 54.4 45.4 26.2 27.0 19.4 28.8 22.2 20.7 23.2 30.0 19.5 16.0 71.5 74.8 103.6 80.6 43.6 44.6 48.7 79.0 56.2 61.4 75.0 17.7 113.4 303.4 100.7 72.5 51.5 181.4 23.3 166.5 107.6 51.5 96.0 105.0 203.6 139.3 36.5 101.2 58.3 100.5 47.0 52.0 71.8 67.4 108.2 157.0 67.6 120.5 178.9 42.1 295.9 62.3 25.8 55.3 118.3 50.5 50.1 147.9 79.9 127.3 97.4 MRPL57 MRP63 ENSG00000173141 "Mitochondrial ribosomal protein L57" Q9BQC6 13 21176645-21179084 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039779, HPA059370" Supported Supported Mitochondria NA NA Mitochondria "HPA039779: AB_10673362, HPA059370: AB_2683993" "unprognostic (1.00e-1)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (9.57e-3)" "unprognostic (1.51e-1)" "unprognostic (5.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.68e-2)" "prognostic favorable (8.35e-4)" "unprognostic (7.65e-2)" "unprognostic (2.01e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (6.78e-2)" 14.0 28.8 23.2 13.8 21.4 16.2 16.5 16.1 22.6 14.6 15.3 12.6 12.9 18.4 13.4 21.0 16.1 17.3 18.7 29.3 20.5 24.7 24.8 40.9 15.0 16.5 21.3 17.9 19.6 30.2 12.3 26.8 12.5 17.1 21.6 12.3 15.1 23.2 18.8 48.0 15.3 17.5 16.4 17.8 16.6 18.1 20.2 13.0 26.4 25.1 24.7 13.8 13.4 12.8 26.1 43.9 23.0 31.5 21.8 32.8 28.8 7.9 14.6 10.3 9.3 7.9 6.5 10.8 9.6 6.0 9.2 6.9 19.1 14.8 4.6 11.3 6.0 7.2 13.8 9.0 9.2 6.9 12.1 15.0 21.0 10.4 21.3 11.7 11.5 10.5 6.6 10.2 7.3 6.9 5.6 8.7 19.0 9.1 6.1 6.4 27.9 25.0 30.4 7.5 26.0 17.1 15.2 15.5 8.1 11.2 9.8 20.6 9.6 7.8 9.8 14.1 7.2 9.9 10.8 6.0 4.8 8.9 10.1 8.5 8.5 6.8 8.2 4.2 13.6 11.9 17.8 31.5 23.0 22.8 24.4 25.8 26.1 29.0 24.3 27.5 25.8 32.8 26.1 4.8 21.8 20.1 43.9 28.8 28.8 23.2 21.4 16.1 22.2 20.5 24.7 21.3 17.9 17.1 13.0 74.5 108.6 101.9 96.1 0.0 88.1 472.9 142.7 148.5 103.5 167.5 43.2 199.3 431.0 129.5 227.3 87.5 174.6 233.6 212.5 168.5 71.9 127.0 69.4 399.2 201.5 73.1 143.6 104.3 112.5 263.9 106.7 94.5 0.0 186.7 167.4 115.5 147.0 171.7 93.0 484.9 81.9 51.8 53.6 92.6 52.4 0.0 186.6 94.7 179.9 93.6 MRPL9 ENSG00000143436 "Mitochondrial ribosomal protein L9" Q9BYD2 1 151759643-151763564 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008579 Approved Supported Mitochondria NA NA Mitochondria "HPA008579: AB_1079412" "unprognostic (2.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.34e-1)" "unprognostic (7.43e-3)" "unprognostic (7.66e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.04e-7)" "unprognostic (1.47e-1)" "unprognostic (5.22e-2)" "unprognostic (9.51e-3)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (6.30e-2)" 28.5 22.3 23.3 26.3 25.3 23.0 26.4 27.3 30.9 22.1 26.7 22.2 19.8 21.7 26.8 25.4 28.4 22.5 24.3 24.5 21.7 24.6 29.9 35.1 19.5 28.7 24.0 19.4 33.2 31.9 35.1 18.4 29.0 27.6 29.0 22.3 19.7 40.6 25.3 50.7 25.7 23.1 23.7 21.2 28.5 23.0 24.0 18.3 41.2 38.2 34.2 29.3 25.3 23.5 30.6 31.5 15.0 16.5 24.4 37.6 21.6 29.4 24.2 15.9 18.7 11.5 12.9 26.1 16.4 15.7 25.6 20.6 36.9 27.6 19.3 33.3 16.5 16.6 26.1 27.8 20.6 20.4 26.3 26.8 15.2 20.5 23.4 18.7 42.2 14.4 14.1 19.1 22.8 28.7 17.0 24.7 29.6 31.6 25.4 19.7 68.7 26.1 30.2 34.5 33.6 35.0 23.1 19.1 37.3 15.5 23.3 26.3 26.9 19.5 28.1 22.9 22.7 42.5 51.1 18.3 20.3 20.6 17.4 36.3 28.5 40.4 61.4 25.4 27.9 22.6 15.0 13.6 8.8 27.8 16.5 31.8 30.6 32.1 32.3 31.5 27.8 30.9 28.8 1.6 24.4 14.2 26.5 37.6 21.6 23.3 25.3 27.3 30.9 21.7 24.6 24.0 19.4 27.6 18.3 26.8 17.9 43.1 41.8 27.8 17.4 3.8 28.1 38.8 33.0 31.4 5.9 85.5 54.7 60.9 60.3 38.8 18.1 0.0 55.8 100.4 33.3 38.4 39.4 26.1 56.9 17.5 27.5 39.9 21.1 21.0 36.2 30.2 33.7 78.5 26.7 30.6 59.8 24.6 44.2 67.2 17.1 71.1 34.0 37.2 31.7 27.7 62.4 44.9 45.9 35.0 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480773 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043752: AB_2678653, HPA050345: AB_2681100" "unprognostic (2.66e-1)" "prognostic favorable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favorable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 12.4 19.1 19.5 9.0 18.3 6.1 13.5 11.2 19.6 7.0 13.4 8.0 11.0 17.6 7.3 9.3 15.1 11.4 10.3 31.0 19.1 17.3 16.5 28.5 8.2 10.5 18.3 15.0 6.0 22.5 9.6 9.3 9.0 15.8 8.9 8.6 8.0 11.4 10.4 44.3 11.5 13.1 10.0 13.7 9.5 10.7 9.9 10.4 12.9 17.7 12.9 10.4 9.7 7.9 18.5 23.0 18.9 19.0 20.9 24.4 17.4 5.6 22.4 3.2 5.7 7.8 3.9 9.2 4.7 8.0 5.9 6.5 15.4 8.8 5.1 9.5 3.8 6.4 8.0 9.3 6.3 2.9 6.8 24.4 6.9 14.5 16.8 9.3 2.4 4.6 7.6 6.2 5.1 5.1 3.2 8.0 6.7 5.0 2.2 9.9 23.9 4.7 10.0 9.3 7.3 23.9 10.2 6.4 12.0 8.3 15.3 11.3 5.5 4.9 11.8 18.3 3.0 11.1 13.6 3.7 8.5 9.4 5.6 6.6 4.7 8.5 5.9 10.6 5.8 8.8 18.9 18.4 13.2 11.7 19.0 13.3 18.5 13.3 13.6 21.2 12.9 14.1 13.7 6.7 20.9 12.1 23.0 24.4 17.4 19.5 18.3 11.2 19.6 19.1 17.3 18.3 15.0 15.8 10.4 6.0 17.8 35.0 31.0 20.3 31.6 5.0 30.6 29.4 22.7 43.6 45.2 79.4 114.4 52.5 21.7 29.2 79.0 46.7 58.5 79.5 31.0 23.1 32.4 74.4 78.6 25.4 23.7 36.2 33.0 25.4 30.8 35.9 30.4 78.5 44.3 37.2 56.5 73.7 40.0 99.0 41.4 19.4 23.9 62.1 38.8 24.7 74.9 44.1 54.1 29.0 MRPS15 FLJ11564 ENSG00000116898 "Mitochondrial ribosomal protein S15" P82914 1 36455718-36464437 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 621.9;Late spermatids: 1487.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028100, HPA028134, HPA067137" Supported Supported Mitochondria NA NA Mitochondria "HPA028100: AB_10600216, HPA028134: AB_10600890, HPA067137: AB_2685787" "unprognostic (2.05e-2)" "unprognostic (6.98e-2)" "unprognostic (7.57e-2)" "unprognostic (4.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.20e-2)" "unprognostic (3.28e-2)" "prognostic favorable (7.83e-4)" "unprognostic (8.48e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (2.31e-1)" "unprognostic (1.44e-1)" "unprognostic (8.94e-2)" "unprognostic (1.39e-1)" 22.6 20.7 17.8 16.9 17.3 24.0 23.8 9.5 16.0 13.2 19.9 9.3 13.7 14.3 13.3 23.0 23.0 10.4 16.6 43.2 15.0 15.2 30.6 61.7 16.6 23.3 17.5 10.6 13.8 23.3 14.3 14.3 23.7 18.3 15.0 18.2 13.8 24.0 14.7 89.5 14.1 18.4 15.7 12.3 17.3 18.8 65.5 10.6 20.3 19.1 41.3 19.3 16.0 12.9 24.5 40.7 7.0 28.7 20.3 28.1 28.6 40.5 22.6 24.7 30.1 24.6 35.7 61.5 22.7 32.6 56.3 51.8 39.9 43.8 37.6 37.1 29.8 33.9 35.8 36.0 57.3 50.8 24.4 45.7 38.4 29.3 43.6 46.1 47.5 27.2 32.9 51.2 50.1 40.6 21.8 45.9 28.3 41.5 29.7 34.7 27.9 45.7 50.9 44.4 34.8 39.9 35.4 43.5 55.0 49.7 34.2 36.7 20.3 31.4 40.2 58.2 38.5 24.8 32.7 21.6 31.7 33.7 39.1 47.8 29.9 41.0 52.5 36.1 32.3 44.2 4.9 26.7 7.0 22.0 28.7 27.2 24.5 25.2 25.0 40.7 21.6 23.9 23.2 1.8 20.3 18.9 27.7 28.1 28.6 17.8 17.3 9.5 16.0 15.0 15.2 17.5 10.6 18.3 10.6 35.7 41.7 43.3 52.5 58.2 23.2 120.0 53.5 38.8 28.4 68.0 13.7 219.1 273.5 113.2 621.9 59.7 89.2 116.8 140.3 210.6 61.7 96.5 41.5 122.3 137.3 12.7 63.4 52.8 79.0 1487.0 58.1 81.5 54.0 95.6 78.7 16.2 134.3 66.6 70.0 248.1 19.2 64.7 69.1 202.9 79.7 70.3 235.5 61.8 99.8 87.6 MRPS2 CGI-91 ENSG00000122140 "Mitochondrial ribosomal protein S2" Q9Y399 9 135499984-135504673 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029487, HPA057261" Approved Supported Mitochondria NA NA Mitochondria "HPA029487: , HPA057261: AB_2683385" "unprognostic (3.18e-3)" "unprognostic (9.42e-3)" "unprognostic (1.46e-1)" "unprognostic (7.81e-2)" "unprognostic (3.55e-1)" "unprognostic (8.45e-2)" "unprognostic (1.63e-1)" "unprognostic (5.63e-3)" "unprognostic (3.83e-1)" "unprognostic (2.90e-2)" "unprognostic (4.81e-2)" "unprognostic (7.58e-2)" "prognostic favorable (6.96e-9)" "unprognostic (2.74e-2)" "unprognostic (1.06e-1)" "unprognostic (8.29e-2)" "unprognostic (2.24e-1)" 18.5 31.7 15.6 14.8 18.4 17.7 32.1 17.9 28.9 15.2 19.6 12.6 31.3 20.9 19.7 15.7 20.7 33.3 20.6 43.6 15.0 15.5 24.5 48.6 17.8 32.7 15.4 15.1 25.6 37.1 21.7 15.5 16.5 14.1 18.3 16.2 15.0 25.7 29.3 43.0 19.7 16.0 22.0 12.8 18.4 20.6 12.3 10.6 18.5 22.5 28.4 18.2 18.5 15.7 20.6 16.2 7.3 15.8 14.5 22.3 13.7 16.4 27.3 10.0 13.6 11.4 12.8 17.3 12.1 11.0 20.5 15.3 41.0 15.6 20.9 16.6 11.1 21.8 37.3 25.1 28.3 8.0 12.8 39.4 10.3 27.6 27.4 20.0 20.9 12.7 17.1 22.1 22.3 16.0 13.2 19.1 21.0 34.0 15.4 11.9 50.6 20.4 36.5 22.9 30.5 44.1 22.4 16.4 43.9 17.0 14.0 30.3 16.0 16.4 31.6 17.4 7.0 26.2 16.6 11.8 15.1 16.9 25.9 21.7 17.0 33.3 23.1 15.5 19.1 13.8 4.8 15.8 7.3 18.0 14.9 20.4 20.6 18.1 19.2 16.2 20.3 19.7 19.6 1.3 14.5 12.2 13.9 22.3 13.7 15.6 18.4 17.9 28.9 15.0 15.5 15.4 15.1 14.1 10.6 11.9 16.0 41.4 32.0 39.8 20.6 28.6 30.6 12.0 28.4 12.2 5.9 59.6 61.3 46.7 11.0 25.6 22.5 0.0 33.5 47.9 22.6 23.0 8.1 40.9 37.4 23.8 20.8 19.0 15.9 24.2 22.5 14.8 18.6 40.5 34.8 16.9 37.7 28.1 21.5 65.5 14.5 32.3 24.7 7.2 19.4 40.0 31.2 29.7 51.6 29.8 MRPS21 ENSG00000266472 "Mitochondrial ribosomal protein S21" 1 150293720-150308979 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078289 Supported Mitochondria NA NA Mitochondria "HPA078289: AB_2686881" "unprognostic (3.48e-2)" "unprognostic (1.94e-2)" "unprognostic (5.46e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (1.15e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (9.71e-2)" "unprognostic (7.59e-2)" "unprognostic (2.12e-2)" "unprognostic (4.02e-2)" "unprognostic (3.97e-2)" "unprognostic (1.46e-1)" 10.5 17.7 10.8 8.6 16.5 8.6 14.2 8.7 18.8 9.7 8.5 8.1 9.7 10.1 10.4 15.1 9.5 12.1 9.3 15.0 8.9 13.3 12.2 8.1 10.3 8.4 16.7 16.4 11.5 10.9 13.6 8.3 15.9 9.3 7.5 10.0 9.9 12.2 16.9 9.0 8.6 10.3 7.9 9.6 9.9 10.3 9.3 6.2 13.8 11.7 11.7 8.7 9.4 37.8 43.7 15.7 25.8 21.2 36.9 30.3 25.9 21.8 28.2 14.3 27.0 26.8 23.3 19.2 16.4 19.1 18.5 4.5 24.8 26.6 13.3 21.0 5.6 24.9 24.1 20.5 17.1 17.9 31.0 15.4 32.3 31.7 21.4 23.0 13.5 29.6 21.9 23.0 26.2 11.4 24.1 23.4 25.4 35.2 25.4 59.7 19.5 21.1 48.0 50.2 38.2 17.8 14.6 45.2 22.0 19.2 21.8 45.9 16.2 32.9 31.2 32.2 17.9 33.7 17.0 7.4 14.1 19.8 21.1 30.5 32.1 26.5 9.6 12.8 14.1 11.8 25.8 15.7 24.8 24.5 29.7 37.8 32.2 28.3 28.6 33.1 36.9 31.3 6.0 21.2 21.9 43.7 30.1 30.3 104.2 104.0 163.5 169.4 106.9 66.9 259.0 229.3 202.1 128.5 249.5 31.4 245.7 446.0 195.9 694.8 155.8 149.1 70.0 269.9 209.7 167.2 161.3 128.3 304.8 248.0 46.1 133.1 141.8 166.8 412.5 213.2 158.3 172.1 281.3 121.3 85.2 275.1 103.0 219.2 414.9 47.8 97.0 163.5 202.6 93.1 128.6 196.7 126.4 148.9 171.7 MRPS22 "C3orf5, GIBT, GK002, MRP-S22" ENSG00000175110 "Mitochondrial ribosomal protein S22" P82650 3 139005806-139357223 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006083, HPA007830" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA006083: AB_1854122, HPA007830: AB_1854123" "unprognostic (8.38e-2)" "unprognostic (1.52e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (5.22e-3)" "unprognostic (5.45e-3)" "unprognostic (4.85e-2)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" "unprognostic (4.49e-3)" "prognostic unfavorable (1.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.22e-3)" "unprognostic (2.56e-2)" "unprognostic (1.49e-1)" "unprognostic (1.77e-1)" "unprognostic (3.40e-1)" 17.6 45.3 16.9 14.5 24.9 22.1 18.3 15.5 26.7 16.3 22.7 14.6 12.2 24.0 17.0 14.7 26.7 14.5 13.8 39.2 23.4 15.0 24.9 43.3 12.9 20.2 18.2 19.7 15.7 22.4 13.6 15.2 16.9 22.6 11.6 22.0 8.8 15.3 15.8 50.8 17.2 21.1 16.8 18.1 14.0 19.0 21.9 19.9 15.3 15.1 31.0 16.0 16.5 16.9 24.9 27.9 21.7 31.6 21.1 27.8 20.9 30.7 13.3 11.3 13.7 17.0 14.4 26.1 18.1 23.4 32.5 26.7 42.3 22.2 21.2 34.1 22.0 32.1 35.0 20.4 24.7 31.3 12.0 19.0 33.9 11.5 29.3 19.0 31.7 18.5 15.4 19.4 19.5 20.4 14.5 19.8 24.5 46.8 13.4 19.6 22.7 15.8 24.9 20.2 30.3 23.4 20.1 19.3 29.7 23.5 18.3 13.5 12.1 29.3 43.2 45.9 11.7 30.2 28.7 14.1 13.0 13.8 25.8 17.0 20.8 11.4 38.0 16.1 22.6 12.6 21.7 24.0 21.2 22.9 31.6 27.6 24.9 24.7 25.7 27.9 21.6 27.3 25.3 5.4 21.1 30.3 17.8 27.8 20.9 16.9 24.9 15.5 26.7 23.4 15.0 18.2 19.7 22.6 19.9 17.9 11.2 18.2 23.5 20.3 19.9 43.4 25.5 37.5 14.8 17.4 13.7 54.0 58.0 36.5 37.3 20.4 26.9 0.0 52.8 37.9 24.4 15.6 26.5 34.2 42.5 19.1 15.0 18.4 17.7 5.6 21.6 21.0 15.1 38.7 25.1 18.5 38.5 20.1 22.3 37.0 25.3 38.8 24.2 73.7 46.5 17.9 63.0 22.4 39.6 26.5 MRPS25 "DKFZp313H0817, FLJ00023, MRP-S25, RPMS25" ENSG00000131368 "Mitochondrial ribosomal protein S25" P82663 3 15042460-15065335 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Late spermatids: 1039.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043490 Approved Supported Mitochondria NA NA Mitochondria "HPA043490: AB_10794888" "unprognostic (3.98e-2)" "unprognostic (5.36e-2)" "unprognostic (4.58e-3)" "unprognostic (1.24e-2)" "unprognostic (4.66e-2)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.93e-3)" "unprognostic (2.23e-1)" "unprognostic (2.10e-1)" "unprognostic (6.29e-2)" "unprognostic (2.68e-3)" "prognostic favorable (3.60e-7)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.91e-3)" 14.8 18.5 18.7 18.4 28.3 12.0 14.3 24.9 21.9 11.7 20.9 13.1 15.2 31.6 16.8 15.8 15.6 15.4 15.0 41.7 15.2 16.5 18.4 27.5 14.4 17.7 16.3 24.0 18.1 24.1 18.1 21.4 11.4 16.8 14.9 23.3 20.3 14.9 17.4 47.6 18.8 26.4 24.5 13.2 17.4 17.3 33.3 15.0 10.2 28.5 15.7 18.6 14.8 13.5 21.1 16.1 3.6 18.6 6.8 15.3 9.4 8.4 12.6 10.3 14.3 10.9 9.4 32.9 11.6 4.5 9.4 8.1 14.3 9.2 22.3 6.2 5.1 6.3 11.0 14.9 11.0 8.1 8.9 20.9 18.4 25.9 17.8 7.7 16.3 14.1 11.3 10.5 14.8 4.5 6.4 8.7 15.1 19.5 13.4 7.0 27.0 12.6 15.8 10.7 19.8 19.8 17.2 8.9 23.0 11.7 14.7 8.2 12.3 8.5 16.2 16.7 6.6 21.9 14.2 10.7 8.5 12.5 11.6 14.5 13.0 13.9 16.0 8.6 21.0 7.9 1.1 15.4 3.6 10.1 18.4 11.8 21.1 9.6 10.4 16.1 18.2 15.3 12.5 1.0 6.8 18.6 13.3 7.4 9.4 18.7 28.3 24.9 21.9 15.2 16.5 16.3 24.0 16.8 15.0 47.6 31.7 62.5 44.0 34.2 56.6 264.1 53.5 44.2 52.4 34.9 155.1 83.6 189.0 44.3 290.5 31.6 105.8 0.0 29.4 55.3 41.2 30.5 25.4 89.4 82.4 63.5 51.9 19.6 22.7 1039.4 42.6 38.5 35.4 39.7 65.2 21.4 40.9 52.6 28.3 157.3 98.1 71.1 42.0 60.3 28.0 42.4 60.8 27.3 108.1 58.0 MRPS28 "HSPC007, MRP-S28, MRPS35" ENSG00000147586 "Mitochondrial ribosomal protein S28" Q9Y2Q9 8 79918717-80030289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 88.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027202 Approved Supported Mitochondria NA NA Mitochondria "HPA027202: AB_1854126" "unprognostic (3.63e-3)" "unprognostic (6.41e-2)" "unprognostic (9.61e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-3)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (4.55e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "prognostic favorable (1.20e-6)" "unprognostic (4.48e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-1)" "unprognostic (7.18e-2)" 18.1 36.9 27.4 13.2 26.7 10.9 19.9 16.7 23.3 14.1 20.9 20.5 10.9 13.4 11.5 16.5 18.1 14.7 12.0 40.4 24.0 24.7 32.5 44.2 12.2 13.7 32.2 17.9 13.4 19.1 20.6 20.2 18.7 21.9 13.1 17.2 16.7 14.2 14.8 56.9 11.8 12.7 13.4 27.8 12.6 14.0 9.7 19.0 18.1 22.4 27.8 15.7 14.0 11.7 19.6 41.7 26.0 28.1 25.4 26.7 18.0 20.1 20.1 18.2 4.3 15.5 20.2 20.0 22.6 21.1 30.9 26.2 17.5 16.4 25.4 26.3 18.3 30.9 16.7 25.2 25.8 24.9 20.1 22.1 30.9 18.4 27.2 17.4 13.7 13.9 17.0 22.1 18.0 24.7 17.0 20.0 20.8 21.8 10.7 30.5 19.3 31.4 22.3 7.4 52.4 34.3 21.5 14.6 14.7 38.8 19.5 8.6 14.6 10.0 88.9 21.0 22.1 21.4 16.6 14.3 11.6 29.1 20.2 19.8 11.6 18.5 22.6 19.7 15.9 8.9 26.0 20.7 10.9 19.0 28.1 20.7 18.7 21.4 23.8 36.7 19.6 25.9 24.9 4.5 25.4 24.9 41.7 26.7 18.0 27.4 26.7 16.7 23.3 24.0 24.7 32.2 17.9 21.9 19.0 20.8 14.5 24.1 17.8 31.3 11.9 51.2 35.7 61.6 34.2 31.4 3.9 66.8 86.2 58.9 11.1 30.8 18.0 0.0 40.7 64.7 23.7 12.0 48.5 58.0 43.9 4.8 35.9 25.8 28.4 7.6 16.4 35.7 42.2 47.7 21.5 17.5 34.1 14.0 20.8 78.1 13.9 32.3 25.0 16.5 34.1 33.1 49.7 23.5 36.8 15.4 MRPS34 "MGC2616, MRP-S12" ENSG00000074071 "Mitochondrial ribosomal protein S34" P82930 16 1771890-1773155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042112 Supported Supported Mitochondria NA NA Mitochondria "HPA042112: AB_10796899" "unprognostic (2.02e-1)" "unprognostic (4.83e-2)" "unprognostic (6.79e-2)" "unprognostic (3.42e-2)" "unprognostic (2.27e-1)" "unprognostic (9.59e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (3.52e-1)" "unprognostic (1.37e-2)" "unprognostic (6.60e-2)" "unprognostic (3.18e-1)" "unprognostic (5.44e-2)" 26.8 30.5 15.6 14.1 18.3 21.1 17.8 20.2 26.8 11.5 28.0 14.7 19.2 28.4 15.1 13.6 24.7 13.7 17.9 21.9 14.0 13.1 22.5 27.7 12.9 14.8 14.0 13.1 12.6 42.0 13.0 15.5 12.6 16.3 21.2 7.0 12.5 46.6 19.4 89.8 21.9 23.6 10.8 13.6 25.8 36.5 8.8 15.1 21.5 21.0 28.1 21.1 14.7 15.7 55.5 54.6 27.2 50.8 41.0 51.9 45.5 14.1 15.8 2.2 5.5 1.9 2.2 18.2 15.6 3.0 5.4 4.1 10.7 8.3 17.9 25.1 1.9 3.0 16.7 3.2 7.5 0.8 12.6 75.4 12.5 14.0 11.3 4.1 22.9 13.4 2.0 3.6 3.3 1.4 2.4 4.1 9.3 20.9 3.8 1.5 22.9 12.4 40.9 21.1 3.7 48.5 28.1 10.7 39.1 2.0 4.0 28.0 20.9 17.5 8.7 15.0 0.6 11.2 9.3 10.4 5.8 18.7 7.8 12.7 32.5 22.4 28.5 4.5 13.0 7.3 15.7 50.8 27.2 41.0 44.0 43.4 50.5 45.8 43.5 54.6 55.5 43.7 39.2 11.0 41.0 37.4 51.0 51.9 45.5 15.6 18.3 20.2 26.8 14.0 13.1 14.0 13.1 16.3 15.1 35.7 27.7 77.0 57.3 89.2 43.8 53.0 94.3 24.1 39.8 92.5 9.8 160.1 212.2 101.1 4.7 53.7 189.8 23.3 157.7 146.2 58.0 69.5 34.7 145.9 153.3 52.4 87.5 63.8 98.1 8.9 67.3 58.7 77.6 88.4 128.4 65.1 127.2 138.9 65.7 174.9 30.5 19.4 65.7 20.0 41.9 105.5 57.2 77.3 177.0 60.1 MRPS36 "DC47, MRP-S36" ENSG00000134056 "Mitochondrial ribosomal protein S36" P82909 5 69217760-69230129 "Predicted intracellular proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035802, HPA056795" Supported Enhanced Mitochondria NA NA Mitochondria "HPA035802: AB_10600933, HPA056795: AB_2683237" "unprognostic (1.19e-1)" "unprognostic (6.78e-3)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.92e-1)" "unprognostic (2.96e-3)" "unprognostic (1.99e-1)" "unprognostic (7.49e-2)" "unprognostic (1.49e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (3.90e-1)" "prognostic favorable (5.02e-6)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.37e-2)" "unprognostic (4.84e-3)" 13.6 13.7 16.7 9.1 21.4 12.8 13.8 10.4 24.8 8.0 16.8 4.7 12.6 17.1 9.1 11.7 14.4 8.2 10.9 42.8 17.6 13.5 34.8 26.5 17.0 12.2 16.3 14.3 8.8 21.7 11.7 10.4 9.3 17.7 10.8 17.8 6.4 9.6 9.5 29.8 8.1 20.9 13.9 11.4 8.0 13.9 6.8 10.0 10.8 12.7 22.3 11.5 9.9 9.0 27.9 24.4 24.7 27.5 21.5 34.7 14.9 15.0 14.5 10.3 14.1 18.1 18.4 27.1 13.5 13.0 17.4 21.5 20.1 16.9 16.2 28.2 11.4 39.0 15.5 17.1 20.5 17.3 19.0 17.9 11.1 17.2 22.3 21.4 11.7 15.1 19.1 14.7 16.6 7.9 18.2 12.8 16.9 13.0 12.2 15.3 16.3 17.9 18.0 7.6 13.9 17.0 10.6 17.9 24.8 29.9 17.1 14.4 14.0 13.9 20.3 23.4 17.6 15.5 17.1 9.2 7.8 13.3 17.2 23.1 12.9 21.1 21.6 13.6 22.0 10.1 24.4 20.4 24.7 21.4 27.5 23.6 27.9 24.5 23.9 24.4 22.4 22.2 23.4 22.0 21.5 24.7 24.1 34.7 14.9 16.7 21.4 10.4 24.8 17.6 13.5 16.3 14.3 17.7 10.0 107.2 66.5 83.4 83.7 72.4 23.1 309.5 66.2 80.3 67.1 83.7 13.7 104.2 339.8 101.8 99.7 60.0 188.1 70.0 121.7 153.6 58.7 76.5 55.4 177.7 110.9 27.0 89.1 47.3 85.0 30.9 59.8 70.3 101.3 140.7 126.9 34.5 120.5 134.0 65.0 323.7 35.2 71.1 78.8 34.6 32.8 67.1 103.1 62.3 150.9 95.7 MRPS5 "MRP-S5, S5mt" ENSG00000144029 "Mitochondrial ribosomal protein S5" P82675 2 95087207-95149434 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055765 Approved Supported Mitochondria No No Mitochondria "HPA055765: AB_2682911" "unprognostic (1.18e-1)" "unprognostic (7.79e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (7.98e-7)" "unprognostic (7.51e-3)" "unprognostic (6.30e-3)" "prognostic unfavorable (7.73e-5)" "unprognostic (8.59e-2)" "unprognostic (1.87e-1)" "unprognostic (2.76e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-1)" "prognostic favorable (6.36e-4)" "unprognostic (1.25e-1)" 17.7 25.0 17.6 16.2 24.1 24.0 15.3 31.7 22.7 14.8 24.7 22.6 15.0 27.2 17.6 14.9 23.8 17.3 12.7 36.7 17.9 17.7 30.9 40.4 16.8 17.2 23.4 15.9 18.5 21.2 20.7 30.1 14.7 20.0 14.6 27.8 14.3 19.1 18.0 45.6 12.8 22.0 18.6 19.3 18.2 19.6 13.3 24.5 20.8 19.9 20.4 20.6 17.2 22.8 24.9 29.3 17.5 38.4 19.3 30.5 20.7 36.5 23.1 16.9 14.5 14.8 19.2 31.6 19.6 9.0 17.3 18.0 45.9 21.6 29.0 16.1 16.1 38.1 24.0 24.6 20.4 24.5 24.4 30.5 20.4 21.0 41.9 24.0 27.3 16.3 18.9 16.7 23.7 25.4 19.9 21.4 23.1 28.6 14.7 17.6 22.5 38.6 31.1 15.9 34.1 36.5 22.8 16.6 37.3 28.6 30.6 23.0 14.8 15.5 29.1 32.8 26.5 13.7 25.2 18.3 21.1 26.2 28.1 29.0 18.1 15.8 26.3 16.4 29.2 18.0 13.4 33.7 17.5 21.9 38.4 21.3 24.9 27.1 23.0 27.5 23.6 24.2 24.1 6.3 19.3 34.7 29.3 30.5 20.7 17.6 24.1 31.7 22.7 17.9 17.7 23.4 15.9 20.0 24.5 74.5 72.9 43.9 46.5 30.9 51.5 113.0 66.2 72.3 66.0 62.8 47.1 71.4 157.5 66.7 42.9 42.6 68.4 0.0 47.7 68.6 45.1 45.4 38.3 122.2 65.2 44.5 57.1 46.6 47.9 32.4 47.5 57.4 42.2 44.1 58.4 32.1 45.5 45.6 50.2 80.6 66.4 38.8 60.9 57.2 78.4 28.0 33.0 50.3 84.0 42.3 MRPS6 "C21orf101, MRP-S6, RPMS6" ENSG00000243927 "Mitochondrial ribosomal protein S6" P82932 21 34073224-34143034 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 633.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007861, HPA008163, HPA049676" Supported Supported Mitochondria NA NA Mitochondria "HPA007861: AB_2667920, HPA008163: AB_2667998, HPA049676: AB_2680846" "unprognostic (2.71e-2)" "unprognostic (4.85e-2)" "unprognostic (5.16e-3)" "unprognostic (4.01e-2)" "unprognostic (9.84e-3)" "unprognostic (3.72e-2)" "unprognostic (7.58e-3)" "unprognostic (1.80e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-3)" "unprognostic (5.87e-2)" "unprognostic (2.52e-1)" "unprognostic (1.02e-3)" "unprognostic (9.37e-2)" "unprognostic (5.13e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.06e-5)" 25.3 29.3 26.1 17.5 27.3 8.5 62.4 20.6 25.3 12.6 28.7 12.9 23.6 14.1 21.8 24.5 14.8 22.7 14.0 23.3 28.6 25.6 67.4 24.2 14.4 23.7 28.9 13.0 18.8 9.9 9.6 17.4 28.3 33.2 15.7 18.8 28.0 12.1 25.7 41.7 20.2 16.1 20.1 35.6 12.4 21.0 26.4 22.8 15.8 98.7 12.4 25.3 19.6 52.1 30.9 42.8 22.2 21.1 41.7 40.5 29.9 15.7 12.4 47.7 17.3 16.8 16.8 16.3 17.8 38.8 14.7 15.4 40.3 29.5 24.0 12.1 21.1 20.8 6.3 27.7 23.3 14.1 42.4 15.7 20.5 7.7 9.5 8.3 9.4 6.8 7.3 23.7 28.1 25.3 22.1 10.0 10.7 25.7 5.9 28.2 13.4 16.2 23.7 30.9 27.2 28.9 22.7 8.8 22.6 61.8 11.1 43.2 11.4 18.9 9.2 22.1 24.0 19.7 11.6 5.7 14.5 8.5 24.7 9.7 30.3 26.3 20.9 47.2 25.7 14.1 22.0 21.1 22.2 38.8 20.2 30.2 30.9 30.9 36.3 22.0 19.4 40.5 39.9 17.5 41.7 20.1 42.8 29.9 29.9 26.1 27.3 20.6 25.3 28.6 25.6 28.9 13.0 33.2 22.8 20.8 33.4 82.3 175.5 237.0 30.2 47.6 20.4 73.6 45.5 239.0 9.8 167.8 633.3 35.0 75.6 32.3 45.3 0.0 31.5 200.0 124.7 236.7 137.1 83.4 108.6 7.9 87.8 28.8 34.4 54.0 25.9 104.8 96.2 214.6 155.9 23.0 44.7 112.2 96.5 119.4 20.4 116.4 46.4 94.2 130.9 289.3 152.5 90.0 91.6 157.8 MRPS7 "MRP-S, RP-S7, RPMS7" ENSG00000125445 "Mitochondrial ribosomal protein S7" Q9Y2R9 17 75261674-75266373 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 335.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022522, HPA023007" Supported Approved Mitochondria No No Mitochondria "HPA022522: AB_1854131, HPA023007: AB_1854132" "unprognostic (1.24e-1)" "unprognostic (4.74e-2)" "prognostic favorable (1.12e-4)" "unprognostic (5.82e-3)" "unprognostic (3.62e-2)" "unprognostic (5.05e-3)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (4.95e-2)" "unprognostic (8.56e-3)" "unprognostic (1.03e-1)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (8.56e-2)" "unprognostic (1.76e-1)" "unprognostic (4.15e-1)" 17.4 22.1 16.8 15.7 17.9 11.6 15.3 15.6 23.5 11.0 19.6 11.2 15.5 19.8 11.2 14.0 20.9 15.0 16.7 56.7 15.0 14.7 22.9 30.6 12.3 15.0 17.8 13.1 12.2 18.1 15.7 14.0 19.6 14.9 13.6 17.1 13.9 16.9 16.9 79.5 11.1 19.6 13.5 12.1 15.1 16.2 29.4 9.4 17.4 16.2 33.9 15.8 13.4 12.2 30.6 38.0 9.9 33.6 26.4 30.8 43.9 23.7 41.1 16.0 12.7 13.0 7.5 31.0 15.9 11.7 28.6 20.8 44.8 20.3 21.3 14.1 15.5 18.4 23.0 25.0 26.3 16.3 11.4 43.4 28.6 27.9 41.8 12.2 26.4 15.0 11.2 26.0 22.0 21.8 14.2 34.6 25.4 28.0 19.2 17.3 44.6 30.4 23.8 18.8 30.2 41.0 21.2 49.8 29.4 25.0 24.6 29.4 27.4 20.8 51.3 29.5 17.6 40.0 23.0 15.8 26.9 28.1 14.0 32.1 21.8 12.7 22.1 19.4 18.6 20.4 7.1 33.6 9.9 26.1 33.2 28.0 30.6 25.9 28.3 36.8 27.5 30.8 28.1 2.6 26.4 27.8 38.0 29.0 43.9 16.8 17.9 15.6 23.5 15.0 14.7 17.8 13.1 14.9 9.4 47.6 42.4 81.1 60.2 35.0 65.6 62.9 61.1 75.0 37.5 54.1 92.3 161.9 195.6 96.6 117.8 44.3 99.5 70.0 90.2 134.4 47.3 56.2 38.1 79.5 131.5 44.5 45.6 37.4 62.3 335.2 44.8 54.2 40.5 135.3 66.7 64.2 79.3 63.1 37.4 178.2 99.5 58.2 54.7 64.1 74.1 36.6 115.3 60.9 107.4 67.2 MRPS9 "MRP-S9, RPMS9, S9mt" ENSG00000135972 "Mitochondrial ribosomal protein S9" P82933 2 105037983-105099960 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043476, HPA048479" Supported Supported Mitochondria No No Mitochondria "HPA043476: AB_2678498, HPA048479: AB_2680412" "unprognostic (8.10e-3)" "unprognostic (4.75e-3)" "unprognostic (3.69e-1)" "unprognostic (3.80e-3)" "unprognostic (5.25e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (3.78e-1)" "unprognostic (2.62e-3)" "unprognostic (4.62e-2)" "unprognostic (5.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" 13.9 25.0 14.1 16.9 18.5 13.3 15.4 13.2 20.6 13.7 18.9 15.9 14.3 19.0 17.6 13.2 16.7 16.2 8.9 39.1 14.4 15.3 24.5 23.5 10.0 14.5 18.1 15.7 21.0 17.3 22.0 23.9 8.4 25.2 15.8 22.0 10.9 15.3 16.4 56.8 14.0 17.0 16.6 15.0 14.0 17.4 20.6 16.6 20.7 15.6 28.7 16.8 15.2 12.4 22.1 20.4 7.1 17.2 20.0 22.8 14.5 22.3 9.7 20.4 18.8 10.8 11.2 23.9 14.4 13.8 22.8 20.6 51.5 15.7 23.4 14.3 11.3 23.9 20.3 40.0 20.9 24.3 14.4 26.3 23.1 14.3 31.1 18.0 17.0 10.3 13.3 14.3 18.8 15.8 13.3 17.5 28.8 32.9 12.2 15.5 17.9 22.9 22.4 32.3 19.1 21.3 29.3 17.5 32.4 28.6 15.7 17.7 10.7 16.6 24.5 19.4 21.0 20.1 17.3 11.4 13.5 27.3 13.4 15.4 11.3 13.3 18.7 11.7 26.2 11.3 7.1 11.6 4.6 19.9 14.6 22.0 22.1 22.0 20.9 20.4 16.5 22.3 21.9 1.3 20.0 17.2 15.2 22.8 14.5 14.1 18.5 13.2 20.6 14.4 15.3 18.1 15.7 25.2 16.6 20.8 23.3 15.2 20.5 17.3 23.1 95.6 17.8 37.5 18.2 21.0 11.8 34.7 91.2 34.3 24.9 25.9 18.2 46.7 36.9 32.2 14.4 14.6 22.0 28.2 25.1 7.9 18.9 15.4 11.5 6.6 22.2 16.4 28.7 28.9 24.6 17.9 21.3 14.0 25.5 53.7 28.2 38.8 20.6 54.8 38.2 11.5 17.0 24.5 35.4 15.6 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 81405.0;Enterocytes: 59874.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 872.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria NA NA Mitochondria "CAB016241: AB_2229888, HPA069328: AB_2686122" "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 114.5 173.2 235.7 256.3 540.3 247.5 249.9 261.4 87.1 66.0 110.6 208.4 373.6 302.7 125.7 198.6 65.0 435.2 26.9 231.6 94.6 143.0 165.0 181.7 872.7 389.9 74.8 104.9 230.2 288.6 241.1 65.3 145.0 306.7 79.4 172.7 115.3 217.3 195.5 277.4 85.7 469.5 59.9 156.0 141.8 112.3 70.4 181.6 334.7 303.0 112.7 150.2 90.6 351.3 163.0 296.6 201.5 352.9 316.5 264.7 180.2 259.8 131.1 103.0 98.6 68.6 130.7 276.7 128.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 2694.8 3022.9 23660.6 9171.4 8678.3 0.0 81405.0 28094.1 4463.5 5243.5 18590.0 0.0 0.0 3606.0 6482.3 1224.4 4243.1 59874.1 34807.7 4485.9 0.0 3116.3 8181.6 3594.1 45857.2 0.0 0.0 7240.0 18002.1 27410.8 6497.0 10830.0 8032.7 6539.1 13021.9 32338.6 0.0 5722.6 29051.7 7980.9 24852.9 0.0 13394.3 6634.5 9840.4 12887.5 10030.7 0.0 18830.6 25753.2 17251.8 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 61379.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 490.3;HeLa: 493.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400, HPA074796" Approved Supported Mitochondria NA NA Mitochondria "CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favorable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 73.4 99.2 123.0 131.3 490.3 78.9 99.1 84.7 35.1 22.2 38.5 97.6 162.5 188.2 41.5 100.3 26.6 231.5 18.2 104.1 54.5 91.9 81.5 105.1 493.3 174.0 92.4 59.0 128.5 170.3 155.3 42.0 90.5 150.2 56.2 76.8 53.7 118.5 113.1 202.8 54.8 121.7 27.3 71.8 67.4 64.8 48.4 117.8 176.2 171.6 43.9 77.6 59.0 111.5 83.4 192.8 162.6 203.7 176.1 77.9 101.9 141.8 65.0 32.5 43.6 80.6 46.8 92.0 48.9 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 1101.8 1182.9 10535.1 6605.8 2949.0 0.0 61379.6 10280.2 2941.7 2205.5 7087.1 0.0 0.0 1833.6 2297.4 679.0 1928.7 15168.1 14904.3 3076.0 0.0 1463.9 4337.7 1777.7 14746.0 0.0 0.0 2756.0 7288.5 8580.4 3048.7 7355.0 2431.1 2478.3 3811.6 11241.0 0.0 2672.3 10113.2 5078.0 11513.5 0.0 5704.4 3210.7 4468.4 3767.8 2992.1 0.0 6827.7 9828.0 8723.5 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 392.9" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 130137.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 821.0" "Low region specificity" "Detected in all" HPA053928 Approved Supported Mitochondria NA NA Mitochondria "HPA053928: AB_2682313" "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 82.5 72.4 124.2 19.8 138.2 14.9 34.5 43.8 78.5 34.1 68.7 56.5 27.8 37.1 32.9 25.2 23.7 292.7 122.4 90.3 129.8 178.5 20.8 17.4 101.6 25.5 58.3 37.8 19.7 39.1 37.3 82.1 61.7 65.6 288.4 61.1 41.0 37.8 63.6 21.7 67.7 29.6 24.3 23.4 26.0 15.3 164.7 87.6 392.9 119.5 87.1 129.7 53.0 102.6 106.9 138.9 205.1 326.5 82.3 97.3 104.6 40.0 24.3 47.5 162.1 117.7 182.9 92.3 89.1 35.8 192.5 12.4 169.4 43.6 105.5 67.2 112.6 821.0 271.8 49.3 113.1 134.0 139.2 179.5 35.8 128.4 229.8 58.7 92.3 93.8 226.5 87.5 231.7 44.5 257.0 39.3 89.7 72.7 60.6 43.6 110.2 177.8 222.1 51.2 69.3 60.8 202.4 104.6 257.3 141.7 267.4 162.8 99.5 96.8 133.1 81.0 135.9 55.1 81.4 64.9 196.6 52.9 392.9 119.5 268.8 82.9 91.3 115.5 148.0 93.0 98.9 65.9 164.7 109.6 129.7 105.7 87.1 89.0 87.6 67.6 53.0 1179.2 1324.7 15760.8 7514.4 3912.5 0.0 130137.0 15452.1 2295.3 2103.1 12148.5 0.0 0.0 2064.1 2636.7 917.0 2449.9 17720.8 23127.3 3538.6 0.0 2017.3 5309.0 2067.8 31565.1 0.0 0.0 4902.7 11944.3 15339.0 4282.8 8180.5 3605.2 3603.6 4879.3 17860.7 0.0 3353.9 12846.0 5441.2 13683.6 0.0 6208.8 3859.5 7259.5 5529.7 4316.1 0.0 9799.9 18174.2 10097.1 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642623 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 432.9;Proximal tubular cells: 398.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Approved Mitochondria NA NA 55000 Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 13.6 19.6 15.6 12.8 20.3 8.3 12.5 14.1 21.3 10.4 22.3 19.3 8.7 28.3 12.6 15.1 21.6 9.9 11.6 15.0 14.0 13.8 40.8 74.8 9.1 13.9 15.2 12.2 9.3 14.4 16.8 9.3 9.5 15.4 11.8 24.7 13.6 13.4 10.0 31.4 12.1 33.9 16.1 11.4 11.4 10.1 44.2 10.2 15.1 15.5 24.9 16.4 11.6 10.7 13.7 25.7 7.9 21.3 12.1 13.6 17.5 18.9 20.8 17.8 24.0 21.1 19.6 13.2 20.6 18.9 27.8 26.4 16.5 19.4 26.2 11.2 25.2 30.1 23.9 31.9 27.1 33.9 13.1 29.8 15.0 29.7 32.9 29.1 31.2 15.1 22.1 21.4 18.5 27.7 16.2 25.1 22.6 27.7 15.8 33.9 27.6 23.9 23.5 19.3 37.2 31.6 22.4 27.1 18.8 32.2 24.6 21.2 14.9 28.2 28.5 14.5 17.6 41.0 14.7 20.8 25.7 22.4 42.5 26.4 16.8 19.1 29.6 21.2 27.2 22.9 5.9 19.8 7.9 12.7 21.3 12.0 13.7 11.1 11.7 25.7 10.9 9.7 11.2 1.9 12.1 17.0 16.9 13.6 17.5 15.6 20.3 14.1 21.3 14.0 13.8 15.2 12.2 15.4 10.2 20.8 33.9 37.2 43.0 41.8 0.0 61.0 81.5 46.8 37.5 50.6 0.0 75.5 154.2 136.5 432.9 25.1 133.4 0.0 95.3 101.6 32.1 64.6 35.9 265.9 146.4 0.0 76.7 35.0 64.2 110.8 26.7 50.7 77.6 112.8 82.5 0.0 85.1 63.1 54.8 398.6 0.0 32.3 38.1 327.5 81.0 47.3 106.9 37.6 134.8 50.4 MTERF1 MTERF ENSG00000127989 "Mitochondrial transcription termination factor 1" Q99551 7 91692008-91880720 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044894, HPA069560" Uncertain Supported Mitochondria NA NA Mitochondria "HPA044894: AB_10966284, HPA069560: AB_2686154" "unprognostic (5.57e-2)" "unprognostic (7.31e-2)" "unprognostic (2.15e-2)" "unprognostic (1.50e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (3.15e-3)" "unprognostic (1.25e-2)" "unprognostic (1.46e-3)" "unprognostic (7.62e-2)" "unprognostic (2.67e-1)" "unprognostic (5.19e-2)" "unprognostic (3.21e-2)" "unprognostic (1.14e-1)" "unprognostic (3.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" 8.9 11.5 16.1 10.9 18.1 13.9 14.4 23.2 18.9 10.4 11.8 12.1 10.0 11.5 11.6 11.0 13.4 9.8 8.3 8.7 15.2 10.5 13.2 17.6 8.3 19.4 20.3 13.1 14.7 11.4 10.0 18.0 10.6 18.8 11.6 12.1 8.5 12.5 9.2 9.3 9.9 13.6 9.7 22.7 17.6 12.5 10.0 18.5 11.9 12.2 10.3 19.0 12.0 11.4 15.0 9.4 24.8 8.8 9.8 19.0 10.0 10.4 9.1 8.8 5.9 8.5 9.0 7.7 8.9 9.0 9.6 11.9 11.0 10.0 21.5 7.4 7.0 14.1 9.2 13.1 7.9 13.7 1.2 9.5 9.7 9.8 8.5 7.6 17.1 10.8 10.7 10.5 10.5 11.2 7.6 8.3 5.4 17.7 8.9 11.1 13.3 17.9 19.6 13.2 12.9 10.2 5.1 11.7 14.7 9.9 11.4 8.1 15.6 9.0 19.0 17.9 16.8 6.6 12.3 5.3 11.4 14.0 15.4 9.0 12.8 12.9 29.1 8.2 5.6 15.9 24.8 8.8 11.9 10.6 7.5 12.7 14.6 13.8 15.2 9.4 15.0 19.0 15.1 4.2 9.8 8.2 7.4 13.2 10.0 16.1 18.1 23.2 18.9 15.2 10.5 20.3 13.1 18.8 18.5 8.9 11.7 3.4 3.4 0.0 0.0 4.5 5.1 2.7 4.5 3.5 0.0 8.2 5.0 5.1 0.9 2.9 3.8 0.0 4.5 6.1 1.9 2.9 4.7 8.9 4.5 0.0 1.2 6.7 7.6 1.1 6.4 5.3 0.0 7.2 3.2 0.0 3.2 3.5 6.7 6.2 0.0 12.9 1.4 11.2 9.8 0.0 3.8 8.6 4.6 1.8 MTFP1 "HSPC242, MTP18" ENSG00000242114 "Mitochondrial fission process 1" Q9UDX5 22 30425530-30429053 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 56.3;Exocrine glandular cells: 45.3;monocytes: 60.5;Pancreatic endocrine cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077396 Approved Mitochondria NA NA Mitochondria "HPA077396: AB_2686837" "unprognostic (2.19e-2)" "unprognostic (1.18e-1)" "unprognostic (3.12e-1)" "unprognostic (6.20e-2)" "unprognostic (4.86e-2)" "unprognostic (1.72e-3)" "unprognostic (1.52e-3)" "unprognostic (8.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.65e-1)" "unprognostic (6.37e-3)" "unprognostic (1.54e-1)" "unprognostic (1.49e-1)" "unprognostic (6.40e-2)" "unprognostic (3.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.66e-2)" 8.9 9.6 6.4 13.0 6.6 9.8 13.5 3.7 6.5 7.6 13.3 2.8 14.5 11.7 2.9 16.2 12.3 2.8 10.2 18.3 5.0 6.0 27.4 20.8 8.3 17.3 7.2 2.2 9.3 12.9 10.3 5.7 9.2 9.8 8.5 12.9 9.8 9.0 4.4 14.6 4.6 10.2 4.1 3.8 17.4 11.3 3.2 5.9 5.3 11.2 8.9 13.0 7.7 5.6 13.0 7.6 0.7 6.4 4.8 25.7 9.9 26.2 19.5 6.8 11.0 1.4 0.7 8.2 2.5 1.7 15.0 23.4 9.2 16.0 27.9 7.1 1.4 11.9 12.2 23.8 18.3 13.1 15.1 27.1 8.1 11.6 19.3 4.1 20.4 15.7 2.1 7.2 8.1 13.9 3.8 10.3 13.1 12.8 11.0 5.0 31.5 18.4 23.0 12.3 24.7 20.0 23.7 6.8 26.7 19.0 6.9 12.3 12.8 5.3 28.4 10.3 6.8 8.7 10.1 5.2 16.0 21.5 8.2 6.6 5.7 3.9 25.0 6.3 23.0 6.7 0.0 5.5 0.0 19.3 6.4 25.7 13.0 16.2 16.5 7.6 9.3 16.8 19.6 0.7 4.8 3.8 3.7 13.3 9.9 6.4 6.6 3.7 6.5 5.0 6.0 7.2 2.2 9.8 5.9 6.0 4.0 28.4 1.4 4.9 0.0 4.0 7.6 0.0 3.4 3.5 0.0 10.1 13.3 56.3 0.0 3.1 25.2 0.0 45.3 27.0 4.3 3.0 9.2 12.5 15.5 0.0 8.1 4.3 8.7 0.0 0.6 3.7 3.3 60.5 17.7 0.0 42.1 11.5 0.4 9.2 0.0 0.0 1.9 0.4 1.4 4.8 14.1 14.6 36.7 1.6 MTG1 GTPBP7 ENSG00000148824 "Mitochondrial ribosome associated GTPase 1" Q9BT17 10 133394094-133421307 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA037826, HPA037827" Approved Supported Mitochondria NA NA Mitochondria "HPA037826: AB_2675692, HPA037827: AB_10670959" "unprognostic (2.94e-2)" "unprognostic (8.08e-2)" "unprognostic (5.90e-3)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-2)" "unprognostic (5.85e-2)" "unprognostic (6.20e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.08e-4)" "unprognostic (4.63e-3)" "prognostic unfavorable (6.79e-7)" "unprognostic (3.88e-2)" "unprognostic (5.96e-2)" "unprognostic (5.19e-2)" "prognostic favorable (1.03e-5)" 14.5 29.4 16.5 20.2 19.0 14.8 17.9 23.9 19.2 16.1 19.7 23.0 16.7 26.6 19.9 13.5 21.7 20.5 17.9 14.1 14.4 13.1 26.6 47.0 14.4 19.3 17.3 14.5 20.0 27.9 18.1 22.3 16.6 16.4 19.8 16.4 16.9 23.8 24.4 26.4 18.2 22.5 17.7 14.1 27.3 21.3 29.1 20.8 21.3 19.5 12.3 21.2 15.1 15.8 22.9 20.2 10.4 18.2 21.0 14.2 9.9 16.7 20.5 12.9 27.9 7.8 6.1 18.5 9.9 10.6 18.6 15.7 25.9 12.1 12.5 15.1 10.1 7.7 14.5 14.1 19.7 8.8 11.6 18.7 12.0 10.6 23.3 19.9 8.8 13.2 15.7 11.1 17.6 28.2 13.0 26.7 12.8 10.5 2.2 14.2 21.4 8.6 12.3 17.4 21.4 7.1 12.1 12.4 2.9 16.3 13.7 4.9 16.0 14.1 14.6 21.7 7.7 13.3 13.2 15.1 6.5 12.4 6.7 11.2 4.0 2.8 17.7 11.8 8.0 9.2 0.2 10.6 10.4 13.9 16.1 14.2 18.7 12.4 11.6 9.7 22.9 9.7 10.2 1.5 21.0 18.2 20.2 12.5 9.9 16.5 19.0 23.9 19.2 14.4 13.1 17.3 14.5 16.4 20.8 8.9 2.2 13.7 5.3 3.8 0.0 1.4 2.5 6.7 4.5 3.5 0.0 7.7 5.0 11.3 2.0 6.2 9.7 0.0 8.5 6.5 4.3 5.7 5.8 4.3 4.7 0.0 12.1 7.4 4.6 3.8 8.3 4.1 5.0 10.0 6.7 0.0 9.0 8.6 4.6 5.4 0.0 12.9 5.2 8.6 7.9 3.0 5.6 10.0 9.2 6.5 MTHFD1L "DKFZP586G1517, FLJ21145, FTHFSDC1" ENSG00000120254 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like" Q6UB35 6 150865549-151101887 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "One-carbon metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 107.1;Syncytiotrophoblasts: 61.6;Urothelial cells: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015006, HPA029040, HPA029041, HPA050052, HPA074911" Approved Enhanced Mitochondria NA NA Mitochondria "HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723" "unprognostic (3.66e-2)" "prognostic unfavorable (1.68e-5)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (3.25e-1)" "prognostic unfavorable (5.10e-4)" "prognostic unfavorable (8.33e-5)" "unprognostic (6.35e-3)" "unprognostic (2.45e-1)" "unprognostic (1.44e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "unprognostic (2.93e-2)" "unprognostic (3.51e-1)" "unprognostic (2.91e-1)" "prognostic unfavorable (8.69e-5)" 10.4 10.6 8.0 12.1 8.1 12.2 7.1 32.4 10.5 6.5 6.2 7.8 10.2 3.4 8.5 7.2 6.4 8.0 7.3 10.7 7.5 7.9 9.5 6.9 17.1 11.0 12.3 7.6 22.2 13.7 7.1 9.1 15.5 8.5 5.0 9.1 12.7 3.4 10.5 2.5 5.7 4.7 10.9 10.2 8.7 5.6 13.6 6.6 6.7 12.2 5.0 11.4 8.7 5.1 1.1 3.0 0.2 0.8 1.0 5.0 0.6 12.0 10.5 13.7 33.7 3.6 12.6 33.5 19.0 20.8 19.1 23.6 21.1 11.3 44.5 12.7 29.0 11.3 12.9 21.9 18.5 23.8 18.3 19.9 18.5 18.7 19.3 22.6 33.8 3.0 14.9 23.7 18.5 33.8 17.2 31.9 24.9 43.9 23.3 19.6 25.4 16.5 7.0 14.0 12.1 9.7 19.8 10.2 19.8 12.9 5.9 13.7 10.2 25.1 11.1 15.5 13.0 3.5 23.7 24.2 12.8 28.1 28.4 26.9 19.4 18.0 46.4 21.3 31.6 16.5 0.2 0.7 0.0 0.8 0.8 1.3 0.8 1.9 2.1 3.0 1.1 1.8 1.9 0.0 1.0 0.8 1.5 5.0 0.6 8.0 8.1 32.4 9.5 7.5 7.9 12.3 7.6 8.5 6.6 0.0 1.7 10.7 5.1 5.8 0.0 2.4 2.5 4.0 2.3 14.0 0.0 18.7 6.6 10.4 19.2 7.1 0.9 0.0 15.4 107.1 15.4 4.1 0.0 1.0 21.7 0.0 1.2 3.7 2.4 3.4 0.6 10.1 33.7 1.0 2.5 0.0 15.0 0.8 7.4 12.2 0.0 0.0 6.1 0.5 6.4 3.0 61.6 3.2 3.5 39.1 MTHFD2 ENSG00000065911 "Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase" P13995 2 74198562-74217565 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "monocytes: 263.3;Smooth muscle cells: 264.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003684, HPA049657" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB003684: AB_425867, HPA049657: AB_2680842" "unprognostic (1.82e-3)" "unprognostic (4.60e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.07e-5)" "prognostic favorable (1.01e-4)" "unprognostic (3.10e-3)" "unprognostic (2.24e-3)" "unprognostic (4.75e-3)" "unprognostic (2.64e-2)" "unprognostic (3.96e-2)" "unprognostic (3.76e-3)" "unprognostic (3.57e-3)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.66e-2)" "unprognostic (6.52e-2)" "unprognostic (9.07e-2)" "unprognostic (2.34e-3)" 26.2 5.7 5.8 21.6 14.1 12.1 21.9 3.0 8.0 15.1 12.4 5.9 12.6 10.1 15.8 8.7 14.1 17.5 10.5 12.1 10.0 8.2 12.0 3.4 15.9 21.0 19.0 1.5 20.6 39.7 1.5 15.6 8.2 16.1 12.7 15.3 3.0 32.9 12.0 39.4 8.6 9.2 21.0 25.6 26.3 15.3 11.9 11.8 8.4 11.4 16.7 23.5 20.3 41.8 4.8 11.4 13.6 19.7 10.7 12.7 6.3 18.6 6.9 7.8 26.6 8.6 9.7 20.6 23.5 15.9 13.8 19.6 15.9 7.9 39.4 6.3 12.7 15.4 6.6 25.9 13.8 26.1 21.2 10.8 38.0 3.9 15.4 35.2 27.6 25.4 20.0 44.1 17.2 74.8 7.1 9.2 63.6 17.5 57.4 13.5 11.7 17.3 34.2 17.0 27.2 11.5 19.3 21.9 34.7 7.9 5.5 20.4 14.9 8.1 24.4 55.1 5.9 20.9 38.4 4.0 4.3 34.7 9.8 26.3 47.5 21.0 32.0 11.9 33.9 12.2 13.6 8.1 9.6 3.3 19.7 4.8 4.8 6.0 3.6 11.4 3.0 4.3 3.3 1.1 10.7 19.1 5.0 12.7 6.3 5.8 14.1 3.0 8.0 10.0 8.2 19.0 1.5 16.1 11.8 14.9 26.5 62.1 28.1 79.3 0.0 8.2 7.6 2.7 13.6 1.8 0.0 20.5 3.3 54.8 3.2 18.0 6.9 93.5 92.6 49.1 52.6 48.5 53.0 0.6 64.6 0.0 18.3 13.5 55.9 2.9 21.0 92.7 67.4 263.3 33.2 0.0 75.9 5.8 19.8 1.4 0.0 135.8 264.7 30.1 55.8 65.2 11.7 30.5 21.6 55.0 MTIF2 IF-2mt ENSG00000085760 "Mitochondrial translational initiation factor 2" P46199 2 55236595-55269347 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006021, HPA061422" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA006021: AB_2147687, HPA061422: AB_2684514" "unprognostic (2.91e-2)" "unprognostic (9.58e-2)" "unprognostic (1.52e-2)" "unprognostic (1.87e-3)" "unprognostic (8.86e-2)" "unprognostic (5.57e-2)" "unprognostic (9.76e-3)" "unprognostic (1.88e-1)" "unprognostic (6.85e-3)" "unprognostic (3.01e-2)" "unprognostic (6.58e-3)" "unprognostic (1.76e-1)" "unprognostic (3.98e-2)" "unprognostic (2.54e-2)" "unprognostic (1.66e-1)" "unprognostic (9.45e-3)" "unprognostic (1.33e-1)" 13.8 17.8 13.6 12.0 15.8 9.6 15.5 9.4 17.7 12.0 21.1 11.2 17.7 21.0 10.0 15.9 17.5 10.6 11.2 24.5 13.5 12.1 27.4 32.2 10.6 17.5 15.5 11.8 10.4 24.6 20.2 20.2 12.5 22.6 12.2 25.1 9.7 16.3 14.3 31.5 12.3 26.9 15.0 16.9 16.3 16.3 9.0 14.6 16.1 20.6 27.1 15.2 14.5 11.6 9.6 13.9 9.4 12.8 17.2 12.7 6.9 15.5 15.1 8.9 15.3 11.1 15.2 20.5 14.3 11.5 13.8 12.1 17.9 15.1 25.6 27.2 13.1 15.5 13.9 21.2 20.6 22.9 28.4 16.3 23.6 11.8 33.0 21.2 37.1 14.0 16.7 21.4 19.1 40.0 12.3 11.0 14.4 41.7 14.7 14.3 12.9 11.4 25.0 19.0 19.5 18.6 12.1 28.7 24.7 13.4 13.8 16.1 10.2 12.7 21.1 25.8 11.4 11.2 12.4 10.9 14.5 16.6 17.2 23.4 27.6 24.6 7.0 15.3 27.8 11.4 5.4 11.0 9.4 10.1 12.8 12.6 8.3 10.3 9.4 13.9 9.6 12.5 12.7 4.2 17.2 10.7 6.8 11.7 6.9 13.6 15.8 9.4 17.7 13.5 12.1 15.5 11.8 22.6 14.6 20.8 20.5 13.7 15.4 6.8 0.0 72.4 30.6 30.8 15.9 7.0 0.0 25.4 24.9 27.1 13.6 7.9 20.9 0.0 29.3 25.7 10.8 11.5 20.8 25.5 21.3 0.0 18.5 9.2 18.0 14.8 8.3 15.7 8.5 36.1 15.7 0.0 26.3 17.5 9.9 20.7 0.0 6.5 11.7 27.4 16.2 6.5 13.6 8.3 32.1 12.4 MTPAP "FLJ10486, mtPAP, PAPD1, SPAX4" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "Early spermatids: 194.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria NA NA Mitochondria "HPA038620: AB_10673015, HPA058232: AB_2683646" "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 10.9 12.7 9.9 10.2 12.4 32.8 11.1 12.4 16.1 9.6 9.9 7.3 6.5 11.0 10.4 7.0 12.6 9.5 7.6 11.5 7.8 7.2 10.6 11.1 9.4 10.5 11.9 13.0 11.4 18.9 9.5 7.2 10.0 11.4 8.0 12.0 8.2 10.7 10.2 22.3 13.1 10.0 14.3 9.0 9.3 9.7 10.6 8.3 6.7 11.0 12.4 10.5 11.7 9.1 15.6 22.9 18.4 24.4 16.9 17.1 8.3 14.2 14.3 9.1 13.1 9.0 8.5 11.8 10.0 3.5 10.2 10.7 15.1 20.1 20.4 7.1 6.5 9.4 16.9 17.5 11.6 12.5 10.3 13.7 20.7 13.5 15.2 9.4 13.5 16.3 8.3 10.8 11.4 6.8 5.7 11.0 19.2 22.3 16.1 7.6 11.9 16.2 12.0 6.1 10.8 7.7 16.4 16.1 19.0 9.4 9.5 15.0 12.1 9.0 9.4 13.9 8.9 9.1 8.7 10.6 10.8 13.9 15.0 11.0 3.6 8.7 27.9 9.2 24.8 3.8 16.4 18.5 18.4 16.2 24.4 17.1 15.6 15.4 15.6 22.9 13.1 16.7 16.8 3.0 16.9 18.1 12.0 15.5 8.3 9.9 12.4 12.4 16.1 7.8 7.2 11.9 13.0 11.4 8.3 8.9 6.1 9.7 10.8 22.3 0.0 15.3 5.1 10.7 11.4 3.5 0.0 12.2 16.6 7.7 194.2 12.0 7.8 0.0 7.9 9.8 11.5 8.6 4.7 12.1 12.7 0.0 4.1 10.4 12.3 17.1 11.2 11.5 8.5 10.8 13.7 0.0 8.4 0.0 15.6 11.0 0.0 12.9 11.4 21.9 17.2 21.8 9.6 9.6 16.6 14.0 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208699-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 517.8;Late spermatids: 1060.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Approved Mitochondria NA NA Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 15.4 19.8 11.6 9.9 12.6 22.9 15.8 5.7 18.1 15.8 15.9 12.2 14.8 12.4 14.9 13.9 18.0 21.4 13.5 11.8 10.8 10.0 24.4 36.4 12.8 18.7 11.8 12.9 14.0 26.3 23.4 12.0 28.4 11.7 12.3 12.7 14.6 20.7 19.2 10.4 13.8 13.7 12.7 10.2 17.1 14.7 60.0 9.0 14.5 19.3 14.3 18.0 11.6 11.5 14.4 23.1 43.8 26.8 12.2 14.0 14.4 17.4 28.7 9.2 13.1 17.2 15.5 29.1 9.0 18.3 26.9 18.8 35.7 29.2 14.4 29.9 20.7 8.5 17.5 13.5 25.5 9.8 10.5 31.7 9.1 23.0 34.4 27.2 16.8 12.9 19.8 23.9 27.7 18.7 10.3 23.7 21.3 18.4 7.2 15.9 42.3 18.8 21.2 18.3 24.8 33.4 15.5 5.8 34.1 24.2 15.1 15.0 18.7 11.2 35.6 10.3 14.7 28.8 27.3 9.8 12.9 14.5 8.5 15.1 13.9 11.5 14.6 17.0 8.6 13.7 10.2 26.8 6.3 9.8 13.7 9.2 14.4 12.1 10.3 23.1 12.4 12.1 10.9 43.8 12.2 7.9 12.4 14.0 14.4 11.6 12.6 5.7 18.1 10.8 10.0 11.8 12.9 11.7 9.0 8.9 17.1 31.2 37.1 18.0 0.0 1.1 30.6 36.1 9.1 33.2 0.0 91.6 82.9 61.0 517.8 26.4 34.8 0.0 73.6 112.1 34.7 39.6 26.5 48.6 89.5 0.0 19.0 20.9 42.2 1060.3 40.0 30.1 47.2 74.9 33.2 0.0 60.6 41.8 37.1 103.2 0.0 45.3 25.4 80.9 35.8 18.3 74.1 22.4 48.1 34.2 MTX3 ENSG00000177034 "Metaxin 3" Q5HYI7 5 79976731-79991265 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047858, HPA062061" Approved Approved Mitochondria NA NA Mitochondria "HPA047858: AB_2680185, HPA062061: AB_2684672" "unprognostic (2.56e-2)" "unprognostic (2.32e-1)" "unprognostic (2.47e-2)" "unprognostic (4.21e-2)" "unprognostic (4.59e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (5.08e-5)" "unprognostic (4.02e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (8.58e-2)" "unprognostic (8.46e-2)" "unprognostic (5.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.11e-2)" "unprognostic (3.09e-2)" "unprognostic (2.28e-1)" 9.4 13.9 11.8 8.9 18.7 8.6 12.0 10.9 20.7 9.9 9.4 8.5 5.9 6.2 13.4 10.1 10.6 11.2 6.4 8.5 14.5 5.8 10.7 6.5 7.6 11.8 7.4 10.8 17.7 9.9 21.0 11.1 6.8 15.9 12.0 7.6 8.3 12.0 11.1 11.6 10.0 12.2 13.0 12.0 8.5 9.3 6.2 8.2 2.8 12.3 7.0 11.6 12.2 10.1 3.7 0.9 1.2 1.1 1.4 3.6 1.0 6.8 4.6 10.2 5.8 4.9 10.1 2.6 6.1 5.0 5.7 6.7 1.7 7.6 10.8 2.0 6.2 9.1 7.9 0.0 14.8 10.2 2.8 7.1 4.3 11.3 4.7 9.4 0.0 5.5 7.7 13.9 9.9 16.8 7.5 4.0 0.0 2.5 6.8 9.2 6.9 0.0 0.1 10.5 2.0 4.2 0.0 15.7 4.6 4.5 8.0 14.2 10.4 8.8 5.7 12.0 8.8 9.7 6.9 4.0 10.1 8.4 8.0 14.0 9.0 9.0 9.8 14.6 0.0 11.6 0.7 0.8 1.2 2.6 1.1 1.9 3.7 2.9 3.5 0.4 2.6 3.6 2.8 1.0 1.4 0.5 0.9 1.4 1.0 11.8 18.7 10.9 20.7 14.5 5.8 7.4 10.8 15.9 8.2 26.8 4.0 1.9 4.1 1.3 0.0 8.7 12.7 16.0 11.4 12.2 0.0 4.1 5.0 3.7 2.1 4.2 2.8 0.0 2.2 2.2 4.6 7.9 1.1 6.8 2.8 0.0 0.0 9.2 4.3 3.1 11.8 3.3 0.0 1.8 6.8 0.0 4.3 5.3 11.7 6.7 0.0 12.9 2.8 7.1 6.3 3.0 1.5 6.9 6.4 4.2 MXRA5 DKFZp564I1922 ENSG00000101825 "Matrix remodeling associated 5" Q9NR99 X 3308565-3346641 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 49.4;pancreas: 46.6" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 34.2;Collecting duct cells: 29.6;Exocrine glandular cells: 53.2;Pancreatic endocrine cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.8;BJ hTERT+: 49.0;fHDF/TERT166: 23.0;HaCaT: 20.3;HSkMC: 9.9" "HPA000508, HPA076518" Uncertain Uncertain Mitochondria "Secreted - unknown location" NA NA 1700000 Mitochondria "HPA000508: AB_2147995, HPA076518: " "unprognostic (7.51e-2)" "unprognostic (6.45e-2)" "unprognostic (8.00e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (7.05e-2)" "unprognostic (7.25e-2)" "unprognostic (1.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-2)" "unprognostic (6.32e-3)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.94e-4)" 6.5 12.1 0.5 10.4 1.2 0.0 7.5 0.4 0.8 49.4 4.4 0.6 18.8 2.1 11.4 6.0 8.7 4.2 5.8 9.2 0.6 0.5 8.0 4.5 5.9 0.9 0.6 0.7 7.9 46.6 0.5 1.4 7.9 0.8 11.0 5.9 10.2 11.5 29.5 1.1 16.6 7.8 8.8 0.5 7.7 5.1 4.0 0.3 5.7 15.0 11.7 6.2 12.7 9.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 12.8 0.0 7.6 49.0 0.0 0.0 0.0 0.2 0.0 0.6 23.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.4 0.8 0.6 0.5 0.6 0.7 0.8 0.3 0.0 0.0 0.0 3.9 34.2 0.0 1.6 0.0 1.4 5.7 29.6 0.0 0.0 0.0 1.7 0.0 2.2 0.0 0.0 53.2 0.2 19.5 0.1 0.0 0.0 0.3 0.0 0.0 17.2 0.8 0.0 0.0 0.0 16.9 1.0 0.0 0.0 47.4 0.0 1.4 0.0 0.1 0.0 9.2 0.0 0.0 19.1 0.2 0.0 0.0 1.4 MYOM2 ENSG00000036448 "Myomesin 2" P54296 8 2045040-2165552 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "heart muscle: 170.7;skeletal muscle: 75.9" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 554.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "HEK 293: 10.1;SCLC-21H: 4.3;U-266/84: 5.3" "Not detected" "Not detected" "HPA001765, HPA005953" Enhanced Approved Mitochondria NA NA 120000 Mitochondria "HPA001765: AB_1079443, HPA005953: AB_1854258" "unprognostic (2.81e-2)" "unprognostic (1.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.86e-2)" "unprognostic (2.30e-5)" "unprognostic (1.10e-1)" "unprognostic (5.17e-2)" "unprognostic (1.34e-2)" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (3.89e-2)" "unprognostic (2.71e-2)" "unprognostic (9.01e-2)" "unprognostic (3.22e-1)" "unprognostic (1.14e-1)" 2.0 0.0 0.3 0.1 0.4 0.0 1.7 0.9 0.9 0.2 0.2 0.0 0.2 0.0 0.5 2.7 1.2 0.1 0.1 170.7 0.3 0.1 0.7 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.2 1.2 1.0 75.9 0.2 0.1 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.6 8.9 1.2 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 10.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.2 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.4 0.9 0.9 0.3 0.1 0.2 0.0 0.1 0.0 6.0 4.0 0.0 2.3 3.2 2.8 554.8 17.8 6.7 0.0 3.5 0.0 0.0 11.6 3.4 5.4 2.3 1.0 0.0 1.5 0.0 1.4 1.0 5.7 6.4 1.4 6.4 0.0 5.5 2.8 6.2 0.6 2.3 3.3 3.6 2.5 7.0 2.5 0.0 1.4 21.4 4.1 0.0 17.0 36.9 22.7 2.5 0.1 8.7 1.1 1.4 MYORG "KIAA1161, NET37" ENSG00000164976 "Myogenesis regulating glycosidase (putative)" Q6NSJ0 9 34366670-34376853 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 56.1" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 41.5;Exocrine glandular cells: 10.3;Syncytiotrophoblasts: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 17.6;SK-BR-3: 29.4;T-47d: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060533, HPA067487" Enhanced Approved Mitochondria NA NA Mitochondria "HPA060533: AB_2684311, HPA067487: AB_2685848" "unprognostic (6.56e-2)" "unprognostic (1.51e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (2.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (4.68e-3)" "unprognostic (1.91e-3)" "unprognostic (3.20e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.08e-3)" "unprognostic (3.68e-1)" "unprognostic (3.09e-1)" "unprognostic (1.00e-3)" 6.3 5.6 16.7 4.7 20.5 2.1 3.5 6.9 16.0 2.0 19.9 9.8 1.3 20.9 2.2 2.8 4.8 3.6 11.6 2.9 11.1 8.7 11.7 31.8 3.1 1.7 11.2 12.6 1.6 16.6 2.0 4.0 15.4 10.7 3.2 13.1 0.5 4.7 4.9 56.1 3.6 26.7 4.8 7.0 1.7 9.9 1.7 6.9 0.0 2.2 6.4 2.1 3.5 1.9 1.1 0.8 1.9 0.8 1.9 3.3 0.6 4.1 2.9 4.9 2.9 2.0 0.7 10.4 0.8 0.6 0.4 0.7 7.1 4.3 2.3 8.4 0.7 2.1 8.4 3.4 7.8 0.6 0.7 1.9 0.4 13.0 17.6 0.3 0.4 1.4 1.0 3.8 1.3 1.6 2.3 1.9 1.7 0.5 2.4 1.1 6.8 1.3 0.7 2.9 13.7 2.3 2.1 2.5 0.7 2.6 1.5 0.7 6.8 5.8 29.4 0.5 4.3 27.3 0.7 1.7 1.1 6.0 0.9 1.8 1.5 3.2 0.9 0.9 1.6 0.9 1.9 0.6 1.2 3.3 0.6 2.6 0.8 2.0 1.9 0.3 1.1 1.3 1.6 1.6 1.9 0.8 0.8 2.6 0.6 16.7 20.5 6.9 16.0 11.1 8.7 11.2 12.6 10.7 6.9 8.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 3.5 0.0 41.5 1.7 5.6 0.0 0.0 0.0 0.0 10.3 1.9 0.0 0.0 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 9.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 NADK2 "C5orf33, FLJ30596, MNADK, NADKD1" ENSG00000152620 "NAD kinase 2, mitochondrial" Q4G0N4 5 36192592-36242279 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 128.6" "Group enriched" "Detected in many" 7 "Early spermatids: 231.1;Hepatocytes: 160.3;Late spermatids: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038366, HPA038367, HPA061492" Enhanced Supported Mitochondria NA NA 28000 Mitochondria "HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538" "unprognostic (1.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.01e-2)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (1.97e-2)" "unprognostic (4.06e-3)" "unprognostic (8.84e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-3)" "unprognostic (1.09e-1)" "unprognostic (1.76e-1)" "unprognostic (9.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" 5.7 10.2 13.7 4.1 12.5 4.4 6.8 6.7 13.4 6.6 6.0 13.3 5.9 7.0 5.9 4.1 4.9 6.0 5.5 8.3 14.3 8.5 10.0 128.6 4.0 4.2 11.6 12.0 8.8 12.2 4.8 3.1 7.2 11.6 9.5 6.2 3.9 5.6 7.7 11.1 3.3 5.5 24.8 20.3 3.8 7.6 7.3 11.4 2.5 7.6 3.5 5.1 15.2 5.9 5.1 3.3 9.1 4.2 9.5 3.2 1.7 9.1 6.0 9.2 10.5 14.1 12.0 12.6 8.6 5.7 7.9 5.9 16.8 11.5 32.9 6.4 9.8 9.8 6.4 8.6 6.3 11.1 9.1 7.6 8.8 17.8 9.8 10.4 19.1 3.5 13.2 9.7 8.7 13.2 9.8 8.3 12.8 23.2 11.8 7.9 3.6 17.8 7.3 5.1 7.4 8.7 17.3 22.8 7.0 10.1 7.8 4.1 9.3 44.4 14.1 4.6 7.6 10.0 16.8 6.2 15.4 8.4 11.6 10.2 10.8 13.0 9.7 6.5 24.9 6.0 9.1 2.0 1.9 2.1 2.0 2.7 2.2 3.2 2.5 3.3 5.1 2.7 2.2 0.1 9.5 4.2 1.5 2.9 1.7 13.7 12.5 6.7 11.4 14.3 8.5 11.6 12.0 11.6 11.4 3.0 5.8 6.7 5.9 6.1 5.5 25.5 22.9 8.1 7.9 5.2 7.9 6.8 21.6 3.9 231.1 6.8 5.2 0.0 8.0 6.9 11.2 12.7 1.1 160.3 7.5 3.2 6.9 13.5 8.9 119.7 18.4 4.9 13.5 2.8 11.7 15.3 8.4 7.0 21.5 19.6 5.0 0.0 13.0 16.7 10.5 5.0 6.1 5.7 12.3 8.1 NAGS "AGAS, ARGA, NAT7" ENSG00000161653 "N-acetylglutamate synthase" Q8N159 17 44004546-44009063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Urea cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.4;liver: 30.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA027300 Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA027300: AB_2672207" "unprognostic (1.51e-3)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (8.67e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.38e-2)" "unprognostic (1.98e-1)" "unprognostic (3.14e-2)" "unprognostic (2.73e-2)" "unprognostic (2.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.19e-2)" "unprognostic (6.99e-2)" "unprognostic (1.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" 0.6 0.6 0.5 0.4 2.4 0.0 1.0 0.7 1.5 0.3 7.2 0.5 5.6 16.4 0.5 2.6 0.9 0.3 0.3 0.9 0.7 1.5 4.4 30.2 2.5 0.2 1.8 0.6 0.5 0.3 3.6 0.4 0.4 1.2 0.8 0.4 0.1 0.9 6.5 0.1 0.6 13.4 0.3 2.0 0.5 0.3 0.4 1.1 0.2 2.9 0.0 0.1 0.8 0.8 1.5 2.0 2.3 2.7 1.0 3.5 1.3 3.4 0.2 0.0 0.5 0.0 6.4 0.1 0.6 0.0 0.2 0.0 2.2 0.8 0.0 1.4 0.0 0.1 1.5 0.0 1.2 0.1 0.3 0.8 0.1 0.2 2.7 6.6 0.0 0.0 2.8 0.1 0.2 0.0 0.6 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 1.7 2.7 0.1 0.2 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.1 0.2 0.1 8.1 3.0 0.8 0.2 0.7 0.2 0.2 0.2 12.1 0.1 0.4 1.8 1.4 2.3 3.5 1.5 2.8 1.2 2.2 2.9 2.0 1.5 1.1 1.7 0.8 1.0 2.7 0.3 1.7 1.3 0.5 2.4 0.7 1.5 0.7 1.5 1.8 0.6 1.2 1.1 3.0 3.4 0.5 0.8 1.3 0.4 2.4 5.1 1.4 4.5 12.2 0.0 0.9 6.6 1.6 4.4 0.9 10.4 0.0 3.6 1.6 0.6 0.4 0.0 18.8 1.0 0.0 6.9 1.3 2.6 2.2 1.4 4.2 0.0 9.0 2.6 0.9 3.7 3.2 0.7 14.6 0.5 0.0 1.0 5.5 1.5 0.6 0.3 1.5 3.3 0.6 NAT14 KLP1 ENSG00000090971 "N-acetyltransferase 14 (putative)" Q8WUY8 19 55485004-55487568 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 60.2;Horizontal cells: 139.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047187 Approved Mitochondria NA NA Mitochondria "HPA047187: AB_2679974" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (5.43e-2)" "unprognostic (1.32e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-2)" "unprognostic (7.01e-2)" "unprognostic (1.94e-1)" "unprognostic (2.97e-1)" "unprognostic (9.12e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (7.00e-2)" "unprognostic (6.74e-2)" "unprognostic (9.85e-2)" "unprognostic (1.58e-1)" 3.6 10.1 15.8 5.7 19.6 4.5 5.5 25.8 25.8 8.2 7.0 8.9 3.1 3.5 12.6 10.1 2.9 24.1 6.5 5.9 15.4 16.7 9.2 2.5 7.8 4.6 10.8 15.5 14.1 5.6 11.2 19.2 8.5 10.6 6.8 3.1 7.8 5.0 10.5 2.9 4.1 3.4 11.1 6.5 3.7 5.6 4.9 9.5 42.2 9.8 1.3 3.8 6.0 4.3 1.8 1.8 2.3 0.3 0.3 1.0 0.6 2.4 8.9 9.8 18.1 4.1 5.1 6.2 9.2 10.7 10.1 14.4 3.1 7.9 1.0 3.2 5.9 5.0 3.3 6.4 5.6 6.2 9.9 55.3 8.0 11.9 6.7 7.4 5.9 8.1 7.3 2.1 7.4 1.9 19.9 7.3 14.5 9.9 2.8 5.8 3.0 9.9 9.0 14.0 4.7 4.9 9.8 6.3 3.6 23.0 4.6 30.3 20.6 3.7 5.4 8.1 3.8 4.4 5.7 8.8 3.7 10.2 0.5 7.3 5.7 2.3 4.2 8.2 1.0 9.2 0.0 0.3 0.2 0.5 0.3 1.0 0.6 0.4 0.3 0.0 1.8 0.7 0.7 2.3 0.3 0.3 1.8 0.0 0.6 15.8 19.6 25.8 25.8 15.4 16.7 10.8 15.5 10.6 9.5 6.0 2.7 7.3 6.1 2.6 60.2 4.5 2.5 14.7 2.3 27.9 33.4 10.6 13.3 14.0 1.4 4.3 0.7 0.0 1.0 6.9 8.2 4.4 0.0 2.9 2.6 139.8 12.2 4.9 0.8 1.7 10.9 0.7 5.0 3.6 1.8 34.9 4.7 0.0 9.9 3.5 34.0 0.0 9.2 4.1 2.9 0.5 5.0 1.3 0.9 1.4 NAT8L "FLJ37478, Hcml3" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059512-2069089 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 45.9;brain: 45.9;testis: 11.8" "Group enriched" "Detected in some" 5 "Horizontal cells: 76.3;Muller glia cells: 25.6" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria NA NA Mitochondria "HPA040677: AB_2732486" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 45.9 2.0 23.5 1.3 28.3 1.2 7.9 16.4 45.9 1.2 1.5 7.4 0.3 1.3 1.6 2.8 1.3 2.4 1.3 2.1 20.8 12.9 8.2 1.2 1.2 1.4 16.4 12.6 1.4 3.9 1.2 5.6 1.3 12.8 2.4 1.3 1.2 3.8 3.2 7.3 2.4 1.5 1.4 6.5 1.5 1.6 11.8 8.2 0.0 1.6 0.0 1.2 1.2 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 6.6 3.6 7.3 0.7 0.0 4.2 0.1 0.0 0.2 0.0 2.9 0.2 0.0 1.3 0.0 1.1 0.1 8.2 0.0 0.1 0.0 9.6 0.1 1.4 4.7 1.2 10.1 5.0 0.0 0.1 0.0 0.0 1.4 0.0 2.5 7.8 0.0 0.3 4.4 0.1 14.7 10.3 0.0 3.0 0.5 1.7 0.2 0.1 0.3 19.0 6.3 4.8 0.0 15.1 0.6 0.5 5.9 0.0 0.0 2.5 0.1 3.9 0.0 0.0 0.1 0.0 4.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 23.5 28.3 16.4 32.7 20.8 12.9 16.4 12.6 12.8 8.2 0.0 0.0 0.0 0.0 0.2 7.1 2.0 0.0 0.0 0.0 1.8 5.9 0.0 0.0 4.2 0.8 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.7 76.3 1.7 0.0 0.0 3.1 0.0 0.1 10.1 0.0 0.0 25.6 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 NDUFA10 CI-42k ENSG00000130414 "NADH:ubiquinone oxidoreductase subunit A10" O95299 2 239892450-240025402 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059529, HPA067045, CAB070846" Approved Supported Mitochondria "Intracellular and membrane" NA NA 12000 Mitochondria "CAB070846: AB_11152346, HPA059529: AB_2684051, HPA067045: AB_2732756" "unprognostic (2.12e-2)" "unprognostic (8.94e-3)" "unprognostic (8.73e-2)" "unprognostic (2.02e-2)" "unprognostic (8.96e-2)" "unprognostic (2.53e-1)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (5.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.05e-1)" "prognostic favorable (2.09e-7)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.98e-1)" "unprognostic (2.95e-1)" 19.0 37.5 19.7 18.2 30.4 20.3 19.5 26.2 31.5 14.5 31.0 24.5 18.6 30.4 14.8 18.4 28.5 18.8 17.1 66.0 28.6 18.7 36.3 40.6 13.1 13.8 21.4 27.7 19.8 23.5 25.1 15.5 15.9 33.4 13.7 34.7 16.2 20.6 26.7 67.0 26.1 24.3 18.6 27.0 13.8 24.9 15.4 19.8 13.2 16.9 34.1 20.2 19.3 17.7 24.6 35.7 11.0 27.7 21.2 24.6 24.5 16.9 16.6 12.4 20.8 15.0 25.0 20.3 14.4 18.6 20.8 20.9 16.6 21.2 12.6 6.7 16.0 15.5 22.8 27.9 25.8 26.7 16.7 18.5 16.5 15.7 35.5 22.6 22.5 13.4 24.2 21.1 16.6 22.7 18.1 26.3 20.4 25.0 8.9 22.2 25.9 21.3 23.2 14.6 26.3 18.1 21.8 27.6 22.0 29.5 33.3 19.6 12.9 14.2 32.2 22.5 9.4 29.9 22.9 16.4 14.8 15.1 18.8 16.0 15.3 6.8 20.1 16.1 20.6 17.7 6.3 26.1 11.0 18.9 27.7 24.6 24.6 19.1 20.5 35.7 18.3 19.0 19.0 5.8 21.2 23.4 12.7 22.0 24.5 19.7 30.4 26.2 31.5 28.6 18.7 21.4 27.7 33.4 19.8 71.5 71.5 70.9 81.5 93.2 72.1 304.5 79.0 77.6 80.8 73.3 58.9 175.7 263.6 95.5 40.3 66.1 150.4 0.0 68.2 97.5 68.1 53.9 64.6 119.2 111.3 47.7 89.3 62.6 83.6 48.6 46.3 74.1 106.3 115.4 134.7 70.1 74.8 106.6 46.3 181.4 103.3 64.7 75.1 53.2 69.0 104.0 182.4 62.3 201.1 84.3 NDUFA11 B14.7 ENSG00000174886 "NADH:ubiquinone oxidoreductase subunit A11" Q86Y39 19 5891276-5904006 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA072209 Uncertain Mitochondria NA NA Mitochondria "HPA072209: AB_2686495" "unprognostic (2.24e-1)" "prognostic favorable (4.54e-5)" "unprognostic (8.20e-3)" "prognostic favorable (3.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.73e-2)" "unprognostic (6.30e-2)" "unprognostic (7.26e-3)" "unprognostic (3.95e-1)" "unprognostic (4.20e-2)" "unprognostic (1.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.12e-2)" "unprognostic (2.91e-1)" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (6.16e-3)" 32.3 70.8 50.2 40.9 41.3 43.4 49.3 29.9 75.2 35.3 45.1 25.8 41.2 41.6 35.9 36.9 53.1 38.4 41.4 149.3 41.9 45.8 44.1 59.8 37.9 51.9 48.3 45.8 38.4 70.9 13.5 33.8 32.5 35.9 35.1 19.6 35.9 76.3 41.1 106.0 32.4 39.5 45.2 40.2 31.5 38.8 21.2 27.0 37.3 37.8 72.1 30.5 38.3 37.2 63.3 90.2 54.3 87.4 44.8 73.7 121.4 49.2 38.1 28.4 46.2 23.3 37.9 31.8 34.1 39.4 62.5 57.8 45.5 26.3 48.7 53.8 32.5 26.8 32.6 19.6 39.7 15.1 42.0 73.5 20.0 36.6 72.7 61.0 29.7 29.8 51.8 36.1 35.4 16.8 24.1 40.7 44.8 42.2 54.3 31.4 37.5 77.1 53.0 43.0 39.3 95.9 53.5 35.5 69.7 38.6 33.0 41.1 43.7 26.5 43.6 60.0 12.7 33.5 63.4 36.4 34.9 33.5 69.3 55.6 82.6 71.6 63.0 58.8 71.4 44.7 54.3 87.4 47.7 53.5 68.0 54.8 63.3 59.6 54.0 74.9 54.6 56.7 49.5 39.2 44.8 57.7 90.2 73.7 121.4 50.2 41.3 29.9 75.2 41.9 45.8 48.3 45.8 35.9 27.0 134.0 182.8 195.8 195.3 182.6 52.9 357.1 252.3 159.3 142.1 277.4 23.6 487.2 712.9 246.9 126.8 162.6 455.6 140.2 261.1 500.5 250.4 204.0 208.9 654.2 369.3 47.7 337.5 259.7 354.1 271.6 180.4 216.7 271.7 380.5 351.7 119.5 275.3 350.7 157.3 766.8 60.4 116.4 219.2 83.0 80.8 212.9 496.2 182.7 391.9 191.2 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 2344.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.1 24.5 45.3 45.0 46.2 37.5 42.5 39.5 43.8 44.6 43.5 39.7 49.8 44.1 93.0 47.6 27.8 27.0 32.0 42.9 18.4 26.9 72.4 33.7 39.1 48.6 41.3 63.3 47.6 50.3 39.0 31.2 36.0 31.5 32.0 51.6 37.2 63.2 35.4 65.9 75.1 62.9 46.1 85.3 68.2 43.1 29.4 67.4 65.0 47.6 43.0 54.4 40.2 47.4 39.3 26.4 29.3 87.2 33.3 43.7 14.8 50.9 49.0 45.0 35.4 47.5 38.5 49.2 31.9 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 122.1 153.3 217.5 53.6 114.6 57.3 436.5 216.6 210.1 204.8 237.3 23.6 341.6 517.3 485.5 369.3 147.4 952.4 140.2 502.5 299.6 215.0 71.6 253.9 389.3 292.2 39.7 534.5 181.7 314.3 2344.2 142.1 234.7 249.7 531.2 516.2 105.2 438.1 641.8 121.3 667.2 59.7 90.5 183.3 59.7 92.9 111.0 416.8 195.8 508.5 65.7 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Approved Approved Mitochondria NA NA 18000 Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favorable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 11.4 19.7 33.6 38.7 19.1 18.0 15.5 14.5 13.8 13.7 12.1 24.7 31.5 22.4 13.9 20.9 37.5 20.3 22.3 17.3 15.0 11.0 16.3 18.7 23.2 23.0 16.7 25.8 18.5 19.3 17.4 16.7 14.8 26.1 19.0 20.2 27.8 30.5 28.5 22.1 11.5 22.7 36.8 78.1 40.0 15.6 24.0 25.1 34.7 24.9 21.1 21.9 23.1 66.5 13.1 49.0 42.0 31.7 16.6 16.3 22.6 23.4 24.0 18.5 23.6 25.7 22.6 27.9 50.7 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 455.6 386.9 389.1 472.6 361.6 472.0 3966.4 996.2 704.0 533.5 903.7 251.3 756.7 3355.6 748.9 115.7 549.6 532.5 186.9 833.3 599.3 543.2 716.7 552.0 1498.2 844.7 149.4 201.3 748.3 552.8 81.7 457.0 587.9 868.9 625.8 610.1 384.0 636.5 584.4 737.2 2069.7 472.4 329.8 932.8 105.9 274.8 422.2 550.9 350.3 618.2 678.3 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Group enriched" "Detected in many" 4 "Muller glia cells: 315.5;Sertoli cells: 1112.4;Smooth muscle cells: 398.4" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Cell line enriched" "Detected in many" 7 "AN3-CA: 55.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA055323, HPA078265" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 55.4 2.3 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.2 2.3 0.8 0.0 0.4 0.3 0.4 0.0 1.2 0.1 0.2 0.1 0.0 7.9 1.6 0.8 5.1 1.0 0.1 2.0 0.3 0.0 3.1 0.2 2.9 0.1 1.1 0.4 0.0 0.1 0.2 1.0 0.8 0.4 4.2 0.0 0.0 3.0 1.0 0.1 0.1 1.8 0.0 0.6 5.8 0.2 0.5 0.0 0.4 0.2 4.2 1.3 1.0 2.0 3.9 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 0.0 0.3 0.9 0.7 134.3 28.0 0.8 0.0 0.0 0.0 0.0 17.7 0.8 0.0 1.0 1.0 3.6 0.0 0.0 0.0 0.8 18.6 1.5 9.2 0.0 1.5 11.1 0.0 4.9 0.0 1.3 2.8 1.4 28.7 1.8 0.0 315.5 7.7 0.0 2.1 0.0 17.5 1112.4 398.4 8.1 0.9 141.0 0.9 0.0 0.0 0.9 NDUFA7 B14.5a ENSG00000267855 "NADH:ubiquinone oxidoreductase subunit A7" O95182 19 8308768-8321396 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.6" "Cell type enhanced" "Detected in many" 4 "monocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA059251, HPA071866" Enhanced Supported Mitochondria NA NA Mitochondria "HPA059251: AB_2683960, HPA071866: AB_2686465" "unprognostic (6.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (3.85e-1)" "unprognostic (2.18e-1)" "unprognostic (5.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (3.40e-1)" "unprognostic (1.13e-3)" "unprognostic (1.81e-2)" "unprognostic (1.43e-1)" "unprognostic (1.09e-2)" "unprognostic (5.53e-2)" "unprognostic (1.29e-2)" "unprognostic (2.59e-2)" "unprognostic (9.35e-3)" 17.7 30.0 28.0 15.5 30.5 15.3 18.9 15.4 32.0 9.0 17.2 11.3 15.7 12.6 9.9 32.1 18.9 26.2 16.1 69.1 22.1 21.0 26.5 30.9 20.3 22.1 25.9 19.7 10.1 28.5 11.9 30.2 13.0 26.7 20.5 17.6 16.7 23.0 20.7 110.6 16.2 16.0 13.1 18.5 14.7 19.3 13.8 11.1 19.3 22.0 47.5 16.8 14.3 9.1 30.6 65.5 25.1 39.7 24.9 33.5 26.7 15.4 13.2 16.8 8.7 11.5 6.1 9.5 4.4 5.7 16.6 11.1 13.9 13.1 8.7 6.8 10.6 9.5 13.4 7.6 23.2 7.8 22.8 48.1 6.4 20.3 33.0 17.9 9.7 8.9 12.4 15.1 8.9 8.2 13.4 19.3 42.1 11.0 45.4 20.6 16.8 18.5 48.1 13.6 30.4 50.4 10.3 3.1 18.9 33.7 9.2 14.1 10.8 6.4 19.8 11.0 9.9 7.5 16.0 5.7 9.3 7.5 13.0 12.5 17.8 13.7 10.4 13.3 16.8 14.6 14.2 38.9 25.1 22.6 39.7 24.4 29.9 24.7 22.2 47.9 30.6 24.1 23.4 9.7 24.9 34.4 65.5 33.5 26.7 28.0 30.5 15.4 32.0 22.1 21.0 25.9 19.7 26.7 11.1 41.7 57.7 13.4 8.7 0.0 12.0 0.0 28.1 129.8 37.5 50.6 5.9 55.6 84.6 128.2 25.6 8.7 82.6 23.3 137.5 37.8 2.0 14.6 19.8 58.9 45.6 7.9 84.3 27.6 40.8 12.2 12.4 28.3 0.0 190.2 132.6 19.5 142.9 146.3 12.4 67.1 13.2 6.5 0.0 18.4 23.7 0.0 39.2 27.7 136.7 10.8 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 528.1;Distal tubular cells: 520.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria NA NA 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favorable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 17.9 33.3 22.1 29.1 23.9 22.0 27.4 21.0 24.9 28.8 24.3 42.2 17.9 26.3 20.8 24.5 52.6 45.3 41.8 45.3 28.4 25.8 28.9 20.7 55.9 36.4 25.8 36.5 21.4 24.0 44.3 28.8 18.5 26.5 41.2 29.5 31.5 19.8 32.8 45.7 22.6 23.8 20.2 81.0 64.2 18.2 34.9 38.3 41.4 25.0 38.3 15.1 32.9 39.1 26.0 23.6 41.4 17.6 26.7 16.0 16.1 30.0 23.4 22.4 36.1 26.0 33.3 23.7 26.4 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 26.8 30.2 50.6 59.9 42.8 43.3 528.1 56.0 69.6 48.9 78.5 27.5 106.7 520.6 91.1 282.6 89.5 102.7 46.7 88.4 95.7 43.5 75.0 19.7 93.1 108.4 42.9 74.3 58.3 41.0 68.2 52.3 46.0 89.4 88.4 92.7 52.1 87.8 87.7 70.7 161.2 38.8 25.8 56.7 227.6 125.0 49.7 105.8 45.0 118.7 71.0 NDUFAF2 "B17.2L, mimitin, MMTN, NDUFA12L" ENSG00000164182 "NADH:ubiquinone oxidoreductase complex assembly factor 2" Q8N183 5 60945129-61153037 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048082, HPA054776" Supported Enhanced Mitochondria NA NA Mitochondria "HPA048082: AB_2680254, HPA054776: AB_2682598" "unprognostic (7.28e-2)" "unprognostic (6.83e-2)" "unprognostic (1.37e-1)" "unprognostic (2.46e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (8.40e-3)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.79e-2)" "unprognostic (6.10e-2)" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" 25.5 25.9 22.5 16.7 24.9 11.4 27.1 13.6 24.4 16.9 20.5 11.7 8.2 16.0 16.3 12.2 19.3 12.6 15.0 33.6 19.9 21.2 19.1 27.2 11.9 13.4 20.5 14.2 23.5 41.2 14.2 25.3 9.8 18.5 19.0 18.2 13.2 16.0 16.8 56.3 12.9 13.3 23.9 18.3 10.0 17.2 20.1 12.6 4.9 17.7 16.0 12.3 26.9 19.5 15.9 20.9 1.5 13.1 17.3 20.3 9.1 30.8 16.3 11.3 36.2 21.9 31.1 21.3 36.1 19.3 22.9 28.2 27.1 22.3 38.8 37.3 24.5 44.1 12.8 19.2 31.6 28.4 20.5 27.6 13.3 29.1 25.3 33.1 19.3 7.9 16.7 34.1 20.8 63.4 15.3 20.4 17.3 22.0 20.7 23.9 24.4 17.1 28.5 9.3 11.9 38.7 19.0 31.0 52.6 21.8 13.3 23.7 10.6 22.5 19.5 35.0 10.5 23.3 13.7 18.9 16.5 25.2 35.5 39.9 15.2 21.9 42.6 21.9 34.8 19.2 0.0 13.1 1.5 12.5 11.9 14.3 15.9 15.9 14.6 20.9 11.0 13.9 14.3 0.6 17.3 9.1 7.5 20.3 9.1 22.5 24.9 13.6 24.4 19.9 21.2 20.5 14.2 18.5 12.6 11.9 21.7 43.3 50.0 53.8 27.8 79.5 45.9 24.1 34.2 36.6 11.8 19.0 79.6 47.4 137.5 33.3 26.9 0.0 48.4 45.3 50.0 52.9 19.7 80.5 44.4 39.7 23.7 33.7 26.7 9.8 71.1 42.3 42.2 10.8 49.7 19.5 60.3 45.8 58.4 88.8 22.6 25.8 60.6 82.5 68.2 55.7 11.9 24.5 59.0 51.4 NDUFAF4 "bA22L21.1, C6orf66, HRPAP20, HSPC125, My013" ENSG00000123545 "NADH:ubiquinone oxidoreductase complex assembly factor 4" Q9P032 6 96889313-96897881 "Disease related genes, Predicted intracellular proteins" Calmodulin-binding "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046560 Uncertain Supported Mitochondria NA Yes Mitochondria "HPA046560: AB_10966700" "prognostic unfavorable (1.31e-4)" "unprognostic (1.32e-1)" "unprognostic (1.09e-2)" "unprognostic (1.14e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (6.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (2.78e-2)" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (4.20e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" 7.9 10.1 16.1 5.4 19.0 2.7 9.0 20.4 27.4 8.9 9.1 5.0 5.7 6.2 7.3 6.4 7.1 6.0 6.0 30.2 18.7 17.3 17.3 18.1 4.3 5.4 18.1 12.3 10.4 7.2 7.3 6.5 6.1 28.5 9.5 9.7 4.5 7.7 12.8 25.0 6.2 6.5 7.3 9.6 7.6 6.4 5.7 8.4 4.9 9.5 11.2 5.8 8.2 5.1 6.4 4.5 0.6 4.3 3.3 10.0 4.1 1.5 4.3 7.5 10.1 7.5 4.4 4.0 4.2 4.0 6.3 4.8 5.8 2.6 14.1 7.7 3.8 6.0 3.1 17.4 6.5 6.1 9.9 13.7 15.7 2.3 5.0 8.2 16.4 6.6 4.1 10.1 5.4 5.5 3.2 4.9 10.0 14.1 9.6 9.8 4.8 10.5 8.9 14.2 7.8 7.1 5.0 4.2 7.3 10.4 4.2 12.8 6.0 2.1 7.6 11.9 7.7 2.3 11.0 4.0 3.3 2.5 11.5 6.8 2.2 3.6 13.9 4.5 12.4 4.8 0.2 2.2 0.6 5.1 4.3 6.6 6.4 6.7 6.7 3.8 6.3 10.0 8.8 0.4 3.3 2.6 4.5 6.8 4.1 16.1 19.0 20.4 27.4 18.7 17.3 18.1 12.3 28.5 8.4 8.9 16.6 43.3 52.1 96.7 15.5 108.1 25.5 17.4 27.3 22.7 0.0 40.6 142.6 37.3 2.3 31.6 17.5 23.3 23.9 34.6 34.7 26.3 19.7 43.9 47.0 25.4 37.6 25.8 18.0 4.4 24.2 27.4 52.3 15.4 38.0 14.0 21.1 10.5 23.3 99.4 12.4 25.8 69.8 36.9 55.8 84.6 27.5 27.9 48.2 38.3 NDUFAF8 C17orf89 ENSG00000224877 "NADH:ubiquinone oxidoreductase complex assembly factor 8" A1L188 17 81239239-81241281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 237.1;Exocrine glandular cells: 106.9;Hofbauer cells: 113.1;Proximal tubular cells: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057732 Uncertain Approved Mitochondria NA NA Mitochondria "HPA057732: AB_2683513" "unprognostic (4.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" "unprognostic (1.97e-1)" "unprognostic (9.32e-2)" "unprognostic (3.06e-1)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.71e-2)" "unprognostic (2.40e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.70e-6)" "unprognostic (5.74e-2)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" 21.6 24.6 44.7 16.6 45.9 19.1 18.2 16.9 33.3 13.0 18.5 18.3 14.0 13.6 10.1 22.5 12.6 12.1 17.5 28.5 36.6 25.0 23.9 30.0 13.4 14.8 34.8 23.2 13.3 24.5 14.6 15.8 9.3 17.0 14.7 19.3 15.0 22.9 15.1 78.1 9.0 11.7 19.1 22.8 11.5 15.4 10.8 16.4 8.4 11.3 29.0 19.2 10.3 8.8 34.2 46.7 22.9 27.8 25.7 36.5 25.3 29.8 45.4 16.8 16.4 18.9 19.9 17.6 25.9 11.2 18.9 11.0 23.0 13.6 27.4 12.9 19.2 15.8 14.9 15.6 26.3 22.7 6.7 87.6 21.3 48.5 51.4 19.8 30.0 13.6 26.7 32.1 13.6 29.0 20.4 30.1 23.4 25.5 17.6 24.3 28.6 40.7 30.9 9.1 25.4 57.4 25.1 24.0 21.2 20.2 21.5 19.3 24.1 21.9 18.8 26.2 25.9 26.2 28.4 16.9 23.6 34.1 16.8 26.6 23.0 8.1 26.5 21.3 15.9 18.1 12.9 27.8 22.9 26.4 21.3 27.0 34.2 29.9 32.8 28.7 29.3 36.5 35.2 3.7 25.7 24.2 46.7 29.3 25.3 44.7 45.9 16.9 33.3 36.6 25.0 34.8 23.2 17.0 16.4 17.9 15.9 0.0 0.0 0.0 0.0 0.0 0.0 6.7 17.0 96.0 0.0 100.5 237.1 95.7 0.0 0.0 0.0 0.0 106.9 76.2 0.0 0.0 1.1 0.0 113.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 89.2 0.0 0.0 100.1 0.0 0.0 188.8 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria NA NA Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.9 29.7 23.5 27.1 20.3 17.5 25.0 14.5 16.9 23.8 23.1 31.6 24.5 24.6 12.6 15.8 25.1 25.6 26.4 15.4 16.0 23.7 70.6 14.1 40.6 26.1 20.4 23.6 21.7 19.1 14.1 20.6 13.7 15.3 17.7 32.1 16.8 32.4 13.3 45.1 27.8 65.3 36.7 23.8 54.6 30.3 23.2 55.8 24.1 21.3 43.3 32.0 27.6 31.8 22.0 31.3 45.6 30.9 13.5 16.7 22.8 31.0 17.0 32.0 27.9 27.5 18.2 14.8 22.2 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 98.3 106.3 255.4 204.6 230.6 88.2 209.9 272.6 84.3 121.7 275.7 35.3 385.7 494.0 274.0 3.3 148.1 318.7 303.7 319.8 368.1 203.9 216.1 191.4 557.4 340.7 52.4 317.3 186.6 292.7 7.4 168.2 251.5 251.4 301.2 382.3 151.0 288.4 321.1 165.9 606.1 75.5 161.7 184.4 17.2 37.7 253.9 377.1 200.3 398.2 277.3 NDUFB6 "B17, CI" ENSG00000165264 "NADH:ubiquinone oxidoreductase subunit B6" O95139 9 32552999-32573184 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 591.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044001, HPA053334" Supported Enhanced Mitochondria No No Mitochondria "HPA044001: AB_10959448, HPA053334: AB_2682116" "unprognostic (4.09e-1)" "prognostic favorable (3.18e-4)" "unprognostic (1.81e-2)" "unprognostic (1.53e-2)" "unprognostic (1.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-3)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.47e-10)" "unprognostic (2.70e-1)" "unprognostic (1.82e-1)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" 21.9 26.8 33.9 17.7 31.8 16.0 18.7 22.6 28.3 13.7 21.9 15.5 17.3 26.5 16.8 17.4 18.6 15.4 15.9 58.6 27.6 27.9 32.8 36.6 13.9 15.4 28.4 27.2 14.1 19.5 15.4 17.8 15.5 22.9 15.1 18.2 14.6 22.7 16.1 87.2 14.6 25.5 16.4 25.9 13.5 20.0 28.9 17.1 19.2 22.2 34.4 14.5 14.1 13.5 26.0 38.8 77.4 27.3 22.2 27.5 26.5 30.2 18.6 20.7 23.7 14.1 13.2 13.3 20.3 16.6 18.8 20.8 18.2 13.7 22.6 21.2 13.9 19.5 17.2 19.5 22.4 14.1 31.0 31.3 53.7 28.6 18.8 13.8 26.7 13.9 13.6 10.9 16.9 12.9 14.2 16.9 34.7 17.1 25.5 20.9 17.5 36.0 63.1 21.9 26.0 41.4 24.8 17.4 20.9 21.0 11.4 20.9 23.6 23.5 27.0 13.6 16.2 25.5 20.8 15.0 20.5 31.1 22.6 29.7 11.4 21.2 36.6 34.3 18.9 9.6 25.0 25.8 33.3 21.0 23.1 20.2 26.0 22.4 21.6 27.6 21.8 23.0 24.3 77.4 22.2 27.3 38.8 27.5 26.5 33.9 31.8 22.6 28.3 27.6 27.9 28.4 27.2 22.9 17.1 116.1 94.0 77.4 80.5 83.7 39.2 514.3 107.0 155.2 108.1 102.9 5.9 175.9 452.6 143.9 591.4 96.3 138.7 93.5 145.0 113.2 93.0 79.2 86.8 170.4 141.7 17.5 62.0 71.8 59.8 88.6 84.8 89.6 151.8 111.8 116.6 72.0 133.2 118.5 84.5 440.9 40.8 103.5 124.6 143.8 114.3 84.6 87.1 65.4 146.3 88.4 NDUFB8 "ASHI, CI-ASHI" ENSG00000166136 "NADH:ubiquinone oxidoreductase subunit B8" O95169 10 100523740-100530000 "Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 742.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003886, HPA065549" Supported Enhanced Mitochondria NA NA Mitochondria "HPA003886: AB_1079463, HPA065549: " "unprognostic (4.07e-2)" "unprognostic (1.95e-3)" "unprognostic (2.28e-1)" "unprognostic (7.33e-2)" "unprognostic (4.88e-2)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (6.46e-2)" "unprognostic (8.33e-2)" "unprognostic (9.09e-2)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (4.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (5.10e-2)" 35.2 39.8 86.7 27.0 67.4 35.6 26.1 39.3 81.5 25.4 37.7 23.8 23.1 38.8 24.7 42.3 36.8 28.8 28.2 110.0 70.6 62.8 50.4 50.6 19.8 28.1 63.9 54.1 27.7 36.3 31.5 31.4 19.9 49.9 26.6 36.2 25.7 39.7 34.5 88.5 24.3 33.8 41.5 38.9 22.1 31.5 12.0 41.4 18.3 28.3 49.2 27.8 25.2 21.5 76.6 88.6 62.2 74.4 60.5 105.9 129.7 42.2 71.3 38.5 68.3 29.2 28.4 42.6 28.9 62.8 44.4 48.1 96.6 49.3 44.8 26.1 32.3 32.8 50.7 28.8 46.9 35.4 29.4 73.6 31.5 60.5 78.2 39.6 64.3 54.3 34.9 42.4 44.3 59.8 32.2 48.5 59.6 32.7 28.5 38.2 51.3 62.0 81.0 25.8 54.4 66.6 43.3 42.1 59.1 52.0 48.4 26.7 37.4 21.3 40.5 41.9 27.6 60.3 57.6 32.5 25.4 28.8 27.1 50.5 51.7 46.9 55.6 50.5 68.2 28.3 35.1 74.4 62.2 59.0 72.9 69.5 76.6 73.6 67.8 80.4 64.1 79.8 76.7 17.1 60.5 61.4 88.6 105.9 129.7 86.7 67.4 39.3 81.5 70.6 62.8 63.9 54.1 49.9 41.4 71.5 126.9 126.6 146.5 0.0 174.3 341.7 234.4 156.6 88.7 188.5 55.0 285.1 742.8 226.5 20.4 131.5 123.8 116.8 230.9 258.4 136.0 175.3 101.1 286.9 348.6 144.6 101.8 146.7 171.1 43.8 202.0 160.0 0.0 261.5 229.2 129.5 225.4 259.6 204.4 592.8 122.1 168.1 220.6 53.7 79.5 0.0 257.3 174.0 305.7 185.2 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria NA NA Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.3 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 13.5 32.9 29.7 22.6 24.5 33.2 40.5 69.5 19.0 42.0 28.4 21.6 19.0 21.2 32.9 23.7 51.3 14.1 23.5 20.8 42.9 24.1 20.7 90.1 34.0 43.3 20.6 104.1 59.4 23.0 15.6 39.0 34.0 24.4 28.6 22.4 30.9 254.6 30.4 12.9 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 116.1 101.5 163.0 206.1 193.5 71.0 877.9 259.9 172.6 153.6 272.2 92.3 413.9 678.1 287.5 321.0 148.3 490.6 46.7 353.1 228.0 195.3 239.3 136.2 450.4 353.4 35.0 224.5 179.2 208.1 585.5 147.0 181.9 234.5 201.0 282.2 86.2 298.7 372.2 143.5 593.2 52.3 168.1 258.4 306.2 277.3 164.6 437.4 148.2 397.6 262.6 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Cell type enhanced" "Detected in all" 8 "Cardiomyocytes: 1810.7;Distal tubular cells: 963.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044556, HPA062427" Enhanced Approved Mitochondria No No Mitochondria "HPA044556: AB_10794402, HPA062427: " "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favorable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favorable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.7 3.7 10.7 13.3 7.7 8.4 8.6 10.8 7.2 8.0 6.1 6.5 11.0 3.8 3.9 7.6 7.9 5.2 20.9 7.1 6.3 5.5 6.7 6.1 7.1 10.4 9.7 5.0 3.3 12.1 10.7 7.6 11.2 10.3 7.9 8.8 14.0 16.4 5.5 6.2 7.4 12.4 8.2 16.4 5.0 6.3 6.6 29.1 12.8 5.7 9.1 6.9 7.7 9.5 4.9 9.0 10.4 9.9 3.9 7.9 3.7 5.5 6.1 13.2 23.2 9.6 8.5 13.3 6.3 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 83.4 126.2 85.5 146.6 124.6 118.7 1810.7 239.5 211.5 137.6 417.0 31.4 127.4 963.3 232.9 260.2 150.4 371.3 93.5 293.9 141.6 109.0 170.1 69.5 334.5 190.8 112.8 212.7 108.1 87.2 30.8 156.8 98.4 253.1 220.0 288.1 223.0 228.9 313.4 194.1 826.9 103.1 97.0 148.0 386.4 224.2 156.7 98.7 62.3 275.8 158.3 NDUFC2 "B14.5b, HLC-1" ENSG00000151366 "NADH:ubiquinone oxidoreductase subunit C2" O95298 11 78068304-78080219 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" "unprognostic (7.32e-2)" "unprognostic (5.91e-3)" "unprognostic (4.00e-2)" "unprognostic (6.14e-2)" "unprognostic (1.94e-1)" "unprognostic (8.97e-2)" "unprognostic (1.60e-1)" "unprognostic (4.23e-3)" "unprognostic (4.75e-3)" "unprognostic (3.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "prognostic favorable (5.00e-5)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (4.18e-2)" "unprognostic (3.61e-3)" 55.0 70.8 40.8 23.3 44.4 32.3 46.2 51.4 58.4 22.5 41.1 31.2 68.0 63.4 31.8 32.8 41.8 35.6 31.9 60.4 41.0 44.5 37.5 89.6 30.1 36.4 43.2 47.0 27.3 48.4 25.3 34.7 31.8 40.8 27.3 20.3 29.7 79.5 59.0 122.8 29.0 55.3 23.7 41.1 24.5 36.6 28.6 23.2 26.9 63.5 43.7 23.3 31.9 24.1 50.3 78.2 70.3 73.2 44.5 46.3 81.2 36.0 45.0 24.5 15.4 23.3 14.7 30.2 44.1 26.5 35.1 25.0 120.6 40.5 21.6 80.9 20.8 28.7 38.1 18.4 25.9 13.4 40.9 52.1 23.2 46.7 94.9 39.8 50.7 23.1 20.4 24.1 26.9 10.2 21.6 23.8 23.2 45.7 36.5 19.6 62.1 33.1 91.4 27.6 88.8 56.9 29.0 46.6 73.1 26.5 54.3 34.6 30.7 31.4 64.8 22.7 22.3 51.3 42.1 31.1 34.2 42.2 81.4 37.8 33.6 65.8 49.7 19.5 30.5 32.7 65.8 73.2 70.3 39.4 58.2 36.2 50.3 45.6 41.5 77.2 45.5 39.6 41.3 21.0 44.5 48.0 78.2 46.3 81.2 40.8 44.4 51.4 58.4 41.0 44.5 43.2 47.0 40.8 23.2 154.9 160.2 100.4 139.2 84.8 134.1 213.8 247.1 202.1 144.5 371.6 62.8 347.5 258.6 334.7 231.4 158.7 177.9 70.0 374.9 317.5 154.4 190.2 148.0 738.1 305.1 85.8 161.2 184.1 179.8 53.3 199.6 133.3 232.8 193.8 274.2 214.0 379.3 301.9 189.5 354.7 91.8 232.8 163.6 380.6 170.3 100.0 323.7 113.3 343.3 186.0 NDUFC2-KCTD14 ENSG00000259112 "NDUFC2-KCTD14 readthrough" E9PQ53 11 78016971-78079865 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Alveolar cells type 2: 1.3;Ciliated cells: 2.7;Club cells: 2.3;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 10.4;EFO-21: 8.5;RPMI-8226: 7.5;U-2 OS: 13.0" "HPA038873, HPA056195" Approved Supported Mitochondria NA NA Mitochondria "HPA038873: AB_10673480, HPA056195: AB_2683063" 7.1 11.3 6.3 5.8 7.9 9.7 8.9 13.8 11.7 9.6 7.4 5.5 13.8 27.3 8.8 5.9 9.5 9.7 5.6 11.3 7.7 7.1 6.9 18.7 6.6 6.7 6.4 9.1 6.6 8.8 5.4 5.6 5.6 7.7 8.4 6.3 5.1 18.0 11.8 10.1 5.7 10.6 5.9 5.9 5.9 15.9 4.9 3.7 4.5 12.7 8.3 4.8 4.6 6.1 30.7 37.7 30.7 33.7 16.5 33.2 39.7 0.0 2.1 0.6 0.6 0.6 0.0 1.4 1.5 0.9 1.3 2.9 10.4 1.2 0.2 8.5 0.0 1.8 0.3 1.7 0.0 0.7 5.9 0.0 1.2 0.0 0.0 0.7 0.8 2.1 0.0 0.3 0.3 1.8 1.8 0.9 6.4 0.3 0.1 0.2 0.0 3.0 1.1 5.2 1.0 0.3 1.0 0.1 7.5 0.0 0.0 1.5 2.3 0.0 1.1 3.3 0.0 0.6 1.1 0.9 0.5 13.0 4.2 0.0 1.2 1.4 3.0 0.8 0.3 1.4 22.5 33.7 30.7 24.5 24.1 19.3 30.7 22.8 23.0 37.7 23.7 20.5 21.5 10.0 16.5 25.7 37.5 33.2 39.7 6.3 7.9 13.8 11.7 7.7 7.1 6.4 9.1 7.7 3.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 534.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Enhanced Supported Mitochondria NA NA Mitochondria "CAB070844: , HPA064605: AB_2685297" "prognostic unfavorable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 12.9 18.8 13.6 17.6 14.3 21.9 19.1 20.6 31.9 23.2 33.5 15.2 14.7 16.9 23.8 31.7 18.2 25.1 18.5 28.4 6.7 11.8 29.3 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 14.3 24.8 18.6 31.7 14.9 20.7 16.2 17.4 14.0 17.4 21.9 23.1 17.6 26.3 25.4 26.4 23.7 18.4 14.4 22.0 21.6 31.2 26.9 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.6 17.5 17.9 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 56.6 24.1 13.7 19.6 14.3 94.7 534.9 63.7 60.2 35.2 36.6 113.9 40.2 79.6 36.7 9.9 33.7 63.8 0.0 24.5 26.7 24.7 17.4 35.9 83.9 29.8 111.2 49.0 33.7 34.6 5.2 31.1 25.2 28.7 27.1 47.3 60.7 29.2 35.1 42.1 80.9 78.2 32.3 27.8 28.6 37.3 14.4 43.8 18.7 52.8 23.9 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria NA NA 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 17.2 27.8 17.6 20.4 25.9 23.0 15.2 15.7 23.1 31.1 24.5 30.5 18.0 22.0 29.6 24.2 17.1 23.2 28.1 28.1 27.5 14.6 23.6 21.4 20.9 26.6 26.9 23.2 19.9 33.1 24.8 25.1 28.7 20.6 35.5 23.0 27.4 12.0 29.2 19.9 14.7 12.4 32.1 60.6 25.7 12.7 18.2 30.9 36.9 20.7 18.7 27.8 19.0 46.9 26.8 26.3 42.1 60.8 22.7 15.1 12.9 10.6 21.2 16.9 26.7 18.4 23.1 19.6 19.4 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 32.8 43.7 52.8 39.4 34.6 72.7 193.6 76.5 68.3 35.2 73.3 29.5 125.8 281.8 158.0 7.1 61.2 199.4 23.3 126.2 94.3 73.7 24.9 68.1 177.0 131.6 87.4 69.2 58.9 83.7 4.7 40.3 64.2 79.2 127.2 94.1 51.2 124.2 89.2 31.5 226.7 49.8 45.3 68.0 36.7 32.1 37.9 132.5 50.1 138.8 41.7 NDUFS4 "AQDQ, CI-18" ENSG00000164258 "NADH:ubiquinone oxidoreductase subunit S4" O43181 5 53560633-53683340 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003884 Supported Supported Mitochondria NA NA Mitochondria "HPA003884: AB_1079465" "unprognostic (1.25e-1)" "unprognostic (3.61e-3)" "unprognostic (3.44e-2)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (6.73e-3)" "unprognostic (6.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.93e-1)" "unprognostic (4.38e-1)" "unprognostic (1.72e-2)" "unprognostic (3.11e-1)" "prognostic favorable (3.85e-6)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" 27.5 26.5 29.8 15.7 35.7 14.3 34.0 23.3 35.3 20.8 30.0 12.9 21.3 27.6 24.0 24.2 27.0 22.9 20.9 65.1 24.4 23.2 45.3 48.1 18.7 14.9 28.5 34.4 35.7 19.5 22.2 24.9 20.7 26.7 22.9 30.5 16.4 24.4 26.3 105.5 23.0 25.5 34.3 27.0 13.6 24.1 20.9 24.6 12.9 25.1 67.3 19.3 21.7 22.4 24.3 41.0 6.7 32.8 24.5 25.2 21.9 30.0 26.7 53.2 31.4 36.3 52.8 44.7 36.6 35.7 40.7 49.9 32.5 39.6 21.4 48.2 31.2 39.1 22.2 18.8 43.6 47.1 19.7 35.9 14.7 26.5 29.2 38.7 35.3 25.5 43.7 50.5 28.0 49.5 45.0 35.3 24.3 12.5 23.4 37.1 28.1 26.6 29.7 16.1 11.5 30.2 32.1 30.0 42.1 43.3 29.0 24.5 26.6 25.1 24.4 43.0 29.7 39.1 37.2 27.0 25.0 26.7 18.1 47.7 18.0 22.4 25.8 26.7 51.9 36.0 6.7 28.9 2.4 17.5 32.8 19.5 24.3 22.2 20.2 41.0 16.5 25.1 25.2 2.4 24.5 32.4 31.0 23.5 21.9 29.8 35.7 23.3 35.3 24.4 23.2 28.5 34.4 26.7 24.6 35.7 44.6 76.7 128.0 111.7 41.6 329.5 76.5 76.3 71.7 80.3 39.3 136.6 469.2 144.1 42.2 91.5 124.0 0.0 145.6 142.3 128.2 89.3 73.9 126.2 125.7 28.6 86.8 73.6 66.4 51.2 145.9 104.9 111.3 170.5 117.4 77.9 141.9 140.3 143.5 309.1 67.6 122.9 122.6 70.4 45.1 88.7 150.5 58.9 149.5 126.8 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.6" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 706.2;Proximal tubular cells: 686.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018524, HPA067429" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA018524: AB_1854355, HPA067429: " "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 26.0 62.0 29.9 16.9 40.5 21.0 19.1 18.4 50.1 18.6 24.7 19.7 24.3 34.7 18.2 15.1 28.3 19.0 22.7 82.4 26.5 27.5 50.3 47.6 16.3 19.1 28.3 22.4 20.8 41.3 25.4 26.7 18.0 25.9 22.9 18.3 30.1 41.3 32.2 156.6 17.3 26.7 19.8 18.2 20.3 25.0 21.1 15.7 29.6 29.2 53.9 24.2 19.1 14.8 37.3 66.6 23.6 46.1 59.0 39.6 42.6 26.4 65.7 18.2 24.7 13.6 12.2 23.9 18.8 16.3 29.1 22.7 61.1 28.3 20.5 34.3 16.3 26.2 32.7 20.8 22.8 10.5 24.5 48.0 18.6 41.9 32.1 32.5 17.4 20.5 15.4 23.7 21.4 24.5 16.1 19.5 28.9 19.1 22.2 19.0 62.7 38.3 37.3 22.3 70.4 55.7 26.7 17.7 66.2 36.6 21.5 22.9 18.6 13.7 31.7 66.4 13.6 43.5 19.1 15.1 28.3 24.9 40.9 25.9 30.5 32.0 17.4 45.5 21.0 19.7 15.8 46.1 23.6 39.6 45.1 37.0 37.3 34.2 36.0 63.3 30.2 33.0 36.7 4.4 59.0 24.9 66.6 39.6 42.6 29.9 40.5 18.4 50.1 26.5 27.5 28.3 22.4 25.9 15.7 83.4 69.0 76.7 81.4 75.9 80.5 251.3 155.4 84.3 69.4 202.4 51.1 253.0 706.2 176.2 170.4 79.8 264.8 0.0 174.1 132.3 109.2 89.4 94.6 216.5 241.0 47.7 197.0 64.4 119.9 632.4 93.2 101.9 155.3 202.8 173.3 94.1 168.6 178.9 101.5 686.8 98.3 58.2 128.2 84.2 59.4 101.6 144.2 120.4 242.9 99.3 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 701.2;Late spermatids: 1042.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.4 11.0 18.0 13.6 11.9 13.6 19.2 11.0 11.5 9.6 20.7 11.9 10.7 15.2 7.2 15.6 10.5 12.8 16.9 7.5 6.1 15.5 35.3 13.3 16.2 21.4 12.0 18.5 13.3 14.7 11.6 18.4 10.4 14.4 7.4 27.9 14.0 13.1 18.9 8.0 18.2 14.4 21.5 22.4 13.9 8.0 33.4 15.4 12.8 8.1 8.4 19.3 22.8 12.7 6.2 19.6 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.2 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 50.6 37.7 43.0 46.0 17.6 69.1 701.2 89.2 92.3 27.3 85.5 64.8 46.1 195.6 69.0 416.9 34.9 128.4 140.2 87.3 49.8 41.1 75.6 30.1 285.4 97.8 54.0 75.1 62.0 81.5 1042.9 61.5 68.7 35.4 67.7 73.4 56.3 83.6 77.2 58.7 265.4 102.6 71.1 47.2 216.7 86.2 20.6 75.2 34.6 82.9 49.3 NEK9 "DKFZp434D0935, MGC16714, Nek8, NERCC" ENSG00000119638 "NIMA related kinase 9" Q8TD19 14 75079353-75127344 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001405 Approved Approved Mitochondria NA NA 190000 Mitochondria "HPA001405: AB_1079467" "unprognostic (1.00e-1)" "unprognostic (5.37e-2)" "unprognostic (9.97e-3)" "unprognostic (2.64e-2)" "unprognostic (3.86e-1)" "unprognostic (2.77e-1)" "unprognostic (1.12e-1)" "unprognostic (5.60e-3)" "unprognostic (2.81e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.63e-4)" "unprognostic (8.58e-2)" "unprognostic (1.36e-2)" "unprognostic (4.54e-2)" "unprognostic (9.22e-2)" "unprognostic (2.61e-1)" "unprognostic (1.57e-2)" 17.0 20.4 12.7 17.7 17.4 7.3 15.1 15.4 13.3 18.6 18.7 18.3 23.5 14.0 25.0 13.8 15.6 20.0 15.9 23.5 11.4 8.7 14.0 13.3 12.9 16.2 20.2 10.6 25.6 15.7 24.7 23.6 14.3 13.0 15.3 8.1 15.4 12.4 18.9 36.2 10.6 15.3 24.7 14.5 14.7 14.8 16.6 18.2 21.5 17.0 14.1 14.4 23.6 18.7 6.0 6.4 7.5 5.4 5.5 6.2 3.1 10.1 12.0 15.2 17.0 19.6 26.9 17.4 16.5 11.7 8.1 7.9 10.1 8.9 17.5 0.1 11.3 6.7 14.0 11.6 6.4 9.0 14.2 6.7 8.5 12.0 7.3 12.8 5.1 11.4 18.3 7.6 8.4 6.4 21.5 10.1 12.1 9.6 11.3 9.7 1.1 10.8 5.2 9.0 12.9 6.1 17.5 19.4 9.0 6.1 12.5 7.4 18.7 13.3 6.4 12.8 16.7 15.9 14.8 15.3 12.3 5.2 14.3 6.4 18.3 19.5 17.6 9.0 8.7 8.3 7.5 5.4 5.8 4.2 5.0 5.9 2.8 4.8 3.9 6.4 6.0 6.2 5.9 5.5 5.5 3.5 1.8 2.6 3.1 12.7 17.4 15.4 13.3 11.4 8.7 20.2 10.6 13.0 18.2 11.9 33.3 10.4 7.4 7.8 16.5 47.6 5.1 14.7 19.4 10.4 33.4 13.4 6.6 5.0 9.2 14.3 10.6 0.0 4.3 13.7 11.8 6.1 15.1 28.4 12.0 12.7 5.2 17.8 18.7 6.4 23.0 12.6 3.3 6.4 10.5 12.1 5.0 9.0 24.8 7.8 22.6 0.0 12.3 23.8 12.8 8.9 11.7 10.0 10.6 4.8 NF1 ENSG00000196712 "Neurofibromin 1" P21359 17 31094927-31382116 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 149.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.3;granulocytes: 6.5;T-cells: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045502 Uncertain Approved Mitochondria No No Mitochondria "HPA045502: AB_2679352" "unprognostic (6.69e-2)" "unprognostic (8.73e-2)" "unprognostic (8.26e-2)" "unprognostic (1.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.11e-1)" "unprognostic (1.30e-2)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.00e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (3.70e-1)" 12.9 15.9 22.6 13.3 25.9 5.5 18.5 30.2 26.0 17.6 13.6 19.8 12.2 11.0 16.9 17.0 10.5 15.2 13.1 17.3 21.6 19.6 20.0 15.1 12.7 11.5 19.4 25.6 22.9 16.5 34.1 19.0 19.4 20.9 16.1 14.7 12.1 14.4 20.5 14.8 12.0 12.1 14.5 21.4 11.9 13.0 15.4 21.5 11.6 31.1 7.6 12.4 15.3 19.5 2.3 0.7 6.5 0.4 0.9 8.4 1.0 9.8 12.9 15.7 8.4 13.4 17.5 7.9 8.6 15.5 12.7 14.4 11.6 6.7 9.5 2.5 16.0 15.0 17.3 14.2 12.0 21.5 4.6 8.9 8.4 12.1 5.9 9.5 15.0 7.0 13.8 7.7 13.5 16.5 14.4 6.1 10.1 12.0 9.5 12.1 7.8 12.5 5.5 4.6 6.1 4.3 9.8 24.0 7.6 9.6 14.2 6.5 9.8 15.9 5.3 8.8 11.6 16.2 9.6 8.9 10.2 14.2 12.0 3.2 8.7 4.2 10.5 8.3 6.3 10.5 6.5 0.4 0.9 2.3 0.2 1.6 2.3 4.4 3.9 0.5 2.1 3.3 3.2 1.0 0.9 0.4 0.7 8.4 1.0 22.6 25.9 30.2 23.5 21.6 19.6 19.4 25.6 20.9 21.5 29.8 23.6 12.7 38.9 34.3 61.1 39.2 40.8 29.4 20.5 38.4 129.6 44.8 19.9 23.9 149.0 31.8 28.2 0.0 19.3 22.1 28.2 47.4 10.4 31.7 18.9 66.7 19.0 31.9 24.3 70.0 34.5 21.8 20.3 16.2 26.8 49.7 28.6 35.4 47.4 23.7 66.0 45.3 36.7 28.2 25.6 29.6 41.2 18.5 22.6 60.1 NHLRC4 ENSG00000257108 "NHL repeat containing 4" P0CG21 16 566996-569495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 17.3" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 9.4;Collecting duct cells: 22.7;Erythroid cells: 23.3;Leydig cells: 7.5;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 5.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 4.6;HMC-1: 13.8;REH: 3.6;RPMI-8226: 5.8" "Low region specificity" "Detected in single" HPA077301 Approved Mitochondria NA NA Mitochondria "HPA077301: " "unprognostic (7.95e-2)" "unprognostic (5.87e-2)" "unprognostic (4.28e-3)" "unprognostic (2.53e-2)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" "unprognostic (2.28e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-3)" "unprognostic (1.19e-2)" "unprognostic (1.16e-2)" "unprognostic (5.16e-3)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.60e-1)" 1.3 6.9 1.6 1.4 2.3 3.4 1.4 1.4 1.8 2.4 0.9 1.7 9.5 1.4 2.5 21.1 0.7 17.3 1.5 1.8 2.4 2.4 7.0 0.3 4.8 3.8 0.5 0.9 5.1 0.2 5.9 1.4 1.5 2.0 2.2 0.3 2.1 3.1 10.9 2.3 0.3 1.7 0.5 0.8 4.8 0.8 2.8 0.7 7.8 0.4 0.4 1.2 1.3 0.7 1.1 4.4 5.0 0.5 0.7 1.5 0.7 0.0 0.0 0.6 0.1 0.1 0.3 0.1 0.0 0.8 0.2 0.2 0.1 0.2 0.8 0.6 0.1 0.0 0.1 0.0 0.1 0.0 2.4 0.2 4.6 0.0 1.0 1.0 0.3 13.8 2.9 0.0 0.1 0.3 0.0 0.3 0.8 1.4 1.6 0.0 0.0 0.5 3.4 0.3 0.0 0.0 3.6 0.0 5.8 0.3 0.2 0.0 1.3 0.0 0.0 0.5 0.1 0.6 0.7 0.7 0.0 0.1 0.0 0.0 2.1 1.9 0.9 0.0 0.2 0.4 0.0 0.5 5.0 0.4 0.2 0.7 1.1 1.3 0.6 0.6 0.7 1.5 0.8 0.0 0.7 0.2 4.4 1.4 0.7 1.6 2.3 1.4 1.8 2.4 2.4 0.5 0.9 2.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 9.4 2.3 22.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.3 0.2 0.0 0.4 0.2 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 7.5 0.5 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 0.0 6.5 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 97.3;skeletal muscle: 144.4" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 161.9;Distal tubular cells: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 80.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria NA NA Mitochondria "HPA063084: AB_2684938" "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 14.5 19.3 18.4 8.4 22.9 8.6 16.6 11.8 24.5 12.6 14.6 8.9 11.8 8.1 11.0 11.1 12.9 13.4 8.0 97.3 18.7 15.9 16.6 5.2 13.2 16.6 17.0 16.7 9.5 13.5 11.8 8.6 8.0 17.2 14.3 14.2 6.8 18.9 15.5 144.4 6.3 8.3 21.6 19.3 6.5 11.6 5.8 12.1 7.4 22.6 39.8 7.2 12.4 7.8 14.3 34.1 14.1 33.1 15.2 14.1 24.7 80.6 14.3 18.9 31.4 10.9 19.1 9.3 6.8 16.1 19.7 15.2 9.9 17.9 11.8 11.4 12.7 19.1 10.8 14.2 14.4 19.6 7.5 20.9 8.4 8.5 12.6 15.7 18.1 8.5 17.3 22.1 6.7 18.3 22.4 20.7 17.2 14.9 11.7 15.2 3.5 18.0 18.8 18.5 18.0 14.5 18.3 8.8 24.3 26.5 12.7 20.2 22.8 15.5 18.7 21.0 15.6 36.2 19.6 12.0 9.0 13.6 3.1 14.0 9.6 8.1 21.9 9.9 11.4 26.5 13.4 33.1 14.1 8.7 31.8 10.6 14.3 11.7 9.3 34.1 12.3 14.1 10.1 5.8 15.2 23.9 14.1 13.6 24.7 18.4 22.9 11.8 24.5 18.7 15.9 17.0 16.7 17.2 12.1 47.6 42.3 0.0 0.0 0.0 0.0 0.0 0.0 161.9 79.6 59.3 0.0 65.3 192.3 62.3 0.0 0.0 0.0 0.0 50.1 44.3 0.0 0.0 15.1 0.0 79.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 69.5 0.0 0.0 39.8 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.0 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 31.6;Horizontal cells: 54.0;Muller glia cells: 23.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 26.1" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria NA NA Mitochondria "HPA055321: AB_2682783, HPA069278: AB_2686105" "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 13.0 10.9 31.3 9.9 45.3 2.4 7.4 32.7 47.0 16.9 11.3 18.3 9.5 4.4 25.3 16.4 9.0 13.8 15.5 6.6 28.8 16.0 5.7 3.3 6.2 6.1 13.9 27.5 24.3 7.4 20.7 8.3 8.5 21.3 11.6 5.9 11.2 6.5 19.2 6.3 8.7 5.4 24.3 19.4 7.5 5.9 4.8 15.9 0.0 4.8 1.7 5.0 9.8 11.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.2 5.9 26.1 15.1 8.0 11.2 0.6 7.0 11.1 11.9 11.0 1.3 1.4 0.0 3.4 9.7 7.0 2.4 4.8 2.9 6.4 6.3 4.9 1.8 5.3 1.0 4.1 1.8 6.4 9.0 2.4 9.8 1.6 18.0 4.0 2.3 1.7 3.4 5.0 4.0 0.8 1.8 4.4 0.2 2.8 7.5 3.1 0.8 3.5 0.9 0.4 10.5 3.2 1.5 1.8 5.4 4.2 0.2 5.5 10.3 13.1 6.5 3.4 3.9 1.3 0.7 10.7 1.7 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 45.3 32.7 37.2 28.8 16.0 13.9 27.5 21.3 15.9 0.0 1.6 0.0 2.5 4.1 31.6 10.9 0.0 0.0 0.0 0.0 7.9 0.3 0.0 2.7 1.3 5.2 0.0 0.0 0.3 5.7 11.2 2.1 0.0 2.1 0.8 54.0 0.0 4.9 0.3 2.5 15.8 0.0 1.7 1.0 0.0 23.0 2.1 0.0 20.8 1.0 15.3 32.3 10.3 0.3 1.3 3.3 0.7 1.0 0.0 1.0 NLN "AGTBP, KIAA1226" ENSG00000123213 Neurolysin Q9BYT8 5 65722196-65871725 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 5 "dendritic cells: 4.1;monocytes: 5.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031862 Approved Approved Mitochondria Yes No 53000 Mitochondria "HPA031862: AB_10600827" "unprognostic (5.91e-3)" "unprognostic (4.52e-2)" "unprognostic (1.34e-3)" "unprognostic (4.37e-2)" "unprognostic (3.85e-1)" "unprognostic (1.45e-2)" "unprognostic (7.29e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-1)" "unprognostic (3.58e-1)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.27e-1)" "prognostic favorable (5.58e-7)" "unprognostic (1.52e-2)" "unprognostic (1.98e-1)" "unprognostic (1.29e-1)" "unprognostic (6.18e-3)" 4.5 2.4 7.6 4.7 10.5 2.9 7.3 2.8 11.9 4.1 6.8 5.8 1.0 2.4 5.8 5.0 5.2 3.3 2.7 5.1 7.2 7.6 7.5 18.9 3.4 5.1 8.7 8.5 4.0 11.0 3.6 2.4 4.9 9.8 5.4 6.5 2.0 4.3 2.6 15.0 5.7 5.3 5.5 10.9 5.8 7.5 2.4 6.2 1.8 5.5 7.9 4.0 4.3 3.3 0.9 4.1 0.6 5.9 0.9 0.7 1.8 9.2 8.9 5.3 8.7 6.7 11.5 10.6 9.4 4.0 5.5 6.0 5.1 5.5 13.2 11.9 11.2 11.1 7.4 6.8 14.4 9.7 3.9 4.6 3.6 6.7 12.8 5.8 8.3 2.2 8.7 7.9 7.6 9.1 4.7 15.5 5.9 7.8 2.8 11.9 7.1 5.7 7.5 16.1 4.7 2.6 6.7 11.2 20.9 9.1 4.1 16.4 8.5 7.6 7.8 7.7 14.9 9.3 9.9 8.9 3.7 4.4 5.4 7.0 2.4 4.8 5.8 5.7 16.4 5.5 0.2 4.7 0.2 0.2 5.9 0.3 0.9 0.4 0.3 4.1 0.9 0.7 0.5 0.6 0.9 4.1 0.2 0.1 1.8 7.6 10.5 2.8 11.9 7.2 7.6 8.7 8.5 9.8 6.2 6.0 3.2 1.5 5.1 5.0 0.6 13.2 10.2 2.7 11.4 12.2 3.9 5.2 5.0 15.3 0.2 5.0 20.6 0.0 12.3 12.1 5.2 8.8 15.0 26.4 24.7 4.8 1.7 5.5 23.4 0.0 4.0 8.4 1.7 2.8 7.1 13.2 23.5 10.7 2.1 17.4 3.5 0.0 3.1 1.4 4.3 4.5 2.4 0.9 7.1 5.5 NLRP4 "CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2" ENSG00000160505 "NLR family pyrin domain containing 4" Q96MN2 19 55836578-55881854 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.4;lymphoid tissue: 9.0;testis: 12.1" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 10.4;Late spermatids: 5.5;Spermatogonia: 2.3" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 5 "B-cells: 2.4" "Cell line enriched" "Detected in some" 8 "Daudi: 42.9" HPA062128 Approved Mitochondria NA NA Mitochondria "HPA062128: " "unprognostic (2.48e-1)" "unprognostic (7.01e-2)" "unprognostic (4.21e-2)" "unprognostic (1.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.81e-1)" "unprognostic (2.36e-3)" "unprognostic (3.72e-2)" "unprognostic (2.36e-1)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" 0.2 0.2 1.9 1.0 1.8 0.0 0.2 0.2 2.9 0.2 0.2 2.7 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 1.0 0.3 0.2 0.2 0.2 2.8 5.1 0.6 0.4 0.2 0.1 0.3 0.0 2.9 0.2 0.1 0.0 0.8 0.0 0.2 0.2 0.3 0.1 9.4 0.3 0.2 12.1 2.2 0.0 0.2 0.4 9.0 0.2 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 1.8 0.2 2.9 1.0 0.3 5.1 0.6 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.0 NME4 "NDPKD, nm23-H4, NM23H4" ENSG00000103202 "NME/NM23 nucleoside diphosphate kinase 4" O00746 16 396725-410367 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid transport, Nucleotide metabolism, Transport" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB045997, HPA072588" Approved Supported Mitochondria Yes No Mitochondria "CAB045997: AB_11126630, HPA072588: AB_2686538" "unprognostic (3.27e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (3.70e-2)" "unprognostic (7.16e-3)" "unprognostic (1.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (4.46e-3)" "unprognostic (1.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.74e-2)" "unprognostic (7.79e-3)" "prognostic unfavorable (1.61e-7)" "unprognostic (3.78e-2)" "unprognostic (2.16e-1)" "unprognostic (6.04e-2)" "unprognostic (3.08e-1)" 34.5 34.4 21.5 13.9 17.6 46.8 34.6 10.4 13.6 25.6 44.6 12.8 40.7 9.7 21.7 33.7 25.1 20.0 39.9 26.9 16.6 16.5 20.2 61.2 13.5 27.5 16.9 11.3 31.9 19.2 22.0 17.3 19.4 11.7 46.9 10.6 32.2 44.4 44.0 13.7 7.5 15.3 83.9 12.4 17.8 27.1 13.3 10.9 19.6 21.0 14.2 14.5 64.1 27.5 13.1 28.6 18.2 6.3 1.2 13.7 5.2 0.1 50.4 44.8 61.6 18.0 31.6 10.0 23.7 28.6 35.9 30.9 33.6 29.3 0.5 17.9 37.8 13.0 0.6 24.2 25.5 10.6 20.3 36.2 24.4 6.9 44.9 34.0 17.8 9.0 40.6 13.4 22.0 2.1 25.9 23.0 35.1 25.3 4.3 26.7 41.3 15.5 22.4 45.7 12.3 11.2 78.4 10.0 12.7 24.9 0.2 13.1 71.0 6.0 0.4 22.1 17.2 30.0 41.8 28.7 25.7 37.4 17.1 5.9 0.5 0.3 13.3 11.2 3.2 29.6 4.1 6.3 18.2 7.5 5.6 6.5 12.3 7.7 8.3 8.7 13.1 13.7 7.1 2.2 1.2 4.8 28.6 0.4 5.2 21.5 17.6 10.4 13.6 16.6 16.5 16.9 11.3 11.7 10.9 0.0 11.5 29.0 48.4 28.6 13.9 34.0 35.7 4.0 4.5 55.8 2.0 59.9 212.2 109.2 3.5 43.9 11.0 186.9 35.0 20.4 74.3 109.3 29.9 119.9 107.7 7.9 43.4 47.9 41.0 14.6 82.6 23.2 59.1 66.7 34.5 18.6 75.4 17.3 89.1 59.0 5.4 51.8 95.1 1.4 43.5 21.5 18.2 14.9 56.3 48.5 NME7 "CFAP67, FLJ37194, NM23-H7" ENSG00000143156 "NME/NM23 family member 7" Q9Y5B8 1 169132531-169367967 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038014, HPA054289" Approved Approved Mitochondria NA NA Mitochondria "HPA038014: AB_10673037, HPA054289: AB_2682437" "unprognostic (1.28e-1)" "unprognostic (8.52e-2)" "unprognostic (6.21e-2)" "unprognostic (6.30e-2)" "unprognostic (1.11e-1)" "unprognostic (7.44e-3)" "prognostic unfavorable (3.24e-5)" "unprognostic (1.42e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (2.00e-1)" "unprognostic (6.63e-2)" "unprognostic (2.67e-2)" "unprognostic (1.12e-1)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" 7.7 12.1 13.5 8.0 22.8 3.7 12.8 14.6 16.8 15.6 11.5 5.5 13.4 4.6 16.0 15.8 8.6 31.1 11.2 8.4 18.9 11.3 13.9 8.6 8.9 6.0 9.5 11.5 17.0 8.1 18.9 39.9 5.6 15.6 9.6 6.7 9.3 5.9 14.3 5.1 4.9 5.5 17.2 9.5 5.2 8.1 17.2 9.6 11.9 15.9 5.8 7.0 10.0 8.2 8.5 5.2 1.7 7.1 9.1 12.0 4.7 10.5 11.3 12.3 9.6 12.4 12.5 4.4 7.3 11.1 13.3 16.9 6.4 16.0 3.1 13.4 6.5 18.4 7.4 6.9 15.8 21.8 11.0 5.7 5.6 10.8 6.5 8.5 10.2 3.6 9.1 9.6 13.4 18.2 19.2 19.0 9.6 5.3 4.3 13.3 3.4 9.2 7.5 12.1 12.7 11.6 7.2 13.3 6.8 21.6 3.1 13.3 19.2 11.1 3.3 8.2 14.4 11.4 7.4 11.4 8.3 27.5 7.3 17.7 5.2 8.8 6.5 9.1 3.6 8.2 1.4 3.3 1.7 8.3 5.1 10.1 8.5 10.8 8.8 5.2 7.0 9.3 10.6 1.0 9.1 7.1 4.4 12.0 4.7 13.5 22.8 14.6 16.8 18.9 11.3 9.5 11.5 15.6 9.6 6.0 7.5 8.2 29.3 12.8 17.2 4.1 15.3 72.3 15.9 26.2 23.6 6.8 19.9 22.8 19.4 13.7 2.6 0.0 7.9 6.3 18.5 7.6 20.8 10.4 12.0 27.0 16.8 11.1 4.0 7.9 16.7 8.2 8.5 2.8 3.9 18.0 13.9 6.0 19.4 30.7 61.3 19.4 17.5 51.2 20.0 8.9 2.3 14.1 6.6 17.3 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039077, HPA057402" Approved Supported Mitochondria NA NA Mitochondria "HPA039077: AB_2676336, HPA057402: AB_2683427" "unprognostic (9.45e-3)" "prognostic favorable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 6.2 6.3 9.9 7.0 9.8 14.1 10.8 7.7 9.8 7.4 7.4 6.8 2.7 7.8 7.9 7.3 6.5 11.6 7.9 12.6 11.9 8.1 7.9 6.2 4.7 3.6 7.7 14.0 17.9 10.0 6.2 6.6 1.8 6.7 7.6 6.4 12.7 7.5 4.8 21.9 14.9 6.5 7.3 7.0 4.2 4.8 16.8 8.4 2.4 8.3 9.0 4.8 6.3 6.8 7.2 4.2 11.9 5.0 6.1 5.1 2.1 6.8 3.0 3.3 3.7 0.8 0.7 4.4 2.9 0.4 0.5 0.4 3.9 5.2 4.8 8.8 0.6 3.3 3.5 2.3 1.0 0.7 4.4 3.9 22.3 6.3 5.0 1.8 4.2 4.3 1.2 5.8 0.9 1.4 7.0 0.5 2.9 3.9 10.6 0.5 4.7 4.0 3.7 7.5 12.0 2.9 3.5 3.7 3.2 1.0 5.2 7.2 4.4 6.9 3.8 2.5 6.5 9.5 11.2 3.9 4.7 10.4 5.6 4.3 17.6 8.3 3.4 3.2 6.7 4.3 11.9 5.0 3.0 4.1 4.5 3.0 3.6 3.6 3.4 3.6 7.2 5.1 5.1 10.8 6.1 4.4 4.2 2.2 2.1 9.9 9.8 7.7 9.8 11.9 8.1 7.7 14.0 6.7 8.4 527.0 437.0 3.0 5.2 3.7 2.5 7.5 2.5 459.0 396.9 8.7 3.9 0.3 10.0 2.6 101.2 2.3 2.0 0.0 2.7 0.3 4.7 3.7 256.9 2.1 1.9 1.6 6.4 3.1 2.6 164.7 7.2 4.0 6.8 0.0 5.5 7.8 0.7 3.5 6.0 12.0 18.2 6.5 1.2 39.2 2.6 8.4 0.1 0.0 11.4 3.8 NOA1 "C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3" ENSG00000084092 "Nitric oxide associated 1" Q8NC60 4 56963370-56978823 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 22.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035838, HPA035839" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035838: AB_10669531, HPA035839: AB_10669658" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (1.65e-3)" "unprognostic (5.19e-2)" "unprognostic (9.06e-2)" "unprognostic (1.49e-2)" "unprognostic (2.04e-2)" "unprognostic (1.29e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.38e-4)" "unprognostic (8.97e-2)" "unprognostic (6.87e-2)" "unprognostic (1.79e-2)" "unprognostic (4.27e-2)" 4.5 4.7 2.6 3.0 3.2 5.4 5.3 4.3 2.8 4.3 5.3 7.0 5.9 3.8 6.1 6.0 2.9 3.5 2.5 2.1 3.6 2.8 3.3 5.1 2.1 5.6 13.9 3.6 2.1 2.3 3.8 4.9 5.9 3.7 10.5 6.8 4.9 3.2 2.6 3.8 6.0 1.7 4.0 5.8 6.7 4.5 20.2 16.5 7.0 14.1 20.3 22.3 14.3 7.5 7.0 5.2 9.2 9.6 17.2 14.3 6.0 10.8 6.9 7.0 12.0 14.2 27.1 10.4 5.0 5.7 8.1 9.8 10.6 6.6 5.0 12.7 6.8 6.2 13.0 7.5 12.3 7.4 15.9 12.9 6.4 11.2 14.7 11.5 11.9 11.4 9.8 9.3 10.9 17.6 16.5 6.8 14.5 10.8 12.3 5.6 10.2 9.9 11.3 12.0 10.2 6.1 25.0 8.9 6.9 11.2 8.8 7.5 5.6 13.4 6.7 11.1 12.6 5.2 14.1 5.7 7.9 7.1 6.2 14.1 7.0 12.2 13.0 18.3 20.2 18.2 15.2 16.5 17.0 22.3 18.4 4.8 20.3 11.2 13.3 21.1 14.3 3.0 4.3 15.3 14.0 22.6 6.3 12.0 12.7 18.7 10.3 7.0 3.9 27.0 16.6 15.6 19.3 11.3 11.0 0.0 19.7 29.3 15.0 12.7 8.1 4.3 16.0 1.6 16.8 6.7 17.8 9.1 15.0 14.6 11.8 19.0 19.9 8.0 18.7 21.0 21.9 11.2 8.0 12.9 16.5 7.5 10.5 21.7 23.3 19.1 38.8 19.5 NOD1 "CARD4, CLR7.1, NLRC1" ENSG00000106100 "Nucleotide binding oligomerization domain containing 1" Q9Y239 7 30424527-30478784 "Predicted intracellular proteins" "Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 10.8;Ito cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074367 Approved Mitochondria NA NA Mitochondria "HPA074367: AB_2686683" "unprognostic (2.58e-1)" "unprognostic (1.56e-2)" "unprognostic (9.73e-2)" "unprognostic (8.09e-3)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-3)" "unprognostic (6.63e-2)" "unprognostic (2.26e-1)" "unprognostic (2.74e-1)" "unprognostic (8.78e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.68e-4)" "unprognostic (6.62e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.95e-4)" "unprognostic (2.64e-1)" 15.2 3.2 3.9 11.1 3.7 6.6 18.3 2.0 2.4 6.5 6.2 4.3 5.0 2.2 8.7 8.9 6.1 7.3 10.1 10.9 2.9 2.1 5.0 2.9 13.8 6.0 3.2 2.2 13.6 4.6 3.8 4.6 13.3 4.7 5.5 4.7 6.4 7.7 7.6 7.2 7.1 6.2 16.3 4.7 12.4 6.9 3.2 3.5 5.1 27.2 6.4 11.1 7.6 6.1 10.9 8.2 13.3 6.2 8.7 9.8 2.4 4.3 2.3 3.2 9.6 2.1 9.9 5.0 3.0 2.1 5.1 6.5 2.0 5.2 6.1 3.6 3.8 5.7 10.1 3.2 5.2 3.5 3.2 2.7 8.6 7.1 2.0 2.6 3.8 6.5 9.1 2.3 3.2 2.8 4.6 16.7 9.3 4.5 2.2 4.6 2.5 5.4 6.8 3.8 4.7 4.1 6.5 3.7 5.5 1.7 3.4 0.6 11.7 3.8 9.9 3.3 4.7 3.3 8.6 7.0 4.5 7.4 5.5 4.1 2.0 6.8 0.2 3.3 13.5 4.6 12.7 3.9 13.3 8.8 5.2 9.8 7.6 6.1 5.7 3.4 10.9 5.6 4.5 3.0 8.7 6.2 8.2 4.6 2.4 3.9 3.7 2.0 2.4 2.9 2.1 3.2 2.2 4.7 3.5 3.0 10.8 0.0 0.4 0.7 0.6 4.0 0.0 4.0 7.9 5.2 0.0 4.5 0.0 1.3 0.0 6.0 2.0 0.0 1.8 2.0 3.4 0.2 2.3 0.8 3.8 0.0 0.0 10.4 4.3 0.0 0.6 4.4 5.0 3.6 5.7 0.9 1.1 0.0 1.8 0.5 0.0 0.0 4.7 0.0 0.5 1.6 1.3 2.9 5.2 0.9 NUBPL "C14orf127, FLJ12660, huInd1, IND1" ENSG00000151413 "Nucleotide binding protein like" Q8TB37 14 31489956-31861224 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029203 Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA029203: AB_10602810" "unprognostic (1.49e-1)" "unprognostic (1.71e-2)" "unprognostic (5.21e-3)" "unprognostic (8.28e-2)" "unprognostic (8.25e-2)" "unprognostic (1.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.93e-2)" "unprognostic (1.15e-1)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "prognostic favorable (3.64e-8)" "unprognostic (2.82e-2)" "unprognostic (6.60e-2)" "unprognostic (3.67e-3)" "unprognostic (1.56e-2)" 12.0 16.0 11.4 11.6 10.7 2.1 12.1 5.7 11.5 7.5 10.1 10.6 9.1 6.6 14.7 13.3 7.6 9.0 7.4 22.5 11.5 9.2 16.5 16.2 10.2 6.9 11.0 8.9 11.3 7.8 14.1 19.0 7.4 12.7 8.9 10.7 10.0 15.4 9.0 16.7 8.1 7.7 11.3 13.5 8.5 8.0 19.2 12.2 6.2 10.8 6.3 8.7 9.7 7.5 4.9 7.5 0.7 2.0 4.1 5.4 1.5 10.5 6.7 5.1 2.5 7.3 13.5 8.9 5.4 6.5 6.9 8.4 4.6 12.2 7.5 7.2 7.1 5.9 9.4 6.8 11.7 12.4 5.4 8.7 2.7 5.0 23.6 7.2 7.9 2.4 8.8 13.8 4.8 10.5 5.9 4.0 5.4 4.9 4.0 7.8 5.8 5.8 5.5 4.2 8.4 10.2 6.6 10.6 4.1 8.3 7.9 4.9 5.0 9.2 8.7 11.3 6.1 17.0 4.2 3.8 7.0 4.8 4.5 5.3 6.4 6.4 7.4 4.7 5.7 6.3 0.0 2.0 0.6 3.9 2.0 3.1 4.9 4.5 4.2 7.5 2.9 5.4 4.2 0.7 4.1 1.1 3.6 2.5 1.5 11.4 10.7 5.7 11.5 11.5 9.2 11.0 8.9 12.7 12.2 11.9 9.8 3.9 7.4 8.5 14.6 31.5 15.3 22.7 14.8 8.7 19.6 9.4 6.6 5.5 15.6 8.0 6.3 0.0 5.0 8.4 9.8 4.9 13.9 11.6 4.4 9.5 6.9 4.9 3.3 5.3 6.1 7.2 11.8 1.0 10.0 15.8 4.2 2.9 11.0 14.6 27.1 12.9 6.5 13.7 5.2 10.2 4.8 4.4 16.8 5.5 OCIAD1 "Asrij, FLJ20455, OCIA, TPA018" ENSG00000109180 "OCIA domain containing 1" Q9NX40 4 48805212-48861817 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044803 Approved Approved Mitochondria NA NA Mitochondria "HPA044803: AB_10961287" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" "unprognostic (4.82e-2)" "unprognostic (7.39e-2)" "unprognostic (1.69e-1)" "unprognostic (4.17e-2)" "unprognostic (2.53e-1)" "unprognostic (1.60e-1)" "unprognostic (4.10e-1)" "unprognostic (2.83e-3)" "unprognostic (1.34e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (9.23e-2)" "unprognostic (2.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" 28.8 43.6 59.9 24.7 73.5 21.8 35.9 55.3 82.2 37.4 37.6 36.1 35.4 33.5 34.1 49.3 28.1 41.6 29.9 47.9 62.7 61.9 57.8 79.0 27.7 32.0 51.4 60.7 40.4 34.6 52.4 53.5 29.0 53.6 34.8 39.6 29.1 34.8 36.4 53.5 23.9 30.1 33.4 51.0 23.7 31.0 23.7 35.1 29.1 55.1 37.2 31.0 31.6 24.0 33.2 35.9 30.7 33.6 41.9 43.2 30.0 25.3 18.6 38.3 26.2 38.0 45.9 29.6 41.5 64.9 42.7 50.1 18.1 72.1 29.4 41.5 36.4 50.3 22.2 36.3 38.4 51.9 24.4 24.3 45.8 18.9 14.7 56.3 47.1 49.6 48.9 56.2 33.5 41.4 50.5 43.7 28.7 50.9 16.5 49.6 17.3 40.4 47.1 31.5 31.6 17.5 28.2 37.2 31.1 82.7 25.6 22.5 41.4 20.4 16.2 45.9 31.9 32.7 41.3 33.0 28.3 32.7 19.4 51.7 42.8 59.3 46.3 34.5 37.8 34.5 17.6 26.0 30.7 30.5 28.5 41.6 33.2 34.7 36.2 32.5 29.3 43.2 37.2 21.2 41.9 33.6 35.9 29.0 30.0 59.9 73.5 55.3 82.2 62.7 61.9 51.4 60.7 53.6 35.1 148.9 102.8 64.1 94.0 70.7 125.5 130.0 91.7 135.1 126.3 115.1 62.8 145.3 116.0 119.6 27.3 96.7 127.3 23.3 111.9 141.2 103.1 99.3 136.5 146.0 135.1 84.2 124.9 116.0 90.1 28.7 122.6 103.2 82.7 75.7 122.7 180.6 107.9 109.4 130.8 136.7 91.1 122.9 84.8 156.2 74.3 66.4 137.8 88.7 125.2 76.6 OCIAD2 MGC45416 ENSG00000145247 "OCIA domain containing 2" Q56VL3 4 48885019-48906937 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.2;U-251 MG: 66.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040979, HPA041090" Enhanced Enhanced Mitochondria No No Mitochondria "HPA040979: AB_10795497, HPA041090: AB_10796236" "unprognostic (4.29e-1)" "unprognostic (2.69e-1)" "unprognostic (3.76e-2)" "prognostic favorable (7.37e-4)" "unprognostic (3.49e-2)" "unprognostic (1.66e-2)" "unprognostic (9.05e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-1)" "prognostic favorable (6.56e-4)" "prognostic unfavorable (6.89e-4)" "unprognostic (1.38e-1)" "prognostic favorable (2.67e-5)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (8.24e-3)" "prognostic favorable (2.34e-4)" 4.0 10.7 24.5 15.7 18.3 4.7 8.1 3.7 14.0 7.2 23.0 1.9 14.0 41.6 8.9 19.5 12.4 7.7 22.3 7.2 19.9 11.7 51.6 43.6 6.6 10.7 9.7 9.9 3.7 13.2 9.4 18.7 2.9 8.8 8.8 17.3 6.6 18.3 12.9 1.8 9.0 37.5 5.2 4.1 5.2 27.9 4.1 5.7 24.9 14.9 5.8 13.3 9.3 8.5 29.7 22.9 32.7 0.6 27.1 60.8 26.1 34.4 18.4 0.2 0.0 0.0 0.0 0.5 9.0 4.1 4.8 4.6 0.0 42.8 6.0 40.1 5.1 43.2 11.1 5.1 56.2 5.0 14.0 3.8 0.0 13.5 0.0 4.5 16.9 0.0 2.6 25.7 0.0 11.0 14.2 20.1 24.2 0.0 3.0 5.1 13.0 28.3 11.4 17.7 39.1 24.9 6.4 0.0 9.9 49.9 22.7 39.8 12.1 12.9 4.4 0.9 0.1 4.5 4.2 33.4 0.0 37.2 0.2 66.8 8.5 9.7 19.0 28.7 0.0 0.0 32.7 0.6 12.4 20.4 0.2 27.0 29.7 38.4 29.2 3.4 27.0 50.2 33.6 2.1 27.1 0.2 22.9 60.8 26.1 24.5 18.3 3.7 14.0 19.9 11.7 9.7 9.9 8.8 5.7 26.8 63.5 79.5 119.3 96.9 7.4 32.5 201.2 73.6 62.6 167.5 27.5 30.6 184.1 416.6 0.8 82.3 395.2 46.7 497.9 9.4 14.8 156.3 35.8 172.0 35.7 1.6 294.2 16.5 3.7 1.2 4.6 15.3 62.4 17.2 244.9 20.9 896.7 160.4 20.1 1166.8 52.0 0.0 20.8 0.9 2.2 114.8 12.8 114.6 155.7 207.5 OGDH E1k ENSG00000105953 "Oxoglutarate dehydrogenase" Q02218 7 44606572-44709066 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.3" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019514, HPA020347" Supported Enhanced Mitochondria No No 53000 Mitochondria "HPA019514: AB_1854772, HPA020347: AB_1854773" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (4.39e-1)" "unprognostic (5.64e-3)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (3.45e-1)" "unprognostic (7.58e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-2)" "unprognostic (3.38e-1)" "unprognostic (3.30e-2)" "prognostic favorable (2.22e-14)" "unprognostic (1.53e-1)" "unprognostic (1.62e-1)" "unprognostic (2.23e-2)" "unprognostic (5.88e-3)" 18.9 20.8 12.3 14.5 18.5 8.7 11.0 14.3 23.7 10.1 19.4 15.9 13.5 29.0 16.2 11.1 19.5 11.1 11.8 73.9 11.3 12.8 28.8 14.8 13.0 11.1 14.2 11.7 9.8 13.0 25.5 11.0 14.5 22.2 12.3 13.3 22.3 23.7 15.9 99.3 15.6 35.5 16.4 10.1 12.1 14.9 11.3 11.0 11.3 17.8 39.8 15.8 13.0 10.8 7.2 13.4 7.5 20.4 11.2 25.7 11.6 10.8 22.8 13.7 20.8 21.2 23.3 13.3 17.0 16.6 19.3 16.9 20.7 22.5 47.8 20.2 24.7 39.0 33.8 27.0 25.4 18.9 27.9 7.1 14.5 46.1 10.2 10.8 17.9 16.3 21.6 19.3 27.4 19.7 14.2 26.2 16.0 16.7 14.3 20.4 15.3 17.7 10.3 12.6 30.2 25.7 17.0 9.6 53.6 22.2 32.4 23.4 11.2 24.5 34.1 10.6 25.9 20.2 18.0 20.6 13.9 12.6 24.2 19.6 13.0 24.9 26.4 25.3 20.3 25.3 4.8 12.1 7.3 11.7 17.7 12.8 7.2 13.5 11.7 13.4 5.9 5.8 7.0 7.5 11.2 20.4 6.6 25.7 11.6 12.3 18.5 14.3 23.7 11.3 12.8 14.2 11.7 22.2 11.0 6.0 22.7 20.4 11.1 17.3 20.1 100.7 15.3 12.0 9.1 45.4 17.7 19.4 26.6 13.2 43.1 14.2 61.4 0.0 14.8 14.3 16.4 14.4 20.8 17.5 29.3 58.8 22.4 14.1 22.4 20.0 10.9 21.9 20.3 21.6 29.2 15.4 16.7 21.0 16.3 38.9 22.2 19.4 18.2 9.1 20.0 23.1 30.7 13.8 27.6 14.2 OSGEPL1 "OSGEPL, Qri7" ENSG00000128694 "O-sialoglycoprotein endopeptidase like 1" Q9H4B0 2 189746660-189763227 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030693 Uncertain Supported Mitochondria NA NA Mitochondria "HPA030693: AB_10601978" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (8.19e-2)" "unprognostic (6.70e-2)" "unprognostic (6.07e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (4.18e-3)" "unprognostic (1.06e-3)" "prognostic favorable (3.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-2)" "unprognostic (2.68e-1)" "unprognostic (1.51e-2)" "unprognostic (6.39e-2)" "unprognostic (1.55e-3)" 6.6 17.0 8.6 6.5 12.1 2.6 11.1 12.9 10.9 7.3 5.6 14.8 2.9 5.0 11.8 9.1 7.0 8.1 4.8 13.0 8.4 7.3 13.0 11.6 5.8 11.2 18.9 9.3 13.8 6.1 7.5 9.8 6.1 11.6 6.9 6.1 9.0 9.7 6.1 16.6 9.2 6.5 8.1 13.4 9.6 5.8 9.4 15.4 10.6 8.2 7.3 9.2 8.0 5.8 9.3 6.0 2.1 2.6 6.6 11.5 3.0 5.6 3.1 13.9 10.6 11.0 6.1 8.3 8.8 6.2 12.5 13.5 3.7 5.9 3.8 9.9 3.7 7.0 8.3 12.4 10.4 14.3 9.7 9.5 12.3 7.7 4.8 5.8 6.9 6.4 6.7 8.9 9.4 4.7 8.6 9.3 9.7 4.4 6.0 8.2 3.2 5.4 8.0 6.7 7.7 14.5 5.9 11.2 6.5 8.1 3.2 8.5 9.4 5.9 10.8 19.2 18.1 8.4 7.6 3.9 8.2 7.2 11.9 5.4 6.1 5.1 6.1 10.8 8.9 8.9 0.2 2.6 2.1 7.3 2.4 10.5 7.4 7.7 8.4 3.5 9.3 11.5 10.2 0.4 6.6 2.1 6.0 5.9 3.0 8.6 12.1 12.9 10.9 8.4 7.3 18.9 9.3 11.6 15.4 6.0 2.2 1.3 2.3 1.6 8.0 8.1 2.5 8.1 1.2 0.0 11.8 8.6 6.6 2.4 0.6 2.3 0.9 0.0 2.0 6.1 3.8 1.2 3.5 3.0 3.8 9.5 0.0 4.3 1.0 0.0 10.3 2.3 1.7 0.0 1.1 12.4 1.5 0.0 7.8 8.4 10.0 25.8 3.1 10.7 12.6 1.8 1.8 5.0 2.3 0.5 OTC ENSG00000036473 "Ornithine carbamoyltransferase" P00480 X 38352545-38421450 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 59.1;liver: 90.3" "Group enriched" "Detected in some" 7 "Hepatocytes: 74.1;Ito cells: 20.3" "Cancer enriched" "Detected in some" 20 "liver cancer: 59.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NB-4: 1.7;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8" "Not detected" "Not detected" "HPA000243, HPA000570" Enhanced Supported Mitochondria NA NA 1800000 Mitochondria "HPA000243: AB_1079535, HPA000570: AB_1079534" "unprognostic (6.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.89e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.70e-3)" "unprognostic (5.61e-2)" 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.8 16.5 0.0 0.2 26.9 1.1 0.2 0.2 0.3 5.3 0.2 0.1 0.2 0.1 90.3 0.7 2.3 0.2 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.1 0.1 59.1 0.8 0.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.6 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 1.7 0.0 0.2 0.0 0.0 0.0 0.0 74.1 0.0 0.0 1.2 20.3 1.9 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.5 0.0 OXA1L "MGC133129, OXA1" ENSG00000155463 "OXA1L, mitochondrial inner membrane protein" Q15070 14 22766522-22773041 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003531 Approved Supported Mitochondria NA NA Mitochondria "HPA003531: AB_1079539" "unprognostic (4.04e-3)" "unprognostic (2.41e-2)" "unprognostic (3.39e-1)" "unprognostic (2.24e-2)" "unprognostic (7.25e-2)" "unprognostic (1.42e-2)" "unprognostic (1.08e-2)" "unprognostic (1.06e-2)" "unprognostic (1.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "prognostic favorable (4.82e-4)" "unprognostic (8.35e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (1.15e-3)" 27.8 36.0 11.9 21.2 15.5 25.1 28.4 13.5 23.0 25.4 30.9 18.5 24.3 27.2 22.7 23.9 30.2 21.5 30.6 48.3 12.9 13.0 31.9 58.4 25.8 45.0 15.2 10.9 31.4 59.6 30.0 12.3 18.3 17.9 25.3 24.2 28.1 24.9 27.5 76.3 24.9 32.8 23.9 13.5 32.9 29.9 17.0 10.3 32.7 37.3 49.0 38.3 31.3 22.3 22.1 39.9 7.2 29.4 16.3 22.6 19.9 21.3 29.5 13.3 22.3 37.8 56.3 24.5 16.3 34.4 23.7 27.5 22.1 24.5 40.2 21.9 18.9 18.4 30.6 25.6 31.7 23.9 16.7 16.5 19.9 20.4 80.9 42.3 37.1 24.8 55.1 35.3 19.6 30.4 30.4 68.2 23.6 14.7 32.9 26.0 31.4 21.9 14.4 13.5 28.4 37.2 22.5 22.0 30.5 30.3 26.8 9.1 17.6 23.7 52.8 31.2 16.5 22.5 30.1 21.8 14.2 16.5 25.8 18.6 24.8 19.7 18.8 11.1 21.4 15.2 4.8 27.9 7.2 13.4 29.4 16.3 22.1 19.2 16.9 39.9 21.9 21.9 16.3 6.3 16.3 22.9 11.3 22.6 19.9 11.9 15.5 13.5 23.0 12.9 13.0 15.2 10.9 17.9 10.3 44.7 38.2 84.8 43.0 61.7 27.2 99.9 84.1 38.8 36.4 27.9 9.8 61.8 63.0 75.1 6.3 57.3 51.9 23.3 140.4 103.7 55.7 38.4 77.5 82.5 125.3 17.5 39.0 57.7 124.8 10.2 52.9 86.1 49.0 93.8 66.6 20.9 92.6 80.7 34.6 95.3 30.4 38.8 51.5 34.7 25.8 58.8 47.8 70.4 100.6 68.0 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 212.2;Distal tubular cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 56.9;SiHa: 74.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA 1000000 Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favorable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 21.9 8.0 17.3 7.5 30.3 5.8 9.5 26.6 36.8 6.7 9.2 8.3 10.7 4.4 8.6 8.7 13.1 6.9 7.5 108.8 19.3 15.2 25.3 1.2 4.2 9.5 13.1 25.7 7.2 3.0 20.9 8.4 2.8 21.2 12.5 10.4 6.6 8.5 14.7 13.4 10.7 6.5 17.0 8.9 5.2 14.6 6.2 5.3 22.8 13.0 10.7 11.8 8.0 7.5 8.0 4.6 3.3 1.6 7.5 15.6 5.1 7.9 0.3 6.6 7.9 20.5 11.0 0.0 14.3 9.1 11.9 7.2 1.2 5.4 20.7 3.5 10.9 6.1 4.7 18.0 12.9 14.0 17.7 2.1 14.5 56.9 2.7 8.9 28.2 4.9 10.3 3.5 11.6 19.6 5.8 10.8 18.9 2.9 26.7 13.6 1.0 23.5 1.3 1.4 0.0 5.7 18.7 18.5 15.6 9.7 0.6 6.6 6.8 74.0 0.0 8.7 0.6 0.1 6.1 6.5 9.5 12.4 16.2 11.5 4.4 3.6 0.8 14.3 20.7 7.2 1.0 1.0 3.3 9.1 1.1 10.9 8.0 9.2 9.8 4.6 6.1 10.8 8.9 0.3 7.5 1.6 1.8 15.6 5.1 17.3 30.3 26.6 36.8 19.3 15.2 13.1 25.7 21.2 5.3 6.0 8.6 7.5 12.0 13.2 13.1 212.2 7.6 5.3 18.2 10.4 2.0 5.2 159.2 4.7 14.3 5.6 2.3 0.0 0.6 9.8 8.4 11.2 9.2 0.0 29.1 12.7 12.7 4.9 1.0 5.6 5.8 4.4 15.1 3.6 13.4 11.3 3.9 3.5 7.1 11.3 19.5 12.9 15.6 36.7 14.9 18.9 5.7 17.3 15.5 5.2 PACS2 "KIAA0602, PACS1L" ENSG00000179364 "Phosphofurin acidic cluster sorting protein 2" Q86VP3 14 105300563-105398147 "Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.7;skeletal muscle: 63.8" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 92.2;Late spermatids: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077892 Approved Mitochondria NA NA Mitochondria "HPA077892: AB_2686865" "unprognostic (4.31e-2)" "unprognostic (2.61e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.18e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "prognostic favorable (2.95e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.56e-4)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.30e-1)" 15.3 10.8 18.8 7.7 25.5 6.1 13.3 20.5 29.8 8.0 7.7 41.7 6.5 8.4 10.0 8.1 8.9 9.6 8.7 15.1 23.9 18.0 6.8 3.7 9.3 6.1 36.8 13.9 11.8 21.3 10.3 8.1 6.9 26.3 7.6 5.5 6.7 11.8 9.8 63.8 7.2 9.1 8.1 65.7 10.9 7.4 13.4 26.8 2.7 7.1 7.0 4.4 8.3 7.3 0.6 5.4 0.3 4.0 2.1 2.0 0.9 9.3 12.9 12.2 11.5 12.2 11.9 14.5 7.1 8.3 6.1 5.4 5.6 17.8 10.2 12.1 10.8 7.9 10.8 7.4 10.2 4.4 12.7 6.1 4.6 5.1 8.3 16.1 3.8 8.5 13.8 9.8 4.3 10.0 7.8 11.1 10.4 2.9 9.6 5.3 29.3 6.4 5.1 4.7 11.9 10.7 14.4 7.4 6.5 5.2 21.6 27.5 14.6 6.8 6.2 10.6 8.0 15.6 7.1 16.8 9.1 4.2 14.3 7.1 12.7 8.2 3.8 13.9 6.9 8.8 0.0 1.6 0.2 0.9 2.7 1.7 0.2 0.8 1.0 2.7 0.6 0.3 1.0 0.3 2.1 4.0 5.4 2.0 0.9 18.8 25.5 20.5 18.9 23.9 18.0 36.8 13.9 26.3 26.8 8.9 14.3 0.8 6.5 8.0 30.2 17.8 7.6 1.4 13.6 5.2 11.8 3.8 11.6 11.7 47.3 15.8 19.0 0.0 19.9 2.8 11.2 8.4 1.1 7.8 15.0 92.2 12.5 19.6 14.3 63.1 16.1 13.3 25.3 8.2 13.4 14.7 14.0 10.5 15.6 10.5 22.4 6.5 12.7 12.9 11.3 7.3 2.9 5.3 16.6 7.1 PAGE5 "CT16.1, CT16.2, PAGE-5" ENSG00000158639 "PAGE family member 5" Q96GU1 X 55220355-55224108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 32.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 84.1;Spermatogonia: 158.4" "Group enriched" "Detected in many" 6 "liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.5" "Lineage enriched" "Detected in single" 14 "T-cells: 4.5" "Group enriched" "Detected in some" 164 "Karpas-707: 67.1;U-266/84: 141.6" "HPA052619, HPA055869" Supported Approved Mitochondria NA NA Mitochondria "HPA052619: AB_2681887, HPA055869: " "unprognostic (4.03e-1)" "unprognostic (4.51e-2)" "unprognostic (7.86e-4)" "unprognostic (1.39e-2)" "unprognostic (7.21e-2)" "unprognostic (1.06e-4)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 32.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 141.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 4.5 0.3 3.8 1.6 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.3 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 9.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 6.5 0.0 84.1 158.4 0.1 0.0 0.0 0.0 0.0 PAPSS2 ATPSK2 ENSG00000198682 "3'-phosphoadenosine 5'-phosphosulfate synthase 2" O95340 10 87659613-87747705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 59.2;liver: 49.0" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 7 "dendritic cells: 2.7;monocytes: 9.7" "Cell line enhanced" "Detected in many" "BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071224, HPA075267" Enhanced Approved Mitochondria No No Mitochondria "HPA071224: AB_2686366, HPA075267: " "unprognostic (3.98e-3)" "unprognostic (7.06e-2)" "unprognostic (4.95e-3)" "unprognostic (1.02e-1)" "unprognostic (2.67e-1)" "unprognostic (1.61e-2)" "unprognostic (4.96e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (3.50e-2)" "prognostic favorable (6.58e-4)" "unprognostic (1.14e-1)" "unprognostic (4.90e-2)" "unprognostic (6.72e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.21e-5)" "unprognostic (3.46e-3)" 16.0 59.2 3.5 18.1 6.0 0.3 18.1 1.9 4.3 8.6 25.5 2.2 1.9 9.2 4.0 7.0 3.7 5.3 10.7 9.1 3.9 2.1 9.9 49.0 31.3 15.6 4.4 1.6 10.8 21.2 0.4 1.7 19.0 5.2 3.8 21.2 6.2 6.2 2.0 4.8 1.7 19.4 5.5 3.4 2.9 2.9 3.6 4.3 0.8 7.3 6.2 11.0 5.7 5.3 0.0 2.7 0.8 9.7 0.0 0.1 0.8 3.5 3.7 1.2 0.0 25.7 32.8 0.0 35.4 30.3 21.6 15.6 0.1 0.7 0.0 1.8 89.6 0.6 1.5 2.6 2.5 24.7 0.0 1.9 1.6 2.6 0.0 38.9 0.0 0.7 11.6 0.0 12.4 1.0 26.0 17.9 0.2 0.0 16.7 15.1 13.5 0.0 0.1 1.4 0.8 4.6 0.0 0.0 0.0 22.5 1.6 0.1 0.3 17.2 0.6 0.2 2.5 2.5 0.9 22.4 7.3 4.3 24.7 2.5 0.0 0.1 0.0 3.5 0.0 0.0 0.0 1.4 0.0 0.0 5.3 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.8 0.0 9.7 0.0 0.0 0.8 3.5 6.0 1.9 4.3 3.9 2.1 4.4 1.6 5.2 4.3 223.4 31.0 5.2 0.8 2.1 0.0 3.5 5.1 2.7 14.8 8.7 0.0 0.4 11.6 4.4 0.9 11.3 147.6 0.0 25.2 0.6 18.5 2.7 0.0 93.7 11.5 0.0 12.1 28.8 29.3 0.2 16.1 25.7 1.7 1.8 25.6 1.0 24.6 48.9 4.9 8.4 0.0 12.9 11.3 0.4 0.6 1.1 1.1 1.3 42.4 0.9 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019545 Approved Approved Mitochondria NA NA Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favorable (9.11e-5)" 24.2 20.6 26.2 19.2 30.1 21.2 30.4 22.1 29.6 22.7 29.0 24.4 19.4 21.5 20.2 43.8 21.4 19.6 21.2 30.9 23.1 23.4 27.0 26.7 20.3 26.5 28.4 20.3 20.3 47.5 22.0 20.6 18.5 19.5 22.1 31.3 25.9 35.1 33.4 41.2 22.3 27.0 38.1 19.4 22.3 24.5 22.2 18.9 22.1 20.7 25.4 24.3 23.2 18.2 21.5 45.4 44.3 50.0 21.5 25.9 35.4 32.6 15.5 11.5 9.8 11.2 12.9 23.9 12.3 16.7 23.7 18.6 47.7 17.1 14.6 27.4 15.6 21.3 14.6 18.3 18.9 26.7 20.7 22.5 22.0 10.4 26.1 16.8 21.8 18.6 17.5 24.3 16.6 20.3 11.2 16.8 23.2 12.5 13.6 19.4 35.4 41.6 53.4 30.9 27.4 15.9 18.4 22.5 26.5 22.1 27.3 11.6 16.5 14.6 47.2 30.0 14.7 48.5 41.4 9.8 8.8 19.2 18.2 31.2 27.4 18.5 33.6 16.9 22.2 10.5 27.6 50.0 44.3 19.0 35.4 21.7 21.5 21.6 22.1 45.4 19.9 25.9 21.1 14.5 21.5 26.2 27.0 24.4 35.4 26.2 30.1 22.1 29.6 23.1 23.4 28.4 20.3 19.5 18.9 20.8 26.1 28.3 47.3 27.0 33.9 33.9 20.4 18.7 15.9 29.6 29.5 49.5 99.5 41.8 15.3 30.4 28.2 0.0 73.6 40.6 37.9 39.4 69.2 28.2 68.8 31.8 32.4 30.1 52.8 7.4 26.7 58.0 40.5 60.5 36.5 35.7 49.3 35.1 25.5 71.7 38.7 6.5 49.1 43.3 46.0 26.2 35.2 38.5 49.1 46.1 PARP15 "FLJ40597, pART7" ENSG00000173200 "Poly(ADP-ribose) polymerase family member 15" Q460N3 3 122577602-122639047 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.9;lymphoid tissue: 40.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5" "Group enriched" "Detected in many" 6 "B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3" "Cell line enhanced" "Detected in some" "HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6" "Not detected" "Not detected" HPA035757 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035757: AB_10669656" "unprognostic (8.19e-3)" "unprognostic (2.88e-3)" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (9.01e-5)" "unprognostic (4.79e-2)" "unprognostic (1.83e-2)" "unprognostic (3.91e-2)" "unprognostic (5.40e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "unprognostic (9.24e-7)" "unprognostic (9.03e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (1.22e-2)" 2.4 0.9 0.5 24.5 0.4 9.8 1.3 0.3 0.8 1.2 2.8 1.2 0.5 1.0 1.5 2.3 1.9 1.4 2.8 1.5 0.6 0.5 1.5 1.9 5.6 20.3 0.6 0.6 1.1 2.7 0.0 1.0 1.0 0.6 1.3 2.1 1.8 5.5 0.2 2.6 0.7 22.9 0.9 0.9 40.4 1.7 1.7 0.4 9.4 1.9 1.7 34.8 3.6 1.2 11.9 1.2 1.3 0.6 5.2 9.3 2.7 0.6 0.2 0.5 0.5 0.2 0.3 0.6 0.3 0.2 0.1 0.1 0.3 1.0 0.8 0.6 0.2 0.3 0.6 0.1 0.0 0.0 1.9 0.2 10.6 0.8 0.5 0.2 0.7 0.5 2.2 0.1 0.4 0.2 0.4 2.4 6.6 0.3 2.1 0.0 0.5 3.2 0.7 0.7 0.2 0.3 4.9 0.4 0.6 0.0 1.0 0.8 0.5 0.3 0.2 0.3 0.6 0.8 5.1 12.6 0.4 1.1 0.5 0.4 1.0 0.7 2.4 0.7 0.3 0.2 1.3 0.2 0.1 9.3 0.5 6.5 11.2 5.0 6.4 0.9 11.9 4.3 5.9 0.7 5.2 0.6 1.2 4.5 2.7 0.5 0.4 0.3 0.8 0.6 0.5 0.6 0.6 0.6 0.4 17.9 12.8 22.9 0.0 0.5 0.0 0.4 0.0 18.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 18.5 0.5 6.6 0.0 0.0 2.5 3.5 0.0 0.0 3.2 1.7 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 12.9 0.0 0.0 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848233-66958376 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 41.1;liver: 76.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria Yes No 96000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 41.1 10.7 11.1 2.8 14.6 3.1 12.9 13.1 14.9 2.4 3.8 10.7 21.4 5.6 2.1 2.4 5.0 2.7 2.9 4.0 11.3 8.9 18.7 76.0 2.1 1.6 15.5 11.5 4.4 4.3 19.4 4.0 4.1 10.9 5.4 3.1 3.4 24.2 24.4 5.7 2.8 6.7 1.8 9.4 1.5 3.3 6.1 13.1 0.6 4.2 2.5 2.5 2.2 2.1 0.6 2.6 0.0 3.8 0.3 2.9 2.0 2.9 9.1 3.4 8.3 13.9 5.5 3.5 1.9 7.9 3.6 3.5 4.5 3.3 0.0 3.8 2.9 4.8 3.9 3.8 21.0 1.1 1.8 5.3 4.5 28.3 17.3 10.9 0.0 5.9 21.0 5.4 2.9 6.6 2.3 2.9 7.9 8.5 0.0 1.2 19.4 5.1 2.4 6.4 7.7 7.6 3.8 7.0 1.8 3.3 0.9 7.4 10.5 17.6 9.4 7.2 2.6 7.7 1.2 3.2 4.0 3.7 4.7 2.1 2.0 2.3 0.0 4.1 2.9 3.4 0.0 3.8 0.0 1.2 0.9 1.4 0.2 0.5 1.9 2.6 0.6 2.9 1.6 0.0 0.3 0.5 1.0 1.5 2.0 11.1 14.6 13.1 13.6 11.3 8.9 15.5 11.5 10.9 13.1 0.0 4.8 2.2 1.1 1.1 4.7 3.7 10.2 0.0 1.2 3.5 2.0 15.6 1.7 3.1 15.2 1.4 18.6 0.0 1.6 3.5 1.9 2.4 9.2 192.6 11.2 0.0 8.6 4.3 6.9 39.9 0.6 1.6 5.0 32.5 4.2 9.2 2.3 7.0 3.9 37.8 4.7 0.0 1.4 6.0 4.2 0.5 21.3 1.3 6.0 1.1 PCCA ENSG00000175198 "Propionyl-CoA carboxylase alpha subunit" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 106.7" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 84.6;Proximal tubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 54.3;SCLC-21H: 30.1;U-937: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria NA NA 120000 Mitochondria "HPA041716: AB_2677635, HPA047792: AB_2680156" "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favorable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 15.6 26.2 9.7 11.3 11.1 3.2 12.0 24.0 10.7 12.0 17.5 12.0 14.3 6.7 16.4 106.7 8.8 8.4 7.6 12.4 9.5 7.5 51.3 44.3 8.1 4.0 11.2 8.2 9.7 12.7 5.5 12.4 10.5 12.6 13.1 13.7 11.7 12.2 10.4 10.7 7.7 7.8 17.0 12.0 8.2 16.1 4.7 10.9 4.2 11.9 5.0 6.9 10.8 8.8 3.7 13.0 1.6 10.8 7.3 6.1 4.7 3.3 5.9 9.8 3.2 9.4 8.2 5.5 3.3 5.0 3.1 2.9 7.3 4.5 0.2 5.1 3.2 4.0 3.8 2.9 4.6 5.1 5.5 3.2 7.7 4.2 15.8 5.2 0.3 3.7 7.5 5.0 2.9 4.8 7.6 6.4 4.2 3.0 4.4 5.6 3.6 0.8 17.3 6.1 11.8 2.6 6.7 4.2 5.4 54.3 6.6 30.1 3.6 2.2 12.6 5.5 11.1 9.1 13.7 4.6 3.2 2.7 2.2 2.3 4.3 3.9 0.1 6.1 41.9 2.2 1.5 8.5 1.6 4.6 10.3 6.1 3.7 3.0 4.3 13.0 2.6 4.1 5.1 1.3 7.3 10.8 1.1 6.0 4.7 9.7 11.1 24.0 10.7 9.5 7.5 11.2 8.2 12.6 10.9 3.0 8.3 7.3 25.7 1.6 15.4 8.7 38.2 10.7 10.3 19.2 27.5 21.2 84.6 13.8 14.8 9.9 14.0 0.0 7.3 5.4 7.1 14.3 13.9 41.9 10.3 27.0 3.5 11.6 10.2 7.9 8.1 7.2 5.0 2.8 10.1 10.4 6.2 14.0 12.7 63.9 32.3 12.9 8.9 4.8 4.3 3.3 25.3 4.9 26.5 19.5 PCDHB15 PCDH-BETA15 ENSG00000113248 "Protocadherin beta 15" Q9Y5E8 5 141245349-141249365 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.2;Early spermatids: 5.6;Horizontal cells: 4.8;Peritubular cells: 3.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 9.3;LHCN-M2: 7.7;WM-115: 7.5" "HPA007172, CAB026471, HPA074676" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026471: , HPA007172: AB_1079576, HPA074676: AB_2732263" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (7.37e-3)" "unprognostic (1.75e-1)" "unprognostic (2.06e-2)" "unprognostic (6.19e-2)" "unprognostic (1.60e-1)" "unprognostic (4.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.58e-2)" "unprognostic (7.01e-2)" "unprognostic (6.00e-2)" "unprognostic (9.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.02e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 8.6 3.6 7.9 5.5 8.4 0.6 4.0 15.1 17.1 8.5 5.3 8.0 0.3 1.5 12.9 6.0 3.5 7.2 4.7 8.6 5.9 4.1 3.8 2.6 5.4 2.0 4.9 6.0 13.6 5.7 2.7 5.7 3.6 8.9 6.4 2.6 3.7 3.1 5.1 2.9 2.6 2.7 9.1 9.4 5.6 4.8 9.1 7.6 0.0 4.5 4.4 1.6 5.6 5.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.1 9.3 1.2 2.5 2.6 0.1 0.7 1.8 0.1 0.5 0.0 0.5 0.0 1.8 1.4 2.4 0.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.3 0.0 0.0 1.2 2.2 0.1 0.3 2.4 0.4 0.0 0.1 1.7 7.7 0.0 0.0 0.2 2.3 0.0 0.1 0.3 0.6 0.0 0.6 0.0 0.5 1.3 0.3 0.5 2.5 1.3 0.4 0.0 0.0 0.7 1.0 2.9 0.1 0.1 1.2 0.0 1.2 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.4 15.1 7.3 5.9 4.1 4.9 6.0 8.9 7.6 0.0 0.0 0.0 0.1 0.1 4.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.7 0.0 0.0 1.3 0.0 0.5 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 2.0 0.6 0.0 1.7 0.0 0.0 1.5 1.0 0.0 3.2 0.3 0.5 0.0 2.0 1.8 0.1 0.5 0.0 0.0 0.0 0.2 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 156.3;liver: 115.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria NA NA 3300000 Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 8.2 2.5 1.0 4.9 1.9 1.0 4.3 1.3 1.3 1.3 69.7 1.4 6.9 51.8 1.3 8.5 4.5 1.2 4.2 2.6 1.5 1.0 26.4 115.1 6.0 4.4 1.7 1.2 1.8 8.5 3.4 1.7 1.2 1.8 2.0 5.4 1.9 11.5 4.9 1.0 2.7 156.3 1.1 1.7 6.7 3.3 3.9 1.3 1.3 5.8 1.9 4.6 2.8 1.9 8.8 10.8 2.4 15.1 1.5 6.5 3.9 5.5 3.1 0.9 5.9 3.7 3.7 15.0 6.9 8.3 5.8 9.4 5.1 6.4 14.1 0.8 10.6 1.9 8.1 6.0 8.9 4.8 7.2 0.2 2.5 1.7 27.5 35.3 4.9 11.1 4.3 34.3 3.6 8.9 1.6 4.6 16.4 7.2 26.1 2.2 23.9 1.2 2.5 1.0 12.5 4.2 2.8 3.4 8.0 1.7 8.6 3.7 5.9 5.3 6.8 32.5 0.9 9.2 7.6 0.8 1.2 6.7 1.8 1.9 17.9 5.6 3.5 3.5 7.7 3.1 0.1 8.2 2.4 3.1 15.1 3.4 8.8 3.5 3.5 10.8 6.1 2.2 2.0 1.0 1.5 14.4 1.9 6.5 3.9 1.0 1.9 1.3 1.3 1.5 1.0 1.7 1.2 1.8 1.3 11.9 22.0 24.4 8.8 3.0 4.1 1.2 20.4 2.7 3.4 17.4 0.0 3.4 29.9 17.2 49.9 3.5 152.4 0.0 67.0 11.6 5.3 6.8 1.1 291.7 56.2 0.0 8.7 10.4 15.0 15.5 3.1 14.5 6.8 29.7 43.0 5.6 27.0 63.4 2.8 166.4 5.4 0.0 5.1 8.6 0.9 4.3 2.5 9.6 63.5 11.9 PDCD2L MGC13096 ENSG00000126249 "Programmed cell death 2 like" Q9BRP1 19 34404384-34426168 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 28.8;Spermatogonia: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA052181 Approved Approved Mitochondria NA NA Mitochondria "HPA052181: AB_2681751" "unprognostic (5.39e-2)" "unprognostic (3.48e-1)" "unprognostic (1.51e-1)" "unprognostic (6.99e-2)" "unprognostic (1.07e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (8.78e-2)" "unprognostic (1.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.75e-1)" "unprognostic (1.72e-1)" "unprognostic (3.00e-2)" "unprognostic (5.98e-2)" 6.2 6.6 7.7 7.3 8.9 4.5 6.1 8.8 15.6 5.4 5.8 6.8 6.3 4.6 5.8 6.1 5.8 6.9 6.3 9.3 7.1 7.8 4.5 9.7 4.0 7.1 5.8 6.2 6.9 16.0 4.0 6.8 4.4 5.7 5.7 6.1 5.5 8.9 8.1 26.7 7.4 4.2 5.4 5.8 5.8 7.3 22.9 4.3 6.2 6.1 12.2 7.7 5.3 4.2 9.9 17.4 0.5 3.8 8.5 10.5 4.1 10.5 18.1 2.3 4.4 1.1 2.2 7.2 3.4 2.5 5.7 5.8 16.8 7.8 8.8 15.1 2.0 6.1 3.6 9.2 7.7 5.8 12.9 19.0 8.7 2.8 13.2 7.6 16.7 4.9 2.7 6.8 3.4 11.4 2.3 5.8 14.5 17.2 4.7 5.2 13.5 6.3 6.2 8.9 24.0 18.0 9.6 4.1 13.0 7.4 6.2 13.5 4.7 0.3 11.1 6.1 4.4 4.7 7.0 3.0 3.8 4.7 4.6 11.4 10.4 15.8 16.0 4.7 14.8 3.2 0.0 2.5 0.0 7.3 3.8 10.0 9.9 7.2 7.0 5.1 7.5 10.5 8.0 0.5 8.5 2.3 17.4 8.1 4.1 7.7 8.9 8.8 15.6 7.1 7.8 5.8 6.2 5.7 4.3 3.0 3.7 6.0 8.7 7.2 3.2 4.3 10.2 5.3 3.4 3.5 2.0 6.8 6.6 13.4 17.6 2.9 0.7 0.0 13.2 5.8 4.6 6.0 4.6 3.9 6.6 1.6 11.6 4.3 2.8 2.3 4.9 3.8 3.3 9.0 3.4 5.0 11.7 6.6 6.3 8.0 2.5 0.0 5.6 28.8 36.7 9.4 1.5 7.0 6.8 9.1 PDHA1 PDHA ENSG00000131828 "Pyruvate dehydrogenase E1 alpha 1 subunit" P08559 X 19343893-19361705 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.3" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 422.4;Distal tubular cells: 300.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria "Intracellular and membrane" NA NA 15000 Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" "unprognostic (5.71e-3)" "unprognostic (2.46e-3)" "unprognostic (5.71e-2)" "unprognostic (3.36e-3)" "unprognostic (3.12e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-2)" "unprognostic (4.28e-1)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (6.90e-2)" "unprognostic (8.68e-2)" "prognostic favorable (1.13e-7)" "unprognostic (3.72e-2)" "unprognostic (3.03e-1)" "unprognostic (1.92e-2)" "unprognostic (9.06e-2)" 22.5 16.1 14.7 11.7 24.3 20.4 14.7 18.6 25.0 12.3 28.6 13.0 27.7 22.7 13.0 21.6 17.2 12.4 11.8 89.3 15.5 12.2 36.6 26.6 10.5 8.9 14.8 19.9 12.2 28.7 25.0 11.6 14.9 19.0 10.8 28.2 12.7 41.8 18.3 107.3 12.7 21.1 21.2 12.7 11.5 24.9 6.3 12.0 11.3 15.0 44.9 14.9 13.1 12.4 39.4 45.1 34.8 46.1 35.5 36.6 31.9 25.6 31.9 23.1 24.3 22.4 17.2 28.4 17.7 15.8 36.7 28.4 45.4 16.5 43.8 13.2 21.3 49.1 33.5 70.9 30.7 38.7 14.5 39.5 21.7 54.9 39.9 23.8 34.7 17.8 22.1 28.6 33.8 33.6 18.6 22.3 27.4 19.1 18.6 25.6 33.9 28.9 35.6 23.5 47.1 55.8 29.9 38.8 53.6 63.2 26.2 12.8 13.6 28.2 35.8 32.0 52.0 37.7 24.4 13.8 19.0 17.1 51.6 22.4 15.8 16.2 29.0 17.9 24.3 16.4 34.8 35.0 24.2 30.3 46.1 36.6 39.4 29.4 32.8 45.1 29.3 29.0 30.6 6.1 35.5 39.1 29.8 31.1 31.9 14.7 24.3 18.6 25.0 15.5 12.2 14.8 19.9 19.0 12.0 41.7 37.7 36.5 48.9 26.6 58.2 422.4 79.0 26.8 50.0 144.8 31.4 91.3 300.1 74.7 2.0 28.6 76.1 23.3 52.1 102.6 45.2 31.9 42.6 65.5 65.3 23.8 40.3 16.0 21.0 2.9 32.8 35.5 54.0 51.3 52.9 37.8 43.3 57.5 38.2 164.1 60.9 32.3 48.4 17.4 13.0 29.2 111.6 30.9 97.8 51.0 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 alpha 2 subunit" P29803 4 95840019-95841474 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 60.5" "Group enriched" "Detected in some" 6 "Early spermatids: 311.1;Late spermatids: 202.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria NA NA Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 311.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 45.9 1.6 0.0 0.0 0.0 0.0 0.0 PDP2 "KIAA1348, PPM2B, PPM2C2" ENSG00000172840 "Pyruvate dehyrogenase phosphatase catalytic subunit 2" Q9P2J9 16 66878589-66895754 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019950, HPA062059" Approved Approved Mitochondria NA NA Mitochondria "HPA019950: AB_1855156, HPA062059: AB_2684671" "unprognostic (8.42e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.31e-2)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (4.90e-3)" "unprognostic (1.57e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" "unprognostic (1.39e-1)" "prognostic favorable (9.75e-7)" "unprognostic (1.89e-1)" "unprognostic (5.10e-1)" "unprognostic (3.20e-1)" "unprognostic (6.15e-2)" 10.7 7.2 7.4 3.7 10.5 3.2 8.7 11.5 16.5 4.9 7.5 10.1 5.7 10.4 7.9 7.2 8.9 7.2 6.0 4.8 7.4 7.1 18.1 16.5 8.6 5.0 9.0 9.4 14.9 13.8 12.0 7.0 7.7 16.0 7.8 8.4 8.5 7.1 6.9 6.3 4.7 6.2 4.6 6.3 4.0 6.7 8.6 8.9 4.6 18.0 4.0 5.9 6.3 5.5 3.3 1.3 1.8 0.4 6.1 6.3 2.0 7.2 8.9 5.5 10.8 14.9 7.7 6.9 3.8 14.8 8.9 13.4 18.1 5.2 10.2 5.5 5.3 8.5 9.3 16.0 8.6 8.6 2.4 8.1 5.1 4.5 11.8 8.1 6.5 9.0 5.8 6.5 12.6 13.1 9.7 3.8 11.5 9.8 7.3 7.9 4.8 12.6 4.7 6.5 4.9 11.3 12.5 7.7 16.0 4.7 7.8 11.1 6.3 12.3 5.0 4.6 4.5 6.7 3.2 3.5 5.4 7.4 3.3 5.6 13.0 12.0 10.1 7.5 5.2 5.4 1.3 0.4 1.8 6.3 0.3 5.2 1.8 3.1 5.1 1.3 3.3 4.5 5.0 1.3 6.1 0.2 0.8 0.9 2.0 7.4 10.5 11.5 16.5 7.4 7.1 9.0 9.4 16.0 8.9 8.9 18.5 5.9 4.3 4.6 7.9 4.5 7.6 1.4 4.5 8.7 13.7 9.1 6.6 2.7 0.1 1.8 5.1 0.0 2.5 1.6 4.2 6.7 5.8 11.5 2.1 4.8 3.5 6.7 0.6 1.9 2.8 0.8 3.3 0.0 4.0 8.4 2.8 5.8 4.2 8.1 6.3 0.0 3.1 4.4 1.3 2.0 3.0 1.9 5.8 7.0 PDPR PDP3 ENSG00000090857 "Pyruvate dehydrogenase phosphatase regulatory subunit" Q8NCN5 16 70113626-70162537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048092, HPA070386" Uncertain Approved Mitochondria NA NA Mitochondria "HPA048092: AB_2680261, HPA070386: AB_2686263" "unprognostic (8.30e-2)" "unprognostic (1.32e-1)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.57e-1)" "unprognostic (9.04e-3)" "unprognostic (6.81e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (2.90e-1)" "prognostic favorable (8.36e-4)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (2.17e-1)" "unprognostic (6.24e-2)" 11.9 13.3 12.0 13.3 15.4 14.4 11.6 21.1 16.0 14.0 12.5 23.8 10.4 9.3 18.7 14.5 11.1 12.9 11.7 14.7 9.9 6.7 18.4 7.7 9.8 15.8 10.2 12.6 15.1 13.5 14.2 9.9 10.8 10.7 10.0 12.9 15.4 11.1 17.3 20.9 11.9 13.4 19.7 9.0 14.1 12.0 19.9 10.3 16.0 13.5 9.5 12.6 16.4 10.0 6.0 5.4 5.1 5.0 3.2 7.1 3.1 3.6 10.4 9.8 17.1 17.0 11.5 6.5 5.9 10.5 9.6 7.3 13.0 7.3 7.3 10.3 18.7 8.6 14.2 14.1 12.4 11.3 1.8 4.8 18.7 6.4 8.6 4.8 20.7 15.2 14.9 11.6 13.8 12.5 13.0 10.1 14.0 12.8 3.6 7.9 10.4 12.9 11.3 14.6 2.4 5.1 25.7 10.0 7.9 7.1 8.7 4.5 6.6 16.3 3.1 4.3 13.0 12.9 6.2 5.8 11.1 15.1 9.4 9.3 8.3 9.1 27.5 5.0 7.0 7.1 5.1 4.9 4.5 5.0 5.0 7.1 3.5 3.9 4.8 5.4 6.0 4.8 5.2 4.1 3.2 4.6 5.2 4.3 3.1 12.0 15.4 21.1 16.0 9.9 6.7 10.2 12.6 10.7 10.3 20.8 12.8 7.5 4.2 2.5 19.2 17.7 17.8 20.1 13.6 1.8 29.5 6.2 5.0 4.6 42.6 14.3 8.2 0.0 5.7 6.1 7.4 7.2 17.4 9.8 13.7 30.2 4.7 18.4 16.5 14.2 10.0 11.2 6.8 1.8 10.9 12.4 4.9 3.5 15.6 3.3 21.1 19.4 4.2 7.5 15.6 1.6 4.1 12.2 12.4 4.1 PET100 C19orf79 ENSG00000229833 "PET100 homolog" P0DJ07 19 7629737-7631956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 106.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067288 Approved Mitochondria NA NA Mitochondria "HPA067288: AB_2732762" "unprognostic (7.02e-2)" "prognostic favorable (6.81e-4)" "unprognostic (1.57e-1)" "unprognostic (9.87e-3)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (1.70e-1)" "prognostic favorable (7.97e-4)" "unprognostic (4.89e-1)" "unprognostic (2.88e-3)" "unprognostic (2.49e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (2.66e-2)" "prognostic favorable (2.44e-4)" 18.7 27.8 24.9 21.3 23.3 42.3 22.9 16.1 27.8 13.2 21.9 9.7 29.3 22.2 13.4 27.4 18.0 11.0 24.0 47.3 31.6 18.3 24.7 36.8 14.9 20.5 19.8 25.3 11.9 24.7 11.0 20.7 18.0 21.0 16.4 16.4 14.7 29.9 30.1 41.1 14.8 18.8 12.9 21.3 18.2 25.6 14.4 12.4 16.4 17.5 29.9 17.5 10.2 13.6 52.6 86.9 106.6 82.2 33.8 60.1 72.1 18.4 16.6 30.5 18.2 14.8 10.7 11.2 15.8 9.1 10.9 10.7 14.8 12.5 12.3 27.9 11.9 13.5 16.4 13.7 14.4 9.0 28.1 27.8 17.6 35.1 23.6 7.4 30.0 16.9 12.1 9.3 7.3 7.7 17.4 15.4 30.3 12.7 47.7 11.4 20.1 32.2 47.2 19.7 21.4 36.3 20.3 17.3 28.6 21.9 22.5 17.0 20.3 21.0 18.9 17.0 19.5 13.8 39.8 16.7 8.6 10.6 17.2 23.5 42.9 33.5 22.4 15.8 23.2 10.2 106.6 82.2 89.2 41.9 63.7 39.0 52.6 48.6 43.8 49.8 51.0 45.4 47.7 77.2 33.8 56.1 86.9 60.1 72.1 24.9 23.3 16.1 27.8 31.6 18.3 19.8 25.3 21.0 12.4 140.0 188.2 119.3 34.8 44.6 49.0 48.4 231.8 145.9 121.7 246.0 21.6 109.5 182.4 187.3 33.6 64.6 254.8 210.2 275.3 108.9 79.7 58.6 101.9 470.9 149.2 17.5 184.1 168.8 266.1 38.0 94.0 169.6 108.0 232.6 239.3 60.6 286.3 280.5 78.1 209.8 67.5 84.1 54.7 111.8 89.1 51.7 149.5 147.2 189.2 40.8 PGAM5 "BXLBv68, MGC5352" ENSG00000247077 "PGAM family member 5, mitochondrial serine/threonine protein phosphatase" Q96HS1 12 132710819-132722734 "Enzymes, Predicted intracellular proteins" Necrosis Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036978, HPA036979, CAB068215" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559" "unprognostic (9.57e-2)" "unprognostic (2.00e-2)" "unprognostic (3.83e-2)" "unprognostic (3.11e-2)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.13e-6)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (5.67e-2)" "unprognostic (1.23e-1)" "unprognostic (6.92e-2)" "unprognostic (6.42e-3)" "unprognostic (1.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (5.53e-2)" 12.2 16.5 11.7 14.3 14.0 12.5 18.6 14.6 22.1 8.4 13.9 8.3 9.9 13.6 10.4 9.9 22.0 11.5 13.4 22.6 14.2 12.1 13.9 26.3 8.5 17.6 9.9 11.8 11.9 30.2 8.1 9.6 10.3 10.4 10.1 10.4 8.5 16.0 11.4 27.4 15.2 12.0 10.2 7.5 13.0 11.7 13.6 5.1 17.6 16.3 17.4 14.5 11.6 12.9 4.0 6.7 7.7 3.1 3.3 3.7 1.4 19.2 37.1 7.9 22.3 5.6 4.5 18.6 9.9 6.2 16.7 9.4 46.2 11.2 24.9 18.4 8.6 8.6 16.9 37.2 18.7 6.9 12.2 29.3 29.9 17.4 24.1 12.7 28.3 17.5 5.6 13.8 19.5 21.1 5.5 12.2 20.4 37.4 10.3 6.5 34.9 38.3 28.3 30.1 16.9 26.3 29.4 8.8 19.9 10.8 26.8 29.1 16.4 17.2 24.2 10.7 6.6 30.6 15.7 10.5 8.5 18.6 17.1 24.1 21.6 31.7 35.8 11.1 23.2 14.2 7.7 2.4 0.7 2.5 2.5 3.7 3.6 2.9 2.8 2.0 4.0 2.9 3.6 2.0 3.3 3.1 6.7 2.0 1.4 11.7 14.0 14.6 22.1 14.2 12.1 9.9 11.8 10.4 5.1 3.0 6.7 6.7 10.3 10.2 9.2 12.6 20.4 4.0 0.0 5.2 13.7 5.6 5.0 4.0 12.9 5.3 6.3 0.0 6.7 12.5 3.3 9.0 0.0 21.9 6.4 6.4 12.6 4.3 6.9 15.9 5.5 4.8 3.3 2.8 8.9 3.9 6.9 5.8 6.3 9.0 12.2 6.5 5.5 9.8 9.4 15.2 5.1 4.4 14.0 11.6 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330318-74398473 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 48.6" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 76.3;Exocrine glandular cells: 109.6;Pancreatic endocrine cells: 102.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 13.4;LHCN-M2: 16.0;RH-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria No No 64000 Mitochondria "HPA056995: AB_2683305, HPA060948: AB_2684394" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 3.0 4.0 30.6 4.9 19.8 4.0 3.2 6.3 48.6 6.1 4.5 1.3 1.0 2.3 6.1 1.9 2.1 4.7 4.8 1.6 30.1 15.1 2.5 2.1 2.7 4.0 9.7 20.4 1.7 4.4 1.4 4.5 2.1 11.7 3.8 5.1 2.9 3.2 2.5 7.1 1.7 2.6 5.6 2.6 2.5 3.4 2.3 0.3 10.0 4.1 1.3 4.0 5.2 2.6 2.4 1.7 2.5 0.6 3.0 7.5 1.1 2.1 3.0 11.8 2.1 3.6 1.6 0.3 2.8 2.1 2.4 2.7 1.1 5.5 0.2 7.0 1.8 4.3 1.0 2.3 0.5 2.3 0.8 1.2 1.6 1.6 0.9 0.4 1.9 2.6 0.8 0.5 5.5 1.0 2.7 13.4 4.0 2.1 1.5 16.0 0.3 7.6 1.7 2.3 1.6 2.7 2.4 15.4 0.1 6.4 0.4 0.5 2.3 4.5 1.0 2.0 3.4 0.2 0.3 11.1 5.5 5.1 2.2 2.9 2.0 2.9 0.2 0.5 2.7 1.3 2.5 0.6 1.1 2.1 0.6 2.8 2.4 3.5 2.3 0.5 1.8 3.3 1.9 0.7 3.0 0.3 1.7 7.5 1.1 30.6 19.8 6.3 24.4 30.1 15.1 9.7 20.4 11.7 0.3 6.0 5.4 13.7 35.5 6.8 10.1 6.1 12.7 76.3 30.7 8.7 15.7 0.6 5.0 31.7 9.2 20.2 5.3 70.0 109.6 4.7 15.4 55.2 8.1 0.9 4.8 7.9 11.3 20.3 20.4 2.3 2.3 14.4 15.1 3.6 15.9 5.0 102.3 7.0 3.5 3.3 9.9 25.8 11.3 17.6 14.5 4.5 0.1 17.0 18.7 42.9 PHB PHB1 ENSG00000167085 Prohibitin P35232 17 49404049-49414905 "Plasma proteins, Predicted intracellular proteins" "DNA synthesis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 190.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003280 Supported Supported Mitochondria "Intracellular and membrane" NA NA 3800000 Mitochondria "HPA003280: AB_1855732" "unprognostic (2.31e-2)" "unprognostic (5.70e-2)" "unprognostic (1.19e-2)" "unprognostic (7.88e-3)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.58e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (5.81e-2)" "unprognostic (4.40e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (7.36e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.10e-2)" "unprognostic (1.77e-1)" "unprognostic (2.71e-2)" "unprognostic (3.09e-3)" 27.4 31.6 21.8 19.9 24.9 19.0 30.6 12.9 25.9 21.6 38.9 24.0 17.0 26.9 24.1 17.7 28.6 24.3 18.6 41.6 21.9 20.9 54.0 53.7 19.2 18.5 27.6 21.4 27.1 24.1 27.8 18.8 24.1 22.0 25.3 40.7 24.7 41.8 20.2 41.7 19.5 32.7 26.6 20.5 22.7 25.0 16.6 18.2 23.3 42.5 35.6 22.3 22.4 24.0 33.4 84.6 6.3 28.0 28.4 34.7 40.2 36.2 67.8 16.3 31.9 21.9 17.3 45.3 26.9 17.9 43.6 28.6 190.5 32.7 67.3 49.2 24.7 40.2 23.7 44.2 38.8 45.2 29.2 58.1 33.9 44.0 86.1 16.2 67.0 21.0 19.2 26.9 47.1 17.4 16.1 31.8 33.3 60.5 18.2 28.3 61.8 46.4 41.9 30.2 90.0 64.8 37.1 61.8 55.2 29.6 38.5 33.0 28.1 20.3 23.8 37.7 31.7 40.4 31.2 27.7 41.4 32.0 32.3 57.6 23.3 63.7 65.1 27.1 44.6 35.8 6.3 25.3 6.2 32.3 28.0 34.7 33.4 28.7 31.0 38.1 29.9 30.4 30.9 2.5 28.4 21.0 84.6 28.1 40.2 21.8 24.9 12.9 25.9 21.9 20.9 27.6 21.4 22.0 18.2 44.7 38.5 91.0 108.8 104.4 37.8 5.0 99.3 58.9 45.5 80.3 35.3 200.2 344.8 205.1 11.2 83.1 152.0 0.0 137.6 226.4 92.2 139.6 72.6 90.4 199.3 20.6 126.7 58.9 47.1 19.5 82.8 74.2 150.1 170.5 170.0 63.9 145.3 121.0 108.2 332.8 35.0 51.8 84.4 14.9 52.8 108.4 127.5 73.5 226.1 142.5 PHB2 "Bap37, BCAP37, p22, REA" ENSG00000215021 "Prohibitin 2" Q99623 12 6965327-6970825 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014889, CAB026335, HPA039874" Supported Enhanced Mitochondria NA NA 780000 Mitochondria "CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448" "unprognostic (4.64e-3)" "unprognostic (4.32e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (3.80e-4)" "unprognostic (3.07e-3)" "unprognostic (1.67e-1)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (1.98e-1)" "unprognostic (7.18e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.07e-1)" "unprognostic (8.17e-2)" "unprognostic (5.61e-2)" 36.2 46.2 20.0 41.5 21.3 33.5 37.1 21.6 29.7 42.7 48.6 19.8 42.8 40.0 46.3 36.2 55.6 37.7 29.1 44.3 17.9 17.2 36.0 72.8 24.0 64.9 18.8 18.8 68.9 92.3 28.0 22.1 27.4 17.2 48.6 39.5 25.8 62.7 29.1 72.9 39.5 46.3 56.0 17.5 36.6 37.5 20.5 19.0 57.2 50.4 77.4 45.7 46.4 39.9 36.4 47.6 20.9 35.9 38.1 41.6 34.4 36.9 35.7 30.0 40.6 24.3 42.5 67.0 26.2 33.8 46.4 36.8 56.4 38.9 77.0 11.6 25.3 28.7 30.2 54.7 46.2 37.6 42.7 45.7 40.4 23.1 52.9 40.9 65.1 29.8 43.8 31.6 29.4 64.1 46.8 45.5 22.5 36.0 17.7 32.7 36.7 59.8 59.6 114.6 32.2 31.9 42.0 48.1 47.8 37.1 41.6 15.5 53.6 21.1 60.4 67.7 63.9 9.5 52.2 27.4 20.0 32.8 15.8 55.2 17.8 21.6 79.2 27.0 34.0 28.4 20.9 30.0 14.6 30.8 35.9 37.3 36.4 35.3 35.8 47.6 34.8 32.0 31.8 12.4 38.1 30.4 44.4 41.6 34.4 20.0 21.3 21.6 29.7 17.9 17.2 18.8 18.8 17.2 19.0 44.7 42.0 120.9 90.2 66.1 40.4 39.9 81.5 40.2 38.7 33.2 37.3 183.0 97.8 103.8 2.2 69.9 132.2 46.7 140.2 226.3 64.5 78.8 63.4 148.3 144.5 17.5 96.5 85.3 105.7 4.4 90.0 74.4 69.2 134.3 123.4 72.7 115.8 66.6 64.7 112.8 33.1 71.1 81.1 32.6 58.9 66.7 142.2 78.4 212.2 93.2 PHYKPL "AGXT2L2, MGC15875" ENSG00000175309 "5-phosphohydroxy-L-lysine phospho-lyase" Q8IUZ5 5 178208497-178232791 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036461, HPA063608" Approved Approved Mitochondria Yes No 190000 Mitochondria "HPA036461: AB_10670717, HPA063608: AB_2685059" "unprognostic (3.29e-3)" "unprognostic (2.60e-1)" "unprognostic (5.51e-2)" "unprognostic (9.75e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-2)" "unprognostic (3.29e-1)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "prognostic unfavorable (3.82e-5)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.41e-3)" 18.7 13.1 10.5 25.0 10.8 9.8 15.5 8.3 10.9 13.9 24.3 13.4 14.4 15.1 13.5 14.9 10.7 13.6 17.5 15.5 8.9 4.9 18.1 44.4 14.7 16.8 13.7 9.3 13.2 18.0 11.9 11.9 11.8 10.2 12.4 23.9 12.1 12.3 13.7 20.2 7.6 29.8 14.1 10.7 20.2 15.3 16.4 11.7 16.3 16.6 10.5 17.4 14.0 11.8 13.9 32.8 16.7 21.7 10.7 14.0 14.3 5.8 2.4 5.8 2.3 14.7 11.7 8.8 3.7 4.1 4.9 7.9 6.2 7.5 7.6 11.2 11.2 6.2 3.8 5.0 9.4 5.7 15.6 5.0 9.7 9.8 4.4 23.9 5.5 6.3 13.3 9.9 6.2 15.1 10.1 16.3 11.4 7.1 17.7 7.4 8.5 7.7 2.9 1.2 7.3 8.0 5.1 2.8 15.3 8.9 5.3 3.6 3.3 5.8 3.4 6.1 7.1 3.7 4.5 6.6 5.1 4.6 3.3 3.9 11.3 3.1 4.6 1.5 5.9 3.4 6.3 19.5 16.7 10.0 21.7 10.1 13.9 11.3 11.4 25.2 12.6 14.0 11.3 4.4 10.7 21.3 32.8 12.9 14.3 10.5 10.8 8.3 10.9 8.9 4.9 13.7 9.3 10.2 11.7 17.9 14.7 36.2 35.3 9.5 20.4 15.7 33.1 12.0 9.1 22.7 23.6 14.0 16.6 17.9 16.8 22.4 97.5 0.0 16.2 15.1 23.7 24.7 12.7 27.6 27.2 14.3 18.5 22.7 23.8 45.2 39.4 30.7 23.6 63.1 33.9 26.4 14.7 54.6 23.7 31.0 26.5 12.9 16.5 28.6 23.7 9.2 18.4 34.6 33.9 31.3 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin-like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 51.1;neutrophil: 34.8" "Group enriched" "Detected in many" 8 "granulocytes: 51.1;monocytes: 16.8" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.3" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" NA Yes Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 10.6 11.3 8.2 11.2 8.2 11.2 10.2 25.2 10.3 9.9 8.2 8.2 8.2 11.4 10.3 12.6 8.2 10.0 8.8 8.2 8.2 5.0 18.6 17.6 8.2 13.2 8.2 8.2 12.1 12.9 19.0 27.6 9.8 8.2 13.6 10.2 8.2 12.0 10.7 12.3 15.8 10.1 8.2 10.5 16.7 9.2 80.1 8.2 8.2 18.3 8.2 11.0 9.9 8.2 0.3 4.3 51.1 16.8 4.0 2.9 4.7 14.0 11.9 13.7 23.7 15.2 3.5 13.3 8.5 3.8 6.1 6.0 8.4 16.4 11.5 16.3 4.4 10.9 15.1 7.5 9.0 4.2 9.4 11.1 10.6 39.9 7.2 3.4 10.6 27.6 4.4 10.6 8.2 16.8 7.6 5.1 17.2 11.3 28.0 4.2 19.0 16.7 55.3 5.9 11.8 6.3 9.8 4.0 11.7 27.5 23.1 12.8 9.2 7.2 81.3 10.1 15.3 14.2 16.5 12.2 21.8 13.9 13.9 11.0 16.9 21.5 13.9 6.1 15.9 12.8 4.1 8.5 51.1 2.9 14.0 1.7 0.1 0.3 1.8 4.3 0.3 0.3 0.7 34.8 4.0 16.8 0.1 0.1 4.7 8.2 8.2 25.2 10.3 8.2 5.0 8.2 8.2 8.2 8.2 35.7 41.6 25.1 19.4 14.0 37.1 1.1 63.7 37.5 42.1 14.0 64.8 10.8 1.7 5.8 13.5 16.4 15.8 0.0 4.9 9.6 8.9 14.5 23.3 62.2 8.5 71.5 28.3 17.8 14.3 9.1 68.4 12.3 18.6 10.0 23.8 26.5 6.4 17.3 48.1 3.4 60.9 25.8 12.0 43.6 9.8 11.8 13.2 66.0 24.8 10.8 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 149.7;Late spermatids: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria NA NA Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 26.7 39.4 22.7 20.4 34.4 31.0 21.5 29.7 47.8 21.6 23.4 29.8 19.1 19.1 27.6 27.2 25.0 21.3 23.7 41.0 22.1 19.3 28.8 47.1 23.6 21.2 22.9 25.6 35.3 25.7 31.2 26.0 17.8 38.8 27.2 22.4 29.2 25.1 23.8 62.0 28.0 25.3 26.3 19.1 18.9 21.6 41.6 20.4 48.6 28.7 33.0 26.8 26.0 22.4 11.5 13.7 6.0 13.9 12.4 13.9 9.1 25.7 20.9 8.3 11.2 23.6 25.6 9.5 38.2 17.9 30.6 16.7 18.8 15.8 13.0 13.3 23.9 11.8 19.9 13.3 29.5 23.1 22.4 18.9 18.3 17.1 14.1 13.4 7.1 21.9 21.1 22.0 33.4 19.1 20.9 31.7 20.2 18.5 17.1 40.3 22.3 17.8 7.3 5.7 33.1 25.4 8.8 11.5 18.4 24.3 19.8 10.6 6.5 29.0 21.2 16.1 12.2 24.7 8.5 39.0 24.2 6.8 59.1 18.3 13.7 14.4 13.4 36.9 13.0 11.8 6.0 9.4 4.9 13.1 12.0 12.9 11.5 11.3 12.2 13.7 6.8 12.1 13.9 1.4 12.4 13.9 7.6 13.8 9.1 22.7 34.4 29.7 47.8 22.1 19.3 22.9 25.6 38.8 20.4 26.8 22.3 6.5 17.3 6.1 13.1 36.4 10.2 22.7 29.6 3.5 19.6 10.5 6.6 14.9 149.7 11.3 11.1 0.0 25.0 16.4 10.8 18.9 13.9 13.0 12.9 6.4 17.3 7.4 9.4 75.9 15.8 9.4 18.6 13.6 10.9 5.8 26.9 8.6 13.8 7.5 19.1 6.5 14.2 25.1 19.3 5.0 11.3 8.7 12.4 15.7 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 10.8;Club cells: 3.4;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Cell line enhanced" "Detected in many" "SuSa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Approved Mitochondria No No Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 2.7 3.5 2.8 4.7 5.2 1.8 2.2 2.2 2.0 3.1 1.0 4.5 3.1 2.3 1.3 1.6 1.4 2.5 1.4 1.3 1.0 0.9 1.0 3.7 0.6 4.5 0.8 0.2 4.9 3.4 2.2 4.9 5.8 2.3 6.1 0.5 2.0 2.3 0.4 2.9 1.9 4.2 0.3 1.1 3.9 2.6 1.9 3.1 1.4 2.5 2.1 1.0 0.5 0.8 11.0 1.0 0.9 1.5 2.3 0.9 0.7 0.2 6.4 4.0 1.0 1.1 1.7 0.9 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 6.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.8 0.0 0.9 3.3 1.1 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLA2G16 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754." ENSG00000176485 "Phospholipase A2 group XVI" P53816 11 63573195-63616883 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 113.6" "Cell type enhanced" "Detected in many" 9 "monocytes: 759.2;Proximal tubular cells: 471.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 52.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.4;T-cells: 16.0" "Cell line enhanced" "Detected in many" "A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011749, HPA058997" Uncertain Supported Mitochondria NA NA Mitochondria "HPA011749: , HPA058997: AB_2683874" "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favorable (2.54e-5)" "unprognostic (2.35e-1)" 113.6 15.2 32.0 4.4 39.4 1.6 33.9 4.8 30.2 6.1 7.2 46.6 6.1 4.0 5.0 11.5 5.9 13.9 12.9 39.0 37.6 25.2 24.7 28.9 13.5 4.5 58.4 22.2 30.9 13.2 15.1 8.1 16.2 30.5 5.9 3.7 8.8 10.1 13.2 37.8 2.4 7.5 8.0 70.4 6.4 10.2 17.8 48.9 0.1 17.1 11.1 2.3 8.0 4.7 2.1 52.4 0.4 6.2 5.3 16.0 6.4 20.6 32.7 0.9 0.0 37.1 6.4 6.0 0.7 6.6 5.5 2.7 7.4 59.7 0.0 13.8 1.6 18.0 1.0 30.9 1.6 4.2 25.5 1.2 0.3 7.8 1.2 22.1 0.0 0.3 3.8 0.1 13.6 0.5 22.0 8.6 0.0 0.3 2.3 5.8 3.6 0.0 0.1 2.6 13.0 10.6 0.0 0.0 2.0 17.3 2.9 0.4 2.4 4.4 12.5 6.8 14.0 27.1 1.0 12.6 2.4 0.1 8.3 1.8 9.8 6.4 0.0 9.9 0.0 0.2 0.0 6.2 0.0 16.0 2.4 8.8 2.1 3.7 11.6 1.7 0.3 1.2 9.4 0.4 5.3 0.1 52.4 2.4 6.4 32.0 39.4 4.8 21.9 37.6 25.2 58.4 22.2 30.5 48.9 95.3 77.4 17.6 17.3 10.3 10.6 128.7 96.8 113.8 45.5 109.9 3.9 112.1 96.2 54.1 56.9 116.5 22.2 0.0 99.5 300.4 35.3 29.0 56.6 210.7 56.9 38.1 3.4 165.7 48.0 16.0 28.7 51.4 25.3 759.2 4.5 120.3 123.3 14.4 20.5 471.4 17.2 12.9 42.8 135.2 4.9 8.2 243.0 69.8 1.7 59.6 PLEKHJ1 FLJ10297 ENSG00000104886 "Pleckstrin homology domain containing J1" Q9NW61 19 2230084-2237704 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 300.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA048989 Approved Approved Mitochondria No No Mitochondria "HPA048989: AB_2680590" "unprognostic (5.11e-1)" "unprognostic (4.84e-3)" "unprognostic (2.33e-1)" "unprognostic (9.82e-2)" "unprognostic (1.38e-1)" "unprognostic (7.83e-2)" "unprognostic (2.03e-3)" "unprognostic (2.89e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (9.03e-3)" "unprognostic (3.49e-2)" "prognostic favorable (1.10e-5)" "prognostic favorable (6.99e-4)" "unprognostic (5.67e-2)" "unprognostic (1.15e-1)" "unprognostic (6.26e-3)" 13.6 18.0 15.2 30.2 15.6 18.7 15.7 10.1 22.9 9.5 41.3 10.6 12.0 58.9 10.1 15.7 16.8 9.1 30.0 17.9 14.3 11.9 27.5 21.0 18.2 26.1 14.9 14.5 13.6 36.7 5.0 11.0 14.2 15.8 12.1 19.6 9.6 30.4 12.1 43.6 13.9 51.4 11.3 9.3 18.4 35.5 29.0 10.0 18.5 24.3 17.7 16.3 10.2 11.8 47.3 55.9 43.2 34.7 16.9 38.0 30.8 26.4 11.0 20.1 24.4 6.6 8.6 11.9 14.9 7.0 16.0 14.6 28.2 12.5 25.1 12.5 10.2 10.4 20.7 19.1 9.8 4.9 25.6 24.2 13.1 12.2 36.7 10.5 27.9 20.4 12.5 10.2 7.6 6.9 6.4 10.2 22.0 27.7 29.9 11.6 17.5 27.0 24.9 36.1 15.8 15.1 32.4 14.0 30.8 16.3 26.6 50.6 27.9 9.4 17.4 29.3 8.5 23.0 27.8 10.8 6.8 20.5 20.5 16.1 43.8 26.8 28.2 20.3 26.9 8.7 23.8 27.4 43.2 32.8 33.0 28.7 42.5 32.3 34.0 28.4 47.3 26.5 25.7 23.2 16.9 34.7 55.9 38.0 30.8 15.2 15.6 10.1 22.9 14.3 11.9 14.9 14.5 15.8 10.0 35.7 22.6 77.8 44.5 30.9 21.7 37.5 86.6 29.4 15.9 43.6 15.7 77.8 139.3 111.2 53.1 25.1 300.7 0.0 157.2 79.5 36.4 58.9 18.4 42.7 81.8 23.8 51.9 21.5 41.7 91.2 43.7 34.6 28.7 88.4 170.2 26.6 125.6 146.2 33.2 109.9 19.1 32.3 32.5 70.5 91.9 37.3 39.9 29.2 192.0 49.9 PLEKHO1 "CKIP-1, OC120" ENSG00000023902 "Pleckstrin homology domain containing O1" Q53GL0 1 150149183-150164720 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 60.7" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 188.6;Late spermatids: 315.7;monocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061018 Supported Mitochondria NA NA Mitochondria "HPA061018: AB_2684416" "unprognostic (1.41e-2)" "unprognostic (7.04e-3)" "unprognostic (2.01e-2)" "unprognostic (1.78e-2)" "unprognostic (3.23e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-2)" "unprognostic (8.33e-2)" "unprognostic (3.84e-2)" "unprognostic (3.18e-2)" "unprognostic (8.71e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.47e-11)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (1.87e-1)" "unprognostic (6.52e-2)" 10.9 17.0 14.2 34.4 22.1 10.2 10.5 17.0 14.4 9.6 44.5 5.4 6.4 11.8 16.9 7.7 16.8 11.9 14.1 17.8 10.2 6.9 5.8 5.8 12.9 29.0 8.2 13.1 13.5 2.5 1.4 3.5 10.1 8.0 18.2 8.3 7.9 4.7 12.1 15.8 3.6 17.4 60.7 6.5 29.4 22.3 24.8 7.3 15.0 3.8 3.1 17.4 29.3 17.7 11.0 16.0 18.7 15.8 2.1 5.1 5.4 5.1 1.2 17.5 13.6 5.6 5.0 1.4 9.0 12.5 12.3 10.9 0.3 0.1 0.1 1.8 10.6 9.1 0.4 8.7 0.4 4.0 31.1 4.4 1.0 0.7 3.2 10.7 7.1 29.6 7.4 0.4 15.3 2.3 11.7 11.6 14.5 1.9 13.7 16.7 2.4 27.1 14.2 16.4 0.0 2.4 24.7 9.5 5.9 2.0 1.5 11.0 17.9 0.7 0.0 6.8 8.8 0.9 7.1 16.2 8.1 9.2 8.4 10.8 5.2 0.1 3.2 32.3 0.0 3.1 1.5 15.8 0.3 3.5 14.1 3.8 11.0 5.1 3.7 11.7 10.5 3.5 3.0 18.7 2.1 12.8 16.0 3.7 5.4 14.2 22.1 17.0 14.4 10.2 6.9 8.2 13.1 8.0 7.3 32.8 12.8 62.7 62.8 19.2 5.4 33.9 5.1 0.0 2.3 0.0 0.0 1.4 1.7 6.5 188.6 39.6 0.0 0.0 6.7 2.5 27.6 51.8 5.7 0.9 96.3 7.9 17.0 51.5 68.8 315.7 16.1 106.5 23.6 146.1 0.1 32.6 10.1 0.0 23.0 0.0 6.1 71.1 83.4 126.2 12.1 12.4 1.3 24.5 0.3 24.4 PLGRKT "AD025, C9orf46, FLJ14688, MDS030, Plg-RKT" ENSG00000107020 "Plasminogen receptor with a C-terminal lysine" Q9HBL7 9 5357973-5437878 "Predicted intracellular proteins" "Chemotaxis, Inflammatory response, Plasminogen activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 74.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008214, HPA011144" Supported Uncertain Mitochondria NA NA Mitochondria "HPA008214: AB_1078363, HPA011144: AB_1078364" "prognostic favorable (5.56e-4)" "unprognostic (5.31e-2)" "unprognostic (2.96e-2)" "unprognostic (9.67e-2)" "unprognostic (1.05e-1)" "unprognostic (2.12e-2)" "unprognostic (1.72e-1)" "unprognostic (1.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.45e-3)" "unprognostic (2.19e-2)" "unprognostic (1.84e-1)" "prognostic favorable (5.09e-5)" "unprognostic (1.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-1)" 11.3 15.6 10.6 12.9 12.1 6.8 15.5 8.7 17.6 11.4 24.0 12.6 11.8 25.6 9.6 17.3 16.4 11.9 9.3 34.5 8.9 7.5 23.1 13.9 13.3 36.5 9.9 9.8 9.2 10.9 7.8 10.1 16.7 14.1 10.6 28.4 13.1 10.7 10.5 30.5 12.1 20.6 15.6 13.3 12.0 11.9 7.4 10.1 18.2 15.2 26.3 14.8 10.7 9.9 14.1 12.9 59.3 7.2 14.1 21.4 13.5 16.3 4.7 9.9 7.1 6.4 9.0 0.0 8.0 9.0 7.0 8.1 0.0 7.4 3.8 4.3 6.0 10.3 3.8 6.8 22.2 14.7 74.5 4.3 29.4 4.0 5.2 14.0 8.8 7.0 9.8 8.1 6.5 13.4 6.0 10.0 12.7 1.6 26.8 16.9 3.6 9.4 10.0 6.4 13.4 2.8 6.0 4.9 11.9 15.8 3.5 7.9 10.3 7.9 12.7 15.1 7.4 10.2 12.5 7.1 8.9 10.9 7.7 15.5 5.1 7.4 7.7 15.4 5.6 5.0 59.3 5.7 10.7 13.6 7.2 16.9 14.1 17.3 17.9 8.1 11.8 16.7 16.5 6.7 14.1 4.8 12.9 21.4 13.5 10.6 12.1 8.7 17.6 8.9 7.5 9.9 9.8 14.1 10.1 11.9 26.7 19.3 18.6 23.5 10.6 52.9 22.9 46.8 23.9 21.0 0.0 76.9 92.9 68.8 0.6 17.9 129.2 23.3 44.8 96.5 28.0 25.8 88.9 24.3 72.3 9.5 25.5 17.2 19.0 1.5 15.3 35.1 32.1 139.7 115.7 18.3 64.0 135.5 18.7 58.8 11.6 0.0 20.9 11.9 8.5 26.5 55.0 34.1 97.8 17.5 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291504 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 188.5;Ciliated cells: 167.3;Ductal cells: 295.2;Rod photoreceptor cells: 190.0;Urothelial cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4;MAIT T-cell: 9.4" "Lineage enriched" "Detected in single" 52 "T-cells: 9.4" "Cell line enhanced" "Detected in many" "A549: 34.1;CAPAN-2: 37.1;OE19: 63.6" "Low region specificity" "Detected in many" HPA055540 Uncertain Approved Mitochondria NA NA Mitochondria "HPA055540: AB_2682839" "prognostic unfavorable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favorable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 1.4 4.7 8.3 5.3 20.9 0.2 17.5 2.0 11.1 30.4 18.2 28.1 13.4 27.5 7.7 4.1 9.1 38.1 31.2 1.5 13.6 7.1 4.7 1.1 3.7 0.8 37.1 6.5 2.4 19.8 0.6 4.1 1.8 16.6 10.7 15.3 6.7 45.8 19.0 0.3 19.0 21.9 3.3 26.0 1.4 22.2 2.2 25.8 0.7 2.2 5.9 5.0 12.1 5.7 0.0 0.1 0.1 0.0 0.0 9.4 0.3 20.0 34.1 0.5 0.0 0.0 0.1 0.0 2.0 0.0 6.3 4.9 9.8 37.1 0.0 21.9 2.9 0.0 11.1 0.0 4.4 2.9 0.2 0.6 0.0 13.7 0.0 7.6 0.0 1.3 1.3 1.9 3.2 4.3 13.9 1.0 0.0 0.1 0.0 0.0 22.8 0.1 0.0 15.2 63.6 0.0 0.0 0.0 0.5 16.0 3.2 4.3 10.2 5.6 9.4 14.7 1.5 12.3 0.6 1.1 13.9 9.2 0.1 14.8 0.1 23.3 16.5 3.9 0.0 11.4 0.0 0.0 0.0 4.4 0.0 9.4 0.0 2.0 2.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 8.3 20.9 2.0 11.1 13.6 7.1 37.1 6.5 16.6 25.8 6.0 6.9 0.0 113.1 0.0 17.7 0.0 188.5 167.3 64.8 21.0 9.8 0.2 3.3 295.2 0.2 3.3 108.1 0.0 125.6 5.1 0.0 71.8 1.1 0.4 0.9 15.9 8.2 0.0 1.3 1.4 0.0 1.3 0.0 4.6 39.9 12.1 100.4 109.1 0.0 1.0 190.0 0.0 0.0 0.3 28.1 0.0 0.7 0.0 113.0 167.4 PLSCR3 ENSG00000187838 "Phospholipid scramblase 3" Q9NRY6 17 7389727-7394843 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.0;Ductal cells: 5.1;Exocrine glandular cells: 3.2;monocytes: 3.6;Pancreatic endocrine cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048387, HPA068609" Supported Supported Mitochondria NA NA Mitochondria "HPA048387: AB_2680381, HPA068609: AB_2686011" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (2.29e-2)" "unprognostic (1.56e-2)" "unprognostic (4.36e-2)" "unprognostic (5.02e-2)" "unprognostic (2.27e-2)" "unprognostic (9.71e-2)" "unprognostic (1.75e-3)" "unprognostic (1.91e-1)" "unprognostic (1.11e-2)" "unprognostic (1.77e-2)" "unprognostic (2.11e-5)" "unprognostic (1.24e-2)" "unprognostic (1.48e-1)" "unprognostic (1.97e-1)" "unprognostic (2.55e-2)" 21.9 11.5 6.2 17.8 6.1 5.2 31.0 4.4 7.9 24.0 12.7 7.4 16.3 5.6 29.2 22.0 21.6 15.6 17.7 25.3 5.6 5.7 15.3 12.9 25.0 67.2 5.8 7.6 19.9 10.0 10.1 9.0 17.3 8.4 15.4 6.3 10.2 12.5 17.8 16.1 17.8 10.5 21.4 13.1 29.0 11.6 8.6 6.4 12.1 12.2 26.0 21.0 21.5 20.1 12.9 9.5 1.9 13.3 6.6 30.8 12.1 14.3 3.2 2.7 8.4 10.4 18.3 3.7 13.0 12.0 11.1 10.5 4.9 3.3 3.6 10.7 18.8 4.8 19.6 3.5 21.3 5.7 9.8 1.9 3.4 4.4 3.4 14.0 1.2 4.5 13.2 14.5 11.2 16.8 17.8 17.3 7.7 2.0 2.8 14.5 7.3 3.8 1.0 2.5 4.0 9.2 7.9 2.3 3.8 10.5 9.3 2.4 8.1 6.6 4.8 3.1 2.7 8.3 0.6 28.0 7.7 7.8 8.8 5.4 3.2 3.6 1.4 12.0 4.3 8.9 1.9 10.0 1.1 16.8 13.3 17.1 12.9 30.5 17.1 9.5 12.0 25.2 15.0 1.0 6.6 10.9 1.1 30.8 12.1 6.2 6.1 4.4 7.9 5.6 5.7 5.8 7.6 8.4 6.4 3.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148723-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.5;retina: 40.6" "Cell type enhanced" "Detected in many" 14 "Kupffer cells: 41.4;Macrophages: 32.1;Melanocytes: 91.1" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.2" "Group enriched" "Detected in many" 4 "granulocytes: 14.2;monocytes: 6.7" "Cell line enhanced" "Detected in many" "HAP1: 15.3;Karpas-707: 11.9;SK-MEL-30: 19.0;U-266/70: 30.1;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066899 Approved Mitochondria NA NA 82000 Mitochondria "HPA066899: AB_2685743" "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.6 7.5 7.1 16.1 6.9 12.6 3.9 16.8 8.6 8.0 5.1 3.1 0.8 3.1 7.3 2.2 4.9 4.3 8.3 4.1 6.3 15.2 3.2 2.0 15.2 43.5 4.5 7.7 13.0 2.3 0.5 6.3 7.5 5.2 4.3 5.4 40.6 3.7 3.7 2.9 6.6 5.0 5.7 4.9 28.6 3.4 12.1 3.3 8.6 3.3 2.7 10.2 9.6 6.5 2.4 2.5 14.2 6.7 0.9 1.7 1.5 0.4 0.2 1.2 0.2 0.7 0.5 0.1 0.6 0.8 0.8 2.4 4.1 0.0 9.8 0.0 0.9 0.7 0.0 15.3 0.6 0.5 6.8 0.3 0.5 0.2 2.7 8.5 2.0 3.4 8.4 0.0 0.9 0.4 1.0 0.0 0.9 0.2 11.9 0.2 0.1 0.4 1.0 2.5 0.1 0.5 1.6 0.4 5.3 0.0 0.7 1.0 0.7 0.1 0.1 19.0 3.1 0.0 1.6 0.3 0.2 1.1 0.1 0.3 30.1 31.3 0.6 0.1 5.3 0.6 0.0 3.0 12.2 1.4 5.2 1.6 2.4 1.6 1.7 2.5 1.4 1.4 1.5 14.2 0.9 6.7 0.9 1.0 1.5 7.1 6.9 16.8 8.6 6.3 15.2 4.5 7.7 5.2 3.3 3.0 3.7 11.2 0.2 5.5 2.1 3.7 2.5 4.0 0.0 0.0 0.0 0.1 1.7 0.2 6.7 1.8 0.2 0.0 0.5 0.1 2.6 0.2 16.1 0.8 19.6 0.0 19.0 9.8 41.4 5.9 1.4 32.1 91.1 19.8 1.6 0.0 0.4 0.0 3.2 3.1 0.6 6.5 1.4 1.5 1.2 1.4 0.1 3.2 1.0 0.1 PMPCA "Alpha-MPP, INPP5E, KIAA0123" ENSG00000165688 "Peptidase, mitochondrial processing alpha subunit" Q10713 9 136410570-136423761 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021648, HPA063735" Supported Enhanced Mitochondria NA NA 6500 Mitochondria "HPA021648: AB_1855491, HPA063735: AB_2685108" "unprognostic (9.80e-2)" "unprognostic (1.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.69e-2)" "unprognostic (4.01e-2)" "unprognostic (8.19e-2)" "unprognostic (6.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.97e-1)" "unprognostic (3.32e-2)" "prognostic favorable (8.00e-5)" "unprognostic (9.47e-3)" "prognostic favorable (2.14e-6)" "unprognostic (4.27e-3)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (3.54e-2)" 15.2 27.3 19.8 14.6 23.8 20.1 13.2 20.3 24.3 12.3 15.1 13.0 10.4 18.6 14.2 14.1 16.5 13.6 14.9 37.0 15.6 14.8 17.0 48.3 12.3 18.4 15.2 21.9 15.5 18.2 14.7 19.5 15.6 16.8 15.2 11.9 12.8 20.3 17.1 56.7 17.5 17.0 13.8 14.1 18.9 16.3 23.2 12.5 14.0 15.0 19.8 15.3 13.1 13.4 25.5 30.1 17.0 25.1 32.1 30.8 28.2 14.4 27.2 13.0 26.2 9.9 14.5 20.0 15.1 12.2 21.2 15.4 31.0 17.3 20.3 15.9 15.3 11.3 33.9 24.0 22.1 9.4 29.1 29.0 16.3 35.0 37.4 17.4 21.2 14.2 21.2 15.3 16.5 8.5 12.0 17.9 18.9 41.3 13.4 13.1 40.1 20.0 27.3 26.5 25.9 25.7 24.9 18.4 44.9 14.5 10.4 26.7 17.6 20.3 29.0 17.6 9.3 39.5 28.9 14.7 15.1 16.2 12.4 19.2 8.3 10.9 21.8 19.9 18.5 13.5 15.4 25.1 17.0 27.2 24.4 26.4 25.5 25.7 29.3 30.1 23.7 30.8 26.9 5.9 32.1 23.2 15.3 24.3 28.2 19.8 23.8 20.3 24.3 15.6 14.8 15.2 21.9 16.8 12.5 14.9 25.3 23.9 29.5 24.5 22.5 31.3 10.2 13.4 18.2 21.0 21.6 90.0 41.4 28.9 19.7 20.2 19.7 0.0 26.4 41.5 17.6 17.8 24.3 54.0 33.8 17.5 20.0 20.3 17.4 12.4 17.5 14.1 15.1 21.6 22.3 19.3 25.1 17.3 21.2 37.9 25.3 38.8 16.9 32.8 39.5 23.5 86.8 23.0 30.4 23.5 PMPCB "MPPB, MPPP52" ENSG00000105819 "Peptidase, mitochondrial processing beta subunit" O75439 7 103297422-103329511 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040674, HPA074168" Approved Enhanced Mitochondria No No 57000 Mitochondria "HPA040674: AB_10961998, HPA074168: AB_2686671" "prognostic favorable (2.79e-4)" "unprognostic (3.11e-1)" "unprognostic (7.18e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-2)" "unprognostic (1.72e-1)" "unprognostic (1.06e-1)" "unprognostic (7.67e-2)" "unprognostic (7.74e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.42e-3)" "prognostic favorable (2.95e-8)" "unprognostic (2.59e-2)" "unprognostic (9.79e-2)" "unprognostic (2.40e-1)" "unprognostic (4.39e-2)" 29.1 41.8 31.8 23.0 34.3 41.5 31.6 41.1 38.4 29.0 26.9 21.6 28.2 35.1 32.0 25.9 27.9 26.9 23.5 41.4 27.7 20.1 45.9 47.2 21.9 31.3 32.6 35.0 36.8 40.6 41.1 33.9 24.8 34.2 31.6 31.5 20.8 30.6 31.0 31.5 31.6 31.0 25.7 27.8 27.9 33.6 31.3 35.9 37.2 33.2 24.2 30.0 30.7 27.9 19.5 18.4 9.7 16.1 12.9 21.9 15.7 12.4 18.0 21.2 28.6 12.9 26.2 16.0 11.6 20.0 23.5 28.0 19.2 14.3 32.0 18.6 19.7 25.1 16.2 25.5 18.7 22.4 11.2 30.4 11.1 30.9 25.6 15.7 15.2 13.1 23.9 17.4 18.3 17.7 22.5 12.4 24.1 21.4 32.6 21.4 28.9 25.1 35.8 26.0 24.8 22.6 17.6 14.9 32.5 22.0 22.3 26.7 32.6 15.6 46.2 22.8 22.4 18.9 20.4 10.2 20.7 24.9 36.9 21.5 25.0 31.9 24.6 15.4 24.5 16.3 9.7 14.1 9.3 14.7 16.1 16.1 19.5 17.1 14.7 18.4 14.3 21.5 17.4 4.4 12.9 13.6 9.4 21.9 15.7 31.8 34.3 41.1 38.4 27.7 20.1 32.6 35.0 34.2 35.9 29.8 31.7 53.2 52.9 32.5 29.3 64.2 28.1 49.5 40.9 26.2 21.6 104.2 61.3 64.5 72.7 34.3 36.7 0.0 64.0 49.3 41.1 31.6 58.9 46.5 48.7 22.3 26.0 24.5 42.2 18.6 48.1 38.4 25.3 93.8 43.0 33.6 54.8 42.1 46.7 96.5 33.4 64.7 42.9 84.6 53.0 32.9 104.5 57.5 55.1 47.7 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2" ENSG00000127838 "Paroxysmal nonkinesigenic dyskinesia" Q8N490 2 218270392-218346793 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria NA NA 31000 Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 21.8 28.3 33.2 15.9 41.0 13.4 16.4 26.6 51.1 29.8 27.5 14.3 28.9 18.1 14.6 37.0 13.3 28.3 30.4 37.3 31.0 26.5 42.4 107.0 23.4 34.2 33.2 23.6 18.1 18.8 22.3 15.6 28.1 26.8 34.8 25.1 15.9 27.3 27.1 33.8 12.9 15.9 16.6 25.7 18.0 29.5 23.3 20.6 11.6 29.7 15.3 16.3 19.0 13.4 64.0 32.7 44.9 35.4 38.4 43.3 38.9 15.3 20.2 14.8 23.2 22.3 18.9 27.4 9.7 21.0 23.1 26.0 33.1 15.2 18.0 19.5 16.1 25.5 16.0 28.5 18.2 16.2 37.4 35.6 26.3 37.0 48.9 24.4 16.9 11.7 25.7 18.0 15.7 4.6 15.5 24.9 14.3 19.3 23.6 20.4 44.2 22.0 40.5 14.7 35.6 20.7 21.7 14.9 15.1 26.5 23.4 14.4 12.1 6.9 47.4 27.5 16.6 15.7 16.5 15.3 9.6 16.5 11.3 13.2 9.8 10.0 19.4 24.4 28.0 11.6 33.7 35.4 44.9 32.1 34.1 30.4 64.0 35.1 38.3 32.7 52.0 38.8 37.3 9.8 38.4 31.0 30.4 43.3 38.9 33.2 41.0 26.6 51.1 31.0 26.5 33.2 23.6 26.8 20.6 65.5 73.4 56.6 80.2 49.0 53.5 126.7 104.4 100.4 62.6 186.7 5.9 149.0 431.0 54.5 7.7 70.9 168.7 0.0 43.7 85.9 107.8 126.2 56.5 206.0 114.9 33.4 116.6 73.1 82.4 10.5 95.5 48.6 129.9 72.1 149.8 127.6 39.4 144.0 116.7 212.9 34.8 90.5 76.9 45.9 44.3 54.5 64.6 55.8 176.1 86.0 POLDIP2 "DKFZP586F1524, PDIP38" ENSG00000004142 "DNA polymerase delta interacting protein 2" Q9Y2S7 17 28347177-28357522 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 115.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007700 Approved Mitochondria NA NA Mitochondria "HPA007700: AB_2667900" "unprognostic (5.71e-2)" "unprognostic (4.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.07e-2)" "unprognostic (3.23e-1)" "unprognostic (5.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (2.46e-1)" "unprognostic (1.24e-1)" "unprognostic (2.98e-1)" "unprognostic (1.62e-1)" "unprognostic (3.04e-3)" "unprognostic (1.57e-1)" "unprognostic (2.13e-1)" "unprognostic (8.40e-2)" "unprognostic (4.39e-2)" 12.5 24.4 15.3 11.2 16.5 10.0 14.4 9.1 20.6 11.2 14.0 11.0 14.1 12.2 9.0 12.1 17.0 11.0 15.2 42.0 14.6 11.1 26.8 50.6 9.2 15.2 13.2 11.5 10.8 26.9 15.5 9.3 10.7 11.8 11.2 14.9 10.6 14.1 13.1 63.5 11.3 15.1 13.8 10.2 13.3 16.4 15.3 7.1 17.0 14.8 22.0 12.5 10.3 8.8 29.3 37.5 24.9 29.5 19.7 29.0 28.6 19.3 36.0 13.1 21.1 20.6 19.8 16.1 20.2 21.5 43.8 31.3 115.5 11.5 35.1 19.8 26.3 22.7 26.0 31.0 21.9 32.6 27.4 33.2 12.4 21.1 24.0 32.3 26.7 15.5 22.5 32.9 30.3 25.0 19.6 24.3 25.0 28.2 20.8 25.8 27.0 30.9 17.1 15.6 33.1 18.4 23.6 28.3 35.6 24.3 18.1 18.9 17.5 36.2 73.4 20.4 21.4 38.5 20.2 20.6 19.7 14.9 22.5 35.9 18.3 21.9 24.3 27.4 18.8 19.7 20.0 29.5 24.9 22.5 28.3 23.0 29.3 23.7 29.0 37.5 20.4 25.9 25.2 12.1 19.7 20.2 25.1 24.9 28.6 15.3 16.5 9.1 20.6 14.6 11.1 13.2 11.5 11.8 7.1 8.9 14.9 31.5 25.9 24.5 23.6 84.4 50.9 4.0 9.1 45.4 3.9 71.3 160.8 71.6 35.4 24.5 60.0 23.3 124.6 81.0 28.2 34.3 11.5 114.6 61.8 27.0 22.5 22.7 29.9 99.3 28.4 29.4 55.6 67.7 37.2 28.7 92.5 28.1 31.1 161.2 15.9 12.9 29.7 58.1 43.2 26.3 68.0 23.5 59.3 34.4 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease mutation, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria NA NA Mitochondria "HPA056821: AB_2683247, HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 17.8 15.2 19.8 19.0 19.2 16.8 24.6 23.2 20.9 14.1 16.0 14.6 13.6 20.0 17.6 9.0 20.7 14.3 14.0 17.4 16.7 8.8 14.9 19.5 17.8 21.8 17.3 15.3 16.6 17.9 17.7 12.9 16.2 16.0 15.4 13.2 10.5 15.9 12.0 35.9 19.8 18.5 14.1 12.7 22.9 16.2 12.4 17.3 29.0 15.4 12.1 19.2 16.5 18.9 6.0 9.0 9.0 6.5 9.2 10.9 6.7 6.7 12.8 8.8 11.5 14.4 9.2 11.2 13.4 7.2 13.8 10.9 18.6 16.8 10.6 20.7 10.5 16.5 14.6 23.5 11.4 4.7 22.8 20.2 16.0 13.4 6.7 12.2 14.9 26.5 8.3 16.7 9.5 8.2 12.3 16.4 30.2 14.1 11.9 11.1 11.8 16.9 15.2 8.0 13.4 5.7 17.4 10.8 15.0 7.9 16.5 19.6 7.2 19.1 14.0 15.6 10.9 11.6 16.7 12.3 18.7 12.9 27.4 12.8 12.8 7.5 14.7 12.0 17.1 14.9 4.9 6.3 9.0 9.2 6.5 8.0 3.3 7.6 10.9 9.0 6.0 6.6 6.9 2.3 9.2 5.2 6.0 4.3 6.7 19.8 19.2 23.2 20.9 16.7 8.8 17.3 15.3 16.0 17.3 11.9 11.0 15.5 9.7 10.9 6.8 15.7 10.2 1.4 6.8 10.4 2.0 12.0 8.3 9.0 0.9 12.1 12.3 0.0 9.3 13.6 11.4 12.5 8.1 14.0 11.4 3.2 5.2 17.2 19.0 1.1 13.3 12.7 18.6 20.8 23.4 6.0 10.2 17.0 9.9 6.2 6.2 6.5 15.1 7.4 12.9 10.5 18.2 16.6 15.7 12.0 POLRMT "APOLMT, h-mtRPOL, MTRNAP, MTRPOL" ENSG00000099821 "RNA polymerase mitochondrial" O00411 19 617224-633604 "Enzymes, Predicted intracellular proteins" Transcription "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 63.9;Spermatogonia: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006366 Uncertain Supported Mitochondria NA NA Mitochondria "HPA006366: AB_1079654" "unprognostic (3.24e-1)" "unprognostic (4.31e-2)" "unprognostic (7.96e-2)" "prognostic favorable (4.50e-4)" "unprognostic (9.46e-2)" "unprognostic (2.94e-2)" "unprognostic (3.04e-2)" "unprognostic (9.41e-2)" "unprognostic (1.45e-1)" "unprognostic (3.48e-1)" "unprognostic (7.64e-3)" "unprognostic (1.81e-2)" "unprognostic (1.62e-1)" "unprognostic (1.28e-3)" "unprognostic (1.66e-1)" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" 10.2 10.7 10.1 16.3 11.9 6.9 8.1 12.1 20.7 9.5 11.6 12.3 4.4 16.7 9.8 12.2 14.4 8.7 12.7 24.7 11.5 8.9 12.9 21.4 7.3 11.8 9.4 15.1 10.1 15.9 9.5 10.7 6.2 9.7 10.2 8.8 8.5 9.6 11.7 42.2 16.7 12.8 10.8 8.4 12.8 11.2 32.1 6.3 11.6 11.1 8.6 10.4 10.1 7.8 8.2 7.3 3.1 5.5 7.5 9.0 5.3 10.5 19.1 4.4 19.2 9.2 5.2 16.1 4.9 5.9 7.4 6.7 19.2 7.3 10.8 10.1 4.5 3.7 10.9 16.2 9.4 5.5 12.1 38.5 8.4 11.9 24.6 9.6 14.2 16.1 5.0 13.3 7.5 9.1 5.3 10.3 15.2 15.8 10.9 6.7 14.9 18.8 19.5 17.4 13.8 13.4 18.2 6.0 18.5 9.7 9.0 14.0 10.0 4.5 12.2 12.3 4.9 6.9 13.0 6.1 8.0 10.2 12.5 14.5 25.9 21.3 16.5 17.1 11.9 9.7 0.0 3.7 3.1 9.0 5.2 7.1 7.8 6.7 6.6 7.3 8.2 5.7 6.3 0.6 7.5 5.5 7.2 4.1 5.3 10.1 11.9 12.1 20.7 11.5 8.9 9.4 15.1 9.7 6.3 11.9 14.4 8.8 5.0 7.1 17.9 15.6 10.2 4.0 9.1 15.7 17.7 13.3 6.6 5.3 31.3 7.1 22.6 0.0 6.7 7.0 6.0 5.1 12.7 22.5 9.2 11.1 12.5 8.6 7.9 63.9 11.5 9.2 10.1 3.6 12.0 7.8 5.6 11.5 12.4 14.6 15.8 6.5 9.9 30.7 84.7 6.4 6.4 8.7 19.1 5.4 PPA2 FLJ20459 ENSG00000138777 "Pyrophosphatase (inorganic) 2" Q9H2U2 4 105369077-105474081 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030888, HPA031671, HPA031672" Supported Approved Mitochondria NA NA 8300 Mitochondria "HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988" "prognostic unfavorable (2.98e-4)" "unprognostic (5.64e-2)" "prognostic favorable (6.60e-4)" "unprognostic (9.26e-3)" "unprognostic (2.93e-2)" "unprognostic (5.10e-2)" "unprognostic (1.15e-1)" "unprognostic (2.44e-1)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "unprognostic (9.54e-2)" "prognostic favorable (1.27e-11)" "unprognostic (3.69e-1)" "unprognostic (1.94e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" 9.2 18.0 18.4 17.2 15.4 24.0 20.6 12.3 17.6 10.2 19.8 9.3 20.3 18.1 13.3 20.7 14.8 10.7 18.7 42.5 15.6 15.3 23.7 21.2 23.1 34.8 17.2 12.1 9.5 25.0 10.4 15.0 9.3 15.4 16.1 16.7 12.6 21.4 26.8 29.6 15.0 16.8 22.8 12.4 12.1 15.0 9.7 10.7 9.4 14.3 28.2 10.6 12.2 9.5 20.0 35.3 14.7 20.8 22.0 17.0 14.6 11.4 5.4 10.6 18.0 6.8 5.4 7.7 6.5 8.5 8.0 5.7 12.1 16.8 9.4 8.6 5.2 6.4 5.7 21.2 10.3 9.4 13.3 7.6 8.4 8.8 11.0 5.3 19.9 8.2 5.2 10.6 5.5 4.3 9.1 7.6 16.5 14.0 13.0 7.2 14.5 17.0 14.4 7.7 22.3 18.5 15.1 6.5 9.3 26.3 8.8 11.0 6.5 4.4 26.6 9.4 6.5 13.9 16.3 4.0 5.7 11.2 6.2 11.2 11.5 14.5 9.8 10.1 10.8 7.7 14.7 15.0 9.7 15.3 20.8 13.3 20.0 16.0 16.2 35.3 16.6 15.5 17.0 6.4 22.0 16.2 17.7 15.9 14.6 18.4 15.4 12.3 17.6 15.6 15.3 17.2 12.1 15.4 10.7 8.9 50.5 30.0 71.8 44.4 30.3 55.7 53.5 57.6 43.3 31.4 15.7 106.7 223.8 100.3 91.0 35.1 73.1 23.3 104.8 78.8 31.9 70.3 43.9 59.7 73.9 20.6 63.1 23.4 36.7 95.8 25.6 65.5 72.6 46.9 86.9 28.4 66.2 97.6 30.4 222.1 16.9 38.8 49.5 16.1 9.4 50.4 70.8 45.8 109.9 75.5 PPCS FLJ11838 ENSG00000127125 "Phosphopantothenoylcysteine synthetase" Q9HAB8 1 42456117-42473385 "Enzymes, Predicted intracellular proteins" Ligase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031361, HPA031363" Approved Approved Mitochondria NA NA 16000 Mitochondria "HPA031361: AB_10602150, HPA031363: AB_2673844" "unprognostic (1.49e-1)" "unprognostic (6.71e-2)" "unprognostic (8.15e-2)" "unprognostic (1.55e-1)" "unprognostic (3.84e-3)" "unprognostic (1.68e-2)" "prognostic unfavorable (5.96e-5)" "unprognostic (2.71e-1)" "unprognostic (7.79e-3)" "unprognostic (9.13e-3)" "unprognostic (3.24e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-2)" "unprognostic (6.45e-2)" "unprognostic (2.32e-1)" "unprognostic (2.80e-1)" "unprognostic (4.30e-2)" 23.4 36.3 18.9 20.5 21.9 10.7 30.7 12.0 26.0 23.2 32.0 12.4 27.3 25.5 18.2 34.4 31.6 14.5 30.9 22.1 17.8 16.4 41.4 43.9 26.5 28.1 19.3 14.9 19.6 47.0 22.8 16.1 37.6 17.2 27.2 27.3 19.6 36.6 35.0 19.6 21.9 41.0 27.6 18.9 24.4 27.2 13.5 13.4 22.6 31.3 26.0 20.5 24.0 19.4 41.9 44.4 76.1 55.7 42.0 41.0 52.0 22.9 9.6 5.6 8.7 17.4 18.1 20.9 11.6 13.4 15.7 13.9 8.1 28.1 6.9 22.9 14.7 9.1 13.5 3.7 17.6 13.2 18.3 11.1 11.6 10.6 9.6 23.9 11.9 20.6 15.9 31.9 11.0 20.4 19.3 14.5 8.6 4.7 5.0 16.0 13.7 5.8 11.8 6.4 21.2 14.9 6.6 5.7 12.3 34.3 21.7 6.6 7.3 14.2 34.8 36.0 17.0 16.4 52.7 9.1 8.6 11.5 13.1 13.2 16.5 10.3 5.0 3.6 13.8 17.6 58.1 55.7 76.1 30.7 55.1 35.7 41.9 37.0 33.0 44.4 39.9 41.0 34.9 41.2 42.0 51.8 33.2 36.4 52.0 18.9 21.9 12.0 26.0 17.8 16.4 19.3 14.9 17.2 13.4 53.6 69.7 61.9 43.1 20.7 9.2 94.6 86.6 54.9 59.1 61.1 5.9 137.5 336.5 81.6 2.8 50.7 119.1 0.0 120.2 108.8 45.6 37.4 54.4 103.6 97.2 11.1 30.1 43.0 68.9 3.4 56.1 87.5 77.6 111.0 116.6 40.7 82.5 122.6 59.8 254.9 21.8 25.8 44.7 8.4 19.2 31.7 112.6 52.4 93.7 42.7 PPFIBP2 Cclp1 ENSG00000166387 "PPFIA binding protein 2" Q8ND30 11 7513298-7657127 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.8;OE19: 37.0;RT4: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001935, HPA003911" Enhanced Approved Mitochondria NA NA Mitochondria "HPA001935: AB_1079667, HPA003911: AB_1079666" "unprognostic (4.14e-2)" "unprognostic (7.04e-3)" "unprognostic (7.20e-3)" "unprognostic (5.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (2.32e-4)" "unprognostic (1.33e-1)" "prognostic favorable (2.26e-5)" "unprognostic (6.66e-3)" "unprognostic (2.90e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "prognostic favorable (5.39e-8)" "unprognostic (1.78e-1)" "unprognostic (3.38e-1)" "unprognostic (2.52e-2)" "prognostic favorable (1.34e-5)" 6.9 6.0 9.2 11.6 13.3 3.1 8.5 6.6 12.9 7.0 13.7 21.4 38.7 12.2 5.7 17.3 17.7 8.4 14.0 6.3 10.0 6.3 17.2 22.1 5.9 6.5 24.0 4.0 8.4 6.0 56.2 3.3 10.0 10.2 12.0 13.3 15.3 34.9 55.9 12.4 20.3 15.4 7.0 10.8 8.0 20.2 18.7 19.3 0.8 17.7 10.2 15.9 20.0 15.3 12.1 7.0 5.4 11.8 2.0 6.1 4.5 0.6 11.9 2.1 1.3 2.9 0.1 29.8 2.7 6.1 1.8 1.7 9.7 1.7 3.3 1.3 1.8 5.8 5.6 8.6 0.8 1.5 1.6 0.8 0.0 0.0 6.1 3.9 7.0 3.2 4.7 2.8 0.0 2.2 0.1 0.5 0.7 0.3 10.0 1.4 6.5 0.0 6.6 13.9 37.0 0.0 1.0 0.0 5.5 0.0 41.4 0.5 4.6 0.3 11.0 7.8 6.0 1.6 5.4 0.1 0.7 1.0 2.3 0.2 4.9 3.6 2.9 0.9 1.6 4.7 2.0 7.9 5.4 2.8 9.4 2.1 12.1 4.4 2.0 7.0 7.1 6.1 4.5 3.8 2.0 11.8 0.5 0.8 4.5 9.2 13.3 6.6 12.9 10.0 6.3 24.0 4.0 10.2 19.3 14.9 9.9 22.3 17.5 4.8 0.0 4.3 10.2 9.4 19.4 14.0 17.7 6.7 8.3 4.4 43.7 2.8 23.1 0.0 8.2 50.5 9.5 11.3 6.9 11.6 6.8 0.0 3.5 1.8 6.0 33.0 4.4 7.2 15.1 18.0 19.2 1.2 7.7 20.7 6.7 13.5 3.1 0.0 6.1 11.9 3.0 8.7 4.0 0.5 15.6 17.4 PPIF "Cyp-D, hCyP3" ENSG00000108179 "Peptidylprolyl isomerase F" P30405 10 79347469-79355337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Necrosis" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 32.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077416 Supported Mitochondria NA NA 27000000 Mitochondria "HPA077416: AB_2686840" "unprognostic (2.21e-1)" "unprognostic (5.48e-2)" "unprognostic (1.68e-1)" "unprognostic (1.72e-3)" "unprognostic (1.69e-1)" "unprognostic (3.16e-3)" "unprognostic (3.45e-1)" "unprognostic (4.33e-3)" "unprognostic (1.66e-1)" "unprognostic (1.97e-1)" "unprognostic (2.82e-1)" "unprognostic (9.37e-3)" "unprognostic (1.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.88e-2)" 16.5 76.2 12.1 15.7 18.8 52.0 16.9 7.1 21.3 8.3 18.1 27.1 13.2 13.3 5.2 7.6 21.0 8.8 10.0 36.5 13.0 14.5 21.0 73.1 9.4 19.4 23.3 16.6 7.2 42.0 12.0 6.2 11.3 25.2 6.6 19.9 7.5 12.7 21.9 44.4 22.5 11.1 9.9 28.0 19.6 34.0 20.8 18.0 8.8 10.0 73.9 19.8 12.5 11.0 8.0 18.6 32.8 14.9 3.6 5.0 6.5 35.6 15.2 10.7 21.0 10.0 13.0 13.7 20.8 27.3 45.8 43.4 35.5 17.3 37.1 11.6 14.6 32.6 21.4 33.1 19.4 71.5 11.7 31.2 58.1 14.9 62.4 17.0 40.0 13.8 30.4 13.9 45.4 45.5 14.9 8.0 14.6 56.5 45.8 15.5 18.3 10.3 33.5 9.0 16.4 84.5 17.8 16.5 19.0 17.8 33.3 21.3 15.8 10.7 43.3 16.0 7.3 18.9 30.9 7.2 20.1 18.3 23.6 40.0 21.3 21.6 30.0 19.9 52.1 5.4 5.1 14.9 7.3 4.7 11.4 5.0 8.0 4.2 4.3 18.6 3.9 3.8 3.7 32.8 3.6 4.1 2.3 4.2 6.5 12.1 18.8 7.1 21.3 13.0 14.5 23.3 16.6 25.2 18.0 6.0 5.0 34.4 26.4 37.8 4.4 106.2 15.3 12.0 9.1 12.2 5.9 70.1 77.9 37.7 11.0 13.8 22.2 46.7 24.2 113.4 24.0 17.4 13.8 70.1 83.0 7.9 20.7 8.6 32.4 11.1 5.8 60.2 33.7 33.3 62.3 9.9 40.0 17.5 5.6 31.1 4.9 19.4 24.1 7.0 22.2 33.0 119.0 17.5 63.7 28.5 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 59.1" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 417.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria No No Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 3.6 6.1 19.2 8.8 17.2 5.9 9.3 21.1 26.8 12.9 3.8 12.5 2.5 3.0 21.8 5.5 7.6 14.1 6.0 59.1 23.1 14.6 11.8 5.1 6.5 14.5 21.6 15.9 22.0 7.3 10.4 8.4 6.4 17.0 11.1 4.3 4.7 7.1 5.3 8.3 1.9 6.7 18.2 15.0 10.9 5.4 12.3 19.4 7.3 5.4 1.9 15.8 6.5 8.1 31.8 38.8 5.5 3.4 7.9 16.1 7.1 2.2 0.7 2.8 5.0 4.3 5.6 1.1 3.5 6.4 11.8 14.0 5.7 0.5 27.5 3.9 2.2 5.7 0.2 8.4 2.7 4.7 21.2 3.5 4.9 2.2 5.1 3.3 6.7 2.6 3.7 1.3 7.2 6.3 2.4 1.9 11.9 7.3 24.0 3.4 3.1 8.8 3.7 1.7 1.6 1.1 5.0 4.7 10.5 4.1 0.9 2.2 1.9 2.2 0.2 2.6 4.9 11.4 1.9 0.4 4.1 2.1 1.3 2.0 7.6 6.9 23.0 4.5 5.5 6.8 5.5 2.9 2.3 12.4 3.4 16.1 30.4 11.8 12.4 5.5 31.8 11.7 14.1 0.9 7.9 0.9 38.8 13.3 7.1 19.2 17.2 21.1 26.8 23.1 14.6 21.6 15.9 17.0 19.4 44.7 11.3 104.3 16.5 8.8 97.4 417.4 7.6 24.1 17.0 47.1 17.7 9.4 132.6 5.9 6.1 17.6 2.0 46.7 5.4 2.6 28.3 31.2 18.5 22.1 23.1 81.0 9.2 20.3 11.1 6.2 22.2 13.9 20.3 111.0 15.6 19.2 6.3 4.9 29.7 39.1 14.1 25.8 38.7 35.6 21.3 4.6 2.4 54.8 2.9 5.7 PPP3CB "CALNA2, CALNB, CNA2, PP2Bbeta" ENSG00000107758 "Protein phosphatase 3 catalytic subunit beta" P16298 10 73436428-73496024 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 133.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008233, HPA008823" Uncertain Approved Mitochondria NA NA Mitochondria "HPA008233: AB_1855661, HPA008823: AB_2668148" "unprognostic (3.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "unprognostic (8.93e-2)" "unprognostic (4.28e-2)" "prognostic unfavorable (9.59e-4)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (2.12e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" 17.3 16.1 40.0 11.7 36.3 7.6 22.5 44.5 42.7 13.4 16.1 7.9 9.5 10.1 17.0 15.0 14.0 12.3 12.0 16.7 39.7 20.5 11.9 9.1 9.8 13.1 18.2 40.7 17.2 10.5 19.3 16.8 10.6 21.1 16.8 12.8 9.5 10.4 17.6 133.0 10.9 9.4 23.0 18.1 10.0 10.7 11.6 11.9 8.4 10.1 10.0 14.3 14.1 14.4 4.2 5.7 4.8 3.8 4.5 10.6 2.7 19.1 10.6 19.0 19.6 27.3 37.9 9.1 17.6 24.2 17.3 17.2 6.7 9.8 17.0 5.7 25.4 8.2 10.3 15.3 13.5 24.4 23.8 12.5 7.2 9.6 12.7 16.3 16.0 15.1 26.8 16.3 16.3 21.9 31.9 11.9 14.9 9.0 20.0 34.8 6.0 14.3 14.8 7.7 8.4 31.0 9.6 10.3 8.0 16.8 9.3 10.2 11.8 10.3 25.8 12.9 16.5 19.4 15.5 13.0 13.8 12.7 11.0 23.8 13.4 36.5 11.9 17.1 23.1 7.8 3.2 2.9 4.8 6.2 3.8 7.3 4.2 6.7 6.6 3.0 3.0 5.3 7.9 1.7 4.5 2.3 5.7 10.6 2.7 40.0 36.3 44.5 42.7 39.7 20.5 18.2 40.7 21.1 11.9 3.0 11.0 18.2 26.7 22.8 52.0 42.6 10.2 13.4 11.4 17.4 19.6 17.9 53.0 15.6 5.9 18.3 10.2 0.0 16.6 13.6 21.4 23.8 20.7 12.3 17.9 36.5 40.9 17.2 30.2 7.6 31.1 18.8 25.3 27.1 12.3 32.9 15.6 14.4 27.3 25.6 28.0 6.5 37.1 38.5 44.0 27.6 18.5 15.7 14.4 19.3 PRDX1 "NKEFA, PAGA" ENSG00000117450 "Peroxiredoxin 1" Q06830 1 45511036-45523047 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004682, HPA007730" Approved Approved Mitochondria NA NA 110000000 Mitochondria "CAB004682: AB_437046, HPA007730: AB_1855204" "unprognostic (1.28e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.68e-2)" "unprognostic (3.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.39e-2)" "unprognostic (5.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.89e-4)" 43.3 58.2 71.0 43.8 57.4 12.0 75.5 31.6 60.0 46.9 51.1 72.2 42.6 78.5 40.8 75.7 136.1 49.7 46.9 84.2 56.5 73.0 121.7 136.5 52.9 51.0 99.1 51.2 43.0 20.4 34.1 34.3 58.3 87.8 42.2 53.0 48.8 53.5 52.2 78.9 46.9 77.6 52.4 98.3 46.5 52.5 25.7 72.6 29.7 130.1 114.3 91.0 49.1 56.3 44.7 50.3 64.4 64.5 20.4 72.3 58.7 64.7 119.4 49.2 62.6 55.9 47.8 105.4 73.7 76.7 80.1 66.6 59.4 28.1 57.2 77.8 79.1 97.3 67.2 106.9 71.3 79.2 44.0 82.6 43.3 168.6 166.0 24.3 50.0 56.7 41.0 53.3 79.4 18.8 44.0 91.7 68.2 79.1 19.8 79.4 52.0 67.1 48.9 154.3 144.4 125.2 118.3 62.1 75.4 143.8 55.9 65.5 32.9 67.6 183.7 4.7 150.5 49.9 40.5 77.9 32.0 72.4 68.4 98.1 13.8 77.4 109.1 52.9 34.8 18.7 64.4 55.6 18.4 28.5 60.6 37.5 44.7 45.5 37.9 50.3 36.2 28.3 31.0 2.4 20.4 64.5 33.5 72.3 58.7 71.0 57.4 31.6 60.0 56.5 73.0 99.1 51.2 87.8 72.6 485.3 206.7 314.1 835.1 539.4 156.1 25.5 438.2 477.8 340.1 586.2 98.2 1056.6 802.4 878.0 14.3 395.3 667.0 116.8 386.1 1465.8 343.6 670.3 319.6 809.1 1307.1 195.5 167.4 307.6 343.8 26.3 461.7 625.9 551.7 763.8 204.7 292.0 608.7 403.3 386.1 1911.4 290.8 304.0 372.5 90.5 393.1 462.1 932.4 124.6 344.7 1354.4 PRDX3 "AOP-1, AOP1, MER5, SP-22" ENSG00000165672 "Peroxiredoxin 3" P30048 10 119167703-119178833 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 898.6;Proximal tubular cells: 684.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008656, HPA041488, CAB079909" Enhanced Supported Mitochondria NA NA 14000000 Mitochondria "CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508" "unprognostic (8.29e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (1.72e-3)" "unprognostic (4.62e-3)" "unprognostic (2.40e-1)" "unprognostic (2.06e-1)" "unprognostic (3.65e-2)" "unprognostic (1.29e-2)" "unprognostic (9.48e-2)" "unprognostic (6.03e-3)" "unprognostic (2.77e-1)" "unprognostic (2.77e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" 34.0 100.7 28.8 18.8 28.3 14.4 29.1 16.1 28.9 23.0 27.1 20.7 25.1 28.1 25.5 26.3 30.6 24.8 21.8 55.8 26.7 28.2 78.8 114.8 16.3 20.0 29.9 23.2 19.2 34.1 25.2 24.6 29.9 33.6 27.4 29.6 21.2 40.5 29.3 80.9 10.3 34.6 26.8 24.1 27.4 24.6 14.0 24.6 24.3 48.9 46.1 20.5 25.9 17.9 30.9 65.7 41.4 74.9 20.9 34.2 73.0 54.1 62.1 37.9 43.0 40.1 43.5 23.7 38.9 66.4 59.4 62.5 47.6 54.3 63.6 34.1 45.8 28.3 24.8 62.6 47.0 67.1 62.2 65.9 28.6 27.0 84.2 42.0 53.5 34.7 50.9 30.3 47.4 44.2 42.7 42.9 39.1 35.1 13.3 54.3 21.7 40.4 45.3 35.4 41.3 36.8 43.0 55.1 43.9 100.3 26.0 16.7 24.3 41.3 55.8 51.0 34.2 28.9 64.5 30.2 19.4 29.3 27.7 50.4 20.8 30.3 51.0 30.5 79.5 17.2 19.5 74.9 40.8 20.3 61.8 25.9 30.9 27.1 24.5 65.7 24.3 28.3 25.2 41.4 20.9 53.2 36.8 34.2 73.0 28.8 28.3 16.1 28.9 26.7 28.2 29.9 23.2 33.6 24.6 44.7 64.4 72.5 95.3 62.0 25.6 212.3 122.3 104.4 39.8 139.6 9.8 296.9 898.6 109.2 4.2 70.9 99.7 70.0 65.9 187.6 95.6 106.7 51.9 340.4 218.6 38.1 106.5 71.2 159.0 8.6 71.7 113.7 126.5 146.1 117.2 58.7 65.7 98.2 95.1 684.3 19.1 71.1 104.2 10.0 22.8 45.9 129.6 54.3 181.8 109.3 PRDX5 "ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10" ENSG00000126432 "Peroxiredoxin 5" P30044 11 64318088-64321811 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008661, HPA037915, HPA037916" Enhanced Supported Mitochondria NA NA 19000000 Mitochondria "CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736" "unprognostic (2.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-1)" "unprognostic (9.43e-2)" "unprognostic (6.71e-3)" "unprognostic (1.08e-3)" "unprognostic (3.11e-1)" "unprognostic (9.30e-2)" "unprognostic (1.07e-3)" "unprognostic (1.57e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.24e-5)" "unprognostic (8.19e-2)" "unprognostic (2.30e-1)" "unprognostic (9.63e-2)" "unprognostic (5.03e-2)" 28.7 69.7 70.3 38.6 60.3 57.0 35.5 69.3 73.9 47.2 79.3 31.9 49.0 49.5 26.6 54.8 69.6 94.9 44.8 102.4 56.7 74.2 57.3 54.2 50.3 25.0 68.6 70.2 42.2 72.0 36.0 53.7 49.1 71.4 30.7 71.2 33.9 77.5 62.6 104.7 27.0 51.2 30.9 44.1 27.3 64.5 35.0 29.3 25.1 82.0 64.8 33.5 34.4 50.4 55.2 69.2 115.0 66.9 48.4 40.5 75.3 26.3 53.8 32.6 53.9 35.1 52.9 37.7 33.0 52.9 24.3 30.3 39.1 54.1 38.6 57.8 52.7 87.4 60.3 30.4 70.1 15.4 53.6 24.0 39.0 84.6 44.5 72.1 14.7 33.3 53.6 91.6 40.7 41.3 47.5 36.8 45.9 21.9 91.9 34.1 66.8 25.7 64.1 49.3 41.7 68.8 24.8 33.5 136.5 90.8 52.3 27.6 52.6 27.6 61.3 94.1 32.6 44.9 33.6 35.5 34.7 32.3 40.1 14.5 47.0 56.0 45.5 42.0 29.8 27.0 79.8 66.9 85.4 37.7 59.6 32.7 53.8 35.0 30.8 52.4 55.2 34.8 35.0 115.0 48.4 52.5 69.2 40.5 75.3 70.3 60.3 69.3 73.9 56.7 74.2 68.6 70.2 71.4 29.3 247.1 407.2 232.2 603.5 290.1 156.4 523.8 356.7 1310.3 342.4 427.5 66.8 1002.3 1366.1 644.2 57.6 187.4 757.5 163.5 919.1 972.3 308.0 330.5 103.7 331.1 418.0 87.4 770.7 194.0 207.8 207.7 258.3 234.8 413.3 423.8 875.2 180.0 1093.8 547.1 213.2 1094.9 109.1 194.1 199.4 113.7 345.0 225.2 818.7 191.8 959.8 988.5 PRKAR2B PRKAR2 ENSG00000005249 "Protein kinase cAMP-dependent type II regulatory subunit beta" P31323 7 107044649-107161811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 80.2;breast: 114.1" "Cell type enhanced" "Detected in many" 7 "Peritubular cells: 49.8;Smooth muscle cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008421, HPA063879" Enhanced Uncertain Mitochondria NA NA 1600000 Mitochondria "HPA008421: AB_1855421, HPA063879: " "unprognostic (3.18e-1)" "unprognostic (2.48e-2)" "prognostic favorable (6.38e-4)" "unprognostic (1.63e-2)" "unprognostic (3.33e-3)" "unprognostic (2.43e-3)" "unprognostic (2.76e-1)" "unprognostic (8.14e-3)" "unprognostic (1.70e-1)" "unprognostic (5.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.50e-1)" "unprognostic (5.12e-3)" "unprognostic (2.39e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (7.15e-2)" 80.2 21.5 9.4 6.0 17.2 8.4 114.1 4.5 17.0 3.9 9.1 1.9 2.4 3.1 5.1 3.9 8.4 3.4 4.7 9.0 8.8 8.6 4.5 2.4 3.2 3.0 8.4 12.1 19.5 6.5 5.6 8.1 10.7 3.0 6.4 5.5 2.6 6.8 3.9 2.2 1.6 4.7 7.4 3.4 11.1 4.1 14.5 4.6 0.8 1.6 2.8 3.3 8.4 11.8 0.2 3.1 1.3 1.5 0.5 0.1 2.5 0.0 0.4 2.6 20.1 10.8 0.0 0.0 1.0 3.2 0.8 0.8 0.0 0.0 27.6 0.2 0.6 2.5 0.0 2.0 0.0 1.6 0.7 2.2 9.2 0.0 0.0 3.0 0.1 1.3 0.1 0.0 0.0 0.0 0.9 12.1 1.5 16.6 0.8 0.0 2.0 3.7 0.1 4.9 0.0 0.8 1.1 0.0 0.0 0.0 0.0 3.3 4.8 1.5 0.3 1.0 6.9 0.6 1.9 6.8 1.0 2.6 0.0 1.9 0.6 0.0 71.0 0.7 4.8 9.6 1.3 1.5 0.0 0.0 1.4 0.1 0.2 0.0 0.0 3.1 0.0 0.1 0.1 0.7 0.5 0.7 1.1 0.0 2.5 9.4 17.2 4.5 17.0 8.8 8.6 8.4 12.1 3.0 4.6 3.0 1.0 0.8 1.4 2.2 29.0 26.0 10.2 6.7 1.2 7.0 9.8 0.0 0.0 1.7 6.2 15.5 0.0 0.0 0.0 0.4 5.1 5.9 4.6 0.0 1.5 4.8 0.0 14.1 14.0 4.7 27.6 10.4 16.9 13.6 0.5 5.5 0.2 2.6 49.8 0.6 9.1 19.4 35.8 1.6 4.5 2.0 0.0 2.9 1.9 3.9 PTCD1 KIAA0632 ENSG00000106246 "Pentatricopeptide repeat domain 1" O75127 7 99416739-99466163 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 22.3" "HPA020106, HPA047679" Uncertain Approved Mitochondria NA NA Mitochondria "HPA020106: AB_2176551, HPA047679: AB_2680119" "unprognostic (4.70e-2)" "unprognostic (3.38e-2)" "unprognostic (4.19e-2)" "unprognostic (6.05e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (4.39e-2)" "unprognostic (2.00e-1)" "unprognostic (4.09e-2)" "unprognostic (1.14e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.49e-1)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (7.10e-3)" 10.3 11.4 9.9 12.0 11.9 21.9 10.6 13.9 16.3 9.4 15.7 5.3 12.0 13.2 12.4 10.6 17.7 12.7 13.2 22.9 10.5 9.1 18.3 29.5 11.5 14.8 9.2 13.1 13.5 19.9 9.3 9.7 9.8 10.7 13.4 7.4 9.1 17.4 13.6 43.8 19.7 18.9 6.4 8.6 15.8 11.6 18.0 7.5 16.0 12.2 30.8 11.3 12.4 10.5 6.2 4.7 4.5 5.0 4.1 8.0 3.2 3.6 7.5 2.6 7.2 2.4 2.0 7.3 5.0 1.9 3.7 2.6 22.3 4.4 7.3 5.9 1.4 6.1 3.9 3.1 4.6 1.3 5.7 8.7 3.7 6.0 5.4 3.8 3.6 7.1 1.6 2.9 3.0 3.0 2.5 1.1 4.7 7.4 5.0 1.8 10.2 6.7 9.6 4.8 3.6 6.3 4.1 3.4 9.0 1.9 3.9 4.8 5.2 5.6 18.8 4.8 3.9 4.0 4.0 2.0 5.6 6.5 10.8 5.4 7.6 6.5 7.8 5.7 5.1 7.6 3.5 4.5 1.8 8.0 5.0 5.2 4.2 5.0 5.2 3.2 6.2 5.9 7.1 4.5 4.1 3.5 4.7 3.3 3.2 9.9 11.9 13.9 16.3 10.5 9.1 9.2 13.1 10.7 7.5 0.0 4.3 11.3 3.5 5.6 7.8 5.5 2.5 8.1 3.4 5.2 9.8 8.1 1.7 4.4 1.0 4.3 3.0 0.0 5.9 4.6 5.0 3.0 12.7 5.9 5.8 7.9 7.0 3.7 1.6 1.5 3.4 4.8 3.3 3.6 5.8 4.6 3.6 3.4 2.8 2.4 8.3 0.0 5.4 6.5 7.1 3.6 4.7 5.7 5.6 2.4 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106182-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria NA NA Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favorable (6.86e-4)" 13.9 18.6 18.5 12.2 23.2 18.0 14.5 24.5 22.7 13.0 17.5 19.7 11.3 14.3 15.2 15.5 12.7 13.6 9.6 35.0 17.7 16.6 18.0 21.9 11.7 15.4 20.2 19.0 20.2 13.8 17.9 22.7 13.2 21.4 13.0 19.7 11.4 11.1 12.9 45.4 14.2 14.2 13.4 17.9 15.8 14.8 22.8 20.5 20.4 14.9 13.1 15.3 12.4 13.0 13.4 9.4 6.3 11.1 11.9 14.7 7.5 7.8 18.9 11.2 9.4 8.4 8.8 13.5 17.3 7.0 9.2 9.3 35.1 7.6 19.7 6.1 9.1 9.9 14.5 22.6 8.9 11.8 8.8 19.9 15.6 11.8 29.0 8.7 12.6 11.9 10.4 6.5 7.0 12.6 9.7 8.0 14.8 16.2 7.5 8.1 7.3 10.4 15.1 10.2 15.6 12.1 14.1 15.9 14.9 12.6 15.8 12.3 7.5 7.6 12.7 14.8 11.0 6.7 7.8 5.6 7.3 7.9 7.5 9.5 17.7 22.8 16.0 7.1 14.5 5.6 3.4 8.6 6.3 11.6 5.9 13.6 13.4 10.5 12.2 9.4 13.4 14.7 10.7 0.3 11.9 11.1 9.4 11.8 7.5 18.5 23.2 24.5 22.7 17.7 16.6 20.2 19.0 21.4 20.5 53.6 27.4 22.3 21.6 23.1 60.5 94.8 17.8 24.1 42.1 22.7 62.8 46.9 21.6 16.2 23.2 22.4 21.0 0.0 10.3 21.6 24.3 12.7 32.4 38.0 18.9 35.0 29.9 22.7 15.0 17.5 25.0 13.2 8.5 16.2 21.0 49.5 14.2 22.4 18.4 24.4 63.1 12.9 16.5 90.5 54.4 21.7 30.7 24.5 35.3 17.5 PTGES2 "C9orf15, FLJ14038" ENSG00000148334 "Prostaglandin E synthase 2" Q9H7Z7 9 128120693-128128462 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.5" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 606.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020631, HPA020733" Approved Approved Mitochondria No No Mitochondria "HPA020631: AB_1855887, HPA020733: AB_2670508" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-2)" "unprognostic (5.13e-3)" "unprognostic (2.56e-1)" "unprognostic (1.57e-1)" "unprognostic (7.10e-2)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "prognostic favorable (5.83e-7)" "unprognostic (2.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" 9.3 17.0 16.5 9.2 17.8 4.4 7.4 15.3 24.1 7.1 14.8 9.9 7.6 17.7 8.1 9.0 12.6 8.4 10.0 36.4 17.4 14.0 13.2 13.0 5.8 10.2 14.2 11.6 9.2 18.3 11.7 14.3 10.7 10.5 8.0 7.0 13.2 16.2 12.0 73.5 9.3 13.2 5.9 7.0 9.5 14.3 5.8 9.8 9.3 10.5 16.2 13.3 8.5 7.3 5.2 8.2 1.2 6.3 3.7 6.5 2.9 12.7 35.8 4.0 14.8 3.6 3.7 12.2 9.8 5.5 12.4 6.6 26.7 20.0 11.3 15.7 3.9 9.7 33.2 5.8 12.1 1.7 8.1 15.6 5.8 27.1 24.9 11.1 11.7 11.6 5.0 8.8 10.0 6.9 3.8 8.5 12.0 12.8 7.0 4.1 39.5 14.0 22.4 12.8 15.4 29.0 10.6 7.9 28.8 8.4 9.6 20.0 12.0 14.2 22.6 9.5 2.0 20.2 6.3 11.1 12.8 15.8 17.2 17.8 16.2 7.9 11.0 9.7 9.1 11.8 1.2 6.0 1.0 5.6 6.3 6.5 5.2 3.7 5.9 6.7 4.5 4.3 5.1 1.1 3.7 2.8 8.2 4.2 2.9 16.5 17.8 15.3 24.1 17.4 14.0 14.2 11.6 10.5 9.8 14.9 5.4 25.3 29.8 20.4 34.7 606.9 35.7 0.0 6.8 22.7 19.6 69.1 124.3 64.1 1.9 21.1 88.3 0.0 44.8 49.4 20.3 34.0 14.9 33.3 50.6 35.0 43.4 15.4 22.9 3.2 28.4 33.8 54.0 154.1 52.3 18.2 52.2 51.8 20.5 79.0 38.1 19.4 28.3 2.3 56.6 21.5 55.7 21.7 83.1 40.8 PTPMT1 "DUSP23, MOSP, PLIP" ENSG00000110536 "Protein tyrosine phosphatase, mitochondrial 1" Q8WUK0 11 47565430-47573461 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043932, HPA060060" Approved Enhanced Mitochondria NA NA Mitochondria "HPA043932: AB_2678738, HPA060060: " "unprognostic (6.61e-2)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (3.29e-2)" "unprognostic (2.77e-2)" "unprognostic (1.93e-3)" "unprognostic (6.76e-2)" "unprognostic (1.72e-1)" "unprognostic (2.68e-3)" "unprognostic (1.21e-1)" "unprognostic (5.39e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 24.0 24.5 22.3 13.1 23.2 19.8 23.3 16.5 25.2 15.7 14.8 18.5 17.5 14.6 14.7 21.4 14.3 16.9 17.9 17.1 18.5 21.9 20.1 21.8 25.1 16.7 23.1 16.2 15.7 39.3 18.3 18.7 21.8 14.4 15.8 11.5 20.1 26.4 19.5 23.4 11.2 13.1 12.7 17.6 14.7 16.9 44.6 10.3 10.8 19.9 15.7 15.0 11.0 11.5 20.4 40.8 22.1 24.4 15.4 17.5 16.8 22.2 12.6 1.5 10.1 11.7 9.0 4.3 13.1 12.4 13.1 12.5 20.9 11.9 16.0 14.5 9.8 12.2 19.1 10.4 13.6 14.0 19.5 31.3 7.4 25.8 26.3 17.2 14.3 9.8 8.9 15.5 6.1 18.8 10.1 9.3 15.9 18.8 12.3 9.6 42.0 12.2 18.5 9.4 3.8 23.4 22.4 8.5 13.7 15.8 14.3 9.4 11.5 19.9 7.3 11.8 6.6 33.8 15.4 10.0 9.7 15.0 15.7 19.7 18.7 12.5 10.9 7.6 12.4 5.9 6.0 24.4 22.1 16.0 20.9 15.4 20.4 15.2 17.3 27.7 18.0 15.2 14.4 1.9 15.4 19.4 40.8 17.5 16.8 22.3 23.2 16.5 25.2 18.5 21.9 23.1 16.2 14.4 10.3 20.8 25.4 25.3 13.5 15.9 13.5 5.3 48.4 41.5 22.7 38.4 3.9 63.4 61.3 87.9 188.7 19.1 21.4 0.0 74.6 54.2 24.4 20.5 16.2 36.5 56.1 4.8 30.1 30.1 29.8 522.3 43.1 32.4 43.9 60.5 41.0 48.4 92.6 28.1 43.9 62.0 11.6 19.4 21.2 109.7 21.3 15.2 64.2 24.9 61.2 18.6 PTPRH SAP-1 ENSG00000080031 "Protein tyrosine phosphatase, receptor type H" Q9HD43 19 55181248-55209506 "Enzymes, Predicted membrane proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 106.7;Paneth cells: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Cell line enhanced" "Detected in many" "HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042300 Approved Mitochondria NA NA Mitochondria "HPA042300: AB_10796900" "unprognostic (1.87e-1)" "unprognostic (1.10e-1)" "unprognostic (2.59e-1)" "unprognostic (7.57e-3)" "unprognostic (5.01e-3)" "unprognostic (8.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.96e-3)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-11)" "unprognostic (4.08e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-2)" "unprognostic (1.57e-1)" 0.5 8.9 0.5 5.2 0.7 0.0 0.5 0.5 1.0 0.7 39.9 0.6 0.5 30.1 0.5 0.5 0.6 0.0 29.6 0.5 1.3 1.6 0.6 7.8 0.6 0.5 3.0 0.5 0.6 2.8 0.0 3.0 0.6 0.5 1.0 9.6 0.6 0.5 0.5 0.5 0.0 84.3 0.7 6.9 21.2 10.2 0.5 0.5 0.5 0.5 1.0 0.8 1.1 2.4 0.0 0.7 0.0 1.5 0.0 0.0 0.0 4.9 3.0 0.0 1.2 1.0 2.7 0.0 0.1 2.7 0.5 1.1 1.3 7.0 0.0 0.2 0.5 6.2 0.0 0.0 0.0 0.6 0.0 0.1 0.4 0.1 3.5 9.1 0.0 3.6 0.7 2.2 1.7 2.7 0.3 0.1 0.0 10.6 0.5 0.0 0.0 0.0 0.2 0.0 22.4 7.2 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 3.1 15.9 0.0 0.0 1.4 0.0 0.7 1.1 0.3 0.0 0.0 2.6 0.0 0.8 0.1 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.7 0.5 0.5 1.3 1.6 3.0 0.5 0.5 0.5 0.0 0.0 0.0 2.4 1.5 0.0 0.6 20.4 0.0 0.0 1.8 0.0 0.0 0.0 11.7 0.0 0.2 106.7 0.0 22.9 0.0 0.2 3.1 0.0 5.1 0.2 15.9 4.6 1.3 0.0 0.0 0.0 0.8 0.0 1.0 14.0 0.2 20.1 38.6 0.0 0.0 0.3 0.0 0.4 0.0 0.2 1.0 0.1 0.0 15.6 17.9 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria NA NA Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 15.9 22.9 17.1 12.4 17.1 9.9 20.7 12.5 22.1 15.6 17.2 11.8 16.3 11.6 14.3 36.7 16.4 13.8 13.1 12.6 19.3 17.8 14.8 34.7 12.1 12.5 16.7 15.2 14.2 19.9 10.3 18.3 13.6 21.0 15.9 20.7 8.1 13.7 18.7 23.3 11.4 11.0 16.8 17.1 15.5 14.3 15.7 18.1 9.0 11.8 13.5 16.9 13.0 10.5 15.6 21.6 12.6 29.3 13.1 15.5 13.0 18.9 36.2 11.7 10.6 22.2 19.1 12.5 18.3 16.1 15.7 23.0 23.4 14.9 13.8 27.8 15.3 26.9 18.9 25.1 23.6 22.9 26.5 34.1 24.6 18.8 42.8 34.3 21.7 14.0 21.5 30.7 24.3 28.3 11.2 26.1 9.7 27.4 15.4 23.3 45.8 18.5 17.7 10.0 49.3 28.7 10.1 19.6 20.1 26.1 27.3 15.1 19.6 9.4 10.3 22.4 14.0 24.1 15.5 17.1 20.5 20.7 12.2 19.8 20.0 22.2 20.4 13.5 13.6 15.6 1.9 25.8 1.1 9.2 24.4 12.4 15.6 10.8 10.4 18.5 13.1 15.5 11.1 12.6 13.1 29.3 21.6 12.3 13.0 17.1 17.1 12.5 22.1 19.3 17.8 16.7 15.2 21.0 18.1 14.9 12.8 13.4 31.9 32.5 3.3 14.8 7.6 30.8 50.0 10.4 3.9 22.1 10.0 25.9 17.7 18.3 9.1 0.0 22.0 20.6 19.7 23.3 22.0 27.3 15.2 7.9 6.4 11.6 7.3 7.9 16.1 18.7 13.5 10.0 9.7 6.6 25.9 13.9 9.2 13.2 3.2 12.9 21.7 16.7 11.4 31.1 26.5 8.3 13.2 31.5 PYCR2 P5CR2 ENSG00000143811 "Pyrroline-5-carboxylate reductase 2" Q96C36 1 225919877-225924340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA056873 Approved Approved Mitochondria NA NA Mitochondria "HPA056873: AB_2683263" "unprognostic (1.11e-1)" "unprognostic (8.08e-2)" "prognostic unfavorable (5.02e-5)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-3)" "unprognostic (1.56e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (9.07e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.69e-2)" "unprognostic (2.61e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" 21.4 37.2 25.7 24.0 28.2 29.5 17.2 14.3 38.2 21.8 17.4 40.0 25.8 16.1 25.3 20.0 17.7 33.2 24.6 38.0 27.9 28.3 23.4 35.0 22.0 30.3 34.0 30.8 34.5 29.0 26.6 29.8 22.2 29.5 22.4 13.7 21.5 26.3 32.1 36.0 15.3 16.7 22.3 38.4 25.9 20.1 17.6 24.7 35.0 19.2 20.0 23.5 24.6 16.2 19.3 25.9 16.4 12.7 28.3 36.1 18.1 16.9 14.0 8.6 14.4 9.7 10.1 18.1 17.9 11.2 12.2 10.9 18.3 14.1 29.8 38.5 13.1 9.6 19.6 12.3 14.1 7.0 35.8 25.6 28.5 14.6 18.3 15.1 25.0 46.8 9.7 17.8 13.8 15.9 10.9 11.6 25.0 41.1 20.0 12.3 13.9 31.4 28.4 47.9 26.7 19.5 28.2 19.2 61.8 15.8 13.5 10.8 14.0 14.9 11.9 37.4 7.2 15.3 47.9 9.7 9.6 11.5 20.3 24.6 32.0 35.1 29.5 15.1 19.1 26.5 15.1 8.7 16.4 21.1 12.7 22.2 15.9 20.6 19.5 13.6 19.3 36.1 29.2 6.0 28.3 10.8 25.9 18.6 18.1 25.7 28.2 14.3 38.2 27.9 28.3 34.0 30.8 29.5 24.7 17.9 21.4 27.4 51.9 13.2 13.0 38.6 15.3 60.2 17.0 33.2 13.7 79.6 41.4 44.2 5.9 22.9 13.5 46.7 30.3 34.9 22.5 33.6 38.1 16.3 35.3 12.7 25.4 19.0 20.8 5.6 35.4 21.2 32.1 65.9 14.1 38.4 25.0 13.9 35.3 24.0 36.1 25.8 18.9 33.6 40.3 11.2 34.9 45.7 13.6 34.4 PYROXD2 "C10orf33, FLJ23849" ENSG00000119943 "Pyridine nucleotide-disulphide oxidoreductase domain 2" Q8N2H3 10 98383565-98415184 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.8" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 50.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 50.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 28.6;U-937: 18.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037566, HPA037567, HPA067394" Approved Approved Mitochondria NA NA Mitochondria "HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832" "unprognostic (2.35e-2)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (6.76e-2)" "unprognostic (1.27e-2)" "unprognostic (3.38e-2)" "unprognostic (2.69e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic favorable (3.37e-4)" 11.0 15.5 5.1 9.0 7.0 2.7 9.2 2.6 6.3 12.2 6.5 12.0 14.2 2.5 8.3 15.5 4.1 11.6 13.1 9.5 5.3 3.8 6.7 11.7 8.6 2.9 12.6 3.0 11.5 4.3 7.5 6.0 5.0 9.6 12.9 5.8 12.5 26.9 11.3 9.6 3.2 4.1 12.2 8.1 5.2 5.5 3.7 10.7 4.3 9.2 2.3 3.0 11.9 6.9 0.0 0.5 50.8 0.0 11.3 1.8 0.4 2.1 5.3 3.0 0.1 4.7 9.5 1.1 3.5 10.9 2.0 3.8 0.0 7.4 0.0 6.3 3.7 0.5 1.0 0.9 1.2 2.1 0.2 0.8 4.3 8.8 0.4 6.1 0.0 10.0 5.6 1.6 1.6 1.9 28.6 1.5 2.0 0.1 0.1 3.0 6.5 0.1 10.2 0.9 4.1 1.8 1.3 1.1 0.0 2.9 3.3 0.2 0.1 3.8 0.5 2.6 4.3 3.1 4.8 2.0 0.0 2.3 0.6 3.4 0.7 0.4 0.0 3.5 18.7 0.3 1.1 0.0 50.8 1.8 0.0 0.4 0.0 0.6 1.5 0.5 0.0 0.3 1.1 0.1 11.3 0.0 0.1 0.1 0.4 5.1 7.0 2.6 6.3 5.3 3.8 12.6 3.0 9.6 10.7 8.9 3.2 0.0 5.5 0.5 0.0 8.1 0.0 13.4 6.8 1.8 0.0 4.5 6.6 2.1 0.2 3.1 2.0 0.0 2.2 3.3 4.6 2.8 2.3 2.4 7.5 0.0 1.2 4.3 3.8 0.2 3.1 2.5 1.7 1.0 4.9 3.1 1.1 0.0 3.5 7.3 0.8 6.5 4.2 2.6 1.5 0.5 1.5 4.4 6.0 8.4 QDPR "DHPR, PKU2, SDR33C1" ENSG00000151552 "Quinoid dihydropteridine reductase" P09417 4 17460261-17512234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Oxidoreductase "Disease mutation, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.1;liver: 64.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 298.8;Muller glia cells: 301.8;Proximal tubular cells: 369.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058951, HPA065649" Enhanced Approved Mitochondria NA NA 1800000 Mitochondria "HPA058951: AB_2683861, HPA065649: AB_2685526" "unprognostic (1.30e-2)" "unprognostic (4.29e-1)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (3.29e-3)" "unprognostic (3.80e-3)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "unprognostic (6.82e-3)" "unprognostic (2.07e-1)" "prognostic favorable (7.84e-6)" "unprognostic (1.58e-1)" "unprognostic (2.60e-1)" "unprognostic (9.01e-2)" "unprognostic (3.19e-1)" 22.5 25.9 67.8 3.4 111.9 4.4 7.4 16.0 54.1 5.7 7.5 56.3 2.6 9.1 5.5 12.5 5.2 6.4 6.3 15.0 80.7 58.2 36.1 64.8 8.0 3.7 114.1 36.7 6.7 10.3 13.7 6.2 4.1 82.5 10.3 5.9 2.6 12.4 7.5 34.2 4.6 8.1 6.4 93.6 4.8 9.1 4.1 94.7 0.7 7.7 2.8 4.4 4.5 2.6 7.5 42.5 1.0 21.9 9.9 15.0 12.3 11.6 22.8 9.0 12.5 21.9 11.1 15.9 16.6 7.0 15.5 13.6 18.2 15.4 4.3 10.7 9.2 17.3 6.6 12.8 18.8 9.7 13.1 2.6 11.8 11.8 43.0 13.2 15.3 1.1 13.7 11.9 9.7 13.4 8.3 7.8 11.0 12.6 9.9 16.6 6.0 22.8 24.6 15.3 11.0 15.4 9.5 6.9 17.2 16.0 6.4 17.1 21.8 11.0 1.8 47.2 10.3 5.0 5.9 13.5 9.0 16.1 8.9 13.2 15.4 24.0 30.2 18.0 13.5 14.9 0.0 14.4 1.0 12.3 21.9 11.1 7.5 13.3 12.8 18.0 6.2 15.0 12.9 0.4 9.9 16.3 42.5 6.9 12.3 67.8 111.9 16.0 54.1 80.7 58.2 114.1 36.7 82.5 94.7 26.8 26.9 18.2 16.6 17.7 34.9 59.2 38.2 4.0 14.8 36.6 7.9 65.3 92.9 37.2 0.8 17.8 14.2 0.0 20.5 28.8 26.3 26.4 25.3 298.8 69.8 77.9 167.4 25.8 34.9 3.3 21.0 26.9 145.1 20.8 22.6 301.8 17.0 7.0 35.7 369.1 26.6 25.8 26.4 3.3 60.7 14.1 15.3 16.7 36.6 11.1 QTRT1 TGT ENSG00000213339 "Queuine tRNA-ribosyltransferase catalytic subunit 1" Q9BXR0 19 10701430-10713437 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 232.5;Paneth cells: 244.4;Undifferentiated cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042695, HPA048651, HPA049440" Approved Approved Mitochondria NA NA Mitochondria "HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767" "unprognostic (6.19e-2)" "prognostic favorable (7.63e-5)" "unprognostic (2.90e-2)" "unprognostic (3.05e-1)" "unprognostic (4.90e-2)" "prognostic favorable (4.90e-4)" "unprognostic (2.52e-1)" "unprognostic (8.76e-3)" "unprognostic (3.88e-1)" "unprognostic (4.81e-3)" "prognostic favorable (2.13e-4)" "unprognostic (1.14e-2)" "prognostic unfavorable (1.13e-6)" "unprognostic (2.04e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" 14.0 18.4 20.6 13.4 29.1 14.2 11.5 18.0 21.3 11.3 14.5 13.3 19.4 12.8 15.3 11.6 14.6 15.8 13.5 19.5 19.7 13.1 11.8 18.9 8.4 13.5 22.9 19.3 22.1 33.9 5.8 12.0 9.8 19.9 13.7 6.6 10.5 26.6 12.7 20.5 12.6 14.2 13.3 12.7 11.5 12.5 5.0 22.2 5.3 19.0 11.9 10.3 12.0 10.3 19.6 19.1 0.9 14.4 18.5 18.8 10.4 17.2 13.9 6.6 19.3 7.0 8.4 8.7 8.8 7.9 10.3 10.2 11.1 6.6 19.5 21.7 5.0 6.2 11.6 6.0 10.6 3.4 11.5 8.4 12.8 5.6 23.3 12.1 19.0 11.3 12.4 9.1 6.7 9.9 4.7 10.5 10.8 14.1 22.4 5.1 26.9 16.3 23.7 17.5 10.8 21.5 17.2 8.8 30.1 8.4 11.1 21.5 9.3 13.5 14.8 11.5 2.9 9.5 8.0 8.1 15.9 8.9 25.4 20.5 24.7 19.0 9.5 8.6 23.1 19.2 0.9 8.3 0.2 15.1 14.4 18.8 19.6 16.3 13.1 16.4 19.0 17.5 13.9 0.6 18.5 7.3 19.1 17.7 10.4 20.6 29.1 18.0 21.3 19.7 13.1 22.9 19.3 19.9 22.2 0.0 5.0 26.7 54.7 56.6 36.4 5.6 28.1 12.0 5.7 54.1 47.1 41.0 54.7 20.6 1.3 27.0 191.9 70.0 23.8 30.6 33.2 38.0 16.1 26.7 26.1 85.8 185.1 16.5 20.2 1.1 46.9 9.6 47.2 7.2 232.5 24.4 15.1 244.4 35.3 58.5 54.3 19.4 30.3 12.1 28.9 36.6 23.5 26.2 247.9 33.9 RARS2 "DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL" ENSG00000146282 "Arginyl-tRNA synthetase 2, mitochondrial" Q5T160 6 87514378-87590003 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039987, HPA042645" Uncertain Approved Mitochondria NA NA Mitochondria "HPA039987: AB_2676786, HPA042645: AB_2678097" "unprognostic (1.49e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (6.98e-2)" "unprognostic (9.27e-2)" "unprognostic (5.41e-2)" "unprognostic (6.61e-2)" "unprognostic (4.30e-2)" "unprognostic (1.88e-1)" "unprognostic (1.08e-3)" "unprognostic (8.28e-2)" "unprognostic (2.20e-1)" "unprognostic (7.56e-3)" "unprognostic (1.62e-1)" "unprognostic (1.89e-2)" "unprognostic (5.73e-2)" "unprognostic (7.16e-3)" 27.0 44.1 13.3 21.1 15.9 16.0 22.9 24.0 17.3 25.1 21.4 18.6 25.2 17.5 35.5 25.5 20.4 21.1 19.2 21.5 14.4 12.8 23.7 32.1 20.5 24.4 17.3 14.2 22.2 30.1 20.5 36.9 28.3 17.2 20.7 23.1 24.0 23.5 27.7 23.0 20.4 30.5 24.7 16.8 21.1 20.5 23.9 13.6 28.0 21.2 20.5 27.3 24.3 20.2 16.7 18.9 22.8 20.2 18.1 28.8 16.2 10.1 10.1 24.3 26.4 24.7 27.0 17.3 24.4 29.2 16.9 21.5 19.4 11.4 12.9 14.5 25.0 17.1 14.2 20.4 14.0 24.0 9.5 19.3 13.3 12.8 30.8 31.1 15.7 11.5 26.9 13.6 14.2 18.1 23.7 22.2 13.6 30.7 12.8 24.9 18.7 5.1 16.7 15.8 21.8 10.9 10.3 24.5 11.3 20.8 21.4 22.0 29.7 12.8 6.4 17.1 21.4 11.9 24.0 15.1 11.2 9.0 12.3 20.1 13.6 22.8 10.7 17.6 16.6 19.4 15.9 19.1 22.8 18.1 19.3 21.3 16.7 23.4 17.0 16.7 16.2 23.0 19.1 11.6 18.1 20.2 18.9 28.8 16.2 13.3 15.9 24.0 17.3 14.4 12.8 17.3 14.2 17.2 13.6 17.9 14.1 14.5 30.7 15.3 13.2 19.7 7.6 20.1 26.1 10.4 19.6 27.0 38.1 25.7 69.3 24.2 16.2 0.0 41.3 37.9 29.7 24.9 17.4 13.2 18.2 6.4 8.6 22.7 14.8 27.7 23.6 14.2 18.6 22.6 23.2 12.1 29.9 21.8 22.6 23.7 15.6 25.8 24.7 38.7 31.1 15.7 33.1 21.8 24.1 29.1 RASGEF1C FLJ35841 ENSG00000146090 "RasGEF domain family member 1C" Q8N431 5 180100791-180209153 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 27.4;testis: 7.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 2.5;Late spermatids: 3.2;Spermatocytes: 5.5;Syncytiotrophoblasts: 1.6" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 3.7;HEK 293: 2.8;MCF7: 3.9;SCLC-21H: 12.6;U-2 OS: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028242 Uncertain Approved Mitochondria NA NA Mitochondria "HPA028242: AB_10602294" "unprognostic (2.21e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (4.75e-4)" "unprognostic (4.65e-2)" "unprognostic (4.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.02e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.65e-4)" "unprognostic (5.89e-2)" "unprognostic (8.25e-3)" "unprognostic (3.70e-1)" "unprognostic (1.77e-2)" 1.1 1.1 7.0 1.1 5.4 0.6 1.4 27.4 22.0 1.4 2.3 9.2 0.0 0.8 0.6 0.8 1.2 1.7 1.2 1.5 4.5 2.8 0.6 0.6 0.6 0.6 5.1 4.9 0.8 0.9 0.8 0.2 0.8 7.7 0.8 1.1 0.4 3.0 2.7 0.7 1.1 1.4 1.0 8.3 0.7 0.8 7.1 4.7 0.0 2.1 0.0 0.6 0.8 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.2 0.0 3.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 7.0 5.4 27.4 11.1 4.5 2.8 5.1 4.9 7.7 4.7 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 5.5 0.9 0.0 1.6 0.0 0.0 0.0 RBFA "C18orf22, FLJ21172, HsT169" ENSG00000101546 "Ribosome binding factor A" Q8N0V3 18 80034358-80046397 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040485, HPA041479" Approved Approved Mitochondria NA NA Mitochondria "HPA040485: AB_10795368, HPA041479: AB_10795697" "unprognostic (5.31e-3)" "unprognostic (3.21e-2)" "unprognostic (1.87e-1)" "unprognostic (4.55e-2)" "unprognostic (7.33e-2)" "unprognostic (5.00e-3)" "prognostic unfavorable (2.06e-6)" "unprognostic (2.98e-1)" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (4.28e-2)" "unprognostic (3.76e-2)" "unprognostic (2.43e-1)" "unprognostic (3.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.82e-1)" "unprognostic (5.00e-3)" 19.4 21.0 11.3 14.4 15.8 16.7 30.9 20.4 17.3 12.1 12.5 15.9 10.0 14.8 13.6 14.3 17.7 11.4 12.9 13.8 10.6 8.6 14.5 36.9 11.0 18.5 12.5 14.2 12.3 20.0 12.5 9.7 12.6 12.7 11.8 12.7 11.3 13.4 12.3 21.3 18.6 11.1 18.3 13.8 13.2 12.1 13.8 12.8 9.9 11.6 18.6 15.7 14.0 14.2 10.7 8.3 0.3 10.1 7.5 11.7 5.7 14.3 16.2 11.4 10.5 11.6 13.8 14.8 12.3 7.8 18.1 16.3 9.4 12.7 30.3 4.6 11.0 12.4 13.6 12.7 15.8 14.5 11.0 13.2 18.0 11.7 24.9 8.9 28.4 8.9 13.2 15.4 12.0 17.3 6.4 15.1 19.2 9.6 18.9 11.0 13.8 28.2 19.6 11.9 9.7 16.1 19.0 10.6 37.0 17.3 16.9 19.7 11.9 11.0 13.1 8.3 10.3 9.5 14.3 10.3 20.6 19.2 3.0 13.2 7.0 12.1 25.3 11.9 24.7 11.7 0.0 5.1 0.0 7.5 7.0 11.7 10.7 7.6 7.3 8.3 8.3 8.4 7.9 0.3 7.5 10.1 6.5 5.8 5.7 11.3 15.8 20.4 17.3 10.6 8.6 12.5 14.2 12.7 12.8 29.8 7.5 26.0 20.9 16.5 12.9 9.2 12.7 17.4 25.0 26.2 17.7 41.8 26.6 23.9 14.1 14.8 9.2 0.0 21.0 42.0 21.6 15.3 12.7 36.5 21.9 30.2 20.1 14.1 6.7 12.1 17.5 17.6 32.1 7.2 20.5 9.5 20.1 2.9 17.3 34.6 21.4 19.4 20.8 28.3 58.3 20.6 20.8 10.1 22.1 13.9 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668086-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 288.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Mitochondria NA NA Mitochondria "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favorable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 15.2 22.8 19.9 26.4 22.3 25.8 16.4 33.3 22.6 14.6 27.2 14.7 19.5 29.5 16.4 27.6 17.3 17.3 28.5 26.5 18.4 11.5 21.8 23.0 15.7 23.4 20.1 20.5 17.3 25.1 18.1 25.3 17.7 19.9 23.3 8.9 30.5 31.7 20.2 21.9 25.3 25.1 13.8 10.4 27.0 24.5 15.8 15.3 20.2 22.1 14.6 20.8 16.6 16.3 11.0 16.4 16.9 18.6 8.7 20.1 13.2 9.4 18.2 10.6 16.4 5.3 5.6 18.9 15.8 7.4 13.5 10.3 25.3 14.5 10.6 11.3 6.4 4.7 17.8 7.5 15.0 3.5 15.1 31.1 12.6 22.5 18.1 9.8 11.6 17.3 9.0 12.9 10.0 5.9 7.9 9.6 14.6 22.9 8.9 7.1 38.6 12.2 12.8 26.2 8.2 12.6 28.3 11.9 22.1 8.6 18.0 23.0 27.2 14.9 19.7 8.6 6.3 20.3 18.2 15.4 10.6 17.0 8.9 11.4 23.9 15.1 14.8 6.9 11.0 15.0 4.5 16.1 16.9 20.1 18.6 12.2 10.1 16.0 15.9 15.9 11.0 12.2 10.3 13.8 8.7 14.3 16.4 18.0 13.2 19.9 22.3 33.3 22.6 18.4 11.5 20.1 20.5 19.9 15.3 29.8 28.0 27.6 25.8 30.0 90.3 21.7 30.6 17.4 15.9 27.9 249.4 51.8 18.3 35.5 4.3 24.8 52.3 0.0 31.1 43.7 26.8 20.0 50.7 31.0 31.5 81.0 41.2 21.5 34.9 4.0 25.0 26.4 27.0 56.9 37.2 36.1 33.9 37.1 24.1 19.5 288.4 51.8 33.5 28.6 51.3 27.7 56.1 51.2 38.3 20.5 RICTOR "AVO3, KIAA1999, MGC39830, PIA" ENSG00000164327 "RPTOR independent companion of MTOR complex 2" Q6R327 5 38937919-39074408 "Predicted intracellular proteins" "Host-virus interaction" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 192.4;Rod photoreceptor cells: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 22.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 22.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037802, HPA037803" Approved Approved Mitochondria NA NA Mitochondria "HPA037802: AB_10672286, HPA037803: AB_2675676" "unprognostic (2.25e-2)" "unprognostic (8.30e-2)" "unprognostic (4.02e-1)" "unprognostic (7.94e-3)" "unprognostic (5.47e-2)" "unprognostic (2.95e-3)" "unprognostic (2.95e-3)" "unprognostic (1.33e-1)" "unprognostic (3.55e-2)" "unprognostic (4.37e-1)" "unprognostic (2.73e-2)" "unprognostic (8.29e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-2)" 15.4 10.0 12.4 14.2 15.7 35.5 16.4 25.6 20.1 14.7 12.7 18.8 9.8 9.4 17.7 12.7 10.8 12.7 11.0 16.1 13.6 9.8 12.7 13.2 18.7 17.7 20.0 10.1 18.0 12.7 14.3 20.0 21.6 24.1 12.1 11.8 10.0 12.9 9.7 22.1 15.2 15.3 17.9 16.3 16.4 12.4 15.2 21.4 31.6 15.1 8.3 15.3 17.1 14.4 3.5 3.6 22.2 2.2 2.5 4.6 0.5 4.7 8.6 6.3 6.3 8.1 9.3 9.3 6.6 15.4 7.3 7.4 5.2 8.6 7.8 2.5 6.5 11.1 7.8 5.5 7.2 8.8 6.8 4.9 9.1 20.5 6.3 5.2 7.6 12.2 7.9 5.4 9.0 9.9 7.2 12.0 6.4 7.4 15.0 4.9 2.5 7.8 12.8 4.0 2.5 6.7 6.3 11.3 6.8 6.0 7.9 5.4 3.7 17.2 6.4 8.9 6.2 4.5 8.4 10.2 14.9 7.2 6.0 4.9 6.7 4.1 7.8 6.3 10.3 5.4 6.1 1.0 5.6 3.7 1.0 3.0 2.6 3.7 3.2 1.0 3.5 3.9 4.6 22.2 2.5 2.2 3.6 2.2 0.5 12.4 15.7 25.6 20.1 13.6 9.8 20.0 10.1 24.1 21.4 59.6 45.8 63.3 35.5 43.4 67.6 32.3 28.1 14.7 25.0 26.2 192.4 33.1 0.0 20.7 1.7 43.5 22.5 23.3 13.7 15.3 41.7 48.0 32.3 32.1 16.9 49.3 41.9 46.6 42.1 3.2 44.0 44.8 32.1 30.7 25.5 31.6 22.7 22.6 30.4 11.3 174.9 12.9 23.1 37.5 29.4 39.4 80.7 76.2 19.0 39.4 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452181 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria NA NA Mitochondria "HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.9 15.7 9.0 6.8 12.1 4.0 17.0 14.5 15.6 10.5 12.8 7.7 6.4 13.2 10.9 11.7 8.3 12.2 8.0 11.4 9.9 11.7 34.0 29.1 7.8 8.2 10.1 13.5 15.7 9.9 6.9 11.2 14.4 14.0 8.0 11.5 10.5 7.3 8.0 10.9 7.9 14.9 11.2 8.9 6.9 8.0 8.6 7.0 11.2 18.9 6.0 9.5 10.6 11.9 11.3 7.2 6.8 12.2 13.2 11.3 5.0 8.2 3.8 8.5 17.6 11.5 26.1 11.6 12.9 12.6 10.1 13.9 10.8 6.2 7.9 9.3 8.2 12.4 7.1 15.5 8.1 17.5 9.0 12.4 12.4 6.1 22.2 23.4 27.7 4.0 18.2 10.4 14.3 21.9 12.1 13.0 11.8 13.5 6.4 15.2 26.9 9.4 8.9 6.3 9.3 7.6 10.7 10.5 9.7 14.2 3.7 14.2 13.7 9.2 11.7 15.4 10.7 19.5 17.9 7.4 7.9 10.3 16.3 10.1 6.5 8.6 9.0 19.7 21.7 9.1 2.1 5.9 6.8 7.1 8.2 11.2 11.3 8.5 9.9 7.2 9.0 11.2 10.2 2.9 13.2 12.2 3.3 11.3 5.0 9.0 12.1 14.5 15.6 9.9 11.7 10.1 13.5 14.0 7.0 0.0 12.8 7.3 6.0 3.4 8.7 9.8 2.5 13.4 14.8 12.2 11.8 23.3 14.9 13.6 7.0 4.5 7.3 0.0 9.2 18.4 4.8 2.6 9.2 13.5 12.0 4.8 2.9 8.6 8.6 3.3 6.4 11.6 3.3 13.6 9.9 6.4 9.4 13.9 6.0 30.5 6.7 0.0 9.5 10.4 15.6 2.4 14.1 5.0 12.6 3.1 RNF138 "NARF, STRIN" ENSG00000134758 "Ring finger protein 138" Q8WVD3 18 32091855-32131561 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4" "Group enriched" "Detected in many" 16 "Early spermatids: 845.1;Late spermatids: 2984.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041101 Approved Mitochondria NA NA Mitochondria "HPA041101: AB_10805837" "unprognostic (2.37e-2)" "unprognostic (4.63e-3)" "unprognostic (2.03e-3)" "unprognostic (1.01e-1)" "unprognostic (2.34e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-2)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (6.90e-2)" "unprognostic (1.27e-2)" "unprognostic (6.15e-2)" "unprognostic (9.52e-3)" "unprognostic (2.77e-1)" "unprognostic (9.58e-2)" "unprognostic (1.90e-1)" 8.2 5.0 6.5 11.0 7.4 40.4 7.7 9.9 7.1 6.5 11.0 9.0 5.8 8.0 7.5 6.3 7.4 9.7 7.1 5.0 6.8 6.4 5.9 10.1 7.6 17.9 10.6 6.3 9.0 7.8 5.6 8.7 7.2 6.7 6.5 10.0 4.5 6.9 4.9 5.1 5.6 11.2 5.6 9.1 14.3 6.6 73.4 8.1 28.3 7.0 5.7 9.9 6.1 6.8 14.4 24.3 25.7 24.9 16.4 43.8 24.2 9.1 5.4 22.4 11.1 2.9 6.1 12.7 9.3 5.3 11.7 13.6 6.4 6.4 22.0 11.7 6.1 7.6 9.5 11.7 10.5 16.0 12.2 19.6 17.3 7.0 7.8 11.5 47.6 15.4 5.9 10.6 12.9 18.4 6.8 11.9 19.7 23.8 9.0 7.5 8.7 32.1 21.3 25.0 15.8 7.5 33.2 14.1 12.6 10.7 6.8 25.4 12.7 12.5 7.2 9.7 10.7 4.7 20.1 9.1 14.1 10.3 3.4 10.4 15.0 19.9 38.1 7.7 26.6 13.8 8.0 24.9 24.0 10.5 18.6 13.4 14.0 22.9 14.8 24.3 14.4 43.8 27.9 25.7 16.4 15.3 10.5 16.7 24.2 6.5 7.4 9.9 7.1 6.8 6.4 10.6 6.3 6.7 8.1 14.9 22.4 13.8 29.1 61.6 6.1 6.7 25.5 16.0 18.2 15.7 0.0 25.9 14.9 15.3 845.1 21.2 16.7 0.0 16.0 16.6 21.4 26.1 22.0 14.7 21.1 7.9 28.7 20.3 27.6 2984.7 27.3 30.7 25.3 10.8 21.0 8.0 10.5 20.1 20.8 10.7 4.8 32.3 25.9 118.9 102.4 45.7 7.4 27.7 27.0 31.8 RPLP2 "D11S2243E, LP2, MGC71408, P2, RPP2" ENSG00000177600 "Ribosomal protein lateral stalk subunit P2" P05387 11 809647-812880 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 318.8" "Low region specificity" "Detected in all" HPA053635 Approved Approved Mitochondria "Intracellular and membrane" NA NA 730000 Mitochondria "HPA053635: AB_2682212" "unprognostic (6.98e-3)" "unprognostic (2.21e-1)" "unprognostic (4.57e-2)" "unprognostic (8.63e-2)" "unprognostic (2.30e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (1.63e-1)" "unprognostic (2.98e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (2.19e-6)" "unprognostic (6.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-2)" 165.8 66.1 52.7 134.4 47.8 132.4 240.5 28.0 42.6 110.3 108.3 43.2 78.6 82.6 103.7 95.7 160.7 76.7 99.1 129.1 45.8 37.0 67.4 118.5 103.2 499.1 51.9 28.5 190.5 241.9 20.4 49.2 75.3 35.9 118.4 70.3 53.1 154.6 97.8 160.3 125.6 95.7 108.6 52.4 176.3 75.7 60.0 32.4 207.7 111.3 106.1 155.0 136.0 190.6 232.5 127.3 27.8 82.7 82.7 233.6 233.4 79.6 85.0 46.1 63.1 65.4 69.0 64.9 47.9 32.7 52.6 42.7 131.8 67.3 101.6 35.5 43.9 46.0 76.6 53.4 75.0 25.9 47.0 318.8 51.8 72.3 190.7 74.4 99.2 59.1 89.1 113.5 21.2 67.1 75.2 53.0 96.2 92.4 68.5 36.4 98.5 92.1 160.8 100.6 138.3 225.4 106.2 42.7 112.8 51.3 62.9 62.6 92.3 31.2 98.7 109.5 40.6 36.8 134.5 51.4 33.3 43.3 29.4 61.8 116.0 93.1 99.1 54.1 76.5 39.7 27.8 82.7 27.2 100.7 65.2 140.1 232.5 189.1 142.1 94.0 222.8 233.6 178.0 11.9 82.7 51.5 127.3 106.4 233.4 52.7 47.8 28.0 42.6 45.8 37.0 51.9 28.5 35.9 32.4 991.6 1490.9 7641.0 5455.0 5430.4 205.9 564.1 2489.2 1006.5 1874.5 1519.7 74.6 4512.3 2196.7 2810.0 1146.6 3224.8 2324.9 2733.2 6455.7 6707.6 3165.9 4519.9 1638.7 2939.5 3968.0 138.2 2281.0 3329.3 4720.2 2348.5 5919.8 5263.8 2832.5 3803.6 5348.0 406.2 4700.1 3847.1 2652.5 3432.0 167.5 1959.6 3005.2 957.2 2076.7 6894.6 4884.8 5234.3 6955.8 5526.4 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 59.6" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SiHa: 15.1" HPA075932 Uncertain Mitochondria NA NA Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 59.6 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Cell line enhanced" "Detected in many" "OE19: 273.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria Yes No 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.33e-4)" "prognostic unfavorable (1.00e-4)" "prognostic unfavorable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavorable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 63.5 65.2 0.2 13.5 73.8 98.4 48.6 36.0 48.7 32.3 32.8 117.1 88.5 0.0 35.0 62.8 38.3 111.1 18.5 140.1 30.1 11.4 5.3 7.7 29.7 27.4 26.4 2.9 6.7 25.5 118.1 35.2 40.5 29.0 71.4 4.2 0.1 0.1 42.9 55.1 0.5 18.6 8.8 273.2 72.5 0.0 12.6 1.2 136.1 18.9 0.5 0.5 58.8 21.1 27.4 77.4 46.6 7.4 75.8 15.5 38.8 73.4 25.1 1.7 0.3 10.9 91.1 2.6 54.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 2373.2 509.0 165.5 824.9 1416.6 10.1 91.6 634.4 507.3 913.4 902.0 3.9 1028.8 1291.5 1817.5 320.0 1052.4 1898.6 46.7 1882.2 473.9 2108.7 1493.1 280.8 168.1 1060.4 15.9 1037.0 742.7 952.8 225.8 599.2 1623.9 1548.8 1432.9 1679.7 14.1 2865.9 3115.1 60.8 287.0 25.8 142.3 345.1 12.6 80.7 1085.7 314.3 441.6 1750.5 1802.8 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9" "Cell type enhanced" "Detected in many" 15 "B-cells: 50.4;Hofbauer cells: 26.6;Kupffer cells: 27.5;T-cells: 64.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 11.0;HL-60: 14.7;NB-4: 14.5;REH: 41.0;U-937: 14.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria NA NA Mitochondria "HPA060601: AB_2797261, HPA067232: AB_2797271" "prognostic favorable (3.13e-4)" "prognostic favorable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favorable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 2.0 0.5 0.7 8.3 0.3 14.9 1.3 0.6 0.7 0.5 0.9 0.4 0.2 0.8 0.7 0.7 1.2 1.4 0.7 2.1 0.3 0.2 1.2 1.4 6.4 35.9 0.3 0.4 0.7 0.3 0.0 0.2 1.7 0.6 0.7 0.0 1.0 1.3 0.2 1.1 0.4 7.1 0.2 0.5 34.2 3.9 0.3 0.3 10.2 1.5 0.2 10.7 1.9 0.6 14.1 7.3 44.2 15.3 5.4 23.1 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 4.7 0.1 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.1 0.0 41.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 14.0 0.0 16.4 10.4 27.4 11.8 11.6 10.5 11.3 14.7 11.4 7.3 14.1 12.4 11.9 44.2 5.4 15.3 6.6 23.1 7.2 0.7 0.3 0.6 0.7 0.3 0.2 0.3 0.4 0.6 0.3 3.0 5.8 50.4 0.2 1.1 0.0 0.4 0.0 0.0 2.3 1.8 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.1 0.1 0.2 5.7 0.0 26.6 0.0 0.0 3.1 27.5 0.0 0.0 13.2 1.7 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 64.7 0.0 0.3 SAMD13 ENSG00000203943 "Sterile alpha motif domain containing 13" Q5VXD3 1 84298366-84389957 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.4" "Cell type enhanced" "Detected in many" 10 "Mucus-secreting cells: 19.6;Paneth cells: 35.1;Spermatocytes: 20.4;Undifferentiated cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 11.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058929 Enhanced Approved Mitochondria NA NA Mitochondria "HPA058929: AB_2683855" "unprognostic (3.78e-2)" "unprognostic (4.93e-2)" "unprognostic (8.51e-3)" "unprognostic (7.55e-2)" "prognostic favorable (1.14e-8)" "unprognostic (1.78e-1)" "unprognostic (1.65e-6)" "unprognostic (2.05e-1)" "unprognostic (5.50e-2)" "unprognostic (2.80e-3)" "unprognostic (9.42e-2)" "unprognostic (3.29e-1)" "unprognostic (1.98e-7)" "unprognostic (3.99e-2)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.56e-3)" 1.2 5.2 4.9 1.0 12.9 2.1 2.0 9.1 5.8 1.5 16.6 7.4 0.6 2.6 1.8 4.5 1.1 3.7 1.4 1.7 4.8 2.3 1.7 0.4 0.7 0.8 7.9 6.5 0.5 2.3 1.0 2.3 0.5 4.5 3.4 19.4 0.4 13.6 1.9 7.6 1.2 3.0 2.1 5.1 1.5 5.6 12.4 8.5 3.5 8.6 2.0 0.4 2.7 0.7 0.6 1.4 11.2 0.8 0.7 0.5 0.3 0.7 2.5 1.2 4.0 4.3 4.3 2.7 0.3 0.3 0.3 0.3 0.2 4.0 4.2 7.5 0.2 0.8 0.8 0.4 1.3 0.6 2.2 2.1 1.5 1.8 0.3 1.1 4.8 0.1 1.5 1.9 0.1 1.2 3.0 10.1 9.5 0.6 1.2 1.2 1.2 6.2 0.6 4.0 3.2 2.6 0.7 3.1 1.6 7.9 2.7 1.6 6.2 0.1 0.2 9.2 1.7 1.2 4.5 1.6 1.4 0.4 0.4 1.1 3.2 0.6 7.2 0.5 4.3 1.2 11.2 0.4 0.0 0.1 0.8 0.3 0.2 0.1 0.1 0.9 0.6 0.5 0.5 0.2 0.7 0.3 1.4 0.0 0.3 4.9 12.9 9.1 5.8 4.8 2.3 7.9 6.5 4.5 8.5 0.0 1.1 0.0 0.6 0.3 1.0 1.2 5.1 1.4 1.2 1.8 0.0 3.4 5.0 1.3 3.9 1.3 6.2 0.0 0.6 0.6 2.0 2.8 5.7 0.0 1.4 0.0 10.9 1.8 1.6 3.1 1.7 0.9 8.5 0.0 19.6 2.6 0.9 35.1 2.5 2.2 0.0 0.0 0.1 20.4 2.0 0.3 0.7 0.0 16.6 1.3 SAMM50 "CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W" ENSG00000100347 "SAMM50 sorting and assembly machinery component" Q9Y512 22 43955421-44010531 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034537 Enhanced Supported Mitochondria NA NA 3700000 Mitochondria "HPA034537: AB_10602794" "unprognostic (2.92e-1)" "unprognostic (1.01e-1)" "unprognostic (1.95e-3)" "prognostic favorable (2.63e-7)" "unprognostic (2.43e-3)" "unprognostic (2.28e-1)" "unprognostic (5.28e-3)" "unprognostic (1.70e-3)" "unprognostic (3.37e-2)" "unprognostic (1.95e-1)" "unprognostic (2.42e-1)" "unprognostic (3.52e-1)" "prognostic favorable (4.43e-8)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (2.41e-1)" "unprognostic (1.60e-1)" 21.7 25.1 12.4 13.9 13.6 10.2 16.0 10.5 20.1 17.4 15.6 11.2 17.2 18.9 12.6 13.5 14.6 16.3 18.2 34.3 11.3 11.9 18.5 18.8 8.9 18.6 12.7 14.7 16.0 16.7 60.6 12.2 7.6 16.4 10.4 13.7 14.3 19.3 13.6 79.5 15.8 21.2 14.2 12.3 12.2 18.5 11.5 8.6 17.4 10.8 34.6 15.1 11.5 11.0 27.7 34.0 22.4 19.6 18.2 29.3 18.5 22.3 21.2 20.7 25.1 26.8 28.5 29.0 22.0 23.6 32.5 28.1 30.3 16.5 37.1 16.2 25.0 18.8 27.0 30.6 29.4 29.3 10.2 37.8 20.1 27.9 35.7 18.8 63.6 30.3 32.8 23.6 28.0 13.0 22.9 33.4 17.8 17.1 12.3 29.1 31.9 24.8 25.0 20.2 27.1 25.5 29.2 22.4 30.0 27.1 28.7 12.4 20.2 24.3 26.1 35.9 23.1 24.4 21.0 20.5 21.1 25.4 19.4 17.9 18.3 25.2 28.6 26.4 23.2 21.0 19.2 19.6 22.4 21.2 19.2 29.3 27.7 19.8 21.5 34.0 24.5 20.8 19.5 3.2 18.2 14.7 13.4 22.7 18.5 12.4 13.6 10.5 20.1 11.3 11.9 12.7 14.7 16.4 8.6 32.8 17.6 39.3 18.4 18.3 20.2 60.5 22.9 37.5 22.7 8.7 7.9 36.5 51.4 35.6 27.0 31.5 56.1 23.3 48.0 43.0 24.4 14.5 26.5 35.8 45.7 30.2 17.9 21.5 29.2 33.7 24.2 25.7 15.1 39.7 29.6 27.1 37.2 38.6 28.7 78.9 23.3 19.4 21.1 41.3 20.6 19.7 17.2 32.0 51.0 12.9 SARDH "DMGDHL1, SDH" ENSG00000123453 "Sarcosine dehydrogenase" Q9UL12 9 133663560-133739955 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 25.3;liver: 52.8;pancreas: 39.4" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 94.3" "Cancer enriched" "Detected in many" 8 "liver cancer: 18.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7" "Lineage enriched" "Detected in single" 15 "T-cells: 9.7" "Cell line enhanced" "Detected in many" "AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA057267, HPA058086" Approved Approved Mitochondria NA NA 190000 Mitochondria "HPA057267: AB_2683388, HPA058086: AB_2683601" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (2.31e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.62e-4)" "unprognostic (5.83e-2)" "unprognostic (1.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "unprognostic (7.74e-3)" "unprognostic (2.78e-1)" "unprognostic (3.48e-1)" "unprognostic (9.73e-2)" "unprognostic (1.30e-2)" 0.5 1.1 1.7 1.0 1.8 0.3 0.4 0.8 1.9 0.9 0.5 1.1 2.9 0.8 1.4 25.3 0.3 0.9 1.2 1.1 1.1 1.4 5.8 52.8 1.3 1.7 1.2 2.1 3.4 39.4 2.0 1.9 0.3 1.2 1.4 0.1 3.7 8.2 0.9 0.3 0.2 0.6 0.6 0.6 0.7 1.2 1.1 0.8 2.2 0.8 0.2 1.2 0.6 0.6 0.4 0.3 0.6 0.1 0.1 9.7 1.6 0.0 0.1 0.9 11.1 0.0 0.3 1.5 0.1 0.4 0.5 0.7 0.2 0.1 0.0 1.5 0.2 1.4 0.0 0.0 0.2 0.4 0.0 0.2 1.5 0.0 18.7 1.2 0.0 0.2 2.6 0.0 1.3 0.0 0.3 0.1 8.3 0.0 0.2 7.0 1.9 13.5 1.4 1.7 1.0 0.1 0.9 11.6 23.4 0.0 0.1 1.0 9.3 0.0 0.3 2.3 0.5 1.5 0.1 0.0 2.1 2.0 0.2 0.0 0.1 0.0 0.8 1.3 0.8 0.0 0.1 0.1 0.1 0.4 0.0 1.0 0.0 4.1 1.0 0.0 0.4 8.4 1.5 0.6 0.1 0.0 0.3 9.7 1.6 1.7 1.8 0.8 1.9 1.1 1.4 1.2 2.1 1.2 0.8 0.0 3.4 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 1.0 0.2 1.1 94.3 0.1 0.0 1.2 2.5 2.4 0.2 4.4 0.2 0.0 0.0 0.0 2.1 0.2 0.0 2.8 14.7 0.2 0.0 1.0 0.1 0.9 0.1 0.0 2.9 0.0 0.1 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 24.2" "Cell type enriched" "Detected in single" 25 "Cardiomyocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA078322 Approved Mitochondria NA NA Mitochondria "HPA078322: AB_2732379" "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.1 24.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 3.3 5.6 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.0 0.0 2.5 0.1 0.6 0.2 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCO2 "MYP6, SCO1L" ENSG00000130489 "SCO2, cytochrome c oxidase assembly protein" O43819 22 50523568-50525606 "Disease related genes, Predicted membrane proteins" Chaperone "Cardiomyopathy, Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 296 "Cytotrophoblasts: 22.9;Extravillous trophoblasts: 29.8;Hofbauer cells: 52.1;Syncytiotrophoblasts: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046943, HPA056254" Approved Approved Mitochondria NA NA Mitochondria "HPA046943: AB_2732536, HPA056254: AB_2683080" "unprognostic (8.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.62e-1)" "unprognostic (6.14e-3)" "unprognostic (3.74e-1)" "unprognostic (5.86e-3)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (4.05e-3)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (5.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (4.51e-2)" 13.0 11.6 8.8 20.6 9.0 27.9 16.6 15.2 14.7 8.1 25.1 4.5 7.9 21.6 7.4 9.0 19.7 22.9 10.1 19.7 8.8 10.9 21.3 28.0 14.9 12.3 7.4 11.3 8.0 18.4 2.6 8.9 10.0 7.2 7.7 6.6 5.5 22.1 4.6 9.9 14.3 18.8 8.1 8.0 13.9 8.9 8.4 5.0 6.9 12.2 13.8 14.1 10.1 6.9 17.4 23.8 7.0 7.9 11.7 22.1 15.1 15.0 14.3 6.9 9.2 6.8 9.3 10.4 10.2 8.2 13.5 11.8 17.6 8.5 20.4 7.9 8.0 8.6 17.9 7.0 11.8 2.4 5.8 38.3 6.5 22.0 23.1 15.8 17.2 12.7 13.8 17.9 6.9 5.9 5.7 8.9 6.1 7.3 27.9 5.7 28.1 8.5 34.6 7.1 11.0 23.6 14.1 8.8 22.9 10.2 10.6 10.4 12.8 11.5 32.7 23.4 3.2 12.7 16.5 10.7 11.8 11.4 13.2 11.1 13.3 6.7 9.1 16.1 13.3 10.0 5.2 6.3 2.9 22.1 7.3 20.9 17.4 18.6 21.8 10.6 15.4 14.6 17.0 7.0 11.7 7.9 23.8 15.4 15.1 8.8 9.0 15.2 14.7 8.8 10.9 7.4 11.3 7.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 SCO2 ENSG00000284194 "SCO2, cytochrome c oxidase assembly protein" 22 50523568-50526439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.6;bone marrow: 13.0" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 107.9;Paneth cells: 129.8;Suprabasal keratinocytes: 86.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.6" "HPA046943, HPA056254" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046943: AB_2732536, HPA056254: AB_2683080" 2.4 1.1 0.7 6.3 0.6 13.0 6.7 0.6 1.2 1.5 2.3 0.0 1.1 0.6 0.6 0.7 4.6 0.8 2.4 4.3 0.1 2.8 4.2 3.7 9.3 0.4 0.0 1.2 0.8 0.0 0.0 0.9 0.6 1.6 0.5 0.1 4.2 0.2 0.7 1.8 3.5 1.6 1.7 5.7 1.9 0.4 0.6 10.6 1.0 1.4 2.6 1.6 0.7 10.3 17.6 10.4 12.6 4.0 10.3 10.7 4.0 2.8 0.1 2.6 0.0 0.5 2.3 2.8 1.9 2.5 1.9 0.4 3.8 7.0 2.0 0.9 1.4 2.5 1.0 0.0 0.0 1.3 10.7 3.6 0.7 0.4 4.9 9.4 2.9 3.3 1.2 1.3 0.5 0.8 0.5 0.0 4.5 9.5 1.4 1.5 1.1 9.9 1.4 0.2 4.1 6.5 0.8 13.6 1.8 1.1 0.6 2.4 1.2 0.4 9.6 0.3 1.4 7.3 3.2 1.7 3.7 2.9 2.4 8.1 2.5 9.7 4.0 2.1 1.7 8.4 12.6 8.7 7.2 7.3 8.7 10.3 9.4 7.8 17.6 8.9 6.9 5.5 10.4 4.0 6.8 12.6 10.3 10.7 3.0 2.4 30.9 16.7 76.1 6.2 14.5 22.9 1.4 2.3 0.0 2.0 0.0 0.0 0.0 13.8 19.1 107.9 0.0 0.0 0.0 13.8 24.3 16.1 48.9 0.0 11.1 24.8 19.0 25.2 16.0 15.3 20.8 40.5 0.0 50.5 4.2 0.1 129.8 10.3 0.0 6.9 0.0 21.5 12.0 26.6 86.4 0.0 15.0 77.7 19.3 SDHAF1 LYRM8 ENSG00000205138 "Succinate dehydrogenase complex assembly factor 1" A6NFY7 19 35995199-35996315 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064277 Approved Mitochondria NA NA Mitochondria "HPA064277: AB_2685231" "unprognostic (2.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.22e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-1)" "unprognostic (4.47e-2)" "unprognostic (5.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.24e-1)" "unprognostic (3.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.83e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.38e-2)" "unprognostic (2.59e-1)" "unprognostic (2.24e-1)" "unprognostic (3.59e-2)" 11.2 15.7 13.5 11.1 14.7 7.3 14.0 24.5 23.4 14.0 16.7 17.0 13.1 25.0 12.4 13.1 14.8 12.1 11.9 11.1 14.8 13.7 14.4 23.5 10.4 17.6 19.0 10.3 13.6 24.5 11.2 15.1 10.5 12.5 13.9 10.0 9.9 23.7 13.8 17.4 12.4 20.6 15.3 14.3 15.0 16.8 7.7 14.4 14.4 21.9 12.6 11.2 15.8 14.0 31.5 28.5 33.4 26.4 32.7 33.2 20.9 5.9 15.7 4.7 10.8 4.6 5.9 8.1 5.8 6.3 6.4 7.4 11.2 4.6 11.2 11.4 3.8 4.3 6.0 6.1 3.3 3.1 20.9 14.4 4.9 6.5 14.6 5.6 5.8 8.2 5.1 10.7 3.9 4.2 2.5 3.5 11.8 15.1 12.2 2.8 14.6 11.1 11.5 7.2 19.7 7.6 12.2 5.2 12.5 6.1 7.7 18.4 13.7 9.4 15.4 9.9 4.0 8.8 9.9 4.6 7.3 11.0 6.9 8.8 16.6 7.6 13.0 6.4 11.3 6.5 23.3 22.1 33.4 27.5 24.3 29.4 27.6 29.4 26.5 22.7 31.5 33.2 27.8 12.1 32.7 26.4 28.5 30.2 20.9 13.5 14.7 24.5 23.4 14.8 13.7 19.0 10.3 12.5 14.4 6.0 2.6 23.0 10.5 26.7 20.4 8.1 10.2 0.0 1.2 17.4 5.9 20.4 23.2 18.6 20.9 18.2 23.8 0.0 25.7 29.5 18.8 16.9 4.6 19.6 19.5 17.5 27.6 16.5 20.2 5.1 21.3 15.6 23.6 27.1 29.0 15.0 19.4 32.5 27.6 23.7 11.9 25.8 11.9 9.8 14.1 36.4 19.3 29.4 31.0 14.4 SDHAF3 "ACN9, DC11, LYRM10, Sdh7" ENSG00000196636 "Succinate dehydrogenase complex assembly factor 3" Q9NRP4 7 97116590-97181763 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 126.0;Proximal tubular cells: 122.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020515, HPA020523" Approved Approved Mitochondria NA NA Mitochondria "HPA020515: , HPA020523: AB_2670464" "unprognostic (3.94e-2)" "unprognostic (9.11e-2)" "unprognostic (6.51e-2)" "unprognostic (2.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.61e-2)" "unprognostic (9.60e-3)" "unprognostic (3.21e-2)" "unprognostic (3.74e-2)" "unprognostic (3.07e-3)" "unprognostic (4.27e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-3)" "unprognostic (2.82e-1)" "unprognostic (3.79e-3)" "unprognostic (2.34e-1)" "unprognostic (8.45e-2)" 8.2 16.0 11.8 11.6 12.0 11.4 9.6 5.4 15.5 6.7 12.3 7.9 11.1 15.2 8.3 11.8 12.0 8.8 12.5 22.0 11.3 12.8 17.6 20.1 10.2 14.6 12.9 11.5 7.4 16.2 5.8 13.7 5.8 16.6 8.4 12.8 9.4 16.8 12.4 18.3 9.7 13.2 9.8 15.7 11.5 12.1 14.9 9.6 15.6 14.6 11.2 8.7 9.6 7.9 12.0 25.9 11.3 8.7 6.4 15.0 12.2 7.4 6.1 3.2 20.7 2.0 1.7 3.2 2.3 1.5 2.4 4.1 1.1 6.0 12.1 7.6 2.1 3.6 2.7 7.9 6.6 5.3 8.7 11.1 8.3 6.2 11.2 3.7 17.3 3.3 3.6 4.1 4.3 5.8 1.7 2.2 10.0 21.5 0.3 4.9 0.0 20.3 24.4 7.0 11.2 6.7 4.2 2.9 17.5 3.1 5.5 15.5 8.1 8.9 11.7 10.4 5.8 0.1 4.7 3.6 0.9 11.6 19.0 2.3 7.1 17.0 32.3 3.4 30.6 11.8 5.4 6.9 2.7 9.1 8.7 12.1 12.0 11.6 14.3 9.5 9.8 15.0 14.9 11.3 6.4 8.2 25.9 10.2 12.2 11.8 12.0 5.4 15.5 11.3 12.8 12.9 11.5 16.6 9.6 17.9 8.4 34.0 19.4 0.0 13.1 32.7 25.5 29.4 12.5 24.4 3.9 33.2 126.0 25.1 89.5 10.1 4.6 0.0 33.8 22.6 9.5 17.7 4.7 49.5 26.9 9.5 12.9 17.8 19.4 10.2 21.0 16.4 0.0 4.6 30.6 28.6 20.6 35.1 23.3 122.5 16.9 32.3 12.2 18.4 51.7 0.0 8.0 25.9 48.7 19.2 SETD3 "C14orf154, FLJ23027" ENSG00000183576 "SET domain containing 3" Q86TU7 14 99397746-99480889 "Enzymes, Predicted intracellular proteins" "Actin-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003591, HPA003639" Approved Approved Mitochondria NA NA Mitochondria "HPA003591: AB_1079930, HPA003639: AB_1079931" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-2)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (6.46e-4)" "unprognostic (1.04e-2)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" "unprognostic (2.73e-2)" "unprognostic (2.01e-1)" "unprognostic (4.42e-1)" "prognostic favorable (1.89e-15)" "unprognostic (6.81e-2)" "unprognostic (3.21e-1)" "unprognostic (2.20e-1)" "unprognostic (2.62e-3)" 17.1 12.5 24.7 13.3 26.8 9.2 16.6 14.6 23.8 14.3 22.7 18.7 26.9 16.2 14.2 39.6 16.9 21.7 13.4 34.1 24.1 17.9 43.4 21.0 16.7 11.9 23.7 13.9 11.7 16.9 17.4 14.5 19.4 18.4 16.9 17.6 16.2 24.9 20.2 68.7 14.1 16.5 26.0 25.3 13.7 15.4 39.1 15.3 11.5 25.6 20.3 10.9 24.0 21.4 9.2 18.6 19.9 17.4 16.0 18.2 11.3 13.8 15.9 12.0 11.4 14.0 15.8 42.8 17.5 13.4 18.4 18.9 15.3 23.5 13.6 14.4 19.7 14.5 18.0 14.7 19.7 29.4 13.3 7.8 12.3 10.3 14.0 17.5 18.5 18.6 11.0 26.0 16.3 23.9 13.9 22.8 20.5 9.7 20.6 20.3 25.9 19.2 20.1 7.1 34.6 18.1 11.7 24.6 11.2 26.4 17.1 21.5 10.0 15.7 16.4 13.4 22.8 22.2 16.2 20.1 8.3 11.5 55.9 13.3 14.7 16.7 14.7 15.7 18.5 12.6 6.4 15.0 19.9 15.5 17.4 18.2 9.2 13.4 14.5 18.6 7.6 11.2 13.9 9.4 16.0 14.8 11.7 9.7 11.3 24.7 26.8 14.6 23.8 24.1 17.9 23.7 13.9 18.4 15.3 23.8 35.6 13.7 15.9 21.6 24.5 76.3 25.5 34.8 29.6 24.4 25.5 52.8 28.2 21.0 146.2 23.8 28.2 0.0 24.3 35.0 18.6 20.9 31.3 24.9 31.6 17.5 20.8 15.4 28.0 98.0 17.5 26.8 10.1 16.2 24.4 39.5 20.0 21.0 19.8 84.0 33.4 6.5 22.0 89.9 86.5 28.2 25.1 20.3 27.1 17.3 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 34.2;T-cells: 16.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Approved Enhanced Mitochondria NA NA Mitochondria "HPA019543: AB_1856789, HPA063745: AB_2685111" "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 5.6 14.0 15.2 12.0 20.9 12.9 8.1 20.7 24.5 6.5 18.8 7.9 5.3 13.2 6.5 6.0 12.6 6.6 7.1 9.4 14.5 18.3 28.3 66.8 5.3 17.0 15.3 17.0 13.6 9.7 7.4 11.8 10.4 15.1 7.6 12.5 5.7 7.7 8.0 11.7 6.3 13.4 8.1 15.0 8.2 10.1 5.0 11.0 13.9 7.7 7.3 17.8 11.3 9.1 4.5 3.0 34.2 2.6 4.8 16.0 5.6 10.2 32.6 16.7 18.1 5.7 12.4 26.9 26.3 11.1 22.2 21.5 40.8 20.8 21.5 20.5 13.7 27.4 13.2 31.9 45.8 24.1 52.5 26.7 15.8 29.4 17.8 8.4 30.8 20.0 10.1 9.0 24.6 10.8 13.2 17.0 20.0 22.6 17.1 16.1 36.0 35.9 2.4 13.1 17.4 10.7 30.2 17.1 23.0 8.4 40.4 28.5 18.2 25.3 24.0 12.8 14.4 11.6 10.2 16.5 17.6 27.9 12.9 34.2 21.8 25.6 49.1 28.9 27.8 18.3 34.2 2.1 10.4 11.3 2.6 9.4 4.5 16.0 12.6 3.0 3.8 12.7 12.9 0.6 4.8 1.7 1.4 12.7 5.6 15.2 20.9 20.7 24.5 14.5 18.3 15.3 17.0 15.1 11.0 3.0 15.7 26.8 27.4 17.3 52.5 14.8 12.7 13.4 11.4 17.4 45.2 35.0 21.6 24.5 0.9 12.0 58.5 23.3 16.4 61.7 22.4 20.3 9.2 86.9 14.8 73.1 30.0 7.4 9.4 2.0 43.7 8.0 10.1 7.2 18.2 24.5 26.6 17.5 32.9 46.2 47.8 25.8 27.4 3.0 3.0 18.9 25.9 42.7 18.0 23.5 SFXN2 SLC56A2 ENSG00000156398 "Sideroflexin 2" Q96NB2 10 102714538-102743492 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 31.4;Proximal tubular cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018150, HPA026834" Enhanced Approved Mitochondria NA NA Mitochondria "HPA018150: AB_1856790, HPA026834: AB_1856791" "unprognostic (1.70e-2)" "prognostic favorable (2.28e-4)" "unprognostic (3.30e-2)" "unprognostic (2.95e-1)" "unprognostic (6.10e-2)" "unprognostic (1.44e-2)" "prognostic favorable (9.95e-4)" "unprognostic (4.24e-2)" "unprognostic (9.69e-2)" "unprognostic (3.98e-2)" "unprognostic (1.32e-1)" "unprognostic (8.98e-3)" "prognostic favorable (2.28e-5)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (3.77e-2)" "prognostic favorable (6.52e-4)" 2.4 3.1 2.3 5.1 5.8 3.8 4.0 2.9 3.5 3.3 4.4 3.7 6.3 3.7 4.8 8.3 2.9 6.0 3.5 1.8 2.4 1.9 24.2 13.7 3.0 10.1 2.8 1.4 8.4 8.1 11.0 9.2 4.7 3.1 4.1 4.3 7.3 17.5 6.4 1.5 2.6 3.3 1.7 1.7 3.3 4.9 2.2 2.5 15.3 7.1 2.0 6.8 3.0 2.3 5.6 3.2 2.5 1.2 3.3 6.3 1.4 3.0 1.5 2.7 2.8 1.0 0.7 3.8 1.0 0.4 1.4 0.7 5.2 1.4 6.6 2.0 0.9 0.7 2.3 0.5 3.5 0.8 1.1 2.1 9.6 2.9 3.2 0.4 5.4 0.8 0.8 0.5 1.3 1.4 1.0 1.2 5.7 4.3 3.1 0.8 2.9 7.9 1.8 1.6 2.9 0.7 4.0 3.3 0.9 1.3 2.4 2.0 2.1 0.9 2.3 0.4 1.1 28.7 1.2 0.9 1.1 3.3 1.4 2.3 3.4 4.5 5.7 1.3 6.6 0.8 2.5 1.2 0.4 3.7 0.5 3.5 1.6 3.9 3.9 1.5 5.6 6.3 5.3 2.5 3.3 0.9 3.2 3.8 1.4 2.3 5.8 2.9 3.5 2.4 1.9 2.8 1.4 3.1 2.5 0.0 8.5 1.5 2.5 0.8 5.0 2.4 0.0 0.0 2.3 1.8 31.4 6.7 8.3 1.7 0.8 1.4 2.0 0.0 2.5 3.0 1.1 3.6 0.0 13.4 7.6 0.0 3.5 5.5 5.6 0.0 2.0 1.6 0.0 1.0 3.4 0.9 1.6 0.0 1.4 24.5 14.4 0.0 1.9 1.2 1.2 1.1 3.8 0.8 7.2 1.0 SFXN3 "SFX3, SLC56A3" ENSG00000107819 "Sideroflexin 3" Q9BWM7 10 101031234-101041244 "Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008028, HPA048105" Approved Enhanced Mitochondria NA NA 81000 Mitochondria "HPA008028: AB_1079938, HPA048105: AB_2680265" "unprognostic (2.55e-1)" "unprognostic (3.32e-2)" "unprognostic (4.94e-2)" "unprognostic (2.82e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (3.79e-4)" "unprognostic (3.84e-3)" "unprognostic (8.46e-2)" "unprognostic (1.05e-2)" "unprognostic (9.09e-3)" "unprognostic (1.04e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (3.56e-1)" "unprognostic (3.05e-2)" "unprognostic (3.70e-2)" "unprognostic (1.71e-1)" 14.4 8.1 11.5 8.7 13.9 4.1 10.7 40.2 22.9 14.5 19.0 15.5 13.6 24.4 13.8 17.7 6.5 14.9 12.9 11.3 12.5 9.8 9.2 3.4 16.4 5.4 18.3 13.7 10.6 7.0 17.1 6.9 16.2 18.4 8.8 8.4 9.1 8.4 13.8 2.7 15.7 44.8 19.9 13.7 8.3 8.2 5.6 16.9 4.3 7.5 5.1 5.5 10.7 11.2 2.2 15.7 8.9 14.8 4.3 9.8 8.3 15.2 5.9 0.6 1.8 16.0 17.0 1.6 9.3 32.9 11.9 9.6 9.7 16.8 0.6 8.9 21.7 10.0 11.2 2.8 20.3 5.2 4.2 3.6 1.8 9.8 7.0 11.0 1.4 14.8 11.7 3.0 10.4 9.9 33.2 26.0 4.4 0.1 0.5 19.3 2.5 0.6 2.2 0.7 5.6 14.3 1.4 11.7 4.1 17.5 2.4 3.2 15.9 5.1 0.6 13.8 4.4 4.9 10.8 21.4 10.5 8.3 9.3 4.5 2.4 0.9 0.0 25.6 8.2 8.4 8.9 14.8 7.1 9.8 11.1 7.5 2.2 6.7 6.6 15.7 1.0 4.1 5.1 2.8 4.3 6.1 2.5 7.0 8.3 11.5 13.9 40.2 22.9 12.5 9.8 18.3 13.7 18.4 16.9 11.9 4.0 0.9 4.8 12.4 61.6 2.4 12.7 18.7 3.4 5.2 45.2 0.9 1.7 28.4 54.3 14.7 10.8 0.0 13.5 37.4 14.4 3.9 13.9 0.8 32.6 9.5 5.2 17.2 20.0 97.0 16.1 21.3 32.1 7.2 5.7 7.8 29.0 5.8 13.8 12.3 23.1 12.9 13.0 1.1 0.5 9.5 9.2 13.1 2.5 2.6 SGIP1 DKFZp761D221 ENSG00000118473 "SH3 domain GRB2 like endophilin interacting protein 1" Q9BQI5 1 66533383-66748299 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 91.2;Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 347.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 17.0;BJ hTERT+: 22.0;fHDF/TERT166: 13.9;hTERT-RPE1: 9.2;RPTEC TERT1: 16.2;SH-SY5Y: 8.8;U-138 MG: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017963 Approved Approved Mitochondria NA NA Mitochondria "HPA017963: AB_10964882" "unprognostic (1.74e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" "unprognostic (9.04e-2)" "unprognostic (9.51e-2)" "unprognostic (7.64e-2)" "unprognostic (1.86e-1)" "unprognostic (1.61e-1)" "unprognostic (1.83e-1)" "unprognostic (1.95e-1)" "unprognostic (3.48e-7)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (4.25e-2)" "unprognostic (9.63e-2)" 6.2 7.5 19.6 3.8 30.2 1.3 2.7 26.2 36.5 7.5 2.7 11.4 1.3 3.4 17.1 8.0 5.2 4.7 8.1 6.8 22.9 12.4 14.0 1.7 9.6 2.0 10.8 26.3 3.6 1.2 1.9 7.0 3.9 26.4 5.4 3.4 5.8 3.5 9.1 3.2 1.7 3.2 7.0 11.3 1.4 5.1 7.4 14.9 0.0 8.0 0.8 1.5 6.1 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.4 0.0 17.0 22.0 1.3 2.0 0.0 0.0 0.0 0.0 13.9 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 3.9 0.0 0.0 2.4 0.0 1.3 0.0 9.2 6.4 0.1 0.0 0.0 7.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.4 8.8 0.0 0.0 0.0 0.3 0.0 0.6 1.1 16.1 0.0 0.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 19.6 30.2 26.2 35.0 22.9 12.4 10.8 26.3 26.4 14.9 0.0 0.0 0.0 0.2 0.9 91.2 1.6 2.5 0.0 0.0 8.7 329.9 0.0 6.6 0.3 0.5 11.1 0.0 0.0 0.0 0.0 4.1 0.4 9.3 0.0 0.2 69.9 0.0 0.6 0.0 0.5 2.0 0.0 10.1 0.0 0.0 55.4 0.0 0.0 10.6 0.0 347.4 12.9 52.6 0.0 0.0 0.9 0.2 0.0 0.0 0.3 SH3GL3 "CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13" ENSG00000140600 "SH3 domain containing GRB2 like 3, endophilin A3" Q99963 15 83447228-83618743 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 30.3;testis: 31.6" "Group enriched" "Detected in many" 10 "Early spermatids: 502.6;Late spermatids: 937.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 21.8;HEK 293: 10.8;K-562: 17.0;RH-30: 6.7;SuSa: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039381, HPA077877" Enhanced Approved Mitochondria NA NA Mitochondria "HPA039381: AB_10794635, HPA077877: AB_2686863" "unprognostic (1.10e-3)" "unprognostic (6.62e-2)" "unprognostic (4.25e-2)" "unprognostic (1.86e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-1)" "unprognostic (9.76e-2)" "unprognostic (2.26e-1)" "unprognostic (8.20e-3)" "unprognostic (2.72e-3)" "unprognostic (1.43e-6)" "unprognostic (4.42e-2)" "unprognostic (3.59e-2)" "unprognostic (2.93e-1)" "unprognostic (5.78e-4)" 1.1 1.3 12.5 1.1 26.6 1.4 1.3 6.3 30.3 1.2 1.1 28.2 0.0 1.2 1.8 2.0 2.9 3.5 1.1 1.2 14.2 9.9 2.3 1.1 4.1 1.3 25.5 14.6 1.2 1.0 1.1 0.7 1.8 17.6 1.7 1.2 0.0 1.0 1.8 1.0 1.6 1.2 1.2 16.7 1.1 1.2 31.6 26.0 1.2 1.2 0.5 1.9 1.6 0.7 0.4 0.7 0.7 0.3 0.0 0.4 0.3 0.0 0.0 1.8 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 21.8 1.3 0.0 0.0 10.8 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 4.5 17.0 0.0 0.0 0.6 1.3 0.0 2.6 0.0 0.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 9.5 0.0 0.0 0.3 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.3 0.7 0.0 0.1 0.7 0.2 0.3 12.5 26.6 6.3 18.5 14.2 9.9 25.5 14.6 17.6 26.0 8.9 1.7 0.0 1.3 0.8 4.1 0.4 0.0 1.4 0.0 3.5 0.0 0.6 0.0 0.4 502.6 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.3 73.1 0.0 0.0 0.0 937.4 8.6 0.0 1.7 0.0 0.0 2.5 0.5 0.0 3.9 0.0 1.1 0.0 0.2 9.5 6.8 0.1 0.6 0.0 0.0 0.1 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574529-13615158 "FDA approved drug targets, Predicted intracellular proteins" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 47.2;Distal tubular cells: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria NA NA Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favorable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 5.9 6.2 8.8 6.8 10.4 5.9 9.2 11.1 13.5 4.9 7.2 6.4 12.5 8.1 6.8 6.7 5.7 8.0 6.6 22.9 8.5 8.3 9.9 29.9 9.8 6.9 9.5 6.9 8.8 10.5 12.9 7.6 5.3 8.3 6.5 8.3 6.2 8.6 8.7 25.8 8.8 8.5 6.2 6.9 9.5 7.6 6.6 6.1 7.5 8.5 7.0 6.5 6.8 6.0 9.2 4.6 10.9 9.3 7.3 10.0 5.6 5.8 4.6 5.9 7.6 3.7 4.8 4.4 3.0 3.2 3.3 5.0 7.3 7.0 8.4 18.3 2.4 7.3 9.5 4.1 5.9 5.0 3.8 6.8 5.3 4.2 11.8 6.1 4.3 4.6 5.2 12.1 2.9 10.4 7.2 6.0 11.9 7.5 3.2 3.9 7.1 4.7 8.5 4.9 9.1 7.3 8.4 3.8 15.3 6.8 6.4 9.7 3.5 3.4 5.9 13.4 16.7 6.8 2.8 5.3 5.1 2.9 3.1 3.3 7.8 8.8 5.7 2.9 4.3 4.8 0.5 4.5 10.9 8.1 6.1 8.2 9.2 10.0 7.9 4.6 9.1 9.5 8.5 1.5 7.3 9.3 4.6 7.2 5.6 8.8 10.4 11.1 13.5 8.5 8.3 9.5 6.9 8.3 6.1 26.8 2.7 9.1 9.2 3.7 6.4 47.2 10.2 21.4 17.0 10.4 0.0 17.1 44.7 10.5 2.2 8.7 9.6 23.3 6.0 9.0 4.9 5.7 0.0 22.2 8.5 1.6 5.8 10.4 10.4 0.5 7.5 6.1 5.0 5.4 12.6 8.4 6.7 13.9 5.3 24.0 6.2 0.0 5.0 6.5 7.8 4.0 8.9 6.9 16.5 7.3 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria No No Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 11.3 15.1 12.8 9.6 26.2 9.6 20.8 14.7 22.1 20.8 11.3 38.2 8.4 35.3 12.3 12.7 17.3 15.4 12.1 12.9 14.5 14.2 16.1 18.0 18.6 7.9 40.0 15.4 10.4 20.6 29.8 21.7 16.4 29.7 18.0 11.8 18.7 26.9 14.8 17.6 15.6 11.6 11.0 33.1 9.5 12.5 8.7 31.0 15.8 29.9 8.7 16.5 12.9 13.9 4.1 9.8 3.0 9.5 8.3 7.1 4.6 7.7 10.0 13.2 12.1 14.7 12.5 44.4 8.4 30.5 8.0 9.4 12.6 14.6 4.8 16.6 9.4 15.3 10.7 11.9 7.9 9.4 6.9 7.2 11.4 12.1 14.3 15.6 7.7 23.0 13.7 9.9 14.9 15.2 19.6 9.5 9.8 9.8 2.4 9.3 8.9 9.1 5.2 19.6 8.2 6.9 5.9 12.1 8.5 9.7 11.6 9.1 8.1 6.4 19.5 8.5 16.0 21.9 5.1 11.4 8.2 6.9 9.2 4.4 6.0 8.1 2.0 23.1 4.2 3.4 0.7 6.6 2.4 6.4 9.5 5.8 3.6 5.0 6.3 9.8 4.1 7.1 6.6 3.0 8.3 6.0 4.1 3.8 4.6 12.8 26.2 14.7 22.1 14.5 14.2 40.0 15.4 29.7 31.0 35.7 40.3 11.5 22.2 13.7 23.8 12.0 28.1 45.5 43.3 54.1 17.7 20.6 3.3 25.3 0.8 14.3 8.6 70.0 24.8 18.3 17.5 32.8 67.2 38.4 29.8 27.0 15.7 9.8 13.3 1.5 8.9 25.8 25.3 9.0 13.5 27.5 20.6 14.7 8.1 8.8 16.5 6.5 12.4 5.5 12.8 11.7 16.2 7.9 16.1 19.0 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" 10 89430299-89556641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 28.0;kidney: 55.6" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Region enriched" "Detected in many" 6 "pons and medulla: 11.7" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC TERT1: 22.8;HSkMC: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria NA NA Mitochondria "HPA037587: AB_2732475" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favorable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 2.3 1.3 1.0 0.1 0.7 0.0 2.4 1.3 0.6 4.9 1.6 2.6 6.2 0.1 2.0 28.0 0.5 2.2 0.1 4.0 1.8 0.8 55.6 1.0 3.3 0.1 0.8 0.3 1.8 13.3 0.0 5.0 5.9 11.7 1.4 0.1 16.3 0.9 7.9 4.4 1.1 0.8 0.5 0.6 0.1 1.7 2.4 0.3 0.0 3.8 0.7 0.0 1.8 1.5 0.7 0.5 1.8 0.3 0.9 0.3 0.0 0.2 0.0 0.1 0.1 3.0 22.8 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.1 3.7 0.0 0.0 8.1 0.2 1.1 1.4 1.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.8 0.0 2.7 0.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.7 0.2 0.3 0.8 0.9 0.1 0.5 0.0 0.0 1.0 0.7 1.3 0.6 1.8 0.8 0.8 0.3 11.7 0.3 3.0 3.8 0.0 1.5 0.0 0.0 2.0 2.5 8.1 4.5 14.0 0.0 14.3 13.3 0.0 3.0 1.1 0.0 0.0 3.7 0.6 1.1 0.8 1.1 1.7 1.1 3.2 17.4 0.6 0.0 3.0 25.0 1.0 0.0 0.0 0.0 0.0 3.5 0.0 25.1 55.2 0.3 12.9 1.4 0.1 0.2 0.3 7.6 0.0 0.0 1.4 SLC22A4 "DFNB60, MGC34546, OCTN1" ENSG00000197208 "Solute carrier family 22 member 4" Q9H015 5 132294443-132344206 "Disease related genes, Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ciliated cells: 89.7;Erythroid cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 23.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;U-138 MG: 14.9" "Region enhanced" "Detected in all" "cerebellum: 72.4" "Low region specificity" "Detected in all" "CAB015468, HPA036974" Approved Approved Mitochondria NA NA Mitochondria "CAB015468: , HPA036974: AB_2732474" "unprognostic (1.33e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (8.42e-3)" "unprognostic (6.17e-2)" "unprognostic (6.22e-3)" "unprognostic (4.17e-3)" "unprognostic (3.33e-1)" "unprognostic (1.30e-1)" "unprognostic (9.79e-2)" "unprognostic (1.95e-3)" "unprognostic (7.82e-2)" "unprognostic (1.74e-2)" "unprognostic (2.31e-3)" "unprognostic (1.20e-1)" "unprognostic (1.95e-2)" "unprognostic (4.06e-2)" 2.7 4.1 3.5 3.8 5.0 22.4 3.1 3.1 4.7 2.4 5.9 4.4 1.8 4.6 2.1 3.2 0.8 14.7 2.6 3.0 3.9 4.9 15.4 1.6 7.2 3.8 3.2 2.0 5.0 1.0 7.7 6.9 6.8 12.6 5.4 3.1 13.8 2.6 4.1 9.2 1.7 18.1 1.5 9.9 7.7 2.2 0.9 2.7 0.5 1.0 2.7 0.8 2.5 2.2 0.0 1.7 23.0 3.5 0.0 0.0 0.6 1.1 1.7 0.1 0.4 0.8 0.6 0.5 7.6 35.1 5.9 6.1 0.7 1.9 0.3 2.1 4.4 4.4 1.9 0.0 1.2 4.1 1.4 0.2 0.1 3.3 0.1 0.6 2.3 0.0 1.4 0.2 3.2 3.0 2.1 2.5 0.2 3.0 4.0 4.5 0.6 0.0 5.4 0.2 0.1 1.9 0.0 0.4 0.2 0.9 0.1 0.5 0.2 8.3 0.5 0.2 0.2 0.3 1.4 3.1 14.9 1.4 5.8 1.9 0.0 1.5 0.0 4.4 2.7 1.7 0.0 3.5 3.5 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 23.0 0.0 0.2 0.2 0.0 0.6 3.5 5.0 3.1 4.7 3.9 4.9 3.2 2.0 12.6 2.7 3.0 0.0 0.0 1.0 0.7 1.6 0.8 2.5 89.7 13.6 0.0 0.0 0.6 0.0 3.2 0.0 2.1 5.3 70.0 0.3 1.6 1.4 2.2 0.0 0.0 4.2 3.2 1.2 0.6 1.5 0.0 0.6 4.3 0.0 0.0 0.4 1.5 1.2 1.4 0.0 4.9 0.3 0.0 1.0 0.4 0.2 0.4 2.1 0.0 1.1 0.9 SLC22A5 "CDSP, OCTN2, SCD" ENSG00000197375 "Solute carrier family 22 member 5" O76082 5 132369752-132395614 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.3;skeletal muscle: 93.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 22.3;SiHa: 23.0" HPA063062 Approved Mitochondria NA NA Mitochondria "HPA063062: AB_2684934" "unprognostic (3.88e-1)" "unprognostic (1.69e-1)" "unprognostic (2.19e-2)" "prognostic favorable (2.87e-5)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.50e-2)" "unprognostic (9.24e-2)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.53e-2)" "prognostic favorable (8.36e-4)" "unprognostic (1.12e-2)" "unprognostic (2.98e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-2)" 3.0 4.7 4.0 1.9 4.9 0.6 4.4 9.0 4.2 4.4 10.6 3.6 15.0 11.8 3.6 12.6 2.5 7.4 5.2 7.2 3.8 3.8 42.3 4.5 2.3 1.5 3.5 3.2 3.9 5.2 17.9 8.5 8.1 3.9 8.2 8.3 5.9 4.2 21.8 93.6 3.5 19.6 2.9 3.8 1.7 4.4 2.5 2.7 1.0 5.0 3.2 2.4 3.9 3.2 1.4 6.4 0.4 4.1 1.5 4.0 2.1 3.6 8.7 0.5 7.0 2.8 1.3 12.1 1.6 1.8 2.8 3.9 6.4 7.5 1.7 3.8 1.6 8.1 8.7 5.8 4.3 3.3 2.2 7.1 0.9 22.3 2.9 4.7 1.4 1.5 1.3 8.1 1.9 9.9 4.8 0.7 3.2 4.0 1.1 2.6 6.2 2.1 1.4 0.6 6.3 3.8 0.8 0.0 9.4 8.4 9.1 3.0 2.1 23.0 18.0 4.4 1.9 8.3 1.8 0.4 0.5 2.5 5.9 2.0 3.8 7.4 0.1 1.8 3.6 1.6 0.0 4.1 0.0 2.6 2.2 2.8 1.4 2.4 3.1 6.4 1.4 2.6 3.0 0.4 1.5 0.7 0.6 4.0 2.1 4.0 4.9 9.0 4.2 3.8 3.8 3.5 3.2 3.9 2.7 8.9 5.1 2.7 5.9 6.8 6.5 5.2 20.4 6.7 3.4 15.7 11.8 16.6 1.7 8.8 1.4 3.0 46.4 0.0 4.5 4.8 4.0 12.8 0.0 5.9 4.0 9.5 6.9 1.3 8.7 2.3 6.1 2.6 5.0 0.0 12.6 8.7 5.4 25.9 3.9 23.2 7.4 0.0 1.9 7.2 2.5 5.5 6.9 2.9 16.1 7.8 SLC25A13 "ARALAR2, CITRIN, CTLN2" ENSG00000004864 "Solute carrier family 25 member 13" Q9UJS0 7 96120220-96322147 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 79.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018997 Enhanced Supported Mitochondria NA NA Mitochondria "HPA018997: AB_1857023" "unprognostic (3.61e-2)" "unprognostic (7.99e-2)" "unprognostic (6.99e-2)" "unprognostic (7.19e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (1.42e-2)" "unprognostic (6.67e-2)" "unprognostic (2.31e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-1)" "unprognostic (6.99e-2)" "prognostic favorable (9.14e-4)" "unprognostic (1.15e-1)" "unprognostic (1.05e-1)" "unprognostic (3.32e-1)" "unprognostic (7.09e-2)" 7.7 10.3 4.2 4.9 11.8 4.1 6.7 3.0 7.5 5.4 12.5 21.1 15.6 8.9 5.1 8.0 6.9 5.9 6.7 4.5 5.6 5.3 17.7 79.1 5.5 4.9 14.5 4.8 5.9 7.3 8.2 8.8 8.9 12.4 5.9 10.2 12.6 5.7 17.3 4.6 8.2 9.7 5.0 13.1 7.2 7.9 4.3 12.6 1.8 7.9 3.0 4.8 5.0 5.3 3.7 8.9 3.1 6.7 2.8 2.4 2.1 16.1 14.3 16.5 5.7 2.8 2.3 23.2 4.1 3.1 10.0 10.1 25.6 15.2 7.3 19.6 2.6 21.8 9.7 18.5 5.9 11.8 2.8 12.2 8.3 13.5 19.9 6.7 10.5 6.5 6.1 6.3 8.5 7.7 3.8 11.4 1.1 23.3 2.8 4.8 17.8 0.0 9.8 29.1 17.3 8.9 4.1 9.8 16.8 23.8 15.3 7.9 26.0 14.2 30.2 24.3 28.7 9.0 8.1 6.6 7.4 16.6 17.5 12.4 5.7 14.3 4.6 9.1 10.1 12.2 0.6 4.6 3.1 2.2 6.3 2.4 3.7 1.8 2.0 8.9 2.0 1.2 1.5 0.8 2.8 6.7 4.7 1.8 2.1 4.2 11.8 3.0 7.5 5.6 5.3 14.5 4.8 12.4 12.6 8.9 9.3 10.5 6.9 6.5 34.3 7.1 38.2 14.7 6.8 17.4 51.1 25.9 23.2 17.3 9.5 16.9 23.5 0.0 16.5 20.5 14.8 9.8 13.9 124.1 20.1 9.5 36.2 12.3 22.7 6.7 12.0 19.6 20.3 2.8 19.4 22.1 18.9 24.6 14.9 50.8 47.6 12.9 8.3 5.4 9.1 6.9 16.7 5.7 23.3 12.2 SLC25A14 "BMCP1, UCP5" ENSG00000102078 "Solute carrier family 25 member 14" O95258 X 130339888-130373361 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060316 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA060316: AB_2684251" "unprognostic (1.65e-2)" "prognostic favorable (1.72e-5)" "unprognostic (1.82e-1)" "unprognostic (2.74e-1)" "unprognostic (1.27e-1)" "unprognostic (1.16e-1)" "unprognostic (3.36e-3)" "unprognostic (8.92e-3)" "unprognostic (3.52e-2)" "unprognostic (2.95e-3)" "prognostic favorable (1.78e-4)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.52e-6)" "unprognostic (6.05e-2)" "unprognostic (1.12e-1)" "unprognostic (6.92e-2)" "prognostic favorable (1.39e-5)" 3.1 9.3 9.2 3.4 18.3 3.7 5.5 13.6 20.6 4.8 3.8 6.1 4.2 2.2 6.7 11.0 4.3 9.7 4.6 7.7 8.7 15.8 5.2 4.1 4.6 4.1 7.3 11.4 6.8 4.5 5.6 15.0 3.6 11.2 5.1 4.1 5.7 5.1 6.7 3.4 4.7 3.6 7.7 5.3 3.5 4.8 10.2 4.2 4.2 5.7 4.6 5.3 3.1 3.8 7.5 9.3 8.7 7.2 8.1 9.5 4.9 6.9 9.1 6.5 4.8 4.4 4.2 3.5 5.2 7.0 10.2 10.2 3.6 4.2 4.7 18.2 7.0 12.5 3.9 9.4 3.9 10.1 6.0 11.9 1.5 8.4 8.5 6.2 5.9 2.8 3.9 4.7 12.8 3.9 6.0 5.6 6.6 4.1 6.7 16.1 10.6 6.2 8.3 5.5 7.5 15.0 5.3 8.5 9.4 5.9 3.0 8.2 7.3 5.5 5.6 8.8 4.5 3.6 3.3 3.7 5.5 3.6 12.5 10.5 6.3 16.1 4.1 10.0 7.3 4.9 5.8 7.2 5.2 6.4 5.8 7.8 7.5 5.4 6.1 7.5 4.6 4.2 7.0 8.7 8.1 5.2 9.3 9.5 4.9 9.2 18.3 13.6 15.6 8.7 15.8 7.3 11.4 11.2 4.2 6.0 2.1 8.3 6.8 8.9 8.8 3.2 7.6 26.8 1.2 3.5 2.0 8.0 14.9 9.4 9.0 4.4 3.8 0.0 7.9 7.3 6.0 4.1 3.5 3.8 4.6 6.4 8.6 4.9 3.3 5.1 4.6 5.1 8.5 2.8 4.0 8.5 7.5 4.5 7.8 8.3 12.7 6.5 6.2 21.6 39.2 7.3 4.5 7.0 5.2 4.7 SLC25A16 "D10S105E, GDA, HGT.1, ML7" ENSG00000122912 "Solute carrier family 25 member 16" P16260 10 68477999-68527474 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036243, HPA044580" Uncertain Approved Mitochondria NA NA Mitochondria "HPA036243: AB_2675019, HPA044580: AB_10962723" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (6.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.23e-2)" "unprognostic (9.13e-3)" "unprognostic (1.92e-1)" "unprognostic (4.13e-2)" "unprognostic (8.65e-2)" "unprognostic (1.17e-1)" "unprognostic (8.37e-3)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (2.06e-2)" "unprognostic (1.44e-3)" 18.7 8.0 6.4 5.5 8.9 7.0 15.5 9.6 13.5 5.1 6.9 8.1 4.8 8.1 7.7 7.8 5.9 5.4 8.8 5.9 8.4 7.3 12.0 22.6 10.2 9.2 7.8 8.6 6.3 21.1 6.9 7.3 7.1 9.2 17.3 6.4 8.5 15.0 6.6 9.4 6.5 11.0 8.4 6.3 6.4 9.4 3.5 6.6 6.4 7.8 4.8 7.7 6.4 5.4 3.2 2.9 5.0 2.7 2.4 2.5 1.2 3.0 1.2 3.5 4.8 4.7 5.7 3.8 4.1 4.5 2.7 2.9 7.1 2.0 3.2 3.0 8.1 1.4 1.8 11.0 2.1 6.8 2.4 6.8 1.7 3.2 3.1 5.8 5.4 3.8 4.9 5.4 5.0 7.1 4.0 2.2 2.9 1.9 5.4 5.6 2.8 3.1 3.9 0.8 0.8 15.9 1.7 2.5 1.0 7.3 9.8 2.5 2.0 5.9 5.8 4.6 2.5 3.2 2.2 9.5 4.1 5.3 6.6 4.7 5.5 2.9 5.2 3.9 4.5 1.8 4.0 2.7 2.7 1.7 1.9 1.6 1.7 1.6 1.4 1.8 3.2 1.6 2.5 5.0 2.4 1.5 2.9 1.7 1.2 6.4 8.9 9.6 13.5 8.4 7.3 7.8 8.6 9.2 6.6 41.7 20.2 6.9 5.6 5.7 16.9 8.0 15.3 13.4 7.9 12.2 37.3 14.4 10.0 6.6 7.7 5.8 13.8 0.0 16.7 23.1 7.2 16.0 8.1 35.0 9.4 19.1 14.5 14.7 7.2 9.2 2.8 5.8 1.7 3.6 7.8 8.5 12.2 7.0 7.4 19.2 31.5 0.0 8.9 4.1 2.5 5.9 50.0 4.3 7.4 8.6 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria NA NA Mitochondria "HPA009675: AB_2668252, HPA050883: AB_2681260" "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favorable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 20.0 8.1 11.8 37.1 15.9 7.0 5.4 5.8 9.6 11.4 13.8 20.4 13.4 11.2 14.3 14.7 12.5 17.1 24.0 14.0 9.1 0.0 20.2 8.1 17.2 16.2 14.8 0.5 19.2 20.0 12.3 10.1 4.4 23.3 11.9 12.5 23.3 14.3 2.2 14.6 7.0 11.5 8.5 21.6 25.0 3.4 3.2 17.2 30.5 3.6 0.8 11.6 4.2 25.8 10.7 13.4 13.5 17.8 4.1 3.6 15.4 0.9 3.8 2.6 3.5 9.9 1.6 19.1 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 8.9 18.1 7.0 8.3 9.3 9.8 34.8 48.4 1.4 4.5 43.6 7.9 1.2 16.6 52.9 16.5 5.5 100.4 0.0 24.8 1.5 5.8 13.9 6.9 27.0 2.1 7.9 13.3 12.9 2.1 45.5 17.5 2.2 16.9 1.8 35.6 14.6 40.3 35.4 27.6 22.6 16.4 12.9 6.2 0.3 3.2 20.5 0.7 4.3 23.9 24.3 SLC25A24 "APC1, DKFZp586G0123" ENSG00000085491 "Solute carrier family 25 member 24" Q6NUK1 1 108134036-108200849 "Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028519, HPA063636" Enhanced Enhanced Mitochondria NA NA 8900 Mitochondria "HPA028519: AB_10603890, HPA063636: AB_2685068" "unprognostic (1.94e-2)" "unprognostic (7.30e-3)" "prognostic favorable (1.01e-4)" "unprognostic (7.11e-2)" "unprognostic (1.64e-2)" "unprognostic (2.91e-1)" "unprognostic (8.54e-4)" "unprognostic (1.51e-2)" "unprognostic (7.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-3)" "unprognostic (6.18e-2)" "unprognostic (6.76e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 19.8 10.8 3.0 13.1 3.3 3.8 25.2 2.3 4.5 15.9 26.6 3.9 9.6 13.6 12.4 11.8 11.4 9.0 16.1 12.4 2.8 3.3 15.3 2.9 17.8 10.8 3.0 2.7 13.5 7.2 13.2 7.7 10.4 5.3 12.4 18.2 9.8 11.2 9.7 7.4 6.9 42.4 9.7 4.0 17.0 9.0 5.1 1.5 10.3 13.7 10.8 9.4 10.8 18.2 2.9 4.8 4.4 7.1 1.7 4.3 2.1 24.2 5.4 16.6 5.1 11.4 15.1 8.3 8.5 10.0 15.1 16.7 6.6 8.1 0.0 7.8 15.6 6.7 9.5 4.9 13.7 20.5 6.0 2.5 1.5 8.1 3.2 9.5 3.9 3.2 11.2 9.7 8.8 11.3 9.8 11.5 3.5 4.1 8.2 19.1 15.9 2.2 0.8 9.8 10.0 6.2 4.1 21.7 7.2 10.2 12.5 3.2 5.5 12.0 8.6 11.2 16.4 8.3 6.9 7.8 8.6 4.4 15.3 9.1 2.3 1.3 0.0 2.9 7.1 5.1 2.8 4.9 4.4 2.3 5.7 2.9 2.9 2.7 2.3 4.8 2.3 1.3 2.3 0.6 1.7 7.1 1.4 4.3 2.1 3.0 3.3 2.3 4.5 2.8 3.3 3.0 2.7 5.3 1.5 50.6 26.7 15.9 17.7 13.9 14.1 12.9 20.4 57.6 36.4 17.4 7.9 5.8 18.3 29.1 2.2 20.4 70.3 0.0 32.1 55.2 18.8 10.7 21.9 0.4 48.5 9.5 17.4 36.8 51.2 2.1 18.1 43.2 21.9 26.2 43.1 8.9 48.3 51.2 17.0 19.3 31.4 51.8 17.9 4.3 1.3 13.0 5.1 13.1 47.4 29.8 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria NA NA Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favorable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 11.8 12.9 20.2 8.5 14.8 13.3 16.5 7.9 27.2 10.3 12.6 15.8 9.2 9.7 11.1 12.9 14.3 13.1 10.1 19.5 16.9 12.8 15.7 22.7 10.0 15.2 17.6 11.8 20.0 21.2 16.2 11.6 11.9 14.6 10.8 13.4 12.6 16.1 12.6 29.8 16.5 11.0 16.8 14.3 11.4 12.7 18.3 12.6 12.0 19.0 14.2 12.9 13.4 10.8 12.0 12.2 3.6 7.1 10.5 14.4 9.1 6.3 6.2 3.8 7.7 8.5 8.8 8.0 5.3 10.2 7.2 6.8 8.1 8.5 6.5 3.2 9.7 8.8 4.7 4.4 9.9 7.4 6.8 10.3 9.9 4.9 11.7 10.2 13.8 8.4 12.0 19.7 5.7 13.8 6.9 5.3 13.2 4.4 8.7 8.6 7.9 5.8 15.9 11.1 14.4 3.6 6.0 6.9 11.0 5.9 4.7 2.9 8.9 7.7 6.7 12.6 7.0 5.6 10.9 6.0 7.6 7.2 9.5 9.3 12.9 16.8 8.4 10.5 13.2 8.2 1.3 6.8 3.6 10.9 7.1 9.9 12.0 12.1 11.1 12.2 10.2 14.4 12.3 0.4 10.5 4.1 11.6 11.1 9.1 20.2 14.8 7.9 27.2 16.9 12.8 17.6 11.8 14.6 12.6 29.8 20.3 23.3 31.4 31.8 17.7 96.8 20.4 13.4 12.5 17.4 11.8 29.9 29.9 25.2 20.6 19.7 19.1 0.0 38.7 36.6 33.9 31.6 18.5 34.2 26.5 11.1 17.9 9.2 19.0 19.2 15.0 17.8 35.4 20.8 25.5 22.4 26.4 14.0 20.5 46.3 21.5 19.4 29.5 21.4 30.2 32.1 27.3 46.5 33.0 33.6 SLC25A27 "FLJ33552, UCP4" ENSG00000153291 "Solute carrier family 25 member 27" O95847 6 46652915-46678193 "Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069732 Supported Mitochondria NA NA Mitochondria "HPA069732: AB_2686185" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (9.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.87e-1)" "unprognostic (2.03e-1)" "unprognostic (2.81e-1)" "unprognostic (1.24e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "prognostic favorable (6.16e-4)" "unprognostic (3.82e-3)" "unprognostic (1.01e-1)" "unprognostic (7.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.74e-1)" "unprognostic (7.47e-3)" 13.3 15.0 18.5 6.6 28.8 1.5 18.7 63.8 30.2 11.8 13.2 20.2 11.3 5.0 28.4 50.9 7.6 13.9 14.2 11.9 17.6 10.5 12.6 12.2 10.1 4.2 24.7 28.9 39.4 9.7 25.8 37.8 2.6 19.6 31.0 11.5 23.6 14.3 17.9 11.2 28.1 6.8 17.0 18.0 6.3 9.1 12.6 26.9 0.4 21.7 7.7 3.8 11.4 17.6 0.0 0.4 0.3 0.0 0.0 0.3 0.0 2.0 1.4 2.4 8.0 9.1 6.3 0.1 1.1 3.7 1.1 0.2 0.0 2.9 0.8 5.5 2.0 2.6 4.1 1.1 3.5 0.7 0.0 11.8 0.0 26.3 2.9 4.8 0.1 0.3 9.8 14.8 0.0 9.4 5.8 0.2 8.0 0.1 0.0 0.9 0.8 0.0 0.1 1.2 2.0 3.1 0.0 3.1 0.1 6.0 7.5 7.3 0.8 5.5 0.3 2.9 3.6 5.9 0.0 0.8 5.0 3.3 0.5 1.0 3.2 0.0 16.2 0.8 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 18.5 28.8 63.8 30.2 17.6 10.5 24.7 28.9 19.6 26.9 3.0 2.9 0.0 3.6 0.8 20.5 7.0 0.0 6.7 2.3 5.2 27.5 0.0 0.0 0.6 23.2 3.1 0.3 0.0 0.6 0.0 2.5 5.8 1.1 1.7 0.2 19.1 5.8 2.5 0.3 16.0 2.8 0.1 1.7 0.0 1.3 8.3 0.3 0.0 4.9 0.5 38.2 0.0 2.3 0.5 0.7 2.0 0.0 0.0 1.5 2.1 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria NA NA 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favorable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 74.7 58.4 77.5 64.2 70.6 117.4 99.9 65.6 87.5 85.1 71.2 104.8 39.3 102.2 39.0 79.5 38.5 64.4 78.6 88.7 89.8 38.4 62.7 60.9 43.1 69.5 86.9 71.3 48.4 111.0 79.4 61.8 88.9 128.1 120.1 53.0 65.6 30.3 101.4 55.8 66.1 79.6 71.7 64.7 96.0 75.6 80.8 113.4 110.0 75.1 39.8 53.4 78.5 70.7 108.3 68.5 95.5 78.0 80.7 47.4 44.8 52.0 65.6 51.4 60.4 71.5 37.4 42.1 61.0 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 199.5 265.4 295.0 454.5 334.1 211.9 1401.5 384.7 145.9 192.2 204.1 74.6 677.0 741.1 434.4 31.9 273.0 744.3 163.5 762.2 755.9 400.5 371.4 205.5 373.5 527.3 276.5 300.1 249.2 430.8 19.5 236.2 288.2 415.0 543.8 392.0 226.4 536.4 501.2 241.1 802.3 176.2 297.5 387.5 94.1 178.4 316.8 681.4 269.7 620.6 559.0 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 113.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 113.2 11.9 0.0 0.0 0.0 0.0 0.0 SLC25A32 MFTC ENSG00000164933 "Solute carrier family 25 member 32" Q9H2D1 8 103398635-103415189 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024763, HPA047402" Uncertain Supported Mitochondria NA NA Mitochondria "HPA024763: , HPA047402: AB_2680032" "unprognostic (2.45e-3)" "unprognostic (8.19e-2)" "unprognostic (3.87e-3)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.06e-2)" "unprognostic (6.50e-3)" "unprognostic (1.22e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (9.47e-2)" "unprognostic (8.43e-2)" "unprognostic (2.08e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (7.82e-2)" "unprognostic (2.12e-1)" "unprognostic (1.62e-1)" "unprognostic (4.49e-2)" 24.1 14.9 11.1 19.6 17.0 21.6 21.6 22.1 21.9 16.3 14.7 15.4 8.8 11.0 19.4 13.0 13.1 18.8 19.6 16.4 12.6 16.5 15.2 29.6 16.1 23.9 16.4 11.6 21.0 13.4 17.3 30.1 16.5 24.2 14.9 14.2 15.7 13.0 13.1 17.8 13.9 14.1 18.5 14.1 25.1 14.4 15.3 13.6 17.2 14.9 11.7 19.8 18.3 14.2 8.9 5.0 1.8 4.6 5.7 9.3 6.5 15.0 5.4 7.4 9.0 10.1 11.8 4.9 12.8 18.1 14.4 15.0 6.6 9.3 32.8 12.2 13.8 8.6 9.7 10.6 10.8 22.4 20.0 7.5 24.2 4.6 8.4 17.6 11.8 11.0 11.6 9.0 16.2 24.2 5.8 14.9 9.6 14.9 12.9 14.3 6.0 20.1 9.7 8.9 17.7 10.9 15.1 7.9 22.6 9.8 6.9 20.7 9.0 6.2 10.3 21.4 6.2 9.1 8.5 10.3 17.9 11.9 20.6 16.5 9.2 8.6 34.2 15.2 17.3 13.2 0.7 3.9 1.8 7.7 4.4 9.3 8.9 8.3 8.8 5.0 6.5 8.6 8.7 1.1 5.7 4.6 4.3 6.5 6.5 11.1 17.0 22.1 21.9 12.6 16.5 16.4 11.6 24.2 13.6 3.0 3.5 26.5 13.0 20.5 8.9 9.9 10.2 1.4 3.4 5.2 5.9 10.3 6.6 7.8 3.0 19.4 3.2 0.0 8.2 11.5 13.8 8.2 9.2 13.0 9.3 7.9 10.9 16.5 5.0 2.8 8.6 7.4 10.1 10.0 6.3 7.1 8.1 3.5 8.1 7.4 7.4 19.4 12.6 20.0 17.9 22.6 11.7 13.1 6.2 14.0 SLC25A34 DKFZp781A10161 ENSG00000162461 "Solute carrier family 25 member 34" Q6PIV7 1 15736405-15741396 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.8;skeletal muscle: 22.2" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 16.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 10.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069806 Approved Mitochondria NA NA Mitochondria "HPA069806: AB_2686202" "unprognostic (2.06e-1)" "unprognostic (4.72e-1)" "unprognostic (1.15e-1)" "unprognostic (2.43e-1)" "unprognostic (2.58e-1)" "unprognostic (8.08e-3)" "unprognostic (1.98e-2)" "unprognostic (9.92e-2)" "unprognostic (1.55e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-4)" "unprognostic (5.74e-2)" "unprognostic (6.10e-2)" "unprognostic (4.02e-1)" "unprognostic (1.82e-1)" "unprognostic (4.04e-2)" "unprognostic (2.40e-4)" 2.5 2.4 1.2 0.9 1.9 2.8 0.7 10.4 1.8 1.1 25.9 0.8 0.5 13.5 1.7 1.4 1.6 1.3 3.6 13.3 1.5 1.2 7.3 3.9 1.1 1.1 0.7 1.8 2.4 18.6 0.6 2.1 1.2 1.5 1.1 1.9 3.7 11.1 0.8 22.2 0.8 38.8 1.0 1.1 1.9 1.4 2.3 1.2 0.5 1.9 11.0 1.9 0.7 1.1 0.7 0.5 2.0 0.5 2.2 4.1 1.1 0.7 0.5 3.5 1.6 1.7 0.7 1.5 0.5 0.3 0.8 0.6 1.4 1.9 0.9 0.8 0.7 1.8 0.7 0.6 0.6 0.8 1.2 0.7 1.5 1.1 0.5 0.6 0.4 2.2 0.8 2.7 1.0 0.5 2.2 0.4 4.6 0.6 3.2 0.6 1.8 3.7 2.0 2.9 0.4 1.0 1.9 3.1 1.0 0.3 0.1 0.7 2.8 0.8 1.0 7.4 3.4 1.9 2.5 1.7 1.7 2.2 2.3 0.6 3.8 3.5 0.7 0.6 2.2 1.4 1.2 0.5 0.4 1.4 0.2 3.1 0.5 3.0 2.0 0.2 0.7 4.1 2.3 2.0 2.2 0.2 0.5 1.3 1.1 1.2 1.9 10.4 1.8 1.5 1.2 0.7 1.8 1.5 1.2 0.0 0.0 0.0 0.3 0.2 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.7 16.0 0.0 0.2 0.2 0.7 0.3 0.0 2.1 1.2 3.2 3.4 2.5 2.6 0.4 0.9 0.1 0.0 1.8 2.4 1.7 0.2 5.3 0.4 3.0 1.4 0.0 0.9 0.5 0.6 0.1 1.1 0.0 4.1 0.4 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143241-185150382 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 4236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favorable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 3.0 4.2 6.9 2.0 10.8 1.4 3.1 19.4 14.4 2.6 6.6 3.7 2.9 2.8 3.0 3.4 6.7 3.7 3.5 163.7 7.4 7.3 8.3 4.3 3.0 2.0 6.3 6.1 3.6 3.0 4.6 4.6 2.2 12.8 6.2 3.4 7.9 4.4 8.5 92.5 2.3 4.1 5.5 4.5 2.1 5.3 3.1 2.3 0.0 4.6 62.4 3.4 4.4 2.1 3.5 3.0 0.4 0.0 0.7 4.1 1.5 0.7 3.3 2.7 5.5 3.0 0.3 5.0 2.7 0.9 3.3 3.3 7.1 1.8 2.4 2.0 3.3 2.6 2.6 10.4 2.9 2.2 4.0 8.9 1.6 4.9 8.3 6.1 1.4 1.6 2.2 7.1 5.1 1.4 7.8 2.4 4.2 3.8 1.9 2.0 5.1 1.6 3.2 4.4 2.3 7.1 2.6 1.4 3.3 7.5 5.1 8.8 6.7 3.2 1.4 12.6 5.1 2.6 1.2 1.8 0.2 1.5 1.7 3.5 7.9 3.6 3.1 2.4 0.3 3.0 0.0 0.0 0.0 4.1 0.0 3.1 3.5 1.4 3.5 0.1 2.2 1.2 3.0 0.4 0.7 0.0 3.0 1.2 1.5 6.9 10.8 19.4 14.1 7.4 7.3 6.3 6.1 12.8 2.3 80.4 55.4 33.5 125.8 39.2 174.4 4236.1 140.1 112.4 42.1 68.0 98.2 59.7 837.3 68.4 15.8 25.9 41.2 0.0 65.1 47.9 24.6 55.0 11.5 83.9 50.1 151.0 51.6 24.5 7.6 7.7 43.1 7.9 180.5 15.4 35.7 473.2 51.1 24.6 106.1 140.9 178.4 103.5 194.8 24.0 35.3 15.8 33.9 10.7 48.8 46.9 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Yes No Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favorable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favorable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.2 0.8 1.6 2.8 6.1 5.1 2.5 3.0 4.6 4.7 5.4 1.2 12.5 4.5 7.1 2.8 4.7 1.1 3.2 2.5 2.7 1.1 6.2 1.5 1.7 10.0 4.9 0.7 3.2 5.1 1.8 3.6 2.2 3.8 2.1 14.7 17.5 8.1 2.5 5.6 7.5 7.1 0.9 1.7 6.5 5.8 2.8 8.6 1.8 1.1 1.8 1.3 3.2 0.1 1.3 2.2 5.7 3.5 1.9 3.5 2.0 7.3 2.9 9.4 5.1 3.5 3.7 9.6 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 0.0 9.6 8.9 2.4 2.9 68.0 8.9 2.5 1.4 3.4 8.7 17.7 5.7 11.6 1.4 1.2 3.5 5.4 0.0 2.7 2.7 3.6 2.6 3.5 44.5 1.5 3.2 8.1 4.3 0.3 0.6 4.6 1.1 3.3 0.0 4.0 11.9 1.9 2.9 6.0 27.0 42.5 6.5 5.7 7.9 6.4 2.5 3.9 11.4 2.9 1.3 SLC25A46 ENSG00000164209 "Solute carrier family 25 member 46" Q96AG3 5 110738136-110765161 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 176.3;Late spermatids: 325.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039601, HPA071582" Approved Supported Mitochondria NA NA Mitochondria "HPA039601: AB_2676592, HPA071582: AB_2686422" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "prognostic favorable (8.41e-4)" "unprognostic (4.91e-2)" "unprognostic (2.27e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "unprognostic (1.77e-2)" "unprognostic (5.14e-2)" "unprognostic (1.97e-2)" "unprognostic (1.67e-1)" "unprognostic (2.40e-1)" "unprognostic (2.25e-2)" "unprognostic (2.26e-1)" "unprognostic (2.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (1.98e-1)" 16.9 15.6 11.9 12.7 19.3 11.3 13.6 17.6 25.7 12.5 14.0 12.2 8.5 15.7 13.4 9.5 16.4 9.5 10.0 20.8 10.4 10.0 18.7 22.0 11.4 13.7 14.5 14.8 10.2 12.4 12.7 20.2 11.5 27.7 10.2 14.7 8.3 14.2 10.7 55.6 13.0 15.4 13.9 15.0 12.1 12.9 15.8 12.3 20.4 12.5 14.3 17.5 13.1 10.9 14.6 15.1 20.2 17.3 17.7 16.3 14.9 12.5 9.7 9.2 7.4 21.3 20.2 3.7 15.7 20.4 18.0 22.5 13.2 10.7 33.8 16.1 18.3 23.9 10.4 14.5 26.0 20.4 21.7 8.3 14.5 14.1 9.5 19.0 12.6 14.6 17.0 7.7 21.2 15.0 9.4 11.2 12.9 10.9 21.3 18.6 10.0 18.4 5.4 6.9 8.2 9.7 9.0 20.6 25.1 11.4 14.7 16.2 12.0 13.6 10.5 16.5 9.1 11.4 10.5 14.7 15.9 8.0 14.4 18.8 40.9 25.6 25.4 16.5 14.8 8.5 20.2 14.7 11.5 12.3 17.3 12.4 14.1 13.7 12.6 15.1 14.6 14.8 14.8 6.2 17.7 15.2 10.6 16.3 14.9 11.9 19.3 17.6 25.7 10.4 10.0 14.5 14.8 27.7 12.3 20.8 22.7 11.9 7.5 20.4 16.0 56.7 5.1 12.0 7.9 19.2 21.6 18.8 16.6 15.0 176.3 20.2 27.2 23.3 22.2 16.5 20.2 7.3 18.5 39.4 23.8 17.5 22.5 30.1 24.3 325.8 19.5 18.9 28.7 22.6 25.4 21.5 14.4 25.7 20.8 30.4 13.6 19.4 20.6 20.0 10.2 23.5 17.2 25.4 19.0 5.5 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468400-119471319 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 2147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7800000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.25e-2)" "prognostic favorable (7.35e-4)" "prognostic favorable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 26.0 28.9 26.8 32.2 29.5 36.5 36.6 21.8 39.0 23.0 74.1 16.3 26.0 120.7 22.5 18.3 64.1 17.5 39.5 31.4 22.5 18.8 80.7 71.0 38.3 53.8 27.2 23.8 18.1 128.2 22.5 14.6 30.7 24.2 18.9 84.9 20.1 58.3 21.5 16.6 42.1 157.5 33.6 20.5 34.3 68.2 16.8 17.1 87.0 31.1 59.9 47.0 30.8 33.8 51.6 97.8 18.5 113.2 33.4 48.0 84.9 82.0 78.9 30.9 53.1 19.8 29.2 57.4 30.7 33.5 64.8 58.0 65.5 52.1 104.2 41.3 29.4 46.8 57.8 75.8 64.1 59.2 27.5 73.1 35.1 47.7 46.6 25.1 95.3 58.0 31.7 72.1 66.7 42.6 24.7 67.2 53.7 28.1 43.2 35.3 182.7 84.3 96.8 65.0 112.7 127.2 46.3 39.1 80.8 49.3 66.0 37.4 35.4 52.7 80.3 62.1 32.9 33.1 48.3 27.9 30.7 44.4 68.3 110.0 50.7 62.9 83.4 33.9 97.5 49.5 10.1 68.1 18.5 20.7 113.2 23.9 51.6 30.1 26.9 97.8 39.7 30.1 28.3 11.3 33.4 84.9 53.9 48.0 84.9 26.8 29.5 21.8 39.0 22.5 18.8 27.2 23.8 24.2 17.1 151.8 244.7 335.6 401.9 724.7 105.3 125.5 328.6 187.4 221.8 177.9 56.9 945.1 2147.0 467.3 2.7 209.6 1628.0 163.5 919.2 321.7 246.2 228.4 191.3 343.1 785.8 25.4 385.2 119.1 477.4 13.9 134.6 447.5 519.6 300.2 755.1 85.2 524.3 956.2 104.0 1138.1 131.4 129.4 460.4 8.9 116.7 839.4 1329.0 292.0 958.7 657.9 SLC25A51 "CG7943, MCART1, MGC14836" ENSG00000122696 "Solute carrier family 25 member 51" Q9H1U9 9 37879400-37904353 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 74.4;Late spermatids: 125.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046388, HPA058261" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046388: AB_2679649, HPA058261: AB_2683657" "unprognostic (5.46e-2)" "unprognostic (2.28e-1)" "unprognostic (2.67e-2)" "unprognostic (5.63e-2)" "unprognostic (1.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (6.87e-2)" "unprognostic (1.04e-1)" "unprognostic (7.98e-3)" "unprognostic (1.26e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.52e-4)" "unprognostic (8.27e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (2.08e-2)" 17.6 9.1 11.7 9.9 12.9 21.2 27.6 11.3 14.2 12.0 10.7 12.0 10.8 15.3 10.3 10.2 12.6 8.1 10.7 11.5 12.9 9.3 13.3 9.7 14.6 10.8 11.9 14.9 11.0 16.7 20.6 12.8 9.7 11.9 10.5 9.0 8.2 13.3 8.4 15.9 11.7 13.4 12.2 11.4 12.6 9.7 18.8 12.4 14.4 9.8 7.6 12.9 9.1 10.2 3.1 1.4 13.4 3.9 2.1 3.6 1.1 8.2 6.6 5.1 8.0 24.5 10.7 5.2 7.0 7.3 6.1 8.9 8.6 3.6 17.4 4.1 16.6 8.6 4.1 13.6 9.9 11.8 11.9 4.2 5.3 18.2 12.0 13.8 8.3 7.8 10.7 11.6 9.1 11.7 9.7 11.0 16.7 11.6 13.9 13.0 4.7 10.0 1.9 6.3 8.5 4.8 7.0 6.8 10.7 6.1 6.0 10.7 6.9 5.6 6.8 4.0 9.0 3.7 9.1 11.9 10.3 12.1 4.8 8.7 5.3 11.2 12.2 13.5 6.1 8.5 13.4 1.9 3.2 2.1 3.9 3.6 3.1 2.3 3.0 1.4 2.2 2.2 2.5 1.5 2.1 1.6 0.6 3.4 1.1 11.7 12.9 11.3 14.2 12.9 9.3 11.9 14.9 11.9 12.4 8.9 0.6 4.2 5.0 4.1 4.3 5.7 2.5 1.4 2.3 1.8 3.9 3.2 14.9 8.3 74.4 3.4 5.1 0.0 6.3 11.8 4.2 3.9 3.5 3.2 10.5 1.6 3.5 0.6 5.9 125.5 3.4 5.0 1.7 9.0 4.2 3.4 7.2 7.0 3.9 13.4 3.4 0.0 3.1 10.2 10.3 5.1 3.3 3.2 3.5 3.4 SLC25A52 MCART2 ENSG00000141437 "Solute carrier family 25 member 52" 18 31759562-31760880 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 18.2" "Group enriched" "Detected in some" 10 "Early spermatids: 41.8;Late spermatids: 77.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.5" "HPA046388, HPA058261" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046388: AB_2679649, HPA058261: AB_2683657" "unprognostic (8.97e-2)" "unprognostic (4.85e-2)" "unprognostic (2.93e-1)" "unprognostic (4.87e-1)" "unprognostic (2.50e-1)" "unprognostic (9.05e-2)" "unprognostic (2.97e-2)" "unprognostic (1.30e-4)" "unprognostic (7.15e-3)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.41e-1)" "unprognostic (3.34e-2)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.3 0.4 0.4 0.0 0.8 0.4 0.5 1.3 0.4 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.0 0.4 1.1 0.0 0.3 0.2 0.5 0.0 0.9 2.5 0.6 0.0 1.5 1.1 0.0 0.2 0.0 0.3 0.0 0.0 0.9 0.7 1.0 0.0 0.0 1.3 0.1 0.3 0.3 0.0 1.1 0.9 0.0 0.0 0.4 0.7 1.5 0.8 1.0 0.2 0.1 0.6 1.7 1.3 0.6 0.6 0.5 0.7 1.3 1.5 0.7 0.8 0.6 1.2 0.8 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.4 0.4 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 0.0 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392724 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7200000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 18.5 19.7 12.1 12.2 14.0 23.7 14.4 8.2 12.2 9.8 16.5 28.9 14.3 4.8 16.4 10.4 7.0 9.4 10.3 8.2 18.4 5.4 11.1 14.4 9.4 25.6 38.7 10.1 14.0 8.6 12.4 8.8 45.0 12.5 6.1 14.9 23.3 7.7 5.8 15.4 19.2 2.4 16.3 9.5 14.2 11.2 62.2 85.7 3.7 69.0 30.1 43.6 71.2 22.2 48.7 34.6 35.3 24.0 46.8 37.5 34.1 32.7 25.2 25.1 64.4 27.2 82.8 27.6 22.4 38.0 14.5 23.2 40.7 7.9 20.7 73.8 45.2 33.4 73.5 56.3 32.5 55.2 77.2 75.0 19.7 29.0 32.7 37.3 26.1 31.5 19.5 24.6 47.4 60.1 62.3 43.9 8.8 65.7 30.4 28.6 64.2 30.7 56.0 56.6 88.9 23.1 70.1 97.0 21.0 38.9 67.0 42.7 25.7 14.4 50.2 34.0 50.6 8.1 55.8 3.8 31.4 13.9 2.4 58.1 3.7 29.4 69.0 43.6 62.2 40.4 34.8 85.7 47.5 38.1 37.2 3.0 30.1 67.9 41.0 38.7 71.2 137.0 195.3 871.5 1042.4 1022.6 282.9 87.0 257.4 128.5 280.9 300.1 92.3 1322.2 1405.9 633.0 8.9 418.0 863.0 303.7 1275.3 963.9 807.0 855.9 337.0 132.8 1090.5 228.8 892.0 411.9 1235.3 26.5 618.4 976.3 715.3 1354.4 1107.0 100.8 835.0 866.6 344.4 1021.3 199.6 336.3 860.1 13.3 52.8 1155.2 1458.6 553.5 1380.0 1328.6 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 43.2" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 54.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048185, HPA050695, HPA060150" Enhanced Approved Mitochondria NA NA Mitochondria "HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 3.0 2.5 2.4 7.4 2.2 1.3 2.7 2.1 2.4 7.4 8.1 1.8 3.8 8.4 2.6 4.8 5.0 6.2 5.9 2.4 3.7 2.6 5.6 2.0 4.0 7.7 2.4 2.2 3.4 3.4 0.3 2.6 9.7 1.9 10.6 9.8 5.2 43.2 2.7 2.3 8.5 7.4 1.8 4.2 2.7 2.8 3.7 2.3 1.8 3.2 6.7 6.9 3.4 3.7 9.3 5.9 0.5 0.2 2.9 11.2 1.6 8.5 5.6 0.6 7.9 4.7 7.0 8.1 2.0 1.1 5.3 6.8 24.2 9.0 14.2 20.3 5.9 28.6 17.9 11.3 18.1 10.5 11.8 10.4 7.9 5.5 10.0 7.7 18.5 4.0 4.8 10.5 17.5 37.9 15.9 27.6 11.3 20.7 5.9 3.7 5.1 7.6 17.8 6.0 18.9 54.7 15.5 7.2 18.6 28.3 7.8 13.8 5.8 6.4 14.9 3.9 7.9 11.0 3.9 20.5 9.7 16.1 0.2 20.4 15.4 17.4 15.6 6.2 5.9 6.3 0.1 0.2 0.0 2.8 0.1 7.3 9.3 4.8 4.9 5.9 6.1 1.8 2.5 0.5 2.9 0.0 0.3 11.2 1.6 2.4 2.2 2.1 2.4 3.7 2.6 2.4 2.2 1.9 2.3 8.9 1.0 11.1 30.1 40.9 1.1 0.5 0.0 0.0 15.9 3.5 11.8 0.7 3.3 10.1 0.3 5.8 14.0 0.0 7.2 13.5 5.1 19.0 2.3 0.0 5.0 0.0 5.8 0.0 0.8 0.9 0.9 3.9 21.9 6.4 10.2 1.3 17.0 10.5 2.5 5.5 7.5 6.5 4.1 0.3 4.9 44.0 3.8 2.5 22.6 15.2 SLC37A4 "G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d" ENSG00000137700 "Solute carrier family 37 member 4" 11 119024114-119030906 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.2" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 183.4;Hepatocytes: 134.8;Muller glia cells: 96.7;Proximal tubular cells: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.4;HEK 293: 17.3;Hep G2: 21.6;MCF7: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038939, HPA038940" Enhanced Approved Mitochondria NA NA Mitochondria "HPA038939: AB_2676279, HPA038940: AB_2676280" "unprognostic (4.77e-2)" "unprognostic (3.49e-1)" "unprognostic (2.08e-2)" "unprognostic (2.35e-2)" "unprognostic (4.70e-2)" "unprognostic (6.95e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (4.08e-2)" "unprognostic (8.27e-3)" "unprognostic (4.72e-2)" "unprognostic (3.89e-1)" "unprognostic (1.98e-1)" "unprognostic (4.04e-2)" "unprognostic (2.60e-1)" "unprognostic (4.34e-2)" "unprognostic (5.39e-2)" 2.1 3.7 4.8 4.8 3.7 1.4 3.7 7.8 5.9 1.7 5.0 2.7 13.6 26.0 2.6 15.9 2.5 4.0 6.9 4.6 3.7 4.9 29.6 42.2 3.3 4.7 3.7 3.1 3.3 15.5 5.9 2.2 3.3 2.3 4.3 5.3 3.0 4.6 13.6 27.7 2.0 6.7 1.9 3.1 3.4 1.8 4.5 1.4 2.9 3.3 3.3 2.4 1.7 2.3 1.2 0.7 2.7 3.7 2.0 4.1 1.2 0.4 7.2 2.6 1.9 4.7 1.9 1.5 0.2 5.9 1.6 4.1 16.4 1.2 1.8 4.0 2.3 3.4 0.4 1.1 8.2 2.5 2.1 17.3 5.4 1.6 21.6 1.7 3.1 0.9 0.0 2.3 0.8 4.4 6.6 5.4 0.4 2.1 4.8 2.7 15.1 0.1 6.9 0.1 1.6 8.6 4.4 0.0 8.5 1.8 7.6 3.3 3.3 0.0 0.4 2.7 3.5 3.2 2.3 0.0 0.0 2.6 0.1 2.8 0.8 1.3 0.5 0.7 7.9 0.7 0.0 1.9 2.7 3.3 3.7 2.8 1.2 1.9 4.1 0.7 1.1 1.6 2.3 0.0 2.0 1.5 0.2 2.1 1.2 4.8 3.7 7.8 5.9 3.7 4.9 3.7 3.1 2.3 1.4 3.0 5.6 6.7 7.2 1.5 6.4 3.6 183.4 8.1 4.5 15.7 0.0 22.4 26.6 25.4 9.2 6.3 26.5 23.3 22.1 16.5 3.7 9.0 0.0 134.8 24.5 15.9 23.7 21.5 9.1 1.9 8.9 7.0 3.3 16.2 17.5 96.7 18.6 24.6 9.9 134.4 11.0 0.0 4.1 7.1 22.6 2.4 12.7 4.6 37.7 5.1 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789093-205813748 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.1;pancreas: 36.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria NA NA Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 6.0 7.2 6.2 4.0 7.3 3.3 3.4 9.0 8.3 3.6 3.9 10.8 4.0 1.6 5.0 5.9 3.8 7.3 4.7 78.1 7.2 3.8 6.1 1.2 5.3 4.5 7.8 4.9 7.5 36.8 5.8 3.6 2.6 6.9 5.1 1.5 5.8 2.8 4.8 26.5 2.6 2.7 4.0 8.5 3.3 6.6 11.6 7.3 2.1 11.2 11.9 4.5 5.2 5.0 1.8 0.0 0.1 0.3 1.0 4.6 2.0 10.8 9.6 6.1 9.7 7.6 7.5 8.3 11.2 11.0 11.4 10.1 4.8 6.2 15.7 7.1 10.2 9.5 11.3 5.9 8.2 3.9 28.8 9.0 3.8 9.5 0.7 7.3 0.0 11.0 9.5 6.9 13.0 9.3 9.5 7.0 12.8 7.0 6.6 9.1 6.7 7.0 1.1 7.2 2.9 4.4 8.3 18.3 3.8 2.6 13.5 5.1 6.5 8.6 7.7 7.0 5.3 5.5 4.0 8.7 13.6 8.8 12.4 11.6 22.0 14.6 5.2 10.6 5.0 8.4 0.0 0.1 0.1 3.6 0.3 4.6 1.5 3.4 3.4 0.0 1.8 3.2 3.3 0.0 1.0 0.0 0.0 3.3 2.0 6.2 7.3 9.0 8.3 7.2 3.8 7.8 4.9 6.9 7.3 3.0 16.5 12.6 19.3 18.4 12.9 157.4 10.2 9.4 12.5 0.0 47.1 1.7 1.7 8.2 1.5 20.4 0.0 0.0 9.4 12.7 8.0 15.4 6.9 1.8 2.7 17.5 5.8 4.3 2.2 1.7 9.2 3.2 8.5 0.0 0.8 18.0 8.8 0.6 8.9 13.7 21.3 0.0 19.4 6.8 15.0 15.8 2.6 8.5 1.0 20.0 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039249 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 56.2;liver: 75.6" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced Uncertain Mitochondria No NA Mitochondria "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.8 2.1 32.2 1.6 31.0 3.0 1.8 15.1 56.2 2.0 1.7 25.4 0.0 1.7 1.9 3.9 4.3 2.4 2.3 3.3 22.2 16.6 2.1 75.6 2.5 1.7 22.7 25.3 2.4 1.4 9.3 1.0 2.0 17.0 2.1 1.8 1.7 1.6 5.0 3.3 1.7 1.7 1.8 13.7 1.9 1.7 4.4 14.3 0.5 1.9 0.0 1.7 1.9 0.9 1.0 0.8 1.2 0.3 0.2 0.8 0.2 0.8 0.6 1.9 1.3 1.5 0.4 1.1 0.7 0.2 0.8 1.1 1.5 1.0 1.6 0.3 0.4 1.8 1.3 2.3 0.9 0.7 0.2 1.8 1.3 4.6 2.8 0.7 2.2 2.3 1.1 0.2 0.2 1.3 0.5 0.3 1.7 1.1 3.7 0.2 1.1 0.7 1.8 0.8 1.2 1.4 1.2 0.2 0.1 0.6 1.8 0.8 0.3 1.0 0.7 0.2 1.1 1.0 1.0 0.3 0.8 0.5 0.7 0.7 1.1 0.3 1.2 0.9 1.7 0.4 0.3 0.3 1.1 0.5 0.1 0.8 0.9 0.6 0.5 0.3 1.0 0.3 0.5 1.2 0.2 0.3 0.8 0.3 0.2 32.2 31.0 15.1 41.5 22.2 16.6 22.7 25.3 17.0 14.3 0.0 0.3 0.0 0.0 0.2 1.8 1.4 17.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.5 0.0 0.0 0.0 0.0 1.0 0.2 5.2 0.0 0.0 0.0 0.0 41.9 0.0 0.0 9.6 0.1 3.3 12.9 2.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008043, HPA008044" Enhanced Approved Mitochondria NA NA Mitochondria "HPA008043: , HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.3 0.4 1.7 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.6 4.8 1.5 28.3 0.8 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.7 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 0.0 0.0 0.0 0.0 0.5 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 3.6 0.0 0.4 0.0 1.1 0.4 0.1 0.0 0.0 0.0 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1046.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria No No 38000 Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 31.9 36.0 65.2 25.0 55.1 33.6 49.9 24.3 54.7 29.2 49.8 30.6 23.2 37.2 23.7 65.1 38.1 24.4 26.5 63.6 47.5 50.5 57.5 69.8 19.1 24.3 53.7 40.6 26.1 49.3 19.3 34.8 30.0 44.9 25.2 46.7 27.8 36.9 30.6 105.7 20.5 42.1 31.9 46.3 26.3 32.0 31.7 34.4 16.5 27.4 72.9 34.6 27.9 23.5 35.2 52.2 20.9 59.6 18.3 33.0 40.5 41.5 82.6 33.9 33.0 22.4 22.5 45.7 23.6 22.3 46.9 41.0 111.7 38.1 30.2 24.9 26.8 29.7 41.1 61.8 48.1 62.3 16.5 69.4 30.5 78.1 111.0 34.3 20.2 22.0 24.1 31.7 37.6 41.9 23.3 38.5 39.3 29.8 17.3 40.8 134.5 30.9 55.3 52.6 89.7 116.8 28.4 28.4 33.7 48.1 79.3 43.4 28.4 25.0 53.2 34.0 38.8 55.7 35.9 22.4 24.0 43.1 25.9 41.1 18.7 34.0 56.5 32.9 39.7 30.7 17.4 59.6 20.9 23.8 56.5 25.0 35.2 31.7 23.3 50.8 31.2 33.0 27.3 19.1 18.3 56.9 52.2 31.7 40.5 65.2 55.1 24.3 54.7 47.5 50.5 53.7 40.6 44.9 34.4 101.3 132.2 131.6 134.2 158.9 62.3 1046.2 321.0 215.5 236.6 251.2 45.2 353.2 653.2 329.0 411.9 162.1 390.6 186.9 458.2 301.6 205.6 130.6 164.3 649.5 274.7 41.3 237.0 176.8 193.5 63.4 155.6 186.2 237.8 215.6 299.7 100.1 358.6 298.1 159.8 577.8 85.2 168.1 217.8 171.1 196.1 187.3 201.2 82.8 331.8 147.8 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Group enriched" "Detected in some" 9 "Bipolar cells: 4.5;Hepatocytes: 2.4" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria No NA 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: AB_2732542" "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM12 "C1orf212, FLJ90372" ENSG00000163866 "Small integral membrane protein 12" Q96EX1 1 34712737-34859816 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065331 Approved Approved Mitochondria NA NA Mitochondria "HPA065331: AB_2685470" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.64e-1)" "unprognostic (2.05e-1)" "unprognostic (5.71e-2)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "prognostic favorable (1.15e-5)" "unprognostic (7.33e-2)" "unprognostic (6.70e-2)" "unprognostic (3.58e-2)" "unprognostic (2.52e-2)" 26.6 28.8 16.4 19.0 21.9 16.0 21.0 14.2 27.1 12.2 22.6 14.2 12.4 22.6 14.8 15.5 22.4 13.9 15.7 25.5 15.6 21.7 31.7 61.5 17.1 21.4 19.0 18.7 13.3 25.5 10.9 15.3 19.3 19.8 11.3 21.8 15.4 17.3 16.8 32.2 15.7 23.1 23.9 13.8 19.2 17.0 13.7 13.1 20.3 18.1 20.1 20.1 15.7 16.8 25.7 38.5 54.4 35.1 25.5 36.6 35.3 21.7 16.7 18.8 13.6 24.6 19.4 13.0 23.7 20.7 30.7 26.6 16.8 27.8 22.9 21.4 24.3 24.2 22.0 23.8 31.8 23.6 27.8 16.7 40.7 26.8 20.0 22.9 44.3 24.1 29.4 31.2 33.2 27.0 11.1 31.2 20.0 28.9 31.3 27.0 15.8 21.4 22.9 30.3 17.1 21.8 18.3 18.4 29.8 27.1 22.9 18.0 14.2 22.0 20.8 33.3 24.7 14.1 12.6 29.3 21.1 21.6 32.2 27.8 17.6 24.2 23.2 19.8 26.5 13.8 36.4 34.7 54.4 31.1 35.1 36.6 25.4 29.2 33.9 38.5 25.7 24.4 31.4 22.8 25.5 28.0 27.6 32.5 35.3 16.4 21.9 14.2 27.1 15.6 21.7 19.0 18.7 19.8 13.1 23.8 12.5 54.1 17.0 60.7 14.8 28.3 56.0 26.8 17.0 21.0 9.8 43.4 72.9 68.9 51.5 46.6 46.3 70.0 73.0 49.7 30.1 24.0 23.1 74.6 73.0 19.1 20.9 44.2 34.6 23.8 13.8 47.4 37.1 111.8 21.6 21.4 68.8 33.2 21.9 69.5 14.5 12.9 67.9 35.2 22.7 66.0 48.5 47.4 34.9 38.3 SMYD5 "NN8-4AG, RAI15, RRG1, ZMYND23" ENSG00000135632 "SMYD family member 5" Q6GMV2 2 73214222-73227237 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015514, HPA049002" Uncertain Approved Mitochondria NA NA Mitochondria "HPA015514: AB_2669205, HPA049002: AB_2680595" "unprognostic (1.75e-1)" "unprognostic (3.39e-1)" "unprognostic (5.22e-2)" "unprognostic (6.66e-3)" "unprognostic (3.86e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.58e-7)" "unprognostic (1.28e-1)" "unprognostic (1.60e-2)" "unprognostic (3.84e-2)" "unprognostic (3.84e-1)" "unprognostic (2.49e-1)" "unprognostic (3.03e-2)" "unprognostic (3.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (2.40e-1)" 13.9 16.5 16.9 14.9 23.6 11.2 20.1 18.3 24.5 14.5 11.3 18.5 16.0 8.3 16.2 23.0 17.0 22.7 9.4 19.1 16.4 18.2 15.9 19.0 10.6 18.3 15.3 15.0 33.4 27.1 22.6 13.9 15.2 15.7 13.4 13.2 17.1 13.4 16.4 16.4 15.0 10.3 16.8 13.1 14.7 9.7 15.7 14.5 9.4 16.4 13.2 17.2 12.4 17.6 6.8 3.2 0.0 4.1 4.2 12.0 4.3 11.7 22.8 13.6 13.0 10.0 14.8 23.2 11.3 11.5 22.0 13.6 29.1 12.1 21.0 10.6 19.0 26.5 12.1 21.0 24.4 20.0 12.7 14.8 20.3 9.2 31.8 13.5 19.9 8.4 12.4 15.8 20.1 24.2 9.8 13.3 16.9 21.4 10.2 13.9 16.5 18.6 13.1 21.2 24.8 18.2 12.5 25.6 17.3 14.4 17.1 8.8 13.2 10.3 15.4 13.0 13.0 12.6 7.1 9.1 15.2 23.9 18.4 18.5 11.2 8.3 18.7 17.1 17.2 12.1 0.0 1.3 0.0 5.5 3.8 12.0 6.5 7.6 7.3 3.2 6.8 7.7 8.3 0.0 4.2 4.1 3.0 3.1 4.3 16.9 23.6 18.3 24.5 16.4 18.2 15.3 15.0 15.7 14.5 3.0 6.4 5.1 3.6 4.5 8.5 6.9 2.5 0.0 5.7 5.2 3.9 7.7 1.7 8.2 0.5 4.3 0.9 0.0 7.6 8.1 3.3 2.3 6.9 4.7 5.2 4.8 0.0 2.5 1.6 2.5 2.6 2.0 5.0 5.4 4.0 3.5 5.0 0.0 2.8 6.8 5.6 6.5 3.1 6.5 10.8 3.0 4.0 2.5 5.0 3.0 SNX19 "CHET8, KIAA0254" ENSG00000120451 "Sorting nexin 19" Q92543 11 130875436-130916509 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013447 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013447: AB_1857347" "unprognostic (8.79e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (1.56e-1)" "unprognostic (2.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.17e-2)" "unprognostic (9.19e-2)" "unprognostic (3.43e-2)" "unprognostic (4.05e-2)" "unprognostic (2.89e-1)" "unprognostic (4.97e-2)" "prognostic favorable (3.56e-5)" "unprognostic (1.05e-1)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" 22.3 23.1 24.0 16.9 30.6 10.0 17.2 18.0 38.0 17.1 23.8 35.6 25.3 17.1 22.9 32.5 17.9 19.8 20.4 22.6 22.8 22.2 24.1 25.6 17.5 15.3 31.0 15.3 20.6 26.6 32.9 28.5 18.5 28.0 21.7 22.2 23.7 23.1 27.2 26.4 19.0 17.8 26.0 30.8 18.5 22.3 36.2 28.2 24.6 31.1 12.1 18.1 23.0 16.4 5.9 5.4 11.3 6.6 3.6 6.2 5.2 6.7 7.5 9.6 13.4 29.0 20.4 6.4 18.0 21.4 9.1 9.5 8.4 13.0 6.4 12.6 19.9 20.3 12.3 1.4 12.9 11.7 10.3 5.8 11.7 7.4 0.0 21.0 0.0 9.1 23.2 16.0 9.3 10.2 18.8 11.1 8.8 10.3 0.0 19.4 4.9 9.4 7.7 2.9 16.8 9.5 7.2 9.1 3.7 9.9 12.2 9.4 8.8 7.7 12.4 6.1 7.8 22.0 7.3 14.7 12.8 9.5 10.5 10.5 2.2 0.0 0.0 5.3 7.7 14.6 11.3 6.0 4.4 4.8 6.4 6.2 5.9 4.7 5.7 5.3 4.4 5.6 4.4 3.6 3.6 6.6 5.4 4.1 5.2 24.0 30.6 18.0 38.0 22.8 22.2 31.0 15.3 28.0 28.2 23.8 6.4 10.9 5.9 3.5 22.7 17.9 22.9 14.7 13.6 22.7 9.8 7.7 8.3 10.2 23.3 9.3 11.8 0.0 14.0 4.7 7.4 8.7 18.4 18.8 8.9 15.9 10.9 15.4 11.9 35.0 12.7 10.3 3.3 2.8 10.6 21.3 13.4 11.4 14.9 8.7 37.1 12.9 8.3 31.9 11.5 3.8 11.7 6.5 8.5 9.1 SOD2 ENSG00000112096 "Superoxide dismutase 2" 6 159669057-159745186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 254.9;skeletal muscle: 475.1" "Cell type enriched" "Detected in some" 8 "Hofbauer cells: 286.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "neutrophil: 254.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 254.9" "Cell line enhanced" "Detected in all" "BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3" "HPA001814, CAB002013" Supported Enhanced Mitochondria NA NA Mitochondria "CAB002013: , HPA001814: AB_1080134" "unprognostic (2.47e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "unprognostic (1.37e-1)" "unprognostic (6.67e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.99e-2)" "unprognostic (1.82e-1)" 77.8 28.6 6.2 82.8 13.8 147.9 32.5 3.6 12.5 13.1 25.6 5.7 3.6 9.1 13.3 16.6 20.3 12.6 19.9 42.4 5.8 6.4 157.4 197.5 33.9 52.7 14.3 2.6 31.8 24.9 6.9 7.0 10.0 16.1 27.1 6.1 6.4 39.9 7.4 475.1 9.0 8.1 27.9 25.5 18.4 13.8 13.6 7.3 3.0 36.8 20.8 11.8 43.4 52.8 2.3 5.8 254.9 22.7 0.9 4.5 15.0 3.6 4.6 4.1 9.4 26.6 44.5 2.1 5.3 182.1 6.5 15.1 9.5 2.1 7.5 16.0 5.9 70.6 6.3 4.3 4.6 4.9 7.3 8.9 7.9 7.8 16.2 19.8 7.5 3.4 80.3 7.7 20.6 15.4 4.6 3.3 4.8 10.8 9.0 6.2 3.9 6.2 4.8 6.9 4.4 5.8 8.4 5.6 6.9 12.1 6.0 7.8 3.0 11.2 5.7 2.3 1.6 3.5 3.6 3.1 19.2 6.9 10.1 9.2 3.8 9.8 9.0 21.1 5.8 2.4 6.2 19.2 9.4 2.2 14.9 2.4 2.3 3.1 2.2 5.8 1.8 2.6 2.1 254.9 0.9 22.7 0.8 4.5 15.0 6.2 13.8 3.6 12.5 5.8 6.4 14.3 2.6 16.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.0 286.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 SP9 ZNF990 ENSG00000217236 "Sp9 transcription factor" P0CG40 2 174334946-174338492 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 5.1;skin 1: 4.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.0;fHDF/TERT166: 6.8;HEK 293: 2.8;THP-1: 14.4" "Group enriched" "Detected in some" 6 "basal ganglia: 6.0;olfactory region: 14.4" "Region enriched" "Detected in many" 4 "olfactory region: 44.8" HPA062616 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062616: AB_2684808" "unprognostic (2.04e-2)" "unprognostic (6.94e-3)" "unprognostic (1.44e-1)" "unprognostic (3.95e-1)" "unprognostic (7.55e-3)" "unprognostic (8.54e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" 0.7 0.3 4.6 0.3 12.4 0.3 1.1 0.0 6.1 0.6 0.3 0.4 0.0 0.3 0.4 0.3 0.3 5.1 0.3 0.3 2.3 2.2 0.3 0.3 0.3 0.4 1.1 4.3 0.3 0.3 0.3 0.0 1.1 1.0 0.3 0.3 0.0 0.4 0.3 0.6 4.5 0.3 0.3 0.5 0.3 0.3 2.0 1.4 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 9.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 6.8 0.0 0.1 0.2 0.0 0.0 0.0 2.8 0.6 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 12.4 0.0 6.1 2.3 2.2 1.1 4.3 1.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 SPACA9 "C9orf9, Mast" ENSG00000165698 "Sperm acrosome associated 9" Q96E40 9 132878027-132890201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "epididymis: 55.8;fallopian tube: 29.1;testis: 53.8" "Cell type enriched" "Detected in some" 4 "Ciliated cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "JURKAT: 32.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA022243, HPA051600" Enhanced Approved Mitochondria No No Mitochondria "HPA022243: AB_1845844, HPA051600: AB_2681546" "unprognostic (2.69e-1)" "unprognostic (2.14e-3)" "unprognostic (8.00e-3)" "prognostic favorable (8.61e-4)" "unprognostic (1.59e-1)" "unprognostic (5.73e-2)" "unprognostic (3.76e-3)" "unprognostic (2.60e-1)" "unprognostic (6.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.15e-2)" "unprognostic (9.51e-2)" "prognostic favorable (8.31e-4)" "unprognostic (5.11e-2)" "unprognostic (1.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" 2.7 6.0 7.8 1.6 8.4 1.7 3.9 4.3 9.3 5.1 4.8 8.5 7.9 1.7 5.3 55.8 5.3 29.1 4.5 7.0 7.0 8.9 7.0 1.8 4.6 2.1 7.2 7.3 9.2 2.8 2.7 5.8 3.0 6.9 4.1 2.1 5.7 7.7 6.2 1.5 8.0 1.7 4.3 7.7 2.3 3.1 53.8 5.1 6.2 10.2 3.6 3.0 2.9 3.8 6.0 3.0 5.6 3.3 7.8 3.5 1.6 1.9 2.1 3.2 2.7 4.6 5.9 3.9 1.2 2.3 1.7 1.9 0.5 6.1 0.5 2.9 5.7 3.7 2.8 1.3 3.6 1.6 2.3 2.6 0.5 1.5 0.7 6.7 1.4 0.2 6.7 7.7 4.3 4.8 7.3 2.0 32.5 0.5 1.7 4.7 4.2 4.9 5.6 0.7 3.7 2.0 2.3 0.7 1.4 7.1 0.7 0.9 3.2 5.3 0.9 4.2 2.5 7.0 0.5 1.9 3.8 2.6 3.6 0.5 0.7 1.1 1.7 7.0 0.5 1.8 5.6 2.2 3.6 2.2 2.0 2.5 6.0 2.4 1.3 3.0 4.7 2.9 2.6 3.1 7.8 3.3 1.0 3.5 1.6 7.8 8.4 4.3 9.3 7.0 8.9 7.2 7.3 6.9 5.1 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 116.4 9.1 22.7 0.0 14.2 28.2 6.2 0.0 0.0 0.0 0.0 6.2 10.9 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.4 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051331-52097292 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 41.7;testis: 65.7" "Group enriched" "Detected in many" 10 "Early spermatids: 536.7;Late spermatids: 1836.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 20.1;BEWO: 15.1;BJ hTERT+: 9.7;HSkMC: 18.5;hTCEpi: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036854, HPA036855" Enhanced Supported Mitochondria NA NA Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favorable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 4.2 2.6 1.2 3.3 0.0 3.7 0.1 1.1 6.8 2.3 3.6 5.3 1.2 2.5 9.9 4.9 41.7 11.5 1.5 3.1 2.8 3.7 4.4 12.0 0.3 0.6 0.6 7.6 1.6 4.2 6.1 1.8 12.5 3.5 3.5 1.4 13.2 6.0 1.1 4.3 2.8 1.8 0.8 0.5 2.9 65.7 0.8 1.3 1.6 4.1 3.1 2.3 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.0 8.0 20.1 15.1 5.6 9.7 0.3 0.4 0.0 0.9 0.0 0.0 7.4 0.1 0.1 0.0 4.3 0.2 0.0 0.6 0.0 0.0 4.7 7.1 0.0 0.0 18.5 17.8 0.6 2.8 3.2 4.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 1.2 0.6 0.0 0.0 6.3 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.3 0.1 1.1 3.1 2.8 0.6 0.6 12.5 0.8 8.9 4.0 0.0 6.6 4.6 0.0 2.4 7.6 115.1 18.2 0.0 0.0 1.4 1.7 0.9 536.7 0.4 1.1 0.0 2.4 1.1 2.3 5.1 2.3 1.7 0.3 0.0 1.7 2.5 1.2 1836.3 10.0 1.2 0.0 0.0 1.6 0.0 1.2 2.9 10.3 5.4 0.0 0.0 1.8 11.7 6.8 6.6 0.7 0.0 3.8 6.4 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Group enriched" "Detected in some" 15 "Early spermatids: 467.1;Late spermatids: 349.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 4.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA010848, HPA076967" Approved Approved Mitochondria NA NA Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 0.8 2.8 0.0 0.0 0.0 0.2 0.5 1.8 0.2 0.0 0.6 0.6 0.5 1.6 0.0 0.6 0.0 0.9 0.6 1.1 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.5 0.0 4.0 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 467.1 0.0 0.0 0.0 0.0 27.7 0.4 0.2 0.0 0.0 1.1 1.6 0.0 0.0 0.3 349.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.2 0.0 0.2 0.0 0.5 3.6 2.9 0.1 3.5 0.0 0.0 0.1 SPSB3 "C16orf31, SSB-3" ENSG00000162032 "SplA/ryanodine receptor domain and SOCS box containing 3" Q6PJ21 16 1776712-1793700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 138.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046602 Uncertain Approved Mitochondria NA NA Mitochondria "HPA046602: AB_2679717" "unprognostic (1.18e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-3)" "unprognostic (1.82e-1)" "unprognostic (8.91e-4)" "unprognostic (1.07e-2)" "unprognostic (8.31e-2)" "unprognostic (5.65e-2)" "unprognostic (8.43e-2)" "unprognostic (3.41e-2)" "unprognostic (4.83e-2)" "unprognostic (5.25e-7)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-1)" "unprognostic (4.72e-4)" 8.5 19.4 7.8 8.2 8.3 12.8 9.5 25.3 11.3 10.5 10.4 10.1 11.0 10.0 7.6 9.5 14.1 9.0 17.7 9.1 6.7 5.7 8.2 138.5 8.3 7.8 11.1 8.8 15.9 19.5 7.5 5.6 7.6 8.4 9.3 4.2 10.6 14.0 12.9 29.4 18.1 8.3 9.4 6.9 8.3 8.6 5.8 8.3 16.3 10.5 6.5 8.9 8.5 9.3 18.0 15.9 32.6 16.8 15.6 34.5 17.0 3.4 5.3 6.5 7.6 9.1 8.9 10.6 4.3 7.0 7.6 8.3 3.8 11.7 1.7 8.6 3.9 2.7 7.0 3.2 6.6 1.2 6.1 7.8 3.4 7.6 5.0 12.6 1.3 6.0 7.8 17.3 4.9 5.7 11.6 11.5 12.0 3.9 9.2 3.7 12.6 8.8 8.6 4.4 6.8 2.6 14.8 2.5 14.1 6.7 0.7 8.5 8.4 5.5 17.2 15.8 4.9 8.5 8.1 8.1 3.5 5.3 6.2 2.9 13.6 15.7 4.4 2.8 4.9 4.0 32.3 16.8 29.7 26.1 15.2 32.6 18.0 24.4 24.1 15.4 16.8 17.6 18.4 32.6 15.6 13.3 15.9 34.5 17.0 7.8 8.3 25.3 11.3 6.7 5.7 11.1 8.8 8.4 8.3 35.7 28.0 37.1 47.6 87.3 69.1 0.2 22.9 26.8 21.6 52.4 37.3 52.7 44.7 43.7 41.0 35.3 65.2 23.3 41.4 63.9 36.6 44.8 33.6 50.8 28.6 85.8 46.8 45.4 33.5 65.6 71.4 44.0 72.6 62.3 50.2 76.4 42.2 71.9 70.4 41.0 84.0 38.8 49.2 18.6 35.8 112.0 53.9 76.1 48.8 50.3 SPTLC2 "hLCB2a, KIAA0526, LCB2, LCB2A" ENSG00000100596 "Serine palmitoyltransferase long chain base subunit 2" O15270 14 77505997-77616773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027552 Approved Mitochondria Yes No Mitochondria "HPA027552: AB_10601717" "unprognostic (3.16e-1)" "unprognostic (2.82e-2)" "unprognostic (1.24e-1)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (1.46e-2)" "unprognostic (3.09e-1)" "unprognostic (4.05e-1)" "unprognostic (1.98e-2)" "unprognostic (2.51e-1)" "prognostic favorable (6.69e-8)" "unprognostic (1.29e-2)" "unprognostic (2.35e-1)" "unprognostic (4.94e-2)" "unprognostic (1.32e-1)" 30.0 12.8 15.4 11.4 27.0 27.3 25.6 6.9 18.5 15.3 17.0 32.4 8.5 13.4 10.2 7.6 22.8 13.7 11.1 7.8 20.8 14.1 17.1 7.2 12.2 17.5 33.1 13.3 10.2 7.6 12.8 9.8 18.8 21.2 8.2 18.8 6.0 16.6 9.6 5.5 11.3 15.8 11.0 47.6 23.5 18.8 4.7 34.9 10.0 10.3 8.8 12.0 13.2 17.1 4.8 18.2 15.1 18.2 10.0 4.2 6.9 12.1 8.0 6.1 6.7 6.3 8.0 10.5 18.1 13.4 12.5 13.1 10.1 27.1 12.1 4.6 18.3 6.4 15.0 16.3 10.1 19.0 5.3 4.8 34.4 6.2 6.0 5.4 3.5 11.4 5.2 5.0 8.1 9.1 7.1 17.5 8.4 6.7 5.9 7.1 10.5 9.1 11.9 4.0 19.2 7.2 9.9 6.3 4.1 14.4 27.3 5.9 7.5 6.5 21.8 6.8 11.3 26.8 6.4 11.0 11.5 8.2 4.2 4.1 3.3 5.5 8.2 7.6 12.4 6.5 8.8 18.2 15.1 3.8 13.8 3.5 4.1 3.2 4.2 18.2 4.8 2.2 3.6 11.2 10.0 16.7 6.5 3.3 6.9 15.4 27.0 6.9 18.5 20.8 14.1 33.1 13.3 21.2 34.9 26.8 23.5 25.0 21.1 28.7 13.3 7.3 10.2 24.1 27.3 45.4 33.4 10.3 1.7 21.2 1.4 32.3 28.5 46.7 14.2 10.9 16.6 24.2 49.7 6.6 21.7 4.8 12.7 57.1 63.4 1.5 13.6 29.2 18.6 15.4 36.9 10.3 24.7 28.1 14.9 9.1 18.8 32.3 8.6 6.7 16.0 25.5 5.5 22.7 27.5 47.7 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691294 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 14 "Ductal cells: 93.9;Exocrine glandular cells: 153.6;Hofbauer cells: 133.1;monocytes: 269.7;Pancreatic endocrine cells: 118.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 64.9;RPTEC TERT1: 41.1" "HPA017079, HPA041589" Enhanced Supported Mitochondria NA NA 30000 Mitochondria "HPA017079: AB_1857467, HPA041589: AB_2677565" "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 23.6 8.6 4.4 33.5 5.7 12.0 16.7 1.6 3.8 11.9 54.7 3.0 12.1 14.2 11.7 11.4 38.7 8.4 15.2 12.2 2.8 2.3 16.9 34.2 27.1 22.4 6.8 2.3 8.7 27.7 7.4 7.5 7.0 4.8 18.0 48.5 11.2 21.5 15.2 66.9 14.3 31.5 21.5 4.9 21.4 19.7 4.6 3.1 11.7 19.0 36.6 30.3 24.6 20.7 11.0 27.8 62.3 43.5 10.0 29.2 29.2 7.7 13.9 0.0 0.8 28.7 34.5 0.0 8.4 28.5 5.1 7.8 0.5 12.2 7.2 8.2 6.4 16.1 7.0 0.4 64.9 3.1 24.4 0.2 0.6 3.1 9.7 8.3 3.9 1.1 10.1 19.2 11.9 27.3 13.4 14.1 6.4 0.0 8.9 5.5 6.1 2.4 9.2 0.0 31.7 8.3 0.3 1.4 9.7 41.1 11.4 0.2 0.2 2.1 5.6 2.7 0.1 12.0 12.6 15.7 2.1 0.5 30.2 1.8 11.3 11.8 0.4 20.7 21.3 2.2 18.4 43.5 16.2 16.3 32.9 22.8 11.0 21.6 18.3 27.8 9.5 11.3 12.2 62.3 10.0 29.0 8.1 29.2 29.2 4.4 5.7 1.6 3.8 2.8 2.3 6.8 2.3 4.8 3.1 29.8 54.4 0.0 0.0 0.0 0.0 0.0 0.0 44.2 27.3 14.0 0.0 0.6 10.0 93.9 0.0 0.0 0.0 0.0 153.6 0.6 0.0 0.0 10.5 0.0 133.1 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 269.7 0.0 0.0 118.9 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 SSBP1 "mtSSB, SSBP" ENSG00000106028 "Single stranded DNA binding protein 1" Q04837 7 141738321-141787922 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002866 Supported Supported Mitochondria NA NA 250000 Mitochondria "HPA002866: AB_1080092" "unprognostic (2.95e-1)" "unprognostic (2.99e-1)" "unprognostic (2.49e-2)" "unprognostic (3.62e-2)" "unprognostic (7.36e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (4.42e-4)" "unprognostic (3.68e-2)" "unprognostic (6.03e-2)" "prognostic favorable (3.40e-4)" "unprognostic (9.23e-3)" "unprognostic (4.02e-1)" "unprognostic (9.65e-3)" "unprognostic (1.62e-1)" "unprognostic (9.38e-2)" "unprognostic (1.25e-2)" "unprognostic (9.58e-2)" 41.1 52.5 45.4 40.9 52.6 41.7 51.6 26.8 44.3 41.7 42.4 33.9 38.7 36.9 45.2 58.9 61.0 37.1 36.8 57.8 38.6 38.6 55.2 83.4 31.0 56.0 42.7 41.0 45.2 49.6 40.7 44.4 47.2 44.4 38.8 44.8 34.1 41.2 39.0 62.9 42.4 40.8 45.5 36.7 50.7 44.6 38.3 33.3 62.9 45.6 67.4 54.7 42.8 38.6 42.6 41.2 31.3 35.9 36.3 48.7 40.8 39.6 46.0 41.1 51.7 18.3 29.8 37.8 28.6 27.6 36.6 41.2 48.5 45.5 62.0 40.6 24.0 60.0 29.9 47.6 50.0 52.1 29.8 49.7 30.4 34.6 42.8 36.2 89.1 24.2 28.0 34.1 38.3 54.0 26.0 44.6 39.0 76.6 26.3 50.0 58.2 63.1 116.4 90.6 64.7 57.6 36.6 37.4 80.7 47.9 39.1 37.0 50.9 33.5 44.5 44.4 32.2 30.1 39.3 32.1 26.1 25.2 40.2 75.9 47.4 62.7 111.0 53.5 80.3 56.9 31.3 29.1 26.6 30.1 35.5 44.0 42.6 48.7 40.2 36.8 37.0 45.1 48.1 7.5 36.3 35.9 41.2 46.4 40.8 45.4 52.6 26.8 44.3 38.6 38.6 42.7 41.0 44.4 33.3 95.3 94.9 115.3 144.9 103.0 51.8 257.7 158.0 105.7 114.9 143.1 39.3 266.1 296.8 270.0 118.1 112.7 85.6 46.7 306.8 254.8 138.8 122.4 145.8 187.5 221.5 41.3 92.5 95.8 119.0 35.7 127.1 153.1 99.5 206.4 126.8 92.4 270.9 108.7 116.3 344.0 71.9 97.0 135.8 228.3 170.8 113.2 218.9 139.5 153.1 201.9 STARD7 GTT1 ENSG00000084090 "StAR related lipid transfer domain containing 7" Q9NQZ5 2 96184859-96208825 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033965, HPA064958, HPA064978" Supported Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.56e-5)" "prognostic favorable (3.89e-6)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.72e-3)" "unprognostic (2.38e-1)" "unprognostic (2.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.38e-6)" "unprognostic (1.02e-1)" "unprognostic (2.04e-1)" "unprognostic (2.64e-2)" "unprognostic (2.42e-2)" 17.3 26.6 30.3 20.6 27.1 11.5 32.1 26.5 28.7 14.4 22.6 24.4 15.2 21.6 13.9 12.8 17.0 18.0 13.5 66.7 26.1 24.5 32.5 29.1 24.0 30.1 34.1 17.1 12.4 24.6 28.2 11.7 11.4 23.6 16.1 22.8 17.3 24.2 19.7 74.4 14.4 22.2 15.0 24.1 21.7 17.4 8.1 29.9 26.3 22.7 24.1 32.9 16.4 15.2 26.4 25.0 14.5 18.6 18.1 24.1 13.7 32.3 20.1 26.3 27.2 35.5 17.8 39.8 31.9 27.3 31.4 33.9 47.2 29.9 57.7 35.3 24.7 24.9 26.3 46.6 26.9 41.1 39.1 35.8 50.9 19.8 54.4 16.3 39.0 28.6 17.2 19.9 26.0 25.8 20.0 31.3 23.9 52.6 22.9 27.8 28.1 44.1 39.6 44.8 27.4 30.1 43.7 40.5 57.3 18.9 41.0 50.7 24.2 16.1 51.8 28.5 34.2 15.4 42.9 26.1 26.1 27.1 29.1 31.8 30.6 28.4 51.8 24.1 44.0 28.8 14.5 14.9 13.9 16.4 18.6 16.9 26.4 14.1 17.1 22.7 21.5 16.2 15.0 1.7 18.1 11.8 25.0 24.1 13.7 30.3 27.1 26.5 28.7 26.1 24.5 34.1 17.1 23.6 29.9 125.0 43.6 35.0 37.3 56.6 26.0 163.8 63.7 30.8 52.4 43.6 102.1 30.8 63.0 27.4 2.1 47.5 46.7 0.0 32.7 31.1 29.1 59.0 15.1 103.7 60.0 38.1 42.7 37.4 105.5 5.2 21.6 53.5 40.5 98.2 56.1 31.6 31.3 10.5 23.7 53.6 55.8 25.8 48.4 12.4 39.7 50.2 29.6 41.5 67.9 31.4 STMP1 "C7orf73, PL-5283" ENSG00000243317 "Short transmembrane mitochondrial protein 1" E0CX11 7 135662496-135693418 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 209.3;Extravillous trophoblasts: 217.6;monocytes: 256.1;Proximal tubular cells: 171.0;Syncytiotrophoblasts: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 71.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 71.6" "Low cell line specificity" "Detected in all" HPA065565 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA065565: AB_2685512" "unprognostic (3.94e-2)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (3.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.81e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-1)" "unprognostic (4.43e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (7.21e-3)" "unprognostic (4.90e-2)" "unprognostic (9.99e-2)" "unprognostic (9.62e-3)" "unprognostic (6.81e-2)" 15.6 32.2 22.5 19.7 24.3 33.5 27.3 13.8 20.4 20.1 19.0 25.0 20.3 17.4 16.5 26.7 51.4 16.2 19.3 29.5 19.3 20.6 28.4 34.7 19.7 28.1 22.3 13.5 16.5 25.4 14.6 25.4 28.1 20.4 20.7 22.5 31.2 23.0 18.5 40.7 21.1 23.2 21.3 22.0 18.7 19.5 38.7 17.0 38.4 31.9 42.6 34.9 18.2 28.0 5.3 12.5 71.6 13.1 7.6 6.6 9.2 15.2 7.1 17.3 16.1 20.6 29.3 10.5 16.9 16.5 14.1 14.7 4.4 16.9 13.9 15.1 25.5 13.7 6.3 16.6 21.3 19.2 17.4 13.7 21.9 8.2 10.7 20.3 22.2 14.2 18.0 24.4 16.8 15.7 21.3 11.6 18.2 23.5 12.6 30.9 18.9 31.6 25.6 34.0 21.2 18.2 16.0 18.5 23.0 39.2 8.0 21.9 21.1 22.5 15.7 15.7 17.5 6.3 24.6 18.9 13.8 11.2 24.4 23.5 14.6 21.0 27.0 42.5 23.2 24.9 71.6 12.0 25.0 5.3 12.3 5.0 5.3 5.1 5.3 12.5 4.5 4.9 5.4 9.3 7.6 13.1 7.1 6.6 9.2 22.5 24.3 13.8 20.4 19.3 20.6 22.3 13.5 20.4 17.0 38.7 43.1 0.0 0.0 0.0 0.0 0.0 0.0 62.9 51.2 92.5 0.0 209.3 167.5 157.0 0.0 0.0 0.0 0.0 84.6 217.6 0.0 0.0 52.3 0.0 164.1 0.0 0.0 0.0 0.0 0.0 0.0 40.5 0.0 256.1 0.0 0.0 115.5 0.0 0.0 171.0 0.0 0.0 0.0 0.0 0.0 0.0 230.3 0.0 0.0 0.0 SUCLA2 ENSG00000136143 "Succinate-CoA ligase ADP-forming beta subunit" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 204.8;Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria NA NA 6600 Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.22e-4)" 21.6 18.5 19.2 8.6 22.1 5.2 17.5 29.7 32.4 15.3 15.7 11.7 15.6 24.5 12.7 12.1 14.6 11.3 9.4 42.1 20.0 21.6 34.0 12.9 7.9 11.4 22.6 19.1 14.4 10.8 19.8 14.9 12.2 28.7 16.2 16.5 8.9 13.9 14.8 89.0 10.0 22.7 14.7 18.3 9.7 12.3 8.0 15.4 15.6 16.9 25.6 10.2 11.0 12.6 17.1 29.5 12.4 25.0 23.4 25.2 17.2 15.7 18.3 23.3 13.9 26.7 20.1 14.0 24.2 27.1 25.2 17.1 32.5 18.0 22.2 18.5 23.6 15.1 22.0 30.7 23.0 31.9 21.2 26.3 24.9 17.4 21.0 18.6 25.1 14.6 19.0 27.1 17.1 20.3 21.0 18.5 25.7 16.8 8.0 25.0 10.9 25.9 28.8 24.1 54.9 23.4 22.1 21.3 17.2 36.4 15.3 12.9 15.4 20.1 18.7 14.2 26.8 16.5 22.4 14.1 14.0 9.0 19.9 16.7 8.4 13.0 25.8 8.7 18.4 20.5 5.7 24.5 12.4 17.6 25.0 21.2 17.1 19.7 21.6 29.5 16.3 25.2 24.9 4.5 23.4 20.0 24.3 21.6 17.2 19.2 22.1 29.7 32.4 20.0 21.6 22.6 19.1 28.7 15.4 23.8 12.6 14.3 29.8 28.7 43.5 135.6 17.8 20.1 17.0 29.6 11.8 41.8 139.3 28.6 204.8 21.5 31.6 0.0 15.6 35.7 34.0 31.8 33.4 11.5 26.3 42.9 18.5 18.4 16.2 235.9 34.2 23.7 40.5 27.9 17.8 38.6 17.5 36.8 43.5 98.7 33.0 38.8 40.8 31.2 27.2 27.7 43.6 13.1 28.8 31.9 SUPV3L1 SUV3 ENSG00000156502 "Suv3 like RNA helicase" Q8IYB8 10 69180232-69209099 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038380, HPA038405" Supported Supported Mitochondria NA NA Mitochondria "HPA038380: AB_2675983, HPA038405: AB_10675797" "unprognostic (4.70e-2)" "unprognostic (1.85e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.74e-2)" "unprognostic (3.32e-2)" "unprognostic (1.44e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (9.47e-3)" "unprognostic (1.70e-1)" "unprognostic (1.06e-1)" "unprognostic (5.48e-3)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (5.27e-2)" "unprognostic (1.33e-1)" 12.8 17.0 11.1 12.6 17.3 26.1 17.7 21.9 19.9 10.8 14.4 12.6 7.8 11.2 13.5 12.4 13.2 11.9 12.6 19.2 12.0 11.3 16.4 22.2 9.6 15.2 9.9 13.1 15.8 18.2 15.4 14.7 10.9 16.1 11.4 16.7 12.4 11.8 13.9 31.1 15.6 12.5 13.9 9.9 15.5 13.0 26.6 9.9 12.7 14.1 13.4 14.8 12.4 11.6 10.1 7.3 5.6 7.7 7.4 13.7 6.2 11.5 8.1 7.3 22.3 8.2 7.0 9.6 7.2 11.2 14.6 13.8 20.8 9.8 20.8 5.9 7.2 10.4 13.3 17.4 11.2 14.1 8.7 13.7 9.1 6.4 10.9 20.7 21.6 6.9 8.8 14.2 13.4 30.8 10.0 8.4 13.3 23.7 10.9 8.0 7.5 13.1 13.4 8.7 11.0 44.4 12.1 10.3 9.1 6.6 5.6 10.4 7.9 9.9 20.8 18.9 8.4 6.4 9.5 5.2 5.8 10.5 8.8 13.9 8.6 10.0 19.5 9.6 22.9 3.6 5.6 5.2 4.3 12.3 7.7 13.7 10.1 8.9 10.5 7.3 8.3 9.9 10.6 0.9 7.4 5.2 4.0 8.7 6.2 11.1 17.3 21.9 19.9 12.0 11.3 9.9 13.1 16.1 9.9 6.0 9.0 10.0 9.6 21.2 21.5 19.6 10.2 14.7 13.6 7.0 3.9 15.0 10.0 10.0 8.2 8.5 7.8 0.0 7.4 9.9 9.7 6.9 7.0 10.9 8.7 11.1 8.6 6.7 3.1 3.4 6.4 5.6 5.0 5.4 8.6 10.8 8.0 9.0 8.5 12.2 11.3 6.5 13.4 28.6 24.5 19.4 18.8 15.8 11.8 9.5 SUV39H2 "FLJ23414, KMT1B" ENSG00000152455 "Suppressor of variegation 3-9 homolog 2" Q9H5I1 10 14878820-14904315 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 302.5;Late spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045901, HPA057554" Enhanced Approved Mitochondria NA NA Mitochondria "HPA045901: AB_10960702, HPA057554: AB_2683466" "prognostic unfavorable (5.55e-4)" "unprognostic (1.45e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-3)" "unprognostic (6.80e-2)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (3.59e-3)" "unprognostic (2.42e-1)" "unprognostic (4.13e-3)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" "unprognostic (5.55e-2)" "unprognostic (1.39e-1)" 3.0 2.9 4.7 3.4 7.4 4.9 5.2 20.0 8.6 3.1 3.8 1.6 2.1 3.2 3.8 2.3 4.0 3.0 3.2 2.4 5.4 2.8 3.5 3.8 2.7 3.6 3.3 4.4 4.2 2.4 2.4 6.3 5.1 3.3 3.9 4.7 1.6 2.4 3.6 2.4 3.3 2.9 3.7 3.0 3.4 2.7 41.8 4.4 10.3 2.8 4.9 4.0 3.3 2.8 0.8 3.1 0.5 1.8 5.6 4.0 0.8 13.7 13.1 22.0 12.5 4.1 5.0 8.6 7.5 4.6 14.0 19.9 19.6 7.9 11.1 6.8 4.5 12.3 9.7 16.3 9.1 17.3 11.3 10.8 16.7 9.3 12.1 2.4 7.5 8.0 2.4 3.2 14.2 4.4 3.1 9.6 18.9 21.5 7.5 10.3 13.5 14.8 2.1 13.6 12.6 3.5 18.4 14.5 8.9 5.9 6.6 7.3 8.1 11.7 7.3 6.3 13.5 12.9 6.5 5.6 10.1 16.3 12.3 11.9 4.3 16.1 25.5 6.2 8.2 6.5 0.5 0.4 0.3 2.8 1.8 4.0 0.8 2.4 3.5 2.2 0.6 3.8 3.6 0.3 5.6 0.5 3.1 3.7 0.8 4.7 7.4 20.0 8.6 5.4 2.8 3.3 4.4 3.3 4.4 0.0 1.0 0.0 7.0 7.3 7.4 2.4 0.0 4.0 7.9 1.8 9.8 11.4 5.0 3.5 302.5 5.2 0.9 0.0 1.8 20.4 5.5 6.6 2.3 2.9 4.3 11.1 3.4 1.8 1.8 78.4 4.4 2.4 1.7 1.0 2.8 2.4 2.2 1.1 2.5 5.0 9.8 6.5 6.6 37.0 52.7 7.8 7.4 1.8 3.9 10.9 SYNJ2BP Arip2 ENSG00000213463 "Synaptojanin 2 binding protein" P57105 14 70366496-70417061 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000866 Approved Supported Approved Mitochondria NA NA Mitochondria "HPA000866: AB_2276678" "unprognostic (2.68e-1)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (3.31e-1)" "unprognostic (1.28e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.60e-2)" "unprognostic (5.70e-2)" "unprognostic (6.14e-2)" "unprognostic (6.35e-3)" "unprognostic (1.44e-2)" "prognostic favorable (1.11e-16)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (5.35e-3)" "unprognostic (1.14e-2)" 12.0 13.8 10.8 8.2 13.0 1.7 11.2 15.8 13.7 11.8 20.1 14.1 14.1 21.0 12.5 10.4 16.3 9.5 11.7 15.7 10.5 8.9 32.0 25.9 10.4 6.8 11.0 6.4 10.3 11.0 28.9 22.2 12.0 13.4 15.3 16.7 11.6 13.2 15.0 27.4 6.7 32.2 15.2 12.4 11.3 16.8 16.9 9.9 7.0 16.9 14.4 7.9 15.4 9.1 4.6 5.1 0.6 5.3 3.8 7.4 1.9 9.7 6.3 11.1 7.4 8.6 10.0 7.8 7.5 7.9 5.4 6.1 6.1 9.2 0.0 7.3 8.7 5.4 8.4 11.1 8.2 12.8 1.3 5.6 3.6 9.7 7.9 7.6 0.0 1.2 7.7 6.8 6.7 3.8 9.6 11.7 4.2 2.1 2.0 9.6 7.0 5.0 1.5 8.1 9.8 7.7 6.3 16.1 2.7 11.7 14.8 8.1 14.2 10.4 8.7 6.1 7.5 16.3 2.5 12.8 12.9 9.0 4.9 6.1 2.7 10.3 0.0 11.4 1.2 10.6 0.6 5.3 0.1 4.3 5.1 4.9 4.6 5.2 5.0 5.1 3.9 7.4 5.9 0.6 3.8 3.3 3.2 3.9 1.9 10.8 13.0 15.8 13.7 10.5 8.9 11.0 6.4 13.4 9.9 35.7 36.9 17.6 23.9 5.4 40.6 75.0 53.5 22.7 35.2 71.5 76.6 33.0 119.3 39.0 15.9 38.3 52.7 0.0 34.4 27.1 19.9 26.7 9.2 42.3 21.8 28.6 19.0 31.3 22.7 5.4 28.1 19.1 13.5 30.7 45.5 35.5 32.5 35.1 38.9 59.1 83.2 25.8 20.2 26.1 10.2 4.3 9.2 29.8 56.5 28.8 SYNJ2BP-COX16 ENSG00000258644 "SYNJ2BP-COX16 readthrough" 14 70326064-70417074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Club cells: 1.2;Distal tubular cells: 1.7;Early spermatids: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000866, HPA062659" Approved Supported Approved Mitochondria NA NA Mitochondria "HPA000866: AB_2276678, HPA062659: AB_2684823" "unprognostic (9.44e-2)" "unprognostic (2.42e-1)" "unprognostic (4.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (8.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.96e-2)" "unprognostic (3.00e-1)" "unprognostic (2.21e-2)" "unprognostic (6.41e-2)" "unprognostic (6.73e-4)" "unprognostic (6.68e-2)" "unprognostic (6.93e-2)" "unprognostic (2.55e-1)" "unprognostic (2.12e-2)" 5.5 7.1 3.8 4.7 5.7 7.7 5.7 7.1 7.4 5.1 9.3 6.2 6.2 8.2 4.3 4.3 7.4 2.1 5.4 7.0 3.9 15.4 12.3 4.1 4.9 3.4 2.3 4.7 14.0 0.9 10.4 5.2 5.9 6.9 3.6 5.0 3.4 6.7 30.7 2.5 15.5 6.8 3.6 5.4 7.3 16.3 4.1 2.6 7.7 6.4 3.1 6.9 1.6 16.2 18.2 11.1 13.4 18.3 15.8 13.5 18.5 3.4 15.1 10.0 2.4 1.9 10.4 13.4 4.8 6.0 4.1 1.4 19.3 2.2 8.7 3.3 9.0 9.8 1.8 1.8 7.1 0.4 2.0 6.1 6.1 2.5 3.2 3.6 9.8 3.2 1.6 4.5 2.5 9.5 3.5 15.4 2.3 10.4 2.4 3.2 19.9 7.1 15.2 12.4 2.7 14.0 10.0 2.7 3.7 9.8 9.7 7.8 8.0 20.4 14.0 9.8 21.1 13.9 7.7 13.3 33.7 12.4 5.7 13.4 7.2 12.0 15.3 4.0 14.8 11.1 12.1 0.9 11.8 13.4 12.9 16.2 15.6 12.4 14.8 15.7 13.8 14.4 0.4 18.3 8.9 18.2 15.8 13.5 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.3 1.7 0.2 1.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.7 0.2 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.3 0.0 TACO1 CCDC44 ENSG00000136463 "Translational activator of cytochrome c oxidase I" Q9BSH4 17 63600872-63608365 "Disease related genes, Predicted intracellular proteins" "Translation regulation" Activator "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 76.5;Proximal tubular cells: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021626, HPA021643, HPA024294" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150" "unprognostic (1.26e-1)" "unprognostic (2.92e-2)" "unprognostic (4.55e-3)" "unprognostic (9.82e-2)" "unprognostic (1.30e-1)" "unprognostic (9.30e-3)" "unprognostic (2.83e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (7.38e-2)" "prognostic favorable (3.73e-4)" "unprognostic (1.35e-1)" "unprognostic (4.12e-3)" "unprognostic (5.21e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" 8.3 11.3 8.7 6.3 11.1 4.9 6.9 6.4 14.2 5.9 12.1 7.6 6.2 13.0 7.6 7.2 7.5 6.7 10.1 21.2 7.6 8.6 20.7 42.5 7.0 7.3 9.3 7.2 6.0 10.7 8.3 5.7 7.5 9.3 6.4 11.4 8.1 11.4 6.9 37.5 6.1 15.7 6.9 6.5 7.3 8.0 8.1 6.2 8.7 8.7 15.9 8.1 6.3 5.1 8.9 9.9 7.9 8.1 16.6 13.6 7.9 17.3 27.4 8.8 9.1 7.7 11.1 11.8 12.7 12.1 25.7 20.5 18.0 10.4 14.3 9.8 14.6 17.9 16.0 19.3 18.6 24.3 7.6 26.9 14.1 14.0 31.4 21.3 16.6 9.9 13.5 13.0 22.2 23.6 9.6 13.3 11.0 19.1 10.9 12.0 31.3 19.3 12.6 7.6 18.8 28.5 12.2 21.7 17.9 15.0 12.2 13.5 14.8 8.7 29.0 24.2 12.1 24.1 13.0 11.7 18.4 13.9 12.5 22.4 11.9 11.6 17.0 14.0 11.4 13.3 2.1 8.1 7.9 9.5 7.5 10.6 7.1 13.6 9.5 9.9 8.9 12.8 10.3 1.4 16.6 6.6 6.4 9.0 7.9 8.7 11.1 6.4 14.2 7.6 8.6 9.3 7.2 9.3 6.2 3.0 4.6 12.3 7.4 2.3 7.5 50.4 10.2 6.7 5.7 14.0 2.0 28.9 46.4 24.0 12.5 12.8 41.2 0.0 23.8 23.1 9.4 8.0 9.2 76.5 23.2 6.4 13.3 10.4 10.3 37.7 10.9 8.5 10.1 29.7 21.7 13.2 23.6 24.1 10.6 101.0 10.4 19.4 9.0 23.2 15.5 3.8 16.6 11.5 31.0 5.7 TAOK3 "DPK, JIK, MAP3K18" ENSG00000135090 "TAO kinase 3" Q9H2K8 12 118149801-118372945 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 324.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017160 Approved Uncertain Mitochondria NA NA Mitochondria "HPA017160: AB_1851994" "unprognostic (3.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.65e-1)" "unprognostic (3.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "unprognostic (7.38e-2)" "unprognostic (2.76e-2)" "unprognostic (8.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.08e-2)" "unprognostic (4.14e-3)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" 14.6 16.2 31.9 24.1 31.0 30.8 14.6 44.3 33.5 11.6 21.2 17.2 10.3 23.1 15.2 11.4 16.0 9.8 16.9 15.1 27.8 31.7 14.0 15.3 19.4 26.3 25.7 20.8 17.5 10.9 20.2 23.6 11.9 20.7 25.6 21.3 12.0 13.6 14.6 18.5 17.0 31.6 15.3 23.7 24.2 20.9 8.9 28.6 28.3 18.1 9.9 26.9 18.5 18.3 20.9 22.4 38.2 37.8 36.4 27.8 17.1 8.3 5.8 4.3 3.8 10.7 13.1 4.9 8.8 10.0 5.1 6.7 2.9 13.0 25.6 2.9 11.7 7.4 7.6 3.7 7.8 8.0 9.2 3.2 30.2 2.9 3.8 12.5 30.9 42.6 8.8 9.4 16.1 23.7 10.8 16.3 15.3 17.5 3.0 9.3 5.9 16.3 20.3 1.7 3.9 3.1 9.5 5.9 2.7 4.8 14.5 0.8 4.3 8.1 3.7 11.2 2.0 7.6 23.2 25.3 8.8 1.5 8.2 7.5 2.9 2.8 20.3 12.5 21.4 11.8 38.2 17.0 37.6 27.8 23.3 26.2 20.9 21.2 24.1 22.4 19.3 18.8 24.5 37.7 36.4 37.8 20.9 19.3 17.1 31.9 31.0 44.3 33.5 27.8 31.7 25.7 20.8 20.7 28.6 32.8 78.2 81.8 42.2 31.3 72.1 47.4 63.7 6.7 30.7 43.6 200.3 29.7 59.7 35.4 11.4 29.2 94.6 23.3 52.0 83.1 34.9 47.7 159.8 52.0 71.7 38.1 24.1 26.4 84.7 8.2 35.9 117.0 33.7 141.5 60.6 40.4 64.9 98.2 44.9 27.2 324.3 45.3 40.5 20.5 22.8 27.5 36.6 86.3 58.2 47.4 TBC1D32 "bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235" ENSG00000146350 "TBC1 domain family member 32" Q96NH3 6 121079494-121334745 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.4" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 111.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013413 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013413: AB_10602702" "unprognostic (3.31e-2)" "unprognostic (1.28e-1)" "unprognostic (9.12e-3)" "unprognostic (4.82e-2)" "unprognostic (2.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.60e-4)" "unprognostic (7.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (8.14e-2)" "unprognostic (2.01e-2)" "unprognostic (3.73e-2)" "unprognostic (1.57e-2)" "unprognostic (7.62e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 3.2 7.3 7.3 5.5 8.8 2.4 5.0 3.9 11.1 5.7 3.5 4.8 3.8 4.5 5.1 4.1 4.1 4.8 5.6 3.5 7.0 4.1 4.5 1.8 3.2 3.0 8.1 7.8 6.5 4.0 9.7 25.4 8.2 8.0 5.0 2.4 4.2 4.6 3.2 1.7 5.5 4.6 2.4 7.0 3.1 3.8 9.2 7.9 8.1 7.0 2.1 3.2 3.7 5.1 6.4 10.7 5.8 1.3 3.4 3.7 0.4 1.6 2.0 3.2 4.2 2.9 4.4 1.6 1.8 2.7 3.1 4.6 0.1 1.1 2.9 3.1 2.0 4.7 1.5 1.5 1.6 3.8 22.0 2.1 3.7 0.6 0.7 1.3 1.8 1.5 1.7 1.1 2.9 2.0 3.7 0.6 3.7 2.1 0.0 2.4 1.0 2.1 1.1 1.9 1.0 0.7 1.8 1.6 0.3 1.7 0.8 6.6 3.3 2.3 1.3 1.0 1.8 2.0 1.5 0.4 2.1 2.1 0.5 2.1 1.5 0.0 1.3 2.8 1.0 3.2 5.8 1.3 1.7 2.6 0.7 1.9 3.4 1.9 1.8 0.8 6.4 3.7 2.8 1.1 3.4 1.1 10.7 2.1 0.4 7.3 8.8 3.9 11.1 7.0 4.1 8.1 7.8 8.0 7.9 3.0 5.9 1.5 3.2 5.5 27.8 2.9 5.1 24.1 13.6 7.0 41.2 3.8 0.0 2.2 3.4 3.2 4.2 0.0 1.9 1.3 6.1 2.8 3.5 1.0 1.2 12.7 5.2 3.7 1.3 2.1 2.3 3.3 1.7 1.0 5.2 5.8 0.9 3.5 1.8 1.0 111.1 0.0 3.1 12.6 7.9 4.4 1.9 3.2 2.8 1.8 TBRG4 "Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948" ENSG00000136270 "Transforming growth factor beta regulator 4" Q969Z0 7 45100100-45112047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020582, HPA050430" Approved Enhanced Mitochondria NA NA Mitochondria "HPA020582: AB_1857804, HPA050430: AB_2681125" "unprognostic (2.22e-1)" "unprognostic (4.75e-2)" "unprognostic (1.19e-1)" "unprognostic (3.46e-3)" "unprognostic (1.41e-2)" "unprognostic (9.29e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (3.15e-2)" "unprognostic (1.86e-1)" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (1.25e-2)" "unprognostic (3.66e-3)" "unprognostic (3.91e-2)" "unprognostic (3.84e-2)" "unprognostic (3.30e-1)" "unprognostic (1.52e-1)" 13.7 16.8 10.8 16.0 15.6 14.9 13.0 12.9 22.1 10.5 20.8 15.6 14.1 21.8 14.2 8.2 20.1 12.8 12.4 26.2 9.8 10.0 20.9 27.7 10.5 17.0 10.6 8.9 15.6 16.9 11.3 10.1 16.2 14.7 13.6 14.1 10.8 14.2 12.4 42.6 16.9 17.8 13.9 9.9 16.2 14.0 22.5 9.5 15.0 13.8 23.7 20.3 14.5 13.3 15.8 20.1 10.9 24.2 9.7 21.0 17.5 13.0 30.4 9.7 21.3 8.8 8.2 19.6 10.6 9.8 20.6 17.1 32.9 18.4 25.0 16.4 10.8 28.5 34.2 22.6 24.2 10.5 12.9 21.1 17.1 19.9 22.4 14.7 19.5 17.7 10.8 22.5 19.6 14.1 7.3 12.6 21.5 47.4 12.6 12.6 22.0 19.8 44.7 30.8 29.3 24.3 17.6 12.5 36.4 12.1 13.4 19.3 18.3 10.8 60.2 20.9 13.2 26.8 32.5 9.8 15.3 18.5 9.3 17.2 22.7 22.6 36.5 14.1 28.1 34.4 7.4 13.3 10.9 18.4 24.2 17.6 15.8 15.4 17.8 20.1 12.3 21.0 19.9 1.0 9.7 20.4 7.5 14.6 17.5 10.8 15.6 12.9 22.1 9.8 10.0 10.6 8.9 14.7 9.5 3.0 18.9 26.9 23.8 31.1 14.5 24.1 15.3 5.3 9.1 19.2 0.0 53.3 36.5 29.7 12.3 11.7 28.7 0.0 16.1 61.7 16.9 15.1 13.9 27.7 30.7 11.1 21.4 10.4 12.6 14.5 15.3 17.8 16.9 45.9 30.0 14.0 25.4 21.0 11.0 36.6 12.9 12.9 19.4 46.1 32.2 25.6 40.0 17.0 44.5 25.9 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039016-68050895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 102.9;Kupffer cells: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 40.6;RPMI-8226: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria NA NA Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favorable (9.45e-6)" 25.8 24.1 5.0 20.1 7.2 39.5 10.2 1.3 5.4 20.1 21.8 3.9 19.9 20.1 14.1 27.1 11.9 12.5 16.4 5.9 2.4 1.6 8.9 25.2 24.1 20.7 7.1 2.2 11.4 69.6 2.6 4.7 14.4 6.9 15.7 4.1 6.8 18.3 11.0 3.5 5.2 25.8 10.8 7.7 44.7 17.4 4.2 5.5 7.5 11.7 8.3 24.3 13.0 13.4 3.3 13.4 40.4 36.8 8.2 4.9 10.7 9.2 17.1 0.2 0.0 7.9 6.2 12.0 18.4 9.0 5.3 5.0 0.3 27.8 0.8 10.1 6.5 8.1 11.7 1.1 7.1 1.1 24.1 0.5 6.4 20.8 5.5 7.3 4.7 40.6 7.2 4.1 6.5 0.4 0.0 3.6 0.3 3.3 2.5 1.7 3.1 0.2 28.2 1.0 13.2 4.3 7.9 0.3 40.4 5.0 5.2 0.9 0.2 7.8 10.2 5.0 1.9 11.1 12.1 12.6 10.3 8.1 28.6 3.3 0.4 0.3 1.3 23.0 7.9 4.9 5.5 16.6 18.8 4.5 28.8 3.7 3.3 3.4 4.9 13.4 2.2 2.0 2.1 40.4 8.2 36.8 9.0 3.3 10.7 5.0 7.2 1.3 5.4 2.4 1.6 7.1 2.2 6.9 5.5 26.8 66.3 28.6 11.5 5.6 0.7 1.2 17.8 29.4 27.3 7.0 0.0 18.1 0.0 29.8 0.3 15.8 46.0 0.0 58.5 45.5 19.9 9.3 48.5 16.3 102.9 0.0 23.0 17.8 127.9 0.2 5.5 82.1 5.0 46.9 25.2 0.9 44.8 87.7 12.4 2.1 0.7 38.8 16.5 0.1 3.0 4.5 22.2 49.4 25.3 17.1 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906820 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria No No Mitochondria "HPA023788: AB_1848818, HPA053044: AB_2682023" "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 7.0 9.6 11.8 10.2 13.7 4.0 11.1 23.3 16.6 7.5 8.1 7.4 7.2 10.6 8.6 9.6 9.7 7.6 6.8 12.7 10.1 6.9 13.0 12.3 6.9 10.0 15.4 8.5 10.5 7.3 10.8 16.8 10.4 10.6 10.6 10.3 8.6 7.9 10.4 7.7 8.5 9.1 9.6 11.0 13.7 7.4 5.7 13.3 8.6 10.7 6.7 9.8 7.9 11.8 6.7 6.4 4.9 10.0 4.3 6.7 4.8 6.1 9.9 5.9 7.4 4.6 6.0 5.1 6.1 5.1 13.7 11.4 6.5 2.9 7.9 6.0 4.5 7.2 8.7 10.9 4.4 11.9 2.5 13.6 3.8 9.9 6.5 4.9 6.9 4.9 4.5 5.2 7.8 3.0 3.7 5.8 5.5 8.5 7.1 9.0 4.4 5.9 10.1 4.4 7.1 5.1 3.1 10.4 6.2 10.2 5.8 10.1 3.0 5.5 4.4 5.2 5.7 9.9 4.7 4.0 5.3 6.3 6.0 5.8 3.4 5.7 5.5 4.2 5.7 5.2 3.5 6.6 4.9 4.6 10.0 5.8 6.7 5.6 4.2 6.4 6.4 6.7 6.6 1.9 4.3 7.3 5.8 5.7 4.8 11.8 13.7 23.3 16.6 10.1 6.9 15.4 8.5 10.6 13.3 14.9 11.7 4.2 7.2 3.7 18.6 4.4 10.2 17.4 9.1 8.7 7.9 22.7 21.6 11.8 8.8 6.8 5.1 0.0 7.5 14.1 6.6 4.6 4.7 9.0 17.4 15.9 5.2 12.3 9.1 4.4 7.5 10.2 6.8 14.4 6.2 17.1 10.5 5.8 7.1 13.4 18.2 19.4 8.4 23.6 17.0 3.8 14.9 5.4 7.3 3.5 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385022-58399221 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 617.4;Late spermatids: 619.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favorable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favorable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 19.3 21.2 11.1 21.0 12.1 28.5 15.3 15.4 13.9 16.8 21.0 7.7 12.5 17.6 20.7 12.1 17.4 15.3 11.0 15.9 10.2 11.2 22.4 31.4 11.5 21.5 12.5 10.7 18.4 14.3 12.3 23.9 22.2 12.9 17.2 14.7 9.2 16.3 10.6 21.7 10.2 18.7 16.1 10.8 21.0 14.5 40.2 11.6 35.4 22.2 14.8 18.4 16.6 11.8 13.1 14.1 7.2 9.5 14.3 13.1 6.8 21.5 12.3 13.9 14.4 4.1 5.1 15.9 9.8 9.8 12.3 13.8 43.3 23.2 43.0 14.4 4.5 9.3 16.9 25.4 13.8 19.6 18.3 22.6 16.3 9.4 16.1 6.4 41.2 13.4 5.1 6.4 15.0 13.8 5.9 10.6 12.9 38.4 19.9 8.6 11.8 32.6 16.2 26.3 9.9 12.9 26.0 30.0 19.3 7.6 14.6 18.6 12.8 19.6 27.4 24.1 11.9 29.7 12.3 8.1 9.2 29.4 10.5 26.3 20.2 30.8 54.2 11.8 31.8 6.9 1.0 9.5 3.7 8.5 9.0 11.0 12.2 10.3 8.9 11.5 13.1 13.1 10.4 7.2 14.3 7.2 14.1 8.5 6.8 11.1 12.1 15.4 13.9 10.2 11.2 12.5 10.7 12.9 11.6 50.6 24.7 36.3 36.6 44.5 22.3 31.1 43.3 37.5 61.4 19.2 15.7 83.2 74.6 32.4 617.4 32.7 10.6 23.3 38.6 59.4 34.2 33.1 27.8 54.6 37.5 36.5 14.9 23.9 17.8 619.6 38.3 33.8 21.9 26.2 34.1 37.2 30.5 21.0 29.0 61.4 19.4 25.8 30.9 42.9 56.9 47.8 43.8 30.2 47.6 24.4 TFB2M "FLJ22661, FLJ23182, Hkp1" ENSG00000162851 "Transcription factor B2, mitochondrial" Q9H5Q4 1 246540560-246566324 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028482, HPA028554, HPA030265" Approved Enhanced Mitochondria NA NA Mitochondria "HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209" "unprognostic (4.38e-2)" "unprognostic (2.45e-2)" "unprognostic (3.79e-3)" "unprognostic (5.63e-2)" "unprognostic (1.10e-1)" "unprognostic (8.13e-2)" "unprognostic (8.76e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-2)" "unprognostic (1.68e-2)" "unprognostic (2.46e-1)" "unprognostic (6.81e-2)" "unprognostic (5.26e-2)" "unprognostic (2.27e-1)" "unprognostic (9.44e-2)" "unprognostic (6.41e-2)" "unprognostic (3.53e-2)" 10.6 23.1 4.2 7.2 8.4 15.5 9.0 8.4 9.9 7.0 8.9 6.5 9.4 8.2 9.5 7.2 9.5 6.9 8.5 11.3 4.3 5.5 15.5 42.3 5.9 8.7 4.8 5.7 6.5 19.7 5.6 7.8 10.5 7.6 8.9 9.6 5.9 13.6 8.9 21.4 8.7 10.3 6.8 6.5 9.0 9.6 8.7 5.7 13.0 15.6 7.3 12.0 9.1 6.5 10.6 11.0 1.2 7.5 12.6 10.4 4.5 12.6 12.2 4.7 8.4 5.9 8.5 16.6 9.3 9.6 10.6 9.8 14.8 12.3 22.7 14.6 9.4 6.9 11.0 11.4 9.9 14.7 8.8 4.4 11.5 7.5 13.0 9.8 20.2 10.4 8.4 11.9 9.1 10.3 5.8 8.2 8.1 33.1 7.8 9.1 5.9 10.2 9.1 21.1 22.2 12.5 10.2 9.4 27.5 9.6 14.0 10.5 21.3 9.0 16.4 30.8 5.5 11.9 19.5 6.0 7.4 9.0 10.4 24.3 22.6 37.7 17.9 9.1 20.0 9.3 0.2 4.7 1.2 8.4 4.8 10.4 10.6 7.5 8.8 11.0 10.4 9.6 8.2 1.0 12.6 7.5 9.5 10.3 4.5 4.2 8.4 8.4 9.9 4.3 5.5 4.8 5.7 7.6 5.7 6.0 6.5 9.3 11.9 47.4 3.0 15.1 2.5 8.1 17.0 15.7 9.8 20.8 24.9 11.2 1.0 11.7 6.8 0.0 13.3 23.0 10.8 10.8 13.9 32.0 10.9 0.0 10.9 6.2 9.7 1.9 6.1 7.6 5.0 5.4 12.1 4.5 9.1 8.6 4.2 28.3 3.6 12.9 16.0 7.2 22.3 39.3 17.6 8.7 19.0 9.2 THAP9 FLJ34093 ENSG00000168152 "THAP domain containing 9" Q9H5L6 4 82900684-82919969 "Predicted intracellular proteins, Transcription factors" "DNA integration, DNA recombination" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 33.8;Late spermatids: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037420, HPA037421" Uncertain Approved Mitochondria No No Mitochondria "HPA037420: AB_2675467, HPA037421: AB_10673631" "unprognostic (7.54e-3)" "unprognostic (8.52e-2)" "unprognostic (4.14e-2)" "unprognostic (1.51e-2)" "unprognostic (2.06e-1)" "unprognostic (1.18e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (1.17e-1)" "unprognostic (2.30e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-2)" "prognostic favorable (3.50e-5)" "unprognostic (1.39e-1)" "unprognostic (1.62e-1)" "unprognostic (4.64e-3)" "unprognostic (8.74e-4)" 3.5 4.0 6.1 4.8 11.4 4.2 7.6 5.6 7.8 4.9 3.7 5.0 6.8 3.6 5.9 8.8 3.4 4.4 3.4 5.9 7.0 5.5 7.3 7.4 4.6 3.9 11.8 4.3 7.9 6.1 8.5 10.3 5.9 7.5 6.0 4.1 3.0 6.6 10.5 20.5 4.2 3.9 3.7 8.8 3.7 3.5 14.0 13.4 6.0 9.8 5.9 3.9 4.6 5.2 3.7 2.6 0.3 4.0 1.5 3.5 1.7 1.5 2.1 8.2 4.5 2.5 3.0 5.7 1.5 2.6 1.6 1.5 3.1 2.8 8.6 2.9 2.1 3.0 2.0 6.4 2.6 2.0 3.3 2.4 3.7 3.2 4.0 2.9 3.4 3.0 3.1 4.2 0.8 4.0 2.5 2.5 7.1 3.2 5.9 2.0 2.1 8.1 4.1 6.5 3.0 1.2 7.5 3.4 5.0 2.9 1.8 6.8 4.7 3.1 4.2 5.6 7.1 2.6 3.0 1.6 2.1 2.3 1.6 1.1 3.9 1.7 8.4 2.5 2.0 3.1 0.0 2.3 0.3 1.6 4.0 2.0 3.7 1.1 1.4 2.6 3.1 3.5 2.9 0.1 1.5 2.7 1.7 0.6 1.7 6.1 11.4 5.6 7.8 7.0 5.5 11.8 4.3 7.5 13.4 3.0 2.2 0.5 2.6 0.7 2.1 5.0 0.0 1.4 2.3 1.8 5.9 2.7 0.0 1.3 33.8 1.5 1.1 0.0 2.2 1.8 1.1 2.3 1.1 0.9 1.1 0.0 2.9 1.3 0.8 43.1 1.7 1.8 0.0 1.0 1.5 4.1 0.9 0.0 0.0 2.1 4.6 6.5 1.2 4.8 5.3 1.5 2.7 0.0 1.4 1.4 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528463-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria NA NA Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 22.2 19.5 29.1 16.7 28.5 18.3 27.4 14.8 34.3 16.6 21.6 17.1 25.9 16.8 13.7 29.1 20.2 16.0 15.4 25.2 25.1 22.7 26.7 41.3 13.1 25.1 27.2 24.6 13.0 25.8 18.3 14.3 13.8 19.9 14.4 23.1 15.8 23.8 20.2 32.3 15.3 12.4 17.2 21.0 20.1 15.9 20.5 16.1 18.4 18.5 25.9 29.8 13.6 12.1 45.1 38.8 5.9 22.6 16.5 33.4 32.4 27.1 41.5 19.5 18.7 17.0 14.5 24.7 23.3 18.8 37.3 21.3 30.5 23.9 51.8 26.9 20.7 32.6 20.9 27.7 27.1 33.8 17.6 20.5 32.8 15.9 39.3 18.0 43.0 37.1 13.6 22.0 36.1 25.2 9.9 23.0 34.6 36.3 23.7 27.3 57.9 23.1 57.6 20.5 23.7 44.7 38.9 41.2 45.2 18.9 18.9 15.9 20.4 24.6 49.1 29.8 20.1 36.7 16.5 14.4 21.5 40.3 36.9 44.7 33.2 43.4 41.7 19.9 21.7 35.8 5.9 22.6 5.0 19.9 21.4 22.8 45.1 24.5 21.9 38.7 41.9 33.4 29.1 1.3 16.5 19.8 38.8 21.3 32.4 29.1 28.5 14.8 34.3 25.1 22.7 27.2 24.6 19.9 16.1 11.9 8.3 59.6 36.7 109.2 16.9 112.2 84.1 14.7 31.8 41.8 3.9 61.1 179.1 67.1 101.9 57.3 85.0 70.0 108.7 85.9 56.1 50.4 51.9 191.0 112.4 7.9 25.9 41.1 52.6 211.2 42.8 77.1 77.6 106.4 36.8 30.6 73.4 48.9 48.1 130.8 11.8 12.9 87.7 92.4 50.6 113.3 33.1 41.5 65.1 45.8 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972449-46003734 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031408 Approved Supported Mitochondria NA NA Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favorable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 5.7 4.6 1.2 6.8 3.8 6.0 13.6 4.1 8.6 2.6 4.2 1.5 5.8 6.1 2.9 7.3 4.2 2.4 3.2 11.5 5.3 6.6 8.3 4.8 9.9 1.6 2.5 2.2 2.8 3.0 3.4 8.1 5.5 3.4 4.1 2.6 7.5 5.2 16.2 2.4 3.5 3.6 2.2 2.5 2.8 17.2 1.4 4.5 4.5 4.0 4.4 3.3 1.7 29.5 39.7 18.5 45.3 26.7 29.8 39.6 40.7 43.0 28.6 28.8 23.8 22.3 27.9 33.7 40.5 41.1 43.7 54.2 32.5 36.5 28.0 35.4 29.5 35.2 43.6 36.0 40.8 27.0 43.0 23.3 32.3 58.2 38.4 43.2 26.1 26.7 32.2 35.1 50.0 17.1 37.9 31.9 41.1 20.6 36.0 40.8 38.5 60.1 34.5 30.2 13.4 29.9 27.6 26.7 46.1 28.6 33.6 30.9 18.7 41.7 33.7 23.1 44.1 25.9 27.8 19.9 34.7 25.4 47.9 22.1 36.4 51.3 37.0 62.6 16.5 15.7 35.6 18.5 28.0 45.3 28.7 29.5 27.1 29.8 39.7 27.9 24.6 27.2 8.2 26.7 39.3 32.8 29.6 39.6 8.9 17.4 24.2 12.4 19.5 13.0 86.5 30.6 28.1 19.4 12.2 7.9 39.3 38.1 39.5 62.9 13.7 15.7 23.3 26.2 38.0 14.2 16.2 26.6 23.3 30.2 0.0 9.8 17.8 17.5 15.7 16.4 18.4 21.9 33.3 15.8 22.1 29.8 14.0 11.0 47.3 9.2 6.5 16.5 85.7 48.5 18.9 29.7 13.8 23.3 16.0 TIMM44 TIM44 ENSG00000104980 "Translocase of inner mitochondrial membrane 44" O43615 19 7926718-7943920 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043052, HPA073108" Supported Enhanced Mitochondria NA NA Mitochondria "HPA043052: AB_10795713, HPA073108: " "unprognostic (1.75e-1)" "unprognostic (7.44e-3)" "unprognostic (2.68e-2)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-2)" "unprognostic (5.81e-3)" "unprognostic (8.78e-2)" "unprognostic (2.42e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (8.93e-2)" "unprognostic (1.80e-2)" "unprognostic (6.01e-2)" "unprognostic (6.43e-2)" "unprognostic (2.07e-2)" "unprognostic (4.18e-2)" 12.8 15.3 11.8 13.0 12.4 7.5 12.7 16.2 17.2 10.8 15.3 8.5 14.1 16.1 12.1 11.8 19.4 10.8 12.6 39.2 12.9 10.3 13.5 19.7 9.0 9.2 11.7 7.7 13.8 20.2 7.4 10.3 8.9 12.3 10.8 6.3 8.5 17.3 21.4 48.8 12.6 10.5 17.7 9.0 12.2 12.2 9.4 11.6 5.8 12.5 26.6 8.8 13.0 9.4 9.0 16.2 10.1 12.2 9.6 12.1 8.4 18.5 10.8 5.8 10.2 10.1 9.4 8.5 11.2 9.1 15.5 14.1 23.8 4.0 27.2 12.9 9.3 12.4 13.0 23.8 12.5 3.9 12.7 36.2 13.6 9.2 20.0 24.8 16.3 5.7 11.0 16.1 13.2 16.4 5.3 9.8 17.5 25.0 9.7 6.7 18.8 14.2 10.7 16.8 17.9 46.0 15.0 8.3 12.7 6.8 12.0 13.9 7.2 9.9 13.5 31.7 5.2 8.3 15.9 5.2 7.4 11.6 18.7 21.1 19.1 24.0 26.4 5.2 23.7 12.5 10.1 11.7 3.7 12.1 12.2 10.7 8.7 11.1 11.2 16.2 9.0 10.7 10.4 0.6 9.6 7.2 13.2 9.4 8.4 11.8 12.4 16.2 17.2 12.9 10.3 11.7 7.7 12.3 11.6 32.8 13.1 36.5 29.5 24.7 51.6 31.9 30.6 10.7 12.5 27.9 39.3 33.9 56.3 37.7 8.0 22.3 35.7 0.0 36.8 32.1 23.8 24.1 32.3 52.9 31.0 49.3 38.5 21.5 16.7 9.9 33.9 18.0 20.3 11.8 35.3 22.0 38.9 24.6 27.6 29.0 55.4 32.3 29.2 35.1 33.3 17.3 27.2 20.3 48.5 25.1 TIMM8A "DDP, DFN1, MTS" ENSG00000126953 "Translocase of inner mitochondrial membrane 8A" O60220 X 101345659-101349196 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Deafness, Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 90.8;Suprabasal keratinocytes: 77.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 76.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003628 Supported Supported Mitochondria NA NA Mitochondria "HPA003628: AB_1080284" "prognostic unfavorable (7.89e-5)" "unprognostic (1.36e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (8.87e-5)" "unprognostic (2.06e-1)" "unprognostic (9.28e-3)" "unprognostic (5.14e-3)" "unprognostic (8.32e-2)" "unprognostic (1.90e-2)" "unprognostic (1.86e-3)" "unprognostic (6.41e-2)" "unprognostic (8.57e-3)" "prognostic favorable (1.69e-4)" "unprognostic (1.14e-2)" "unprognostic (7.75e-2)" "unprognostic (1.70e-1)" "unprognostic (3.86e-2)" 6.8 6.9 7.6 7.5 12.2 7.0 8.0 5.2 13.3 5.6 7.8 6.1 3.1 6.9 6.5 5.7 10.4 6.2 4.1 11.8 7.6 7.2 12.1 27.7 4.9 8.4 8.6 8.2 7.2 17.0 5.5 4.5 6.9 11.9 7.5 8.6 5.7 6.7 4.2 10.1 8.1 7.4 5.4 6.1 6.3 5.6 4.0 6.5 6.5 7.1 16.4 9.4 4.9 6.5 14.1 11.6 1.9 5.3 5.8 11.1 4.8 10.8 9.5 5.4 10.1 4.2 4.6 7.1 7.6 3.7 6.8 13.6 8.5 6.8 11.2 10.3 5.8 11.4 8.5 14.3 8.3 10.0 5.2 9.6 21.8 12.5 14.1 4.0 12.4 76.4 4.3 6.7 9.7 6.0 3.1 6.8 4.8 15.6 12.8 8.7 16.1 6.0 12.2 18.3 14.4 15.9 9.7 9.9 15.8 5.9 7.4 7.2 6.3 9.5 7.3 6.8 6.3 6.1 6.2 5.1 8.9 10.9 12.4 8.5 6.2 14.2 14.9 4.8 16.6 6.7 1.9 4.4 0.2 6.7 5.3 7.8 12.2 7.3 7.7 5.1 14.1 11.1 9.3 0.6 5.8 3.0 11.6 3.8 4.8 7.6 12.2 5.2 13.3 7.6 7.2 8.6 8.2 11.9 6.5 3.0 4.1 13.7 25.8 90.8 6.5 25.4 2.5 8.1 11.4 10.4 5.9 30.9 33.2 12.5 0.4 9.0 6.3 0.0 9.3 35.1 15.4 10.7 16.1 57.6 18.6 3.2 8.1 4.9 6.7 0.0 6.1 7.0 13.5 2.8 7.0 5.2 13.1 7.0 2.5 33.5 7.7 0.0 15.0 1.7 9.6 77.3 30.7 10.0 18.4 19.7 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408494-58427614 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria NA NA Mitochondria "HPA002932: AB_1080287" "prognostic favorable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 22.2 20.8 23.0 14.6 33.9 14.6 25.0 18.7 25.2 18.2 22.5 16.4 19.5 19.7 20.3 29.7 23.3 18.8 19.7 18.7 20.8 19.1 23.7 21.4 14.5 25.9 20.2 20.6 31.8 42.8 11.9 18.9 17.5 22.1 19.5 15.0 15.4 29.1 20.3 33.5 17.8 13.9 25.9 20.9 18.5 20.2 21.4 22.3 20.1 25.2 24.8 19.3 26.6 17.9 17.6 14.3 4.0 10.6 16.5 19.2 7.6 25.2 21.6 17.2 16.5 19.8 36.0 23.5 24.6 13.0 18.6 16.4 21.9 27.3 33.8 26.5 14.3 17.0 17.7 22.7 23.8 27.2 22.7 12.9 17.6 14.6 24.9 49.7 28.2 16.9 28.5 30.4 18.1 36.9 30.2 19.1 17.4 28.3 21.0 18.7 42.8 26.2 35.2 14.7 37.9 38.1 22.2 26.1 21.3 24.7 22.5 22.0 13.2 15.6 40.5 42.8 20.8 28.8 16.6 19.0 23.6 32.4 15.6 26.6 14.4 14.3 31.0 18.5 27.5 27.6 4.0 9.0 2.2 9.4 10.1 17.4 17.6 15.0 13.9 13.1 14.4 19.2 17.7 0.9 16.5 10.6 14.3 15.1 7.6 23.0 33.9 18.7 25.2 20.8 19.1 20.2 20.6 22.1 22.3 29.8 18.3 54.9 38.9 31.4 13.2 16.9 22.9 17.4 21.6 14.0 21.6 67.7 61.3 33.7 21.8 22.4 19.6 0.0 46.4 80.4 30.9 38.4 35.8 26.1 53.0 4.8 24.2 33.7 38.6 24.7 68.7 33.3 32.1 26.2 36.7 19.3 38.9 24.6 48.4 88.0 21.4 19.4 36.3 66.9 15.8 34.6 61.4 30.6 54.6 36.6 TMEM11 "C17orf35, PM1, PMI" ENSG00000178307 "Transmembrane protein 11" P17152 17 21197280-21214624 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051795, HPA062854" Uncertain Supported Mitochondria No No Mitochondria "HPA051795: AB_2681612, HPA062854: AB_2684882" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (1.13e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (3.55e-1)" "unprognostic (3.36e-3)" "unprognostic (1.45e-2)" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-2)" "unprognostic (1.40e-1)" "unprognostic (1.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.17e-2)" "unprognostic (4.61e-2)" 9.7 6.5 5.5 6.2 5.8 13.2 9.7 6.2 8.7 6.1 6.1 6.3 4.3 5.4 6.8 7.6 8.5 5.1 5.2 8.3 5.1 5.1 8.0 9.0 5.9 5.0 5.6 4.5 6.2 10.7 4.5 5.1 10.6 6.5 7.4 4.1 6.4 11.0 6.2 30.2 8.2 7.2 6.3 5.3 6.0 6.5 8.4 4.5 7.3 8.8 12.8 7.9 5.9 5.7 8.0 7.0 11.7 12.2 5.5 6.5 7.6 3.9 2.9 4.1 2.9 6.0 3.3 5.1 8.1 2.2 7.1 5.0 9.3 1.7 3.8 4.4 6.2 6.0 5.1 5.8 5.9 1.6 4.0 5.8 2.7 2.6 1.6 6.6 3.1 3.8 4.5 4.7 8.0 3.7 2.8 3.5 4.3 3.4 1.4 3.3 2.4 5.0 4.8 4.4 11.6 2.4 3.5 7.7 2.3 3.2 1.1 2.4 4.0 3.2 3.8 3.9 15.4 2.4 2.8 2.9 4.0 6.0 5.7 7.5 2.0 1.9 9.0 3.2 4.1 2.3 4.7 12.2 11.7 5.4 8.7 4.9 6.1 5.5 4.9 7.0 8.0 6.5 4.9 9.8 5.5 10.9 6.1 4.9 7.6 5.5 5.8 6.2 8.7 5.1 5.1 5.6 4.5 6.5 4.5 44.7 17.9 37.9 46.1 75.4 30.4 45.2 22.9 26.8 25.0 34.9 17.7 67.7 43.1 50.5 14.5 32.3 46.6 23.3 35.6 65.2 47.1 49.3 26.5 27.3 48.0 22.3 30.7 35.0 22.9 14.1 33.1 25.2 38.8 55.1 46.9 25.0 41.8 51.8 54.1 42.6 36.5 32.3 48.9 36.2 38.5 80.9 76.0 34.4 42.0 71.1 TMEM126B HT007 ENSG00000171204 "Transmembrane protein 126B" Q8IUX1 11 85628573-85636539 "Predicted membrane proteins" Chaperone "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014480, HPA019186" Uncertain Supported Mitochondria NA NA Mitochondria "HPA014480: AB_1858083, HPA019186: AB_1858084" "unprognostic (1.11e-1)" "unprognostic (4.97e-2)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (5.67e-1)" "unprognostic (1.44e-1)" "unprognostic (5.55e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (6.70e-3)" "unprognostic (4.42e-2)" "unprognostic (4.30e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (6.50e-2)" "unprognostic (5.86e-2)" "unprognostic (2.66e-2)" 15.5 17.0 28.9 13.5 28.0 6.4 22.1 26.7 33.2 19.7 21.2 12.2 15.5 21.7 21.9 35.4 16.5 15.9 19.1 26.2 27.2 31.7 27.5 19.9 16.5 18.9 28.7 25.7 15.9 15.3 13.9 28.0 14.6 28.8 19.8 20.0 14.2 16.8 16.6 15.7 15.1 20.8 24.2 24.9 19.3 18.9 11.7 27.0 15.1 22.6 17.5 18.8 20.8 14.3 14.0 14.9 12.5 13.2 15.8 19.6 11.5 13.8 11.4 13.0 6.1 24.5 19.6 4.1 12.3 13.5 9.8 15.0 31.7 14.1 14.7 27.2 10.4 11.0 16.8 20.7 12.7 9.3 20.4 18.7 11.2 20.2 13.9 13.9 27.3 13.8 14.3 16.2 14.9 18.2 15.8 15.0 18.5 26.5 12.2 24.3 17.8 10.8 33.8 14.0 47.8 18.9 9.4 9.7 12.4 19.3 15.6 11.8 7.3 11.6 9.5 12.0 17.4 19.2 16.9 7.8 15.0 10.6 37.9 12.9 5.7 31.9 17.9 7.6 22.2 7.9 12.5 11.7 5.7 15.4 13.2 19.6 14.0 19.1 18.4 14.9 12.9 19.1 18.9 4.5 15.8 9.6 13.4 18.3 11.5 28.9 28.0 26.7 33.2 27.2 31.7 28.7 25.7 28.8 27.0 20.8 31.8 41.0 29.3 23.2 28.2 69.0 56.0 48.2 33.0 38.4 13.7 35.1 142.6 63.7 3.8 48.7 36.2 0.0 43.2 44.9 49.7 26.1 41.5 37.6 71.4 22.3 33.3 35.0 32.1 5.6 61.5 48.5 69.2 48.7 36.7 41.5 48.0 50.1 83.1 128.5 25.6 38.8 51.5 30.7 40.3 32.2 21.1 60.8 44.7 37.9 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924463-60937159 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.1" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 240.0;Muller glia cells: 177.4;Rod photoreceptor cells: 141.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 46.0;MCF7: 45.5;SK-BR-3: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Approved Mitochondria No No 1900000 Mitochondria "HPA051979: AB_2681681, HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favorable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 3.6 6.1 28.6 9.2 25.2 1.2 4.4 23.9 58.1 14.0 3.2 11.3 0.8 3.4 14.4 2.2 4.8 3.2 6.2 4.0 17.0 22.9 3.1 1.3 4.5 2.4 20.4 21.4 6.9 3.9 1.5 6.6 19.8 13.8 4.1 2.0 19.3 21.5 2.9 4.3 1.8 2.6 4.6 9.3 2.5 8.5 3.4 9.7 0.0 2.0 1.0 6.0 4.9 2.0 0.4 0.1 1.6 0.1 0.0 0.1 0.1 9.0 12.7 11.4 24.3 0.9 0.5 20.2 6.8 22.2 6.3 5.2 4.4 8.6 0.0 46.0 2.0 22.1 17.2 2.6 11.9 2.4 0.1 3.7 0.2 8.1 8.3 8.5 0.1 0.3 2.1 2.3 11.7 1.8 10.3 10.8 1.8 0.5 0.6 2.0 45.5 0.2 0.0 15.1 0.3 7.3 0.1 4.8 1.0 9.5 4.7 11.4 27.0 4.9 46.7 4.1 6.0 32.4 0.1 12.6 2.4 11.6 0.7 12.9 0.1 0.0 0.4 20.5 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.1 28.6 25.2 23.9 36.8 17.0 22.9 20.4 21.4 13.8 9.7 0.0 0.0 0.0 2.1 1.1 42.9 0.7 2.5 0.0 3.4 5.2 17.7 20.0 1.7 65.2 0.4 8.2 0.0 0.0 11.6 24.7 6.1 6.7 0.0 0.0 2.9 240.0 15.0 8.0 0.3 0.6 1.7 0.0 0.0 5.4 1.8 177.4 47.3 0.0 3.2 0.3 141.6 6.5 1.0 1.0 3.6 0.6 22.7 0.0 2.1 6.3 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 195.0;Late spermatids: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 23.7;hTCEpi: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria NA NA Mitochondria "HPA063554: AB_2685039" "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favorable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.6 7.1 0.1 1.4 5.2 7.8 23.7 1.2 1.9 1.1 1.7 8.9 9.8 0.0 1.4 0.3 5.1 1.2 3.3 11.0 1.5 0.0 3.2 4.4 2.2 7.9 1.8 5.5 1.4 5.6 13.6 4.6 1.6 0.3 5.9 1.1 2.9 0.1 8.2 3.0 0.0 0.0 1.8 7.3 1.7 0.0 0.0 0.3 2.0 7.5 1.1 0.0 0.2 9.6 2.7 4.3 6.8 1.5 1.2 2.2 1.8 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 8.9 7.8 0.0 6.7 2.7 0.0 10.6 17.8 5.3 4.5 0.0 0.0 11.5 0.0 9.5 195.0 3.6 34.8 0.0 11.4 5.8 2.0 5.7 4.6 1.0 24.1 0.0 4.7 3.1 19.9 77.6 9.8 10.7 3.3 3.6 17.2 1.3 10.6 14.7 8.5 5.6 0.0 0.0 2.2 1.2 1.7 4.4 7.3 0.0 14.5 4.2 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 76.8;liver: 234.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 38.4;intermediate monocyte: 27.1" "Lineage enriched" "Detected in many" 4 "monocytes: 38.4" "Cell line enriched" "Detected in some" 30 "HSkMC: 127.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria NA NA Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 10.5 4.9 5.8 17.1 6.0 0.7 7.8 1.2 4.3 6.2 32.2 4.8 2.0 16.1 3.6 12.8 7.5 6.3 34.2 15.0 5.2 4.5 76.8 234.5 8.8 23.5 6.9 3.4 19.0 5.0 0.4 2.2 8.9 6.6 6.3 22.3 22.8 3.9 2.0 3.1 3.3 51.2 6.5 6.9 17.3 7.1 3.7 5.4 2.1 4.8 4.8 9.2 13.5 9.1 0.4 9.3 3.3 38.4 0.0 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 3.3 0.1 27.1 0.1 0.4 0.0 0.1 9.3 0.0 0.0 0.0 0.5 0.0 12.9 0.6 0.1 10.7 5.8 6.0 1.2 4.3 5.2 4.5 6.9 3.4 6.6 5.4 0.0 6.9 29.6 0.4 6.5 48.5 19.4 150.3 14.7 15.9 190.1 3.9 0.5 129.3 42.7 0.1 9.6 542.2 0.0 23.6 0.8 57.1 2.4 26.7 864.2 53.0 0.0 71.1 29.4 40.2 0.5 55.8 35.8 5.0 525.8 156.3 73.3 68.7 691.0 7.1 954.7 4.4 0.0 20.0 0.7 1.5 7.3 1.1 7.2 159.5 0.9 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Group enriched" "Detected in some" 12 "Bipolar cells: 41.7;Horizontal cells: 62.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.3 8.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 0.0 0.0 0.0 0.0 0.0 41.7 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 4.3 0.0 0.1 0.6 3.2 0.0 0.0 0.0 0.0 0.0 TMEM246 "C9orf125, MGC12992" ENSG00000165152 "Transmembrane protein 246" Q9BRR3 9 101473171-101533537 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "hTCEpi: 14.4;hTERT-RPE1: 16.4;OE19: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011318, HPA054041" Uncertain Approved Mitochondria NA NA Mitochondria "HPA011318: AB_2668482, HPA054041: AB_2682353" "unprognostic (2.58e-2)" "unprognostic (4.76e-2)" "unprognostic (5.52e-1)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (9.15e-2)" "unprognostic (1.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (3.51e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.62e-1)" "unprognostic (1.91e-1)" "unprognostic (2.50e-1)" "unprognostic (9.16e-2)" 3.4 10.2 10.8 3.1 19.4 0.8 2.9 23.2 31.1 17.1 12.6 7.6 1.6 8.0 5.9 4.0 11.0 13.5 7.0 27.3 17.6 20.6 4.6 2.6 5.4 0.8 10.8 14.3 19.4 10.9 19.6 9.2 1.0 23.2 7.0 10.8 8.1 4.6 9.7 4.3 11.2 7.1 6.7 8.5 1.8 15.1 2.9 4.0 0.0 4.3 4.4 2.9 4.7 8.3 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 8.1 6.3 0.0 0.2 0.1 0.0 5.4 7.9 3.9 7.9 0.4 4.3 0.0 1.8 9.8 0.4 12.8 0.0 8.9 2.4 0.0 3.2 4.4 6.1 0.0 0.3 0.0 0.0 3.5 14.4 0.0 2.1 16.4 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 7.8 26.2 0.0 0.0 3.2 0.0 5.9 1.5 10.7 10.1 3.0 0.0 0.0 1.6 0.0 7.5 0.0 6.1 3.8 0.0 0.0 0.5 0.0 0.0 8.7 0.0 2.7 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 10.8 19.4 23.2 31.1 17.6 20.6 10.8 14.3 23.2 4.0 20.8 0.3 0.0 13.2 4.7 38.3 42.4 33.1 9.4 10.3 15.7 3.9 0.0 0.0 12.9 2.2 5.9 16.1 0.0 15.0 0.1 1.5 11.6 0.0 6.2 0.0 15.9 23.6 1.3 0.3 0.8 4.9 0.0 0.0 1.0 35.3 1.4 12.8 38.6 10.6 4.2 4.4 12.9 5.2 2.3 1.0 8.7 0.0 0.0 26.7 23.0 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA058401: AB_2683707, HPA070655: AB_2686292" "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.8 8.2 0.3 0.6 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.2 0.9 33.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 1.3 0.9 0.6 4.2 0.0 7.0 1.4 0.0 1.6 1.3 0.7 0.0 0.2 0.1 1.1 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.4 0.5 0.7 3.4 0.0 1.6 0.0 5.8 19.5 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 0.0 4.8 4.2 1.0 0.8 0.0 14.8 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 0.0 3.1 0.0 0.0 1.3 23.3 3.6 0.0 22.7 5.0 0.0 0.0 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 41.5 0.0 5.1 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 47.3" "Cell type enriched" "Detected in some" 14 "Enterocytes: 341.7" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA021946 Approved Mitochondria NA NA Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.2 0.0 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 26.8 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.9 0.2 0.2 0.2 0.2 0.0 47.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 24.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 TMLHE "BBOX2, FLJ10727, TMLH, XAP130" ENSG00000185973 "Trimethyllysine hydroxylase, epsilon" Q9NVH6 X 155490115-155669944 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034589, HPA040331" Approved Supported Mitochondria NA NA Mitochondria "HPA034589: AB_10670571, HPA040331: AB_2676929" "unprognostic (1.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.04e-1)" "unprognostic (5.41e-2)" "unprognostic (6.66e-3)" "unprognostic (1.10e-3)" "unprognostic (6.50e-2)" "unprognostic (1.00e-1)" "unprognostic (3.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.20e-3)" "unprognostic (6.97e-2)" "prognostic favorable (3.68e-6)" "unprognostic (1.69e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-1)" "unprognostic (7.75e-2)" 10.1 15.0 8.5 6.7 10.5 6.7 10.4 17.1 13.5 11.3 10.5 10.0 9.1 10.7 10.9 10.1 9.5 9.5 7.4 22.3 10.3 7.5 15.8 16.9 6.9 14.6 12.5 7.4 12.4 10.7 18.4 17.5 7.6 11.5 7.7 11.6 10.6 16.2 9.6 28.1 7.8 10.0 13.8 13.7 9.2 9.8 3.1 11.2 12.2 10.5 5.3 8.7 10.2 9.1 9.1 10.3 14.7 15.7 4.3 5.6 4.5 15.2 7.5 6.2 18.1 7.7 11.9 0.0 6.2 9.1 7.8 20.4 5.3 8.6 0.0 25.0 10.8 18.0 8.3 13.2 6.0 8.9 6.2 9.0 6.8 12.2 6.2 10.8 6.4 4.9 12.6 12.7 8.7 13.2 11.7 12.3 9.8 9.5 5.6 12.9 5.7 7.7 7.2 1.9 13.2 0.1 7.7 9.9 5.8 9.4 5.2 5.9 8.9 5.8 0.3 6.7 7.0 6.7 7.3 10.3 6.6 6.3 13.0 7.6 7.0 7.5 5.8 8.0 10.0 6.0 1.9 10.1 11.3 3.9 11.4 2.9 6.2 4.3 3.3 10.3 9.1 5.6 4.9 14.7 4.3 15.7 4.7 4.2 4.5 8.5 10.5 17.1 13.5 10.3 7.5 12.5 7.4 11.5 11.2 0.0 2.9 10.0 9.7 4.6 3.6 6.5 7.6 9.4 4.5 8.7 0.0 7.2 19.9 8.9 0.0 5.6 8.6 0.0 6.6 5.8 7.5 2.7 9.3 11.3 10.9 0.0 5.8 5.5 14.6 0.0 7.8 11.4 11.8 10.8 6.9 7.2 8.0 7.0 5.3 11.3 5.2 0.0 8.2 0.4 1.7 3.6 5.6 6.9 7.6 8.7 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109336-235128936 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria NA NA Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 27.2 35.0 46.3 15.3 60.2 32.7 52.8 40.0 66.2 36.1 25.5 28.4 29.0 24.4 34.5 39.0 28.0 40.0 27.9 33.9 47.1 48.7 41.2 35.2 24.2 33.6 42.5 40.5 50.9 63.6 38.6 25.4 27.1 48.2 34.0 28.2 23.5 47.8 30.7 33.4 33.0 21.3 33.8 54.5 19.0 27.2 16.3 23.0 18.0 58.7 28.4 21.9 36.2 28.9 15.9 20.9 16.4 13.8 9.8 22.6 14.2 35.9 19.0 25.0 21.0 19.7 39.8 38.8 25.9 22.4 24.4 17.8 24.5 25.4 43.8 34.5 22.4 6.9 28.8 27.7 25.1 32.2 10.5 59.2 26.7 25.4 46.3 33.0 59.8 16.1 35.5 34.5 24.4 33.7 33.2 26.4 17.2 56.0 16.2 26.7 10.5 25.4 27.1 56.2 24.0 10.3 31.1 19.1 56.7 27.4 25.9 32.9 77.1 20.1 28.2 55.1 10.7 43.6 65.8 23.3 21.5 13.0 27.1 54.9 38.4 36.1 32.1 25.2 28.7 36.3 16.4 12.4 4.1 13.9 12.9 17.1 15.9 18.1 17.3 15.1 12.7 22.6 17.6 3.9 9.8 13.8 20.9 15.5 14.2 46.3 60.2 40.0 66.2 47.1 48.7 42.5 40.5 48.2 23.0 128.1 138.6 191.4 199.9 237.5 49.8 120.5 135.0 99.0 162.7 47.1 27.5 147.0 135.9 142.1 230.8 135.2 112.6 46.7 180.7 308.9 116.9 237.5 153.6 148.6 144.2 47.7 154.1 102.5 169.4 269.0 143.5 148.5 141.7 101.0 251.0 122.3 199.7 133.3 144.2 188.2 47.6 103.5 156.9 79.9 69.4 250.1 166.8 109.0 224.1 238.8 TOMM22 TOM22 ENSG00000100216 "Translocase of outer mitochondrial membrane 22" Q9NS69 22 38681948-38685421 "Predicted membrane proteins" "Protein transport, Translocation, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003037 Supported Enhanced Mitochondria NA NA Mitochondria "HPA003037: AB_1080329" "unprognostic (5.54e-2)" "unprognostic (5.04e-3)" "unprognostic (2.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.01e-1)" "unprognostic (4.28e-1)" "unprognostic (7.01e-2)" "unprognostic (1.64e-2)" "unprognostic (7.39e-2)" "unprognostic (5.44e-2)" "unprognostic (5.32e-2)" "unprognostic (1.99e-1)" "unprognostic (7.86e-2)" "unprognostic (1.64e-1)" 27.6 26.2 25.6 30.1 24.3 29.5 29.4 17.6 28.2 22.2 26.8 14.7 22.4 28.0 20.1 25.6 34.1 24.4 23.8 31.6 23.2 21.0 29.4 46.0 18.1 32.1 24.0 19.8 27.8 47.5 10.9 12.6 27.6 18.5 21.0 32.8 15.8 31.4 26.7 38.2 24.6 29.7 22.8 20.0 27.7 23.3 24.7 11.3 44.2 27.4 40.4 33.5 24.1 30.2 22.5 29.7 6.9 22.9 18.0 21.3 28.6 19.9 11.8 18.1 19.2 13.4 12.5 19.6 16.6 11.5 24.3 18.3 21.4 12.0 20.3 13.7 16.2 16.7 16.6 27.5 25.1 19.6 17.5 30.2 27.3 9.3 20.5 17.5 72.2 19.4 17.1 17.9 21.8 14.3 12.7 17.8 19.9 20.6 16.3 16.1 15.5 21.6 33.6 27.8 26.5 24.1 24.1 23.5 19.2 16.1 14.7 21.3 14.1 19.3 24.6 18.8 12.9 17.0 23.9 18.0 14.9 28.0 13.6 24.9 22.5 27.2 31.4 18.7 25.1 20.3 4.7 22.9 6.9 16.9 22.0 21.3 22.5 18.3 17.8 29.7 18.0 18.7 20.0 2.2 18.0 18.1 25.8 21.1 28.6 25.6 24.3 17.6 28.2 23.2 21.0 24.0 19.8 18.5 11.3 23.8 38.6 136.2 98.0 148.4 29.1 63.5 89.2 22.7 36.4 68.0 15.7 155.1 189.0 110.6 102.3 74.4 68.7 23.3 115.2 191.6 75.3 74.7 74.8 86.3 145.2 27.0 100.8 54.6 102.5 107.7 51.2 105.1 108.0 150.5 120.6 48.5 110.8 66.6 51.2 199.7 22.3 71.1 82.1 92.7 139.6 183.8 113.4 104.6 157.8 129.1 TOMM5 "bA613M10.3, C9orf105, Tom5" ENSG00000175768 "Translocase of outer mitochondrial membrane 5" Q8N4H5 9 37582646-37592642 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA048712 Approved Supported Mitochondria NA NA Mitochondria "HPA048712: AB_2680499" "unprognostic (1.81e-2)" "unprognostic (1.96e-1)" "unprognostic (3.37e-2)" "unprognostic (3.34e-2)" "unprognostic (2.02e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (9.89e-3)" "prognostic unfavorable (5.49e-4)" "prognostic favorable (2.37e-4)" "unprognostic (7.80e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (3.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.37e-1)" "unprognostic (9.09e-2)" 33.2 37.8 34.5 31.2 39.7 28.3 44.1 24.3 38.5 26.7 34.7 13.1 28.3 37.5 28.7 32.7 36.9 25.4 31.1 39.6 30.9 34.7 44.3 45.3 24.4 37.4 37.6 26.3 27.4 83.8 12.7 28.8 19.6 32.3 25.2 31.2 17.3 49.6 36.2 51.5 24.1 34.8 34.1 23.9 38.9 31.2 33.0 27.2 24.5 36.3 46.1 37.8 26.7 35.3 59.1 43.1 14.0 33.9 40.2 54.9 50.5 55.1 64.4 38.2 34.2 43.9 43.2 21.1 42.1 27.0 41.1 44.0 68.5 22.9 37.8 34.6 39.9 41.9 19.2 33.9 50.2 42.9 53.1 53.6 33.2 89.6 98.1 36.1 54.4 22.0 37.2 27.6 45.2 44.8 19.5 46.8 42.5 80.8 42.5 41.7 44.2 45.8 47.9 66.5 46.6 40.8 38.9 31.9 55.6 47.0 34.6 33.1 30.4 21.6 29.5 30.7 33.9 20.6 63.8 31.7 28.5 61.0 44.8 64.9 16.2 46.8 63.1 34.9 47.1 43.8 12.3 32.2 14.0 43.0 33.9 52.7 59.1 53.1 47.7 39.0 49.1 54.9 50.5 3.7 40.2 28.5 43.1 42.1 50.5 34.5 39.7 24.3 38.5 30.9 34.7 37.6 26.3 32.3 27.2 26.8 30.2 43.6 35.9 99.7 4.4 20.1 58.6 49.5 53.4 43.6 11.8 22.0 68.0 47.4 168.9 45.6 41.0 0.0 110.0 44.6 34.2 29.9 44.0 129.9 59.4 1.6 17.4 52.2 57.8 127.0 32.5 43.7 59.1 81.2 44.0 6.7 88.5 35.1 29.4 80.6 6.2 0.0 32.3 51.5 22.8 128.0 21.1 47.8 53.1 48.7 TOMM6 "OBTP, Tom6" ENSG00000214736 "Translocase of outer mitochondrial membrane 6" Q96B49 6 41787662-41789898 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Alveolar cells type 2: 16.0;Ciliated cells: 30.8;Club cells: 19.4;granulocytes: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 201.9" "Low region specificity" "Detected in all" HPA004801 Approved Supported Mitochondria NA NA Mitochondria "HPA004801: AB_1859553" 44.1 68.7 54.2 47.4 51.9 55.4 66.4 26.0 52.6 44.0 44.7 43.6 37.1 29.1 38.9 83.4 62.1 49.0 32.1 64.6 45.3 43.8 80.9 92.6 37.7 60.4 45.1 36.3 56.9 84.5 31.6 39.7 49.9 42.3 47.1 53.1 48.4 83.1 43.8 80.2 47.2 48.7 39.4 41.5 58.7 42.0 53.1 37.2 56.7 65.9 78.3 71.9 44.7 38.7 66.2 75.2 39.0 70.5 33.8 56.9 89.2 56.8 28.4 34.4 34.8 32.4 39.2 36.6 28.6 30.3 37.0 35.7 49.3 26.6 26.1 35.0 34.1 41.8 18.2 54.8 47.4 47.7 36.6 57.8 46.8 36.4 80.1 25.6 62.3 30.5 35.1 49.8 40.5 34.8 26.4 44.4 36.9 116.5 32.0 45.3 67.2 44.7 98.9 30.2 201.9 29.0 32.8 21.6 76.7 49.7 29.3 30.5 42.5 19.5 33.8 47.5 38.2 41.1 126.6 31.0 25.4 31.5 25.2 42.6 29.7 63.3 114.8 14.4 53.0 32.7 15.1 69.1 39.0 49.1 68.7 47.7 66.2 50.2 48.7 72.0 61.8 56.9 55.4 9.0 33.8 70.5 75.2 46.5 89.2 54.2 51.9 26.0 52.6 45.3 43.8 45.1 36.3 42.3 37.2 3.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401398 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 22.5;Extravillous trophoblasts: 28.8;Proximal tubular cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria NA NA 120000 Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234" "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 21.7 16.1 16.2 12.4 52.4 9.6 21.3 23.6 26.5 16.9 18.2 12.5 13.8 19.4 17.4 15.0 20.8 14.2 12.2 25.2 16.5 19.8 24.9 40.7 10.5 13.5 16.1 20.6 21.7 18.0 20.1 17.1 15.5 29.0 19.0 20.6 13.3 14.5 19.4 42.8 13.3 17.8 22.3 14.0 12.1 14.8 14.7 15.6 18.7 20.5 19.9 16.6 22.3 22.5 4.3 3.0 2.5 2.5 5.6 5.4 1.8 23.5 16.5 14.1 20.2 20.0 21.8 18.4 20.3 17.2 18.5 19.2 23.4 13.6 28.2 17.8 17.0 16.7 23.4 25.4 18.5 27.4 10.7 11.8 32.4 11.0 22.7 12.5 39.4 14.9 19.4 17.1 16.5 26.9 16.5 13.5 13.9 23.0 23.1 22.0 17.4 26.6 15.9 19.4 36.5 35.3 24.5 28.6 30.0 15.0 17.8 25.6 21.3 14.7 23.6 26.4 14.1 30.6 22.4 12.1 16.4 21.7 9.1 15.0 25.2 35.9 48.0 15.7 23.9 12.4 2.2 2.2 2.5 4.1 2.2 5.1 4.3 5.1 4.5 2.9 3.1 5.3 5.4 0.6 5.6 2.5 3.0 2.0 1.8 16.2 52.4 23.6 26.5 16.5 19.8 16.1 20.6 29.0 15.6 6.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 18.7 20.5 14.0 0.0 22.5 10.0 17.3 0.0 0.0 0.0 0.0 16.9 28.8 0.0 0.0 7.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 10.0 0.0 0.0 19.2 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 TOP1MT ENSG00000184428 "DNA topoisomerase I mitochondrial" Q969P6 8 143304384-143359979 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MOLT-4: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001915, HPA021542" Approved Supported Mitochondria NA NA Mitochondria "HPA001915: AB_1080331, HPA021542: AB_1858186" "unprognostic (5.02e-3)" "unprognostic (3.79e-2)" "unprognostic (6.57e-2)" "unprognostic (6.92e-3)" "unprognostic (2.32e-2)" "unprognostic (1.04e-2)" "unprognostic (3.05e-3)" "unprognostic (1.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (1.52e-7)" "unprognostic (3.66e-2)" "unprognostic (3.62e-2)" "unprognostic (8.55e-3)" "unprognostic (5.66e-3)" 11.7 13.5 8.1 13.7 9.8 33.0 22.1 2.2 10.3 14.7 10.7 4.5 3.9 6.0 10.0 7.4 14.9 11.3 11.0 5.9 8.8 5.6 9.6 22.5 8.5 11.4 6.9 8.1 27.0 15.9 5.9 8.6 5.9 7.3 14.7 8.0 5.9 11.0 10.8 5.7 15.4 8.3 8.8 6.8 11.4 9.3 18.1 6.4 25.1 19.2 9.6 11.4 14.0 30.9 16.7 18.8 11.7 5.5 0.2 14.3 4.7 7.6 11.8 4.9 18.6 7.1 8.0 8.8 3.5 4.6 6.5 6.7 14.8 11.1 22.5 13.5 4.9 4.6 8.2 10.5 6.6 5.6 8.8 16.1 19.8 6.6 14.9 8.0 13.2 21.6 8.1 7.0 5.4 7.9 5.6 7.8 6.5 23.7 8.8 5.7 32.1 58.6 26.4 8.6 16.7 20.2 7.4 6.5 33.7 4.8 12.4 8.9 10.8 10.2 9.1 18.4 6.4 6.0 22.0 5.1 4.5 18.4 5.1 9.1 4.8 5.0 11.5 7.6 19.8 5.4 11.7 5.5 0.2 3.5 3.2 3.6 16.7 6.4 4.8 18.8 8.0 14.3 10.4 0.4 0.2 0.6 16.4 1.7 4.7 8.1 9.8 2.2 10.3 8.8 5.6 6.9 8.1 7.3 6.4 6.0 7.5 9.0 28.1 21.1 1.4 2.0 7.6 4.0 13.6 8.7 0.0 10.3 6.6 9.5 19.8 7.3 2.7 23.3 7.8 19.8 11.7 15.2 6.9 7.8 10.8 3.2 4.7 6.7 5.9 6.7 8.1 10.1 20.3 4.6 8.7 1.4 9.6 8.6 4.2 12.3 0.1 6.5 13.4 31.6 39.0 20.8 8.5 6.4 19.3 18.6 TRAM1L1 MGC26568 ENSG00000174599 "Translocation associated membrane protein 1 like 1" Q8N609 4 117083554-117085576 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 6.9;Horizontal cells: 4.8;Spermatogonia: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 9.6;U-138 MG: 11.8;U-266/70: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044560 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044560: AB_10796097" "unprognostic (9.06e-2)" "unprognostic (2.87e-2)" "unprognostic (4.40e-2)" "unprognostic (2.17e-3)" "unprognostic (9.77e-2)" "unprognostic (2.37e-2)" "unprognostic (5.97e-2)" "unprognostic (3.02e-1)" "unprognostic (1.14e-1)" "unprognostic (3.25e-1)" "unprognostic (1.09e-3)" "unprognostic (1.56e-2)" "unprognostic (2.76e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" 2.1 4.3 7.8 1.1 10.0 0.3 7.3 5.6 14.9 4.6 1.8 9.4 0.0 0.9 3.4 10.5 1.6 6.8 3.1 2.2 8.8 8.6 11.9 0.5 2.9 1.0 8.5 5.9 4.1 5.0 0.6 8.5 1.2 10.3 7.5 2.2 4.5 2.5 4.7 0.7 4.1 1.1 3.6 10.3 1.2 3.2 5.9 7.4 0.0 8.4 0.3 0.9 3.2 1.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 1.4 1.0 4.5 2.2 0.0 0.0 0.0 0.6 0.5 0.9 2.7 0.1 5.2 0.0 0.5 1.2 5.8 0.1 2.1 2.4 3.7 0.0 0.1 1.2 1.2 0.6 1.3 1.3 0.0 4.9 2.1 1.1 0.0 3.8 0.0 0.0 0.0 2.7 7.3 0.3 2.3 0.0 0.3 0.0 1.1 0.0 5.8 0.0 0.8 0.3 2.6 9.6 0.0 3.8 4.4 2.5 6.5 1.4 3.1 11.8 5.2 0.1 1.8 9.6 2.1 0.0 4.5 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 7.8 10.0 5.6 13.9 8.8 8.6 8.5 5.9 10.3 7.4 0.0 1.0 0.0 0.2 0.8 6.9 0.6 0.0 4.0 2.3 1.8 3.9 1.7 1.7 2.1 0.1 1.0 0.0 0.0 0.6 0.2 2.2 0.2 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.1 3.1 0.3 0.0 1.8 1.8 2.9 0.0 0.9 1.7 5.1 1.3 0.2 0.0 0.0 0.0 TRAP1 "HSP75, HSP90L" ENSG00000126602 "TNF receptor associated protein 1" Q12931 16 3651639-3717597 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041082, HPA044227" Enhanced Enhanced Mitochondria NA NA 1100000 Mitochondria "HPA041082: AB_2677291, HPA044227: AB_2678864" "unprognostic (1.18e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.80e-4)" "unprognostic (7.10e-2)" "unprognostic (6.80e-2)" "unprognostic (2.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.61e-2)" "unprognostic (8.58e-2)" "unprognostic (5.71e-3)" "unprognostic (1.54e-1)" "unprognostic (7.69e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "unprognostic (9.90e-2)" "unprognostic (3.82e-2)" 19.1 20.3 19.1 15.9 29.7 14.2 17.5 21.1 38.5 16.8 23.0 18.1 13.1 18.6 17.1 14.2 34.4 28.5 20.8 40.0 22.1 20.4 24.6 62.6 12.3 20.6 17.1 30.7 23.5 54.7 18.3 13.6 15.5 23.2 15.4 17.8 16.4 19.7 13.7 80.3 31.2 14.1 20.9 12.3 15.2 19.7 20.0 15.1 16.4 16.0 39.8 21.2 17.2 18.2 20.0 24.6 1.3 17.0 12.7 22.3 13.8 19.1 48.1 10.0 26.4 11.1 11.4 29.7 11.6 10.6 27.0 17.0 59.8 27.4 61.7 22.1 11.2 7.3 36.1 39.0 29.1 11.9 23.6 42.6 18.0 41.3 41.8 19.1 32.2 12.4 13.4 20.3 21.4 33.6 9.8 18.5 21.0 56.4 22.5 8.8 62.6 23.1 23.9 18.5 22.8 24.5 53.2 21.0 85.1 20.0 14.3 47.7 18.2 12.1 44.8 23.3 8.4 32.4 23.4 10.4 11.4 20.3 19.9 16.9 24.1 26.5 48.5 7.1 26.0 15.5 0.0 10.8 0.3 11.7 17.0 22.3 20.0 17.1 14.8 24.6 13.9 20.3 17.1 1.3 12.7 12.3 3.6 14.2 13.8 19.1 29.7 21.1 38.5 22.1 20.4 17.1 30.7 23.2 15.1 20.8 17.4 12.6 35.8 22.6 26.7 1.7 43.3 20.1 14.8 29.6 9.8 94.7 74.6 58.6 17.5 15.5 13.6 0.0 47.2 42.8 18.6 22.2 16.1 41.4 41.2 44.5 34.1 14.1 14.2 10.0 15.3 15.9 11.8 36.1 32.9 17.6 32.3 3.5 20.1 84.4 17.9 19.4 30.1 35.4 77.7 24.6 56.2 10.2 65.0 31.9 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043396: AB_2678460, HPA048233: AB_2680321" "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favorable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 6.9 5.4 9.0 5.8 8.8 1.6 6.2 34.0 17.1 6.3 8.1 9.4 3.4 22.6 8.7 2.6 3.7 5.9 5.3 6.1 6.8 7.0 3.9 3.8 6.2 3.0 8.1 9.6 5.8 5.3 2.8 3.8 5.3 14.3 7.7 6.5 6.1 9.2 7.7 9.3 7.1 19.5 8.9 7.3 4.9 8.6 3.0 7.0 0.7 4.2 2.5 2.1 6.6 5.8 0.5 3.9 1.8 3.0 2.0 1.9 1.5 4.3 7.5 3.0 5.1 5.1 4.9 4.1 6.2 3.7 4.8 5.4 4.5 3.0 2.4 2.2 4.7 5.6 3.0 3.1 4.6 1.8 2.8 4.6 0.7 7.5 3.0 3.1 0.2 2.5 4.2 2.2 3.7 2.0 2.0 4.8 1.7 1.0 2.9 4.6 9.0 0.2 0.6 2.2 8.9 6.5 1.4 2.6 2.9 1.1 2.2 3.1 4.9 3.4 33.9 4.0 1.6 12.8 0.8 8.1 12.7 6.0 9.2 4.1 3.4 2.0 0.5 6.9 1.0 4.7 0.0 3.0 1.8 1.7 2.9 1.3 0.4 1.4 1.4 3.9 0.5 0.5 1.9 0.0 2.0 0.8 0.8 1.5 1.5 9.0 8.8 34.0 17.1 6.8 7.0 8.1 9.6 14.3 7.0 6.0 0.0 2.0 2.6 4.2 8.5 1.7 2.5 2.7 0.0 0.0 9.8 1.6 0.0 2.8 3.1 4.7 17.1 0.0 2.9 2.0 6.1 4.0 1.1 1.9 4.1 7.9 4.6 4.3 1.0 3.9 5.5 2.8 6.8 3.6 10.7 1.7 2.6 5.7 4.9 2.4 8.7 12.9 10.2 1.9 4.9 4.6 0.7 0.7 5.2 1.6 TRIT1 "FLJ20061, IPT" ENSG00000043514 "TRNA isopentenyltransferase 1" Q9H3H1 1 39841022-39883511 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024174, HPA027330" Approved Supported Mitochondria NA NA Mitochondria "HPA024174: AB_1858346, HPA027330: " "unprognostic (4.61e-2)" "unprognostic (1.77e-1)" "unprognostic (8.38e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (4.00e-2)" "unprognostic (8.55e-2)" "prognostic unfavorable (5.34e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-3)" "unprognostic (3.18e-2)" "unprognostic (3.54e-1)" "unprognostic (6.68e-3)" "prognostic unfavorable (7.08e-8)" "unprognostic (6.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.22e-1)" "unprognostic (6.90e-2)" 9.5 10.3 12.9 10.4 19.1 8.0 19.8 25.8 18.4 15.1 13.4 15.9 22.7 11.4 19.3 21.3 19.8 18.4 9.1 15.9 12.5 12.0 14.6 13.2 11.9 14.8 13.9 10.4 16.7 27.7 14.1 26.7 17.6 14.4 21.4 15.8 13.5 15.1 23.9 10.1 22.9 11.7 18.0 9.8 14.0 12.9 17.3 17.9 15.4 19.2 9.4 14.7 17.2 17.5 3.9 13.4 0.9 6.6 2.4 5.2 2.8 14.7 6.8 14.8 15.1 7.4 11.2 22.4 9.8 13.2 15.8 17.8 13.1 19.5 8.6 13.0 8.4 9.5 15.1 21.3 16.9 22.2 10.4 10.8 18.3 15.8 8.1 17.1 17.7 10.0 9.4 15.3 19.8 19.6 16.2 12.7 18.9 24.7 10.3 9.9 7.2 13.5 19.1 19.9 11.2 6.2 14.4 18.6 19.6 15.0 19.0 16.8 11.2 14.1 9.6 10.8 16.4 10.7 30.4 9.1 10.6 13.0 18.2 16.2 14.0 11.0 17.3 13.4 18.1 9.1 0.0 6.6 0.9 2.7 4.9 5.2 3.9 2.6 2.9 13.4 3.2 3.4 3.5 0.1 2.4 5.8 11.6 2.7 2.8 12.9 19.1 25.8 18.4 12.5 12.0 13.9 10.4 14.4 17.9 20.8 5.6 4.4 14.1 13.2 3.1 8.9 7.6 20.1 10.3 7.0 2.0 27.7 6.6 9.5 3.6 5.1 3.2 0.0 8.1 30.0 8.3 6.6 2.3 5.8 7.2 14.3 9.8 8.6 6.2 2.0 8.9 6.8 5.0 7.2 8.2 5.2 9.2 7.0 10.6 7.0 7.3 0.0 5.2 18.6 16.7 14.9 13.8 3.5 8.9 9.0 TRMT61A "C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61" ENSG00000166166 "TRNA methyltransferase 61A" Q96FX7 14 103529184-103537073 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 45.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024269 Approved Mitochondria NA NA Mitochondria "HPA024269: " "unprognostic (5.12e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (5.59e-3)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (3.70e-2)" "unprognostic (9.86e-3)" "unprognostic (2.88e-3)" "unprognostic (4.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-1)" 12.4 10.6 9.0 10.4 16.4 9.1 8.2 10.3 16.7 9.7 16.7 16.0 9.2 10.5 14.9 8.9 10.6 14.3 10.9 6.2 10.7 8.1 9.1 9.6 7.5 8.0 11.7 8.7 10.5 20.7 6.7 5.9 6.7 10.5 13.1 4.6 9.0 14.4 18.3 9.7 15.5 8.6 19.9 9.1 7.9 9.7 10.9 11.3 6.0 11.9 7.5 7.5 11.9 8.5 3.8 4.1 0.3 12.2 3.0 3.7 2.6 5.5 13.9 2.1 4.4 2.2 2.4 8.9 6.2 2.8 7.8 4.3 18.9 9.6 9.0 7.8 3.2 4.5 14.4 4.6 4.7 2.2 6.1 8.6 6.9 5.2 10.0 4.0 8.9 5.4 2.6 6.1 6.8 2.8 1.8 1.3 6.6 10.2 4.4 2.6 16.1 10.8 6.8 7.5 11.7 28.3 13.5 6.8 7.8 3.1 8.3 11.4 7.1 7.1 6.7 8.3 0.9 12.5 5.2 2.6 7.1 7.6 18.6 12.6 6.0 3.8 11.4 7.6 7.1 13.4 0.0 2.6 0.3 3.4 6.5 2.5 3.4 2.7 3.7 4.1 3.8 3.2 3.1 0.1 3.0 12.2 2.8 2.0 2.6 9.0 16.4 10.3 16.7 10.7 8.1 11.7 8.7 10.5 11.3 0.0 8.9 7.7 12.9 23.2 11.5 45.6 5.1 2.7 2.3 7.0 3.9 11.1 14.9 15.6 3.6 11.3 7.4 0.0 10.4 11.8 12.7 10.0 2.3 7.8 10.9 28.6 10.3 4.3 7.3 11.9 10.3 6.1 10.1 16.2 7.8 7.5 15.5 8.6 17.3 12.7 10.7 0.0 19.1 6.6 10.8 26.2 10.1 7.5 13.3 9.6 TRMU "FLJ10140, MTO2, TRMT" ENSG00000100416 "TRNA 5-methylaminomethyl-2-thiouridylate methyltransferase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Mitochondria NA NA Mitochondria "HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415" "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavorable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favorable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavorable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 8.5 16.1 11.5 9.9 16.0 6.4 7.5 17.8 16.0 9.7 8.7 11.5 10.2 10.9 12.1 18.0 10.9 6.2 7.3 16.8 11.3 11.9 20.5 18.8 7.1 10.2 15.7 11.8 8.0 22.7 20.0 13.6 9.7 11.2 8.7 10.2 9.0 12.5 15.5 17.8 9.8 7.6 9.4 11.4 8.7 9.2 8.3 13.9 6.5 9.6 8.3 9.8 7.1 9.1 6.2 7.6 3.9 9.6 7.5 11.3 6.3 10.8 10.0 4.3 9.7 8.1 5.7 10.8 11.3 8.0 16.1 12.6 14.1 2.8 7.1 8.1 10.1 7.0 9.7 18.2 10.1 13.8 4.6 24.5 8.5 15.3 16.6 6.9 16.2 5.8 5.4 11.4 16.7 5.3 6.7 10.3 3.7 11.7 1.7 9.8 11.4 6.3 13.2 16.1 6.6 17.6 7.4 9.2 13.2 8.0 7.6 10.2 12.3 10.0 11.8 19.0 5.6 6.7 6.7 7.5 7.2 12.9 10.2 12.6 4.2 4.5 7.6 10.2 11.8 14.5 0.0 6.8 3.9 11.1 9.4 9.4 5.7 9.4 10.0 7.6 6.2 8.6 8.0 1.4 7.5 9.6 6.0 11.3 6.3 11.5 16.0 17.8 16.0 11.3 11.9 15.7 11.8 11.2 13.9 8.9 6.7 12.6 9.5 5.6 25.1 12.4 5.1 9.4 5.7 10.4 15.7 20.8 23.2 18.2 0.8 11.9 11.4 23.3 16.7 17.5 10.3 9.9 9.2 16.6 13.8 12.7 12.0 15.4 11.8 1.7 14.1 8.3 8.5 17.2 9.8 11.0 16.7 10.5 15.9 22.8 26.2 6.5 11.7 18.2 13.2 8.4 12.8 10.1 15.3 8.2 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126916-3150879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Yes No Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 15.2 16.9 17.5 17.8 20.7 8.7 18.2 14.5 22.7 12.9 13.2 13.2 17.4 11.1 18.4 14.7 15.9 12.2 15.6 13.9 17.1 16.0 21.1 16.1 13.7 19.0 17.5 15.6 14.6 13.9 14.3 31.0 19.0 21.3 23.9 16.4 10.1 13.2 13.1 14.8 15.3 12.5 15.3 19.3 20.5 15.5 13.5 15.1 22.1 20.9 10.6 19.8 17.8 13.0 15.1 10.5 29.0 12.0 15.1 16.6 7.4 12.0 17.4 13.5 7.7 16.1 13.8 14.4 13.8 11.5 13.8 14.3 16.1 14.8 22.0 9.2 13.3 22.0 8.7 17.8 12.4 17.6 16.3 8.6 20.4 18.6 16.1 21.5 21.6 16.6 12.9 17.6 14.2 4.8 11.6 13.6 17.0 15.9 9.2 23.7 22.5 13.9 19.5 10.6 18.0 12.7 13.3 18.2 21.4 18.4 18.0 7.7 11.1 20.0 14.5 11.5 19.0 13.4 12.3 11.1 15.6 13.6 16.1 17.7 9.5 18.9 27.7 11.7 19.4 17.4 29.0 8.8 22.5 12.1 11.8 11.9 15.1 15.0 12.7 10.5 9.5 16.6 14.3 11.7 15.1 12.0 9.6 11.1 7.4 17.5 20.7 14.5 22.7 17.1 16.0 17.5 15.6 21.3 15.1 14.9 8.3 13.9 18.6 13.2 12.9 12.1 2.5 10.7 13.6 17.4 13.7 21.8 38.1 16.1 1.5 22.5 9.6 0.0 8.7 14.3 13.9 19.8 22.0 7.8 11.6 9.5 8.1 10.4 12.9 1.9 10.0 11.3 6.8 18.0 9.7 15.8 10.1 8.6 8.1 25.6 16.8 0.0 17.7 20.0 16.9 11.4 23.7 13.8 11.5 18.2 TRPT1 MGC11134 ENSG00000149743 "TRNA phosphotransferase 1" Q86TN4 11 64223799-64226254 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038705, HPA038706" Uncertain Approved Mitochondria NA NA Mitochondria "HPA038705: AB_2676161, HPA038706: AB_10671863" "unprognostic (2.50e-2)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" "unprognostic (3.59e-2)" "unprognostic (7.20e-2)" "unprognostic (1.53e-1)" "unprognostic (5.84e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-3)" "unprognostic (1.12e-1)" "unprognostic (7.71e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-1)" "unprognostic (1.99e-1)" "unprognostic (4.58e-3)" 8.1 12.2 10.8 11.1 12.6 4.4 9.1 6.4 12.1 8.8 15.1 10.9 37.4 12.5 7.8 15.3 13.3 10.4 13.5 34.4 10.9 10.3 16.9 13.7 7.0 8.3 13.6 8.5 8.7 23.3 9.1 11.6 8.5 10.8 11.3 10.8 9.9 22.3 33.5 58.8 10.8 13.1 7.0 10.1 10.3 12.2 18.9 10.3 17.2 13.3 23.9 13.2 11.9 7.7 22.9 31.7 14.5 16.2 12.4 13.2 6.5 10.7 10.7 11.9 19.1 14.8 10.9 14.8 7.3 14.1 12.9 10.9 7.0 16.4 10.9 29.3 11.9 10.0 15.1 5.2 15.7 4.5 10.5 6.4 5.5 10.8 12.1 21.4 6.9 9.8 8.1 9.3 14.3 12.7 24.3 9.0 21.8 9.6 12.2 10.7 25.5 12.8 14.8 7.6 14.6 11.9 17.0 8.9 30.8 33.2 12.9 10.6 15.3 5.8 14.4 21.1 8.5 16.6 11.2 10.5 8.9 6.8 17.3 7.1 24.4 6.0 6.9 21.3 3.6 14.2 6.0 9.4 14.5 10.9 16.2 8.4 20.8 10.5 11.2 13.0 22.9 11.9 13.2 8.3 12.4 13.9 31.7 13.2 6.5 10.8 12.6 6.4 12.1 10.9 10.3 13.6 8.5 10.8 10.3 8.9 17.2 12.7 16.5 11.7 9.7 39.2 35.7 49.5 14.8 26.2 0.0 38.4 81.2 35.4 121.1 14.3 67.0 23.3 51.2 36.0 16.3 24.7 23.2 22.7 21.9 9.5 25.8 19.6 13.4 59.9 18.4 14.8 35.4 36.1 72.6 18.7 41.3 45.6 15.9 57.2 10.3 6.5 28.3 51.6 13.5 16.2 30.1 17.8 33.0 17.7 TST RDS ENSG00000128311 "Thiosulfate sulfurtransferase" Q16762 22 37010859-37020183 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.1" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 203.8;Enterocytes: 300.1;Hepatocytes: 350.5;Paneth cells: 284.5;Proximal tubular cells: 229.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 16.0" "Group enriched" "Detected in all" 6 "dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5" "Cell line enhanced" "Detected in many" "OE19: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003044, HPA003643, CAB009546" Enhanced Supported Mitochondria NA NA 2800000 Mitochondria "CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411" "unprognostic (3.09e-2)" "unprognostic (2.70e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-1)" "unprognostic (7.96e-3)" "unprognostic (4.38e-2)" "unprognostic (1.78e-1)" "prognostic favorable (7.59e-6)" "unprognostic (6.08e-3)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.04e-4)" 8.5 29.7 6.0 13.5 7.6 5.7 6.1 5.0 10.5 9.5 38.4 12.9 10.9 37.4 5.9 4.0 16.6 6.8 38.4 14.1 5.1 4.9 19.7 102.1 6.2 3.2 8.2 7.0 7.2 23.9 1.8 2.3 5.0 5.9 8.1 21.6 6.2 13.6 6.9 8.3 5.4 39.5 3.8 4.7 3.5 22.8 3.3 6.7 1.8 8.5 12.8 10.5 7.2 9.2 1.6 16.0 14.3 11.5 2.2 1.2 5.2 11.1 24.9 3.1 10.6 7.7 3.0 5.9 6.2 5.3 3.6 5.4 7.2 7.3 3.0 5.2 4.9 3.5 9.6 2.3 6.2 0.8 8.7 13.9 3.1 4.7 14.0 19.2 4.3 7.4 5.9 7.0 2.7 2.3 5.1 8.8 1.6 3.6 5.2 1.7 25.6 0.1 13.9 5.4 73.6 10.9 10.0 3.4 5.2 10.2 10.5 1.8 4.8 6.5 11.8 8.4 3.2 12.2 10.9 6.6 4.1 7.7 6.8 1.9 3.9 3.9 0.9 1.5 12.4 2.4 5.3 11.5 4.9 0.6 3.0 1.1 1.6 0.5 0.4 16.0 0.8 0.3 0.2 14.3 2.2 0.8 1.1 1.2 5.2 6.0 7.6 5.0 10.5 5.1 4.9 8.2 7.0 5.9 6.7 26.8 66.9 14.5 10.5 1.1 0.8 32.5 203.8 21.4 19.4 19.2 0.0 9.5 39.7 35.3 1.4 5.0 300.1 0.0 38.8 6.0 15.5 9.3 13.9 350.5 13.2 1.6 33.0 36.2 24.7 2.7 12.0 8.3 1.7 17.2 154.8 25.4 33.8 284.5 7.4 229.1 0.6 0.0 3.6 0.7 0.1 2.0 9.5 10.9 155.4 15.2 TTC19 "FLJ20343, MGC19520" ENSG00000011295 "Tetratricopeptide repeat domain 19" Q6DKK2 17 15999380-16045015 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023010, HPA052380" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA023010: AB_1858429, HPA052380: AB_2681806" "unprognostic (1.04e-2)" "unprognostic (4.90e-3)" "unprognostic (2.87e-2)" "unprognostic (4.80e-3)" "unprognostic (8.09e-2)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" "unprognostic (2.84e-2)" "unprognostic (8.34e-2)" "unprognostic (1.72e-2)" "unprognostic (2.30e-3)" "unprognostic (5.14e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.31e-1)" "unprognostic (3.22e-1)" "unprognostic (4.85e-2)" "unprognostic (2.24e-1)" 8.5 13.6 10.3 10.1 16.6 16.4 11.2 16.5 22.6 10.1 13.8 10.3 10.5 18.7 11.1 8.9 9.3 9.9 11.8 13.4 17.0 10.4 15.4 13.2 10.8 7.9 9.2 15.3 12.7 24.8 11.5 15.5 10.1 15.7 12.0 9.6 13.1 14.0 12.7 8.6 13.9 16.1 7.2 8.9 8.3 13.3 6.3 6.8 6.0 18.7 8.0 8.4 10.0 10.9 3.5 2.8 9.0 2.0 1.7 3.3 1.0 6.9 5.9 6.0 10.1 5.1 5.0 4.5 5.9 4.1 2.8 3.0 5.8 12.4 9.9 13.1 3.3 3.8 8.9 8.2 6.8 3.4 16.1 13.9 8.1 7.3 4.9 7.9 8.1 12.5 5.1 5.6 2.3 9.7 7.4 5.9 11.2 4.8 7.1 5.8 6.6 8.7 5.0 9.9 9.3 4.1 13.1 6.7 7.0 8.9 8.3 6.3 4.7 7.6 8.1 14.9 19.1 6.9 3.5 10.9 3.8 1.6 5.4 7.4 5.8 2.5 4.6 9.1 9.1 8.7 9.0 2.0 3.8 2.0 2.0 3.3 2.8 2.5 3.3 2.5 3.5 2.8 3.1 1.7 1.7 1.6 2.8 2.6 1.0 10.3 16.6 16.5 22.6 17.0 10.4 9.2 15.3 15.7 6.8 38.7 30.5 47.9 58.4 93.5 137.2 30.7 33.1 18.7 28.4 43.6 135.5 60.2 59.7 46.3 34.1 65.0 53.6 46.7 35.9 32.8 37.1 61.4 31.1 29.4 22.9 122.3 43.8 28.8 19.2 4.8 38.0 31.9 52.3 30.7 45.4 81.2 37.0 52.6 31.5 37.9 170.0 45.3 31.9 17.6 28.1 102.0 54.8 55.3 51.6 61.7 TTC21B "FLJ11457, IFT139B, JBTS11, NPHP12, THM1" ENSG00000123607 "Tetratricopeptide repeat domain 21B" Q7Z4L5 2 165857475-165953843 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035494, HPA035495, HPA073293" Supported Supported Mitochondria Yes No Mitochondria "HPA035494: AB_2674650, HPA035495: AB_10672866, HPA073293: " "unprognostic (1.63e-2)" "unprognostic (1.17e-1)" "unprognostic (3.10e-1)" "unprognostic (1.60e-2)" "unprognostic (2.96e-1)" "unprognostic (2.51e-1)" "unprognostic (7.09e-3)" "unprognostic (2.81e-2)" "unprognostic (2.98e-2)" "unprognostic (7.57e-2)" "unprognostic (3.52e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (1.84e-2)" 10.4 9.0 11.3 7.0 18.3 8.6 11.7 39.6 19.8 12.3 9.2 7.1 5.3 6.5 13.8 10.0 6.7 15.3 7.5 10.4 10.1 8.1 12.5 8.9 9.4 8.9 12.3 11.9 17.5 10.1 10.4 17.6 9.8 15.7 14.9 8.9 6.3 9.1 10.2 16.4 10.7 8.2 9.7 12.2 8.4 8.5 9.7 13.8 16.2 9.4 7.1 8.0 9.8 11.8 3.8 3.1 8.7 2.7 3.7 4.7 1.8 5.0 3.9 17.7 7.2 12.0 11.7 4.7 10.1 8.2 8.1 8.0 5.5 3.3 11.7 6.1 7.1 7.7 5.3 11.9 6.3 9.7 8.2 5.9 9.6 6.8 13.4 7.0 9.0 0.0 6.3 4.1 9.4 6.8 10.3 8.8 9.1 12.7 8.9 10.3 2.7 11.0 7.1 7.3 5.6 9.6 12.2 14.3 4.0 6.3 10.8 12.7 7.5 7.9 1.9 8.8 9.0 3.0 6.4 6.4 14.4 6.5 8.0 7.4 5.1 7.1 10.8 6.0 5.6 9.0 8.7 1.9 3.3 2.9 2.3 4.2 3.8 3.4 2.9 3.1 3.2 4.4 4.7 0.8 3.7 2.7 1.6 4.2 1.8 11.3 18.3 39.6 19.8 10.1 8.1 12.3 11.9 15.7 13.8 3.0 9.8 4.1 7.8 8.1 21.3 11.8 0.0 38.8 13.6 5.2 31.4 2.6 0.0 2.9 2.1 6.3 3.9 0.0 1.6 3.0 6.1 7.1 5.8 7.4 10.3 14.3 6.9 11.1 9.2 2.3 9.8 4.2 10.1 1.0 5.4 11.5 1.0 7.0 12.0 6.9 22.2 6.5 6.1 6.5 11.9 3.3 2.4 8.7 6.0 4.3 TTLL4 KIAA0173 ENSG00000135912 "Tubulin tyrosine ligase like 4" Q14679 2 218710845-218755416 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in many" 13 "Muller glia cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027091, HPA050252" Approved Approved Mitochondria NA NA Mitochondria "HPA027091: AB_10601828, HPA050252: AB_2681064" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.64e-1)" "unprognostic (1.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.83e-3)" "unprognostic (2.96e-2)" "unprognostic (1.21e-1)" "unprognostic (7.52e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (6.63e-12)" "unprognostic (9.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" "unprognostic (5.29e-3)" 6.1 9.0 10.6 11.1 15.1 7.1 9.0 11.2 12.7 5.9 7.7 17.7 5.9 7.9 8.5 5.5 9.2 10.5 7.0 5.9 10.9 6.8 6.3 7.7 8.7 8.0 16.6 6.3 6.9 9.1 8.8 14.5 11.0 13.1 8.4 9.3 11.2 8.9 5.8 7.0 10.8 8.0 7.6 16.7 7.6 12.6 39.1 14.1 8.6 5.3 5.3 11.9 6.1 7.7 4.0 6.8 13.5 11.3 1.8 3.2 3.9 9.0 6.1 16.3 8.2 4.2 3.3 23.0 6.3 4.9 10.0 8.6 25.7 10.7 7.1 5.4 4.6 9.7 10.1 17.1 8.3 11.8 8.5 15.6 9.2 9.2 24.4 6.0 11.3 6.8 5.4 5.1 9.0 10.2 4.3 9.5 8.0 26.0 11.2 5.5 5.2 6.2 7.7 18.7 6.5 4.3 14.9 7.4 9.3 10.0 7.1 6.7 6.5 4.6 6.9 11.9 26.1 5.5 5.8 4.0 9.0 9.4 6.2 5.9 5.9 4.9 16.1 4.7 7.1 11.6 0.1 11.3 0.7 3.2 5.7 2.9 4.0 2.3 2.2 6.8 3.2 1.5 1.4 13.5 1.8 7.4 4.0 1.4 3.9 10.6 15.1 11.2 12.7 10.9 6.8 16.6 6.3 13.1 14.1 3.0 4.3 2.9 9.9 4.0 5.9 1.4 2.5 1.4 4.5 7.0 25.5 5.5 0.0 4.7 28.9 2.3 2.6 0.0 3.3 6.9 3.7 11.6 1.1 1.7 7.0 3.2 5.2 2.5 3.2 13.2 2.8 5.4 3.3 7.2 4.4 91.9 5.0 2.9 1.4 1.4 12.6 0.0 3.1 14.4 12.1 3.6 4.8 2.5 4.4 10.3 TUFM "EF-TuMT, EFTu" ENSG00000178952 "Tu translation elongation factor, mitochondrial" P49411 16 28842411-28846408 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Elongation factor" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018991, HPA024087, CAB075730, CAB075731, CAB075732" Enhanced Enhanced Mitochondria NA NA 2800000 Mitochondria "CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459" "unprognostic (1.40e-1)" "unprognostic (7.56e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (2.55e-2)" "unprognostic (3.39e-1)" "unprognostic (1.23e-3)" "unprognostic (8.05e-2)" "unprognostic (8.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.69e-6)" "unprognostic (5.26e-2)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (7.36e-2)" 27.3 47.8 28.8 32.3 31.3 27.2 40.4 22.3 41.4 25.3 41.7 27.1 34.4 44.0 26.6 22.3 40.0 32.7 37.6 69.2 25.6 25.8 45.6 68.4 28.6 46.2 33.1 24.4 25.9 75.0 48.3 22.7 23.0 27.3 23.4 37.6 25.4 40.9 33.1 77.3 28.1 36.1 26.2 25.8 28.4 36.9 47.0 21.5 32.5 37.0 55.4 33.9 26.8 23.3 30.6 57.3 21.7 44.2 25.5 38.8 45.4 29.3 55.9 17.9 37.4 26.0 23.9 36.8 21.5 25.1 34.4 32.6 60.2 32.5 66.1 39.8 21.5 19.7 57.6 42.4 41.7 20.6 26.3 64.9 25.2 45.2 72.8 30.9 45.1 23.5 30.5 33.0 37.1 37.0 22.4 40.9 36.7 56.5 26.1 24.9 59.8 43.2 44.1 40.1 36.1 34.7 59.9 32.5 96.1 29.7 28.8 31.4 38.4 18.8 67.2 29.4 15.4 40.0 36.8 26.0 20.6 24.0 25.4 32.8 39.9 41.3 28.8 26.3 56.7 26.9 21.7 44.2 19.5 31.3 42.3 34.8 30.6 29.7 32.7 57.3 27.5 28.5 29.5 9.1 25.5 31.6 34.9 38.8 45.4 28.8 31.3 22.3 41.4 25.6 25.8 33.1 24.4 27.3 21.5 65.5 70.3 105.7 207.8 149.3 93.5 117.0 178.3 137.9 64.8 167.5 82.5 299.6 283.5 183.0 309.9 94.4 289.0 23.3 252.4 240.7 112.6 188.4 103.9 224.8 230.1 69.9 142.6 95.8 162.5 472.6 101.2 129.8 131.6 183.1 194.4 129.6 169.5 172.7 105.0 374.4 91.2 84.1 142.8 184.3 182.3 136.4 240.1 147.2 348.8 236.5 TXN2 MT-TRX ENSG00000100348 "Thioredoxin 2" Q99757 22 36467036-36482030 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000994, CAB008681" Approved Enhanced Mitochondria No No Mitochondria "CAB008681: AB_1623682, HPA000994: AB_1080267" "unprognostic (5.11e-2)" "unprognostic (4.40e-3)" "unprognostic (4.40e-3)" "unprognostic (1.07e-2)" "unprognostic (5.85e-2)" "unprognostic (4.28e-2)" "unprognostic (4.02e-2)" "unprognostic (5.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.78e-1)" "unprognostic (3.17e-2)" "prognostic favorable (2.04e-4)" "prognostic favorable (1.17e-6)" "unprognostic (1.49e-2)" "unprognostic (2.78e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" 22.1 69.9 33.4 24.7 33.2 23.5 41.9 23.2 51.1 23.0 25.9 20.8 24.5 36.9 19.8 22.7 28.7 26.9 27.6 60.1 28.0 28.6 33.4 51.7 27.9 35.5 30.3 31.7 35.0 51.1 30.8 17.3 19.6 30.4 21.6 26.2 24.6 25.0 27.5 72.3 21.0 28.1 26.3 35.6 25.2 26.7 19.1 21.2 16.2 29.2 37.3 23.0 23.0 19.8 31.7 51.3 14.4 43.3 32.0 30.0 45.1 14.4 19.7 21.6 36.9 32.5 35.4 24.8 19.9 31.1 33.5 38.1 23.9 15.3 36.5 18.4 30.9 14.6 22.0 41.4 34.0 19.5 25.0 36.0 41.6 26.9 35.2 27.4 50.0 39.8 47.3 27.0 28.0 21.9 28.1 30.3 20.4 43.5 30.2 29.9 21.3 22.7 38.8 17.5 44.7 26.0 20.8 22.8 25.3 33.9 23.5 30.1 30.4 20.0 43.9 35.7 18.0 30.9 48.5 23.8 37.4 29.2 20.5 19.4 24.6 17.4 35.5 33.7 31.2 21.2 5.2 40.8 7.1 25.7 43.3 26.8 31.7 25.6 27.0 51.3 29.0 30.0 27.9 14.4 32.0 35.2 39.1 24.8 45.1 33.4 33.2 23.2 51.1 28.0 28.6 30.3 31.7 30.4 21.2 56.6 49.0 65.6 79.6 74.1 107.9 96.0 79.0 53.5 53.4 66.3 37.3 190.8 257.0 78.1 16.6 64.6 168.3 0.0 93.1 240.7 63.4 47.2 68.1 102.9 150.9 109.7 86.0 69.3 73.9 27.8 52.3 81.0 74.2 82.0 111.4 131.5 75.1 94.7 47.7 140.1 54.1 19.4 58.7 50.5 41.1 78.4 173.2 69.9 151.3 64.8 TXNDC16 KIAA1344 ENSG00000087301 "Thioredoxin domain containing 16" Q9P2K2 14 52430590-52552522 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 49.1;Rod photoreceptor cells: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002543 Approved Approved Mitochondria "Secreted - unknown location" NA NA Mitochondria "HPA002543: AB_1079199" "unprognostic (1.37e-1)" "unprognostic (7.79e-3)" "unprognostic (5.95e-3)" "unprognostic (2.36e-1)" "unprognostic (5.95e-3)" "unprognostic (9.73e-2)" "unprognostic (2.50e-1)" "unprognostic (1.43e-2)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-2)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (3.55e-3)" "unprognostic (2.04e-1)" 7.0 5.2 10.2 5.9 12.5 5.4 8.6 20.5 15.0 12.1 7.0 7.4 16.1 5.1 8.5 18.4 4.8 5.4 6.5 5.6 9.2 9.4 6.4 8.9 6.1 5.0 9.5 11.3 13.4 7.8 8.6 9.4 7.0 8.9 32.8 7.4 8.1 5.6 24.2 4.2 6.5 5.9 5.6 14.0 11.5 7.4 8.2 10.5 9.7 5.1 3.4 4.8 7.8 7.3 1.2 5.3 3.6 6.3 1.1 4.7 2.2 6.1 0.6 6.9 3.8 5.1 3.8 5.4 2.0 2.7 3.5 6.8 2.2 5.0 10.0 6.9 1.6 2.1 5.8 7.9 2.8 5.4 4.1 10.3 4.6 5.1 2.0 3.7 5.4 2.2 7.0 2.6 4.4 3.3 3.1 3.8 4.4 5.8 15.6 3.0 2.9 6.7 3.8 7.6 4.1 3.7 13.6 13.0 9.0 4.4 6.3 22.5 7.8 9.9 10.4 2.8 6.0 6.6 4.0 2.1 4.7 2.4 5.3 3.4 4.3 5.8 10.1 1.3 5.7 2.7 2.4 6.3 2.5 2.7 4.8 2.9 1.2 2.8 2.0 5.3 0.8 1.4 1.4 3.6 1.1 5.2 2.2 4.7 2.2 10.2 12.5 20.5 15.0 9.2 9.4 9.5 11.3 8.9 10.5 8.9 5.4 5.2 5.3 6.0 35.7 7.9 7.6 5.3 6.8 7.0 7.9 1.7 1.7 3.1 3.3 6.3 5.2 23.3 3.5 1.5 3.3 19.5 2.3 10.5 3.0 9.5 17.7 12.9 15.9 2.7 25.6 5.0 1.7 1.0 17.2 8.4 1.5 9.5 49.1 2.6 45.5 0.0 4.4 9.8 8.4 7.3 0.9 5.7 8.7 3.5 UBE2H "GID3, UBC8, UBCH" ENSG00000186591 "Ubiquitin conjugating enzyme E2 H" P62256 7 129830732-129952949 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003302 Approved Approved Mitochondria NA NA Mitochondria "HPA003302: AB_1858526" "unprognostic (1.15e-1)" "unprognostic (5.85e-2)" "unprognostic (5.67e-3)" "unprognostic (2.76e-1)" "unprognostic (2.25e-1)" "unprognostic (3.08e-2)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (6.19e-2)" "prognostic unfavorable (2.33e-5)" "unprognostic (1.13e-1)" "unprognostic (3.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.12e-1)" "unprognostic (3.58e-1)" "unprognostic (1.23e-1)" 29.0 49.9 31.1 16.6 31.0 22.5 24.5 36.1 30.2 31.1 27.3 33.2 26.6 15.2 35.5 25.3 32.1 29.4 26.6 61.0 26.4 25.4 27.6 28.1 26.3 17.5 28.1 23.4 27.6 52.3 41.8 29.5 37.9 33.3 24.1 16.8 22.9 28.5 28.8 46.3 21.3 16.5 31.5 26.2 19.1 22.7 24.7 29.5 24.7 37.7 23.6 29.5 25.5 34.3 6.1 3.7 7.8 2.2 1.3 6.5 1.9 22.1 12.0 14.3 14.5 35.4 30.5 24.7 20.5 26.5 12.6 14.1 6.4 23.8 9.2 25.7 20.2 32.6 16.9 12.2 21.8 16.5 11.3 6.5 3.2 17.7 7.7 27.9 6.3 10.1 41.0 29.0 17.0 27.3 28.0 24.5 9.8 7.5 26.7 19.4 7.9 8.4 6.9 22.4 15.1 14.3 6.6 7.3 19.6 26.3 29.1 5.4 16.5 18.8 42.1 11.0 44.9 4.4 6.2 24.8 13.7 6.9 19.3 20.4 24.4 17.5 15.2 27.3 7.6 13.3 3.5 2.2 5.1 4.7 1.7 6.4 3.8 4.7 4.2 2.0 6.1 6.0 6.4 7.8 1.3 2.1 3.7 6.5 1.9 31.1 31.0 36.1 30.2 26.4 25.4 28.1 23.4 33.3 29.5 38.7 38.0 39.2 140.7 129.5 52.7 101.3 53.5 54.9 53.4 68.0 56.9 93.6 34.9 51.9 67.1 55.4 27.8 116.8 62.1 57.4 57.8 206.4 14.9 63.8 35.3 41.3 56.6 44.8 35.5 35.6 40.9 28.3 45.5 12.6 27.9 82.0 95.7 31.7 73.9 39.7 32.0 12.9 55.1 22.7 17.7 134.4 167.6 24.9 23.0 232.4 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974667-73983307 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 219.1;lymphoid tissue: 144.8" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria NA NA Mitochondria "CAB025583: , HPA075202: AB_2732284" "unprognostic (1.13e-1)" "prognostic favorable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 19.8 9.8 5.3 40.4 9.5 24.5 15.9 1.1 4.9 8.1 7.7 10.2 20.3 11.4 4.2 12.0 4.5 37.9 13.1 11.5 4.4 5.5 12.8 10.6 20.2 85.6 7.8 2.4 7.2 4.7 1.2 6.2 8.7 6.5 6.5 8.9 14.2 17.4 17.2 45.3 4.3 24.7 6.4 9.0 91.1 12.3 5.5 5.9 144.8 17.9 19.3 55.7 19.4 2.9 141.6 219.1 101.8 135.3 119.8 180.2 172.1 0.1 14.3 3.3 9.8 1.9 0.0 2.5 2.4 1.6 9.8 2.8 25.1 12.2 68.0 34.0 3.7 0.8 0.6 2.3 0.0 4.6 17.2 0.8 39.7 6.0 5.2 5.9 20.8 16.7 2.2 0.0 9.3 0.0 1.9 1.3 26.2 18.2 27.8 1.9 24.5 21.5 11.2 2.6 1.5 2.9 19.9 22.7 38.5 27.4 40.6 5.0 6.1 12.8 87.6 4.8 9.9 25.8 18.6 1.8 0.0 12.6 2.9 4.7 9.5 4.5 56.6 1.7 8.3 0.1 45.7 81.5 101.8 112.6 135.3 69.9 141.6 92.3 95.0 88.4 134.2 86.9 91.1 11.4 119.8 111.3 219.1 180.2 172.1 5.3 9.5 1.1 4.9 4.4 5.5 7.8 2.4 6.5 5.9 3.0 35.4 250.6 2.3 3.1 0.9 3.6 2.5 93.7 23.9 87.2 7.9 6.6 6.6 1.2 16.1 5.0 4.2 420.4 6.5 10.3 6.7 15.6 84.3 0.6 378.7 0.0 285.5 11.6 244.1 37.5 0.9 160.3 25.3 710.6 23.4 2.9 2.5 37.6 0.4 1.9 6.3 6.5 5.3 14.4 13.4 4.0 9.4 172.7 24.7 21.6 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria No No Mitochondria "HPA014405: AB_1858606, HPA065785: AB_2685559" "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favorable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.2 0.1 1.7 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.2 5.8 21.5 6.4 0.5 0.1 5.1 9.1 0.0 0.0 0.0 0.1 4.5 0.1 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 5.4 1.3 0.0 0.1 0.1 0.7 2.5 41.1 3.2 0.6 10.3 0.1 21.3 0.2 12.1 1.8 0.0 1.9 0.3 0.4 0.3 2.1 0.4 0.5 7.3 0.3 6.8 2.1 0.3 0.2 10.6 0.3 6.6 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 6.0 1.0 8.1 1.2 0.0 0.0 0.4 7.6 2.7 6.8 24.4 0.0 0.0 8.3 1.8 5.5 0.1 20.6 0.0 11.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 46.4 0.0 0.0 1.7 1.1 0.7 1.7 0.0 25.7 0.0 9.1 17.5 0.0 1.3 0.0 0.0 0.2 10.6 36.2 0.1 0.0 0.0 21.1 0.9 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 576.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria NA NA 1300000 Mitochondria "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favorable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.1 16.5 6.0 3.6 8.8 8.1 27.1 18.8 15.2 15.6 14.2 25.6 3.0 26.3 11.9 8.4 18.3 9.8 7.5 21.8 2.9 15.6 35.9 27.0 14.3 27.7 17.5 16.9 11.7 11.1 24.8 10.6 17.5 7.4 15.5 17.4 14.5 1.8 9.4 17.7 12.2 19.3 15.0 15.0 65.5 8.3 16.0 21.5 16.1 11.1 6.4 11.4 25.4 3.1 15.0 1.7 6.5 2.7 15.5 4.3 16.5 13.6 19.3 16.0 14.1 15.2 9.6 19.5 13.9 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 53.6 50.3 63.6 133.4 104.5 38.0 576.9 142.7 78.9 46.6 115.1 27.5 292.1 310.0 150.4 116.4 44.8 496.0 46.7 145.4 266.4 68.1 72.4 80.8 173.2 214.8 38.1 138.8 44.2 110.4 218.8 54.1 87.6 113.1 113.6 228.6 55.4 138.8 252.6 66.4 309.3 39.8 58.2 92.9 102.7 76.4 92.1 281.6 56.5 307.7 117.4 UQCRC2 "QCR2, UQCR2" ENSG00000140740 "Ubiquinol-cytochrome c reductase core protein 2" P22695 16 21952660-21983660 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007998, HPA019146" Enhanced Enhanced Mitochondria NA NA 4000000 Mitochondria "HPA007998: AB_1858648, HPA019146: AB_1858649" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.49e-3)" "unprognostic (3.35e-1)" "unprognostic (1.26e-2)" "unprognostic (6.91e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (2.43e-2)" "prognostic favorable (6.58e-9)" "unprognostic (2.33e-1)" "unprognostic (9.78e-3)" "unprognostic (4.67e-3)" "unprognostic (7.36e-2)" 22.7 26.8 20.6 17.1 32.7 20.5 21.3 29.2 33.7 17.7 38.4 17.4 19.5 45.0 20.8 18.6 28.7 20.0 19.1 94.9 19.8 19.3 35.1 35.8 15.9 23.6 20.9 28.5 21.9 20.8 36.6 20.2 17.8 29.6 17.7 40.5 18.5 22.1 20.2 103.9 22.2 42.0 30.4 16.5 16.5 29.3 10.3 19.2 25.2 21.4 70.0 22.9 27.9 20.0 20.0 30.6 14.3 29.3 18.7 25.7 27.4 19.3 21.2 13.1 8.7 14.7 20.6 18.6 18.8 15.3 17.2 17.5 34.3 19.1 38.3 16.9 16.1 12.8 35.3 21.3 18.8 19.9 17.5 19.7 21.7 18.7 48.4 15.5 27.5 54.9 24.0 23.6 13.4 18.5 17.6 22.5 21.3 23.4 20.1 18.6 25.6 28.6 17.9 14.4 24.5 16.4 33.5 30.5 41.9 25.8 22.8 18.2 13.3 26.6 33.6 20.2 16.6 38.4 29.3 19.9 12.2 11.5 11.9 16.7 14.5 10.5 34.0 20.0 29.3 13.9 14.3 24.7 12.8 16.9 29.3 21.9 20.0 20.5 18.6 30.6 15.8 22.8 20.8 9.1 18.7 27.6 13.2 25.7 27.4 20.6 32.7 29.2 33.7 19.8 19.3 20.9 28.5 29.6 19.2 59.6 42.0 98.3 164.9 80.5 95.9 481.5 84.1 72.3 54.6 68.0 82.5 196.5 386.3 104.6 67.7 84.2 282.6 23.3 96.2 128.0 82.0 92.1 91.1 104.1 172.2 65.2 109.2 63.3 130.3 64.8 63.3 104.5 124.9 144.3 181.4 81.7 88.0 175.6 91.2 254.0 122.1 77.6 118.3 52.3 51.5 77.2 232.7 106.2 298.0 149.1 UQCRFS1 "RIP1, RIS1, RISP, UQCR5" ENSG00000169021 "Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1" P47985 19 29205321-29213541 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.3" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 1206.2;Distal tubular cells: 877.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041863, HPA050339" Enhanced Approved Mitochondria NA NA Mitochondria "HPA041863: AB_10794638, HPA050339: AB_2681095" "unprognostic (4.00e-2)" "unprognostic (2.23e-3)" "prognostic favorable (3.29e-4)" "unprognostic (7.91e-3)" "unprognostic (3.93e-2)" "unprognostic (8.68e-2)" "unprognostic (1.84e-1)" "unprognostic (7.53e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.92e-9)" "unprognostic (6.11e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (1.92e-2)" 15.2 27.1 20.1 10.8 18.3 25.4 28.2 18.3 33.4 11.9 27.3 9.1 9.8 24.3 10.5 14.3 16.9 11.9 14.2 95.3 19.4 14.8 34.9 33.8 12.0 21.2 18.3 13.1 9.1 26.4 15.9 10.6 10.8 17.6 11.8 30.3 11.5 17.0 13.9 112.3 12.9 27.0 19.6 11.5 11.3 18.8 16.6 6.5 17.7 12.9 55.0 14.5 13.7 10.0 18.5 35.6 14.9 29.9 15.0 22.1 45.1 21.8 37.0 13.8 12.4 22.6 17.3 15.3 17.1 17.9 23.7 26.3 22.4 13.6 19.9 18.1 19.3 19.4 23.3 30.1 20.4 28.7 13.5 30.1 28.2 14.6 20.3 19.2 26.8 24.8 20.8 22.1 16.2 24.7 14.0 18.9 24.9 20.0 12.5 25.4 20.2 18.7 20.1 14.4 46.7 14.4 17.1 18.4 15.1 29.5 26.4 16.8 8.2 15.6 30.9 19.6 16.1 14.4 22.4 11.9 16.1 24.5 11.0 17.7 6.0 11.3 18.4 14.2 23.3 11.4 14.9 29.9 14.0 17.9 29.3 17.8 18.5 19.2 18.3 35.6 15.7 20.4 19.4 9.1 15.0 24.3 19.7 22.1 45.1 20.1 18.3 18.3 33.4 19.4 14.8 18.3 13.1 17.6 6.5 50.6 43.5 83.4 229.0 131.1 67.3 1206.2 170.7 48.2 45.5 108.2 15.7 255.3 877.0 208.2 176.6 94.4 303.4 70.0 204.7 204.0 122.3 162.8 88.9 250.4 234.4 49.3 153.7 93.9 135.6 102.8 85.4 113.1 156.9 178.5 238.4 96.8 186.1 196.4 76.7 532.4 58.7 97.0 163.6 296.9 77.1 140.0 319.3 108.3 325.0 307.9 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3256.1;Hepatocytes: 4283.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria NA NA Mitochondria "HPA046693: AB_10968453, HPA053323: AB_2682112" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.5 63.7 37.6 91.0 56.4 45.9 32.6 33.1 46.7 53.0 66.1 89.7 53.3 18.7 70.0 43.3 67.4 46.2 34.3 80.6 45.6 34.2 72.0 24.8 100.5 70.5 49.0 28.1 42.8 48.9 56.2 37.8 52.2 35.5 41.3 40.4 31.7 60.4 55.5 86.2 64.6 64.9 26.7 85.4 57.6 42.4 41.7 80.5 68.5 89.0 63.1 52.5 40.9 46.2 70.6 27.0 68.8 64.9 25.7 48.6 61.4 39.8 66.8 66.8 88.7 33.5 64.6 52.5 48.3 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8 232.3 318.2 275.9 309.6 309.4 83.7 3256.1 1189.8 321.2 221.8 746.8 113.9 633.7 1536.9 621.2 357.1 305.7 1715.1 233.6 826.7 362.7 374.6 615.6 285.5 4283.6 668.1 68.3 527.7 324.1 428.0 786.4 261.5 374.1 678.2 396.8 861.3 232.4 704.3 1273.0 271.5 1804.0 170.0 181.1 456.8 296.8 123.0 449.3 470.6 222.6 1052.4 401.6 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625953 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Glandular cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047663, HPA063665" Approved Approved Mitochondria NA NA Mitochondria "HPA047663: AB_2680116, HPA063665: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favorable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 2.9 1.7 12.3 2.5 33.8 0.5 7.7 7.9 21.3 7.9 7.8 43.8 1.8 2.5 4.2 4.5 10.2 7.7 3.1 4.0 14.1 6.8 2.7 1.6 9.0 0.6 49.5 14.2 4.0 6.3 7.1 3.4 1.2 28.6 5.8 11.1 3.4 8.8 3.6 12.0 6.1 2.9 4.0 25.4 1.5 11.3 4.7 42.8 0.4 24.3 1.2 3.6 5.6 4.0 2.4 2.2 1.3 2.4 1.5 3.2 2.3 6.3 6.6 10.2 9.6 2.7 3.2 3.2 3.4 6.7 5.7 6.6 5.5 10.5 4.8 4.0 3.5 4.4 8.8 6.5 2.4 7.6 2.3 6.1 3.0 4.8 3.7 2.2 3.3 1.2 2.5 2.3 6.6 6.6 11.6 2.6 3.5 4.7 0.7 3.9 3.2 3.2 2.1 4.7 17.8 24.0 4.8 9.1 1.8 4.1 6.2 3.3 3.2 6.5 8.0 7.7 6.3 10.4 3.0 3.5 2.2 6.7 4.3 4.3 1.7 3.1 3.4 5.4 3.1 2.0 0.8 2.3 1.3 1.6 1.9 3.1 2.4 2.7 2.5 1.9 1.0 3.2 1.9 0.1 1.5 2.4 2.2 3.0 2.3 12.3 33.8 7.9 21.3 14.1 6.8 49.5 14.2 28.6 42.8 44.7 23.5 0.0 4.6 2.4 7.1 5.6 5.1 17.4 15.9 12.2 15.7 0.6 0.0 4.1 1.6 4.5 11.4 0.0 7.1 0.8 2.9 59.6 3.5 1.7 1.2 4.8 9.9 3.1 0.6 1.7 3.1 1.4 8.5 1.0 20.7 13.0 8.8 7.0 10.3 1.1 11.1 6.5 3.8 8.0 6.6 3.4 1.1 1.3 10.5 10.5 VARS2 "DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL" ENSG00000137411 "Valyl-tRNA synthetase 2, mitochondrial" Q5ST30 6 30908242-30926459 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062449, HPA070267" Approved Approved Mitochondria NA NA Mitochondria "HPA062449: AB_2684766, HPA070267: AB_2686245" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "unprognostic (1.96e-3)" "unprognostic (2.50e-1)" "unprognostic (5.80e-2)" "unprognostic (3.05e-2)" "unprognostic (2.43e-2)" "unprognostic (1.66e-2)" "unprognostic (3.14e-1)" "unprognostic (8.98e-2)" "unprognostic (4.23e-2)" "unprognostic (2.60e-2)" "unprognostic (2.15e-3)" "unprognostic (1.04e-2)" "unprognostic (7.23e-2)" "unprognostic (1.19e-2)" "unprognostic (2.43e-2)" 7.2 7.8 6.3 12.5 8.6 6.9 6.8 21.4 11.4 4.2 6.5 8.9 6.2 6.2 8.8 6.2 20.6 6.3 7.4 4.9 7.4 6.4 12.0 13.5 7.3 12.9 5.6 9.3 8.8 12.5 8.5 9.7 5.1 7.9 6.0 8.1 4.6 8.2 10.5 9.4 11.0 7.4 4.4 6.3 7.8 8.6 8.3 3.4 13.4 8.2 4.6 10.0 4.8 6.1 1.8 1.3 0.1 0.9 0.2 1.8 0.5 8.6 6.9 3.7 14.8 3.1 2.3 0.1 1.2 0.8 1.2 1.1 6.0 4.9 6.5 5.1 0.9 3.4 0.0 10.4 0.0 1.9 3.4 8.9 7.8 5.8 0.6 2.7 1.6 0.0 1.8 2.6 3.7 0.8 0.4 0.9 11.0 0.0 7.4 3.0 0.0 2.5 0.0 0.9 0.0 0.9 6.1 0.0 6.3 4.9 0.0 4.5 0.1 0.0 3.3 3.7 3.2 10.1 4.1 1.6 9.2 0.6 0.5 0.1 6.8 10.5 13.5 0.0 0.3 6.1 0.0 0.2 0.0 1.1 0.9 1.8 1.8 1.0 1.6 1.0 0.7 0.6 0.3 0.1 0.2 0.6 1.3 1.2 0.5 6.3 8.6 21.4 11.4 7.4 6.4 5.6 9.3 7.9 3.4 6.0 15.1 9.3 4.8 3.5 6.2 11.0 10.2 6.7 4.5 8.7 0.0 7.5 1.7 5.3 1.2 3.8 10.5 0.0 6.1 9.2 3.5 2.0 12.7 19.2 8.2 7.9 12.6 8.6 7.5 0.5 3.7 4.9 1.7 8.2 7.2 2.9 6.7 5.9 3.9 10.7 5.7 0.0 3.4 9.1 8.1 3.6 2.9 7.5 8.6 3.3 VDAC2 ENSG00000165637 "Voltage dependent anion channel 2" P45880 10 75210154-75231448 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043475 Enhanced Supported Mitochondria NA NA 4000000 Mitochondria "HPA043475: AB_10795615" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (9.47e-2)" "unprognostic (9.00e-3)" "unprognostic (5.74e-2)" "prognostic unfavorable (4.51e-4)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.83e-3)" "unprognostic (5.89e-2)" "unprognostic (2.45e-1)" "unprognostic (2.02e-2)" "unprognostic (1.56e-2)" "unprognostic (4.27e-2)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (6.28e-2)" "unprognostic (1.34e-2)" 26.2 31.9 27.8 18.7 40.5 25.1 59.7 34.2 55.4 29.0 39.1 24.2 19.9 31.8 25.5 20.3 63.7 25.0 18.5 141.7 28.1 24.1 38.2 24.4 23.2 23.0 27.6 37.7 29.6 38.9 37.6 18.4 24.1 36.5 24.2 40.3 23.0 30.5 30.6 99.7 30.7 30.5 43.7 27.9 17.8 31.1 30.4 16.9 15.6 27.5 31.9 30.0 33.7 39.1 44.8 63.2 39.0 62.9 36.0 49.6 54.6 41.9 34.7 42.0 53.2 37.5 51.1 44.1 54.6 61.6 59.9 56.6 52.3 40.2 50.0 30.7 45.6 33.3 56.5 76.9 54.1 58.9 27.1 44.8 29.1 29.4 59.0 37.5 55.2 32.4 45.2 64.2 51.0 109.3 84.4 44.2 31.7 49.1 40.8 62.9 31.0 35.5 45.0 36.1 47.6 134.3 42.6 33.3 31.7 58.9 26.4 26.7 31.5 30.1 101.0 63.8 51.3 58.8 24.8 34.1 29.9 41.0 44.2 58.5 32.9 44.8 51.6 43.4 54.7 25.4 39.0 51.5 38.0 32.5 54.0 39.6 44.8 44.7 36.4 63.2 36.0 45.5 41.7 17.7 36.0 62.9 30.8 49.6 54.6 27.8 40.5 34.2 55.4 28.1 24.1 27.6 37.7 36.5 16.9 89.3 45.7 134.1 325.8 338.7 144.0 304.7 142.7 73.6 99.0 106.4 41.2 263.8 567.0 389.3 129.8 150.9 543.9 46.7 300.7 379.6 156.9 217.1 110.7 72.5 237.9 122.3 143.7 133.8 127.5 75.8 157.3 179.7 212.6 317.4 241.2 222.4 375.0 269.6 156.3 255.3 119.1 174.6 229.6 245.4 142.7 367.4 331.6 102.2 304.0 486.8 VDAC3 HD-VDAC3 ENSG00000078668 "Voltage dependent anion channel 3" Q9Y277 8 42391624-42405897 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 187.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026864 Uncertain Supported Mitochondria NA NA 9300000 Mitochondria "HPA026864: AB_1858733" "unprognostic (2.55e-2)" "unprognostic (1.96e-2)" "unprognostic (9.88e-3)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-1)" "unprognostic (4.98e-2)" "unprognostic (2.25e-2)" "unprognostic (1.40e-2)" "unprognostic (5.76e-2)" "unprognostic (3.74e-1)" "unprognostic (1.19e-2)" "unprognostic (6.16e-3)" "unprognostic (2.96e-2)" "unprognostic (1.76e-1)" "unprognostic (8.78e-3)" "unprognostic (6.94e-3)" 19.9 18.8 26.0 13.7 29.8 18.6 17.3 38.3 39.1 16.0 23.7 14.5 12.3 19.1 19.1 17.7 26.8 21.5 13.9 85.8 28.2 35.3 27.9 22.1 12.5 14.6 32.5 24.6 18.1 15.0 17.5 16.5 15.4 44.3 17.6 26.2 16.0 22.2 20.8 187.5 13.0 22.7 22.1 19.6 17.3 16.6 27.4 13.0 20.5 21.6 39.7 18.4 23.1 13.3 34.4 59.4 47.5 44.4 31.4 52.4 81.9 48.6 49.1 38.6 41.1 32.6 28.4 19.2 39.0 33.3 50.2 46.0 37.8 41.7 50.0 37.5 33.0 45.3 31.2 52.1 41.8 55.3 25.4 43.0 76.1 32.8 53.8 23.3 36.6 42.5 22.1 31.8 38.0 17.7 33.5 60.9 44.5 59.6 35.0 51.0 27.0 78.2 42.1 45.9 62.4 32.0 41.4 71.1 35.4 53.9 43.4 34.1 29.3 24.7 29.3 24.5 29.8 61.9 28.0 32.5 19.5 34.1 48.6 37.7 32.6 54.2 57.1 26.2 51.8 32.9 31.1 44.4 47.5 42.1 43.8 42.4 34.4 45.1 41.7 59.4 24.2 45.1 43.3 22.0 31.4 38.5 43.8 52.4 81.9 26.0 29.8 38.3 39.1 28.2 35.3 32.5 24.6 44.3 13.0 41.7 19.5 49.6 71.1 57.4 83.7 294.5 58.6 89.7 33.0 62.8 33.4 118.8 260.2 101.6 108.7 64.1 58.2 46.7 78.4 84.2 75.7 46.5 54.3 48.2 122.7 130.3 45.9 60.2 53.6 110.3 64.2 66.6 69.2 161.5 75.4 54.5 76.5 66.6 91.6 145.2 76.0 64.7 82.1 279.8 154.0 61.9 48.7 63.7 98.4 64.8 VPS26C "DCRA, DSCR3" ENSG00000157538 "VPS26 endosomal protein sorting factor C" O14972 21 37223420-37267919 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 23.9;Exocrine glandular cells: 24.1;Hofbauer cells: 29.0;monocytes: 28.9;Pancreatic endocrine cells: 26.6;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023288 Uncertain Approved Mitochondria NA NA Mitochondria "HPA023288: AB_1847872" "unprognostic (1.01e-3)" "unprognostic (6.42e-2)" "unprognostic (7.96e-3)" "unprognostic (2.15e-2)" "unprognostic (4.10e-3)" "unprognostic (2.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.40e-1)" "unprognostic (3.15e-1)" "unprognostic (7.76e-2)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.54e-4)" "unprognostic (1.72e-1)" "unprognostic (3.24e-1)" "unprognostic (5.24e-2)" "unprognostic (3.16e-1)" 23.5 29.1 14.2 15.9 17.4 16.5 17.0 17.1 19.4 16.2 23.4 20.8 12.1 25.5 17.8 13.8 20.6 15.4 17.6 21.3 17.1 11.9 29.2 28.6 19.9 18.1 18.3 16.9 16.8 23.9 14.5 14.7 20.9 15.6 15.9 23.7 22.1 17.3 15.3 30.8 16.8 31.2 19.7 17.4 24.6 21.5 7.4 17.8 21.3 16.7 13.3 20.6 23.0 16.1 19.6 24.2 40.3 30.2 24.9 26.9 24.5 12.2 5.8 12.8 10.8 23.6 21.3 14.2 12.3 27.4 11.4 16.7 8.0 13.4 8.8 4.6 28.3 26.8 6.1 13.6 13.2 10.9 21.1 9.8 14.9 5.9 7.7 20.6 11.0 10.2 18.4 13.1 13.0 21.1 20.1 21.0 16.6 9.4 19.7 21.5 5.8 18.9 9.4 14.2 19.4 5.7 17.5 6.1 12.9 13.9 9.5 10.3 14.0 8.5 16.6 26.1 17.1 15.7 8.9 16.6 12.9 4.5 13.6 7.1 30.3 30.5 12.2 20.4 18.9 14.1 23.5 24.5 40.3 26.9 30.2 25.0 19.6 23.2 24.4 24.2 14.7 21.5 22.6 25.4 24.9 26.3 9.6 26.7 24.5 14.2 17.4 17.1 19.4 17.1 11.9 18.3 16.9 15.6 17.8 8.9 21.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.5 8.7 0.0 13.0 18.3 23.9 0.0 0.0 0.0 0.0 24.1 21.0 0.0 0.0 8.1 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 28.9 0.0 0.0 26.6 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 VPS35L "C16orf62, MGC16824" ENSG00000103544 "VPS35 endosomal protein sorting factor like" Q7Z3J2 16 19555240-19706793 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 24.9;Distal tubular cells: 24.9;Hofbauer cells: 37.3;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042969, HPA053547" Uncertain Approved Mitochondria NA NA Mitochondria "HPA042969: AB_10794920, HPA053547: AB_2682183" "unprognostic (7.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.17e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" "unprognostic (2.52e-1)" "unprognostic (1.22e-3)" "unprognostic (3.57e-2)" "unprognostic (2.06e-1)" "prognostic favorable (1.31e-8)" "unprognostic (1.82e-3)" "unprognostic (8.92e-2)" "unprognostic (5.08e-2)" "unprognostic (1.13e-2)" 19.1 22.5 21.3 13.5 28.6 10.6 15.3 20.1 35.0 21.4 16.5 44.4 9.9 12.5 27.9 21.4 16.1 18.6 16.4 16.1 21.8 21.1 20.7 15.9 14.7 13.9 23.5 14.0 22.7 14.3 37.9 24.6 18.7 28.8 15.4 18.4 22.6 15.4 18.6 18.2 12.5 13.5 23.8 23.9 25.5 12.6 26.1 21.6 16.0 21.5 9.3 15.3 17.2 14.5 11.7 25.5 12.6 23.8 21.9 14.7 15.6 9.0 16.1 15.0 12.0 19.3 27.1 2.3 13.4 22.4 14.7 17.0 2.3 15.8 11.0 29.2 22.1 0.1 2.5 11.8 7.1 16.2 0.6 6.5 6.4 14.5 0.2 25.7 10.4 13.5 19.4 10.3 13.5 8.6 20.8 23.4 5.4 8.8 2.6 23.9 6.4 9.1 2.7 9.7 1.5 2.0 7.8 4.8 2.7 16.2 2.0 9.3 9.4 16.4 0.5 7.4 12.2 5.5 9.1 24.3 7.5 7.1 10.5 1.4 10.1 17.9 4.1 14.7 8.5 11.9 12.6 21.1 9.4 11.9 23.8 14.7 9.2 11.5 11.7 25.5 11.7 13.4 11.9 2.5 21.9 20.8 6.7 12.0 15.6 21.3 28.6 20.1 35.0 21.8 21.1 23.5 14.0 28.8 21.6 6.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 14.8 15.7 0.0 24.9 24.9 16.2 0.0 0.0 0.0 0.0 14.9 15.4 0.0 0.0 3.5 0.0 37.3 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 12.6 0.0 0.0 10.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 WARS2 TrpRS ENSG00000116874 "Tryptophanyl tRNA synthetase 2, mitochondrial" Q9UGM6 1 119031216-119140671 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028007, HPA069692" Enhanced Supported Mitochondria NA NA Mitochondria "HPA028007: , HPA069692: AB_2686172" "unprognostic (1.00e-1)" "unprognostic (2.25e-1)" "unprognostic (2.03e-1)" "unprognostic (5.64e-2)" "unprognostic (3.42e-1)" "unprognostic (7.05e-2)" "unprognostic (7.73e-3)" "unprognostic (3.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.17e-2)" "unprognostic (3.96e-2)" "unprognostic (6.76e-3)" "prognostic favorable (1.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.83e-1)" "unprognostic (9.88e-3)" "unprognostic (4.71e-2)" 17.3 16.7 6.8 11.7 8.3 2.8 14.6 7.5 8.7 12.9 11.2 7.7 7.6 12.3 13.5 10.4 13.4 14.9 8.8 12.1 6.2 6.1 15.3 14.9 9.2 12.4 6.4 6.1 14.7 17.8 15.1 12.3 14.9 8.3 14.1 12.7 11.3 10.5 10.4 12.2 10.0 13.1 9.0 5.4 9.9 11.2 6.9 6.1 11.6 12.8 13.2 14.2 14.3 10.4 7.2 9.0 0.5 6.9 5.3 7.4 4.9 10.3 4.5 6.1 6.4 7.8 17.6 6.6 5.8 8.3 6.1 7.3 11.3 4.7 15.2 9.5 9.3 3.7 7.0 10.9 9.9 9.4 8.2 14.2 7.2 12.1 10.8 15.9 11.6 4.1 13.4 7.7 8.9 16.3 8.1 9.1 6.7 11.2 11.1 11.3 12.0 6.9 6.7 8.2 7.8 9.3 5.1 20.2 7.7 16.7 14.5 9.0 5.5 9.1 12.7 13.1 11.2 5.6 9.1 6.9 6.7 8.0 12.5 11.0 5.4 3.6 6.7 8.2 9.8 12.3 0.0 6.9 0.5 5.1 4.9 7.4 6.6 5.4 6.7 9.0 7.2 6.5 6.2 0.3 5.3 3.0 4.5 6.0 4.9 6.8 8.3 7.5 8.7 6.2 6.1 6.4 6.1 8.3 6.1 8.9 10.5 8.8 16.5 8.5 6.3 9.2 7.6 16.0 10.3 10.4 5.9 14.1 14.9 9.0 52.2 6.8 5.2 0.0 10.3 13.0 10.8 11.7 8.1 7.3 8.4 6.4 6.4 1.8 7.3 24.7 9.2 6.3 10.1 15.4 9.5 4.9 9.1 3.5 7.8 12.6 7.7 6.5 9.5 3.5 5.9 9.4 16.7 6.4 14.6 11.3 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;ovary: 44.7" "Group enriched" "Detected in many" 8 "Leydig cells: 46.9;Peritubular cells: 94.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 18.5;HEK 293: 4.1;K-562: 6.3;NTERA-2: 5.2;RPMI-8226: 11.1;SK-MEL-30: 4.5" "Region enhanced" "Detected in many" "hippocampal formation: 234.6" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favorable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.8 6.6 13.4 1.6 40.6 1.1 1.9 5.5 15.1 1.2 1.4 3.8 1.0 3.6 4.2 21.8 2.1 9.9 3.5 4.6 30.0 5.1 3.3 1.3 1.3 1.4 4.0 12.1 44.7 2.4 1.6 5.6 1.0 1.5 5.5 1.3 0.8 4.5 5.9 23.0 1.7 3.5 5.2 1.7 1.7 6.3 27.6 7.8 0.0 2.8 2.9 2.3 3.2 0.8 0.8 2.1 2.6 1.2 0.9 1.3 0.2 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 18.5 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.1 0.0 0.1 0.0 0.1 5.2 0.0 3.6 0.0 0.0 11.1 0.0 0.0 1.8 1.6 0.1 0.1 4.5 2.6 0.4 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.6 0.5 0.9 0.3 0.7 0.6 0.7 0.9 0.3 0.3 0.8 1.3 0.8 1.2 0.9 1.2 2.1 0.5 0.2 13.4 40.6 5.5 15.1 30.0 5.1 4.0 12.1 1.5 7.8 0.0 0.0 0.0 1.3 1.9 4.9 8.9 0.0 8.1 2.3 3.5 2.0 0.0 3.3 3.7 1.3 1.1 1.3 0.0 3.1 0.1 0.9 1.1 0.0 0.4 4.7 4.8 1.7 0.6 0.0 3.0 46.9 0.0 5.0 0.0 0.5 5.4 2.3 0.8 94.4 3.5 2.7 6.5 2.1 0.5 3.0 0.4 0.0 0.0 1.9 0.3 WISP3 CCN6 ENSG00000112761 "WNT1 inducible signaling pathway protein 3" O95389 6 112054072-112070969 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.5" "Cell type enriched" "Detected in some" 9 "Early spermatids: 82.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 2.3;cerebellum: 5.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.2;THP-1: 3.6;U-2197: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA064196 Supported Mitochondria "Secreted to extracellular matrix" NA NA Mitochondria "HPA064196: AB_2685209" "unprognostic (2.13e-2)" "unprognostic (7.90e-3)" "unprognostic (5.00e-2)" "unprognostic (2.22e-2)" "unprognostic (3.76e-1)" "unprognostic (6.52e-2)" "unprognostic (1.98e-3)" "unprognostic (4.07e-3)" "unprognostic (1.82e-1)" "unprognostic (3.90e-1)" "unprognostic (1.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "unprognostic (3.11e-1)" "unprognostic (4.91e-2)" "unprognostic (2.93e-2)" 0.4 0.5 0.3 0.4 2.3 0.8 4.2 5.9 0.5 1.9 0.3 0.3 0.3 0.1 0.6 9.5 0.9 3.2 1.4 0.4 0.3 0.5 5.3 0.8 0.4 0.5 0.4 0.3 1.6 0.3 0.0 0.3 0.4 0.3 1.1 0.0 0.3 0.6 0.3 0.6 4.8 0.3 0.3 0.4 0.4 0.4 5.8 0.9 0.3 0.3 2.8 2.2 0.3 1.5 1.1 0.6 2.0 0.5 1.7 1.2 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.9 0.2 0.3 0.3 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.7 0.3 0.1 0.0 0.2 0.9 0.4 0.1 0.2 0.3 0.1 0.3 0.0 11.2 0.5 0.6 0.1 0.2 0.9 0.4 0.2 3.6 0.2 0.2 0.2 2.6 0.3 0.3 0.0 0.3 0.4 1.1 0.2 1.4 0.4 0.6 0.5 0.3 0.6 0.8 0.9 0.9 0.3 1.1 1.2 1.1 2.0 1.7 0.5 0.6 0.6 0.2 0.3 2.3 5.9 0.5 0.3 0.5 0.4 0.3 0.3 0.9 0.0 0.0 0.0 2.7 0.7 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 82.4 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.2 6.5 0.0 0.6 0.7 0.6 0.1 0.0 0.0 2.1 WSB1 "DKFZp564A122, DKFZp564B0482, SWIP1" ENSG00000109046 "WD repeat and SOCS box containing 1" Q9Y6I7 17 27294076-27315926 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003293 Approved Approved Mitochondria NA NA Mitochondria "HPA003293: AB_1858863" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.44e-1)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.07e-5)" "unprognostic (2.59e-2)" "unprognostic (5.40e-3)" "unprognostic (2.74e-1)" "unprognostic (9.22e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-7)" "unprognostic (1.44e-1)" "unprognostic (3.18e-1)" "unprognostic (1.62e-1)" "unprognostic (3.74e-2)" 32.9 18.7 19.1 36.3 45.0 36.4 26.1 15.4 28.7 37.9 26.5 59.6 17.6 23.8 47.1 34.6 21.7 34.8 45.8 28.7 23.4 20.7 31.5 15.0 48.4 26.9 56.2 29.6 38.4 21.0 18.0 25.8 61.9 39.5 26.9 27.1 37.6 17.7 29.1 17.0 18.3 23.2 38.1 57.4 55.7 26.0 18.1 48.0 17.9 22.0 12.9 28.8 29.5 30.9 10.6 26.3 27.9 31.1 8.2 12.1 9.0 11.9 8.5 26.7 15.3 16.9 21.0 28.7 10.7 15.2 8.4 16.4 12.7 4.8 12.1 12.2 14.6 10.7 11.4 16.1 7.9 12.8 33.4 13.1 19.2 15.3 12.8 31.9 13.2 28.4 25.3 10.8 12.3 7.5 13.0 33.6 12.7 19.2 11.6 15.0 7.4 16.9 15.1 7.9 6.5 7.0 13.9 14.5 7.2 12.6 9.8 8.6 11.7 11.1 11.2 14.5 33.5 9.0 17.6 18.6 10.5 8.0 14.2 10.1 5.2 13.2 12.3 9.9 10.5 9.3 21.4 16.2 27.9 9.4 28.1 11.2 9.1 7.8 10.2 26.3 10.6 7.5 8.5 15.2 8.2 31.1 8.6 12.1 9.0 19.1 45.0 15.4 28.7 23.4 20.7 56.2 29.6 39.5 48.0 205.4 388.8 133.9 158.7 221.3 81.0 61.8 112.1 108.4 153.6 226.8 327.9 278.3 23.2 90.7 148.8 245.0 158.8 46.7 56.5 165.8 262.8 163.6 159.4 41.9 187.7 77.9 186.5 265.8 360.3 17.5 130.9 273.2 187.3 65.9 159.4 241.1 67.5 164.9 115.2 20.0 357.0 122.9 185.4 104.8 96.4 245.0 597.5 103.6 107.7 135.9 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669365-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.1" "Cell type enriched" "Detected in many" 11 "Spermatocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;hTCEpi: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044430 Enhanced Approved Mitochondria NA NA Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.9 3.4 1.9 0.8 4.3 0.9 1.1 0.6 6.4 0.9 1.7 1.9 0.0 4.9 0.7 2.5 1.1 0.7 4.1 1.0 2.3 1.5 1.0 7.5 2.1 1.0 1.3 7.3 1.0 1.3 0.3 2.1 0.8 7.4 1.4 1.0 2.6 2.0 0.2 0.9 1.7 9.6 3.5 1.7 1.0 3.6 17.1 0.7 0.0 1.0 0.0 1.0 2.5 1.2 1.2 0.3 0.9 0.2 0.6 3.1 0.2 3.9 0.3 0.8 0.4 0.0 1.0 0.6 1.6 0.8 0.5 1.7 5.4 0.4 0.5 2.7 0.1 1.9 0.1 0.1 0.9 2.0 0.8 0.5 0.4 0.3 0.6 0.1 1.2 2.2 1.1 11.1 0.3 0.0 0.5 0.0 2.6 0.2 3.9 0.3 0.5 0.7 0.6 2.2 0.1 0.5 0.5 1.1 0.2 0.3 2.9 2.4 0.4 0.9 1.6 0.5 0.3 0.5 0.2 0.4 0.5 1.1 0.8 0.6 3.4 0.9 2.5 0.2 0.5 0.3 0.9 0.1 0.3 0.9 0.1 1.7 0.9 1.7 0.8 0.1 1.2 2.6 1.7 0.6 0.6 0.2 0.3 3.1 0.2 1.9 4.3 0.6 6.4 2.3 1.5 1.3 7.3 7.4 0.7 6.0 2.1 0.0 3.1 2.4 2.3 0.4 2.5 4.0 4.5 0.0 7.9 0.8 0.0 1.0 4.0 0.1 1.2 0.0 3.9 0.3 0.7 1.1 0.0 0.5 0.3 1.6 0.0 0.0 0.0 2.9 0.9 0.2 0.0 0.0 1.0 1.5 5.3 0.2 0.4 0.3 5.4 0.0 0.3 89.2 5.1 0.6 0.8 0.0 0.1 1.8 YJEFN3 "FLJ44968, hYjeF_N3-19p13.11" ENSG00000250067 "YjeF N-terminal domain containing 3" A6XGL0 19 19528861-19537581 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.8" "Group enriched" "Detected in many" 16 "Early spermatids: 137.6;Late spermatids: 456.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEK 293: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060789 Enhanced Approved Mitochondria NA NA Mitochondria "HPA060789: AB_2684366" "unprognostic (2.59e-2)" "unprognostic (2.50e-1)" "unprognostic (5.99e-6)" "unprognostic (1.65e-1)" "unprognostic (3.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.37e-4)" "unprognostic (2.38e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.25e-4)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.17e-2)" "unprognostic (8.26e-2)" "unprognostic (2.48e-1)" "unprognostic (9.49e-3)" 1.2 0.9 24.2 1.4 47.8 0.8 1.0 0.8 26.5 1.1 1.3 1.1 0.0 1.0 1.3 6.6 1.0 1.6 0.9 0.8 29.5 8.3 1.0 0.8 1.4 1.4 7.7 10.2 1.1 1.0 1.7 0.8 1.3 3.6 2.0 1.6 4.1 0.9 1.5 1.6 3.0 1.6 1.2 1.0 1.1 1.4 7.1 5.1 0.0 1.7 0.0 1.3 1.5 0.0 0.5 0.5 0.3 1.1 0.0 2.2 0.3 0.3 0.8 1.9 0.8 0.3 0.5 11.4 0.5 0.1 0.5 0.7 0.9 0.6 0.4 1.5 0.1 0.2 1.1 0.3 0.2 0.0 0.1 13.4 0.0 1.6 0.0 0.1 0.3 0.6 0.1 0.6 0.3 0.4 0.1 0.0 0.9 0.9 0.6 0.0 1.0 0.0 0.1 3.6 0.0 2.6 2.1 0.4 0.4 0.0 0.1 0.3 3.2 0.2 0.0 0.2 0.6 1.3 1.6 0.7 0.3 0.7 3.5 0.8 3.2 2.2 0.6 0.2 1.7 0.4 0.0 0.7 0.0 0.7 1.1 0.8 0.3 1.2 0.6 0.5 0.5 0.7 1.1 0.3 0.0 0.7 0.0 2.2 0.3 24.2 47.8 0.8 26.5 29.5 8.3 7.7 10.2 3.6 5.1 8.9 0.3 1.3 2.5 1.8 18.1 1.6 2.5 2.7 6.8 0.0 9.8 1.3 1.7 1.7 137.6 1.6 4.7 0.0 0.5 1.0 2.7 2.1 1.1 1.0 1.0 9.5 5.2 1.8 0.3 456.0 3.4 1.5 1.7 0.0 6.3 7.2 0.5 3.5 1.8 0.3 14.9 6.5 3.9 14.0 9.6 3.6 1.5 2.9 5.0 0.9 YRDC "FLJ23476, IRIP, SUA5" ENSG00000196449 "YrdC N6-threonylcarbamoyltransferase domain containing" Q86U90 1 37802944-37808185 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 58.4;Urothelial cells: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 9.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030147 Approved Approved Mitochondria NA NA Mitochondria "HPA030147: AB_10603327" "unprognostic (2.98e-2)" "unprognostic (6.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.08e-3)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.43e-2)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (3.33e-2)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.46e-2)" 10.8 10.0 7.7 9.3 8.0 41.6 13.0 10.6 13.1 8.2 9.6 9.8 7.2 8.2 8.3 8.8 16.3 8.8 13.5 9.0 8.6 9.0 11.7 22.5 9.3 16.2 8.1 7.4 8.1 19.7 7.5 11.3 22.2 8.5 9.2 12.2 8.7 12.5 6.6 13.0 14.6 11.9 9.5 7.5 11.2 10.2 20.6 7.0 13.5 9.3 11.5 12.0 9.1 9.2 1.6 1.6 9.6 1.1 0.9 2.1 0.7 10.5 7.6 8.2 10.4 5.7 6.6 23.7 8.8 7.1 13.9 8.8 10.1 10.2 25.5 14.4 8.7 16.0 8.6 15.4 14.1 13.0 15.3 15.4 17.8 9.3 10.5 12.6 23.1 18.5 6.8 21.2 15.4 22.4 9.1 9.7 19.7 27.6 11.5 11.0 7.5 13.4 13.7 30.8 15.4 16.2 13.6 13.3 16.6 11.4 10.8 21.4 22.1 9.5 12.3 30.0 15.3 6.7 10.3 9.0 12.0 12.5 13.1 28.9 23.7 33.2 21.2 10.5 15.1 19.1 9.6 1.1 0.9 1.2 1.1 1.1 1.0 1.7 0.9 0.9 1.6 1.9 2.1 1.3 0.9 0.7 1.6 1.7 0.7 7.7 8.0 10.6 13.1 8.6 9.0 8.1 7.4 8.5 7.0 0.0 8.6 8.3 58.4 45.0 10.7 3.4 15.3 4.0 4.5 5.2 5.9 21.5 19.9 5.2 2.7 12.0 6.4 0.0 7.9 42.6 12.4 31.3 6.9 9.8 11.4 20.6 15.0 7.4 6.7 1.8 3.7 9.6 5.0 3.6 9.8 9.4 12.2 5.8 3.9 11.7 8.0 6.5 18.9 15.1 35.7 43.2 34.0 10.0 9.6 71.6 ZBTB3 FLJ23392 ENSG00000185670 "Zinc finger and BTB domain containing 3" Q9H5J0 11 62748319-62754188 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035321, HPA035322" Approved Approved Mitochondria NA NA Mitochondria "HPA035321: AB_2674569, HPA035322: AB_10610567" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (3.48e-2)" "unprognostic (1.83e-3)" "unprognostic (2.93e-1)" "unprognostic (5.52e-3)" "unprognostic (7.85e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-2)" "unprognostic (5.02e-2)" "unprognostic (1.23e-2)" "unprognostic (1.83e-1)" "prognostic favorable (1.65e-5)" "prognostic favorable (9.98e-4)" "unprognostic (3.37e-3)" "unprognostic (4.15e-2)" "unprognostic (2.43e-2)" 4.7 6.0 5.8 5.3 10.7 5.5 7.7 6.5 10.9 5.3 6.0 17.8 7.4 5.8 7.9 5.3 6.2 11.1 5.9 7.6 6.1 4.8 5.6 6.8 7.3 5.5 13.1 7.1 6.8 11.5 6.8 4.2 5.6 8.5 5.2 5.6 7.2 8.6 6.2 6.3 14.2 6.7 4.8 6.6 7.9 12.2 9.7 12.1 10.8 7.2 4.2 7.2 5.9 6.0 6.0 7.2 12.3 10.0 6.7 7.9 7.4 3.3 5.0 4.2 5.5 8.0 4.0 3.6 3.5 3.9 4.1 3.7 3.3 4.3 5.2 5.4 3.7 3.0 7.1 3.7 3.9 2.0 6.0 6.2 2.8 10.6 3.9 3.9 4.3 6.0 4.3 4.6 3.2 4.9 5.3 3.4 4.4 4.9 5.7 4.1 6.6 5.2 4.8 12.4 2.5 2.5 4.0 3.3 5.1 3.2 4.3 3.9 3.6 3.7 4.8 2.6 6.3 6.8 3.1 3.1 6.3 2.8 4.4 2.0 5.8 4.1 4.4 6.0 2.5 2.5 2.2 10.0 12.3 6.0 7.8 7.2 6.0 6.1 7.1 7.2 5.5 7.1 5.5 3.6 6.7 6.4 2.1 7.9 7.4 5.8 10.7 6.5 10.9 6.1 4.8 13.1 7.1 8.5 12.1 3.0 2.4 0.8 1.5 0.7 2.3 2.5 2.5 0.0 1.2 0.0 5.9 3.2 6.6 2.4 11.4 1.1 1.3 0.0 1.7 1.8 1.9 0.7 0.0 2.5 2.0 0.0 0.0 0.6 2.1 6.6 1.4 0.8 0.0 0.0 2.9 1.5 1.8 3.7 2.8 1.9 4.1 0.0 1.0 3.4 2.4 1.0 2.1 0.7 1.9 1.1 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.8 1.4 3.4 1.0 4.2 0.7 2.7 11.0 3.8 1.6 1.5 6.3 1.0 9.5 1.7 2.9 3.2 10.3 1.2 6.4 4.2 3.8 2.0 2.6 7.5 1.0 15.2 1.9 1.5 1.9 1.8 7.8 1.2 10.9 2.7 1.2 1.0 1.4 3.4 2.1 2.7 1.7 1.0 5.0 2.4 5.9 6.3 6.1 1.0 1.1 2.3 1.8 1.0 1.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 7.4 4.1 0.8 1.3 0.3 5.5 0.3 0.1 0.2 0.1 1.0 0.3 3.0 0.8 0.1 0.9 6.9 2.2 0.0 0.1 9.0 4.8 0.3 2.6 3.7 0.3 4.3 0.3 0.4 0.3 0.9 1.0 0.3 0.0 1.2 0.7 1.7 0.2 3.3 0.4 2.6 7.3 0.0 2.9 4.5 2.8 4.1 0.2 1.5 4.1 0.7 0.2 0.1 3.1 8.4 11.5 0.7 0.4 0.2 6.9 3.9 0.1 5.5 7.7 0.9 0.3 8.9 0.2 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.2 11.0 3.8 4.2 3.8 15.2 1.9 10.9 6.1 17.9 9.6 0.0 0.3 1.6 2.0 6.7 0.0 42.8 23.9 0.0 0.0 0.2 0.0 0.4 6.6 0.8 1.7 0.0 0.0 0.1 1.7 0.4 3.5 1.7 0.3 6.4 1.7 1.3 0.0 6.8 0.6 0.0 0.0 0.0 2.0 0.3 0.2 1.1 0.0 0.8 1.7 6.5 1.0 9.3 3.8 1.4 0.2 0.0 1.1 0.3 ZDHHC11B ENSG00000206077 "Zinc finger DHHC-type containing 11B" P0C7U3 5 710360-766952 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.81e-1)" "unprognostic (8.38e-3)" "unprognostic (3.79e-2)" "unprognostic (5.11e-3)" "unprognostic (7.18e-2)" "unprognostic (4.02e-3)" "unprognostic (1.19e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.45e-4)" "unprognostic (6.94e-2)" "unprognostic (1.43e-2)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (2.31e-1)" 0.3 1.8 2.9 0.0 3.7 0.0 0.6 11.7 5.3 0.0 1.1 3.8 0.5 0.4 2.8 3.4 0.5 3.8 3.9 2.9 0.4 0.6 5.3 0.0 2.8 0.8 2.4 1.5 3.7 0.1 0.6 1.9 1.0 0.4 3.3 4.8 5.9 0.0 2.5 3.3 3.8 0.8 0.7 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.9 0.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.2 1.0 0.3 0.0 0.8 2.4 5.1 0.2 0.0 3.1 2.3 0.1 1.9 0.9 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.3 0.0 0.0 4.5 0.1 1.5 6.6 1.9 0.1 0.0 0.6 0.6 0.1 7.2 0.1 0.0 2.6 0.0 0.0 2.5 0.8 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 17.9 16.5 0.0 1.0 2.4 6.1 7.3 2.5 36.1 10.3 3.5 0.0 0.0 0.0 0.6 1.1 1.1 2.4 0.0 0.7 0.0 1.1 0.4 1.1 1.6 1.3 9.5 2.9 0.6 0.0 0.0 0.9 0.0 0.0 0.0 2.3 0.5 0.1 0.6 0.0 0.3 0.2 6.5 2.1 1.0 0.8 2.8 0.0 0.0 1.7 0.8 ZNF19 "KOX12, MGC51021" ENSG00000157429 "Zinc finger protein 19" P17023 16 71464555-71565089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 32.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Rod photoreceptor cells: 24.7;Spermatocytes: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063685 Approved Approved Mitochondria NA NA Mitochondria "HPA063685: AB_2685090" "unprognostic (5.59e-4)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-4)" "unprognostic (6.02e-3)" "unprognostic (4.92e-2)" "unprognostic (3.34e-2)" "unprognostic (6.97e-3)" "unprognostic (2.23e-1)" "unprognostic (4.84e-2)" "unprognostic (8.90e-4)" "unprognostic (1.31e-1)" "unprognostic (3.04e-6)" "unprognostic (3.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.83e-2)" "unprognostic (4.87e-2)" 4.7 3.3 4.8 4.1 6.8 2.5 6.3 4.3 5.2 3.8 2.6 7.1 2.9 3.3 5.6 14.4 4.6 9.1 6.9 4.7 4.9 4.1 5.6 3.4 4.5 3.4 3.0 4.4 4.8 6.4 3.9 32.0 1.7 6.8 3.6 2.2 5.2 4.9 3.2 9.0 6.9 3.4 2.6 4.5 3.1 3.0 18.7 5.5 3.0 8.9 2.0 2.6 2.8 1.9 6.1 3.5 4.4 2.5 2.5 4.3 1.7 2.5 1.7 5.7 6.2 2.8 3.8 3.7 3.0 1.4 2.4 3.0 3.8 6.3 4.5 4.1 1.6 3.8 2.4 3.0 2.9 1.1 2.7 3.3 4.6 4.1 4.9 0.9 4.9 4.1 5.0 3.8 2.8 5.3 4.8 2.3 6.2 2.9 4.2 1.8 3.5 3.3 3.6 2.9 1.1 4.5 2.1 4.7 1.8 2.9 5.5 9.1 5.8 6.1 1.8 5.0 4.2 4.5 3.7 2.7 6.2 3.1 4.3 3.5 4.0 3.3 1.7 5.6 3.0 3.4 4.4 2.4 2.1 3.1 2.2 1.3 5.4 3.4 3.0 1.9 6.1 4.3 3.9 4.3 2.5 2.5 3.5 1.4 1.7 4.8 6.8 4.3 4.8 4.9 4.1 3.0 4.4 6.8 5.5 0.0 2.7 0.5 2.0 0.2 3.2 1.1 0.0 13.4 2.3 1.8 9.8 1.1 5.0 3.4 2.4 1.1 1.7 0.0 1.2 0.7 1.0 1.6 0.0 2.9 1.2 9.5 1.2 2.5 0.6 3.6 0.6 0.6 0.0 1.0 1.5 3.8 2.2 1.4 1.8 2.1 24.7 6.5 1.0 14.6 7.0 0.5 0.5 0.9 1.2 0.7 ZNF200 ENSG00000010539 "Zinc finger protein 200" P98182 16 3222325-3236221 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.3" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.6;Spermatocytes: 38.8;Spermatogonia: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018981, HPA059310" Uncertain Approved Mitochondria No No Mitochondria "HPA018981: AB_1859021, HPA059310: AB_2683974" "unprognostic (1.74e-1)" "unprognostic (5.74e-2)" "unprognostic (3.21e-2)" "unprognostic (8.78e-2)" "unprognostic (9.72e-2)" "unprognostic (3.71e-2)" "unprognostic (1.31e-1)" "unprognostic (2.20e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.80e-2)" "unprognostic (2.98e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (1.89e-1)" "unprognostic (1.11e-1)" "unprognostic (5.23e-3)" 5.4 5.5 4.4 7.5 5.4 3.0 5.7 8.6 7.0 5.1 4.9 6.0 4.7 5.5 6.0 6.8 5.1 5.9 4.7 5.2 4.0 4.3 4.8 6.4 5.2 9.5 4.6 3.3 6.2 3.9 7.3 7.1 8.2 5.6 5.3 5.0 4.2 5.1 4.7 4.0 4.1 5.4 5.3 3.8 10.4 4.7 27.3 5.0 9.6 6.8 2.9 8.3 5.8 4.9 5.8 5.0 19.3 5.1 8.7 10.1 5.4 4.9 5.2 11.7 8.3 4.3 4.6 14.1 6.4 8.0 8.9 8.2 7.8 4.2 9.7 5.0 5.2 5.2 3.7 9.1 7.0 10.6 9.0 8.4 8.0 6.9 6.4 5.8 13.6 19.1 4.6 5.8 6.5 5.9 5.1 7.6 6.9 8.8 7.4 7.7 4.5 9.7 7.1 18.4 6.1 5.0 11.8 16.1 11.3 5.5 2.8 6.7 9.9 6.1 4.7 5.3 8.3 6.7 15.3 5.2 9.1 8.5 3.1 5.6 19.0 18.6 8.3 2.2 8.5 7.0 19.3 3.9 13.6 8.5 5.1 8.2 5.8 7.8 10.1 5.0 5.6 8.0 8.9 16.9 8.7 4.7 3.1 9.0 5.4 4.4 5.4 8.6 7.0 4.0 4.3 4.6 3.3 5.6 5.0 3.0 3.0 0.5 4.1 2.9 5.3 3.4 7.6 2.7 5.7 3.5 11.8 5.9 3.3 3.9 31.6 7.0 2.6 23.3 3.4 5.3 5.1 3.4 4.7 3.8 6.0 0.0 6.4 6.7 7.1 17.1 5.2 6.9 6.8 3.6 4.0 5.7 2.9 4.0 2.8 1.9 6.1 6.5 5.7 38.8 31.2 2.8 4.9 6.5 3.3 4.2 ZNF230 FDZF2 ENSG00000159882 "Zinc finger protein 230" Q9UIE0 19 44002948-44013926 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA006172 Approved Mitochondria No No Mitochondria "HPA006172: AB_2667532" "unprognostic (3.55e-3)" "unprognostic (5.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-2)" "unprognostic (3.89e-2)" "unprognostic (3.79e-2)" "unprognostic (1.35e-1)" "unprognostic (4.08e-4)" "unprognostic (2.45e-2)" "unprognostic (1.14e-2)" "unprognostic (8.59e-2)" "unprognostic (1.68e-1)" "unprognostic (4.62e-2)" "unprognostic (1.42e-5)" 7.2 6.0 6.0 7.8 6.4 7.2 8.3 13.3 7.8 8.1 5.2 4.4 5.2 3.4 6.2 5.8 4.3 6.6 4.2 4.7 5.1 4.2 5.3 5.6 6.2 8.9 6.9 4.4 11.3 4.3 7.7 10.2 6.1 5.9 7.2 5.3 6.2 5.3 6.8 2.6 7.3 6.4 4.9 7.2 11.1 5.2 6.8 5.5 16.6 8.6 3.9 9.6 9.0 9.3 5.5 4.3 13.9 4.8 3.2 6.0 3.4 2.9 2.4 5.1 5.2 4.1 5.1 2.0 4.3 4.3 3.9 7.1 1.5 1.7 2.4 2.9 3.1 2.5 2.5 4.2 3.9 5.9 3.0 5.3 4.2 5.4 1.8 2.4 5.3 3.6 3.8 3.6 4.4 4.5 5.3 2.7 2.9 0.8 0.1 4.0 1.5 6.0 3.9 2.9 2.0 2.4 4.5 7.1 1.2 2.3 3.6 2.8 6.5 6.0 2.1 3.1 3.7 1.8 12.5 3.4 6.2 4.6 1.8 3.2 3.1 3.0 0.4 3.0 4.0 3.8 7.6 4.1 9.8 4.7 4.8 4.9 4.8 5.3 4.8 4.3 5.5 6.0 5.5 13.9 3.2 2.3 2.6 4.5 3.4 6.0 6.4 13.3 7.8 5.1 4.2 6.9 4.4 5.9 5.5 0.0 2.1 4.5 2.9 2.5 8.5 5.3 12.7 0.0 3.4 3.5 15.7 3.4 3.3 2.6 1.5 3.8 3.2 0.0 2.2 2.7 3.9 1.9 1.1 3.0 2.8 7.9 1.2 3.7 2.1 1.2 6.1 4.6 3.3 8.2 2.4 5.2 0.8 0.0 4.2 1.4 8.9 6.5 4.1 15.0 4.1 2.4 2.6 7.2 2.6 1.7 ZNF467 "EZI, Zfp467" ENSG00000181444 "Zinc finger protein 467" Q7Z7K2 7 149764182-149773479 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 47.5;Distal tubular cells: 33.2;Kupffer cells: 44.2;Muller glia cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 27.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 27.7" "Cell line enhanced" "Detected in many" "AN3-CA: 22.1;EFO-21: 11.0;HMC-1: 12.8;MCF7: 10.6;SK-BR-3: 10.0;T-47d: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042907 Uncertain Approved Mitochondria NA NA Mitochondria "HPA042907: AB_10966965" "unprognostic (3.01e-1)" "unprognostic (2.41e-1)" "unprognostic (6.40e-4)" "unprognostic (5.99e-2)" "unprognostic (2.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (5.14e-2)" "prognostic favorable (4.56e-4)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.25e-2)" 10.6 8.2 10.5 8.8 16.5 20.1 15.2 3.5 7.4 7.9 6.7 3.2 22.1 2.9 8.5 6.4 4.2 10.0 7.5 11.6 10.1 4.6 14.9 9.2 15.8 24.2 6.3 2.9 8.9 10.8 3.5 11.0 6.2 5.8 5.1 3.7 20.4 12.3 18.4 4.3 11.8 5.2 7.0 9.9 21.4 10.4 2.3 11.0 9.6 11.8 4.0 5.6 4.6 13.3 0.0 3.5 27.7 5.4 0.1 0.4 1.4 0.0 2.7 3.2 22.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 6.8 0.1 11.0 0.1 0.1 0.3 1.6 0.0 0.1 0.1 0.3 1.2 0.0 0.0 6.8 0.0 12.8 4.6 1.1 0.0 0.1 8.0 2.4 0.5 2.0 0.5 0.0 10.6 0.4 1.1 0.3 0.9 6.9 1.7 0.0 8.2 1.5 0.0 1.2 1.0 0.0 10.0 0.0 1.1 12.4 1.3 5.4 0.1 3.6 0.0 0.0 0.5 0.0 0.1 0.1 3.8 0.1 0.0 5.4 2.2 0.2 2.2 0.1 0.0 0.2 0.2 3.5 0.0 0.4 0.1 27.7 0.1 0.7 1.6 0.0 1.4 10.5 16.5 3.5 7.4 10.1 4.6 6.3 2.9 5.8 11.0 0.0 0.3 0.0 0.5 3.2 47.5 1.7 0.0 1.4 1.2 0.0 2.0 0.2 33.2 4.8 0.3 15.5 0.0 0.0 2.5 0.1 4.7 1.2 0.0 5.7 19.3 6.4 2.9 24.5 44.2 0.0 1.4 17.6 1.7 8.2 0.0 69.9 2.2 0.0 1.8 7.5 5.5 0.0 3.1 0.1 2.0 6.5 0.3 1.5 0.0 0.3 ZNF48 "DKFZp762K013, FLJ31751, MGC43952, ZNF553" ENSG00000180035 "Zinc finger protein 48" Q96MX3 16 30378106-30400108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023806 Uncertain Approved Mitochondria No No Mitochondria "HPA023806: AB_1859335" "unprognostic (5.35e-2)" "unprognostic (7.91e-3)" "unprognostic (2.41e-3)" "unprognostic (2.06e-1)" "unprognostic (5.20e-2)" "unprognostic (1.66e-2)" "unprognostic (2.77e-3)" "unprognostic (4.25e-2)" "unprognostic (6.06e-2)" "unprognostic (2.19e-1)" "prognostic favorable (1.20e-6)" "unprognostic (5.36e-2)" "prognostic favorable (7.50e-5)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.45e-3)" 5.6 7.7 8.9 9.1 9.8 4.4 6.7 15.7 16.1 9.1 11.5 10.1 12.1 9.0 12.8 5.7 5.5 10.7 9.5 6.7 8.9 8.7 6.6 6.4 8.0 10.0 9.0 8.5 6.7 15.1 18.8 8.8 4.7 7.1 7.6 6.1 8.0 9.7 12.6 12.1 6.3 6.4 11.2 5.7 7.3 7.9 3.9 9.8 16.1 7.5 7.2 7.3 9.0 8.3 1.4 1.6 1.3 0.2 2.6 3.1 0.5 4.7 8.1 19.8 15.8 2.5 2.0 6.7 3.3 6.0 7.9 7.1 3.8 6.2 8.9 6.6 3.0 2.1 3.8 9.6 5.2 4.2 6.5 11.8 3.9 3.9 5.5 3.6 5.2 5.6 1.5 6.7 6.2 4.2 6.9 6.5 8.6 6.8 4.2 3.1 15.3 12.1 6.4 16.8 3.8 3.0 28.1 4.3 11.8 4.2 3.7 15.4 19.2 1.4 10.6 1.4 5.6 7.0 5.2 2.8 4.5 5.1 4.2 4.0 5.1 5.8 8.7 2.4 3.3 1.0 0.0 0.2 1.3 3.1 0.2 2.4 1.1 1.7 1.8 0.5 1.4 2.1 2.3 0.0 2.6 0.1 1.6 1.7 0.5 8.9 9.8 15.7 16.1 8.9 8.7 9.0 8.5 7.1 9.8 3.0 2.1 6.4 2.6 2.7 10.3 4.8 7.6 0.0 4.5 3.5 7.9 3.1 1.7 8.9 0.1 3.8 2.6 0.0 6.4 1.6 2.2 2.2 17.3 2.8 2.4 15.9 9.2 3.1 2.6 0.0 2.6 1.9 1.7 10.8 3.6 6.0 7.2 5.3 6.3 3.1 7.0 0.0 3.7 3.2 3.0 4.5 0.2 3.2 5.5 1.5 ZNF7 "HF.16, KOX4" ENSG00000147789 "Zinc finger protein 7" P17097 8 144827464-144847509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030296, HPA059090" Uncertain Approved Mitochondria NA NA Mitochondria "HPA030296: AB_10671095, HPA059090: AB_2683901" "unprognostic (1.11e-1)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-2)" "unprognostic (2.52e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-3)" "unprognostic (3.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.46e-8)" "unprognostic (1.15e-1)" "unprognostic (5.00e-1)" "unprognostic (5.43e-2)" "unprognostic (6.53e-2)" 18.5 12.7 11.4 14.9 17.5 14.7 20.4 34.1 21.1 18.3 15.5 17.9 19.8 12.1 18.4 22.2 18.1 16.7 15.5 14.3 11.9 11.0 13.3 14.7 14.1 16.0 15.1 18.3 22.8 21.3 19.1 16.2 17.0 14.7 19.5 15.5 15.7 16.0 17.4 24.3 21.0 16.0 15.7 11.8 21.2 13.6 24.8 15.2 15.8 19.0 14.9 17.8 16.7 18.0 15.7 10.4 22.5 14.6 12.9 18.6 7.6 10.1 13.9 13.6 13.3 11.7 17.9 12.5 10.9 13.9 14.8 12.7 7.0 13.1 14.2 12.8 11.8 8.1 8.9 12.3 15.9 16.2 9.4 10.2 25.3 18.2 8.1 13.6 7.3 11.9 17.1 19.4 11.5 28.6 14.4 9.1 12.0 25.2 10.2 16.4 16.7 19.8 8.0 13.9 13.5 16.8 13.8 12.1 11.2 10.4 14.0 13.4 16.4 23.8 13.7 13.2 13.7 16.5 11.8 10.2 11.2 20.0 8.4 10.4 8.3 5.8 15.5 11.6 9.5 13.7 22.5 9.3 8.8 12.5 8.4 15.2 15.7 14.1 10.8 10.4 13.6 18.6 12.7 9.4 12.9 14.6 8.3 13.1 7.6 11.4 17.5 34.1 21.1 11.9 11.0 15.1 18.3 14.7 15.2 17.9 12.3 9.6 14.4 6.3 34.1 10.1 2.5 8.1 9.1 3.5 27.5 13.8 5.0 11.1 9.6 9.7 7.4 0.0 9.8 10.7 12.0 13.5 3.5 7.4 7.9 27.0 9.2 11.6 6.7 3.2 16.4 10.9 8.5 10.0 7.9 18.9 10.7 7.0 14.9 5.6 29.0 6.5 7.5 40.5 25.2 8.2 16.2 15.2 9.2 11.7 ZNF862 ENSG00000106479 "Zinc finger protein 862" O60290 7 149838367-149867479 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 11.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024154 Uncertain Approved Mitochondria NA NA Mitochondria "HPA024154: AB_1859469" "unprognostic (1.82e-2)" "unprognostic (2.33e-1)" "unprognostic (3.32e-3)" "unprognostic (1.97e-1)" "unprognostic (8.87e-2)" "unprognostic (4.87e-3)" "unprognostic (4.72e-3)" "unprognostic (2.74e-2)" "unprognostic (6.76e-2)" "unprognostic (2.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.73e-2)" "unprognostic (5.88e-2)" "unprognostic (4.29e-2)" "unprognostic (8.90e-2)" "unprognostic (1.30e-2)" "prognostic favorable (8.66e-4)" 7.1 9.7 12.7 11.2 15.5 7.5 11.8 22.6 13.6 11.1 10.0 16.7 18.8 6.6 12.1 18.1 9.0 13.7 12.2 8.0 13.1 8.7 11.3 9.4 9.6 12.8 17.1 12.1 15.1 14.7 22.6 17.7 5.8 12.2 11.5 10.7 12.3 16.9 14.5 8.6 24.1 10.8 10.0 12.6 13.2 9.4 7.4 19.8 18.7 18.2 6.7 13.2 9.9 9.1 3.1 3.0 1.6 4.3 1.6 6.9 2.0 2.9 3.2 7.2 11.3 8.3 9.1 0.2 6.1 6.0 2.1 3.3 0.3 7.8 1.4 8.0 6.9 2.8 2.0 2.0 2.9 1.5 4.4 3.1 1.3 2.2 0.0 7.3 2.1 1.3 10.0 10.8 2.0 3.2 9.0 4.9 8.3 1.5 5.6 3.4 7.5 2.5 5.5 2.4 5.6 3.2 4.5 0.9 8.0 5.8 1.8 2.8 9.6 5.3 3.9 5.3 3.6 3.0 2.6 8.7 5.2 0.2 11.7 2.2 8.7 4.7 1.3 8.8 5.7 5.9 0.0 2.4 1.6 6.9 4.3 1.9 3.1 2.6 3.6 3.0 1.3 3.1 2.7 0.2 1.6 1.3 3.0 1.8 2.0 12.7 15.5 22.6 13.6 13.1 8.7 17.1 12.1 12.2 19.8 0.0 1.0 0.0 0.6 0.7 5.1 3.2 2.5 2.7 3.4 7.0 11.8 0.9 1.7 1.5 1.1 1.7 1.0 0.0 1.2 0.2 1.0 1.5 4.6 2.1 0.9 9.5 1.7 1.3 1.2 1.0 1.4 2.1 0.0 1.0 2.6 2.8 1.2 2.3 2.1 0.7 5.8 0.0 1.0 0.9 2.3 1.1 2.2 2.6 1.3 0.8 ZNFX1 "FLJ11277, KIAA1404" ENSG00000124201 "Zinc finger NFX1-type containing 1" Q9P2E3 20 49237946-49278426 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046629 Approved Approved Mitochondria No No Mitochondria "HPA046629: AB_2616451" "unprognostic (1.03e-1)" "unprognostic (2.80e-1)" "unprognostic (1.15e-1)" "unprognostic (3.21e-2)" "unprognostic (1.21e-1)" "unprognostic (3.58e-1)" "unprognostic (2.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (1.49e-1)" "unprognostic (3.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.50e-1)" "unprognostic (2.79e-1)" "unprognostic (8.71e-3)" "unprognostic (7.40e-2)" "unprognostic (7.86e-2)" 27.2 14.9 13.2 21.5 15.1 32.8 19.3 14.4 19.7 16.6 16.0 20.1 12.1 14.5 21.3 17.4 13.1 17.2 19.2 16.5 12.3 12.0 16.5 13.4 28.2 20.5 13.4 13.8 18.3 12.2 23.8 14.6 17.4 17.1 15.5 14.4 21.1 14.4 13.7 23.0 17.6 20.6 18.3 14.4 25.9 16.2 23.9 14.6 18.6 21.4 14.4 22.7 16.8 15.0 5.7 5.1 30.0 14.0 5.6 8.3 5.4 5.8 9.1 2.2 3.1 12.1 9.5 3.7 8.0 18.9 50.3 21.0 10.4 4.9 4.9 10.3 15.9 14.3 11.4 4.1 10.8 17.5 4.6 1.3 5.8 6.6 4.5 10.5 4.6 7.1 10.0 10.2 11.2 8.4 9.2 7.6 2.9 4.4 6.1 12.5 2.4 5.0 3.1 2.1 5.1 7.7 3.2 7.5 1.3 8.3 8.1 2.2 1.6 11.8 23.0 8.2 2.8 5.9 3.9 18.8 24.7 7.0 8.9 7.7 4.0 1.4 2.7 9.9 3.2 5.4 8.8 6.7 10.8 8.3 8.8 7.3 5.7 8.3 7.8 5.1 4.6 8.0 6.1 30.0 5.6 14.0 3.0 6.0 5.4 13.2 15.1 14.4 19.7 12.3 12.0 13.4 13.8 17.1 14.6 38.7 29.3 17.4 18.7 24.6 14.7 11.4 12.7 29.4 22.7 19.2 9.8 5.5 0.0 20.8 27.6 39.1 15.6 0.0 19.7 6.0 27.4 21.6 26.5 11.5 14.0 11.1 12.6 26.4 25.9 16.0 21.0 25.7 18.6 27.9 11.0 37.0 25.1 17.5 25.5 6.3 12.7 0.0 28.4 41.6 5.7 19.1 9.5 15.2 9.7 31.2 ZNHIT3 TRIP3 ENSG00000273611 "Zinc finger HIT-type containing 3" Q15649 17 36486629-36499310 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 213.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060019, HPA078211" Approved Approved Mitochondria NA NA Mitochondria "HPA060019: AB_2684188, HPA078211: " "unprognostic (5.47e-2)" "unprognostic (1.29e-1)" "unprognostic (8.87e-2)" "unprognostic (1.20e-1)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (4.75e-3)" "unprognostic (6.03e-2)" "unprognostic (6.48e-3)" "unprognostic (2.55e-1)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (2.81e-2)" "unprognostic (1.47e-1)" "unprognostic (2.20e-1)" "unprognostic (1.84e-1)" "unprognostic (6.19e-2)" 5.0 8.2 9.7 7.4 12.9 8.6 9.9 9.1 18.4 6.2 6.5 6.1 6.8 6.0 6.9 11.1 6.9 7.8 5.4 7.8 8.2 9.4 9.5 6.6 10.0 10.2 9.6 10.7 9.1 7.8 5.7 5.9 9.9 7.4 9.2 4.1 7.1 8.0 14.2 6.2 5.4 7.4 12.3 5.8 5.2 11.8 8.6 8.8 9.0 7.3 10.9 7.6 3.9 23.8 18.0 15.8 16.5 12.9 24.1 15.6 14.7 22.5 24.2 16.1 11.3 17.3 12.7 13.5 17.9 20.5 23.2 18.3 17.7 22.0 13.7 11.5 25.7 13.3 18.3 17.6 22.9 14.0 30.7 13.2 14.3 21.4 14.3 27.3 11.6 12.9 18.8 13.3 20.7 20.4 13.8 26.1 23.6 13.8 21.9 15.8 29.7 29.2 15.3 15.9 17.4 13.4 24.8 18.5 20.2 12.7 18.5 15.3 17.6 8.1 21.5 22.7 27.6 21.0 10.9 9.9 22.4 15.9 19.1 15.1 23.6 27.6 17.0 16.3 15.5 15.8 13.0 9.6 17.8 13.5 21.4 23.8 20.8 18.0 16.5 21.8 24.1 22.2 6.9 12.9 16.5 18.0 22.5 15.6 23.8 18.2 51.6 33.1 41.2 22.8 9.6 28.1 22.7 20.5 31.4 11.8 78.2 74.6 50.4 213.4 31.7 25.9 0.0 44.3 85.9 32.3 37.4 33.5 22.9 58.3 14.3 41.8 20.3 46.6 61.6 34.2 37.7 50.6 62.3 31.5 32.3 51.9 37.9 41.8 67.6 24.2 45.3 40.1 105.1 65.2 38.1 64.5 57.3 43.5 30.8